data_6gbm_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6gbm _Structure_validation_residue.Date_analyzed 2019-02-15 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 59.2 m -109.01 143.12 38.72 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 120.956 0.408 . . . . 0.0 110.961 -176.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 24.7 pt -117.8 147.84 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 174.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -99.71 143.54 29.82 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 173.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 19.5 t -127.72 141.36 46.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.813 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -129.06 149.62 50.8 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 88.54 12.67 64.39 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-O 119.818 -0.434 . . . . 0.0 112.633 169.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 65.6 mt -56.93 -51.62 68.44 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 117.532 0.666 . . . . 0.0 110.599 -175.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 147.44 173.41 18.52 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -98.58 -0.85 42.34 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 122.368 -0.489 . . . . 0.0 111.984 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -128.66 13.63 6.44 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.804 0.441 . . . . 0.0 112.168 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.1 m -75.81 165.69 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -173.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 20.7 p -131.17 158.39 40.62 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 123.335 0.654 . . . . 0.0 112.168 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 298' ' ' ILE . . . . . . . . . . . . . 37.5 mt -60.11 -44.27 94.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.267 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -62.93 -36.0 81.95 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.689 0.395 . . . . 0.0 111.505 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 75.3 m -72.22 -43.43 64.44 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 117.893 0.315 . . . . 0.0 110.258 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 71.4 t -62.62 -41.87 93.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.54 -36.86 85.57 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 303' ' ' ASP . . . . . 0.432 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 44.1 t0 -70.21 -27.19 64.29 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 304' ' ' TYR . . . . . 0.418 ' CE2' ' CD1' ' B' ' 354' ' ' PHE . 59.6 t80 -85.21 -25.97 27.03 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -96.54 -23.92 16.3 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 306' ' ' LYS . . . . . 0.432 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.6 ptpt -66.95 -18.19 65.27 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -177.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -72.69 -20.28 61.26 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.8 mm -87.01 -46.46 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.06 0 N-CA-C 110.51 -0.181 . . . . 0.0 110.51 175.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -162.22 167.63 36.91 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 80.0 mt -68.76 119.7 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 120.853 0.358 . . . . 0.0 110.499 -176.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 93.9 mt -73.84 136.39 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 172.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -178.474 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo . . . . . 0 N--CA 1.453 -0.907 0 N-CA-C 109.855 -0.864 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 321' ' ' MET . . . . . 0.406 ' CB ' ' HB3' ' B' ' 340' ' ' SER . 36.0 mtt -72.62 88.34 1.26 Allowed 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 322' ' ' ILE . . . . . . . . . . . . . 4.0 mp -136.07 140.26 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 171.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -133.41 108.09 8.47 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.28 151.04 35.24 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.796 0.839 . . . . 0.0 109.273 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -117.22 150.56 38.55 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 176.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.141 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -175.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 9.2 mmmm . . . . . 0 C--O 1.231 0.097 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.19 6.94 84.2 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -171.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -104.9 148.27 26.86 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.666 0.786 . . . . 0.0 110.379 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -161.96 156.67 22.65 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.845 175.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 21.3 p -103.95 153.15 21.15 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 169.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 23.3 t -135.67 128.37 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 123.582 0.753 . . . . 0.0 109.312 170.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 340' ' ' SER . . . . . 0.406 ' HB3' ' CB ' ' B' ' 321' ' ' MET . 38.7 t -106.73 144.15 33.8 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.883 0.373 . . . . 0.0 111.132 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -109.71 158.77 17.76 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -73.93 -17.61 61.0 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -145.41 149.98 42.75 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 344' ' ' PRO . . . . . 0.443 ' HG2' ' HD3' ' B' ' 345' ' ' PRO . 49.2 Cg_endo -70.51 -31.78 16.63 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.272 2.648 . . . . 0.0 114.408 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 345' ' ' PRO . . . . . 0.443 ' HD3' ' HG2' ' B' ' 344' ' ' PRO . 81.0 Cg_endo -73.43 -21.65 19.45 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 CA-C-N 121.515 1.577 . . . . 0.0 110.261 -177.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 60.1 m -73.05 -37.51 66.82 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 175.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.0 -38.35 88.26 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 174.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 9.5 tmtm? -65.13 -43.42 91.99 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -66.83 -34.15 77.18 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.92 -36.74 85.35 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 67.2 mt -69.73 -51.62 39.32 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.094 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.733 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -54.74 -29.49 53.77 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 57.5 t-105 -97.79 -56.4 2.52 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -177.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 354' ' ' PHE . . . . . 0.418 ' CD1' ' CE2' ' B' ' 304' ' ' TYR . 50.7 m-85 -75.8 -28.42 58.33 Favored 'General case' 0 CA--C 1.523 -0.08 0 N-CA-C 114.571 1.322 . . . . 0.0 114.571 -173.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -52.27 108.23 0.27 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 117.844 0.293 . . . . 0.0 111.506 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 100.41 -0.89 55.78 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-O 119.662 -0.521 . . . . 0.0 112.729 175.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -83.72 -165.01 1.0 Allowed 'General case' 0 N--CA 1.461 0.096 0 CA-C-N 118.296 1.048 . . . . 0.0 110.371 176.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -127.41 153.37 46.34 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-O 121.02 0.438 . . . . 0.0 110.83 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -145.57 136.64 24.73 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.307 1.043 . . . . 0.0 112.212 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 21.5 t 53.99 19.28 1.96 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.57 0.348 . . . . 0.0 111.302 -175.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.14 23.18 41.88 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.871 -0.492 . . . . 0.0 111.871 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -132.37 142.42 44.9 Favored Pre-proline 0 N--CA 1.455 -0.22 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.52 136.15 32.87 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 122.873 2.382 . . . . 0.0 109.67 178.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 25.5 pt -124.05 171.07 13.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-O 121.173 0.511 . . . . 0.0 111.025 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -146.02 119.4 9.0 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.434 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 13.3 t -108.04 150.03 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 123.14 0.576 . . . . 0.0 112.133 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 29.1 t -163.85 173.12 13.11 Favored 'General case' 0 C--N 1.339 0.15 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -69.93 130.13 41.37 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 176.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 121.144 0.497 . . . . 0.0 111.922 -179.094 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 10.4 p30 . . . . . 0 N--CA 1.456 -0.174 0 N-CA-C 110.584 -0.154 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 29.3 m -101.5 141.77 33.87 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.011 0.434 . . . . 0.0 111.521 -173.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 38.2 pt -116.6 146.63 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.958 172.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -97.94 144.56 27.36 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 173.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 19.4 t -132.34 141.5 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 122.783 0.433 . . . . 0.0 110.969 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -130.92 154.4 48.15 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 122.858 0.463 . . . . 0.0 109.797 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 86.46 12.92 68.89 Favored Glycine 0 CA--C 1.521 0.469 0 CA-C-O 119.831 -0.427 . . . . 0.0 112.355 169.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 74.7 mt -57.49 -50.1 74.16 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 117.54 0.67 . . . . 0.0 110.336 -176.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 144.16 171.03 13.93 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -98.0 3.21 49.49 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 122.544 -0.386 . . . . 0.0 111.855 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -128.29 11.9 6.46 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.638 0.375 . . . . 0.0 111.769 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.6 m -74.8 163.75 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -173.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 20.3 p -128.87 158.93 37.37 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 123.589 0.755 . . . . 0.0 111.85 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 298' ' ' ILE . . . . . . . . . . . . . 40.4 mt -60.29 -44.38 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.547 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -68.72 -30.48 69.13 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 74.8 m -72.16 -43.96 63.81 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 118.17 0.441 . . . . 0.0 109.837 177.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 71.8 t -62.78 -41.05 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.21 -37.38 87.27 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 303' ' ' ASP . . . . . 0.417 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 44.4 t0 -70.16 -26.87 64.12 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -85.71 -25.46 26.48 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -96.71 -24.18 16.09 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 306' ' ' LYS . . . . . 0.417 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.6 ptpt -67.11 -18.12 65.17 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 111.576 0.213 . . . . 0.0 111.576 -177.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -72.79 -20.01 61.24 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.2 mm -87.18 -45.69 16.26 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 CA-C-N 117.732 0.242 . . . . 0.0 110.48 175.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.4 167.68 37.74 Favored Glycine 0 C--N 1.335 0.502 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 78.3 mt -69.35 120.4 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-O 120.935 0.397 . . . . 0.0 110.717 -175.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 86.8 mt -75.19 134.47 29.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 171.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt . . . . . 0 N--CA 1.453 -0.314 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.903 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo . . . . . 0 N--CA 1.447 -1.215 0 N-CA-C 109.288 -1.082 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 321' ' ' MET . . . . . 0.468 ' CB ' ' HB2' ' B' ' 340' ' ' SER . 30.1 mtt -71.38 93.62 1.16 Allowed 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.152 0.501 . . . . 0.0 111.636 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 322' ' ' ILE . . . . . . . . . . . . . 3.4 mp -140.89 139.52 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 173.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -132.01 106.32 7.96 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 35.0 mt -78.32 153.41 31.74 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 123.891 0.744 . . . . 0.0 109.361 176.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -119.87 149.49 41.99 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 176.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.454 -0.229 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -174.924 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt . . . . . 0 CA--C 1.519 -0.215 0 CA-C-O 120.445 0.164 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 74.44 5.34 72.41 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -173.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -106.02 149.77 26.37 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.017 0.527 . . . . 0.0 110.167 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -163.52 160.1 22.77 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.727 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 27.4 p -106.88 153.82 21.96 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 169.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 22.1 t -134.26 129.36 53.32 Favored 'Isoleucine or valine' 0 C--O 1.23 0.038 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 170.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 340' ' ' SER . . . . . 0.468 ' HB2' ' CB ' ' B' ' 321' ' ' MET . 20.4 m -108.54 134.62 51.05 Favored 'General case' 0 C--O 1.23 0.068 0 CA-C-O 120.677 0.275 . . . . 0.0 110.3 -176.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -101.14 159.98 14.78 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -70.67 -36.04 73.15 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -127.52 149.06 69.08 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 344' ' ' PRO . . . . . 0.45 ' N ' ' CD ' ' B' ' 345' ' ' PRO . 45.4 Cg_endo -70.83 -31.31 15.98 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.006 2.47 . . . . 0.0 114.647 -177.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 345' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' B' ' 344' ' ' PRO . 89.6 Cg_endo -73.61 -21.05 19.7 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 CA-C-N 121.222 1.472 . . . . 0.0 110.087 -177.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 49.0 m -71.25 -37.64 71.95 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 175.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.14 -39.44 89.84 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 174.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -63.36 -44.22 95.43 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.9 -33.92 75.64 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.117 0.167 . . . . 0.0 110.616 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.71 -37.86 89.04 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 67.3 mt -68.59 -53.05 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 120.35 -0.54 . . . . 0.0 109.973 175.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -54.93 -28.08 48.29 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -97.51 -55.47 2.81 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -76.92 -28.29 55.21 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -173.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -52.29 108.5 0.3 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 117.953 0.342 . . . . 0.0 111.366 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 101.61 -0.8 52.82 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.547 -0.585 . . . . 0.0 112.647 175.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 357' ' ' LYS . . . . . 0.594 ' HZ2' ' HB3' ' B' ' 357' ' ' LYS . 9.2 mtpm? -83.88 -163.11 0.72 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 118.09 0.945 . . . . 0.0 110.57 177.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -130.71 153.27 49.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.046 0.451 . . . . 0.0 110.464 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -145.81 138.0 25.43 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.224 1.01 . . . . 0.0 112.408 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 19.2 t 55.49 17.13 2.09 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.858 0.361 . . . . 0.0 111.026 -175.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.01 22.57 41.44 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.858 -0.497 . . . . 0.0 111.858 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 42.6 m-20 -132.26 142.41 44.89 Favored Pre-proline 0 N--CA 1.455 -0.181 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.84 135.5 32.87 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 122.709 2.272 . . . . 0.0 109.872 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 31.3 pt -121.63 170.69 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-O 120.948 0.404 . . . . 0.0 111.16 -177.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -143.21 112.84 6.93 Favored 'General case' 0 C--O 1.227 -0.083 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.793 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 6.3 t -103.85 149.73 7.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 C-N-CA 122.878 0.471 . . . . 0.0 112.258 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 29.4 t -164.13 175.02 10.59 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -71.73 129.77 39.47 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 175.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 121.329 0.585 . . . . 0.0 112.325 -179.089 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 285' ' ' ASN . . . . . 0.423 HD22 ' C ' ' B' ' 285' ' ' ASN . 0.2 OUTLIER . . . . . 0 CA--C 1.53 0.173 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 87.7 m -107.97 143.76 36.19 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.148 0.499 . . . . 0.0 110.887 -174.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 41.5 pt -117.34 147.13 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.528 -0.76 . . . . 0.0 108.971 174.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -99.45 145.67 27.18 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 173.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 13.5 t -129.69 143.25 41.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 122.651 0.38 . . . . 0.0 111.403 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -131.65 149.57 52.45 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 122.952 0.501 . . . . 0.0 109.829 175.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 88.57 12.06 65.25 Favored Glycine 0 CA--C 1.522 0.494 0 CA-C-O 119.69 -0.506 . . . . 0.0 112.511 169.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 47.0 mt -57.45 -51.53 69.06 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 117.659 0.729 . . . . 0.0 110.836 -174.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 152.55 176.97 25.71 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -95.72 -14.85 23.05 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 122.311 -0.523 . . . . 0.0 112.118 -175.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -128.62 18.72 6.26 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.278 0.49 . . . . 0.0 112.093 -178.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.3 m -65.96 164.4 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -175.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 18.1 p -126.26 160.89 29.07 Favored 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 123.267 0.627 . . . . 0.0 112.265 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 298' ' ' ILE . . . . . . . . . . . . . 28.6 mt -64.54 -43.5 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.966 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -65.26 -37.29 86.76 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 79.5 p -73.29 -42.63 62.2 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 118.137 0.426 . . . . 0.0 110.494 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.5 -41.57 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.79 -36.0 82.92 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 303' ' ' ASP . . . . . 0.407 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.0 t0 -70.43 -26.62 63.75 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -84.17 -26.68 28.63 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -96.43 -24.9 15.9 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 306' ' ' LYS . . . . . 0.407 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.6 ptpt -66.5 -18.89 65.62 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -177.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -71.8 -20.04 61.91 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -178.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 5.4 mm -87.21 -46.17 16.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 175.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -164.03 168.19 38.39 Favored Glycine 0 C--N 1.335 0.49 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 82.4 mt -69.16 122.03 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 122.603 0.361 . . . . 0.0 110.433 -175.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 95.9 mt -75.69 137.58 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 173.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt . . . . . 0 N--CA 1.45 -0.458 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -178.953 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo . . . . . 0 N--CA 1.451 -1.018 0 N-CA-C 109.453 -1.018 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 321' ' ' MET . . . . . 0.419 ' C ' HD11 ' B' ' 322' ' ' ILE . 35.9 mtt -71.54 86.14 0.87 Allowed 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.907 0.384 . . . . 0.0 111.617 -178.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 322' ' ' ILE . . . . . 0.419 HD11 ' C ' ' B' ' 321' ' ' MET . 3.7 mp -134.07 143.48 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 171.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -130.76 138.38 49.92 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 171.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 86.4 mt -110.48 129.36 55.8 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 176.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -94.55 154.23 17.49 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -177.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.141 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -173.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? . . . . . 0 CA--C 1.528 0.098 0 N-CA-C 110.483 -0.191 . . . . 0.0 110.483 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.8 6.07 84.78 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -171.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -104.11 152.16 22.44 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.629 0.771 . . . . 0.0 109.91 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -160.25 169.66 22.74 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.898 0.38 . . . . 0.0 111.171 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 1.7 p -126.48 150.47 48.7 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 170.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 21.3 t -135.35 125.06 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 C-N-CA 123.577 0.751 . . . . 0.0 109.252 172.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 23.5 t -104.26 136.17 44.36 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.552 0.215 . . . . 0.0 110.605 -178.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -101.66 158.63 15.96 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -177.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -72.87 -31.08 64.47 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -129.54 146.68 62.11 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 344' ' ' PRO . . . . . 0.446 ' HG2' ' HD3' ' B' ' 345' ' ' PRO . 46.8 Cg_endo -70.99 -32.21 13.82 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.219 2.613 . . . . 0.0 114.38 -177.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 345' ' ' PRO . . . . . 0.446 ' HD3' ' HG2' ' B' ' 344' ' ' PRO . 77.9 Cg_endo -73.49 -21.93 18.99 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 CA-C-N 121.256 1.484 . . . . 0.0 110.101 -176.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 67.3 m -70.73 -35.14 72.55 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 175.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -68.73 -39.28 80.46 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.62 -43.73 98.31 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 177.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.94 -35.09 76.38 Favored 'General case' 0 C--O 1.225 -0.201 0 O-C-N 122.371 -0.206 . . . . 0.0 110.462 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.31 -36.52 84.33 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 60.0 mt -71.21 -49.18 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.165 175.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -59.98 -27.58 66.95 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -175.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -96.55 -57.33 2.34 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -75.09 -30.93 61.06 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -173.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -54.19 111.17 0.72 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 118.128 0.422 . . . . 0.0 110.947 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 102.03 -3.0 51.65 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 119.556 -0.58 . . . . 0.0 112.559 176.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -84.42 -164.15 0.91 Allowed 'General case' 0 C--O 1.232 0.137 0 CA-C-N 118.093 0.947 . . . . 0.0 109.787 177.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -128.53 153.34 47.28 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.06 0.457 . . . . 0.0 110.971 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -145.01 135.96 24.73 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.041 0.936 . . . . 0.0 112.101 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 62.7 m 53.31 19.5 1.59 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.516 0.327 . . . . 0.0 111.802 -174.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.74 23.23 39.79 Favored Glycine 0 C--N 1.339 0.733 0 N-CA-C 111.784 -0.526 . . . . 0.0 111.784 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 56.9 m-20 -132.55 142.25 44.17 Favored Pre-proline 0 N--CA 1.452 -0.333 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -177.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.83 135.37 30.11 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.804 2.336 . . . . 0.0 109.72 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 30.6 pt -122.9 169.91 13.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.22 0.533 . . . . 0.0 111.166 -177.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 5.3 tmtm? -145.72 114.05 6.66 Favored 'General case' 0 C--N 1.338 0.069 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 11.2 t -103.89 149.73 7.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.077 0.551 . . . . 0.0 112.24 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 28.1 t -162.71 172.42 15.31 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 176.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -70.48 130.17 41.17 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.388 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.277 -177.841 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.456 -0.136 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 35.0 m -104.88 140.79 37.61 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -173.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 41.1 pt -110.29 142.82 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -93.79 141.91 27.97 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 172.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 15.9 t -130.38 141.18 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 O-C-N 123.156 0.285 . . . . 0.0 111.173 177.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -126.98 154.12 45.01 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 174.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 85.47 12.18 73.31 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-O 119.772 -0.46 . . . . 0.0 112.425 169.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 60.0 mt -56.69 -50.59 71.7 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 117.536 0.668 . . . . 0.0 110.752 -175.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 156.79 179.69 31.95 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -97.79 -8.43 28.49 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -177.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -141.22 24.4 2.13 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.5 m -67.95 162.81 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -174.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 20.8 p -122.84 156.51 34.43 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 298' ' ' ILE . . . . . . . . . . . . . 35.4 mt -61.56 -43.23 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.038 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -65.15 -35.73 82.02 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.61 0.364 . . . . 0.0 111.54 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 38.6 t -73.23 -44.1 60.11 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 122.25 -0.281 . . . . 0.0 110.389 -178.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 93.9 t -62.08 -41.51 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.95 -35.23 80.51 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 303' ' ' ASP . . . . . 0.413 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 44.7 t0 -70.97 -29.28 65.22 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 304' ' ' TYR . . . . . 0.413 ' CE1' ' CD1' ' B' ' 354' ' ' PHE . 59.9 t80 -83.77 -24.96 30.88 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -96.62 -23.35 16.53 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 306' ' ' LYS . . . . . 0.413 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.7 ptpt -67.81 -16.76 64.26 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -73.02 -19.86 61.11 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 111.561 0.208 . . . . 0.0 111.561 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 3.9 mm -87.07 -47.76 15.8 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.109 0 CA-C-O 120.525 0.202 . . . . 0.0 110.781 175.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -161.4 175.38 38.0 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 74.4 mt -73.86 111.89 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-O 120.808 0.337 . . . . 0.0 110.133 -176.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 73.6 mt -68.16 135.53 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 172.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 312' ' ' LYS . . . . . 0.436 ' HG2' ' SD ' ' B' ' 321' ' ' MET . 40.7 ttmt . . . . . 0 N--CA 1.451 -0.379 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo . . . . . 0 N--CA 1.445 -1.331 0 N-CA-C 108.88 -1.239 . . . . 0.0 108.88 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 321' ' ' MET . . . . . 0.436 ' SD ' ' HG2' ' B' ' 312' ' ' LYS . 81.2 mtp -85.65 85.27 7.42 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.573 0.702 . . . . 0.0 111.09 -172.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 322' ' ' ILE . . . . . 0.402 HG13 ' CG1' ' B' ' 339' ' ' VAL . 2.3 mp -118.12 149.78 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 125.257 1.423 . . . . 0.0 108.328 174.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -134.94 116.16 14.4 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 170.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 55.5 mt -90.44 150.06 21.98 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 177.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -115.12 150.89 35.29 Favored 'General case' 0 C--O 1.226 -0.183 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 3.1 m . . . . . 0 CA--C 1.52 -0.175 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -176.912 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? . . . . . 0 N--CA 1.461 0.092 0 N-CA-C 110.533 -0.173 . . . . 0.0 110.533 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 72.59 5.12 62.99 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -172.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -103.48 150.63 23.7 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.275 0.63 . . . . 0.0 110.354 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.16 169.4 24.25 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.008 0.433 . . . . 0.0 110.328 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 2.5 p -132.3 147.44 52.4 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 171.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 339' ' ' VAL . . . . . 0.402 ' CG1' HG13 ' B' ' 322' ' ' ILE . 1.0 OUTLIER -137.27 141.46 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 169.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 44.6 t -92.36 145.46 24.46 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.585 -177.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -112.46 151.92 29.34 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 175.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -70.61 -22.77 62.5 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 343' ' ' ASP . . . . . 0.415 ' HB3' ' HD2' ' B' ' 345' ' ' PRO . 48.3 m-20 -144.49 148.31 39.82 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 124.025 0.93 . . . . 0.0 111.769 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 344' ' ' PRO . . . . . 0.448 ' HG2' ' HD3' ' B' ' 345' ' ' PRO . 53.6 Cg_endo -71.62 -31.81 12.87 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.507 2.804 . . . . 0.0 115.063 -172.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 345' ' ' PRO . . . . . 0.448 ' HD3' ' HG2' ' B' ' 344' ' ' PRO . 98.7 Cg_endo -73.51 -22.44 18.35 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 CA-C-N 121.286 1.495 . . . . 0.0 109.841 -178.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 48.7 m -73.21 -34.14 65.76 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 175.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -67.31 -41.21 85.73 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 175.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -70.85 -32.91 70.07 Favored 'General case' 0 C--O 1.227 -0.108 0 C-N-CA 121.16 -0.216 . . . . 0.0 110.841 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.07 -36.88 80.56 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 175.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.43 -36.99 85.58 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 71.5 mt -68.16 -52.67 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 175.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -55.12 -29.75 58.33 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 54.1 t-105 -96.64 -55.14 3.0 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 354' ' ' PHE . . . . . 0.413 ' CD1' ' CE1' ' B' ' 304' ' ' TYR . 51.0 m-85 -76.16 -27.21 56.89 Favored 'General case' 0 CA--C 1.522 -0.119 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 -173.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -49.19 109.68 0.29 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 117.98 0.355 . . . . 0.0 111.932 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 96.79 0.45 60.47 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 119.477 -0.624 . . . . 0.0 112.736 174.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -83.62 -164.6 0.94 Allowed 'General case' 0 C--N 1.339 0.111 0 CA-C-N 118.209 1.004 . . . . 0.0 110.186 176.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -128.97 152.12 48.93 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 120.981 0.42 . . . . 0.0 110.83 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -144.25 136.45 26.45 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.186 0.994 . . . . 0.0 112.451 177.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 20.7 t 54.36 19.0 2.08 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.517 0.327 . . . . 0.0 111.125 -175.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.48 23.78 38.67 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 112.004 -0.438 . . . . 0.0 112.004 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -132.8 142.62 45.4 Favored Pre-proline 0 N--CA 1.455 -0.213 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -177.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.8 136.61 33.32 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 122.751 2.3 . . . . 0.0 109.441 178.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 33.6 pt -123.69 169.95 14.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 CA-C-O 121.203 0.525 . . . . 0.0 111.259 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -143.33 113.79 7.43 Favored 'General case' 0 C--O 1.23 0.043 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.765 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 12.2 t -105.39 147.55 10.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.002 0.521 . . . . 0.0 112.2 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 23.0 t -163.68 172.94 13.53 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -71.76 129.58 39.01 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 175.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.464 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.878 -178.498 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.531 0.226 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 26.4 m -107.39 145.11 33.34 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.044 0.45 . . . . 0.0 111.84 -173.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 30.4 pt -122.06 146.69 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.028 175.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -98.63 143.18 29.3 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 173.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 18.4 t -128.41 142.93 42.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 O-C-N 123.312 0.382 . . . . 0.0 111.177 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -131.69 150.33 52.19 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 176.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.86 12.72 65.84 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-O 119.669 -0.517 . . . . 0.0 112.397 169.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 65.7 mt -55.24 -51.46 66.52 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 117.598 0.699 . . . . 0.0 110.571 -175.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 146.74 176.25 20.37 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -101.54 1.26 37.79 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.607 0.363 . . . . 0.0 111.81 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -128.7 12.12 6.28 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.6 m -74.41 162.93 4.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -172.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 30.5 p -132.12 159.72 38.1 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 123.724 0.81 . . . . 0.0 111.268 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 298' ' ' ILE . . . . . . . . . . . . . 37.7 mt -61.85 -43.6 97.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.169 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -63.53 -35.63 81.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 122.527 0.331 . . . . 0.0 111.472 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 75.0 m -71.73 -44.56 63.91 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-N 118.06 0.391 . . . . 0.0 110.349 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 74.9 t -63.03 -40.68 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -65.18 -36.26 83.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 303' ' ' ASP . . . . . 0.405 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 44.5 t0 -70.61 -26.65 63.59 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -85.05 -25.52 27.58 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -96.44 -24.8 15.94 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 306' ' ' LYS . . . . . 0.405 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.4 ptpt -66.43 -18.9 65.62 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 122.396 -0.19 . . . . 0.0 111.467 -177.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -71.84 -19.78 61.92 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 111.682 0.252 . . . . 0.0 111.682 -178.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.8 mm -88.15 -45.48 15.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.086 0 CA-C-N 117.632 0.196 . . . . 0.0 110.561 175.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -164.4 168.66 38.86 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 87.8 mt -69.02 122.14 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 121.021 0.439 . . . . 0.0 110.305 -175.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 92.0 mt -75.66 138.46 20.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 172.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt . . . . . 0 N--CA 1.454 -0.242 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -178.702 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 N--CA 1.449 -1.121 0 N-CA-C 110.074 -0.779 . . . . 0.0 110.074 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 321' ' ' MET . . . . . . . . . . . . . 39.0 mtt -70.97 92.86 0.95 Allowed 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.023 0.439 . . . . 0.0 111.53 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 322' ' ' ILE . . . . . . . . . . . . . 3.9 mp -140.4 141.56 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 172.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -127.06 132.55 50.66 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 170.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 73.4 mt -107.64 135.12 49.61 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 177.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -102.7 146.25 28.49 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.455 -0.198 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -174.692 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt . . . . . 0 N--CA 1.464 0.227 0 CA-C-O 120.311 0.101 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.41 3.04 76.41 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -174.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -102.84 149.32 24.62 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 117.288 0.544 . . . . 0.0 109.682 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -160.16 167.45 27.66 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.793 0.33 . . . . 0.0 111.473 -176.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 2.7 p -120.25 151.6 38.93 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 169.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 32.4 t -136.73 129.5 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 123.668 0.787 . . . . 0.0 108.927 171.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 47.3 t -109.19 140.45 42.78 Favored 'General case' 0 CA--C 1.523 -0.091 0 CA-C-N 117.795 0.27 . . . . 0.0 111.311 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -105.91 158.88 16.45 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -70.93 -33.78 70.85 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -128.4 147.45 63.88 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 344' ' ' PRO . . . . . 0.449 ' N ' ' CD ' ' B' ' 345' ' ' PRO . 42.6 Cg_endo -70.69 -31.85 15.68 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 123.223 2.616 . . . . 0.0 114.549 -176.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 345' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' B' ' 344' ' ' PRO . 89.7 Cg_endo -73.62 -21.17 19.52 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 CA-C-N 121.059 1.414 . . . . 0.0 110.431 -177.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 69.8 m -70.98 -36.85 72.68 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 175.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -69.27 -36.78 77.44 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 175.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -64.62 -43.37 93.95 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -69.22 -33.43 73.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 110.624 -0.139 . . . . 0.0 110.624 177.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.38 -37.13 86.44 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 63.3 mt -69.69 -52.84 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -55.57 -27.32 48.5 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -97.56 -56.62 2.46 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -75.58 -29.5 59.34 Favored 'General case' 0 C--N 1.337 0.052 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -173.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -53.08 107.71 0.26 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.944 0.338 . . . . 0.0 111.412 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 101.58 -0.98 52.93 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 119.533 -0.593 . . . . 0.0 112.737 176.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -84.75 -164.39 0.97 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-N 117.989 0.895 . . . . 0.0 110.154 176.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -128.91 152.38 48.62 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.825 0.345 . . . . 0.0 111.004 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -143.77 137.07 27.8 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.12 0.968 . . . . 0.0 112.398 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 59.7 m 53.14 18.87 1.28 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -174.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 89.21 21.47 41.52 Favored Glycine 0 C--N 1.338 0.676 0 CA-C-O 119.821 -0.433 . . . . 0.0 112.158 179.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -132.19 143.06 47.35 Favored Pre-proline 0 N--CA 1.457 -0.118 0 CA-C-N 117.501 0.65 . . . . 0.0 109.295 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.57 135.85 31.97 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.987 2.458 . . . . 0.0 109.651 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 25.8 pt -124.11 170.77 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-O 121.112 0.482 . . . . 0.0 110.946 -178.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -145.18 118.13 8.79 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.118 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 12.7 t -106.78 150.32 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 123.165 0.586 . . . . 0.0 111.729 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 27.0 t -163.79 172.5 14.03 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 175.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -70.04 130.64 42.69 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 176.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.484 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.359 177.918 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 8.9 p30 . . . . . 0 CA--C 1.53 0.198 0 CA-C-O 119.933 -0.08 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 84.8 m -103.87 142.4 34.46 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.105 0.479 . . . . 0.0 110.558 -174.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 44.5 pt -114.93 146.75 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -98.85 144.44 28.05 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 173.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 60.7 t -129.28 136.16 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 O-C-N 123.411 0.445 . . . . 0.0 110.57 -178.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -126.64 155.16 43.01 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 176.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 83.32 12.71 78.2 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 172.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 4.2 tp -59.27 -50.82 72.54 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.98 0.912 . . . . 0.0 110.996 -170.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 143.64 165.04 10.63 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.311 -0.715 . . . . 0.0 111.311 176.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -95.81 3.93 53.31 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.532 0.333 . . . . 0.0 111.34 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -128.71 12.73 6.35 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.764 0.426 . . . . 0.0 111.84 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 4.2 m -72.63 166.75 2.45 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -173.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 32.5 p -137.82 160.76 38.39 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 124.072 0.949 . . . . 0.0 110.835 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 298' ' ' ILE . . . . . . . . . . . . . 41.7 mt -63.08 -40.74 90.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -66.36 -38.07 86.75 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 80.6 p -73.25 -44.17 59.89 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 117.945 0.339 . . . . 0.0 110.237 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 71.0 t -60.76 -42.87 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -65.24 -34.82 79.27 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 122.224 -0.297 . . . . 0.0 110.293 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 303' ' ' ASP . . . . . 0.413 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.2 t0 -69.83 -28.09 65.41 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -84.17 -25.83 29.27 Favored 'General case' 0 C--O 1.226 -0.157 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -96.16 -23.71 16.61 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 306' ' ' LYS . . . . . 0.413 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.7 ptpt -68.19 -18.06 64.49 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -177.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -72.45 -19.17 61.61 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -178.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 3.6 mm -87.89 -47.81 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 CA-C-N 117.564 0.165 . . . . 0.0 110.746 175.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -161.61 173.82 38.04 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 76.1 mt -71.89 116.35 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 120.861 0.363 . . . . 0.0 110.099 -175.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 76.1 mt -71.59 137.93 22.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 172.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 312' ' ' LYS . . . . . 0.452 ' HG2' ' SD ' ' B' ' 321' ' ' MET . 40.9 ttmt . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo . . . . . 0 N--CA 1.447 -1.256 0 N-CA-C 109.178 -1.124 . . . . 0.0 109.178 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 321' ' ' MET . . . . . 0.452 ' SD ' ' HG2' ' B' ' 312' ' ' LYS . 62.3 mtp -82.43 85.88 6.84 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.37 0.605 . . . . 0.0 111.558 -172.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 322' ' ' ILE . . . . . . . . . . . . . 2.7 mp -126.46 147.83 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 174.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -134.25 111.88 10.61 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 173.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 30.6 mt -80.76 149.76 29.52 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 123.93 0.769 . . . . 0.0 108.936 176.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -115.48 145.79 42.27 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 6.8 m . . . . . 0 N--CA 1.453 -0.277 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -175.378 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? . . . . . 0 N--CA 1.465 0.298 0 N-CA-C 111.329 0.122 . . . . 0.0 111.329 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.62 22.16 73.16 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -173.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -128.36 146.62 50.72 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.073 0.549 . . . . 0.0 110.18 -178.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -156.04 159.44 39.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.727 0.298 . . . . 0.0 111.587 174.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 3.4 p -104.1 155.81 18.39 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 170.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 16.7 t -138.12 122.48 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.042 0 C-N-CA 123.432 0.693 . . . . 0.0 110.312 172.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 69.2 m -90.78 144.21 25.95 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 117.961 0.346 . . . . 0.0 110.967 177.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -112.89 151.2 30.75 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -69.92 -28.91 65.99 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -177.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -132.71 148.51 69.8 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -178.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 344' ' ' PRO . . . . . 0.455 ' HG2' ' HD3' ' B' ' 345' ' ' PRO . 37.9 Cg_endo -70.42 -33.14 14.59 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.357 2.705 . . . . 0.0 114.205 -177.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 345' ' ' PRO . . . . . 0.455 ' HD3' ' HG2' ' B' ' 344' ' ' PRO . 85.8 Cg_endo -73.54 -20.96 19.98 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 CA-C-N 121.225 1.473 . . . . 0.0 110.252 -177.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 70.3 m -72.05 -37.14 69.75 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -68.26 -38.37 81.71 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 175.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -65.06 -42.43 94.19 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -69.16 -34.71 75.39 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.399 -0.188 . . . . 0.0 110.956 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.17 -37.67 88.28 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 66.0 mt -68.56 -53.62 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.775 175.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -55.01 -27.73 46.53 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 54.8 t-105 -97.52 -55.35 2.85 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -76.26 -28.21 57.01 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -173.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -51.92 109.52 0.38 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 120.959 0.409 . . . . 0.0 111.555 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 101.29 -1.18 54.01 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 119.515 -0.603 . . . . 0.0 112.278 175.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -86.43 -165.64 1.32 Allowed 'General case' 0 C--O 1.231 0.084 0 CA-C-N 118.277 1.039 . . . . 0.0 110.698 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -127.28 155.59 43.26 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 121.061 0.458 . . . . 0.0 111.089 178.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -145.88 135.82 23.55 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.515 1.126 . . . . 0.0 112.196 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 20.8 t 54.11 18.77 1.85 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 120.873 0.368 . . . . 0.0 111.647 -176.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.67 24.17 33.9 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 112.031 -0.427 . . . . 0.0 112.031 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 53.1 m-20 -133.91 142.61 44.13 Favored Pre-proline 0 N--CA 1.454 -0.265 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -69.6 136.53 33.67 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 122.808 2.338 . . . . 0.0 109.308 176.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 31.2 pt -124.25 169.2 15.89 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 121.001 0.429 . . . . 0.0 110.96 -177.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -142.92 113.69 7.54 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.52 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 12.0 t -103.06 148.03 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 C-N-CA 123.144 0.577 . . . . 0.0 111.727 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 22.7 t -162.6 173.54 13.81 Favored 'General case' 0 C--N 1.338 0.099 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 177.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -70.64 128.31 35.65 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 176.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.367 0 CA-C-O 121.125 0.488 . . . . 0.0 112.008 -178.771 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 285' ' ' ASN . . . . . 0.414 HD22 ' C ' ' B' ' 285' ' ' ASN . 0.4 OUTLIER . . . . . 0 CA--C 1.53 0.201 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 87.6 m -109.76 141.67 42.07 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.265 0.555 . . . . 0.0 110.831 -175.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 41.1 pt -118.6 148.92 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-N 115.492 -0.776 . . . . 0.0 108.954 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -98.58 146.95 25.29 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 173.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 15.0 t -131.98 141.37 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-O 120.839 0.352 . . . . 0.0 111.259 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -129.47 150.73 50.69 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 176.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.86 12.5 66.19 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 119.793 -0.448 . . . . 0.0 112.76 169.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 73.3 mt -56.06 -51.61 67.23 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 117.62 0.71 . . . . 0.0 110.748 -175.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 148.51 175.89 21.46 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -101.43 -0.93 34.42 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 122.555 -0.379 . . . . 0.0 111.69 -176.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -128.71 11.29 6.16 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.075 0.55 . . . . 0.0 112.402 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.0 m -73.06 163.94 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -172.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 26.7 p -130.24 158.76 38.87 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 123.661 0.784 . . . . 0.0 111.773 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 298' ' ' ILE . . . . . . . . . . . . . 36.9 mt -60.2 -44.65 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.242 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -62.53 -36.2 81.83 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.711 0.404 . . . . 0.0 111.416 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 72.6 m -71.8 -43.79 65.07 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.991 0.359 . . . . 0.0 110.183 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 71.4 t -62.47 -41.41 91.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.95 -36.32 84.0 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 303' ' ' ASP . . . . . 0.422 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 44.9 t0 -69.91 -27.97 65.23 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -85.33 -25.38 27.18 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -96.28 -23.86 16.48 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 178.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 306' ' ' LYS . . . . . 0.422 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.6 ptpt -66.93 -18.69 65.5 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 -177.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -72.3 -20.41 61.51 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 117.731 0.241 . . . . 0.0 111.612 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.8 mm -87.27 -45.73 16.22 Favored 'Isoleucine or valine' 0 C--N 1.338 0.089 0 CA-C-N 117.677 0.217 . . . . 0.0 110.535 175.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.23 167.38 37.5 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 83.9 mt -68.5 121.79 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 120.834 0.349 . . . . 0.0 110.539 -175.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 89.1 mt -74.37 138.11 21.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 173.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 312' ' ' LYS . . . . . 0.656 ' HE3' ' SD ' ' B' ' 321' ' ' MET . 25.4 ttpt . . . . . 0 N--CA 1.45 -0.43 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -178.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo . . . . . 0 N--CA 1.45 -1.081 0 N-CA-C 109.921 -0.838 . . . . 0.0 109.921 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 321' ' ' MET . . . . . 0.656 ' SD ' ' HE3' ' B' ' 312' ' ' LYS . 33.9 mtt -72.61 92.51 1.52 Allowed 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 120.952 0.406 . . . . 0.0 111.656 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 322' ' ' ILE . . . . . . . . . . . . . 4.2 mp -139.73 138.51 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 171.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -131.36 105.93 7.94 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 176.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -75.39 153.58 37.64 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.812 0.845 . . . . 0.0 109.102 177.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -115.67 148.0 40.2 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.455 -0.199 0 C-N-CA 123.666 0.787 . . . . 0.0 112.82 -175.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt . . . . . 0 CA--C 1.527 0.085 0 N-CA-C 110.76 -0.089 . . . . 0.0 110.76 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 77.81 6.37 87.06 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -174.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -102.76 152.5 21.17 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.034 0.534 . . . . 0.0 110.162 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -164.66 161.38 20.79 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 116.698 -0.228 . . . . 0.0 110.966 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 5.3 p -109.04 155.06 21.37 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 169.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 33.7 t -137.64 128.39 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.043 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 171.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 8.2 t -104.0 146.92 28.0 Favored 'General case' 0 C--O 1.228 -0.064 0 CA-C-N 117.975 0.352 . . . . 0.0 110.689 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -112.71 158.46 20.03 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -77.17 -17.3 58.66 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -143.66 146.83 36.72 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 344' ' ' PRO . . . . . 0.45 ' HG2' ' HD3' ' B' ' 345' ' ' PRO . 41.0 Cg_endo -70.61 -31.87 16.03 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.329 2.686 . . . . 0.0 114.587 -177.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 345' ' ' PRO . . . . . 0.45 ' HD3' ' HG2' ' B' ' 344' ' ' PRO . 80.8 Cg_endo -73.9 -22.5 17.35 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 CA-C-N 121.117 1.435 . . . . 0.0 110.123 -177.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 66.1 m -72.25 -35.1 68.71 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 175.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -68.76 -39.95 80.01 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 175.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -64.81 -42.09 95.27 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.11 -34.89 77.22 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 122.237 -0.289 . . . . 0.0 110.687 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.05 -36.13 83.37 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 67.3 mt -70.92 -50.78 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 C-N-CA 120.626 -0.43 . . . . 0.0 109.873 175.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -54.49 -30.14 52.41 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 55.8 t-105 -97.8 -56.74 2.41 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -177.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -75.83 -29.84 58.77 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -172.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -56.29 110.09 0.71 Allowed 'General case' 0 C--O 1.234 0.247 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.793 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 103.01 -2.83 47.92 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-O 119.647 -0.529 . . . . 0.0 112.234 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -84.44 -163.17 0.76 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 118.092 0.946 . . . . 0.0 110.364 176.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -129.75 152.91 48.73 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.056 0.455 . . . . 0.0 111.239 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -145.49 136.54 24.73 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.135 0.974 . . . . 0.0 112.352 178.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 12.5 t 55.19 17.69 2.11 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.888 0.375 . . . . 0.0 111.077 -174.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.23 22.56 40.77 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.995 -0.442 . . . . 0.0 111.995 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -132.15 142.73 46.1 Favored Pre-proline 0 N--CA 1.454 -0.257 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.48 135.73 31.87 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 123.059 2.506 . . . . 0.0 109.707 178.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 30.1 pt -122.93 170.4 13.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-O 121.025 0.441 . . . . 0.0 111.101 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 5.7 tmtm? -145.66 113.6 6.48 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 9.7 t -103.25 150.27 6.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.21 0.604 . . . . 0.0 112.444 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 28.5 t -162.94 176.11 10.5 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 177.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -74.66 133.52 42.11 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 175.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.353 0 C-N-CA 123.027 0.531 . . . . 0.0 111.94 179.887 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.454 -0.251 0 N-CA-C 111.466 0.172 . . . . 0.0 111.466 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 31.3 m -109.62 145.37 36.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.074 0.464 . . . . 0.0 111.854 -176.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 34.2 pt -122.09 147.51 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.433 176.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -98.7 143.88 28.58 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 173.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 59.7 t -129.17 132.33 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 122.646 0.379 . . . . 0.0 110.57 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -120.78 155.45 33.98 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 175.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 83.82 12.01 78.19 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 171.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 292' ' ' LEU . . . . . 0.411 HD11 ' CD2' ' B' ' 359' ' ' PHE . 4.4 tp -59.09 -51.39 70.25 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.581 0.752 . . . . 0.0 110.946 -171.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 144.8 164.45 10.6 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.449 -0.661 . . . . 0.0 111.449 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -93.45 -1.11 56.1 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.578 0.351 . . . . 0.0 111.36 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -128.86 13.12 6.31 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 5.1 m -68.77 162.67 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -174.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 20.2 p -130.53 158.42 40.0 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.429 175.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 298' ' ' ILE . . . . . . . . . . . . . 25.0 mt -60.26 -43.21 92.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.31 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -70.68 -30.2 66.73 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -177.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 72.0 m -72.98 -45.36 58.4 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 118.298 0.499 . . . . 0.0 109.943 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 74.3 t -62.03 -41.31 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 176.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.3 -36.78 85.23 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 303' ' ' ASP . . . . . 0.415 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 44.3 t0 -70.58 -27.63 64.26 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -178.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -83.86 -26.52 29.39 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -178.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -96.55 -24.95 15.81 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 115.073 1.509 . . . . 0.0 115.073 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 306' ' ' LYS . . . . . 0.415 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.8 ptpt -66.75 -18.38 65.35 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -176.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -71.85 -19.97 61.88 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 111.486 0.18 . . . . 0.0 111.486 -178.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 5.3 mm -87.49 -45.9 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 175.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.9 167.88 38.17 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 178.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 87.9 mt -67.72 123.66 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 122.674 0.389 . . . . 0.0 110.581 -176.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 86.7 mt -77.36 137.29 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 173.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt . . . . . 0 N--CA 1.45 -0.454 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -178.671 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo . . . . . 0 N--CA 1.448 -1.176 0 N-CA-C 109.353 -1.057 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 321' ' ' MET . . . . . 0.417 ' CB ' ' HB3' ' B' ' 340' ' ' SER . 34.9 mtt -70.97 85.74 0.7 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.84 0.353 . . . . 0.0 111.39 -177.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 322' ' ' ILE . . . . . . . . . . . . . 3.1 mp -129.84 137.04 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 170.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -130.45 107.23 9.08 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.839 176.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 23.7 mt -78.13 151.52 33.27 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 123.947 0.78 . . . . 0.0 109.249 176.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -115.9 151.02 36.15 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.52 -0.211 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -174.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.313 0.102 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.95 20.64 75.7 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.154 -1.179 . . . . 0.0 110.154 -174.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -129.94 144.48 51.34 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.177 0.591 . . . . 0.0 110.181 -176.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -156.39 160.26 39.49 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.858 174.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 1.2 p -102.0 155.95 17.84 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 170.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 19.0 t -134.75 129.5 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 123.85 0.86 . . . . 0.0 108.989 169.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 340' ' ' SER . . . . . 0.417 ' HB3' ' CB ' ' B' ' 321' ' ' MET . 45.5 t -109.47 140.75 42.84 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.942 0.401 . . . . 0.0 110.957 -178.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -106.08 158.02 17.11 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -73.62 -20.43 60.59 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -140.81 148.03 50.92 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 123.514 0.726 . . . . 0.0 109.12 -178.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 344' ' ' PRO . . . . . 0.451 ' HG2' ' HD3' ' B' ' 345' ' ' PRO . 40.4 Cg_endo -70.46 -33.32 14.14 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.43 2.753 . . . . 0.0 114.245 -176.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 345' ' ' PRO . . . . . 0.451 ' HD3' ' HG2' ' B' ' 344' ' ' PRO . 83.6 Cg_endo -73.82 -22.47 17.58 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 CA-C-N 121.074 1.419 . . . . 0.0 110.057 -176.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 67.1 m -71.66 -36.47 70.67 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 176.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -69.08 -38.21 78.87 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -65.8 -41.75 91.53 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -69.47 -33.61 73.15 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 110.629 -0.138 . . . . 0.0 110.629 177.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.83 -37.19 86.79 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 68.5 mt -68.1 -53.62 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.673 174.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -54.87 -28.48 50.47 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -178.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 53.6 t-105 -96.67 -54.66 3.15 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -77.73 -27.89 50.66 Favored 'General case' 0 CA--C 1.522 -0.119 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -174.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -52.28 109.3 0.37 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.889 0.313 . . . . 0.0 111.194 178.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 100.29 -1.25 56.02 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-O 119.695 -0.503 . . . . 0.0 112.548 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -84.85 -164.42 0.98 Allowed 'General case' 0 C--O 1.228 -0.065 0 CA-C-N 117.939 0.869 . . . . 0.0 110.434 176.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -128.46 152.69 47.94 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.919 0.39 . . . . 0.0 110.739 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 359' ' ' PHE . . . . . 0.411 ' CD2' HD11 ' B' ' 292' ' ' LEU . 20.9 t80 -142.2 134.71 28.06 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.271 1.028 . . . . 0.0 112.252 178.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 64.5 m 52.77 20.84 1.71 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.79 0.436 . . . . 0.0 111.975 -175.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.93 21.73 41.49 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 112.036 -0.426 . . . . 0.0 112.036 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -131.67 141.45 41.68 Favored Pre-proline 0 N--CA 1.456 -0.126 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.12 136.43 34.68 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.84 2.36 . . . . 0.0 109.464 177.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 32.4 pt -124.34 168.91 16.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-O 121.222 0.534 . . . . 0.0 110.789 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 22.9 tptp -142.89 112.3 6.74 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.035 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 8.6 t -101.96 148.55 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 29.3 t -162.38 175.27 11.72 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 177.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -72.19 130.97 42.1 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 176.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.318 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.082 -178.555 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 12.9 p30 . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 111.222 0.082 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 89.5 m -101.06 137.99 38.7 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.978 0.418 . . . . 0.0 109.909 -174.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 45.9 pt -105.91 148.28 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 172.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -99.94 142.98 30.7 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 171.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 14.6 t -133.77 141.51 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -128.92 154.6 46.39 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 122.873 0.469 . . . . 0.0 109.738 173.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.7 12.35 66.8 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-O 119.932 -0.371 . . . . 0.0 112.497 169.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 85.0 mt -57.14 -51.05 70.87 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 117.677 0.739 . . . . 0.0 110.202 -176.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 143.38 169.6 12.67 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -95.94 3.93 53.14 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 122.621 -0.341 . . . . 0.0 111.585 -178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -128.86 11.55 6.12 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.8 m -76.03 165.48 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -173.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 29.9 p -130.99 157.74 42.16 Favored 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 123.615 0.766 . . . . 0.0 111.623 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 298' ' ' ILE . . . . . . . . . . . . . 34.4 mt -62.06 -42.34 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.154 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.45 -36.41 84.09 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.401 0.28 . . . . 0.0 111.737 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 43.6 t -72.44 -44.04 62.93 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 117.668 0.213 . . . . 0.0 110.48 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 76.9 t -61.61 -41.95 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.67 -35.25 80.44 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 303' ' ' ASP . . . . . 0.432 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.4 t0 -70.68 -29.07 65.29 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 304' ' ' TYR . . . . . 0.4 ' CE2' ' CD1' ' B' ' 354' ' ' PHE . 63.2 t80 -82.61 -25.77 32.88 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -96.88 -24.23 15.97 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 306' ' ' LYS . . . . . 0.432 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.6 ptpt -66.86 -18.77 65.54 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -177.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -71.9 -19.46 61.92 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.5 mm -88.05 -46.73 15.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 120.419 0.152 . . . . 0.0 110.651 175.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -161.73 169.17 37.11 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 90.2 mt -69.18 122.36 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 120.767 0.318 . . . . 0.0 110.261 -175.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 67.7 mt -77.63 137.26 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 175.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 312' ' ' LYS . . . . . 0.402 ' HG2' ' SD ' ' B' ' 321' ' ' MET . 22.8 ttmm . . . . . 0 N--CA 1.455 -0.209 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo . . . . . 0 N--CA 1.445 -1.355 0 N-CA-C 108.639 -1.331 . . . . 0.0 108.639 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 321' ' ' MET . . . . . 0.402 ' SD ' ' HG2' ' B' ' 312' ' ' LYS . 88.0 mtp -78.02 85.91 4.22 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.452 0.644 . . . . 0.0 111.796 -170.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 322' ' ' ILE . . . . . . . . . . . . . 3.1 mp -124.71 143.28 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 174.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -129.66 99.03 5.0 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 48.8 mt -75.56 154.24 36.91 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 176.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -117.54 148.41 41.9 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 175.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 7.6 m . . . . . 0 N--CA 1.454 -0.244 0 C-N-CA 123.113 0.565 . . . . 0.0 111.986 -179.262 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt . . . . . 0 N--CA 1.461 0.115 0 CA-C-O 120.249 0.071 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.17 5.78 81.75 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -175.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -105.76 150.32 25.64 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 117.27 0.535 . . . . 0.0 109.884 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -163.98 163.21 23.53 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.112 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 60.5 p -111.76 155.67 23.15 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 169.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 16.4 t -135.8 120.53 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 O-C-N 123.415 0.447 . . . . 0.0 110.542 173.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 14.8 t -88.42 134.81 33.74 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -103.04 152.54 21.24 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 176.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -65.8 -33.66 76.37 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -178.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -130.36 150.86 77.4 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 344' ' ' PRO . . . . . 0.451 ' HG2' ' HD3' ' B' ' 345' ' ' PRO . 40.5 Cg_endo -70.42 -31.99 16.62 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.604 2.869 . . . . 0.0 114.425 -177.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 345' ' ' PRO . . . . . 0.451 ' HD3' ' HG2' ' B' ' 344' ' ' PRO . 76.9 Cg_endo -73.75 -21.08 19.32 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 CA-C-N 121.078 1.421 . . . . 0.0 110.028 -176.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 66.9 m -72.6 -36.09 68.04 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 175.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -67.64 -38.57 84.03 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 174.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -65.19 -42.18 93.86 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.58 -35.55 77.51 Favored 'General case' 0 N--CA 1.458 -0.035 0 O-C-N 122.446 -0.159 . . . . 0.0 110.574 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -63.75 -37.68 88.26 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 63.1 mt -68.74 -51.62 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 120.379 -0.529 . . . . 0.0 109.634 175.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -55.92 -28.32 56.27 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 53.3 t-105 -97.16 -54.77 3.06 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 354' ' ' PHE . . . . . 0.4 ' CD1' ' CE2' ' B' ' 304' ' ' TYR . 51.7 m-85 -76.95 -27.77 54.95 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -173.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -50.38 109.23 0.28 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 117.993 0.361 . . . . 0.0 111.858 178.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 98.8 -0.43 57.81 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 119.537 -0.591 . . . . 0.0 112.654 175.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -83.55 -164.87 0.97 Allowed 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.136 0.968 . . . . 0.0 110.073 176.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -128.19 152.91 47.49 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 121.084 0.469 . . . . 0.0 110.727 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -144.9 136.27 25.22 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.331 1.053 . . . . 0.0 112.585 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 17.4 t 55.24 17.94 2.26 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 120.794 0.331 . . . . 0.0 110.951 -175.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.89 22.85 40.72 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 112.013 -0.435 . . . . 0.0 112.013 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 41.9 m-20 -132.31 142.6 45.58 Favored Pre-proline 0 C--O 1.226 -0.165 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 -177.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.48 135.73 31.88 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.855 2.37 . . . . 0.0 109.54 178.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 31.9 pt -121.34 170.79 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.101 0 CA-C-O 121.265 0.555 . . . . 0.0 111.207 -177.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -143.18 109.42 5.32 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.747 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 11.3 t -99.45 148.89 5.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 C-N-CA 123.164 0.586 . . . . 0.0 111.952 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 84.7 p -163.47 177.14 9.1 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -76.83 129.4 36.19 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 174.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.413 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.403 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 . . . . . 0 CA--C 1.53 0.201 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 95.4 m -113.22 145.52 40.87 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.318 0.58 . . . . 0.0 110.708 -175.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 33.7 pt -119.85 148.77 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.436 -0.802 . . . . 0.0 108.846 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -101.65 143.87 31.07 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 173.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 12.1 t -127.25 139.87 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 CA-C-O 120.963 0.411 . . . . 0.0 111.302 177.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -125.58 154.1 42.73 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.601 0.76 . . . . 0.0 108.968 177.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 83.3 12.96 77.79 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 173.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 1.5 tp -52.69 -55.08 25.17 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.583 0.753 . . . . 0.0 110.707 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 142.11 172.24 13.48 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -101.45 2.6 39.48 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -128.7 16.77 6.38 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.814 0.446 . . . . 0.0 111.285 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 10.3 m -74.47 166.85 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -173.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 43.1 p -138.23 159.52 41.84 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.729 0.811 . . . . 0.0 110.762 177.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 298' ' ' ILE . . . . . . . . . . . . . 45.3 mt -62.65 -44.13 99.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.16 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -64.39 -35.52 81.18 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.443 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 44.8 t -71.56 -49.97 35.51 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 118.036 0.38 . . . . 0.0 110.741 -177.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 7.5 p -65.44 -33.44 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.681 177.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -65.97 -32.62 74.22 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.579 176.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 303' ' ' ASP . . . . . 0.431 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 44.9 t0 -75.39 -27.25 59.01 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -178.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -85.26 -23.88 28.01 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -96.93 -24.18 15.96 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 178.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 306' ' ' LYS . . . . . 0.431 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.7 ptpt -66.4 -17.7 64.93 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -177.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -72.45 -20.73 61.35 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.6 mm -86.37 -45.94 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 CA-C-N 117.873 0.306 . . . . 0.0 110.226 175.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -162.4 167.0 36.78 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 79.2 mt -69.19 120.42 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 120.725 0.298 . . . . 0.0 110.683 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 88.6 mt -73.97 134.85 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 172.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm . . . . . 0 N--CA 1.451 -0.421 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.028 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo . . . . . 0 N--CA 1.45 -1.047 0 N-CA-C 110.054 -0.787 . . . . 0.0 110.054 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 321' ' ' MET . . . . . . . . . . . . . 37.4 mtt -72.04 94.15 1.47 Allowed 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 120.951 0.405 . . . . 0.0 111.793 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 322' ' ' ILE . . . . . . . . . . . . . 3.5 mp -141.61 142.27 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 173.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -132.3 108.83 9.47 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 173.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 38.0 mt -77.64 153.2 33.38 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 175.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -120.86 143.3 48.98 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 175.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.52 -0.179 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -174.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt . . . . . 0 N--CA 1.461 0.11 0 N-CA-C 110.568 -0.16 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 74.82 22.23 77.29 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 -174.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -133.06 146.55 51.79 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 117.236 0.518 . . . . 0.0 110.511 -178.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -157.76 155.71 30.33 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.133 174.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 10.9 p -95.7 152.6 18.32 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 170.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 40.9 t -135.63 129.96 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 170.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 9.0 t -110.47 143.38 40.88 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-N 117.888 0.313 . . . . 0.0 111.029 -177.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -108.4 160.23 16.04 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -176.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -72.42 -28.57 63.05 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -135.54 150.11 71.25 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -177.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 344' ' ' PRO . . . . . 0.447 ' HG2' ' HD3' ' B' ' 345' ' ' PRO . 39.5 Cg_endo -69.69 -32.71 18.34 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.457 2.772 . . . . 0.0 114.487 -177.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 345' ' ' PRO . . . . . 0.447 ' HD3' ' HG2' ' B' ' 344' ' ' PRO . 96.1 Cg_endo -73.74 -20.88 19.55 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 CA-C-N 121.381 1.529 . . . . 0.0 110.324 -177.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 66.3 m -73.11 -37.48 66.67 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 175.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.13 -38.47 88.25 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 173.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -63.19 -46.09 88.69 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -66.74 -34.09 77.08 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 110.584 -0.154 . . . . 0.0 110.584 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.44 -35.96 82.49 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 64.8 mt -70.71 -51.71 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 175.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -55.17 -28.76 55.19 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 57.5 t-105 -98.04 -55.9 2.65 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -76.16 -30.66 58.2 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -173.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -55.21 110.73 0.72 Allowed 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 118.289 0.495 . . . . 0.0 110.777 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 103.56 -4.42 47.07 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.516 -0.602 . . . . 0.0 112.308 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -84.22 -163.76 0.84 Allowed 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 118.077 0.938 . . . . 0.0 110.165 176.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -127.82 150.67 49.73 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-O 120.95 0.405 . . . . 0.0 110.853 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -141.67 137.35 31.71 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.345 1.058 . . . . 0.0 112.487 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 20.5 t 53.91 18.96 1.78 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.563 0.345 . . . . 0.0 111.183 -175.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.4 21.96 42.56 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 112.056 -0.418 . . . . 0.0 112.056 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 41.0 m-20 -131.91 141.7 42.49 Favored Pre-proline 0 N--CA 1.453 -0.285 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -177.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -68.95 133.5 27.24 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 122.611 2.208 . . . . 0.0 109.403 177.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 29.8 pt -120.47 170.24 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.146 0 CA-C-O 121.336 0.588 . . . . 0.0 111.107 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -144.51 111.24 5.72 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 10.7 t -99.98 149.25 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.305 0.642 . . . . 0.0 111.966 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 23.2 t -162.46 172.72 15.08 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -69.57 128.72 37.46 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 176.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.499 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.905 -179.629 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.454 -0.26 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 91.7 m -105.11 142.24 35.24 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.054 0.454 . . . . 0.0 111.046 -174.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 30.5 pt -115.31 149.46 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -99.87 146.2 26.91 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 173.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 60.3 t -131.26 133.75 61.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.532 -178.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -123.65 153.55 40.61 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 83.31 13.11 77.42 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 172.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 292' ' ' LEU . . . . . 0.406 HD12 ' CD1' ' B' ' 359' ' ' PHE . 4.4 tp -59.07 -50.7 73.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 123.763 0.825 . . . . 0.0 111.027 -169.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 143.89 165.65 10.97 Favored Glycine 0 C--N 1.337 0.637 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 177.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -96.82 2.13 51.47 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.347 0.259 . . . . 0.0 111.282 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -128.47 11.86 6.37 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.868 0.467 . . . . 0.0 111.699 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 4.7 m -68.19 162.63 3.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -174.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 29.8 p -134.33 159.72 40.13 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 123.596 0.758 . . . . 0.0 110.697 176.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 298' ' ' ILE . . . . . . . . . . . . . 33.9 mt -61.33 -41.82 91.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.133 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -66.52 -36.05 81.75 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 122.554 0.342 . . . . 0.0 111.709 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 75.5 m -72.24 -46.08 57.51 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 118.175 0.443 . . . . 0.0 110.319 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 69.9 t -60.56 -42.65 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.32 -36.31 83.7 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 122.201 -0.312 . . . . 0.0 110.203 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 303' ' ' ASP . . . . . 0.438 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.1 t0 -69.88 -28.18 65.43 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -84.35 -25.84 28.88 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -96.1 -24.04 16.49 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 306' ' ' LYS . . . . . 0.438 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.6 ptpt -67.42 -18.68 65.2 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -176.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -72.57 -21.14 61.19 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -177.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.2 mm -85.94 -44.96 17.0 Favored 'Isoleucine or valine' 0 C--O 1.23 0.072 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 175.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.87 165.5 37.01 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 85.2 mt -66.04 123.49 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 120.854 0.359 . . . . 0.0 110.26 -177.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 85.8 mt -77.08 135.79 25.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 173.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm . . . . . 0 N--CA 1.451 -0.401 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -178.265 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 N--CA 1.448 -1.151 0 N-CA-C 109.874 -0.856 . . . . 0.0 109.874 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 321' ' ' MET . . . . . 0.421 ' CB ' ' HB3' ' B' ' 340' ' ' SER . 33.6 mtt -72.51 86.23 1.16 Allowed 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -177.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 322' ' ' ILE . . . . . 0.419 HD13 ' C ' ' B' ' 321' ' ' MET . 3.2 mp -130.29 138.73 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 170.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -129.8 105.15 7.82 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 174.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 31.2 mt -77.82 153.38 32.83 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 123.952 0.783 . . . . 0.0 109.085 177.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -116.39 147.95 41.14 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.455 -0.207 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -177.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt . . . . . 0 N--CA 1.462 0.141 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 78.02 20.81 72.33 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -175.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -129.94 147.67 51.72 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 122.948 0.499 . . . . 0.0 110.252 -178.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -156.38 162.04 40.08 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 120.759 0.314 . . . . 0.0 110.799 174.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 19.1 p -104.79 154.4 20.07 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 169.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 17.3 t -135.47 132.11 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 123.454 0.702 . . . . 0.0 109.345 171.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 340' ' ' SER . . . . . 0.421 ' HB3' ' CB ' ' B' ' 321' ' ' MET . 46.2 t -110.82 136.46 49.84 Favored 'General case' 0 C--O 1.227 -0.109 0 CA-C-N 118.002 0.365 . . . . 0.0 111.101 -178.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -100.5 159.55 15.06 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -178.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -71.91 -30.95 65.9 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -130.04 148.99 71.9 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 344' ' ' PRO . . . . . 0.458 ' HG2' ' HD3' ' B' ' 345' ' ' PRO . 38.0 Cg_endo -69.96 -33.56 15.61 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.361 2.708 . . . . 0.0 114.636 -177.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 345' ' ' PRO . . . . . 0.458 ' HD3' ' HG2' ' B' ' 344' ' ' PRO . 87.5 Cg_endo -73.5 -23.04 17.69 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 CA-C-N 121.083 1.423 . . . . 0.0 110.016 -177.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 58.8 m -71.95 -34.83 69.31 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 175.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.85 -41.07 87.96 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 175.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 40.2 tptt -69.53 -36.14 76.11 Favored 'General case' 0 C--N 1.339 0.121 0 O-C-N 122.176 -0.328 . . . . 0.0 110.706 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -65.75 -35.49 80.87 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 175.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -66.26 -37.49 85.59 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 72.2 mt -67.6 -53.62 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.772 175.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -56.85 -27.47 60.32 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -177.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -96.7 -55.15 2.99 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -76.5 -30.93 57.41 Favored 'General case' 0 CA--C 1.522 -0.117 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -173.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -54.53 110.26 0.61 Allowed 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.126 0.421 . . . . 0.0 110.876 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 104.31 -3.96 43.98 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 119.609 -0.551 . . . . 0.0 112.423 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -84.9 -164.32 0.96 Allowed 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 117.814 0.807 . . . . 0.0 110.373 176.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 42.0 mp0 -128.68 152.6 48.2 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.927 0.394 . . . . 0.0 110.858 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 359' ' ' PHE . . . . . 0.406 ' CD1' HD12 ' B' ' 292' ' ' LEU . 25.1 t80 -143.91 134.83 25.32 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.195 0.998 . . . . 0.0 112.329 178.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 58.8 m 52.59 20.73 1.59 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -174.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.63 22.2 40.81 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 112.099 -0.4 . . . . 0.0 112.099 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 50.9 m-20 -132.21 141.83 42.82 Favored Pre-proline 0 N--CA 1.456 -0.174 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.62 137.91 36.99 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 122.713 2.275 . . . . 0.0 109.472 177.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 35.3 pt -125.87 168.98 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 CA-C-O 121.035 0.445 . . . . 0.0 110.667 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -144.68 113.35 6.7 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 10.7 t -103.16 150.06 6.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 123.165 0.586 . . . . 0.0 112.097 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 31.8 t -161.4 173.16 15.32 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -74.04 130.81 40.56 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 176.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.467 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.062 -179.712 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 285' ' ' ASN . . . . . 0.453 HD22 ' C ' ' B' ' 285' ' ' ASN . 0.3 OUTLIER . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 85.4 m -106.21 143.58 34.14 Favored 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 122.09 -0.381 . . . . 0.0 110.675 -174.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 40.6 pt -120.16 144.53 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 176.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -96.18 145.36 25.59 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 174.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 19.0 t -130.85 144.79 36.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.156 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -133.47 152.97 51.98 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 175.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.55 11.27 68.98 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-O 119.78 -0.456 . . . . 0.0 112.361 169.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 63.8 mt -57.32 -49.95 74.49 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 117.645 0.723 . . . . 0.0 110.78 -175.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 148.54 172.93 18.91 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 -178.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -97.17 -6.25 35.24 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -175.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -128.64 15.77 6.47 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 4.3 m -67.59 161.38 3.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -174.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 19.4 p -123.88 159.95 28.52 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.441 0.696 . . . . 0.0 112.254 -178.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 298' ' ' ILE . . . . . . . . . . . . . 54.7 mt -63.68 -44.51 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.938 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -64.2 -36.3 83.6 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 122.565 0.346 . . . . 0.0 111.38 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 46.8 t -72.3 -47.04 53.01 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 122.247 -0.283 . . . . 0.0 110.812 -177.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 8.1 p -68.31 -33.98 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.005 178.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -65.22 -32.84 74.72 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 176.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 303' ' ' ASP . . . . . 0.42 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.6 t0 -74.02 -27.4 60.93 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -84.06 -24.69 30.31 Favored 'General case' 0 C--O 1.227 -0.13 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -96.8 -24.59 15.84 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 306' ' ' LYS . . . . . 0.42 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.7 ptpt -66.81 -18.04 65.18 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -177.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -70.9 -20.44 62.5 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 122.276 -0.265 . . . . 0.0 111.649 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.9 mm -87.61 -46.3 16.02 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-N 117.584 0.175 . . . . 0.0 110.644 175.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.71 168.78 38.44 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 85.7 mt -69.57 120.5 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-O 121.014 0.435 . . . . 0.0 110.695 -175.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 88.0 mt -73.01 138.77 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 172.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 312' ' ' LYS . . . . . 0.661 ' HE3' ' SD ' ' B' ' 321' ' ' MET . 28.8 ttpt . . . . . 0 N--CA 1.448 -0.548 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -176.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo . . . . . 0 N--CA 1.451 -1.006 0 N-CA-C 110.145 -0.752 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 321' ' ' MET . . . . . 0.661 ' SD ' ' HE3' ' B' ' 312' ' ' LYS . 36.1 mtt -73.87 98.28 2.96 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 322' ' ' ILE . . . . . . . . . . . . . 3.3 mp -144.51 144.8 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 175.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -130.13 133.84 46.92 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 170.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 86.6 mt -106.54 133.8 50.65 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -96.54 151.19 19.83 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -177.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.452 -0.337 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -174.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt . . . . . 0 CA--C 1.527 0.083 0 N-CA-C 110.673 -0.121 . . . . 0.0 110.673 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 79.04 3.4 88.2 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -173.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -99.03 151.39 20.98 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.008 0.523 . . . . 0.0 110.142 178.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -161.65 167.0 25.95 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 120.836 0.351 . . . . 0.0 111.331 -177.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 1.2 p -120.69 149.94 41.72 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 169.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 44.3 t -137.39 124.6 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 173.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 8.5 t -100.87 144.41 29.85 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 118.074 0.397 . . . . 0.0 110.815 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -109.8 158.65 17.93 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -79.09 -14.69 58.99 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -146.63 146.33 26.44 Favored Pre-proline 0 CA--C 1.53 0.204 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 344' ' ' PRO . . . . . 0.447 ' N ' ' CD ' ' B' ' 345' ' ' PRO . 48.2 Cg_endo -70.84 -31.03 16.39 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.051 2.501 . . . . 0.0 114.469 -177.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 345' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' B' ' 344' ' ' PRO . 77.1 Cg_endo -74.14 -22.84 16.42 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 CA-C-N 121.29 1.496 . . . . 0.0 110.01 -177.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 70.1 m -72.62 -34.3 67.26 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 176.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -69.9 -38.46 76.31 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 175.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -63.96 -42.55 97.25 Favored 'General case' 0 CA--C 1.527 0.094 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.26 -34.76 76.78 Favored 'General case' 0 C--N 1.34 0.17 0 O-C-N 122.287 -0.258 . . . . 0.0 110.506 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.59 -36.46 83.8 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 67.6 mt -69.79 -51.99 35.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.811 174.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -53.94 -29.64 43.25 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 56.2 t-105 -97.69 -56.04 2.63 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -75.64 -27.39 58.37 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 -173.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -50.13 110.68 0.42 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.015 0.371 . . . . 0.0 111.814 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 94.66 1.36 63.86 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.55 -0.583 . . . . 0.0 112.606 174.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -83.98 -164.71 0.97 Allowed 'General case' 0 C--N 1.339 0.152 0 CA-C-N 118.32 1.06 . . . . 0.0 110.146 176.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -129.41 152.96 48.39 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.209 0.528 . . . . 0.0 111.246 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -145.51 137.45 25.45 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.188 0.995 . . . . 0.0 112.061 177.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 21.1 t 54.19 18.51 1.82 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.87 0.468 . . . . 0.0 111.211 -175.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 89.29 22.58 37.23 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 111.939 -0.464 . . . . 0.0 111.939 178.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -133.67 141.81 41.45 Favored Pre-proline 0 N--CA 1.455 -0.205 0 CA-C-N 117.442 0.621 . . . . 0.0 109.428 -177.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.32 136.18 33.48 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 122.68 2.253 . . . . 0.0 109.567 177.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 30.4 pt -121.47 170.63 11.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-O 120.957 0.408 . . . . 0.0 111.383 -177.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -144.78 115.68 7.82 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.719 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 12.4 t -107.0 147.86 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 C-N-CA 123.429 0.692 . . . . 0.0 112.416 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 28.5 t -162.73 173.22 14.12 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 176.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -71.11 133.28 46.12 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.308 0 CA-C-O 121.216 0.531 . . . . 0.0 111.647 178.078 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.454 -0.244 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 33.7 m -106.1 143.07 34.76 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 120.764 0.316 . . . . 0.0 111.477 -175.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 45.3 pt -120.72 146.73 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -99.41 146.77 25.95 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 174.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 21.0 t -131.97 144.7 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.972 177.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -131.15 152.41 50.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 176.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.0 11.94 69.15 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 112.324 -0.311 . . . . 0.0 112.324 169.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 77.5 mt -55.6 -49.59 72.39 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 117.605 0.702 . . . . 0.0 110.492 -176.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 145.59 172.51 16.04 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -99.78 1.59 43.29 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.875 0.338 . . . . 0.0 111.787 -177.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -128.87 14.09 6.35 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.7 m -75.41 166.17 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -172.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 25.8 p -130.69 159.73 36.37 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.598 0.759 . . . . 0.0 112.168 -179.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 298' ' ' ILE . . . . . . . . . . . . . 44.4 mt -63.04 -46.38 96.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.337 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -62.37 -36.37 82.07 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.386 0.274 . . . . 0.0 111.437 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 47.0 t -72.44 -46.7 53.82 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 117.71 0.232 . . . . 0.0 110.836 -177.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.94 -33.28 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.341 178.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -65.3 -32.84 74.7 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 303' ' ' ASP . . . . . 0.421 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.4 t0 -74.64 -27.57 60.5 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 304' ' ' TYR . . . . . 0.404 ' CE2' ' CD2' ' B' ' 354' ' ' PHE . 52.3 t80 -83.48 -24.98 31.53 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -96.48 -25.09 15.79 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 178.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 306' ' ' LYS . . . . . 0.421 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.7 ptpt -66.35 -18.24 65.24 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -177.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -71.67 -20.19 61.98 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -178.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 3.9 mm -87.11 -46.33 16.23 Favored 'Isoleucine or valine' 0 C--N 1.337 0.059 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 175.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.98 167.95 38.25 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 85.8 mt -68.41 120.03 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 122.505 0.322 . . . . 0.0 110.634 -175.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 94.0 mt -71.72 138.06 22.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 172.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt . . . . . 0 N--CA 1.45 -0.439 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -177.789 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo . . . . . 0 N--CA 1.45 -1.053 0 N-CA-C 110.096 -0.771 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 321' ' ' MET . . . . . 0.415 ' CB ' ' HB3' ' B' ' 340' ' ' SER . 33.9 mtt -73.45 95.8 2.28 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 120.68 0.276 . . . . 0.0 111.712 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 322' ' ' ILE . . . . . . . . . . . . . 3.7 mp -141.29 141.05 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 172.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -134.37 110.9 9.75 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 175.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.68 152.69 33.63 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.673 0.789 . . . . 0.0 108.895 175.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -121.12 149.1 43.27 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 175.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.454 -0.273 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -175.607 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 8.5 mmmm . . . . . 0 N--CA 1.461 0.11 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 77.26 5.64 85.58 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 -171.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -103.36 147.61 26.89 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.389 0.675 . . . . 0.0 109.992 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -161.95 153.83 19.02 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.006 176.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 12.8 p -98.72 151.77 20.38 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 169.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 42.5 t -136.13 125.99 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 170.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 340' ' ' SER . . . . . 0.415 ' HB3' ' CB ' ' B' ' 321' ' ' MET . 46.5 t -103.18 149.12 24.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 117.862 0.301 . . . . 0.0 111.316 -178.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -114.49 156.81 23.88 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -72.21 -29.11 63.65 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -132.46 147.83 67.2 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -178.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 344' ' ' PRO . . . . . 0.442 ' N ' ' CD ' ' B' ' 345' ' ' PRO . 45.3 Cg_endo -71.39 -31.71 13.59 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.446 2.764 . . . . 0.0 114.649 -178.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 345' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' B' ' 344' ' ' PRO . 78.5 Cg_endo -73.68 -21.86 18.6 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 CA-C-N 121.255 1.484 . . . . 0.0 110.04 -177.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 70.7 m -71.23 -35.92 71.63 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 175.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -68.03 -38.74 82.88 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 174.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -64.06 -42.07 97.14 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.43 -34.6 76.29 Favored 'General case' 0 C--O 1.226 -0.148 0 O-C-N 122.255 -0.278 . . . . 0.0 110.737 178.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.36 -36.71 84.83 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 66.4 mt -70.25 -52.05 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.691 175.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -53.77 -29.86 41.96 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 58.9 t-105 -97.58 -53.95 3.28 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -176.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 354' ' ' PHE . . . . . 0.404 ' CD2' ' CE2' ' B' ' 304' ' ' TYR . 47.7 m-85 -78.09 -27.08 48.43 Favored 'General case' 0 C--O 1.226 -0.134 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -174.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -48.09 110.4 0.32 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 178.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 95.18 1.74 62.61 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 119.612 -0.549 . . . . 0.0 112.764 174.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -84.5 -164.87 1.03 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.261 1.03 . . . . 0.0 110.524 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 41.8 mp0 -127.75 152.85 47.24 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.107 0.479 . . . . 0.0 110.84 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -145.31 136.76 25.15 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.181 0.992 . . . . 0.0 112.349 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 14.8 t 55.32 17.29 2.04 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.075 0.464 . . . . 0.0 111.175 -175.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.72 22.63 38.84 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.955 -0.458 . . . . 0.0 111.955 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 44.9 m-20 -132.07 143.02 47.23 Favored Pre-proline 0 N--CA 1.455 -0.218 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -177.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -68.9 136.69 36.01 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.849 2.366 . . . . 0.0 109.415 177.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 33.5 pt -124.04 171.05 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 CA-C-O 121.178 0.513 . . . . 0.0 111.125 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -143.81 114.89 7.87 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.759 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 11.9 t -102.33 148.65 7.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 123.256 0.623 . . . . 0.0 111.99 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 80.3 p -162.53 168.6 21.63 Favored 'General case' 0 CA--C 1.528 0.1 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -70.28 130.97 43.42 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 174.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.401 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.882 -179.795 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 285' ' ' ASN . . . . . 0.413 HD22 ' C ' ' B' ' 285' ' ' ASN . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.275 0 N-CA-C 111.375 0.139 . . . . 0.0 111.375 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 63.7 m -108.98 146.22 34.22 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.877 0.37 . . . . 0.0 111.206 -172.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 44.9 pt -120.24 148.09 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 174.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -101.4 145.77 28.49 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 174.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 17.2 t -129.75 144.46 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.236 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -133.16 152.45 51.94 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 175.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.21 12.38 67.87 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 119.814 -0.436 . . . . 0.0 112.663 169.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 59.3 mt -57.14 -50.1 73.85 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 117.414 0.607 . . . . 0.0 110.912 -174.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 157.0 -177.94 33.64 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -99.63 -9.32 23.32 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -176.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -139.95 22.0 2.45 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.2 m -68.11 165.15 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -173.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 16.0 p -123.11 159.56 28.27 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -177.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 298' ' ' ILE . . . . . 0.402 HG21 ' HB ' ' B' ' 322' ' ' ILE . 41.1 mt -62.32 -45.8 97.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.128 177.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -63.43 -37.56 87.77 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -177.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 81.1 p -73.35 -42.39 62.31 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 118.043 0.383 . . . . 0.0 110.376 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 54.4 t -61.69 -42.06 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -65.56 -34.36 78.06 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 303' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -70.55 -26.96 63.79 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -84.41 -25.68 28.86 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -96.3 -25.0 15.93 Favored 'General case' 0 C--O 1.231 0.091 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 306' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -66.55 -19.08 65.69 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.241 0.216 . . . . 0.0 111.458 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -71.28 -20.01 62.27 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 111.644 0.238 . . . . 0.0 111.644 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 5.1 mm -88.9 -46.25 15.46 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-N 117.602 0.183 . . . . 0.0 110.945 176.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -162.18 170.37 37.79 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 85.4 mt -72.12 118.58 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 122.61 0.364 . . . . 0.0 110.39 -175.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 93.6 mt -72.56 135.02 28.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 173.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt . . . . . 0 N--CA 1.45 -0.472 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.317 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo . . . . . 0 N--CA 1.449 -1.108 0 N-CA-C 110.144 -0.752 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 321' ' ' MET . . . . . 0.41 ' CB ' ' HB3' ' B' ' 340' ' ' SER . 38.6 mtt -72.53 93.05 1.53 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.863 0.363 . . . . 0.0 111.72 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 322' ' ' ILE . . . . . 0.402 ' HB ' HG21 ' B' ' 298' ' ' ILE . 3.9 mp -140.5 144.21 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 173.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -131.62 132.78 44.31 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 171.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -103.15 137.8 40.82 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 174.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -104.11 155.24 18.86 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 2.9 m . . . . . 0 CA--C 1.523 -0.093 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -176.19 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt . . . . . 0 N--CA 1.465 0.291 0 CA-C-O 120.491 0.186 . . . . 0.0 110.632 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 73.52 5.49 68.11 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -172.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -100.06 151.11 21.75 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.336 0.654 . . . . 0.0 110.024 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.42 167.25 29.21 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.052 0.453 . . . . 0.0 111.592 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 1.4 p -120.66 151.15 39.86 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 169.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 31.3 t -137.66 124.99 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 172.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 340' ' ' SER . . . . . 0.41 ' HB3' ' CB ' ' B' ' 321' ' ' MET . 46.9 t -101.41 148.93 24.59 Favored 'General case' 0 C--O 1.231 0.113 0 O-C-N 122.202 -0.311 . . . . 0.0 111.135 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -116.92 154.12 31.38 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 -178.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -71.74 -13.11 61.62 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 176.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -149.26 146.77 21.78 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 344' ' ' PRO . . . . . 0.452 ' N ' ' CD ' ' B' ' 345' ' ' PRO . 53.4 Cg_endo -71.32 -30.18 15.97 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 123.239 2.626 . . . . 0.0 114.363 -177.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 345' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' B' ' 344' ' ' PRO . 71.5 Cg_endo -73.99 -22.45 17.21 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 CA-C-N 121.403 1.537 . . . . 0.0 109.964 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 66.3 m -71.7 -36.97 70.74 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 175.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.98 -37.83 84.94 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -63.72 -45.02 91.84 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.77 -34.44 76.81 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 110.538 -0.171 . . . . 0.0 110.538 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.33 -38.66 91.81 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 68.8 mt -68.57 -54.0 24.02 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.56 175.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -54.41 -27.9 40.12 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 54.9 t-105 -96.76 -55.07 3.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -76.29 -26.79 56.24 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -174.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -48.35 109.43 0.24 Allowed 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 176.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 94.94 0.76 63.63 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.394 -0.67 . . . . 0.0 112.814 174.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -83.38 -164.94 0.97 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 118.177 0.988 . . . . 0.0 110.374 176.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -128.48 155.11 45.33 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.191 0.519 . . . . 0.0 111.454 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -146.89 136.44 22.92 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.478 1.111 . . . . 0.0 112.158 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 22.7 t 54.45 18.77 2.06 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.455 0.302 . . . . 0.0 111.335 -175.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 86.95 24.31 38.35 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 112.154 -0.378 . . . . 0.0 112.154 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -132.87 142.48 44.88 Favored Pre-proline 0 N--CA 1.454 -0.23 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 -178.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.41 136.16 33.18 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.681 2.254 . . . . 0.0 109.602 177.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 27.9 pt -122.97 171.9 11.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-O 121.25 0.548 . . . . 0.0 110.831 -177.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -144.0 118.13 9.5 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.947 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 11.9 t -107.64 148.52 11.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 C-N-CA 123.22 0.608 . . . . 0.0 112.242 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 27.4 t -163.75 172.57 13.98 Favored 'General case' 0 C--N 1.341 0.204 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 176.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -70.51 130.25 41.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 176.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.314 0 CA-C-N 115.965 -0.562 . . . . 0.0 112.31 -179.027 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 285' ' ' ASN . . . . . 0.427 HD22 ' C ' ' B' ' 285' ' ' ASN . 0.4 OUTLIER . . . . . 0 N--CA 1.452 -0.349 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 60.5 m -107.5 142.16 37.81 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.092 0.473 . . . . 0.0 109.987 -175.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 44.4 pt -113.72 146.69 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 174.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -97.97 141.06 31.4 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 172.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 17.4 t -130.26 142.34 44.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 O-C-N 123.331 0.394 . . . . 0.0 111.252 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -132.3 153.13 51.0 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.46 11.47 68.86 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 119.863 -0.409 . . . . 0.0 112.423 169.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 77.4 mt -56.29 -51.95 66.31 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 117.348 0.574 . . . . 0.0 110.548 -175.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 151.15 171.56 19.31 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -91.47 -9.13 45.62 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 122.484 -0.421 . . . . 0.0 111.772 -174.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -134.34 15.91 3.75 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -177.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.2 m -66.6 160.76 3.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -175.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 25.7 p -117.87 156.66 28.03 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 122.957 0.503 . . . . 0.0 112.053 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 298' ' ' ILE . . . . . . . . . . . . . 40.6 mt -60.67 -44.03 96.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.44 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -68.89 -30.54 69.05 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -177.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 46.6 t -73.79 -43.6 58.44 Favored 'General case' 0 N--CA 1.458 -0.07 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 78.8 t -61.97 -41.25 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.61 -34.84 79.21 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 303' ' ' ASP . . . . . 0.43 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.9 t0 -71.02 -29.01 64.83 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 304' ' ' TYR . . . . . 0.402 ' CE2' ' CD2' ' B' ' 354' ' ' PHE . 59.0 t80 -82.47 -25.31 33.66 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -96.63 -24.88 15.8 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 306' ' ' LYS . . . . . 0.43 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.9 ptpt -67.76 -17.59 64.6 Favored 'General case' 0 C--N 1.338 0.107 0 N-CA-C 111.446 0.165 . . . . 0.0 111.446 -176.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -72.2 -20.07 61.63 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 3.8 mm -87.84 -46.35 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.122 0 CA-C-N 117.61 0.186 . . . . 0.0 110.632 175.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -162.24 172.16 38.29 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 72.5 mt -71.11 118.29 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 122.68 0.392 . . . . 0.0 110.11 -175.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 77.4 mt -74.91 136.93 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 173.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 312' ' ' LYS . . . . . 0.448 ' HG2' ' SD ' ' B' ' 321' ' ' MET . 39.8 ttmt . . . . . 0 N--CA 1.453 -0.275 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo . . . . . 0 N--CA 1.448 -1.195 0 N-CA-C 108.746 -1.29 . . . . 0.0 108.746 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 321' ' ' MET . . . . . 0.448 ' SD ' ' HG2' ' B' ' 312' ' ' LYS . 72.4 mtp -79.77 85.7 5.42 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.307 0.575 . . . . 0.0 111.665 -170.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 322' ' ' ILE . . . . . . . . . . . . . 3.3 mp -129.7 147.08 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.575 1.15 . . . . 0.0 108.25 176.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -132.93 111.08 10.74 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -80.98 148.79 29.6 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.267 1.027 . . . . 0.0 108.833 176.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -113.29 151.66 30.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.522 -0.13 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -173.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt . . . . . 0 CA--C 1.527 0.096 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 78.56 10.29 86.33 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 110.709 -0.957 . . . . 0.0 110.709 -174.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -116.97 150.33 38.74 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.881 0.472 . . . . 0.0 110.408 -177.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -160.06 162.91 34.26 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.881 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 29.6 p -112.4 153.86 26.67 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 169.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 21.8 t -136.6 124.19 33.15 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.11 0 C-N-CA 123.249 0.62 . . . . 0.0 110.218 175.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 45.0 t -90.98 140.85 29.45 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 117.906 0.321 . . . . 0.0 110.404 177.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -108.85 152.84 24.36 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 176.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -70.08 -28.82 65.73 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -177.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -133.05 149.0 71.6 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 344' ' ' PRO . . . . . 0.448 ' N ' ' CD ' ' B' ' 345' ' ' PRO . 36.9 Cg_endo -69.44 -33.33 18.04 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 123.274 2.649 . . . . 0.0 114.2 -177.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 345' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' B' ' 344' ' ' PRO . 93.8 Cg_endo -74.97 -20.2 17.15 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 CA-C-N 121.136 1.441 . . . . 0.0 110.384 -176.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 66.3 m -71.88 -35.72 69.84 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 175.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -70.4 -38.36 74.64 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 174.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -63.6 -43.14 97.78 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.62 -35.33 77.17 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 110.561 -0.162 . . . . 0.0 110.561 178.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -63.88 -37.62 88.06 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 59.2 mt -70.66 -49.16 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.094 175.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -58.95 -27.9 65.76 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -176.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -97.26 -56.47 2.53 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -177.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 354' ' ' PHE . . . . . 0.402 ' CD2' ' CE2' ' B' ' 304' ' ' TYR . 52.2 m-85 -75.7 -25.74 56.95 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -173.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -48.49 108.4 0.17 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 176.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 96.34 2.2 60.52 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 119.435 -0.647 . . . . 0.0 113.227 174.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -84.91 -164.02 0.92 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.3 1.05 . . . . 0.0 110.386 177.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -129.9 153.23 48.53 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-O 121.058 0.456 . . . . 0.0 110.776 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -145.17 136.69 25.26 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.395 1.078 . . . . 0.0 112.296 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 63.4 m 53.35 19.48 1.61 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -173.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 86.38 22.81 46.25 Favored Glycine 0 C--N 1.342 0.868 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 52.6 m-20 -130.71 141.96 43.81 Favored Pre-proline 0 N--CA 1.454 -0.239 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -177.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.18 135.31 31.48 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.998 2.465 . . . . 0.0 109.267 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 29.6 pt -122.4 171.48 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 CA-C-O 121.285 0.564 . . . . 0.0 111.061 -177.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -144.25 116.59 8.51 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.688 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 10.8 t -107.28 147.27 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 123.026 0.53 . . . . 0.0 111.801 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 28.0 t -162.63 174.87 12.01 Favored 'General case' 0 C--N 1.339 0.147 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 177.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -71.97 130.07 40.09 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 176.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.358 177.946 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 285' ' ' ASN . . . . . 0.424 HD22 ' C ' ' B' ' 285' ' ' ASN . 0.3 OUTLIER . . . . . 0 N--CA 1.455 -0.223 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 80.4 m -108.13 144.36 35.63 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.024 0.44 . . . . 0.0 110.912 -174.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 44.5 pt -120.41 147.35 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -99.83 145.93 27.18 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 174.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 16.8 t -129.46 142.14 44.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 122.636 0.374 . . . . 0.0 111.22 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -129.54 149.9 51.11 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.05 14.24 64.88 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-O 119.894 -0.392 . . . . 0.0 112.361 169.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 61.4 mt -57.1 -51.1 70.65 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 117.545 0.673 . . . . 0.0 110.615 -175.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 148.84 177.16 22.8 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -101.54 -2.25 31.04 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -178.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -129.14 14.67 6.23 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.778 0.431 . . . . 0.0 112.145 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.2 m -73.65 163.16 4.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -172.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 27.3 p -129.23 160.71 32.08 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 123.501 0.72 . . . . 0.0 111.604 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 298' ' ' ILE . . . . . . . . . . . . . 44.8 mt -64.51 -45.51 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.274 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -63.6 -35.65 81.22 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 122.497 0.319 . . . . 0.0 111.601 179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 47.1 t -72.28 -47.01 53.37 Favored 'General case' 0 C--O 1.228 -0.057 0 CA-C-N 117.919 0.327 . . . . 0.0 110.772 -177.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 7.8 p -68.16 -33.41 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.2 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -65.78 -32.56 74.16 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 176.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 303' ' ' ASP . . . . . 0.416 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 46.1 t0 -74.23 -28.21 61.14 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 304' ' ' TYR . . . . . 0.409 ' CE1' ' CD1' ' B' ' 354' ' ' PHE . 54.6 t80 -82.2 -25.47 34.21 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -96.51 -25.93 15.47 Favored 'General case' 0 CA--C 1.527 0.086 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 306' ' ' LYS . . . . . 0.416 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.7 ptpt -65.73 -17.69 64.8 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 111.631 0.234 . . . . 0.0 111.631 -177.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -71.72 -20.52 61.89 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 5.0 mm -86.72 -45.8 16.49 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 175.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -165.22 167.92 39.05 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 178.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 82.4 mt -68.13 122.59 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-O 120.854 0.359 . . . . 0.0 110.752 -174.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 92.1 mt -74.56 136.53 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt . . . . . 0 N--CA 1.448 -0.568 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -178.131 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo . . . . . 0 N--CA 1.452 -0.959 0 N-CA-C 109.861 -0.861 . . . . 0.0 109.861 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 321' ' ' MET . . . . . . . . . . . . . 36.4 mtt -71.31 95.71 1.34 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 120.571 0.224 . . . . 0.0 111.576 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 322' ' ' ILE . . . . . . . . . . . . . 3.6 mp -142.44 141.67 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 173.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 323' ' ' ASN . . . . . 0.403 ' O ' ' HA ' ' B' ' 337' ' ' ALA . 17.3 m-80 -132.75 111.16 10.91 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 171.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 43.2 mt -81.55 148.15 29.29 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 174.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -115.28 151.62 34.21 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 178.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.333 -0.141 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -176.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 9.3 mmmm . . . . . 0 N--CA 1.458 -0.048 0 N-CA-C 110.566 -0.161 . . . . 0.0 110.566 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.33 5.24 81.38 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -170.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -103.73 149.68 24.77 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.324 0.65 . . . . 0.0 110.121 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 337' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' B' ' 323' ' ' ASN . . . -164.25 159.69 20.3 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.027 176.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 6.1 p -106.26 151.65 24.53 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 169.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 42.9 t -135.89 126.22 42.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 170.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 23.0 t -105.96 141.88 36.61 Favored 'General case' 0 CA--C 1.527 0.086 0 O-C-N 122.129 -0.357 . . . . 0.0 110.948 -177.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -106.6 158.53 16.87 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -177.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -73.41 -29.97 62.94 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -131.26 146.9 64.04 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -177.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 344' ' ' PRO . . . . . 0.451 ' HG2' ' HD3' ' B' ' 345' ' ' PRO . 40.6 Cg_endo -70.83 -33.23 12.86 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.414 2.743 . . . . 0.0 114.484 -177.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 345' ' ' PRO . . . . . 0.451 ' HD3' ' HG2' ' B' ' 344' ' ' PRO . 87.4 Cg_endo -73.82 -22.65 17.38 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 CA-C-N 121.185 1.459 . . . . 0.0 109.926 -176.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 71.2 m -71.48 -35.74 70.91 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 175.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -68.7 -37.91 79.9 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 175.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -64.77 -43.12 94.3 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -69.45 -33.26 72.67 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 110.474 -0.195 . . . . 0.0 110.474 178.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.89 -36.8 85.52 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 67.9 mt -69.67 -52.36 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 120.378 -0.529 . . . . 0.0 109.612 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -55.74 -29.37 59.42 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 55.5 t-105 -95.55 -55.87 2.88 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 354' ' ' PHE . . . . . 0.409 ' CD1' ' CE1' ' B' ' 304' ' ' TYR . 46.7 m-85 -75.8 -31.54 59.48 Favored 'General case' 0 C--N 1.337 0.06 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -173.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -55.46 108.04 0.39 Allowed 'General case' 0 C--O 1.232 0.16 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.753 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 106.98 -3.17 35.57 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.272 176.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -86.47 -164.78 1.11 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 117.843 0.821 . . . . 0.0 110.428 176.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -128.91 154.69 46.28 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.958 0.409 . . . . 0.0 111.306 177.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -145.19 137.2 25.67 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.573 1.149 . . . . 0.0 112.348 177.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 15.5 t 54.9 16.15 1.37 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 122.773 0.429 . . . . 0.0 111.189 -175.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 90.71 23.45 30.71 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 111.886 -0.485 . . . . 0.0 111.886 178.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -133.9 142.07 42.15 Favored Pre-proline 0 N--CA 1.453 -0.321 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -177.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -68.94 136.33 34.9 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 122.702 2.268 . . . . 0.0 109.518 177.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 29.1 pt -122.12 170.68 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-O 120.978 0.418 . . . . 0.0 111.01 -178.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -144.84 114.1 7.03 Favored 'General case' 0 N--CA 1.457 -0.086 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 11.2 t -102.67 150.47 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 122.907 0.483 . . . . 0.0 112.131 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 23.8 t -163.54 173.43 13.07 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 176.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -70.55 131.09 43.46 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 176.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.47 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.683 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.455 -0.213 0 N-CA-C 111.53 0.196 . . . . 0.0 111.53 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 60.6 m -106.73 142.5 36.27 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 120.988 0.423 . . . . 0.0 110.797 -176.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 38.9 pt -116.85 147.38 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 173.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -100.78 144.36 29.83 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 174.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 18.4 t -129.72 143.13 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.004 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -131.44 151.61 51.4 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 175.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 88.84 11.77 65.02 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 119.782 -0.455 . . . . 0.0 112.272 169.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 76.4 mt -56.47 -51.37 68.71 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.705 0.752 . . . . 0.0 110.46 -176.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 147.61 174.41 19.51 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 -179.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -99.07 -0.32 42.1 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.879 0.34 . . . . 0.0 111.644 -178.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -128.83 13.0 6.32 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.4 m -73.58 162.8 4.27 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -172.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 47.4 p -130.04 158.18 40.33 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 123.532 0.733 . . . . 0.0 111.129 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 298' ' ' ILE . . . . . . . . . . . . . 30.7 mt -62.41 -44.87 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.506 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -63.13 -34.7 78.17 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.448 0.299 . . . . 0.0 111.609 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 47.0 t -73.64 -44.29 57.3 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 79.2 t -62.45 -40.82 89.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 177.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.77 -36.2 83.55 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 303' ' ' ASP . . . . . 0.418 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 44.9 t0 -70.52 -27.95 64.57 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 304' ' ' TYR . . . . . 0.407 ' CE2' ' CD1' ' B' ' 354' ' ' PHE . 60.8 t80 -82.9 -26.42 31.53 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -179.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -96.63 -24.65 15.9 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 179.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 306' ' ' LYS . . . . . 0.418 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.6 ptpt -66.61 -19.25 65.73 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 111.526 0.195 . . . . 0.0 111.526 -177.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -71.01 -19.77 62.48 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -178.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 5.0 mm -88.79 -46.43 15.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 N-CA-C 110.554 -0.165 . . . . 0.0 110.554 175.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.19 167.43 37.49 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 179.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 84.2 mt -68.03 120.44 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-O 120.989 0.423 . . . . 0.0 110.353 -176.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 80.5 mt -74.29 137.37 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 172.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm . . . . . 0 N--CA 1.45 -0.466 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -177.558 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo . . . . . 0 N--CA 1.449 -1.103 0 N-CA-C 110.358 -0.67 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 321' ' ' MET . . . . . . . . . . . . . 37.0 mtt -73.08 91.49 1.61 Allowed 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 122.523 0.329 . . . . 0.0 111.685 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 322' ' ' ILE . . . . . . . . . . . . . 4.1 mp -136.6 139.89 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 170.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -135.21 111.05 9.36 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 25.0 mt -81.44 151.96 27.62 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 176.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -115.99 152.34 33.7 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 177.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.092 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -174.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt . . . . . 0 N--CA 1.461 0.089 0 N-CA-C 110.442 -0.207 . . . . 0.0 110.442 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.13 3.59 76.06 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -172.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -103.56 150.05 24.31 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.163 0.585 . . . . 0.0 110.104 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -162.81 157.55 21.58 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.705 177.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 7.6 p -105.31 152.67 22.62 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 170.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 38.2 t -135.78 126.17 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 123.597 0.759 . . . . 0.0 109.056 170.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 48.3 t -105.39 139.2 40.38 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.701 0.286 . . . . 0.0 110.983 -178.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -104.57 159.76 15.49 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -178.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -72.08 -31.61 66.25 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -130.98 149.85 74.92 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 344' ' ' PRO . . . . . 0.441 ' HG2' ' HD3' ' B' ' 345' ' ' PRO . 40.7 Cg_endo -70.27 -32.12 17.02 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 123.256 2.637 . . . . 0.0 114.396 -177.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 345' ' ' PRO . . . . . 0.441 ' HD3' ' HG2' ' B' ' 344' ' ' PRO . 74.0 Cg_endo -73.68 -21.34 19.19 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 CA-C-N 121.255 1.484 . . . . 0.0 110.199 -177.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 57.6 m -72.09 -36.3 69.46 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 175.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -67.28 -38.64 85.4 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 174.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -63.63 -43.96 95.27 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.23 -34.67 76.67 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 122.227 -0.296 . . . . 0.0 110.542 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.64 -37.18 86.71 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 61.5 mt -69.58 -51.85 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.86 175.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -53.19 -30.63 38.55 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 53.8 t-105 -97.09 -55.39 2.87 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -176.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 354' ' ' PHE . . . . . 0.407 ' CD1' ' CE2' ' B' ' 304' ' ' TYR . 51.9 m-85 -76.35 -26.94 56.22 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -173.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -49.22 109.16 0.24 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 177.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 97.3 -0.32 60.01 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 119.508 -0.606 . . . . 0.0 112.499 174.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -83.25 -165.74 1.17 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 118.203 1.001 . . . . 0.0 110.374 176.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -127.99 154.96 45.01 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.387 0.613 . . . . 0.0 111.233 177.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -145.71 136.44 24.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.531 1.133 . . . . 0.0 112.247 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 13.3 t 54.89 18.11 2.07 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.711 0.291 . . . . 0.0 111.346 -175.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.4 22.92 38.75 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.963 -0.455 . . . . 0.0 111.963 178.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 51.6 m-20 -132.64 142.16 43.8 Favored Pre-proline 0 N--CA 1.457 -0.112 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -177.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.27 135.97 33.05 Favored 'Trans proline' 0 N--CA 1.446 -1.305 0 C-N-CA 122.895 2.397 . . . . 0.0 109.532 178.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 29.8 pt -122.56 171.4 11.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 121.176 0.513 . . . . 0.0 111.009 -177.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -144.45 115.38 7.83 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.781 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 11.7 t -105.9 147.63 11.27 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 C-N-CA 123.174 0.59 . . . . 0.0 112.165 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 22.6 t -162.71 173.04 14.37 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 176.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -70.1 130.17 41.4 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 176.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.439 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.053 -178.954 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.455 -0.205 0 N-CA-C 111.443 0.164 . . . . 0.0 111.443 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 28.2 m -113.49 143.96 43.64 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.866 0.365 . . . . 0.0 111.603 -174.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 32.1 pt -122.02 146.82 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 175.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -100.33 144.24 29.57 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 174.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 20.4 t -129.83 142.24 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 122.808 0.443 . . . . 0.0 111.008 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -129.82 151.98 49.81 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.128 -0.694 . . . . 0.0 109.128 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.61 11.89 67.78 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-O 119.911 -0.383 . . . . 0.0 112.448 169.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 75.4 mt -55.42 -50.27 70.24 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 117.625 0.713 . . . . 0.0 110.679 -175.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 145.71 174.07 17.56 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -100.98 2.16 40.38 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -178.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -128.64 13.94 6.46 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.792 0.437 . . . . 0.0 111.795 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.6 m -75.56 165.32 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -172.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 26.7 p -131.81 160.53 35.35 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.587 0.755 . . . . 0.0 111.969 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 298' ' ' ILE . . . . . . . . . . . . . 48.3 mt -63.82 -43.71 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.099 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.6 -36.6 84.76 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 122.428 0.291 . . . . 0.0 111.499 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 45.4 t -71.82 -46.26 58.72 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.792 0.269 . . . . 0.0 110.795 -177.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 8.2 p -68.33 -32.55 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.271 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -66.76 -32.66 74.09 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 303' ' ' ASP . . . . . 0.428 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.0 t0 -74.15 -27.58 60.91 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 304' ' ' TYR . . . . . 0.417 ' CE1' ' CD2' ' B' ' 354' ' ' PHE . 67.7 t80 -84.19 -24.36 30.16 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -97.01 -24.41 15.81 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 178.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 306' ' ' LYS . . . . . 0.428 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.8 ptpt -66.13 -17.86 64.98 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -177.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -71.78 -20.67 61.83 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 5.1 mm -86.81 -46.09 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 N-CA-C 110.525 -0.176 . . . . 0.0 110.525 175.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.58 165.86 37.01 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.346 -0.701 . . . . 0.0 111.346 178.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 79.5 mt -66.81 119.46 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 122.586 0.354 . . . . 0.0 110.642 -176.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 94.5 mt -72.06 135.55 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 172.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt . . . . . 0 N--CA 1.453 -0.314 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -178.338 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo . . . . . 0 N--CA 1.448 -1.156 0 N-CA-C 110.032 -0.795 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 321' ' ' MET . . . . . . . . . . . . . 37.1 mtt -72.64 95.0 1.79 Allowed 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 120.906 0.384 . . . . 0.0 111.757 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 322' ' ' ILE . . . . . . . . . . . . . 3.5 mp -141.31 141.05 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 173.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -132.75 107.31 8.28 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 174.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 36.6 mt -80.04 154.78 27.93 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -122.7 149.2 44.38 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 176.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 8.7 m . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -174.097 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? . . . . . 0 N--CA 1.463 0.198 0 N-CA-C 110.579 -0.156 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.01 5.44 80.29 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -172.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -102.74 147.38 26.92 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.591 0.756 . . . . 0.0 110.313 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -164.17 158.23 18.89 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.639 0.257 . . . . 0.0 111.423 177.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 32.2 p -104.12 153.3 21.09 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 169.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 40.6 t -136.81 130.94 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 171.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 41.9 t -108.66 149.54 28.8 Favored 'General case' 0 N--CA 1.46 0.072 0 CA-C-O 120.672 0.272 . . . . 0.0 111.425 -178.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -115.27 157.82 23.22 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -70.46 -32.53 70.13 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -129.86 149.05 71.97 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -178.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 344' ' ' PRO . . . . . 0.456 ' HG2' ' HD3' ' B' ' 345' ' ' PRO . 41.0 Cg_endo -69.95 -32.42 17.81 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.198 2.599 . . . . 0.0 114.537 -176.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 345' ' ' PRO . . . . . 0.456 ' HD3' ' HG2' ' B' ' 344' ' ' PRO . 92.7 Cg_endo -74.16 -20.95 18.45 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 CA-C-N 120.874 1.348 . . . . 0.0 110.315 -177.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 68.3 m -71.05 -37.84 72.54 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 175.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.62 -38.18 86.41 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 174.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -64.69 -42.38 95.36 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -69.33 -34.1 74.11 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 110.48 -0.192 . . . . 0.0 110.48 178.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -63.87 -38.02 89.56 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 67.8 mt -68.08 -53.43 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 120.369 -0.532 . . . . 0.0 109.658 175.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -55.54 -27.72 50.55 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -178.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -96.6 -55.22 2.98 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 354' ' ' PHE . . . . . 0.417 ' CD2' ' CE1' ' B' ' 304' ' ' TYR . 48.9 m-85 -76.2 -27.0 56.7 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -173.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -49.18 108.43 0.19 Allowed 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 176.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 96.57 1.03 60.58 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-N 116.154 -0.475 . . . . 0.0 113.068 174.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -82.97 -164.47 0.88 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 117.89 0.845 . . . . 0.0 110.17 176.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -129.46 152.21 49.25 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-O 121.006 0.432 . . . . 0.0 110.982 178.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -145.08 137.27 25.86 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.891 0.877 . . . . 0.0 112.334 178.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 22.0 t 54.73 18.31 2.06 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.69 0.281 . . . . 0.0 111.196 -175.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.65 23.39 39.53 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -132.9 142.94 46.55 Favored Pre-proline 0 N--CA 1.457 -0.09 0 CA-C-N 117.537 0.668 . . . . 0.0 109.312 -177.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.24 135.51 31.89 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 123.148 2.565 . . . . 0.0 109.738 177.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 30.8 pt -123.03 170.43 13.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.122 0.487 . . . . 0.0 111.176 -177.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -144.31 116.91 8.64 Favored 'General case' 0 C--O 1.228 -0.071 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.898 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 12.6 t -106.13 149.0 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 C-N-CA 123.088 0.555 . . . . 0.0 112.124 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 22.6 t -163.27 172.92 14.01 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 177.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -69.94 129.68 40.14 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 176.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.342 0 CA-C-O 121.096 0.474 . . . . 0.0 111.608 179.757 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.287 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 72.1 m -109.07 145.39 35.71 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.024 0.44 . . . . 0.0 111.152 -173.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 46.1 pt -121.9 149.6 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -102.67 145.53 29.54 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 175.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 57.5 t -128.26 136.61 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.412 -178.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -127.23 153.95 45.46 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 176.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 84.31 12.22 76.47 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 173.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 292' ' ' LEU . . . . . 0.403 HD13 ' CD1' ' B' ' 359' ' ' PHE . 4.6 tp -59.1 -49.36 78.18 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.984 0.914 . . . . 0.0 111.219 -170.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 146.59 167.11 12.64 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 176.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -95.38 -1.19 51.62 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.341 0.257 . . . . 0.0 111.312 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -130.67 14.69 5.4 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.5 m -68.58 164.85 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -173.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 77.5 p -135.17 156.76 48.44 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 123.838 0.855 . . . . 0.0 109.782 177.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 298' ' ' ILE . . . . . 0.404 HG21 ' HB ' ' B' ' 322' ' ' ILE . 29.6 mt -61.94 -43.74 97.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.626 -178.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -64.25 -34.24 77.67 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 47.7 t -72.58 -45.36 59.54 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 117.864 0.302 . . . . 0.0 110.482 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 72.5 t -62.16 -41.63 92.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.93 -36.02 83.04 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 303' ' ' ASP . . . . . 0.42 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.2 t0 -69.74 -29.66 67.08 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 304' ' ' TYR . . . . . 0.401 ' CE1' ' CD2' ' B' ' 354' ' ' PHE . 56.3 t80 -82.52 -25.89 33.01 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -96.46 -24.47 16.09 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 306' ' ' LYS . . . . . 0.42 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.6 ptpt -67.15 -18.56 65.34 Favored 'General case' 0 N--CA 1.461 0.077 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -176.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -71.69 -19.73 62.03 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 5.2 mm -88.43 -46.28 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.092 0 CA-C-N 117.729 0.241 . . . . 0.0 110.471 175.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.83 170.53 39.17 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 83.5 mt -70.06 120.18 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 122.675 0.39 . . . . 0.0 110.352 -175.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 87.7 mt -73.83 138.9 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 172.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -178.009 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo . . . . . 0 N--CA 1.45 -1.056 0 N-CA-C 110.262 -0.707 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 321' ' ' MET . . . . . 0.419 ' C ' HD12 ' B' ' 322' ' ' ILE . 34.2 mtt -74.94 86.02 2.27 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 120.913 0.387 . . . . 0.0 111.895 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 322' ' ' ILE . . . . . 0.419 HD12 ' C ' ' B' ' 321' ' ' MET . 3.4 mp -130.65 137.64 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 169.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -133.64 110.72 10.07 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.508 176.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 20.3 mt -78.75 151.77 31.88 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.334 0.654 . . . . 0.0 109.362 177.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -117.58 147.29 42.97 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 177.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.454 -0.225 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -176.806 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 10.5 mmmm . . . . . 0 CA--C 1.521 -0.138 0 CA-C-O 120.244 0.068 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.77 21.87 73.47 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -172.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -127.61 144.87 51.03 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.013 0.525 . . . . 0.0 110.242 -177.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -155.21 155.37 33.75 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.584 0.231 . . . . 0.0 111.229 172.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 1.9 p -96.12 152.28 18.69 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 170.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 23.2 t -134.29 125.65 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 169.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 22.8 t -106.03 141.86 36.7 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.618 -177.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -107.79 158.54 17.22 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -73.06 -31.72 64.59 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -130.07 147.99 67.85 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -178.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 344' ' ' PRO . . . . . 0.442 ' N ' ' CD ' ' B' ' 345' ' ' PRO . 47.7 Cg_endo -71.64 -30.9 14.11 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 123.389 2.726 . . . . 0.0 114.672 -176.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 345' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' B' ' 344' ' ' PRO . 78.3 Cg_endo -73.83 -22.52 17.5 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 CA-C-N 121.326 1.509 . . . . 0.0 109.946 -177.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 71.1 m -71.68 -35.71 70.39 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 175.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -68.72 -38.03 79.9 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 175.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -63.87 -44.56 92.72 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.04 -33.6 74.89 Favored 'General case' 0 N--CA 1.455 -0.175 0 O-C-N 122.474 -0.141 . . . . 0.0 110.63 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.14 -37.69 88.24 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 67.6 mt -68.78 -53.68 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.929 174.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -54.21 -28.67 42.45 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -178.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 56.8 t-105 -95.89 -56.27 2.72 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 354' ' ' PHE . . . . . 0.401 ' CD2' ' CE1' ' B' ' 304' ' ' TYR . 47.3 m-85 -75.99 -25.59 55.94 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -173.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -45.86 107.51 0.1 Allowed 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 175.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 92.64 3.36 66.56 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 119.515 -0.603 . . . . 0.0 113.058 174.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -82.37 -170.84 3.13 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.178 0.989 . . . . 0.0 111.201 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -112.21 150.15 31.28 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.684 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 359' ' ' PHE . . . . . 0.403 ' CD1' HD13 ' B' ' 292' ' ' LEU . 14.2 t80 -146.12 130.8 17.93 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.654 0.782 . . . . 0.0 112.52 173.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 17.5 t 54.71 19.65 2.6 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.807 0.443 . . . . 0.0 111.089 -176.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.16 28.3 25.8 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 111.921 -0.472 . . . . 0.0 111.921 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -140.01 142.69 31.4 Favored Pre-proline 0 N--CA 1.456 -0.157 0 CA-C-N 117.385 0.592 . . . . 0.0 109.62 -177.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.97 136.27 32.01 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.814 2.343 . . . . 0.0 110.019 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 31.8 pt -124.79 170.27 15.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 121.103 0.478 . . . . 0.0 110.979 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -142.73 116.54 9.28 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.229 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 11.6 t -104.58 147.89 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 123.115 0.566 . . . . 0.0 111.78 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 24.4 t -162.41 172.23 15.9 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 177.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -70.06 128.65 37.05 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 177.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.245 0 CA-C-O 121.345 0.593 . . . . 0.0 111.996 -178.575 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 99.4 m -111.24 146.63 36.62 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.211 0.529 . . . . 0.0 110.369 -176.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 39.8 pt -119.04 146.89 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.227 175.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -96.97 145.5 25.86 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 173.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 18.0 t -131.3 142.23 43.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 O-C-N 123.211 0.319 . . . . 0.0 111.148 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -131.17 150.37 52.18 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 177.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.81 12.99 65.48 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 119.776 -0.458 . . . . 0.0 112.402 169.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 65.5 mt -57.29 -49.95 74.47 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 117.653 0.726 . . . . 0.0 110.645 -175.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 146.47 175.41 19.44 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -101.3 0.23 36.87 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.898 0.349 . . . . 0.0 111.861 -177.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -128.66 13.91 6.45 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.57 0.348 . . . . 0.0 111.666 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.5 m -75.33 166.7 2.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -172.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 14.1 p -131.36 162.15 30.77 Favored 'General case' 0 CA--C 1.522 -0.11 0 C-N-CA 123.744 0.818 . . . . 0.0 112.596 -177.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 298' ' ' ILE . . . . . . . . . . . . . 44.1 mt -62.88 -45.45 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.347 178.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -69.79 -33.51 72.48 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -178.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 80.9 p -72.41 -44.66 62.14 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 118.398 0.544 . . . . 0.0 110.37 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 9.5 p -68.35 -33.76 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 O-C-N 121.917 -0.489 . . . . 0.0 110.668 176.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.58 -33.48 76.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 175.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 303' ' ' ASP . . . . . 0.452 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.3 t0 -73.7 -27.32 61.15 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 304' ' ' TYR . . . . . 0.408 ' CE1' ' CD1' ' B' ' 354' ' ' PHE . 59.5 t80 -83.23 -25.85 31.31 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -96.67 -25.48 15.54 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 178.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 306' ' ' LYS . . . . . 0.452 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.9 ptpt -65.86 -18.09 65.1 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -177.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -72.67 -20.06 61.31 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 122.169 -0.332 . . . . 0.0 111.82 -178.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.1 mm -86.29 -46.87 16.62 Favored 'Isoleucine or valine' 0 C--N 1.338 0.071 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 174.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -162.51 166.06 36.44 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 85.6 mt -68.22 121.31 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 C-N-CA 122.604 0.362 . . . . 0.0 110.595 -175.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 94.9 mt -73.94 136.06 26.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 172.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -178.255 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo . . . . . 0 N--CA 1.45 -1.079 0 N-CA-C 109.993 -0.81 . . . . 0.0 109.993 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 321' ' ' MET . . . . . . . . . . . . . 35.3 mtt -71.86 95.48 1.54 Allowed 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 120.814 0.34 . . . . 0.0 111.482 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 322' ' ' ILE . . . . . . . . . . . . . 3.3 mp -144.51 145.68 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 323' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' B' ' 337' ' ' ALA . 18.1 m-80 -134.04 129.16 35.68 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 171.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -97.95 139.59 33.56 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -105.81 149.43 26.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 179.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.455 -0.223 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? . . . . . 0 C--O 1.23 0.058 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 75.95 5.51 80.17 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -171.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -100.05 149.22 23.71 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.491 0.716 . . . . 0.0 110.164 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 337' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' B' ' 323' ' ' ASN . . . -161.14 166.26 28.22 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 120.871 0.367 . . . . 0.0 111.398 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 2.7 p -118.71 149.84 40.76 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 169.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 42.8 t -135.58 123.21 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 171.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 16.0 t -102.04 137.99 39.58 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.001 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -101.75 161.67 13.48 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -74.42 -26.06 59.83 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -137.24 149.48 65.99 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -176.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 344' ' ' PRO . . . . . 0.445 ' HG2' ' HD3' ' B' ' 345' ' ' PRO . 41.6 Cg_endo -70.79 -32.25 14.59 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.391 2.727 . . . . 0.0 114.39 -177.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 345' ' ' PRO . . . . . 0.445 ' HD3' ' HG2' ' B' ' 344' ' ' PRO . 79.2 Cg_endo -73.89 -22.11 17.82 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 CA-C-N 121.324 1.509 . . . . 0.0 110.075 -177.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 61.2 m -71.81 -37.64 70.35 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 175.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -67.05 -37.66 84.46 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 174.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -64.82 -43.52 92.83 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.94 -34.22 75.0 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 110.675 -0.12 . . . . 0.0 110.675 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.41 -36.41 84.07 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 64.4 mt -69.73 -52.62 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 120.357 -0.537 . . . . 0.0 109.758 175.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -55.82 -28.14 54.84 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 59.8 t-105 -96.79 -54.88 3.07 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -177.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 354' ' ' PHE . . . . . 0.408 ' CD1' ' CE1' ' B' ' 304' ' ' TYR . 50.7 m-85 -78.36 -29.86 47.72 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -174.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -51.17 110.77 0.47 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.222 0.465 . . . . 0.0 111.839 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 99.7 -2.18 57.09 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 119.541 -0.588 . . . . 0.0 112.715 175.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -83.54 -163.71 0.8 Allowed 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.065 0.932 . . . . 0.0 110.641 177.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -128.53 155.6 44.61 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 121.315 0.579 . . . . 0.0 111.356 178.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -146.78 136.73 23.33 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 124.637 1.175 . . . . 0.0 112.007 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 64.2 m 52.73 19.53 1.29 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -173.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.51 23.4 39.91 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -133.0 141.48 41.13 Favored Pre-proline 0 N--CA 1.453 -0.29 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -178.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.6 135.37 30.66 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 122.862 2.375 . . . . 0.0 109.611 178.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 27.0 pt -122.48 170.82 12.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 121.187 0.518 . . . . 0.0 110.807 -177.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 9.7 tmtm? -145.66 117.93 8.42 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.537 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 10.9 t -105.48 150.13 8.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 C-N-CA 123.324 0.65 . . . . 0.0 112.01 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 30.0 t -162.27 173.88 13.61 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 176.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -71.16 130.24 40.97 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 176.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.281 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.696 179.551 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.279 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 91.9 p -78.59 7.55 6.62 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.994 0.518 . . . . 0.0 111.589 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -68.03 -6.0 20.29 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.175 0.59 . . . . 0.0 111.559 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 90.8 mtp -140.09 161.49 37.5 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.967 0.507 . . . . 0.0 110.109 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -72.77 -16.88 61.63 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 54.63 21.92 3.72 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.821 0.848 . . . . 0.0 112.578 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 44.5 t -69.97 -14.09 62.54 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.769 0.319 . . . . 0.0 110.622 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 33.7 p30 -128.05 17.62 6.67 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.041 0.937 . . . . 0.0 111.176 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -116.4 110.4 18.6 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -177.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -113.32 6.53 17.35 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.161 0.585 . . . . 0.0 111.7 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 59.2 m -109.01 143.12 38.72 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 120.956 0.408 . . . . 0.0 110.961 -176.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 24.7 pt -117.8 147.84 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 174.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 288' ' ' PHE . . . . . 0.448 ' CE2' ' C6 ' ' A' ' 14' ' ' ' U' . 48.9 t80 -99.71 143.54 29.82 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 173.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 19.5 t -127.72 141.36 46.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.813 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -129.06 149.62 50.8 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 88.54 12.67 64.39 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-O 119.818 -0.434 . . . . 0.0 112.633 169.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 65.6 mt -56.93 -51.62 68.44 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 117.532 0.666 . . . . 0.0 110.599 -175.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 147.44 173.41 18.52 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -98.58 -0.85 42.34 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 122.368 -0.489 . . . . 0.0 111.984 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -128.66 13.63 6.44 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.804 0.441 . . . . 0.0 112.168 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.1 m -75.81 165.69 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -173.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 20.7 p -131.17 158.39 40.62 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 123.335 0.654 . . . . 0.0 112.168 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 298' ' ' ILE . . . . . . . . . . . . . 37.5 mt -60.11 -44.27 94.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.267 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -62.93 -36.0 81.95 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.689 0.395 . . . . 0.0 111.505 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 75.3 m -72.22 -43.43 64.44 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 117.893 0.315 . . . . 0.0 110.258 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 71.4 t -62.62 -41.87 93.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.54 -36.86 85.57 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 303' ' ' ASP . . . . . 0.432 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 44.1 t0 -70.21 -27.19 64.29 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 304' ' ' TYR . . . . . 0.418 ' CE2' ' CD1' ' B' ' 354' ' ' PHE . 59.6 t80 -85.21 -25.97 27.03 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -96.54 -23.92 16.3 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 306' ' ' LYS . . . . . 0.432 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.6 ptpt -66.95 -18.19 65.27 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -177.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -72.69 -20.28 61.26 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.8 mm -87.01 -46.46 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.06 0 N-CA-C 110.51 -0.181 . . . . 0.0 110.51 175.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -162.22 167.63 36.91 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 80.0 mt -68.76 119.7 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 120.853 0.358 . . . . 0.0 110.499 -176.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 93.9 mt -73.84 136.39 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 172.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -71.87 133.44 45.45 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -178.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 2.1 m -95.41 139.29 31.9 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 113.18 0.808 . . . . 0.0 113.18 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -70.93 131.85 44.34 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 175.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -91.56 -4.63 55.17 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -96.8 -23.43 16.39 Favored 'General case' 0 C--N 1.338 0.095 0 C-N-CA 122.995 0.518 . . . . 0.0 110.249 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 7.1 p -128.86 -25.78 2.76 Favored 'General case' 0 C--O 1.231 0.085 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -172.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 85.27 -9.48 66.88 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 119.711 -0.494 . . . . 0.0 111.923 173.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -85.16 156.32 60.2 Favored Pre-proline 0 CA--C 1.53 0.202 0 CA-C-N 118.033 0.917 . . . . 0.0 108.91 175.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.09 156.36 66.09 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.052 1.834 . . . . 0.0 109.855 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 321' ' ' MET . . . . . 0.406 ' CB ' ' HB3' ' B' ' 340' ' ' SER . 36.0 mtt -72.62 88.34 1.26 Allowed 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 322' ' ' ILE . . . . . . . . . . . . . 4.0 mp -136.07 140.26 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 171.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -133.41 108.09 8.47 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.28 151.04 35.24 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.796 0.839 . . . . 0.0 109.273 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -117.22 150.56 38.55 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 176.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -131.52 146.98 52.49 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -175.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -78.55 129.86 35.3 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 48.4 mtp85 -85.65 -8.8 58.01 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 122.455 -0.153 . . . . 0.0 110.699 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -96.92 -14.59 21.66 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.521 0.328 . . . . 0.0 111.733 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 2.9 p -136.41 -22.79 1.29 Allowed 'General case' 0 N--CA 1.462 0.125 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 84.12 -0.03 89.49 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 176.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -82.99 157.42 22.96 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 117.579 0.69 . . . . 0.0 109.487 177.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 32.1 mt -71.68 142.08 49.87 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 9.2 mmmm -70.3 -16.99 63.08 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 123.167 0.587 . . . . 0.0 110.479 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.19 6.94 84.2 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -171.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -104.9 148.27 26.86 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.666 0.786 . . . . 0.0 110.379 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -161.96 156.67 22.65 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.845 175.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 21.3 p -103.95 153.15 21.15 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 169.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 23.3 t -135.67 128.37 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 123.582 0.753 . . . . 0.0 109.312 170.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 340' ' ' SER . . . . . 0.406 ' HB3' ' CB ' ' B' ' 321' ' ' MET . 38.7 t -106.73 144.15 33.8 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.883 0.373 . . . . 0.0 111.132 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -109.71 158.77 17.76 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -73.93 -17.61 61.0 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -145.41 149.98 42.75 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 344' ' ' PRO . . . . . 0.443 ' HG2' ' HD3' ' B' ' 345' ' ' PRO . 49.2 Cg_endo -70.51 -31.78 16.63 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.272 2.648 . . . . 0.0 114.408 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 345' ' ' PRO . . . . . 0.443 ' HD3' ' HG2' ' B' ' 344' ' ' PRO . 81.0 Cg_endo -73.43 -21.65 19.45 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 CA-C-N 121.515 1.577 . . . . 0.0 110.261 -177.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 60.1 m -73.05 -37.51 66.82 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 175.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.0 -38.35 88.26 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 174.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 9.5 tmtm? -65.13 -43.42 91.99 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -66.83 -34.15 77.18 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.92 -36.74 85.35 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 67.2 mt -69.73 -51.62 39.32 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.094 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.733 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -54.74 -29.49 53.77 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 57.5 t-105 -97.79 -56.4 2.52 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -177.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 354' ' ' PHE . . . . . 0.418 ' CD1' ' CE2' ' B' ' 304' ' ' TYR . 50.7 m-85 -75.8 -28.42 58.33 Favored 'General case' 0 CA--C 1.523 -0.08 0 N-CA-C 114.571 1.322 . . . . 0.0 114.571 -173.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -52.27 108.23 0.27 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 117.844 0.293 . . . . 0.0 111.506 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 100.41 -0.89 55.78 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-O 119.662 -0.521 . . . . 0.0 112.729 175.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -83.72 -165.01 1.0 Allowed 'General case' 0 N--CA 1.461 0.096 0 CA-C-N 118.296 1.048 . . . . 0.0 110.371 176.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -127.41 153.37 46.34 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-O 121.02 0.438 . . . . 0.0 110.83 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -145.57 136.64 24.73 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.307 1.043 . . . . 0.0 112.212 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 21.5 t 53.99 19.28 1.96 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.57 0.348 . . . . 0.0 111.302 -175.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.14 23.18 41.88 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.871 -0.492 . . . . 0.0 111.871 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -132.37 142.42 44.9 Favored Pre-proline 0 N--CA 1.455 -0.22 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.52 136.15 32.87 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 122.873 2.382 . . . . 0.0 109.67 178.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 25.5 pt -124.05 171.07 13.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-O 121.173 0.511 . . . . 0.0 111.025 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -146.02 119.4 9.0 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.434 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 13.3 t -108.04 150.03 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 123.14 0.576 . . . . 0.0 112.133 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 29.1 t -163.85 173.12 13.11 Favored 'General case' 0 C--N 1.339 0.15 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -69.93 130.13 41.37 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 176.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -90.15 178.67 6.11 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.144 0.497 . . . . 0.0 111.922 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 10.2 t -144.56 -154.81 0.56 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.827 1.251 . . . . 0.0 107.783 172.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -124.87 82.08 2.02 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 118.966 0.803 . . . . 0.0 110.832 174.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -62.92 -17.25 61.54 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 172.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.89 -31.65 69.99 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 122.499 0.319 . . . . 0.0 110.278 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -63.01 -11.61 20.2 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -174.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -76.41 -15.21 59.99 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -136.83 -12.23 1.73 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -177.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 52.8 mmm-85 . . . . . 0 C--O 1.252 1.184 0 CA-C-O 117.11 -1.424 . . . . 0.0 110.718 175.63 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.537 0 N19-C1'-C2' 109.232 -2.605 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.518 0 C5'-C4'-C3' 111.969 -2.354 . 0.732 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ' C' . . . . . 0.432 HO2' " H5'" ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.518 0 N19-C1'-C2' 109.089 -2.694 . 0.717 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . 0.432 " H5'" HO2' ' A' ' 3' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.423 -2.478 0 N19-C1'-C2' 108.695 -2.941 . 0.804 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.557 0 N19-C1'-C2' 108.271 -3.206 . 0.784 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.423 0 N19-C1'-C2' 108.829 -2.857 . 0.785 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.753 0 O4'-C1'-N19 111.169 2.969 . 0.785 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.501 0 O4'-C1'-N19 111.35 3.15 . 0.745 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.484 0 C4'-C3'-C2' 99.647 -3.053 . 0.667 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.619 0 C4'-C3'-C2' 99.908 -2.792 . 0.585 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ' A' . . . . . 0.666 HO2' " C5'" ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.424 -2.417 0 O4'-C1'-N19 110.842 2.642 . 0.268 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ' A' . . . . . 0.666 " C5'" HO2' ' A' ' 11' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.425 -2.364 0 O4'-C1'-N19 112.15 3.95 . 0.141 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.707 1 C5'-C4'-C3' 109.399 -4.067 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ' U' . . . . . 0.448 ' C6 ' ' CE2' ' B' ' 288' ' ' PHE . . . . . . . . 0 O4'--C4' 1.425 -2.293 0 O4'-C1'-N19 112.054 3.854 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.623 3.042 0 C5'-C4'-C3' 112.162 -2.225 . 0.257 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.162 0 O4'-C1'-N19 111.739 3.539 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ' A' . . . . . 0.578 HO2' " H5'" ' A' ' 18' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.425 -2.328 0 N19-C1'-C2' 109.061 -2.712 . 0.581 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ' U' . . . . . 0.578 " H5'" HO2' ' A' ' 17' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.523 0 O4'-C1'-N19 110.884 2.684 . 0.823 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ' U' . . . . . 0.445 HO2' " C5'" ' A' ' 20' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.597 0 O4'-C1'-N19 110.897 2.697 . 0.841 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ' U' . . . . . 0.571 HO2' " H5'" ' A' ' 21' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.423 -2.483 0 C4'-C3'-C2' 100.252 -2.448 . 0.637 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ' G' . . . . . 0.571 " H5'" HO2' ' A' ' 20' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.577 0 C5'-C4'-C3' 112.076 -2.283 . 0.748 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ' C' . . . . . 0.528 HO2' " H5'" ' A' ' 23' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.421 -2.654 0 O4'-C1'-N19 110.882 2.682 . 0.813 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ' C' . . . . . 0.528 " H5'" HO2' ' A' ' 22' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.419 -2.797 0 C5'-C4'-C3' 111.911 -2.393 . 0.749 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.265 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 91.2 p -77.69 3.25 14.44 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.932 0.493 . . . . 0.0 111.407 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 16.8 m80 -63.34 158.57 20.1 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.191 0.597 . . . . 0.0 110.847 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.7 159.37 27.93 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 122.585 0.354 . . . . 0.0 110.619 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -155.67 155.97 34.14 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 53.83 21.72 2.89 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.573 0.749 . . . . 0.0 112.204 -177.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 88.1 p -69.18 -12.99 62.16 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.646 0.378 . . . . 0.0 110.484 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 32.7 p30 -124.27 20.63 8.88 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.063 0.945 . . . . 0.0 111.139 177.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -128.02 113.78 16.25 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -177.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -113.26 2.34 15.52 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.833 0.453 . . . . 0.0 110.584 -178.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 29.3 m -101.5 141.77 33.87 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.011 0.434 . . . . 0.0 111.521 -173.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 38.2 pt -116.6 146.63 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.958 172.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 288' ' ' PHE . . . . . 0.486 ' CE1' ' C6 ' ' A' ' 14' ' ' ' U' . 54.2 t80 -97.94 144.56 27.36 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 173.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 19.4 t -132.34 141.5 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 122.783 0.433 . . . . 0.0 110.969 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -130.92 154.4 48.15 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 122.858 0.463 . . . . 0.0 109.797 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 86.46 12.92 68.89 Favored Glycine 0 CA--C 1.521 0.469 0 CA-C-O 119.831 -0.427 . . . . 0.0 112.355 169.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 74.7 mt -57.49 -50.1 74.16 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 117.54 0.67 . . . . 0.0 110.336 -176.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 144.16 171.03 13.93 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -98.0 3.21 49.49 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 122.544 -0.386 . . . . 0.0 111.855 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -128.29 11.9 6.46 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.638 0.375 . . . . 0.0 111.769 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.6 m -74.8 163.75 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -173.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 20.3 p -128.87 158.93 37.37 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 123.589 0.755 . . . . 0.0 111.85 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 298' ' ' ILE . . . . . . . . . . . . . 40.4 mt -60.29 -44.38 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.547 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -68.72 -30.48 69.13 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 74.8 m -72.16 -43.96 63.81 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 118.17 0.441 . . . . 0.0 109.837 177.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 71.8 t -62.78 -41.05 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.21 -37.38 87.27 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 303' ' ' ASP . . . . . 0.417 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 44.4 t0 -70.16 -26.87 64.12 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -85.71 -25.46 26.48 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -96.71 -24.18 16.09 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 306' ' ' LYS . . . . . 0.417 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.6 ptpt -67.11 -18.12 65.17 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 111.576 0.213 . . . . 0.0 111.576 -177.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -72.79 -20.01 61.24 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.2 mm -87.18 -45.69 16.26 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 CA-C-N 117.732 0.242 . . . . 0.0 110.48 175.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.4 167.68 37.74 Favored Glycine 0 C--N 1.335 0.502 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 78.3 mt -69.35 120.4 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-O 120.935 0.397 . . . . 0.0 110.717 -175.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 86.8 mt -75.19 134.47 29.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 171.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -71.11 136.21 48.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 4.8 m -96.86 139.86 32.28 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 176.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.74 135.6 40.32 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -90.33 -9.45 47.75 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 174.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 316' ' ' LYS . . . . . 0.524 ' HB3' ' H62' ' A' ' 17' ' ' ' A' . 71.4 mmtt -91.39 -20.39 21.87 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.603 0.761 . . . . 0.0 110.106 -177.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 11.2 p -135.73 -23.42 1.39 Allowed 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -174.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 83.64 -11.36 56.59 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 119.879 -0.401 . . . . 0.0 112.448 175.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -86.83 159.17 52.49 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 117.876 0.838 . . . . 0.0 109.277 175.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -67.21 155.09 72.13 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 121.724 1.616 . . . . 0.0 109.288 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 321' ' ' MET . . . . . 0.468 ' CB ' ' HB2' ' B' ' 340' ' ' SER . 30.1 mtt -71.38 93.62 1.16 Allowed 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.152 0.501 . . . . 0.0 111.636 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 322' ' ' ILE . . . . . . . . . . . . . 3.4 mp -140.89 139.52 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 173.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -132.01 106.32 7.96 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 35.0 mt -78.32 153.41 31.74 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 123.891 0.744 . . . . 0.0 109.361 176.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -119.87 149.49 41.99 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 176.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 3.0 m -131.1 148.16 52.7 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -174.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -76.43 131.24 38.97 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 54.0 mtp85 -84.37 -4.39 58.86 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -99.63 -12.48 20.02 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.936 0.494 . . . . 0.0 111.883 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 29.8 p -136.77 -28.2 0.98 Allowed 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 75.29 12.47 83.53 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -70.28 -108.79 0.0 OUTLIER 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.113 0.965 . . . . 0.0 110.395 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 5.8 mt -160.83 143.63 12.89 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 171.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -77.02 -18.14 58.35 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 122.656 0.382 . . . . 0.0 110.622 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 74.44 5.34 72.41 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -173.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -106.02 149.77 26.37 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.017 0.527 . . . . 0.0 110.167 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -163.52 160.1 22.77 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.727 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 27.4 p -106.88 153.82 21.96 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 169.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 22.1 t -134.26 129.36 53.32 Favored 'Isoleucine or valine' 0 C--O 1.23 0.038 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 170.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 340' ' ' SER . . . . . 0.468 ' HB2' ' CB ' ' B' ' 321' ' ' MET . 20.4 m -108.54 134.62 51.05 Favored 'General case' 0 C--O 1.23 0.068 0 CA-C-O 120.677 0.275 . . . . 0.0 110.3 -176.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -101.14 159.98 14.78 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -70.67 -36.04 73.15 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -127.52 149.06 69.08 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 344' ' ' PRO . . . . . 0.45 ' N ' ' CD ' ' B' ' 345' ' ' PRO . 45.4 Cg_endo -70.83 -31.31 15.98 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.006 2.47 . . . . 0.0 114.647 -177.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 345' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' B' ' 344' ' ' PRO . 89.6 Cg_endo -73.61 -21.05 19.7 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 CA-C-N 121.222 1.472 . . . . 0.0 110.087 -177.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 49.0 m -71.25 -37.64 71.95 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 175.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.14 -39.44 89.84 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 174.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -63.36 -44.22 95.43 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.9 -33.92 75.64 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.117 0.167 . . . . 0.0 110.616 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.71 -37.86 89.04 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 67.3 mt -68.59 -53.05 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 120.35 -0.54 . . . . 0.0 109.973 175.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -54.93 -28.08 48.29 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -97.51 -55.47 2.81 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -76.92 -28.29 55.21 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -173.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -52.29 108.5 0.3 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 117.953 0.342 . . . . 0.0 111.366 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 101.61 -0.8 52.82 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.547 -0.585 . . . . 0.0 112.647 175.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 357' ' ' LYS . . . . . 0.594 ' HZ2' ' HB3' ' B' ' 357' ' ' LYS . 9.2 mtpm? -83.88 -163.11 0.72 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 118.09 0.945 . . . . 0.0 110.57 177.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -130.71 153.27 49.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.046 0.451 . . . . 0.0 110.464 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -145.81 138.0 25.43 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.224 1.01 . . . . 0.0 112.408 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 19.2 t 55.49 17.13 2.09 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.858 0.361 . . . . 0.0 111.026 -175.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.01 22.57 41.44 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.858 -0.497 . . . . 0.0 111.858 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 42.6 m-20 -132.26 142.41 44.89 Favored Pre-proline 0 N--CA 1.455 -0.181 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.84 135.5 32.87 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 122.709 2.272 . . . . 0.0 109.872 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 31.3 pt -121.63 170.69 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-O 120.948 0.404 . . . . 0.0 111.16 -177.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -143.21 112.84 6.93 Favored 'General case' 0 C--O 1.227 -0.083 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.793 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 6.3 t -103.85 149.73 7.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 C-N-CA 122.878 0.471 . . . . 0.0 112.258 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 29.4 t -164.13 175.02 10.59 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -71.73 129.77 39.47 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 175.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -85.44 177.23 7.85 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.329 0.585 . . . . 0.0 112.325 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 14.9 t -147.65 -155.01 0.59 Allowed 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.278 1.031 . . . . 0.0 109.208 174.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -121.56 76.27 1.25 Allowed 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 118.357 0.526 . . . . 0.0 110.356 176.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -61.86 -17.36 56.18 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 171.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.47 -35.17 71.76 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 123.108 0.563 . . . . 0.0 110.316 175.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -64.07 -10.38 21.84 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -173.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -79.96 -16.78 54.52 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 177.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -134.07 -16.12 2.22 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -176.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 7.2 mmp_? . . . . . 0 C--O 1.251 1.157 0 CA-C-O 117.18 -1.391 . . . . 0.0 110.57 177.171 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ' G' . . . . . 0.626 HO2' " H5'" ' A' ' 2' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.421 -2.667 0 N19-C1'-C2' 108.966 -2.772 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ' G' . . . . . 0.626 " H5'" HO2' ' A' ' 1' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.424 -2.427 0 O4'-C1'-N19 110.58 2.38 . 0.642 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.538 0 O4'-C1'-N19 111.187 2.987 . 0.8 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.407 0 N19-C1'-C2' 109.231 -2.606 . 0.738 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ' G' . . . . . 0.489 HO2' " H5'" ' A' ' 6' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.425 -2.371 0 N19-C1'-C2' 108.79 -2.881 . 0.739 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ' A' . . . . . 0.568 HO2' " H5'" ' A' ' 7' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.426 -2.29 0 N19-C1'-C2' 109.217 -2.615 . 0.774 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ' U' . . . . . 0.568 " H5'" HO2' ' A' ' 6' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.424 -2.392 0 O4'-C1'-N19 110.913 2.713 . 0.786 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ' U' . . . . . 0.539 " H5'" HO2' ' A' ' 7' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.421 -2.627 0 C4'-C3'-C2' 99.917 -2.783 . 0.738 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.479 0 C4'-C3'-C2' 99.639 -3.061 . 0.671 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.43 0 C4'-C3'-C2' 100.027 -2.673 . 0.638 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ' A' . . . . . 0.694 HO2' " C5'" ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.514 0 O4'-C1'-N19 110.798 2.598 . 0.345 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ' A' . . . . . 0.694 " C5'" HO2' ' A' ' 11' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.425 -2.352 0 O4'-C1'-N19 111.993 3.793 . 0.103 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.876 1 C5'-C4'-C3' 109.406 -4.063 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ' U' . . . . . 0.486 ' C6 ' ' CE1' ' B' ' 288' ' ' PHE . . . . . . . . 0 O4'--C4' 1.424 -2.427 0 O4'-C1'-N19 112.184 3.984 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.622 2.872 0 C5'-C4'-C3' 111.592 -2.605 . 0.232 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ' U' . . . . . 0.578 HO2' " H5'" ' A' ' 17' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.426 -2.219 0 O4'-C1'-N19 111.419 3.219 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ' A' . . . . . 0.578 " H5'" HO2' ' A' ' 16' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.421 -2.649 0 N19-C1'-C2' 108.991 -2.756 . 0.702 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ' U' . . . . . 0.481 " H5'" HO2' ' A' ' 17' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.424 -2.398 0 O4'-C1'-N19 110.891 2.691 . 0.847 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.59 0 O4'-C1'-N19 110.966 2.766 . 0.807 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ' U' . . . . . 0.638 HO2' " H5'" ' A' ' 21' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.421 -2.632 0 O4'-C1'-N19 111.016 2.816 . 0.723 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ' G' . . . . . 0.638 " H5'" HO2' ' A' ' 20' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.569 0 C4'-C3'-C2' 100.288 -2.412 . 0.711 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.704 0 C5'-C4'-C3' 111.353 -2.765 . 0.809 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.475 0 N19-C1'-C2' 109.705 -2.31 . 0.822 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.076 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 96.2 p -75.16 167.55 21.7 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.72 0.408 . . . . 0.0 110.831 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 55.32 23.34 5.55 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.717 0.807 . . . . 0.0 112.336 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.22 124.04 7.33 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 14.5 p30 -88.01 -24.0 23.64 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 177.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -91.34 31.79 1.11 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.158 0.583 . . . . 0.0 110.608 176.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 46.9 t -64.16 -16.38 61.77 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 122.379 -0.201 . . . . 0.0 111.412 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 26.1 p30 -95.07 7.51 45.88 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.238 0.615 . . . . 0.0 112.554 177.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -144.12 110.82 5.63 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.889 0.376 . . . . 0.0 110.674 -176.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . 0.423 HD22 ' C ' ' B' ' 285' ' ' ASN . 0.2 OUTLIER -113.11 8.87 18.45 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.696 -179.57 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 87.7 m -107.97 143.76 36.19 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.148 0.499 . . . . 0.0 110.887 -174.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 41.5 pt -117.34 147.13 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.528 -0.76 . . . . 0.0 108.971 174.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 288' ' ' PHE . . . . . 0.477 ' CE1' ' C6 ' ' A' ' 14' ' ' ' U' . 54.0 t80 -99.45 145.67 27.18 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 173.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 13.5 t -129.69 143.25 41.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 122.651 0.38 . . . . 0.0 111.403 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -131.65 149.57 52.45 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 122.952 0.501 . . . . 0.0 109.829 175.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 88.57 12.06 65.25 Favored Glycine 0 CA--C 1.522 0.494 0 CA-C-O 119.69 -0.506 . . . . 0.0 112.511 169.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 47.0 mt -57.45 -51.53 69.06 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 117.659 0.729 . . . . 0.0 110.836 -174.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 152.55 176.97 25.71 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -95.72 -14.85 23.05 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 122.311 -0.523 . . . . 0.0 112.118 -175.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -128.62 18.72 6.26 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.278 0.49 . . . . 0.0 112.093 -178.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.3 m -65.96 164.4 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -175.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 18.1 p -126.26 160.89 29.07 Favored 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 123.267 0.627 . . . . 0.0 112.265 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 298' ' ' ILE . . . . . . . . . . . . . 28.6 mt -64.54 -43.5 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.966 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -65.26 -37.29 86.76 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 79.5 p -73.29 -42.63 62.2 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 118.137 0.426 . . . . 0.0 110.494 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.5 -41.57 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.79 -36.0 82.92 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 303' ' ' ASP . . . . . 0.407 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.0 t0 -70.43 -26.62 63.75 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -84.17 -26.68 28.63 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -96.43 -24.9 15.9 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 306' ' ' LYS . . . . . 0.407 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.6 ptpt -66.5 -18.89 65.62 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -177.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -71.8 -20.04 61.91 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -178.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 5.4 mm -87.21 -46.17 16.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 175.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -164.03 168.19 38.39 Favored Glycine 0 C--N 1.335 0.49 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 82.4 mt -69.16 122.03 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 122.603 0.361 . . . . 0.0 110.433 -175.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 95.9 mt -75.69 137.58 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 173.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -72.19 134.08 45.48 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 1.5 m -94.39 139.82 30.61 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -68.75 126.04 28.46 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 175.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -82.37 -8.01 59.63 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 122.433 -0.167 . . . . 0.0 110.594 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.57 -46.05 4.27 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.05 0.54 . . . . 0.0 110.767 -176.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 15.6 p -91.24 -25.47 19.48 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 84.67 -11.54 58.99 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 119.733 -0.482 . . . . 0.0 112.219 174.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -83.9 158.34 62.12 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 117.966 0.883 . . . . 0.0 109.205 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -67.22 154.29 74.68 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 121.812 1.674 . . . . 0.0 109.453 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 321' ' ' MET . . . . . 0.419 ' C ' HD11 ' B' ' 322' ' ' ILE . 35.9 mtt -71.54 86.14 0.87 Allowed 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.907 0.384 . . . . 0.0 111.617 -178.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 322' ' ' ILE . . . . . 0.419 HD11 ' C ' ' B' ' 321' ' ' MET . 3.7 mp -134.07 143.48 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 171.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -130.76 138.38 49.92 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 171.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 86.4 mt -110.48 129.36 55.8 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 176.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -94.55 154.23 17.49 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -177.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.74 143.06 38.87 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -173.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -76.01 134.62 40.08 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -82.24 -15.15 54.1 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 122.588 -0.07 . . . . 0.0 110.875 176.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -92.3 -15.01 27.95 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -176.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 19.3 p -137.68 -22.37 1.1 Allowed 'General case' 0 C--N 1.339 0.145 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 80.04 2.4 88.73 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -85.33 158.64 20.22 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 117.849 0.824 . . . . 0.0 108.987 177.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 10.2 mp -68.23 143.23 55.37 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -178.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -73.15 -16.28 61.44 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 123.062 0.545 . . . . 0.0 110.483 176.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.8 6.07 84.78 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -171.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -104.11 152.16 22.44 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.629 0.771 . . . . 0.0 109.91 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -160.25 169.66 22.74 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.898 0.38 . . . . 0.0 111.171 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 1.7 p -126.48 150.47 48.7 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 170.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 21.3 t -135.35 125.06 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 C-N-CA 123.577 0.751 . . . . 0.0 109.252 172.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 23.5 t -104.26 136.17 44.36 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.552 0.215 . . . . 0.0 110.605 -178.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -101.66 158.63 15.96 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -177.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -72.87 -31.08 64.47 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -129.54 146.68 62.11 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 344' ' ' PRO . . . . . 0.446 ' HG2' ' HD3' ' B' ' 345' ' ' PRO . 46.8 Cg_endo -70.99 -32.21 13.82 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.219 2.613 . . . . 0.0 114.38 -177.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 345' ' ' PRO . . . . . 0.446 ' HD3' ' HG2' ' B' ' 344' ' ' PRO . 77.9 Cg_endo -73.49 -21.93 18.99 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 CA-C-N 121.256 1.484 . . . . 0.0 110.101 -176.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 67.3 m -70.73 -35.14 72.55 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 175.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -68.73 -39.28 80.46 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.62 -43.73 98.31 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 177.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.94 -35.09 76.38 Favored 'General case' 0 C--O 1.225 -0.201 0 O-C-N 122.371 -0.206 . . . . 0.0 110.462 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.31 -36.52 84.33 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 60.0 mt -71.21 -49.18 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.165 175.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -59.98 -27.58 66.95 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -175.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -96.55 -57.33 2.34 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -75.09 -30.93 61.06 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -173.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -54.19 111.17 0.72 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 118.128 0.422 . . . . 0.0 110.947 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 102.03 -3.0 51.65 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 119.556 -0.58 . . . . 0.0 112.559 176.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -84.42 -164.15 0.91 Allowed 'General case' 0 C--O 1.232 0.137 0 CA-C-N 118.093 0.947 . . . . 0.0 109.787 177.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -128.53 153.34 47.28 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.06 0.457 . . . . 0.0 110.971 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -145.01 135.96 24.73 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.041 0.936 . . . . 0.0 112.101 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 62.7 m 53.31 19.5 1.59 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.516 0.327 . . . . 0.0 111.802 -174.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.74 23.23 39.79 Favored Glycine 0 C--N 1.339 0.733 0 N-CA-C 111.784 -0.526 . . . . 0.0 111.784 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 56.9 m-20 -132.55 142.25 44.17 Favored Pre-proline 0 N--CA 1.452 -0.333 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -177.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.83 135.37 30.11 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.804 2.336 . . . . 0.0 109.72 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 30.6 pt -122.9 169.91 13.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.22 0.533 . . . . 0.0 111.166 -177.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 5.3 tmtm? -145.72 114.05 6.66 Favored 'General case' 0 C--N 1.338 0.069 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 11.2 t -103.89 149.73 7.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.077 0.551 . . . . 0.0 112.24 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 28.1 t -162.71 172.42 15.31 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 176.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -70.48 130.17 41.17 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -91.66 -179.88 5.46 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.277 -177.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 9.3 t -148.3 -155.93 0.67 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.893 1.277 . . . . 0.0 107.782 173.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -122.56 92.83 3.8 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 119.033 0.833 . . . . 0.0 111.047 173.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -69.26 -9.05 51.33 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 116.763 -0.199 . . . . 0.0 110.754 173.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -61.21 -24.68 66.52 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 122.492 0.317 . . . . 0.0 110.622 175.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -65.56 -15.44 62.71 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.856 0.462 . . . . 0.0 112.098 -176.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -76.33 -17.77 59.25 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -132.64 -14.01 2.88 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.312 0 CA-C-O 117.788 -1.101 . . . . 0.0 110.326 177.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.493 0 N19-C1'-C2' 108.918 -2.801 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.637 0 O4'-C1'-N19 110.336 2.136 . 0.68 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.624 0 C5'-C4'-C3' 111.386 -2.743 . 0.699 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . 0.525 HO2' " H5'" ' A' ' 5' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.422 -2.544 0 N19-C1'-C2' 109.04 -2.725 . 0.839 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ' G' . . . . . 0.525 " H5'" HO2' ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.576 0 N19-C1'-C2' 108.444 -3.097 . 0.741 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ' A' . . . . . 0.638 HO2' " H5'" ' A' ' 7' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.425 -2.36 0 N19-C1'-C2' 108.965 -2.772 . 0.786 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ' U' . . . . . 0.638 " H5'" HO2' ' A' ' 6' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.771 0 O4'-C1'-N19 111.07 2.87 . 0.74 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.441 0 C4'-C3'-C2' 99.938 -2.762 . 0.731 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.36 0 C4'-C3'-C2' 99.712 -2.988 . 0.662 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.644 0 C4'-C3'-C2' 99.516 -3.184 . 0.486 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ' A' . . . . . 0.679 HO2' " C5'" ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.426 -2.246 0 O4'-C1'-N19 110.973 2.773 . 0.232 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ' A' . . . . . 0.679 " C5'" HO2' ' A' ' 11' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.424 -2.419 1 O4'-C1'-N19 112.505 4.305 . 0.097 1b . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ' U' . . . . . 0.451 " C1'" HO2' ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.685 0 C5'-C4'-C3' 109.672 -3.885 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ' U' . . . . . 0.477 ' C6 ' ' CE1' ' B' ' 288' ' ' PHE . . . . . . . . 0 O4'--C4' 1.422 -2.572 0 O4'-C1'-N19 111.76 3.56 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.623 3.007 0 O4'-C1'-N19 110.31 2.11 . 0.51 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.5 0 O4'-C1'-N19 111.437 3.237 . 0.43 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.272 0 N19-C1'-C2' 109.298 -2.564 . 0.544 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.571 0 O4'-C1'-N19 110.808 2.608 . 0.803 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ' U' . . . . . 0.434 HO2' " C5'" ' A' ' 20' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.423 -2.503 0 O4'-C1'-N19 111.03 2.83 . 0.849 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ' U' . . . . . 0.562 HO2' " H5'" ' A' ' 21' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.422 -2.574 0 O4'-C1'-N19 110.681 2.481 . 0.674 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ' G' . . . . . 0.562 " H5'" HO2' ' A' ' 20' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.424 -2.446 0 C4'-C3'-C2' 100.408 -2.292 . 0.738 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ' C' . . . . . 0.554 " H5'" HO2' ' A' ' 21' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.421 -2.649 0 C5'-C4'-C3' 111.643 -2.572 . 0.779 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.623 0 N19-C1'-C2' 109.492 -2.442 . 0.796 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.167 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 93.2 p -77.13 16.35 0.58 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.401 0.68 . . . . 0.0 111.753 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -66.12 -9.29 29.92 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.176 0.59 . . . . 0.0 111.704 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 279' ' ' MET . . . . . 0.549 ' HG3' ' H ' ' B' ' 281' ' ' ASN . 56.1 tpp -155.44 152.8 29.42 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -65.49 -20.2 66.25 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 281' ' ' ASN . . . . . 0.549 ' H ' ' HG3' ' B' ' 279' ' ' MET . 37.4 m-20 -84.61 39.7 0.75 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.3 0.64 . . . . 0.0 110.135 175.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 92.3 p -61.95 -19.3 62.6 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.545 0.338 . . . . 0.0 111.285 -177.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -93.22 3.72 55.2 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 176.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -144.41 109.96 5.24 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.957 0.408 . . . . 0.0 110.416 -176.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -117.42 8.12 12.95 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 122.987 0.515 . . . . 0.0 112.354 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 35.0 m -104.88 140.79 37.61 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -173.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 41.1 pt -110.29 142.82 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 288' ' ' PHE . . . . . 0.465 ' CE2' ' C6 ' ' A' ' 14' ' ' ' U' . 56.7 t80 -93.79 141.91 27.97 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 172.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 15.9 t -130.38 141.18 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 O-C-N 123.156 0.285 . . . . 0.0 111.173 177.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -126.98 154.12 45.01 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 174.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 85.47 12.18 73.31 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-O 119.772 -0.46 . . . . 0.0 112.425 169.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 60.0 mt -56.69 -50.59 71.7 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 117.536 0.668 . . . . 0.0 110.752 -175.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 156.79 179.69 31.95 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -97.79 -8.43 28.49 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -177.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -141.22 24.4 2.13 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.5 m -67.95 162.81 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -174.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 20.8 p -122.84 156.51 34.43 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 298' ' ' ILE . . . . . . . . . . . . . 35.4 mt -61.56 -43.23 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.038 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -65.15 -35.73 82.02 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.61 0.364 . . . . 0.0 111.54 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 38.6 t -73.23 -44.1 60.11 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 122.25 -0.281 . . . . 0.0 110.389 -178.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 93.9 t -62.08 -41.51 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.95 -35.23 80.51 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 303' ' ' ASP . . . . . 0.413 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 44.7 t0 -70.97 -29.28 65.22 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 304' ' ' TYR . . . . . 0.413 ' CE1' ' CD1' ' B' ' 354' ' ' PHE . 59.9 t80 -83.77 -24.96 30.88 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -96.62 -23.35 16.53 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 306' ' ' LYS . . . . . 0.413 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.7 ptpt -67.81 -16.76 64.26 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -73.02 -19.86 61.11 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 111.561 0.208 . . . . 0.0 111.561 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 3.9 mm -87.07 -47.76 15.8 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.109 0 CA-C-O 120.525 0.202 . . . . 0.0 110.781 175.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -161.4 175.38 38.0 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 74.4 mt -73.86 111.89 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-O 120.808 0.337 . . . . 0.0 110.133 -176.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 73.6 mt -68.16 135.53 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 172.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 312' ' ' LYS . . . . . 0.436 ' HG2' ' SD ' ' B' ' 321' ' ' MET . 40.7 ttmt -66.39 136.17 55.36 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -178.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 4.9 m -110.96 135.69 51.09 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.444 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -67.39 132.8 48.37 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -176.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -80.96 -5.41 57.48 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -108.44 -14.55 14.64 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 123.281 0.632 . . . . 0.0 111.68 -175.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 7.5 p -133.42 -25.04 1.76 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -176.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 80.58 -5.99 62.78 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 119.822 -0.432 . . . . 0.0 112.6 174.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -90.24 157.3 45.35 Favored Pre-proline 0 CA--C 1.531 0.223 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 175.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -66.05 150.19 85.47 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 121.288 1.325 . . . . 0.0 108.88 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 321' ' ' MET . . . . . 0.436 ' SD ' ' HG2' ' B' ' 312' ' ' LYS . 81.2 mtp -85.65 85.27 7.42 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.573 0.702 . . . . 0.0 111.09 -172.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 322' ' ' ILE . . . . . 0.402 HG13 ' CG1' ' B' ' 339' ' ' VAL . 2.3 mp -118.12 149.78 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 125.257 1.423 . . . . 0.0 108.328 174.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -134.94 116.16 14.4 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 170.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 55.5 mt -90.44 150.06 21.98 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 177.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -115.12 150.89 35.29 Favored 'General case' 0 C--O 1.226 -0.183 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 3.1 m -137.7 148.09 45.37 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -176.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -81.47 135.13 35.61 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 38.4 mtt-85 -84.7 -9.82 57.87 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.387 -0.196 . . . . 0.0 110.98 175.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -91.15 -15.02 30.04 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.554 0.342 . . . . 0.0 111.794 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 6.1 p -137.58 -25.83 1.0 Allowed 'General case' 0 C--O 1.232 0.175 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 73.32 10.47 78.81 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 119.659 -0.523 . . . . 0.0 111.913 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -74.6 -101.62 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.173 0.589 . . . . 0.0 110.288 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 2.2 tp -164.84 146.18 7.85 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.072 0.949 . . . . 0.0 108.645 172.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -78.58 -18.93 53.86 Favored 'General case' 0 N--CA 1.461 0.092 0 CA-C-N 117.836 0.289 . . . . 0.0 110.533 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 72.59 5.12 62.99 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -172.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -103.48 150.63 23.7 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.275 0.63 . . . . 0.0 110.354 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.16 169.4 24.25 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.008 0.433 . . . . 0.0 110.328 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 2.5 p -132.3 147.44 52.4 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 171.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 339' ' ' VAL . . . . . 0.402 ' CG1' HG13 ' B' ' 322' ' ' ILE . 1.0 OUTLIER -137.27 141.46 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 169.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 44.6 t -92.36 145.46 24.46 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.585 -177.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -112.46 151.92 29.34 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 175.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -70.61 -22.77 62.5 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 343' ' ' ASP . . . . . 0.415 ' HB3' ' HD2' ' B' ' 345' ' ' PRO . 48.3 m-20 -144.49 148.31 39.82 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 124.025 0.93 . . . . 0.0 111.769 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 344' ' ' PRO . . . . . 0.448 ' HG2' ' HD3' ' B' ' 345' ' ' PRO . 53.6 Cg_endo -71.62 -31.81 12.87 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.507 2.804 . . . . 0.0 115.063 -172.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 345' ' ' PRO . . . . . 0.448 ' HD3' ' HG2' ' B' ' 344' ' ' PRO . 98.7 Cg_endo -73.51 -22.44 18.35 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 CA-C-N 121.286 1.495 . . . . 0.0 109.841 -178.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 48.7 m -73.21 -34.14 65.76 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 175.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -67.31 -41.21 85.73 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 175.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -70.85 -32.91 70.07 Favored 'General case' 0 C--O 1.227 -0.108 0 C-N-CA 121.16 -0.216 . . . . 0.0 110.841 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.07 -36.88 80.56 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 175.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.43 -36.99 85.58 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 71.5 mt -68.16 -52.67 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 175.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -55.12 -29.75 58.33 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 54.1 t-105 -96.64 -55.14 3.0 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 354' ' ' PHE . . . . . 0.413 ' CD1' ' CE1' ' B' ' 304' ' ' TYR . 51.0 m-85 -76.16 -27.21 56.89 Favored 'General case' 0 CA--C 1.522 -0.119 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 -173.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -49.19 109.68 0.29 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 117.98 0.355 . . . . 0.0 111.932 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 96.79 0.45 60.47 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 119.477 -0.624 . . . . 0.0 112.736 174.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -83.62 -164.6 0.94 Allowed 'General case' 0 C--N 1.339 0.111 0 CA-C-N 118.209 1.004 . . . . 0.0 110.186 176.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -128.97 152.12 48.93 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 120.981 0.42 . . . . 0.0 110.83 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -144.25 136.45 26.45 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.186 0.994 . . . . 0.0 112.451 177.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 20.7 t 54.36 19.0 2.08 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.517 0.327 . . . . 0.0 111.125 -175.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.48 23.78 38.67 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 112.004 -0.438 . . . . 0.0 112.004 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -132.8 142.62 45.4 Favored Pre-proline 0 N--CA 1.455 -0.213 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -177.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.8 136.61 33.32 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 122.751 2.3 . . . . 0.0 109.441 178.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 33.6 pt -123.69 169.95 14.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 CA-C-O 121.203 0.525 . . . . 0.0 111.259 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -143.33 113.79 7.43 Favored 'General case' 0 C--O 1.23 0.043 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.765 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 12.2 t -105.39 147.55 10.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.002 0.521 . . . . 0.0 112.2 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 23.0 t -163.68 172.94 13.53 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -71.76 129.58 39.01 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 175.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -80.58 174.43 11.62 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.878 -178.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 3.6 p -134.45 -155.77 0.68 Allowed 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.647 1.179 . . . . 0.0 110.644 174.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -120.43 71.19 0.91 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 118.185 0.448 . . . . 0.0 110.981 176.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -65.24 -10.71 34.13 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 170.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -64.17 -35.53 81.09 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.55 0.74 . . . . 0.0 110.473 171.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -70.24 -6.61 35.93 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -171.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -74.79 -16.28 60.72 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 176.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -136.59 -14.48 1.67 Allowed 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 8.7 ptp85 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 117.787 -1.102 . . . . 0.0 110.477 178.815 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.725 0 N19-C1'-C2' 108.965 -2.772 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.396 0 O4'-C1'-N19 110.667 2.467 . 0.712 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ' C' . . . . . 0.505 HO2' " H5'" ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.487 0 C5'-C4'-C3' 111.523 -2.651 . 0.738 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . 0.632 HO2' " H5'" ' A' ' 5' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.421 -2.661 0 N19-C1'-C2' 108.788 -2.882 . 0.778 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ' G' . . . . . 0.632 " H5'" HO2' ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.793 0 C4'-C3'-C2' 99.578 -3.122 . 0.638 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ' A' . . . . . 0.623 HO2' " H5'" ' A' ' 7' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.603 0 N19-C1'-C2' 109.017 -2.739 . 0.734 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ' U' . . . . . 0.623 " H5'" HO2' ' A' ' 6' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.551 0 O4'-C1'-N19 111.1 2.9 . 0.732 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ' U' . . . . . 0.577 " H5'" HO2' ' A' ' 7' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.423 -2.504 0 O4'-C1'-N19 111.343 3.143 . 0.702 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ' A' . . . . . 0.576 " H5'" HO2' ' A' ' 8' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.425 -2.345 0 C4'-C3'-C2' 99.792 -2.908 . 0.62 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ' C' . . . . . 0.553 " H5'" HO2' ' A' ' 9' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.58 0 O4'-C1'-N19 111.195 2.995 . 0.599 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ' A' . . . . . 0.682 HO2' " C5'" ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.624 0 O4'-C1'-N19 110.838 2.638 . 0.579 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ' A' . . . . . 0.682 " C5'" HO2' ' A' ' 11' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.428 -2.044 1 O4'-C1'-N19 112.584 4.384 . 0.23 1b . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ' U' . . . . . 0.589 " C1'" HO2' ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.64 0 C5'-C4'-C3' 110.129 -3.581 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ' U' . . . . . 0.465 ' C6 ' ' CE2' ' B' ' 288' ' ' PHE . . . . . . . . 0 O4'--C4' 1.422 -2.606 0 O4'-C1'-N19 111.812 3.612 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.624 3.087 0 C5'-C4'-C3' 111.71 -2.527 . 0.627 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.644 0 O4'-C1'-N19 111.634 3.434 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.515 0 N19-C1'-C2' 108.473 -3.079 . 0.712 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.333 0 O4'-C1'-N19 110.97 2.77 . 0.828 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ' U' . . . . . 0.496 HO2' " C5'" ' A' ' 20' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.42 -2.738 0 O4'-C1'-N19 111.091 2.891 . 0.8 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ' U' . . . . . 0.609 HO2' " H5'" ' A' ' 21' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.426 -2.264 0 O4'-C1'-N19 111.003 2.803 . 0.648 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ' G' . . . . . 0.609 " H5'" HO2' ' A' ' 20' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.423 -2.515 0 C5'-C4'-C3' 111.821 -2.452 . 0.716 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ' C' . . . . . 0.555 " H5'" HO2' ' A' ' 21' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.418 -2.893 0 C5'-C4'-C3' 111.447 -2.702 . 0.803 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ' C' . . . . . 0.546 " H5'" HO2' ' A' ' 22' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.421 -2.662 0 N19-C1'-C2' 109.667 -2.333 . 0.77 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.333 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 42.1 t -155.42 162.16 40.83 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.788 0.435 . . . . 0.0 110.071 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 33.4 m170 59.58 12.5 2.86 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.017 0.927 . . . . 0.0 112.04 -178.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 50.9 tpp -75.83 131.94 40.06 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 51.74 17.68 0.64 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 53.3 25.76 4.71 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.672 0.789 . . . . 0.0 112.303 -176.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 74.3 m -71.7 -4.25 26.42 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.59 0.356 . . . . 0.0 111.155 178.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 52.3 p30 -143.22 26.9 1.62 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.105 0.962 . . . . 0.0 109.774 178.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -130.61 111.04 11.86 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.092 -176.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.47 11.23 18.37 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.296 0.639 . . . . 0.0 111.584 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 26.4 m -107.39 145.11 33.34 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.044 0.45 . . . . 0.0 111.84 -173.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 30.4 pt -122.06 146.69 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.028 175.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -98.63 143.18 29.3 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 173.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 18.4 t -128.41 142.93 42.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 O-C-N 123.312 0.382 . . . . 0.0 111.177 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -131.69 150.33 52.19 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 176.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.86 12.72 65.84 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-O 119.669 -0.517 . . . . 0.0 112.397 169.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 65.7 mt -55.24 -51.46 66.52 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 117.598 0.699 . . . . 0.0 110.571 -175.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 146.74 176.25 20.37 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -101.54 1.26 37.79 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.607 0.363 . . . . 0.0 111.81 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -128.7 12.12 6.28 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.6 m -74.41 162.93 4.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -172.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 30.5 p -132.12 159.72 38.1 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 123.724 0.81 . . . . 0.0 111.268 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 298' ' ' ILE . . . . . . . . . . . . . 37.7 mt -61.85 -43.6 97.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.169 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -63.53 -35.63 81.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 122.527 0.331 . . . . 0.0 111.472 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 75.0 m -71.73 -44.56 63.91 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-N 118.06 0.391 . . . . 0.0 110.349 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 74.9 t -63.03 -40.68 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -65.18 -36.26 83.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 303' ' ' ASP . . . . . 0.405 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 44.5 t0 -70.61 -26.65 63.59 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -85.05 -25.52 27.58 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -96.44 -24.8 15.94 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 306' ' ' LYS . . . . . 0.405 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.4 ptpt -66.43 -18.9 65.62 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 122.396 -0.19 . . . . 0.0 111.467 -177.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -71.84 -19.78 61.92 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 111.682 0.252 . . . . 0.0 111.682 -178.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.8 mm -88.15 -45.48 15.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.086 0 CA-C-N 117.632 0.196 . . . . 0.0 110.561 175.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -164.4 168.66 38.86 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 87.8 mt -69.02 122.14 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 121.021 0.439 . . . . 0.0 110.305 -175.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 92.0 mt -75.66 138.46 20.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 172.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -72.35 130.09 39.91 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 3.4 m -92.04 143.17 26.74 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 177.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -76.75 134.57 39.12 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 315' ' ' LYS . . . . . 0.507 ' HE3' ' HA ' ' B' ' 315' ' ' LYS . 0.5 OUTLIER -80.49 -13.48 59.07 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 122.789 0.436 . . . . 0.0 110.458 172.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 316' ' ' LYS . . . . . 0.446 ' HB3' ' H62' ' A' ' 17' ' ' ' A' . 42.4 mmtm -94.27 -23.58 17.8 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.054 0.541 . . . . 0.0 111.439 -173.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 17.1 p -135.44 -20.61 1.6 Allowed 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -172.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 81.89 -11.34 48.2 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 119.837 -0.424 . . . . 0.0 112.411 175.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -84.89 158.83 58.57 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 117.813 0.806 . . . . 0.0 109.16 174.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.75 154.08 74.11 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 121.966 1.777 . . . . 0.0 110.074 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 321' ' ' MET . . . . . . . . . . . . . 39.0 mtt -70.97 92.86 0.95 Allowed 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.023 0.439 . . . . 0.0 111.53 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 322' ' ' ILE . . . . . . . . . . . . . 3.9 mp -140.4 141.56 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 172.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -127.06 132.55 50.66 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 170.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 73.4 mt -107.64 135.12 49.61 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 177.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -102.7 146.25 28.49 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 4.0 m -132.46 146.07 51.66 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -174.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -72.82 129.79 38.97 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 44.4 mtp85 -82.83 -6.78 59.59 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 122.451 -0.155 . . . . 0.0 110.946 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -98.55 -13.51 20.41 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 122.856 0.462 . . . . 0.0 112.113 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 6.3 p -136.21 -26.0 1.17 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 74.54 12.82 82.28 Favored Glycine 0 CA--C 1.533 1.205 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 175.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -72.94 -107.03 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.856 0.862 . . . . 0.0 110.463 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 4.7 mt -161.29 144.84 12.89 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.465 1.106 . . . . 0.0 108.11 171.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -81.59 -20.79 39.11 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 122.622 0.369 . . . . 0.0 110.733 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.41 3.04 76.41 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -174.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -102.84 149.32 24.62 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 117.288 0.544 . . . . 0.0 109.682 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -160.16 167.45 27.66 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.793 0.33 . . . . 0.0 111.473 -176.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 2.7 p -120.25 151.6 38.93 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 169.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 32.4 t -136.73 129.5 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 123.668 0.787 . . . . 0.0 108.927 171.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 47.3 t -109.19 140.45 42.78 Favored 'General case' 0 CA--C 1.523 -0.091 0 CA-C-N 117.795 0.27 . . . . 0.0 111.311 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -105.91 158.88 16.45 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -70.93 -33.78 70.85 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -128.4 147.45 63.88 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 344' ' ' PRO . . . . . 0.449 ' N ' ' CD ' ' B' ' 345' ' ' PRO . 42.6 Cg_endo -70.69 -31.85 15.68 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 123.223 2.616 . . . . 0.0 114.549 -176.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 345' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' B' ' 344' ' ' PRO . 89.7 Cg_endo -73.62 -21.17 19.52 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 CA-C-N 121.059 1.414 . . . . 0.0 110.431 -177.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 69.8 m -70.98 -36.85 72.68 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 175.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -69.27 -36.78 77.44 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 175.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -64.62 -43.37 93.95 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -69.22 -33.43 73.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 110.624 -0.139 . . . . 0.0 110.624 177.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.38 -37.13 86.44 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 63.3 mt -69.69 -52.84 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -55.57 -27.32 48.5 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -97.56 -56.62 2.46 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -75.58 -29.5 59.34 Favored 'General case' 0 C--N 1.337 0.052 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -173.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -53.08 107.71 0.26 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.944 0.338 . . . . 0.0 111.412 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 101.58 -0.98 52.93 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 119.533 -0.593 . . . . 0.0 112.737 176.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -84.75 -164.39 0.97 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-N 117.989 0.895 . . . . 0.0 110.154 176.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -128.91 152.38 48.62 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.825 0.345 . . . . 0.0 111.004 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -143.77 137.07 27.8 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.12 0.968 . . . . 0.0 112.398 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 59.7 m 53.14 18.87 1.28 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -174.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 89.21 21.47 41.52 Favored Glycine 0 C--N 1.338 0.676 0 CA-C-O 119.821 -0.433 . . . . 0.0 112.158 179.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -132.19 143.06 47.35 Favored Pre-proline 0 N--CA 1.457 -0.118 0 CA-C-N 117.501 0.65 . . . . 0.0 109.295 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.57 135.85 31.97 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.987 2.458 . . . . 0.0 109.651 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 25.8 pt -124.11 170.77 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-O 121.112 0.482 . . . . 0.0 110.946 -178.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -145.18 118.13 8.79 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.118 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 12.7 t -106.78 150.32 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 123.165 0.586 . . . . 0.0 111.729 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 27.0 t -163.79 172.5 14.03 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 175.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -70.04 130.64 42.69 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 176.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -88.24 163.4 16.13 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.359 177.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -153.45 132.72 12.73 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 172.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 73.1 mtm-85 -51.27 102.28 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -168.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 372' ' ' ARG . . . . . 0.463 ' HA ' ' CZ ' ' B' ' 375' ' ' PHE . 54.9 ttt180 -69.31 -20.04 63.89 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 171.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -66.35 -7.3 18.13 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.414 0.686 . . . . 0.0 111.254 176.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -99.02 -10.2 22.94 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 114.317 1.228 . . . . 0.0 114.317 -176.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 375' ' ' PHE . . . . . 0.463 ' CZ ' ' HA ' ' B' ' 372' ' ' ARG . 15.0 p90 -138.83 -19.42 1.02 Allowed 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 -178.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -78.61 -12.26 60.01 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 122.386 -0.196 . . . . 0.0 110.723 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 . . . . . 0 C--O 1.252 1.185 0 CA-C-O 117.363 -1.303 . . . . 0.0 110.587 -177.543 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.632 0 N19-C1'-C2' 109.097 -2.689 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ' G' . . . . . 0.611 HO2' " H5'" ' A' ' 3' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.424 -2.442 0 O4'-C1'-N19 110.565 2.365 . 0.7 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ' C' . . . . . 0.611 " H5'" HO2' ' A' ' 2' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.423 -2.501 0 O4'-C1'-N19 110.928 2.728 . 0.773 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . 0.584 HO2' " H5'" ' A' ' 5' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.423 -2.531 0 N19-C1'-C2' 108.732 -2.917 . 0.749 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ' G' . . . . . 0.584 " H5'" HO2' ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.489 0 N19-C1'-C2' 108.764 -2.897 . 0.663 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ' A' . . . . . 0.58 HO2' " H5'" ' A' ' 7' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.426 -2.233 0 N19-C1'-C2' 109.175 -2.64 . 0.808 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ' U' . . . . . 0.58 " H5'" HO2' ' A' ' 6' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.781 0 O4'-C1'-N19 110.667 2.467 . 0.787 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.469 0 C4'-C3'-C2' 99.526 -3.174 . 0.775 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.439 0 C4'-C3'-C2' 99.519 -3.181 . 0.672 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.728 0 C4'-C3'-C2' 99.932 -2.768 . 0.606 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.258 0 C4'-C3'-C2' 100.027 -2.673 . 0.447 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.273 1 O4'-C1'-N19 112.224 4.024 . 0.183 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ' U' . . . . . 0.406 HO2' ' P ' ' A' ' 14' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.423 -2.496 0 C5'-C4'-C3' 109.639 -3.907 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ' U' . . . . . 0.406 ' P ' HO2' ' A' ' 13' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.619 1 C3'-C2'-C1' 105.102 4.002 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.651 0 O4'-C1'-N19 110.896 2.696 . 0.282 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.237 0 O4'-C1'-N19 111.391 3.191 . 0.407 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ' A' . . . . . 0.446 ' H62' ' HB3' ' B' ' 316' ' ' LYS . . . . . . . . 0 O4'--C4' 1.424 -2.377 0 N19-C1'-C2' 109.209 -2.62 . 0.689 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.479 0 C5'-C4'-C3' 111.752 -2.499 . 0.821 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ' U' . . . . . 0.473 HO2' " C5'" ' A' ' 20' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.421 -2.708 0 O4'-C1'-N19 111.004 2.804 . 0.754 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ' U' . . . . . 0.473 " C5'" HO2' ' A' ' 19' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.426 -2.269 0 O4'-C1'-N19 110.78 2.58 . 0.649 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.384 0 C5'-C4'-C3' 112.138 -2.241 . 0.734 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ' C' . . . . . 0.556 HO2' " H5'" ' A' ' 23' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.421 -2.686 0 C5'-C4'-C3' 111.649 -2.567 . 0.789 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ' C' . . . . . 0.556 " H5'" HO2' ' A' ' 22' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.424 -2.433 0 O4'-C1'-N19 110.788 2.588 . 0.791 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.02 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 90.3 p -78.13 4.25 12.96 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.852 0.461 . . . . 0.0 111.436 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -63.05 157.62 21.62 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.039 0.535 . . . . 0.0 110.948 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 279' ' ' MET . . . . . 0.401 ' HA ' ' HE3' ' B' ' 279' ' ' MET . 5.7 tpt -154.08 152.7 30.76 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 31.2 p30 -147.27 174.62 11.46 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.041 0.536 . . . . 0.0 110.967 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 45.2 m-20 52.2 30.99 8.46 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.347 0.659 . . . . 0.0 111.933 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 47.7 t -63.51 -18.97 64.37 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 122.155 -0.341 . . . . 0.0 110.652 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 22.0 p30 -93.7 8.74 39.79 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.398 0.679 . . . . 0.0 112.798 177.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -143.32 110.37 5.66 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.767 0.317 . . . . 0.0 110.2 -177.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -113.79 2.17 15.06 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.859 0.464 . . . . 0.0 111.193 -177.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 286' ' ' THR . . . . . 0.453 ' HG1' " C1'" ' A' ' 15' ' ' ' C' . 84.8 m -103.87 142.4 34.46 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.105 0.479 . . . . 0.0 110.558 -174.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 44.5 pt -114.93 146.75 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -98.85 144.44 28.05 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 173.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 60.7 t -129.28 136.16 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 O-C-N 123.411 0.445 . . . . 0.0 110.57 -178.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -126.64 155.16 43.01 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 176.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 83.32 12.71 78.2 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 172.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 4.2 tp -59.27 -50.82 72.54 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.98 0.912 . . . . 0.0 110.996 -170.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 143.64 165.04 10.63 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.311 -0.715 . . . . 0.0 111.311 176.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -95.81 3.93 53.31 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.532 0.333 . . . . 0.0 111.34 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -128.71 12.73 6.35 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.764 0.426 . . . . 0.0 111.84 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 4.2 m -72.63 166.75 2.45 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -173.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 32.5 p -137.82 160.76 38.39 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 124.072 0.949 . . . . 0.0 110.835 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 298' ' ' ILE . . . . . . . . . . . . . 41.7 mt -63.08 -40.74 90.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -66.36 -38.07 86.75 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 80.6 p -73.25 -44.17 59.89 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 117.945 0.339 . . . . 0.0 110.237 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 71.0 t -60.76 -42.87 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -65.24 -34.82 79.27 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 122.224 -0.297 . . . . 0.0 110.293 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 303' ' ' ASP . . . . . 0.413 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.2 t0 -69.83 -28.09 65.41 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -84.17 -25.83 29.27 Favored 'General case' 0 C--O 1.226 -0.157 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -96.16 -23.71 16.61 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 306' ' ' LYS . . . . . 0.413 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.7 ptpt -68.19 -18.06 64.49 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -177.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -72.45 -19.17 61.61 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -178.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 3.6 mm -87.89 -47.81 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 CA-C-N 117.564 0.165 . . . . 0.0 110.746 175.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -161.61 173.82 38.04 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 76.1 mt -71.89 116.35 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 120.861 0.363 . . . . 0.0 110.099 -175.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 76.1 mt -71.59 137.93 22.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 172.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 312' ' ' LYS . . . . . 0.452 ' HG2' ' SD ' ' B' ' 321' ' ' MET . 40.9 ttmt -68.88 142.42 54.8 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 4.9 m -113.63 136.9 52.32 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -66.12 131.82 47.06 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -79.67 -11.05 59.87 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 32.7 mmtm -99.47 -25.43 14.45 Favored 'General case' 0 CA--C 1.527 0.061 0 C-N-CA 122.684 0.394 . . . . 0.0 111.019 -175.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 6.9 p -126.25 -25.16 3.56 Favored 'General case' 0 C--O 1.23 0.074 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -171.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 81.3 -6.4 64.09 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 119.773 -0.459 . . . . 0.0 112.423 174.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -85.25 156.75 59.79 Favored Pre-proline 0 C--O 1.234 0.249 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 174.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.67 150.67 74.72 Favored 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 121.485 1.456 . . . . 0.0 109.178 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 321' ' ' MET . . . . . 0.452 ' SD ' ' HG2' ' B' ' 312' ' ' LYS . 62.3 mtp -82.43 85.88 6.84 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.37 0.605 . . . . 0.0 111.558 -172.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 322' ' ' ILE . . . . . . . . . . . . . 2.7 mp -126.46 147.83 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 174.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -134.25 111.88 10.61 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 173.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 30.6 mt -80.76 149.76 29.52 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 123.93 0.769 . . . . 0.0 108.936 176.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -115.48 145.79 42.27 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 6.8 m -135.86 146.04 47.02 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -175.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -68.82 125.09 25.49 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 177.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -76.82 -12.63 60.0 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -177.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -94.79 -14.91 24.23 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.897 0.479 . . . . 0.0 111.91 -176.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 4.4 p -135.42 -24.62 1.37 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -177.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 75.54 13.91 82.51 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-O 119.71 -0.494 . . . . 0.0 112.221 172.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -72.75 -111.05 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.55 0.74 . . . . 0.0 110.841 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 6.2 mt -158.55 143.14 15.97 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.189 0.996 . . . . 0.0 108.532 170.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -79.15 -19.96 49.7 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.041 0.536 . . . . 0.0 111.329 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.62 22.16 73.16 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -173.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -128.36 146.62 50.72 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.073 0.549 . . . . 0.0 110.18 -178.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -156.04 159.44 39.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.727 0.298 . . . . 0.0 111.587 174.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 3.4 p -104.1 155.81 18.39 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 170.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 16.7 t -138.12 122.48 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.042 0 C-N-CA 123.432 0.693 . . . . 0.0 110.312 172.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 69.2 m -90.78 144.21 25.95 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 117.961 0.346 . . . . 0.0 110.967 177.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -112.89 151.2 30.75 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -69.92 -28.91 65.99 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -177.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -132.71 148.51 69.8 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -178.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 344' ' ' PRO . . . . . 0.455 ' HG2' ' HD3' ' B' ' 345' ' ' PRO . 37.9 Cg_endo -70.42 -33.14 14.59 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.357 2.705 . . . . 0.0 114.205 -177.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 345' ' ' PRO . . . . . 0.455 ' HD3' ' HG2' ' B' ' 344' ' ' PRO . 85.8 Cg_endo -73.54 -20.96 19.98 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 CA-C-N 121.225 1.473 . . . . 0.0 110.252 -177.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 70.3 m -72.05 -37.14 69.75 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -68.26 -38.37 81.71 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 175.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -65.06 -42.43 94.19 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -69.16 -34.71 75.39 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.399 -0.188 . . . . 0.0 110.956 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.17 -37.67 88.28 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 66.0 mt -68.56 -53.62 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.775 175.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -55.01 -27.73 46.53 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 54.8 t-105 -97.52 -55.35 2.85 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -76.26 -28.21 57.01 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -173.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -51.92 109.52 0.38 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 120.959 0.409 . . . . 0.0 111.555 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 101.29 -1.18 54.01 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 119.515 -0.603 . . . . 0.0 112.278 175.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -86.43 -165.64 1.32 Allowed 'General case' 0 C--O 1.231 0.084 0 CA-C-N 118.277 1.039 . . . . 0.0 110.698 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -127.28 155.59 43.26 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 121.061 0.458 . . . . 0.0 111.089 178.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -145.88 135.82 23.55 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.515 1.126 . . . . 0.0 112.196 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 20.8 t 54.11 18.77 1.85 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 120.873 0.368 . . . . 0.0 111.647 -176.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.67 24.17 33.9 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 112.031 -0.427 . . . . 0.0 112.031 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 53.1 m-20 -133.91 142.61 44.13 Favored Pre-proline 0 N--CA 1.454 -0.265 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -69.6 136.53 33.67 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 122.808 2.338 . . . . 0.0 109.308 176.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 31.2 pt -124.25 169.2 15.89 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 121.001 0.429 . . . . 0.0 110.96 -177.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -142.92 113.69 7.54 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.52 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 12.0 t -103.06 148.03 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 C-N-CA 123.144 0.577 . . . . 0.0 111.727 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 22.7 t -162.6 173.54 13.81 Favored 'General case' 0 C--N 1.338 0.099 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 177.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -70.64 128.31 35.65 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 176.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -88.24 179.71 6.31 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.125 0.488 . . . . 0.0 112.008 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 9.7 t -147.68 -154.04 0.53 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 173.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 72.9 mtt85 -124.48 92.19 3.61 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.037 0.835 . . . . 0.0 110.961 173.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 82.6 mtt-85 -62.95 -14.34 45.97 Favored 'General case' 0 C--N 1.339 0.124 0 N-CA-C 110.614 -0.143 . . . . 0.0 110.614 173.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.29 -8.94 6.62 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.033 0.533 . . . . 0.0 111.162 176.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -100.83 -12.95 18.62 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 114.152 1.168 . . . . 0.0 114.152 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -140.95 -26.41 0.73 Allowed 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 117.218 2.303 . . . . 0.0 117.218 -177.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -78.52 -7.03 57.06 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 . . . . . 0 C--O 1.253 1.28 0 CA-C-O 117.393 -1.289 . . . . 0.0 110.457 -178.296 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ' G' . . . . . 0.65 HO2' " H5'" ' A' ' 2' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.424 -2.449 0 N19-C1'-C2' 109.215 -2.616 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ' G' . . . . . 0.65 " H5'" HO2' ' A' ' 1' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.421 -2.631 0 C5'-C4'-C3' 111.765 -2.49 . 0.696 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ' C' . . . . . 0.63 " H5'" HO2' ' A' ' 2' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.425 -2.342 0 O4'-C1'-N19 111.07 2.87 . 0.706 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . 0.499 " H5'" HO2' ' A' ' 3' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.423 -2.477 0 N19-C1'-C2' 108.479 -3.075 . 0.744 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ' G' . . . . . 0.549 HO2' " H5'" ' A' ' 6' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.459 0 C4'-C3'-C2' 99.56 -3.14 . 0.72 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ' A' . . . . . 0.549 " H5'" HO2' ' A' ' 5' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.424 -2.422 0 N19-C1'-C2' 108.765 -2.897 . 0.743 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.7 0 O4'-C1'-N19 111.146 2.946 . 0.808 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ' U' . . . . . 0.551 HO2' " H5'" ' A' ' 9' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.755 0 O4'-C1'-N19 110.961 2.761 . 0.776 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ' A' . . . . . 0.551 " H5'" HO2' ' A' ' 8' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.424 -2.387 0 C4'-C3'-C2' 99.9 -2.8 . 0.679 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ' C' . . . . . 0.529 " H5'" HO2' ' A' ' 9' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.593 0 C4'-C3'-C2' 99.961 -2.739 . 0.574 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ' A' . . . . . 0.496 " C5'" HO2' ' A' ' 10' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.424 -2.392 0 O4'-C1'-N19 110.564 2.364 . 0.586 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.458 1 O4'-C1'-N19 112.656 4.456 . 0.161 1t . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.412 -3.406 0 C3'-C2'-C1' 99.167 -2.592 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.592 1 C5'-C4'-C3' 108.687 -4.542 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ' C' . . . . . 0.453 " C1'" ' HG1' ' B' ' 286' ' ' THR . . . . . . . . 0 P--O5' 1.624 3.063 0 O4'-C1'-N19 110.376 2.176 . 0.314 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ' U' . . . . . 0.683 HO2' " H5'" ' A' ' 17' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.424 -2.437 0 O4'-C1'-N19 110.772 2.572 . 0.167 2h . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ' A' . . . . . 0.683 " H5'" HO2' ' A' ' 16' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.424 -2.442 0 N19-C1'-C2' 108.986 -2.759 . 0.5 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ' U' . . . . . 0.419 HO2' " H5'" ' A' ' 19' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.555 0 O4'-C1'-N19 110.926 2.726 . 0.797 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ' U' . . . . . 0.469 HO2' " C5'" ' A' ' 20' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.42 -2.743 0 O4'-C1'-N19 110.972 2.772 . 0.81 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ' U' . . . . . 0.612 HO2' " H5'" ' A' ' 21' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.424 -2.421 0 O4'-C1'-N19 111.05 2.85 . 0.646 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ' G' . . . . . 0.612 " H5'" HO2' ' A' ' 20' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.603 0 C5'-C4'-C3' 112.227 -2.182 . 0.712 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ' C' . . . . . 0.582 " H5'" HO2' ' A' ' 21' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.421 -2.683 0 C5'-C4'-C3' 111.505 -2.664 . 0.802 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.59 0 N19-C1'-C2' 110.047 -2.095 . 0.829 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.16 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 65.6 m -146.62 161.06 41.32 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 123.031 0.532 . . . . 0.0 110.257 -178.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 55.6 23.35 6.0 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.403 0.681 . . . . 0.0 111.673 -178.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 90.8 mtp -71.9 170.82 12.91 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.791 0.329 . . . . 0.0 110.883 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 18.1 p30 -66.89 -12.58 59.81 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -83.26 19.54 1.47 Allowed 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.753 0.421 . . . . 0.0 111.276 175.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 43.7 t -62.01 -23.13 66.24 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 122.128 -0.357 . . . . 0.0 110.98 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -87.46 4.88 41.58 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 177.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -132.74 110.33 10.3 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.826 0.346 . . . . 0.0 110.146 -175.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . 0.414 HD22 ' C ' ' B' ' 285' ' ' ASN . 0.4 OUTLIER -113.44 6.59 17.24 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.123 0.569 . . . . 0.0 112.094 -178.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 87.6 m -109.76 141.67 42.07 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.265 0.555 . . . . 0.0 110.831 -175.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 41.1 pt -118.6 148.92 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-N 115.492 -0.776 . . . . 0.0 108.954 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -98.58 146.95 25.29 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 173.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 15.0 t -131.98 141.37 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-O 120.839 0.352 . . . . 0.0 111.259 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -129.47 150.73 50.69 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 176.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.86 12.5 66.19 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 119.793 -0.448 . . . . 0.0 112.76 169.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 73.3 mt -56.06 -51.61 67.23 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 117.62 0.71 . . . . 0.0 110.748 -175.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 148.51 175.89 21.46 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -101.43 -0.93 34.42 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 122.555 -0.379 . . . . 0.0 111.69 -176.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -128.71 11.29 6.16 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.075 0.55 . . . . 0.0 112.402 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.0 m -73.06 163.94 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -172.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 26.7 p -130.24 158.76 38.87 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 123.661 0.784 . . . . 0.0 111.773 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 298' ' ' ILE . . . . . . . . . . . . . 36.9 mt -60.2 -44.65 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.242 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -62.53 -36.2 81.83 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.711 0.404 . . . . 0.0 111.416 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 72.6 m -71.8 -43.79 65.07 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.991 0.359 . . . . 0.0 110.183 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 71.4 t -62.47 -41.41 91.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.95 -36.32 84.0 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 303' ' ' ASP . . . . . 0.422 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 44.9 t0 -69.91 -27.97 65.23 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -85.33 -25.38 27.18 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -96.28 -23.86 16.48 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 178.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 306' ' ' LYS . . . . . 0.422 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.6 ptpt -66.93 -18.69 65.5 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 -177.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -72.3 -20.41 61.51 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 117.731 0.241 . . . . 0.0 111.612 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.8 mm -87.27 -45.73 16.22 Favored 'Isoleucine or valine' 0 C--N 1.338 0.089 0 CA-C-N 117.677 0.217 . . . . 0.0 110.535 175.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.23 167.38 37.5 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 83.9 mt -68.5 121.79 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 120.834 0.349 . . . . 0.0 110.539 -175.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 89.1 mt -74.37 138.11 21.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 173.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 312' ' ' LYS . . . . . 0.656 ' HE3' ' SD ' ' B' ' 321' ' ' MET . 25.4 ttpt -74.02 132.26 42.19 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -178.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 1.8 m -94.95 140.51 29.85 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -70.48 133.5 46.87 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -89.55 -5.39 57.28 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 178.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -105.8 -18.63 14.0 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 122.833 0.453 . . . . 0.0 110.542 -176.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 6.5 p -129.53 -25.59 2.62 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -174.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 84.23 -11.79 56.8 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 119.743 -0.476 . . . . 0.0 112.422 174.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -83.08 157.3 66.2 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 117.912 0.856 . . . . 0.0 109.243 175.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.28 156.16 66.73 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 121.949 1.766 . . . . 0.0 109.921 178.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 321' ' ' MET . . . . . 0.656 ' SD ' ' HE3' ' B' ' 312' ' ' LYS . 33.9 mtt -72.61 92.51 1.52 Allowed 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 120.952 0.406 . . . . 0.0 111.656 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 322' ' ' ILE . . . . . . . . . . . . . 4.2 mp -139.73 138.51 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 171.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -131.36 105.93 7.94 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 176.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -75.39 153.58 37.64 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.812 0.845 . . . . 0.0 109.102 177.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -115.67 148.0 40.2 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -136.66 146.34 45.85 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.666 0.787 . . . . 0.0 112.82 -175.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -73.35 130.82 40.99 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 23.0 mtp-105 -84.64 -7.7 59.14 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 119.674 -0.203 . . . . 0.0 111.098 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -103.57 -13.75 16.44 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.534 0.334 . . . . 0.0 111.567 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 6.6 p -136.34 -19.23 1.46 Allowed 'General case' 0 C--O 1.233 0.23 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 77.98 4.27 85.67 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 119.699 -0.501 . . . . 0.0 112.082 174.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 332' ' ' LYS . . . . . 0.587 ' HA ' ' HE2' ' B' ' 332' ' ' LYS . 7.9 mmpt? -86.32 154.22 21.39 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 117.821 0.811 . . . . 0.0 109.045 177.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 41.5 mt -70.54 139.43 51.54 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.838 0.351 . . . . 0.0 110.342 -177.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -77.59 -16.65 58.48 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 123.249 0.62 . . . . 0.0 110.76 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 77.81 6.37 87.06 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -174.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -102.76 152.5 21.17 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.034 0.534 . . . . 0.0 110.162 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -164.66 161.38 20.79 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 116.698 -0.228 . . . . 0.0 110.966 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 5.3 p -109.04 155.06 21.37 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 169.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 33.7 t -137.64 128.39 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.043 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 171.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 8.2 t -104.0 146.92 28.0 Favored 'General case' 0 C--O 1.228 -0.064 0 CA-C-N 117.975 0.352 . . . . 0.0 110.689 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -112.71 158.46 20.03 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -77.17 -17.3 58.66 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -143.66 146.83 36.72 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 344' ' ' PRO . . . . . 0.45 ' HG2' ' HD3' ' B' ' 345' ' ' PRO . 41.0 Cg_endo -70.61 -31.87 16.03 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.329 2.686 . . . . 0.0 114.587 -177.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 345' ' ' PRO . . . . . 0.45 ' HD3' ' HG2' ' B' ' 344' ' ' PRO . 80.8 Cg_endo -73.9 -22.5 17.35 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 CA-C-N 121.117 1.435 . . . . 0.0 110.123 -177.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 66.1 m -72.25 -35.1 68.71 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 175.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -68.76 -39.95 80.01 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 175.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -64.81 -42.09 95.27 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.11 -34.89 77.22 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 122.237 -0.289 . . . . 0.0 110.687 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.05 -36.13 83.37 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 67.3 mt -70.92 -50.78 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 C-N-CA 120.626 -0.43 . . . . 0.0 109.873 175.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -54.49 -30.14 52.41 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 55.8 t-105 -97.8 -56.74 2.41 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -177.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -75.83 -29.84 58.77 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -172.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -56.29 110.09 0.71 Allowed 'General case' 0 C--O 1.234 0.247 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.793 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 103.01 -2.83 47.92 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-O 119.647 -0.529 . . . . 0.0 112.234 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -84.44 -163.17 0.76 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 118.092 0.946 . . . . 0.0 110.364 176.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -129.75 152.91 48.73 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.056 0.455 . . . . 0.0 111.239 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -145.49 136.54 24.73 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.135 0.974 . . . . 0.0 112.352 178.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 12.5 t 55.19 17.69 2.11 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.888 0.375 . . . . 0.0 111.077 -174.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.23 22.56 40.77 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.995 -0.442 . . . . 0.0 111.995 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -132.15 142.73 46.1 Favored Pre-proline 0 N--CA 1.454 -0.257 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.48 135.73 31.87 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 123.059 2.506 . . . . 0.0 109.707 178.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 30.1 pt -122.93 170.4 13.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-O 121.025 0.441 . . . . 0.0 111.101 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 5.7 tmtm? -145.66 113.6 6.48 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 9.7 t -103.25 150.27 6.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.21 0.604 . . . . 0.0 112.444 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 28.5 t -162.94 176.11 10.5 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 177.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -74.66 133.52 42.11 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 175.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -98.95 177.88 5.12 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.027 0.531 . . . . 0.0 111.94 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 7.2 p -138.41 -158.91 0.9 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 126.028 1.731 . . . . 0.0 109.871 177.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 371' ' ' ARG . . . . . 0.412 ' HG2' ' C6 ' ' A' ' 15' ' ' ' C' . 64.1 mtt180 -120.78 76.89 1.24 Allowed 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.487 0.585 . . . . 0.0 111.829 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 64.2 mtt-85 -60.28 -19.66 55.8 Favored 'General case' 0 N--CA 1.458 -0.063 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 169.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.3 -12.13 5.18 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.471 0.708 . . . . 0.0 111.313 176.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -99.51 -12.09 20.47 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -177.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -139.72 -19.96 0.92 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 116.667 2.099 . . . . 0.0 116.667 -178.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -80.69 -5.19 56.67 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 177.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 33.8 mmm-85 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 117.441 -1.266 . . . . 0.0 110.387 179.672 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.589 0 N19-C1'-C2' 108.986 -2.759 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ' G' . . . . . 0.666 HO2' " H5'" ' A' ' 3' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.424 -2.451 0 O4'-C1'-N19 111.017 2.817 . 0.706 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ' C' . . . . . 0.666 " H5'" HO2' ' A' ' 2' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.423 -2.481 0 C5'-C4'-C3' 111.25 -2.834 . 0.72 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . 0.478 " H5'" HO2' ' A' ' 3' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.42 -2.755 0 N19-C1'-C2' 109.122 -2.674 . 0.781 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.695 0 N19-C1'-C2' 108.541 -3.037 . 0.712 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ' A' . . . . . 0.603 HO2' " H5'" ' A' ' 7' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.423 -2.531 0 N19-C1'-C2' 109.061 -2.712 . 0.774 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ' U' . . . . . 0.603 " H5'" HO2' ' A' ' 6' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.717 0 O4'-C1'-N19 110.92 2.72 . 0.78 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ' U' . . . . . 0.569 " H5'" HO2' ' A' ' 7' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.424 -2.395 0 O4'-C1'-N19 110.896 2.696 . 0.747 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ' A' . . . . . 0.649 HO2' " H5'" ' A' ' 10' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.42 -2.762 0 C4'-C3'-C2' 99.871 -2.829 . 0.647 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ' C' . . . . . 0.649 " H5'" HO2' ' A' ' 9' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.616 0 O4'-C1'-N19 110.947 2.747 . 0.624 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ' A' . . . . . 0.685 HO2' " C5'" ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.559 0 O4'-C1'-N19 111.09 2.89 . 0.588 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ' A' . . . . . 0.685 " C5'" HO2' ' A' ' 11' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.425 -2.309 0 C5'-C4'-C3' 110.009 -3.661 . 0.214 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -1.987 1 O4'-C1'-N19 112.52 4.32 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.012 0 O4'-C1'-N19 110.595 2.395 . 0.629 6p . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ' C' . . . . . 0.412 ' C6 ' ' HG2' ' B' ' 371' ' ' ARG . . . . . . . . 0 P--O5' 1.621 2.806 0 C5'-C4'-C3' 110.77 -3.153 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ' U' . . . . . 0.698 HO2' " H5'" ' A' ' 17' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.424 -2.439 0 C5'-C4'-C3' 110.99 -3.007 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ' A' . . . . . 0.698 " H5'" HO2' ' A' ' 16' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.427 -2.19 0 N19-C1'-C2' 109.219 -2.613 . 0.621 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.395 0 O4'-C1'-N19 111.081 2.881 . 0.835 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ' U' . . . . . 0.485 HO2' " C5'" ' A' ' 20' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.42 -2.724 0 O4'-C1'-N19 111.102 2.902 . 0.819 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ' U' . . . . . 0.485 " C5'" HO2' ' A' ' 19' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.425 -2.374 0 O4'-C1'-N19 110.938 2.738 . 0.649 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.489 0 O4'-C1'-N19 110.461 2.261 . 0.748 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ' C' . . . . . 0.528 HO2' " H5'" ' A' ' 23' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.421 -2.673 0 C5'-C4'-C3' 111.341 -2.773 . 0.796 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ' C' . . . . . 0.528 " H5'" HO2' ' A' ' 22' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.421 -2.637 0 N19-C1'-C2' 109.789 -2.257 . 0.776 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.184 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 38.1 t -155.97 159.53 39.29 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.021 0.529 . . . . 0.0 109.993 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -67.16 157.9 32.57 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.819 0.448 . . . . 0.0 111.008 -179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 91.0 mtp -72.89 172.94 9.95 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.613 0.365 . . . . 0.0 110.578 178.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -65.22 -11.68 43.44 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -81.89 14.84 2.51 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.77 0.428 . . . . 0.0 111.307 175.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 46.1 t -62.14 -17.5 58.07 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.962 -0.461 . . . . 0.0 110.503 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -89.57 6.14 42.44 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 123.117 0.567 . . . . 0.0 112.422 177.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 -142.47 113.77 7.75 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.999 0.428 . . . . 0.0 110.072 -176.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.36 12.62 18.85 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.874 0.47 . . . . 0.0 111.466 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 31.3 m -109.62 145.37 36.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.074 0.464 . . . . 0.0 111.854 -176.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 34.2 pt -122.09 147.51 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.433 176.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -98.7 143.88 28.58 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 173.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 59.7 t -129.17 132.33 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 122.646 0.379 . . . . 0.0 110.57 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -120.78 155.45 33.98 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 175.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 83.82 12.01 78.19 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 171.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 292' ' ' LEU . . . . . 0.411 HD11 ' CD2' ' B' ' 359' ' ' PHE . 4.4 tp -59.09 -51.39 70.25 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.581 0.752 . . . . 0.0 110.946 -171.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 144.8 164.45 10.6 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.449 -0.661 . . . . 0.0 111.449 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -93.45 -1.11 56.1 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.578 0.351 . . . . 0.0 111.36 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -128.86 13.12 6.31 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 5.1 m -68.77 162.67 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -174.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 20.2 p -130.53 158.42 40.0 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.429 175.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 298' ' ' ILE . . . . . . . . . . . . . 25.0 mt -60.26 -43.21 92.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.31 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -70.68 -30.2 66.73 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -177.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 72.0 m -72.98 -45.36 58.4 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 118.298 0.499 . . . . 0.0 109.943 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 74.3 t -62.03 -41.31 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 176.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.3 -36.78 85.23 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 303' ' ' ASP . . . . . 0.415 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 44.3 t0 -70.58 -27.63 64.26 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -178.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -83.86 -26.52 29.39 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -178.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -96.55 -24.95 15.81 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 115.073 1.509 . . . . 0.0 115.073 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 306' ' ' LYS . . . . . 0.415 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.8 ptpt -66.75 -18.38 65.35 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -176.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -71.85 -19.97 61.88 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 111.486 0.18 . . . . 0.0 111.486 -178.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 5.3 mm -87.49 -45.9 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 175.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.9 167.88 38.17 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 178.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 87.9 mt -67.72 123.66 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 122.674 0.389 . . . . 0.0 110.581 -176.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 86.7 mt -77.36 137.29 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 173.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -72.91 142.29 47.87 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -178.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 1.8 m -98.44 142.09 30.5 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -67.09 144.14 56.28 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 174.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -84.74 -19.93 31.89 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.796 -0.184 . . . . 0.0 111.059 -177.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -109.13 -43.88 4.07 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -174.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 23.7 p -86.98 -22.3 25.64 Favored 'General case' 0 N--CA 1.46 0.043 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -177.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 75.96 -10.28 14.96 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 123.294 0.473 . . . . 0.0 112.08 174.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -79.7 160.14 70.09 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 117.769 0.784 . . . . 0.0 109.268 174.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -67.06 154.24 75.15 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 121.593 1.529 . . . . 0.0 109.353 176.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 321' ' ' MET . . . . . 0.417 ' CB ' ' HB3' ' B' ' 340' ' ' SER . 34.9 mtt -70.97 85.74 0.7 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.84 0.353 . . . . 0.0 111.39 -177.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 322' ' ' ILE . . . . . . . . . . . . . 3.1 mp -129.84 137.04 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 170.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -130.45 107.23 9.08 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.839 176.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 23.7 mt -78.13 151.52 33.27 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 123.947 0.78 . . . . 0.0 109.249 176.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -115.9 151.02 36.15 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.52 142.48 43.48 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -174.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -70.93 131.9 44.42 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' B' ' 328' ' ' ARG . 30.2 mtp180 -87.42 -6.26 58.5 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.12 0.168 . . . . 0.0 110.776 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -104.55 -13.84 15.87 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.844 0.458 . . . . 0.0 111.563 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 3.3 p -134.54 -20.19 1.83 Allowed 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 79.18 2.17 86.83 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 112.251 -0.34 . . . . 0.0 112.251 175.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt -88.42 156.76 18.95 Favored 'General case' 0 C--N 1.337 0.034 0 CA-C-N 117.482 0.641 . . . . 0.0 109.397 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 46.8 mt -70.0 143.47 52.58 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.855 0.36 . . . . 0.0 110.696 -176.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -73.7 -15.65 61.22 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 123.562 0.745 . . . . 0.0 111.145 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.95 20.64 75.7 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.154 -1.179 . . . . 0.0 110.154 -174.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -129.94 144.48 51.34 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.177 0.591 . . . . 0.0 110.181 -176.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -156.39 160.26 39.49 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.858 174.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 1.2 p -102.0 155.95 17.84 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 170.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 19.0 t -134.75 129.5 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 123.85 0.86 . . . . 0.0 108.989 169.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 340' ' ' SER . . . . . 0.417 ' HB3' ' CB ' ' B' ' 321' ' ' MET . 45.5 t -109.47 140.75 42.84 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.942 0.401 . . . . 0.0 110.957 -178.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -106.08 158.02 17.11 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -73.62 -20.43 60.59 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -140.81 148.03 50.92 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 123.514 0.726 . . . . 0.0 109.12 -178.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 344' ' ' PRO . . . . . 0.451 ' HG2' ' HD3' ' B' ' 345' ' ' PRO . 40.4 Cg_endo -70.46 -33.32 14.14 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.43 2.753 . . . . 0.0 114.245 -176.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 345' ' ' PRO . . . . . 0.451 ' HD3' ' HG2' ' B' ' 344' ' ' PRO . 83.6 Cg_endo -73.82 -22.47 17.58 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 CA-C-N 121.074 1.419 . . . . 0.0 110.057 -176.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 67.1 m -71.66 -36.47 70.67 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 176.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -69.08 -38.21 78.87 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -65.8 -41.75 91.53 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -69.47 -33.61 73.15 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 110.629 -0.138 . . . . 0.0 110.629 177.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.83 -37.19 86.79 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 68.5 mt -68.1 -53.62 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.673 174.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -54.87 -28.48 50.47 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -178.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 53.6 t-105 -96.67 -54.66 3.15 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -77.73 -27.89 50.66 Favored 'General case' 0 CA--C 1.522 -0.119 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -174.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -52.28 109.3 0.37 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.889 0.313 . . . . 0.0 111.194 178.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 100.29 -1.25 56.02 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-O 119.695 -0.503 . . . . 0.0 112.548 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -84.85 -164.42 0.98 Allowed 'General case' 0 C--O 1.228 -0.065 0 CA-C-N 117.939 0.869 . . . . 0.0 110.434 176.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -128.46 152.69 47.94 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.919 0.39 . . . . 0.0 110.739 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 359' ' ' PHE . . . . . 0.411 ' CD2' HD11 ' B' ' 292' ' ' LEU . 20.9 t80 -142.2 134.71 28.06 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.271 1.028 . . . . 0.0 112.252 178.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 64.5 m 52.77 20.84 1.71 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.79 0.436 . . . . 0.0 111.975 -175.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.93 21.73 41.49 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 112.036 -0.426 . . . . 0.0 112.036 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -131.67 141.45 41.68 Favored Pre-proline 0 N--CA 1.456 -0.126 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.12 136.43 34.68 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.84 2.36 . . . . 0.0 109.464 177.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 32.4 pt -124.34 168.91 16.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-O 121.222 0.534 . . . . 0.0 110.789 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 22.9 tptp -142.89 112.3 6.74 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.035 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 8.6 t -101.96 148.55 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 29.3 t -162.38 175.27 11.72 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 177.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -72.19 130.97 42.1 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 176.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -80.83 175.45 10.67 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.082 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 61.1 p -142.16 -130.95 0.1 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 125.543 1.537 . . . . 0.0 107.913 -178.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 371' ' ' ARG . . . . . 0.427 ' C ' ' H ' ' B' ' 373' ' ' ALA . 10.9 mmm180 -122.28 -33.5 3.47 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.039 0.381 . . . . 0.0 111.492 170.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 60.76 -39.17 0.1 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.506 1.522 . . . . 0.0 113.462 -174.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . 0.427 ' H ' ' C ' ' B' ' 371' ' ' ARG . . . -63.78 -24.47 67.77 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 123.201 0.6 . . . . 0.0 109.626 176.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 19.6 p30 -62.04 -18.8 61.76 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 112.359 0.504 . . . . 0.0 112.359 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -78.73 -12.7 60.03 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 174.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -129.06 -16.67 4.02 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -173.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 . . . . . 0 C--O 1.252 1.201 0 CA-C-O 117.28 -1.343 . . . . 0.0 110.689 179.259 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ' G' . . . . . 0.63 HO2' " H5'" ' A' ' 2' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.424 -2.456 0 N19-C1'-C2' 109.724 -2.298 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ' G' . . . . . 0.63 " H5'" HO2' ' A' ' 1' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.424 -2.412 0 C5'-C4'-C3' 111.904 -2.398 . 0.624 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ' C' . . . . . 0.604 " H5'" HO2' ' A' ' 2' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.421 -2.628 0 O4'-C1'-N19 110.84 2.64 . 0.673 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . 0.429 " H5'" HO2' ' A' ' 3' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.423 -2.516 0 N19-C1'-C2' 108.755 -2.903 . 0.72 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ' G' . . . . . 0.575 HO2' " H5'" ' A' ' 6' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.424 -2.425 0 N19-C1'-C2' 108.489 -3.069 . 0.785 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ' A' . . . . . 0.635 HO2' " H5'" ' A' ' 7' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.425 -2.311 0 N19-C1'-C2' 109.287 -2.571 . 0.752 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ' U' . . . . . 0.635 " H5'" HO2' ' A' ' 6' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.72 0 O4'-C1'-N19 111.192 2.992 . 0.784 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ' U' . . . . . 0.558 " H5'" HO2' ' A' ' 7' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.567 0 O4'-C1'-N19 110.808 2.608 . 0.736 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ' A' . . . . . 0.414 " H5'" HO2' ' A' ' 8' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.421 -2.701 0 C4'-C3'-C2' 100.06 -2.64 . 0.655 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ' C' . . . . . 0.573 HO2' " C5'" ' A' ' 11' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.896 0 C4'-C3'-C2' 100.444 -2.256 . 0.546 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ' A' . . . . . 0.573 " C5'" HO2' ' A' ' 10' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.423 -2.506 0 C4'-C3'-C2' 100.07 -2.63 . 0.378 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.231 0 O4'-C1'-N19 112.164 3.964 . 0.078 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ' U' . . . . . 0.419 HO2' ' P ' ' A' ' 14' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.421 -2.693 0 C5'-C4'-C3' 110.083 -3.611 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ' U' . . . . . 0.419 ' P ' HO2' ' A' ' 13' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.417 -2.988 1 C5'-C4'-C3' 108.764 -4.491 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.488 0 O4'-C1'-N19 111.861 3.661 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.661 0 O4'-C1'-N19 110.957 2.757 . 0.442 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.438 0 N19-C1'-C2' 109.289 -2.569 . 0.591 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.333 0 O4'-C1'-N19 111.541 3.341 . 0.756 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ' U' . . . . . 0.442 HO2' " C5'" ' A' ' 20' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.811 0 C5'-C4'-C3' 111.495 -2.67 . 0.8 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ' U' . . . . . 0.563 HO2' " H5'" ' A' ' 21' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.424 -2.425 0 O4'-C1'-N19 110.842 2.642 . 0.654 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ' G' . . . . . 0.563 " H5'" HO2' ' A' ' 20' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.42 -2.748 0 C5'-C4'-C3' 112.196 -2.203 . 0.741 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ' C' . . . . . 0.561 " H5'" HO2' ' A' ' 21' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.422 -2.594 0 C5'-C4'-C3' 111.509 -2.661 . 0.795 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ' C' . . . . . 0.546 " H5'" HO2' ' A' ' 22' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.421 -2.63 0 N19-C1'-C2' 109.677 -2.327 . 0.767 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.253 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 69.3 m -67.54 158.59 31.63 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.641 0.376 . . . . 0.0 110.85 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 22.2 t-80 -68.43 143.36 55.08 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 122.699 0.4 . . . . 0.0 110.546 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 91.4 mtp -147.65 156.63 42.98 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.205 0.602 . . . . 0.0 110.111 178.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 60.95 150.46 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -86.7 25.79 1.21 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.465 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 44.0 t -64.38 -12.36 41.86 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.824 0.449 . . . . 0.0 111.278 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 34.1 p30 -134.25 18.83 3.7 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.28 0.632 . . . . 0.0 111.198 178.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -114.25 113.42 24.59 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -113.25 -2.41 14.07 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.222 -177.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 286' ' ' THR . . . . . 0.43 ' HG1' " C1'" ' A' ' 15' ' ' ' C' . 89.5 m -101.06 137.99 38.7 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.978 0.418 . . . . 0.0 109.909 -174.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 45.9 pt -105.91 148.28 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 172.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -99.94 142.98 30.7 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 171.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 14.6 t -133.77 141.51 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -128.92 154.6 46.39 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 122.873 0.469 . . . . 0.0 109.738 173.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.7 12.35 66.8 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-O 119.932 -0.371 . . . . 0.0 112.497 169.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 85.0 mt -57.14 -51.05 70.87 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 117.677 0.739 . . . . 0.0 110.202 -176.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 143.38 169.6 12.67 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -95.94 3.93 53.14 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 122.621 -0.341 . . . . 0.0 111.585 -178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -128.86 11.55 6.12 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.8 m -76.03 165.48 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -173.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 29.9 p -130.99 157.74 42.16 Favored 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 123.615 0.766 . . . . 0.0 111.623 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 298' ' ' ILE . . . . . . . . . . . . . 34.4 mt -62.06 -42.34 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.154 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.45 -36.41 84.09 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.401 0.28 . . . . 0.0 111.737 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 43.6 t -72.44 -44.04 62.93 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 117.668 0.213 . . . . 0.0 110.48 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 76.9 t -61.61 -41.95 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.67 -35.25 80.44 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 303' ' ' ASP . . . . . 0.432 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.4 t0 -70.68 -29.07 65.29 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 304' ' ' TYR . . . . . 0.4 ' CE2' ' CD1' ' B' ' 354' ' ' PHE . 63.2 t80 -82.61 -25.77 32.88 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -96.88 -24.23 15.97 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 306' ' ' LYS . . . . . 0.432 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.6 ptpt -66.86 -18.77 65.54 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -177.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -71.9 -19.46 61.92 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.5 mm -88.05 -46.73 15.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 120.419 0.152 . . . . 0.0 110.651 175.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -161.73 169.17 37.11 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 90.2 mt -69.18 122.36 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 120.767 0.318 . . . . 0.0 110.261 -175.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 67.7 mt -77.63 137.26 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 175.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 312' ' ' LYS . . . . . 0.402 ' HG2' ' SD ' ' B' ' 321' ' ' MET . 22.8 ttmm -69.98 151.0 46.09 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 2.6 m -118.97 139.86 50.97 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -71.79 146.61 47.94 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -90.84 -9.01 47.96 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 122.491 0.316 . . . . 0.0 111.532 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 316' ' ' LYS . . . . . 0.444 ' HA ' ' HE2' ' B' ' 316' ' ' LYS . 7.0 mmpt? -108.87 -46.11 3.68 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 122.325 0.25 . . . . 0.0 110.888 -176.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 18.0 p -89.63 -25.76 21.11 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -177.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 77.14 -6.47 42.69 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 123.273 0.464 . . . . 0.0 112.38 175.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -87.01 160.89 48.43 Favored Pre-proline 0 C--O 1.233 0.196 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 176.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.35 150.28 87.33 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 N-CA-C 108.639 -1.331 . . . . 0.0 108.639 176.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 321' ' ' MET . . . . . 0.402 ' SD ' ' HG2' ' B' ' 312' ' ' LYS . 88.0 mtp -78.02 85.91 4.22 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.452 0.644 . . . . 0.0 111.796 -170.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 322' ' ' ILE . . . . . . . . . . . . . 3.1 mp -124.71 143.28 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 174.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -129.66 99.03 5.0 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 48.8 mt -75.56 154.24 36.91 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 176.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -117.54 148.41 41.9 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 175.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 7.6 m -134.99 148.84 50.08 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.113 0.565 . . . . 0.0 111.986 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -75.73 121.29 22.32 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 177.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -76.95 2.86 13.56 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 122.389 -0.194 . . . . 0.0 111.399 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -107.02 -13.13 15.27 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 122.733 0.413 . . . . 0.0 111.623 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 2.8 p -135.01 -27.68 1.23 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 78.2 13.82 82.9 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-O 119.834 -0.426 . . . . 0.0 112.167 172.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -73.56 -114.33 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.295 0.638 . . . . 0.0 110.849 178.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 6.1 mt -158.89 138.79 11.98 Favored 'General case' 0 C--N 1.334 -0.077 0 C-N-CA 124.766 1.226 . . . . 0.0 107.748 171.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -77.68 -19.22 55.7 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 122.115 0.166 . . . . 0.0 111.134 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.17 5.78 81.75 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -175.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -105.76 150.32 25.64 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 117.27 0.535 . . . . 0.0 109.884 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -163.98 163.21 23.53 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.112 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 60.5 p -111.76 155.67 23.15 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 169.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 16.4 t -135.8 120.53 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 O-C-N 123.415 0.447 . . . . 0.0 110.542 173.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 14.8 t -88.42 134.81 33.74 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -103.04 152.54 21.24 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 176.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -65.8 -33.66 76.37 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -178.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -130.36 150.86 77.4 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 344' ' ' PRO . . . . . 0.451 ' HG2' ' HD3' ' B' ' 345' ' ' PRO . 40.5 Cg_endo -70.42 -31.99 16.62 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.604 2.869 . . . . 0.0 114.425 -177.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 345' ' ' PRO . . . . . 0.451 ' HD3' ' HG2' ' B' ' 344' ' ' PRO . 76.9 Cg_endo -73.75 -21.08 19.32 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 CA-C-N 121.078 1.421 . . . . 0.0 110.028 -176.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 66.9 m -72.6 -36.09 68.04 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 175.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -67.64 -38.57 84.03 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 174.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -65.19 -42.18 93.86 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.58 -35.55 77.51 Favored 'General case' 0 N--CA 1.458 -0.035 0 O-C-N 122.446 -0.159 . . . . 0.0 110.574 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -63.75 -37.68 88.26 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 63.1 mt -68.74 -51.62 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 120.379 -0.529 . . . . 0.0 109.634 175.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -55.92 -28.32 56.27 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 53.3 t-105 -97.16 -54.77 3.06 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 354' ' ' PHE . . . . . 0.4 ' CD1' ' CE2' ' B' ' 304' ' ' TYR . 51.7 m-85 -76.95 -27.77 54.95 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -173.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -50.38 109.23 0.28 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 117.993 0.361 . . . . 0.0 111.858 178.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 98.8 -0.43 57.81 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 119.537 -0.591 . . . . 0.0 112.654 175.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -83.55 -164.87 0.97 Allowed 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.136 0.968 . . . . 0.0 110.073 176.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -128.19 152.91 47.49 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 121.084 0.469 . . . . 0.0 110.727 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -144.9 136.27 25.22 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.331 1.053 . . . . 0.0 112.585 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 17.4 t 55.24 17.94 2.26 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 120.794 0.331 . . . . 0.0 110.951 -175.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.89 22.85 40.72 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 112.013 -0.435 . . . . 0.0 112.013 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 41.9 m-20 -132.31 142.6 45.58 Favored Pre-proline 0 C--O 1.226 -0.165 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 -177.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.48 135.73 31.88 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.855 2.37 . . . . 0.0 109.54 178.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 31.9 pt -121.34 170.79 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.101 0 CA-C-O 121.265 0.555 . . . . 0.0 111.207 -177.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -143.18 109.42 5.32 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.747 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 11.3 t -99.45 148.89 5.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 C-N-CA 123.164 0.586 . . . . 0.0 111.952 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 84.7 p -163.47 177.14 9.1 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -76.83 129.4 36.19 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 174.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -86.29 -178.72 6.54 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 11.2 t -149.73 -162.98 1.67 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.014 1.325 . . . . 0.0 109.645 175.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -108.7 70.23 0.74 Allowed 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.118 0.417 . . . . 0.0 111.54 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 55.7 mtt180 -68.71 -6.68 27.72 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 169.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.59 -31.01 71.76 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 123.494 0.718 . . . . 0.0 110.081 169.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -71.05 -1.03 10.81 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -174.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -78.65 -11.56 59.98 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -141.58 -9.25 0.95 Allowed 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 12.6 ptm85 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 117.638 -1.172 . . . . 0.0 110.583 -177.511 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ' G' . . . . . 0.657 HO2' " H5'" ' A' ' 2' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.421 -2.632 0 N19-C1'-C2' 109.402 -2.499 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ' G' . . . . . 0.657 " H5'" HO2' ' A' ' 1' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.423 -2.532 0 C5'-C4'-C3' 111.644 -2.57 . 0.668 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ' C' . . . . . 0.482 HO2' " H5'" ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.606 0 N19-C1'-C2' 109.503 -2.436 . 0.77 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . 0.482 " H5'" HO2' ' A' ' 3' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.423 -2.503 0 N19-C1'-C2' 109.061 -2.712 . 0.759 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.824 0 N19-C1'-C2' 108.509 -3.057 . 0.766 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ' A' . . . . . 0.587 HO2' " H5'" ' A' ' 7' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.798 0 C4'-C3'-C2' 100.093 -2.607 . 0.802 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ' U' . . . . . 0.587 " H5'" HO2' ' A' ' 6' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.718 0 C5'-C4'-C3' 111.416 -2.723 . 0.807 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ' U' . . . . . 0.411 " H2'" ' C8 ' ' A' ' 9' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.825 0 C4'-C3'-C2' 100.106 -2.594 . 0.749 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ' A' . . . . . 0.411 ' C8 ' " H2'" ' A' ' 8' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.424 -2.437 0 C4'-C3'-C2' 99.856 -2.844 . 0.634 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ' C' . . . . . 0.649 HO2' " C5'" ' A' ' 11' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.621 0 O4'-C1'-N19 110.533 2.333 . 0.475 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ' A' . . . . . 0.725 HO2' " C5'" ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.493 0 O4'-C1'-N19 111.023 2.823 . 0.217 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ' A' . . . . . 0.725 " C5'" HO2' ' A' ' 11' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.429 -1.981 0 C5'-C4'-C3' 109.576 -3.95 . 0.219 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ' U' . . . . . 0.534 " C5'" HO2' ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.627 1 O4'-C1'-N19 112.641 4.441 . 0.01 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.762 0 O4'-C1'-N19 111.079 2.879 . 0.594 6p . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ' C' . . . . . 0.43 " C1'" ' HG1' ' B' ' 286' ' ' THR . . . . . . . . 0 P--O5' 1.618 2.522 0 O4'-C1'-N19 111.687 3.487 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.439 0 O4'-C1'-N19 111.226 3.026 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ' A' . . . . . 0.577 HO2' " H5'" ' A' ' 18' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.425 -2.314 0 N19-C1'-C2' 109.46 -2.462 . 0.72 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ' U' . . . . . 0.577 " H5'" HO2' ' A' ' 17' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.648 0 O4'-C1'-N19 111.249 3.049 . 0.776 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ' U' . . . . . 0.42 HO2' " H5'" ' A' ' 20' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.61 0 O4'-C1'-N19 111.253 3.053 . 0.823 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ' U' . . . . . 0.42 " H5'" HO2' ' A' ' 19' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.598 0 O4'-C1'-N19 111.036 2.836 . 0.652 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ' G' . . . . . 0.59 HO2' " H5'" ' A' ' 22' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.421 -2.682 0 C5'-C4'-C3' 112.101 -2.266 . 0.735 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ' C' . . . . . 0.59 " H5'" HO2' ' A' ' 21' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.421 -2.638 0 C5'-C4'-C3' 111.785 -2.477 . 0.782 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ' C' . . . . . 0.539 " H5'" HO2' ' A' ' 22' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.422 -2.571 0 N19-C1'-C2' 109.573 -2.392 . 0.771 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.275 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 99.8 p -155.97 166.14 34.37 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.857 0.463 . . . . 0.0 110.231 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -153.91 150.97 28.91 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 97.6 mmm -139.39 159.02 43.13 Favored 'General case' 0 C--O 1.23 0.068 0 C-N-CA 123.255 0.622 . . . . 0.0 110.632 -178.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -66.1 -13.04 59.4 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -87.78 15.03 7.51 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.597 0.359 . . . . 0.0 111.702 178.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 42.9 t -63.09 -14.77 52.37 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.807 0.443 . . . . 0.0 111.025 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 26.7 p30 -134.07 15.28 3.87 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.291 0.636 . . . . 0.0 111.531 177.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -103.35 110.14 22.03 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -113.69 9.19 17.74 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.806 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 95.4 m -113.22 145.52 40.87 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.318 0.58 . . . . 0.0 110.708 -175.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 33.7 pt -119.85 148.77 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.436 -0.802 . . . . 0.0 108.846 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -101.65 143.87 31.07 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 173.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 12.1 t -127.25 139.87 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 CA-C-O 120.963 0.411 . . . . 0.0 111.302 177.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -125.58 154.1 42.73 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.601 0.76 . . . . 0.0 108.968 177.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 83.3 12.96 77.79 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 173.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 1.5 tp -52.69 -55.08 25.17 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.583 0.753 . . . . 0.0 110.707 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 142.11 172.24 13.48 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -101.45 2.6 39.48 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -128.7 16.77 6.38 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.814 0.446 . . . . 0.0 111.285 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 10.3 m -74.47 166.85 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -173.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 43.1 p -138.23 159.52 41.84 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.729 0.811 . . . . 0.0 110.762 177.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 298' ' ' ILE . . . . . . . . . . . . . 45.3 mt -62.65 -44.13 99.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.16 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -64.39 -35.52 81.18 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.443 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 44.8 t -71.56 -49.97 35.51 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 118.036 0.38 . . . . 0.0 110.741 -177.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 7.5 p -65.44 -33.44 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.681 177.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -65.97 -32.62 74.22 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.579 176.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 303' ' ' ASP . . . . . 0.431 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 44.9 t0 -75.39 -27.25 59.01 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -178.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -85.26 -23.88 28.01 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -96.93 -24.18 15.96 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 178.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 306' ' ' LYS . . . . . 0.431 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.7 ptpt -66.4 -17.7 64.93 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -177.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -72.45 -20.73 61.35 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.6 mm -86.37 -45.94 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 CA-C-N 117.873 0.306 . . . . 0.0 110.226 175.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -162.4 167.0 36.78 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 79.2 mt -69.19 120.42 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 120.725 0.298 . . . . 0.0 110.683 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 88.6 mt -73.97 134.85 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 172.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -70.9 133.3 46.33 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 1.4 m -88.79 139.53 30.36 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 177.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -66.64 128.63 36.97 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 175.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -85.66 -5.03 59.32 Favored 'General case' 0 C--N 1.334 -0.104 0 O-C-N 122.28 -0.263 . . . . 0.0 110.391 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -107.14 -20.98 13.13 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 122.878 0.471 . . . . 0.0 110.769 -176.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 12.2 p -128.09 -23.44 3.31 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -174.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 84.65 -10.37 62.33 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 112.053 -0.419 . . . . 0.0 112.053 173.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -83.01 157.41 66.24 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 117.956 0.878 . . . . 0.0 109.097 174.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.9 155.67 68.88 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.023 1.815 . . . . 0.0 110.054 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 321' ' ' MET . . . . . . . . . . . . . 37.4 mtt -72.04 94.15 1.47 Allowed 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 120.951 0.405 . . . . 0.0 111.793 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 322' ' ' ILE . . . . . . . . . . . . . 3.5 mp -141.61 142.27 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 173.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -132.3 108.83 9.47 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 173.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 38.0 mt -77.64 153.2 33.38 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 175.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -120.86 143.3 48.98 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 175.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.7 142.59 51.43 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -174.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -70.38 126.84 30.78 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -85.92 -5.9 59.16 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 117.018 -0.083 . . . . 0.0 111.137 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -99.66 -13.88 19.17 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.521 0.328 . . . . 0.0 111.655 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 4.0 p -138.31 -23.89 0.99 Allowed 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -178.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 78.6 11.56 85.14 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.649 -0.581 . . . . 0.0 111.649 174.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -73.44 -100.62 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 117.538 0.669 . . . . 0.0 110.724 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 5.7 mt -165.2 146.89 7.66 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.574 1.55 . . . . 0.0 107.697 173.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -77.15 -18.23 58.01 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 122.274 0.229 . . . . 0.0 110.568 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 74.82 22.23 77.29 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 -174.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -133.06 146.55 51.79 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 117.236 0.518 . . . . 0.0 110.511 -178.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -157.76 155.71 30.33 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.133 174.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 10.9 p -95.7 152.6 18.32 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 170.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 40.9 t -135.63 129.96 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 170.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 9.0 t -110.47 143.38 40.88 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-N 117.888 0.313 . . . . 0.0 111.029 -177.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -108.4 160.23 16.04 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -176.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -72.42 -28.57 63.05 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -135.54 150.11 71.25 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -177.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 344' ' ' PRO . . . . . 0.447 ' HG2' ' HD3' ' B' ' 345' ' ' PRO . 39.5 Cg_endo -69.69 -32.71 18.34 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.457 2.772 . . . . 0.0 114.487 -177.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 345' ' ' PRO . . . . . 0.447 ' HD3' ' HG2' ' B' ' 344' ' ' PRO . 96.1 Cg_endo -73.74 -20.88 19.55 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 CA-C-N 121.381 1.529 . . . . 0.0 110.324 -177.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 66.3 m -73.11 -37.48 66.67 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 175.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.13 -38.47 88.25 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 173.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -63.19 -46.09 88.69 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -66.74 -34.09 77.08 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 110.584 -0.154 . . . . 0.0 110.584 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.44 -35.96 82.49 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 64.8 mt -70.71 -51.71 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 175.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -55.17 -28.76 55.19 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 57.5 t-105 -98.04 -55.9 2.65 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -76.16 -30.66 58.2 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -173.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -55.21 110.73 0.72 Allowed 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 118.289 0.495 . . . . 0.0 110.777 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 103.56 -4.42 47.07 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.516 -0.602 . . . . 0.0 112.308 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -84.22 -163.76 0.84 Allowed 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 118.077 0.938 . . . . 0.0 110.165 176.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -127.82 150.67 49.73 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-O 120.95 0.405 . . . . 0.0 110.853 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -141.67 137.35 31.71 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.345 1.058 . . . . 0.0 112.487 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 20.5 t 53.91 18.96 1.78 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.563 0.345 . . . . 0.0 111.183 -175.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.4 21.96 42.56 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 112.056 -0.418 . . . . 0.0 112.056 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 41.0 m-20 -131.91 141.7 42.49 Favored Pre-proline 0 N--CA 1.453 -0.285 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -177.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -68.95 133.5 27.24 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 122.611 2.208 . . . . 0.0 109.403 177.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 29.8 pt -120.47 170.24 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.146 0 CA-C-O 121.336 0.588 . . . . 0.0 111.107 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -144.51 111.24 5.72 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 10.7 t -99.98 149.25 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.305 0.642 . . . . 0.0 111.966 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 23.2 t -162.46 172.72 15.08 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -69.57 128.72 37.46 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 176.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -85.11 179.33 7.28 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.905 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 10.9 t -146.53 -152.57 0.44 Allowed 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.654 1.181 . . . . 0.0 108.054 174.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 371' ' ' ARG . . . . . 0.431 ' HD3' ' C6 ' ' A' ' 15' ' ' ' C' . 54.5 mmm-85 -123.69 95.33 4.54 Favored 'General case' 0 C--N 1.337 0.062 0 CA-C-N 118.691 0.678 . . . . 0.0 110.728 174.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 27.3 mtp85 -68.98 -12.78 61.99 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 120.615 0.245 . . . . 0.0 110.401 170.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.14 -25.05 60.96 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 122.881 0.472 . . . . 0.0 110.621 176.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -63.27 -18.56 63.71 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 122.838 0.455 . . . . 0.0 112.177 -178.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -76.84 -11.79 59.88 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -131.16 -17.76 3.01 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -175.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.235 0 CA-C-O 116.781 -1.58 . . . . 0.0 111.224 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.494 0 N19-C1'-C2' 108.686 -2.946 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.509 0 C5'-C4'-C3' 111.498 -2.668 . 0.704 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.537 0 N19-C1'-C2' 108.822 -2.861 . 0.659 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.414 0 N19-C1'-C2' 108.926 -2.796 . 0.823 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ' G' . . . . . 0.56 HO2' " H5'" ' A' ' 6' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.627 0 N19-C1'-C2' 108.793 -2.879 . 0.653 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ' A' . . . . . 0.56 " H5'" HO2' ' A' ' 5' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.424 -2.409 0 N19-C1'-C2' 108.765 -2.897 . 0.751 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.517 0 O4'-C1'-N19 111.016 2.816 . 0.805 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.423 0 O4'-C1'-N19 111.141 2.941 . 0.754 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ' A' . . . . . 0.582 HO2' " H5'" ' A' ' 10' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.421 -2.658 0 C4'-C3'-C2' 99.917 -2.783 . 0.657 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ' C' . . . . . 0.638 HO2' " H5'" ' A' ' 11' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.571 0 O4'-C1'-N19 111.005 2.805 . 0.631 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ' A' . . . . . 0.638 " H5'" HO2' ' A' ' 10' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.424 -2.435 0 O4'-C1'-N19 110.983 2.783 . 0.633 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ' A' . . . . . 0.576 " H5'" HO2' ' A' ' 11' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.426 -2.219 1 O4'-C1'-N19 112.344 4.144 . 0.038 1b . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ' U' . . . . . 0.439 HO2' ' P ' ' A' ' 14' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.423 -2.489 0 C5'-C4'-C3' 110.233 -3.512 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ' U' . . . . . 0.439 ' P ' HO2' ' A' ' 13' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.421 -2.631 1 C5'-C4'-C3' 109.491 -4.006 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ' C' . . . . . 0.431 ' C6 ' ' HD3' ' B' ' 371' ' ' ARG . . . . . . . . 0 O4'--C4' 1.415 -3.132 0 C5'-C4'-C3' 111.525 -2.65 . 0.128 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.454 0 O4'-C1'-N19 111.076 2.876 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ' A' . . . . . 0.519 HO2' " H5'" ' A' ' 18' ' ' ' U' . . . . . . . . 0 P--O5' 1.616 2.348 0 N19-C1'-C2' 108.936 -2.79 . 0.756 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ' U' . . . . . 0.519 " H5'" HO2' ' A' ' 17' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.723 0 O4'-C1'-N19 111.015 2.815 . 0.839 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ' U' . . . . . 0.488 HO2' " C5'" ' A' ' 20' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.42 -2.724 0 O4'-C1'-N19 110.937 2.737 . 0.781 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ' U' . . . . . 0.488 " C5'" HO2' ' A' ' 19' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.621 0 O4'-C1'-N19 110.791 2.591 . 0.65 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ' G' . . . . . 0.536 HO2' " H5'" ' A' ' 22' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.42 -2.761 0 C4'-C3'-C2' 100.142 -2.558 . 0.734 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ' C' . . . . . 0.536 " H5'" HO2' ' A' ' 21' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.421 -2.638 0 O4'-C1'-N19 110.72 2.52 . 0.791 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.71 0 N19-C1'-C2' 109.702 -2.311 . 0.809 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.344 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 67.9 m -72.08 -9.39 58.33 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 122.244 0.218 . . . . 0.0 111.422 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 54.1 m80 -142.03 167.55 21.85 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.192 0.597 . . . . 0.0 109.536 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 91.2 mtp -67.3 159.69 28.71 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.607 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -69.55 -7.02 34.73 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 21.5 m-20 -78.63 23.59 0.31 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.103 0.561 . . . . 0.0 111.21 178.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 90.1 p -63.38 -17.77 62.98 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.708 0.403 . . . . 0.0 111.171 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 29.3 p30 -98.86 7.53 45.94 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.372 0.669 . . . . 0.0 112.326 177.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -130.45 110.19 11.28 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 120.844 0.354 . . . . 0.0 110.067 -177.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.79 2.84 14.5 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.213 0.605 . . . . 0.0 112.392 -178.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 91.7 m -105.11 142.24 35.24 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.054 0.454 . . . . 0.0 111.046 -174.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 30.5 pt -115.31 149.46 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -99.87 146.2 26.91 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 173.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 60.3 t -131.26 133.75 61.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.532 -178.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -123.65 153.55 40.61 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 83.31 13.11 77.42 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 172.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 292' ' ' LEU . . . . . 0.406 HD12 ' CD1' ' B' ' 359' ' ' PHE . 4.4 tp -59.07 -50.7 73.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 123.763 0.825 . . . . 0.0 111.027 -169.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 143.89 165.65 10.97 Favored Glycine 0 C--N 1.337 0.637 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 177.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -96.82 2.13 51.47 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.347 0.259 . . . . 0.0 111.282 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -128.47 11.86 6.37 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.868 0.467 . . . . 0.0 111.699 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 4.7 m -68.19 162.63 3.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -174.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 29.8 p -134.33 159.72 40.13 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 123.596 0.758 . . . . 0.0 110.697 176.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 298' ' ' ILE . . . . . . . . . . . . . 33.9 mt -61.33 -41.82 91.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.133 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -66.52 -36.05 81.75 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 122.554 0.342 . . . . 0.0 111.709 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 75.5 m -72.24 -46.08 57.51 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 118.175 0.443 . . . . 0.0 110.319 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 69.9 t -60.56 -42.65 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.32 -36.31 83.7 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 122.201 -0.312 . . . . 0.0 110.203 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 303' ' ' ASP . . . . . 0.438 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.1 t0 -69.88 -28.18 65.43 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -84.35 -25.84 28.88 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -96.1 -24.04 16.49 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 306' ' ' LYS . . . . . 0.438 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.6 ptpt -67.42 -18.68 65.2 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -176.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -72.57 -21.14 61.19 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -177.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.2 mm -85.94 -44.96 17.0 Favored 'Isoleucine or valine' 0 C--O 1.23 0.072 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 175.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.87 165.5 37.01 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 85.2 mt -66.04 123.49 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 120.854 0.359 . . . . 0.0 110.26 -177.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 85.8 mt -77.08 135.79 25.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 173.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -70.16 135.35 49.03 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 1.8 m -97.3 144.41 27.11 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -77.4 131.15 37.89 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 174.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -84.56 -10.09 57.72 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 117.326 0.057 . . . . 0.0 111.017 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -102.81 -19.08 14.84 Favored 'General case' 0 C--O 1.227 -0.079 0 C-N-CA 122.516 0.326 . . . . 0.0 110.714 -174.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 10.4 p -127.23 -22.81 3.66 Favored 'General case' 0 N--CA 1.462 0.13 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 -177.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 81.67 -9.61 54.99 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-O 119.899 -0.39 . . . . 0.0 112.361 173.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -85.78 156.87 58.26 Favored Pre-proline 0 N--CA 1.453 -0.323 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.66 156.48 65.37 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.047 1.831 . . . . 0.0 109.874 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 321' ' ' MET . . . . . 0.421 ' CB ' ' HB3' ' B' ' 340' ' ' SER . 33.6 mtt -72.51 86.23 1.16 Allowed 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -177.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 322' ' ' ILE . . . . . 0.419 HD13 ' C ' ' B' ' 321' ' ' MET . 3.2 mp -130.29 138.73 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 170.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -129.8 105.15 7.82 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 174.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 31.2 mt -77.82 153.38 32.83 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 123.952 0.783 . . . . 0.0 109.085 177.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -116.39 147.95 41.14 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -135.1 145.01 47.48 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -177.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -74.16 133.17 42.75 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 46.1 mtp85 -86.42 -6.41 58.93 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 122.22 0.208 . . . . 0.0 111.183 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -101.81 -13.19 17.8 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.722 0.409 . . . . 0.0 111.887 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 26.4 p -138.44 -22.04 1.02 Allowed 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 80.25 3.48 89.75 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 111.549 -0.621 . . . . 0.0 111.549 177.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -84.1 154.72 23.01 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 117.797 0.798 . . . . 0.0 109.189 176.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 48.3 mt -71.3 141.66 50.49 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -177.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -74.81 -15.53 60.74 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 123.343 0.657 . . . . 0.0 111.639 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 78.02 20.81 72.33 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -175.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -129.94 147.67 51.72 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 122.948 0.499 . . . . 0.0 110.252 -178.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -156.38 162.04 40.08 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 120.759 0.314 . . . . 0.0 110.799 174.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 19.1 p -104.79 154.4 20.07 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 169.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 17.3 t -135.47 132.11 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 123.454 0.702 . . . . 0.0 109.345 171.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 340' ' ' SER . . . . . 0.421 ' HB3' ' CB ' ' B' ' 321' ' ' MET . 46.2 t -110.82 136.46 49.84 Favored 'General case' 0 C--O 1.227 -0.109 0 CA-C-N 118.002 0.365 . . . . 0.0 111.101 -178.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -100.5 159.55 15.06 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -178.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -71.91 -30.95 65.9 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -130.04 148.99 71.9 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 344' ' ' PRO . . . . . 0.458 ' HG2' ' HD3' ' B' ' 345' ' ' PRO . 38.0 Cg_endo -69.96 -33.56 15.61 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.361 2.708 . . . . 0.0 114.636 -177.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 345' ' ' PRO . . . . . 0.458 ' HD3' ' HG2' ' B' ' 344' ' ' PRO . 87.5 Cg_endo -73.5 -23.04 17.69 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 CA-C-N 121.083 1.423 . . . . 0.0 110.016 -177.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 58.8 m -71.95 -34.83 69.31 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 175.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.85 -41.07 87.96 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 175.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 40.2 tptt -69.53 -36.14 76.11 Favored 'General case' 0 C--N 1.339 0.121 0 O-C-N 122.176 -0.328 . . . . 0.0 110.706 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -65.75 -35.49 80.87 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 175.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -66.26 -37.49 85.59 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 72.2 mt -67.6 -53.62 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.772 175.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -56.85 -27.47 60.32 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -177.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -96.7 -55.15 2.99 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -76.5 -30.93 57.41 Favored 'General case' 0 CA--C 1.522 -0.117 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -173.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -54.53 110.26 0.61 Allowed 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.126 0.421 . . . . 0.0 110.876 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 104.31 -3.96 43.98 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 119.609 -0.551 . . . . 0.0 112.423 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -84.9 -164.32 0.96 Allowed 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 117.814 0.807 . . . . 0.0 110.373 176.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 42.0 mp0 -128.68 152.6 48.2 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.927 0.394 . . . . 0.0 110.858 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 359' ' ' PHE . . . . . 0.406 ' CD1' HD12 ' B' ' 292' ' ' LEU . 25.1 t80 -143.91 134.83 25.32 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.195 0.998 . . . . 0.0 112.329 178.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 58.8 m 52.59 20.73 1.59 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -174.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.63 22.2 40.81 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 112.099 -0.4 . . . . 0.0 112.099 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 50.9 m-20 -132.21 141.83 42.82 Favored Pre-proline 0 N--CA 1.456 -0.174 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.62 137.91 36.99 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 122.713 2.275 . . . . 0.0 109.472 177.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 35.3 pt -125.87 168.98 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 CA-C-O 121.035 0.445 . . . . 0.0 110.667 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -144.68 113.35 6.7 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 10.7 t -103.16 150.06 6.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 123.165 0.586 . . . . 0.0 112.097 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 31.8 t -161.4 173.16 15.32 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -74.04 130.81 40.56 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 176.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -95.66 -177.17 3.97 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.062 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 12.5 t -153.23 -174.34 4.91 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.825 1.25 . . . . 0.0 108.308 174.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 69.4 mtp85 -97.11 86.59 3.99 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 118.755 0.707 . . . . 0.0 111.435 175.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 372' ' ' ARG . . . . . 0.449 ' HA ' ' CZ ' ' B' ' 375' ' ' PHE . 19.9 ttt180 -67.9 -14.42 62.95 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 169.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -66.74 -4.62 9.45 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.496 1.118 . . . . 0.0 111.931 174.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -104.4 -5.74 21.4 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 114.903 1.445 . . . . 0.0 114.903 -175.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 375' ' ' PHE . . . . . 0.449 ' CZ ' ' HA ' ' B' ' 372' ' ' ARG . 10.9 p90 -131.72 -18.71 2.72 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 176.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -77.27 -8.72 58.07 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.089 0.156 . . . . 0.0 111.336 173.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 . . . . . 0 C--O 1.251 1.183 0 CA-C-O 117.252 -1.356 . . . . 0.0 110.38 -176.092 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.583 0 N19-C1'-C2' 109.573 -2.392 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.501 0 C5'-C4'-C3' 111.461 -2.692 . 0.715 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ' C' . . . . . 0.401 " H2'" ' C8 ' ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.424 -2.43 0 O4'-C1'-N19 111.21 3.01 . 0.842 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . 0.599 HO2' " H5'" ' A' ' 5' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.427 -2.164 0 C4'-C3'-C2' 100.04 -2.66 . 0.736 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ' G' . . . . . 0.599 " H5'" HO2' ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.642 0 C4'-C3'-C2' 99.867 -2.833 . 0.696 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ' A' . . . . . 0.553 HO2' " H5'" ' A' ' 7' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.423 -2.519 0 N19-C1'-C2' 109.109 -2.682 . 0.792 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ' U' . . . . . 0.553 " H5'" HO2' ' A' ' 6' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.621 0 C5'-C4'-C3' 111.819 -2.454 . 0.799 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ' U' . . . . . 0.535 HO2' " H5'" ' A' ' 9' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.751 0 O4'-C1'-N19 110.987 2.787 . 0.736 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ' A' . . . . . 0.676 HO2' " H5'" ' A' ' 10' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.42 -2.714 0 C4'-C3'-C2' 99.853 -2.847 . 0.644 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ' C' . . . . . 0.676 " H5'" HO2' ' A' ' 9' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.591 0 O4'-C1'-N19 110.577 2.377 . 0.63 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ' A' . . . . . 0.577 " C5'" HO2' ' A' ' 10' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.422 -2.599 0 O4'-C1'-N19 111.133 2.933 . 0.539 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.255 0 C5'-C4'-C3' 109.595 -3.937 . 0.442 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.299 1 O4'-C1'-N19 113.178 4.978 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.62 2.678 0 O4'-C1'-N19 111.801 3.601 . 0.443 6p . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.628 3.466 0 N19-C1'-C2' 109.795 -2.253 . 0.158 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ' U' . . . . . 0.636 HO2' " H5'" ' A' ' 17' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.425 -2.301 0 O4'-C1'-N19 111.116 2.916 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ' A' . . . . . 0.636 " H5'" HO2' ' A' ' 16' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.424 -2.453 0 O4'-C1'-N19 110.578 2.378 . 0.666 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ' U' . . . . . 0.534 " H5'" HO2' ' A' ' 17' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.424 -2.418 0 O4'-C1'-N19 110.873 2.673 . 0.767 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ' U' . . . . . 0.509 HO2' " H5'" ' A' ' 20' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.425 -2.348 0 O4'-C1'-N19 111.27 3.07 . 0.771 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ' U' . . . . . 0.509 " H5'" HO2' ' A' ' 19' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.545 0 O4'-C1'-N19 111.146 2.946 . 0.636 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ' G' . . . . . 0.561 HO2' " H5'" ' A' ' 22' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.421 -2.629 0 C5'-C4'-C3' 111.606 -2.596 . 0.728 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ' C' . . . . . 0.561 " H5'" HO2' ' A' ' 21' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.422 -2.582 0 C5'-C4'-C3' 111.056 -2.963 . 0.765 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ' C' . . . . . 0.51 " H5'" HO2' ' A' ' 22' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.423 -2.53 0 O4'-C1'-N19 110.593 2.393 . 0.767 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.079 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 25.8 t -150.26 10.52 0.68 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.478 0.311 . . . . 0.0 110.888 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 41.4 m80 57.2 -178.86 0.05 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.817 0.847 . . . . 0.0 111.911 -177.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 14.2 tmm? -66.93 137.52 56.6 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -155.08 136.35 14.01 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.716 0.406 . . . . 0.0 109.995 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -139.36 20.58 2.57 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.686 0.795 . . . . 0.0 111.018 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 45.2 t -64.55 -16.93 63.41 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.523 0.201 . . . . 0.0 110.956 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 31.5 p30 -114.92 16.62 17.19 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.025 0.93 . . . . 0.0 111.588 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -128.69 110.54 12.3 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 122.6 0.36 . . . . 0.0 110.383 -175.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . 0.453 HD22 ' C ' ' B' ' 285' ' ' ASN . 0.3 OUTLIER -113.7 5.36 16.41 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.148 -178.75 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 85.4 m -106.21 143.58 34.14 Favored 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 122.09 -0.381 . . . . 0.0 110.675 -174.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 40.6 pt -120.16 144.53 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 176.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -96.18 145.36 25.59 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 174.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 19.0 t -130.85 144.79 36.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.156 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -133.47 152.97 51.98 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 175.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.55 11.27 68.98 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-O 119.78 -0.456 . . . . 0.0 112.361 169.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 63.8 mt -57.32 -49.95 74.49 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 117.645 0.723 . . . . 0.0 110.78 -175.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 148.54 172.93 18.91 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 -178.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -97.17 -6.25 35.24 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -175.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -128.64 15.77 6.47 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 4.3 m -67.59 161.38 3.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -174.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 19.4 p -123.88 159.95 28.52 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.441 0.696 . . . . 0.0 112.254 -178.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 298' ' ' ILE . . . . . . . . . . . . . 54.7 mt -63.68 -44.51 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.938 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -64.2 -36.3 83.6 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 122.565 0.346 . . . . 0.0 111.38 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 46.8 t -72.3 -47.04 53.01 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 122.247 -0.283 . . . . 0.0 110.812 -177.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 8.1 p -68.31 -33.98 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.005 178.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -65.22 -32.84 74.72 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 176.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 303' ' ' ASP . . . . . 0.42 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.6 t0 -74.02 -27.4 60.93 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -84.06 -24.69 30.31 Favored 'General case' 0 C--O 1.227 -0.13 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -96.8 -24.59 15.84 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 306' ' ' LYS . . . . . 0.42 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.7 ptpt -66.81 -18.04 65.18 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -177.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -70.9 -20.44 62.5 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 122.276 -0.265 . . . . 0.0 111.649 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.9 mm -87.61 -46.3 16.02 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-N 117.584 0.175 . . . . 0.0 110.644 175.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.71 168.78 38.44 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 85.7 mt -69.57 120.5 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-O 121.014 0.435 . . . . 0.0 110.695 -175.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 88.0 mt -73.01 138.77 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 172.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 312' ' ' LYS . . . . . 0.661 ' HE3' ' SD ' ' B' ' 321' ' ' MET . 28.8 ttpt -72.59 119.88 17.43 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -176.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 1.2 m -87.12 139.9 30.09 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 178.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -69.39 127.86 34.52 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 177.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -82.17 -5.53 58.54 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -108.92 -14.65 14.53 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.141 0.577 . . . . 0.0 111.568 -174.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 16.7 p -133.64 -23.48 1.83 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -178.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 83.56 -8.72 64.15 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 119.715 -0.492 . . . . 0.0 112.316 174.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -84.4 155.72 62.83 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 117.887 0.844 . . . . 0.0 109.248 174.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.61 155.27 59.32 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.227 1.952 . . . . 0.0 110.145 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 321' ' ' MET . . . . . 0.661 ' SD ' ' HE3' ' B' ' 312' ' ' LYS . 36.1 mtt -73.87 98.28 2.96 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 322' ' ' ILE . . . . . . . . . . . . . 3.3 mp -144.51 144.8 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 175.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -130.13 133.84 46.92 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 170.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 86.6 mt -106.54 133.8 50.65 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 325' ' ' TYR . . . . . 0.436 ' CE1' ' C2 ' ' A' ' 12' ' ' ' A' . 67.7 m-85 -96.54 151.19 19.83 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -177.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -139.91 140.56 36.45 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -174.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -76.78 137.56 39.36 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -177.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -83.51 -15.92 47.57 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.407 0.283 . . . . 0.0 110.688 175.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -90.27 -16.02 30.14 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -177.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 2.5 p -137.75 -21.82 1.11 Allowed 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -178.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 80.68 1.88 89.49 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 177.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -90.07 161.19 15.93 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 117.481 0.64 . . . . 0.0 109.801 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 10.4 mp -68.19 141.92 55.85 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -76.45 -16.96 59.55 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.673 176.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 79.04 3.4 88.2 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -173.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -99.03 151.39 20.98 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.008 0.523 . . . . 0.0 110.142 178.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -161.65 167.0 25.95 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 120.836 0.351 . . . . 0.0 111.331 -177.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 1.2 p -120.69 149.94 41.72 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 169.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 44.3 t -137.39 124.6 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 173.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 8.5 t -100.87 144.41 29.85 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 118.074 0.397 . . . . 0.0 110.815 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -109.8 158.65 17.93 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -79.09 -14.69 58.99 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -146.63 146.33 26.44 Favored Pre-proline 0 CA--C 1.53 0.204 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 344' ' ' PRO . . . . . 0.447 ' N ' ' CD ' ' B' ' 345' ' ' PRO . 48.2 Cg_endo -70.84 -31.03 16.39 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.051 2.501 . . . . 0.0 114.469 -177.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 345' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' B' ' 344' ' ' PRO . 77.1 Cg_endo -74.14 -22.84 16.42 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 CA-C-N 121.29 1.496 . . . . 0.0 110.01 -177.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 70.1 m -72.62 -34.3 67.26 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 176.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -69.9 -38.46 76.31 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 175.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -63.96 -42.55 97.25 Favored 'General case' 0 CA--C 1.527 0.094 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.26 -34.76 76.78 Favored 'General case' 0 C--N 1.34 0.17 0 O-C-N 122.287 -0.258 . . . . 0.0 110.506 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.59 -36.46 83.8 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 67.6 mt -69.79 -51.99 35.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.811 174.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -53.94 -29.64 43.25 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 56.2 t-105 -97.69 -56.04 2.63 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -75.64 -27.39 58.37 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 -173.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -50.13 110.68 0.42 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.015 0.371 . . . . 0.0 111.814 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 94.66 1.36 63.86 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.55 -0.583 . . . . 0.0 112.606 174.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -83.98 -164.71 0.97 Allowed 'General case' 0 C--N 1.339 0.152 0 CA-C-N 118.32 1.06 . . . . 0.0 110.146 176.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -129.41 152.96 48.39 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.209 0.528 . . . . 0.0 111.246 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -145.51 137.45 25.45 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.188 0.995 . . . . 0.0 112.061 177.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 21.1 t 54.19 18.51 1.82 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.87 0.468 . . . . 0.0 111.211 -175.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 89.29 22.58 37.23 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 111.939 -0.464 . . . . 0.0 111.939 178.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -133.67 141.81 41.45 Favored Pre-proline 0 N--CA 1.455 -0.205 0 CA-C-N 117.442 0.621 . . . . 0.0 109.428 -177.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.32 136.18 33.48 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 122.68 2.253 . . . . 0.0 109.567 177.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 30.4 pt -121.47 170.63 11.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-O 120.957 0.408 . . . . 0.0 111.383 -177.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -144.78 115.68 7.82 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.719 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 12.4 t -107.0 147.86 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 C-N-CA 123.429 0.692 . . . . 0.0 112.416 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 28.5 t -162.73 173.22 14.12 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 176.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -71.11 133.28 46.12 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -101.28 177.29 4.97 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.216 0.531 . . . . 0.0 111.647 178.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 9.0 p -139.63 -157.1 0.74 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.4 1.48 . . . . 0.0 110.055 174.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 -115.5 81.95 1.67 Allowed 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 118.379 0.536 . . . . 0.0 110.614 170.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 372' ' ' ARG . . . . . 0.526 ' HA ' ' CZ ' ' B' ' 375' ' ' PHE . 26.4 ttt180 -59.34 -22.34 61.16 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 169.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -61.81 -10.35 8.85 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.9 0.88 . . . . 0.0 112.005 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -95.68 -10.28 29.73 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -177.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 375' ' ' PHE . . . . . 0.526 ' CZ ' ' HA ' ' B' ' 372' ' ' ARG . 15.8 p90 -135.11 -15.39 1.97 Allowed 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 35.4 p-10 -76.56 -8.8 57.93 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.585 0.231 . . . . 0.0 110.545 175.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 117.027 -1.463 . . . . 0.0 110.298 -179.346 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ' G' . . . . . 0.639 HO2' " H5'" ' A' ' 2' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.421 -2.63 0 N19-C1'-C2' 109.25 -2.594 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ' G' . . . . . 0.639 " H5'" HO2' ' A' ' 1' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.42 -2.724 0 C5'-C4'-C3' 111.379 -2.747 . 0.668 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ' C' . . . . . 0.601 " H5'" HO2' ' A' ' 2' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.422 -2.613 0 O4'-C1'-N19 110.905 2.705 . 0.793 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . 0.613 HO2' " H5'" ' A' ' 5' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.422 -2.604 0 N19-C1'-C2' 108.62 -2.987 . 0.78 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ' G' . . . . . 0.613 " H5'" HO2' ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.644 0 C4'-C3'-C2' 99.42 -3.28 . 0.681 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ' A' . . . . . 0.617 HO2' " H5'" ' A' ' 7' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.424 -2.382 0 N19-C1'-C2' 108.718 -2.926 . 0.744 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ' U' . . . . . 0.617 " H5'" HO2' ' A' ' 6' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.552 0 O4'-C1'-N19 110.981 2.781 . 0.785 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.618 0 O4'-C1'-N19 111.156 2.956 . 0.754 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.723 0 C4'-C3'-C2' 99.86 -2.84 . 0.666 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.667 0 C4'-C3'-C2' 99.908 -2.792 . 0.606 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ' A' . . . . . 0.722 HO2' " C5'" ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.633 0 O4'-C1'-N19 111.016 2.816 . 0.421 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ' A' . . . . . 0.722 " C5'" HO2' ' A' ' 11' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.43 -1.957 0 O4'-C1'-N19 112.159 3.959 . 0.247 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ' U' . . . . . 0.546 " C5'" HO2' ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.615 1 O4'-C1'-N19 112.362 4.162 . 0.0 OUTLIER '7D dist 2[' 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.622 2.854 1 C5'-C4'-C3' 107.785 -5.143 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.626 3.305 0 O4'-C1'-N19 110.22 2.02 . 0.144 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.549 0 O4'-C1'-N19 111.405 3.205 . 0.177 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ' A' . . . . . 0.63 HO2' " H5'" ' A' ' 18' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.425 -2.342 0 N19-C1'-C2' 108.409 -3.119 . 0.507 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ' U' . . . . . 0.63 " H5'" HO2' ' A' ' 17' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.607 0 O4'-C1'-N19 111.0 2.8 . 0.721 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ' U' . . . . . 0.416 " H5'" HO2' ' A' ' 18' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.421 -2.664 0 O4'-C1'-N19 110.955 2.755 . 0.809 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.474 0 O4'-C1'-N19 110.9 2.7 . 0.69 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ' G' . . . . . 0.529 HO2' " H5'" ' A' ' 22' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.421 -2.68 0 C5'-C4'-C3' 111.879 -2.414 . 0.753 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ' C' . . . . . 0.529 " H5'" HO2' ' A' ' 21' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.42 -2.748 0 O4'-C1'-N19 110.785 2.585 . 0.797 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.653 0 N19-C1'-C2' 109.763 -2.273 . 0.804 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.114 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 96.1 p -151.92 171.78 17.25 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.134 0.574 . . . . 0.0 110.345 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 43.5 m80 -73.9 -11.66 60.43 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.24 0.216 . . . . 0.0 111.231 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 90.2 mtp -79.23 159.77 27.17 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 120.75 0.309 . . . . 0.0 110.576 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -70.01 -14.32 62.64 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 176.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 -83.37 12.37 5.55 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 122.897 0.479 . . . . 0.0 111.345 179.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 44.5 t -62.92 -20.99 65.72 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 122.092 -0.38 . . . . 0.0 110.864 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -89.78 8.31 32.48 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -138.15 110.49 7.43 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 122.2 -0.312 . . . . 0.0 110.47 -175.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.23 7.7 17.91 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.991 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 33.7 m -106.1 143.07 34.76 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 120.764 0.316 . . . . 0.0 111.477 -175.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 45.3 pt -120.72 146.73 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 288' ' ' PHE . . . . . 0.438 ' CE1' ' C6 ' ' A' ' 14' ' ' ' U' . 44.8 t80 -99.41 146.77 25.95 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 174.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 21.0 t -131.97 144.7 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.972 177.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -131.15 152.41 50.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 176.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.0 11.94 69.15 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 112.324 -0.311 . . . . 0.0 112.324 169.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 77.5 mt -55.6 -49.59 72.39 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 117.605 0.702 . . . . 0.0 110.492 -176.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 145.59 172.51 16.04 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -99.78 1.59 43.29 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.875 0.338 . . . . 0.0 111.787 -177.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -128.87 14.09 6.35 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.7 m -75.41 166.17 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -172.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 25.8 p -130.69 159.73 36.37 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.598 0.759 . . . . 0.0 112.168 -179.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 298' ' ' ILE . . . . . . . . . . . . . 44.4 mt -63.04 -46.38 96.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.337 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -62.37 -36.37 82.07 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.386 0.274 . . . . 0.0 111.437 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 47.0 t -72.44 -46.7 53.82 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 117.71 0.232 . . . . 0.0 110.836 -177.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.94 -33.28 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.341 178.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -65.3 -32.84 74.7 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 303' ' ' ASP . . . . . 0.421 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.4 t0 -74.64 -27.57 60.5 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 304' ' ' TYR . . . . . 0.404 ' CE2' ' CD2' ' B' ' 354' ' ' PHE . 52.3 t80 -83.48 -24.98 31.53 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -96.48 -25.09 15.79 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 178.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 306' ' ' LYS . . . . . 0.421 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.7 ptpt -66.35 -18.24 65.24 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -177.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -71.67 -20.19 61.98 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -178.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 3.9 mm -87.11 -46.33 16.23 Favored 'Isoleucine or valine' 0 C--N 1.337 0.059 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 175.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.98 167.95 38.25 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 85.8 mt -68.41 120.03 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 122.505 0.322 . . . . 0.0 110.634 -175.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 94.0 mt -71.72 138.06 22.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 172.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -68.86 125.2 25.88 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -177.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 2.5 m -95.98 137.48 34.99 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -71.05 130.31 41.21 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -82.03 -6.28 59.02 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -108.76 -14.79 14.53 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.043 0.537 . . . . 0.0 111.392 -174.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 10.1 p -131.27 -25.01 2.25 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 82.62 -9.14 59.93 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 119.516 -0.602 . . . . 0.0 112.197 175.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -86.59 155.91 56.3 Favored Pre-proline 0 CA--C 1.53 0.174 0 CA-C-N 117.913 0.857 . . . . 0.0 109.039 175.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -70.78 155.58 62.31 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 122.279 1.986 . . . . 0.0 110.096 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 321' ' ' MET . . . . . 0.415 ' CB ' ' HB3' ' B' ' 340' ' ' SER . 33.9 mtt -73.45 95.8 2.28 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 120.68 0.276 . . . . 0.0 111.712 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 322' ' ' ILE . . . . . . . . . . . . . 3.7 mp -141.29 141.05 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 172.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -134.37 110.9 9.75 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 175.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.68 152.69 33.63 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.673 0.789 . . . . 0.0 108.895 175.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -121.12 149.1 43.27 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 175.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 3.0 m -130.05 148.89 51.95 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -175.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -75.61 129.33 37.0 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 -84.11 -5.16 59.2 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 122.46 -0.15 . . . . 0.0 110.95 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -101.19 -14.33 17.76 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.693 0.397 . . . . 0.0 111.882 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 11.7 p -137.14 -22.94 1.15 Allowed 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 73.32 12.27 79.83 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-O 119.519 -0.6 . . . . 0.0 112.765 171.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -75.12 -103.45 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.929 0.864 . . . . 0.0 110.139 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 5.4 mt -159.45 144.7 15.7 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.688 1.195 . . . . 0.0 108.183 171.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 8.5 mmmm -76.02 -23.18 55.17 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 122.725 0.41 . . . . 0.0 110.32 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 77.26 5.64 85.58 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 -171.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -103.36 147.61 26.89 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.389 0.675 . . . . 0.0 109.992 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -161.95 153.83 19.02 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.006 176.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 12.8 p -98.72 151.77 20.38 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 169.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 42.5 t -136.13 125.99 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 170.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 340' ' ' SER . . . . . 0.415 ' HB3' ' CB ' ' B' ' 321' ' ' MET . 46.5 t -103.18 149.12 24.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 117.862 0.301 . . . . 0.0 111.316 -178.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -114.49 156.81 23.88 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -72.21 -29.11 63.65 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -132.46 147.83 67.2 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -178.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 344' ' ' PRO . . . . . 0.442 ' N ' ' CD ' ' B' ' 345' ' ' PRO . 45.3 Cg_endo -71.39 -31.71 13.59 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.446 2.764 . . . . 0.0 114.649 -178.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 345' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' B' ' 344' ' ' PRO . 78.5 Cg_endo -73.68 -21.86 18.6 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 CA-C-N 121.255 1.484 . . . . 0.0 110.04 -177.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 70.7 m -71.23 -35.92 71.63 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 175.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -68.03 -38.74 82.88 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 174.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -64.06 -42.07 97.14 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.43 -34.6 76.29 Favored 'General case' 0 C--O 1.226 -0.148 0 O-C-N 122.255 -0.278 . . . . 0.0 110.737 178.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.36 -36.71 84.83 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 66.4 mt -70.25 -52.05 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.691 175.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -53.77 -29.86 41.96 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 58.9 t-105 -97.58 -53.95 3.28 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -176.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 354' ' ' PHE . . . . . 0.404 ' CD2' ' CE2' ' B' ' 304' ' ' TYR . 47.7 m-85 -78.09 -27.08 48.43 Favored 'General case' 0 C--O 1.226 -0.134 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -174.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -48.09 110.4 0.32 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 178.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 95.18 1.74 62.61 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 119.612 -0.549 . . . . 0.0 112.764 174.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -84.5 -164.87 1.03 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.261 1.03 . . . . 0.0 110.524 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 41.8 mp0 -127.75 152.85 47.24 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.107 0.479 . . . . 0.0 110.84 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -145.31 136.76 25.15 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.181 0.992 . . . . 0.0 112.349 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 14.8 t 55.32 17.29 2.04 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.075 0.464 . . . . 0.0 111.175 -175.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.72 22.63 38.84 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.955 -0.458 . . . . 0.0 111.955 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 44.9 m-20 -132.07 143.02 47.23 Favored Pre-proline 0 N--CA 1.455 -0.218 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -177.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -68.9 136.69 36.01 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.849 2.366 . . . . 0.0 109.415 177.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 33.5 pt -124.04 171.05 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 CA-C-O 121.178 0.513 . . . . 0.0 111.125 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -143.81 114.89 7.87 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.759 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 11.9 t -102.33 148.65 7.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 123.256 0.623 . . . . 0.0 111.99 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 80.3 p -162.53 168.6 21.63 Favored 'General case' 0 CA--C 1.528 0.1 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -70.28 130.97 43.42 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 174.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -93.82 -179.1 4.88 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.882 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 9.6 t -150.48 -165.83 2.38 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.68 1.192 . . . . 0.0 107.877 172.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 75.5 mtt85 -108.11 75.66 1.0 Allowed 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.804 0.729 . . . . 0.0 110.161 173.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 25.2 ttt180 -60.62 -17.8 49.29 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 175.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.52 -38.55 77.94 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 122.47 0.308 . . . . 0.0 110.576 175.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -61.52 -10.41 7.83 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -171.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -82.29 -16.75 48.29 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 176.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -126.96 -20.27 4.24 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -173.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 75.1 mmt-85 . . . . . 0 C--O 1.253 1.253 0 CA-C-O 117.55 -1.214 . . . . 0.0 110.093 178.394 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.53 0 N19-C1'-C2' 109.273 -2.58 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ' G' . . . . . 0.6 HO2' " H5'" ' A' ' 3' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.421 -2.688 0 C5'-C4'-C3' 111.309 -2.794 . 0.709 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ' C' . . . . . 0.6 " H5'" HO2' ' A' ' 2' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.424 -2.384 0 O4'-C1'-N19 111.142 2.942 . 0.767 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . 0.613 HO2' " H5'" ' A' ' 5' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.424 -2.43 0 N19-C1'-C2' 108.295 -3.191 . 0.746 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ' G' . . . . . 0.613 " H5'" HO2' ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.513 0 N19-C1'-C2' 108.401 -3.124 . 0.689 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ' A' . . . . . 0.649 HO2' " H5'" ' A' ' 7' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.425 -2.322 0 N19-C1'-C2' 108.717 -2.927 . 0.736 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ' U' . . . . . 0.649 " H5'" HO2' ' A' ' 6' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.531 0 O4'-C1'-N19 110.899 2.699 . 0.757 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ' U' . . . . . 0.585 " H5'" HO2' ' A' ' 7' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.425 -2.357 0 C4'-C3'-C2' 99.696 -3.004 . 0.73 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.511 0 C4'-C3'-C2' 99.477 -3.223 . 0.628 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.679 0 C4'-C3'-C2' 100.025 -2.675 . 0.569 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.412 0 C5'-C4'-C3' 112.312 -2.126 . 0.624 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ' A' . . . . . 0.403 HO2' " C1'" ' A' ' 13' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.424 -2.419 1 C5'-C4'-C3' 109.08 -4.28 . 0.208 1t . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ' U' . . . . . 0.403 " C1'" HO2' ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.69 1 C5'-C4'-C3' 108.885 -4.41 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ' U' . . . . . 0.438 ' C6 ' ' CE1' ' B' ' 288' ' ' PHE . . . . . . . . 0 O4'--C4' 1.427 -2.205 1 O4'-C1'-N19 112.54 4.34 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.626 3.281 0 C5'-C4'-C3' 112.75 -1.833 . 0.414 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.39 0 O4'-C1'-N19 111.312 3.112 . 0.089 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ' A' . . . . . 0.641 HO2' " H5'" ' A' ' 18' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.426 -2.238 0 N19-C1'-C2' 108.612 -2.992 . 0.4 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ' U' . . . . . 0.641 " H5'" HO2' ' A' ' 17' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.425 -2.302 0 O4'-C1'-N19 111.301 3.101 . 0.697 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ' U' . . . . . 0.479 HO2' " C5'" ' A' ' 20' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.421 -2.707 0 O4'-C1'-N19 111.151 2.951 . 0.796 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ' U' . . . . . 0.566 HO2' " H5'" ' A' ' 21' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.423 -2.501 0 O4'-C1'-N19 110.792 2.592 . 0.655 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ' G' . . . . . 0.566 " H5'" HO2' ' A' ' 20' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.421 -2.644 0 C5'-C4'-C3' 111.892 -2.405 . 0.747 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.549 0 O4'-C1'-N19 110.715 2.515 . 0.818 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.509 0 O4'-C1'-N19 110.509 2.309 . 0.818 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.169 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 35.4 t 61.11 162.96 0.07 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.259 1.023 . . . . 0.0 112.152 -177.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -76.43 -13.37 60.12 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.858 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 93.8 mmm 58.55 179.88 0.07 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.979 0.912 . . . . 0.0 111.378 -175.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -72.9 139.22 46.7 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 122.597 0.359 . . . . 0.0 111.923 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -146.39 25.69 1.21 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.673 0.789 . . . . 0.0 110.967 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 88.4 p -66.97 -7.51 22.85 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.59 0.356 . . . . 0.0 110.84 178.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 28.1 p30 -131.63 22.0 4.67 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.908 0.883 . . . . 0.0 111.855 178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -141.53 122.58 14.62 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.744 0.307 . . . . 0.0 111.034 -178.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . 0.413 HD22 ' C ' ' B' ' 285' ' ' ASN . 0.3 OUTLIER -113.6 12.28 18.47 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.409 0.684 . . . . 0.0 111.375 177.18 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 63.7 m -108.98 146.22 34.22 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.877 0.37 . . . . 0.0 111.206 -172.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 44.9 pt -120.24 148.09 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 174.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 288' ' ' PHE . . . . . 0.448 ' CE2' ' C6 ' ' A' ' 14' ' ' ' U' . 54.1 t80 -101.4 145.77 28.49 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 174.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 17.2 t -129.75 144.46 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.236 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -133.16 152.45 51.94 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 175.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.21 12.38 67.87 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 119.814 -0.436 . . . . 0.0 112.663 169.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 59.3 mt -57.14 -50.1 73.85 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 117.414 0.607 . . . . 0.0 110.912 -174.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 157.0 -177.94 33.64 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -99.63 -9.32 23.32 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -176.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -139.95 22.0 2.45 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.2 m -68.11 165.15 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -173.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 16.0 p -123.11 159.56 28.27 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -177.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 298' ' ' ILE . . . . . 0.402 HG21 ' HB ' ' B' ' 322' ' ' ILE . 41.1 mt -62.32 -45.8 97.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.128 177.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -63.43 -37.56 87.77 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -177.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 81.1 p -73.35 -42.39 62.31 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 118.043 0.383 . . . . 0.0 110.376 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 54.4 t -61.69 -42.06 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -65.56 -34.36 78.06 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 303' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -70.55 -26.96 63.79 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -84.41 -25.68 28.86 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -96.3 -25.0 15.93 Favored 'General case' 0 C--O 1.231 0.091 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 306' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -66.55 -19.08 65.69 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.241 0.216 . . . . 0.0 111.458 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -71.28 -20.01 62.27 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 111.644 0.238 . . . . 0.0 111.644 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 5.1 mm -88.9 -46.25 15.46 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-N 117.602 0.183 . . . . 0.0 110.945 176.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -162.18 170.37 37.79 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 85.4 mt -72.12 118.58 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 122.61 0.364 . . . . 0.0 110.39 -175.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 93.6 mt -72.56 135.02 28.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 173.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -68.56 130.52 43.09 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 1.5 m -89.7 139.22 30.78 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -65.38 129.35 39.43 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 175.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -79.47 -10.43 59.8 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.789 -0.187 . . . . 0.0 110.962 -177.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -106.18 -48.02 3.69 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 -176.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 17.6 p -92.6 -23.76 18.92 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -174.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 82.29 -9.7 56.96 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 119.737 -0.479 . . . . 0.0 112.289 175.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -83.12 158.64 64.01 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 117.97 0.885 . . . . 0.0 108.887 174.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.37 154.39 69.36 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 121.685 1.59 . . . . 0.0 110.144 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 321' ' ' MET . . . . . 0.41 ' CB ' ' HB3' ' B' ' 340' ' ' SER . 38.6 mtt -72.53 93.05 1.53 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.863 0.363 . . . . 0.0 111.72 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 322' ' ' ILE . . . . . 0.402 ' HB ' HG21 ' B' ' 298' ' ' ILE . 3.9 mp -140.5 144.21 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 173.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -131.62 132.78 44.31 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 171.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -103.15 137.8 40.82 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 174.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -104.11 155.24 18.86 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 2.9 m -135.41 148.15 49.23 Favored 'General case' 0 CA--C 1.523 -0.093 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -176.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -78.67 130.75 36.21 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -79.85 -12.95 59.72 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 122.368 -0.207 . . . . 0.0 111.003 177.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -91.98 -14.83 28.85 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.494 0.317 . . . . 0.0 111.816 -178.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 2.8 p -137.35 -26.18 1.01 Allowed 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 75.31 10.48 84.41 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.849 -0.5 . . . . 0.0 111.849 175.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -75.36 -96.37 0.02 OUTLIER 'General case' 0 C--N 1.341 0.207 0 CA-C-N 117.68 0.74 . . . . 0.0 110.53 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 1.8 tp -164.81 149.49 9.37 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.532 0.733 . . . . 0.0 109.089 172.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -83.09 -22.69 33.37 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.491 0.186 . . . . 0.0 110.632 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 73.52 5.49 68.11 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -172.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -100.06 151.11 21.75 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.336 0.654 . . . . 0.0 110.024 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.42 167.25 29.21 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.052 0.453 . . . . 0.0 111.592 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 1.4 p -120.66 151.15 39.86 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 169.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 31.3 t -137.66 124.99 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 172.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 340' ' ' SER . . . . . 0.41 ' HB3' ' CB ' ' B' ' 321' ' ' MET . 46.9 t -101.41 148.93 24.59 Favored 'General case' 0 C--O 1.231 0.113 0 O-C-N 122.202 -0.311 . . . . 0.0 111.135 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -116.92 154.12 31.38 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 -178.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -71.74 -13.11 61.62 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 176.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -149.26 146.77 21.78 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 344' ' ' PRO . . . . . 0.452 ' N ' ' CD ' ' B' ' 345' ' ' PRO . 53.4 Cg_endo -71.32 -30.18 15.97 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 123.239 2.626 . . . . 0.0 114.363 -177.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 345' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' B' ' 344' ' ' PRO . 71.5 Cg_endo -73.99 -22.45 17.21 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 CA-C-N 121.403 1.537 . . . . 0.0 109.964 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 66.3 m -71.7 -36.97 70.74 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 175.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.98 -37.83 84.94 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -63.72 -45.02 91.84 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.77 -34.44 76.81 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 110.538 -0.171 . . . . 0.0 110.538 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.33 -38.66 91.81 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 68.8 mt -68.57 -54.0 24.02 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.56 175.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -54.41 -27.9 40.12 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 54.9 t-105 -96.76 -55.07 3.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -76.29 -26.79 56.24 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -174.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -48.35 109.43 0.24 Allowed 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 176.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 94.94 0.76 63.63 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.394 -0.67 . . . . 0.0 112.814 174.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -83.38 -164.94 0.97 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 118.177 0.988 . . . . 0.0 110.374 176.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -128.48 155.11 45.33 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.191 0.519 . . . . 0.0 111.454 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -146.89 136.44 22.92 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.478 1.111 . . . . 0.0 112.158 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 22.7 t 54.45 18.77 2.06 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.455 0.302 . . . . 0.0 111.335 -175.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 86.95 24.31 38.35 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 112.154 -0.378 . . . . 0.0 112.154 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -132.87 142.48 44.88 Favored Pre-proline 0 N--CA 1.454 -0.23 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 -178.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.41 136.16 33.18 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.681 2.254 . . . . 0.0 109.602 177.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 27.9 pt -122.97 171.9 11.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-O 121.25 0.548 . . . . 0.0 110.831 -177.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -144.0 118.13 9.5 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.947 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 11.9 t -107.64 148.52 11.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 C-N-CA 123.22 0.608 . . . . 0.0 112.242 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 27.4 t -163.75 172.57 13.98 Favored 'General case' 0 C--N 1.341 0.204 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 176.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -70.51 130.25 41.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 176.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -84.86 -178.2 6.78 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.965 -0.562 . . . . 0.0 112.31 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 10.0 t -148.32 -158.68 0.94 Allowed 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 174.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 371' ' ' ARG . . . . . 0.569 ' C ' ' H ' ' B' ' 373' ' ' ALA . 23.4 mmm180 -92.97 -41.78 9.82 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 118.845 0.748 . . . . 0.0 111.752 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? 60.71 -28.39 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.581 1.153 . . . . 0.0 112.83 -175.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . 0.569 ' H ' ' C ' ' B' ' 371' ' ' ARG . . . -83.47 -36.54 24.07 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 124.449 1.1 . . . . 0.0 111.126 -178.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -67.79 -4.47 12.61 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -170.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -85.69 -7.59 58.71 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.41 0.284 . . . . 0.0 111.57 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -139.93 -22.4 0.86 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -174.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 12.1 ptp85 . . . . . 0 C--O 1.251 1.137 0 CA-C-O 117.284 -1.341 . . . . 0.0 110.952 -179.822 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ' G' . . . . . 0.645 HO2' " H5'" ' A' ' 2' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.422 -2.587 0 N19-C1'-C2' 109.019 -2.738 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ' G' . . . . . 0.645 " H5'" HO2' ' A' ' 1' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.42 -2.743 0 C5'-C4'-C3' 112.224 -2.184 . 0.657 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ' C' . . . . . 0.583 " H5'" HO2' ' A' ' 2' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.422 -2.558 0 O4'-C1'-N19 111.003 2.803 . 0.652 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . 0.547 " H5'" HO2' ' A' ' 3' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.422 -2.571 0 N19-C1'-C2' 109.099 -2.688 . 0.76 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ' G' . . . . . 0.556 HO2' " H5'" ' A' ' 6' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.657 0 C4'-C3'-C2' 99.979 -2.721 . 0.632 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ' A' . . . . . 0.556 " H5'" HO2' ' A' ' 5' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.424 -2.407 0 N19-C1'-C2' 108.875 -2.828 . 0.772 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.571 0 O4'-C1'-N19 110.922 2.722 . 0.793 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ' U' . . . . . 0.468 HO2' " H5'" ' A' ' 9' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.578 0 C4'-C3'-C2' 100.048 -2.652 . 0.727 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ' A' . . . . . 0.468 " H5'" HO2' ' A' ' 8' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.423 -2.511 0 C4'-C3'-C2' 99.634 -3.066 . 0.637 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.318 0 C4'-C3'-C2' 99.821 -2.879 . 0.565 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.39 0 O4'-C1'-N19 111.024 2.824 . 0.54 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.47 1 O4'-C1'-N19 112.56 4.36 . 0.129 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.071 0 C5'-C4'-C3' 111.424 -2.718 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ' U' . . . . . 0.448 ' C6 ' ' CE2' ' B' ' 288' ' ' PHE . . . . . . . . 0 O4'--C4' 1.422 -2.589 0 O4'-C1'-N19 111.463 3.263 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.734 0 C5'-C4'-C3' 111.666 -2.556 . 0.287 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.413 0 O4'-C1'-N19 111.251 3.051 . 0.34 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.551 0 N19-C1'-C2' 109.13 -2.669 . 0.638 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.382 0 O4'-C1'-N19 110.939 2.739 . 0.733 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.548 0 O4'-C1'-N19 110.899 2.699 . 0.744 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.515 0 O4'-C1'-N19 110.878 2.678 . 0.723 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ' G' . . . . . 0.584 HO2' " H5'" ' A' ' 22' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.422 -2.623 0 C4'-C3'-C2' 100.399 -2.301 . 0.741 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ' C' . . . . . 0.584 " H5'" HO2' ' A' ' 21' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.419 -2.867 0 C5'-C4'-C3' 111.381 -2.746 . 0.78 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ' C' . . . . . 0.518 " H5'" HO2' ' A' ' 22' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.42 -2.737 0 N19-C1'-C2' 109.562 -2.399 . 0.756 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.014 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 90.5 p -151.27 15.51 0.71 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.633 0.373 . . . . 0.0 110.916 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -148.33 152.71 37.54 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 122.931 0.492 . . . . 0.0 109.894 -178.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 55.3 ttm 62.45 152.58 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.624 1.169 . . . . 0.0 112.1 -175.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 22.0 t0 53.16 88.55 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.371 1.069 . . . . 0.0 113.428 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 53.46 36.4 23.08 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.265 0.626 . . . . 0.0 112.374 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 88.6 p -65.21 -17.98 64.94 Favored 'General case' 0 N--CA 1.456 -0.141 0 O-C-N 122.342 -0.224 . . . . 0.0 110.921 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 18.5 p30 -95.71 6.32 49.22 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.706 0.802 . . . . 0.0 112.742 178.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -140.14 110.2 6.51 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.954 0.407 . . . . 0.0 110.05 -176.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . 0.427 HD22 ' C ' ' B' ' 285' ' ' ASN . 0.4 OUTLIER -113.43 8.28 17.83 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.859 -177.972 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 286' ' ' THR . . . . . 0.436 ' HG1' " C1'" ' A' ' 15' ' ' ' C' . 60.5 m -107.5 142.16 37.81 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.092 0.473 . . . . 0.0 109.987 -175.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 44.4 pt -113.72 146.69 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 174.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -97.97 141.06 31.4 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 172.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 17.4 t -130.26 142.34 44.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 O-C-N 123.331 0.394 . . . . 0.0 111.252 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -132.3 153.13 51.0 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.46 11.47 68.86 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 119.863 -0.409 . . . . 0.0 112.423 169.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 77.4 mt -56.29 -51.95 66.31 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 117.348 0.574 . . . . 0.0 110.548 -175.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 151.15 171.56 19.31 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -91.47 -9.13 45.62 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 122.484 -0.421 . . . . 0.0 111.772 -174.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -134.34 15.91 3.75 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -177.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.2 m -66.6 160.76 3.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -175.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 25.7 p -117.87 156.66 28.03 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 122.957 0.503 . . . . 0.0 112.053 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 298' ' ' ILE . . . . . . . . . . . . . 40.6 mt -60.67 -44.03 96.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.44 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -68.89 -30.54 69.05 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -177.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 46.6 t -73.79 -43.6 58.44 Favored 'General case' 0 N--CA 1.458 -0.07 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 78.8 t -61.97 -41.25 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.61 -34.84 79.21 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 303' ' ' ASP . . . . . 0.43 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.9 t0 -71.02 -29.01 64.83 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 304' ' ' TYR . . . . . 0.402 ' CE2' ' CD2' ' B' ' 354' ' ' PHE . 59.0 t80 -82.47 -25.31 33.66 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -96.63 -24.88 15.8 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 306' ' ' LYS . . . . . 0.43 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.9 ptpt -67.76 -17.59 64.6 Favored 'General case' 0 C--N 1.338 0.107 0 N-CA-C 111.446 0.165 . . . . 0.0 111.446 -176.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -72.2 -20.07 61.63 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 3.8 mm -87.84 -46.35 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.122 0 CA-C-N 117.61 0.186 . . . . 0.0 110.632 175.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -162.24 172.16 38.29 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 72.5 mt -71.11 118.29 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 122.68 0.392 . . . . 0.0 110.11 -175.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 77.4 mt -74.91 136.93 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 173.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 312' ' ' LYS . . . . . 0.448 ' HG2' ' SD ' ' B' ' 321' ' ' MET . 39.8 ttmt -69.55 142.65 53.58 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 11.0 m -117.59 136.55 53.21 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.618 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -68.49 131.98 46.21 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -178.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.99 -10.67 59.17 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 121.321 -0.152 . . . . 0.0 111.313 178.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 316' ' ' LYS . . . . . 0.444 ' HG2' ' H62' ' A' ' 17' ' ' ' A' . 7.6 mptt -99.05 -49.08 4.63 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.247 0.219 . . . . 0.0 111.354 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 5.9 p -87.04 -25.81 24.03 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -177.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 79.37 -8.73 45.33 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 123.377 0.513 . . . . 0.0 112.407 174.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -88.46 159.39 47.18 Favored Pre-proline 0 CA--C 1.53 0.201 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.84 148.64 82.74 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 121.314 1.343 . . . . 0.0 108.746 177.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 321' ' ' MET . . . . . 0.448 ' SD ' ' HG2' ' B' ' 312' ' ' LYS . 72.4 mtp -79.77 85.7 5.42 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.307 0.575 . . . . 0.0 111.665 -170.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 322' ' ' ILE . . . . . . . . . . . . . 3.3 mp -129.7 147.08 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.575 1.15 . . . . 0.0 108.25 176.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -132.93 111.08 10.74 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -80.98 148.79 29.6 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.267 1.027 . . . . 0.0 108.833 176.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -113.29 151.66 30.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.84 143.41 40.96 Favored 'General case' 0 CA--C 1.522 -0.13 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -173.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -73.7 133.72 43.42 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -87.3 -9.48 54.84 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.179 0.192 . . . . 0.0 110.856 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -98.97 -14.19 19.6 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.808 0.443 . . . . 0.0 111.745 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 4.0 p -136.61 -20.92 1.32 Allowed 'General case' 0 C--N 1.34 0.16 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -178.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 80.0 1.28 87.39 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 175.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -87.87 159.04 18.55 Favored 'General case' 0 C--N 1.338 0.096 0 CA-C-N 117.66 0.73 . . . . 0.0 109.447 177.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 10.5 mp -67.65 144.73 55.38 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.837 0.351 . . . . 0.0 110.112 -175.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -75.26 -15.83 60.49 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 122.873 0.469 . . . . 0.0 110.338 176.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 78.56 10.29 86.33 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 110.709 -0.957 . . . . 0.0 110.709 -174.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -116.97 150.33 38.74 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.881 0.472 . . . . 0.0 110.408 -177.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -160.06 162.91 34.26 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.881 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 29.6 p -112.4 153.86 26.67 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 169.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 21.8 t -136.6 124.19 33.15 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.11 0 C-N-CA 123.249 0.62 . . . . 0.0 110.218 175.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 45.0 t -90.98 140.85 29.45 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 117.906 0.321 . . . . 0.0 110.404 177.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -108.85 152.84 24.36 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 176.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -70.08 -28.82 65.73 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -177.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -133.05 149.0 71.6 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 344' ' ' PRO . . . . . 0.448 ' N ' ' CD ' ' B' ' 345' ' ' PRO . 36.9 Cg_endo -69.44 -33.33 18.04 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 123.274 2.649 . . . . 0.0 114.2 -177.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 345' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' B' ' 344' ' ' PRO . 93.8 Cg_endo -74.97 -20.2 17.15 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 CA-C-N 121.136 1.441 . . . . 0.0 110.384 -176.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 66.3 m -71.88 -35.72 69.84 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 175.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -70.4 -38.36 74.64 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 174.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -63.6 -43.14 97.78 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.62 -35.33 77.17 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 110.561 -0.162 . . . . 0.0 110.561 178.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -63.88 -37.62 88.06 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 59.2 mt -70.66 -49.16 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.094 175.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -58.95 -27.9 65.76 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -176.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -97.26 -56.47 2.53 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -177.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 354' ' ' PHE . . . . . 0.402 ' CD2' ' CE2' ' B' ' 304' ' ' TYR . 52.2 m-85 -75.7 -25.74 56.95 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -173.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -48.49 108.4 0.17 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 176.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 96.34 2.2 60.52 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 119.435 -0.647 . . . . 0.0 113.227 174.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -84.91 -164.02 0.92 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.3 1.05 . . . . 0.0 110.386 177.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -129.9 153.23 48.53 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-O 121.058 0.456 . . . . 0.0 110.776 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -145.17 136.69 25.26 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.395 1.078 . . . . 0.0 112.296 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 63.4 m 53.35 19.48 1.61 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -173.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 86.38 22.81 46.25 Favored Glycine 0 C--N 1.342 0.868 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 52.6 m-20 -130.71 141.96 43.81 Favored Pre-proline 0 N--CA 1.454 -0.239 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -177.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.18 135.31 31.48 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.998 2.465 . . . . 0.0 109.267 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 29.6 pt -122.4 171.48 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 CA-C-O 121.285 0.564 . . . . 0.0 111.061 -177.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -144.25 116.59 8.51 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.688 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 10.8 t -107.28 147.27 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 123.026 0.53 . . . . 0.0 111.801 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 28.0 t -162.63 174.87 12.01 Favored 'General case' 0 C--N 1.339 0.147 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 177.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -71.97 130.07 40.09 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 176.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -82.74 177.95 8.42 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.358 177.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 15.7 p -144.02 -155.37 0.6 Allowed 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.454 1.101 . . . . 0.0 110.212 178.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -118.63 66.56 0.77 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 171.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 372' ' ' ARG . . . . . 0.469 ' HA ' ' CZ ' ' B' ' 375' ' ' PHE . 61.4 ttt180 -57.37 -18.0 15.32 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 173.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.6 -12.93 25.96 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.403 1.081 . . . . 0.0 111.965 176.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -98.74 -32.3 11.45 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -174.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 375' ' ' PHE . . . . . 0.469 ' CZ ' ' HA ' ' B' ' 372' ' ' ARG . 14.2 p90 -113.35 -18.58 12.0 Favored 'General case' 0 N--CA 1.457 -0.083 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 -173.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -81.55 -8.21 59.69 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 . . . . . 0 C--O 1.252 1.187 0 CA-C-O 117.069 -1.443 . . . . 0.0 110.381 -179.002 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.579 0 N19-C1'-C2' 108.955 -2.778 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ' G' . . . . . 0.63 HO2' " H5'" ' A' ' 3' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.423 -2.512 0 O4'-C1'-N19 110.547 2.347 . 0.684 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ' C' . . . . . 0.63 " H5'" HO2' ' A' ' 2' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.423 -2.539 0 C5'-C4'-C3' 111.486 -2.676 . 0.667 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . 0.439 " H5'" HO2' ' A' ' 3' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.42 -2.71 0 N19-C1'-C2' 108.76 -2.9 . 0.779 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ' G' . . . . . 0.584 HO2' " H5'" ' A' ' 6' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.542 0 N19-C1'-C2' 108.721 -2.924 . 0.707 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ' A' . . . . . 0.584 " H5'" HO2' ' A' ' 5' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.422 -2.547 0 N19-C1'-C2' 109.194 -2.629 . 0.739 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.754 0 O4'-C1'-N19 110.922 2.722 . 0.785 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.383 0 O4'-C1'-N19 110.989 2.789 . 0.744 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.276 0 C4'-C3'-C2' 100.031 -2.669 . 0.643 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ' C' . . . . . 0.587 HO2' " C5'" ' A' ' 11' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.532 0 C4'-C3'-C2' 100.111 -2.589 . 0.62 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ' A' . . . . . 0.638 HO2' " C5'" ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.696 0 O4'-C1'-N19 110.633 2.433 . 0.537 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ' A' . . . . . 0.638 " C5'" HO2' ' A' ' 11' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.425 -2.308 1 O4'-C1'-N19 112.606 4.406 . 0.101 1b . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.702 0 C5'-C4'-C3' 109.871 -3.753 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.363 1 C5'-C4'-C3' 109.398 -4.068 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ' C' . . . . . 0.436 " C1'" ' HG1' ' B' ' 286' ' ' THR . . . . . . . . 0 O4'--C4' 1.415 -3.156 0 C5'-C4'-C3' 111.875 -2.417 . 0.263 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ' U' . . . . . 0.649 HO2' " H5'" ' A' ' 17' ' ' ' A' . . . . . . . . 0 P--O5' 1.617 2.426 0 O4'-C1'-N19 111.646 3.446 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ' A' . . . . . 0.649 " H5'" HO2' ' A' ' 16' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.425 -2.347 0 N19-C1'-C2' 109.512 -2.43 . 0.61 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ' U' . . . . . 0.558 " H5'" HO2' ' A' ' 17' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.683 0 O4'-C1'-N19 111.158 2.958 . 0.765 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ' U' . . . . . 0.462 HO2' " C5'" ' A' ' 20' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.423 -2.515 0 O4'-C1'-N19 111.169 2.969 . 0.817 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ' U' . . . . . 0.462 " C5'" HO2' ' A' ' 19' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.423 -2.489 0 O4'-C1'-N19 110.981 2.781 . 0.645 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ' G' . . . . . 0.567 HO2' " H5'" ' A' ' 22' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.423 -2.475 0 C5'-C4'-C3' 111.952 -2.365 . 0.761 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ' C' . . . . . 0.567 " H5'" HO2' ' A' ' 21' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.422 -2.561 0 C5'-C4'-C3' 111.541 -2.639 . 0.778 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.799 0 N19-C1'-C2' 109.778 -2.264 . 0.798 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.053 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 40.4 t -68.8 153.61 43.48 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 122.851 0.46 . . . . 0.0 110.759 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -76.49 -8.35 57.01 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 122.856 0.462 . . . . 0.0 111.038 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 97.9 mmm -69.33 156.92 38.0 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.819 0.342 . . . . 0.0 110.924 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -157.37 164.35 37.64 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 51.55 32.93 9.64 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.191 0.596 . . . . 0.0 111.811 -178.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 47.5 t -64.01 -22.06 66.77 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 122.37 -0.206 . . . . 0.0 110.739 -178.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -89.35 6.51 40.24 Favored 'General case' 0 C--N 1.34 0.18 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -141.8 110.11 5.96 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 120.813 0.34 . . . . 0.0 110.757 -175.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . 0.424 HD22 ' C ' ' B' ' 285' ' ' ASN . 0.3 OUTLIER -113.33 8.41 18.0 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.995 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 80.4 m -108.13 144.36 35.63 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.024 0.44 . . . . 0.0 110.912 -174.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 44.5 pt -120.41 147.35 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 288' ' ' PHE . . . . . 0.455 ' CE2' ' C6 ' ' A' ' 14' ' ' ' U' . 50.9 t80 -99.83 145.93 27.18 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 174.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 16.8 t -129.46 142.14 44.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 122.636 0.374 . . . . 0.0 111.22 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -129.54 149.9 51.11 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.05 14.24 64.88 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-O 119.894 -0.392 . . . . 0.0 112.361 169.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 61.4 mt -57.1 -51.1 70.65 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 117.545 0.673 . . . . 0.0 110.615 -175.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 148.84 177.16 22.8 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -101.54 -2.25 31.04 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -178.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -129.14 14.67 6.23 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.778 0.431 . . . . 0.0 112.145 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.2 m -73.65 163.16 4.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -172.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 27.3 p -129.23 160.71 32.08 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 123.501 0.72 . . . . 0.0 111.604 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 298' ' ' ILE . . . . . . . . . . . . . 44.8 mt -64.51 -45.51 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.274 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -63.6 -35.65 81.22 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 122.497 0.319 . . . . 0.0 111.601 179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 47.1 t -72.28 -47.01 53.37 Favored 'General case' 0 C--O 1.228 -0.057 0 CA-C-N 117.919 0.327 . . . . 0.0 110.772 -177.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 7.8 p -68.16 -33.41 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.2 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -65.78 -32.56 74.16 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 176.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 303' ' ' ASP . . . . . 0.416 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 46.1 t0 -74.23 -28.21 61.14 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 304' ' ' TYR . . . . . 0.409 ' CE1' ' CD1' ' B' ' 354' ' ' PHE . 54.6 t80 -82.2 -25.47 34.21 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -96.51 -25.93 15.47 Favored 'General case' 0 CA--C 1.527 0.086 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 306' ' ' LYS . . . . . 0.416 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.7 ptpt -65.73 -17.69 64.8 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 111.631 0.234 . . . . 0.0 111.631 -177.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -71.72 -20.52 61.89 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 5.0 mm -86.72 -45.8 16.49 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 175.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -165.22 167.92 39.05 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 178.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 82.4 mt -68.13 122.59 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-O 120.854 0.359 . . . . 0.0 110.752 -174.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 92.1 mt -74.56 136.53 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -70.98 130.34 41.32 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -178.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 1.8 m -88.9 138.75 31.12 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 178.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -63.71 131.88 49.29 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -80.62 -10.52 59.73 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.691 -0.231 . . . . 0.0 110.663 -176.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 58.4 mmtt -108.65 -50.0 3.08 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 122.656 0.382 . . . . 0.0 109.985 -175.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 18.1 p -89.56 -24.68 21.67 Favored 'General case' 0 C--N 1.338 0.081 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -175.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 81.92 -9.29 57.22 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-O 119.565 -0.575 . . . . 0.0 112.234 175.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -82.48 159.43 64.27 Favored Pre-proline 0 C--O 1.235 0.313 0 CA-C-N 118.308 1.054 . . . . 0.0 108.896 174.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.62 153.97 74.72 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.741 1.627 . . . . 0.0 109.861 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 321' ' ' MET . . . . . . . . . . . . . 36.4 mtt -71.31 95.71 1.34 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 120.571 0.224 . . . . 0.0 111.576 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 322' ' ' ILE . . . . . . . . . . . . . 3.6 mp -142.44 141.67 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 173.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 323' ' ' ASN . . . . . 0.403 ' O ' ' HA ' ' B' ' 337' ' ' ALA . 17.3 m-80 -132.75 111.16 10.91 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 171.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 43.2 mt -81.55 148.15 29.29 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 174.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -115.28 151.62 34.21 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 178.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -131.41 145.29 51.74 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -176.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -77.51 133.6 38.52 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -87.21 -8.42 56.87 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 122.445 -0.159 . . . . 0.0 111.146 177.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -96.81 -14.57 21.82 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 122.643 0.377 . . . . 0.0 111.567 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 3.2 p -136.17 -22.34 1.36 Allowed 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 80.77 0.46 88.07 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.591 -0.603 . . . . 0.0 111.591 176.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -89.35 158.13 17.91 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 117.647 0.723 . . . . 0.0 109.136 177.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 38.8 mt -69.21 143.1 54.07 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.982 0.42 . . . . 0.0 109.882 -177.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 9.3 mmmm -71.71 -18.74 62.14 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 123.338 0.655 . . . . 0.0 110.566 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.33 5.24 81.38 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -170.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -103.73 149.68 24.77 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.324 0.65 . . . . 0.0 110.121 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 337' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' B' ' 323' ' ' ASN . . . -164.25 159.69 20.3 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.027 176.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 6.1 p -106.26 151.65 24.53 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 169.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 42.9 t -135.89 126.22 42.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 170.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 23.0 t -105.96 141.88 36.61 Favored 'General case' 0 CA--C 1.527 0.086 0 O-C-N 122.129 -0.357 . . . . 0.0 110.948 -177.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -106.6 158.53 16.87 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -177.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -73.41 -29.97 62.94 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -131.26 146.9 64.04 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -177.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 344' ' ' PRO . . . . . 0.451 ' HG2' ' HD3' ' B' ' 345' ' ' PRO . 40.6 Cg_endo -70.83 -33.23 12.86 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.414 2.743 . . . . 0.0 114.484 -177.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 345' ' ' PRO . . . . . 0.451 ' HD3' ' HG2' ' B' ' 344' ' ' PRO . 87.4 Cg_endo -73.82 -22.65 17.38 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 CA-C-N 121.185 1.459 . . . . 0.0 109.926 -176.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 71.2 m -71.48 -35.74 70.91 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 175.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -68.7 -37.91 79.9 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 175.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -64.77 -43.12 94.3 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -69.45 -33.26 72.67 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 110.474 -0.195 . . . . 0.0 110.474 178.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.89 -36.8 85.52 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 67.9 mt -69.67 -52.36 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 120.378 -0.529 . . . . 0.0 109.612 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -55.74 -29.37 59.42 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 55.5 t-105 -95.55 -55.87 2.88 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 354' ' ' PHE . . . . . 0.409 ' CD1' ' CE1' ' B' ' 304' ' ' TYR . 46.7 m-85 -75.8 -31.54 59.48 Favored 'General case' 0 C--N 1.337 0.06 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -173.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -55.46 108.04 0.39 Allowed 'General case' 0 C--O 1.232 0.16 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.753 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 106.98 -3.17 35.57 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.272 176.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -86.47 -164.78 1.11 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 117.843 0.821 . . . . 0.0 110.428 176.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -128.91 154.69 46.28 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.958 0.409 . . . . 0.0 111.306 177.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -145.19 137.2 25.67 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.573 1.149 . . . . 0.0 112.348 177.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 15.5 t 54.9 16.15 1.37 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 122.773 0.429 . . . . 0.0 111.189 -175.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 90.71 23.45 30.71 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 111.886 -0.485 . . . . 0.0 111.886 178.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -133.9 142.07 42.15 Favored Pre-proline 0 N--CA 1.453 -0.321 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -177.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -68.94 136.33 34.9 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 122.702 2.268 . . . . 0.0 109.518 177.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 29.1 pt -122.12 170.68 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-O 120.978 0.418 . . . . 0.0 111.01 -178.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -144.84 114.1 7.03 Favored 'General case' 0 N--CA 1.457 -0.086 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 11.2 t -102.67 150.47 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 122.907 0.483 . . . . 0.0 112.131 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 23.8 t -163.54 173.43 13.07 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 176.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -70.55 131.09 43.46 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 176.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -93.61 178.16 5.78 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 12.2 t -147.69 -159.18 0.99 Allowed 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 125.002 1.321 . . . . 0.0 108.277 173.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 77.0 mtt85 -119.41 88.15 2.88 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 119.033 0.833 . . . . 0.0 110.909 174.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -65.44 -16.37 63.56 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 171.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.02 -27.58 65.59 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 122.969 0.508 . . . . 0.0 110.763 178.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -63.13 -17.31 62.2 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.733 0.413 . . . . 0.0 110.851 -175.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -81.6 -13.31 58.15 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -136.7 -6.18 1.94 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -173.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 117.616 -1.183 . . . . 0.0 110.629 175.935 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.721 0 N19-C1'-C2' 109.248 -2.595 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ' G' . . . . . 0.636 HO2' " H5'" ' A' ' 3' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.422 -2.545 0 C5'-C4'-C3' 111.948 -2.368 . 0.691 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ' C' . . . . . 0.636 " H5'" HO2' ' A' ' 2' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.424 -2.427 0 O4'-C1'-N19 111.083 2.883 . 0.704 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . 0.515 " H5'" HO2' ' A' ' 3' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.422 -2.585 0 N19-C1'-C2' 108.759 -2.901 . 0.716 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.638 0 N19-C1'-C2' 108.678 -2.951 . 0.725 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ' A' . . . . . 0.548 HO2' " H5'" ' A' ' 7' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.424 -2.409 0 N19-C1'-C2' 108.983 -2.761 . 0.781 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ' U' . . . . . 0.548 " H5'" HO2' ' A' ' 6' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.469 0 O4'-C1'-N19 111.326 3.126 . 0.805 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ' U' . . . . . 0.542 " H5'" HO2' ' A' ' 7' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.423 -2.521 0 O4'-C1'-N19 111.175 2.975 . 0.697 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.689 0 C4'-C3'-C2' 99.748 -2.952 . 0.665 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ' C' . . . . . 0.606 HO2' " H5'" ' A' ' 11' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.509 0 O4'-C1'-N19 110.91 2.71 . 0.624 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ' A' . . . . . 0.606 " H5'" HO2' ' A' ' 10' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.425 -2.34 0 O4'-C1'-N19 111.273 3.073 . 0.631 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.276 1 O4'-C1'-N19 112.71 4.51 . 0.107 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.941 0 C5'-C4'-C3' 111.309 -2.794 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ' U' . . . . . 0.455 ' C6 ' ' CE2' ' B' ' 288' ' ' PHE . . . . . . . . 0 O4'--C4' 1.427 -2.167 1 O4'-C1'-N19 112.283 4.083 . 0.0 OUTLIER '7D dist 6p' 0.0 . . . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.624 3.132 0 C5'-C4'-C3' 112.765 -1.823 . 0.487 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.615 2.172 0 O4'-C1'-N19 111.214 3.014 . 0.23 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ' A' . . . . . 0.583 HO2' " H5'" ' A' ' 18' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.426 -2.261 0 N19-C1'-C2' 108.806 -2.871 . 0.642 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ' U' . . . . . 0.583 " H5'" HO2' ' A' ' 17' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.479 0 O4'-C1'-N19 110.765 2.565 . 0.74 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.524 0 O4'-C1'-N19 110.879 2.679 . 0.762 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.352 0 O4'-C1'-N19 110.809 2.609 . 0.688 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.586 0 C5'-C4'-C3' 111.973 -2.352 . 0.74 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ' C' . . . . . 0.561 HO2' " H5'" ' A' ' 23' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.423 -2.47 0 C5'-C4'-C3' 111.422 -2.719 . 0.824 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ' C' . . . . . 0.561 " H5'" HO2' ' A' ' 22' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.418 -2.918 0 O4'-C1'-N19 110.716 2.516 . 0.768 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.278 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 39.1 t -154.95 158.62 39.52 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 122.879 0.472 . . . . 0.0 110.356 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -72.81 -16.54 61.61 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.192 0.197 . . . . 0.0 110.534 176.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 279' ' ' MET . . . . . 0.592 ' HG3' ' H ' ' B' ' 281' ' ' ASN . 17.5 tpt -77.75 151.61 34.01 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 122.826 0.45 . . . . 0.0 109.999 177.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -65.39 -12.86 56.28 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 281' ' ' ASN . . . . . 0.592 ' H ' ' HG3' ' B' ' 279' ' ' MET . 9.2 m-20 -81.44 10.67 5.39 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.874 0.47 . . . . 0.0 111.198 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 37.7 t -63.75 -20.39 65.71 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 122.3 -0.25 . . . . 0.0 110.574 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -89.45 7.21 37.18 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.963 0.505 . . . . 0.0 112.175 177.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -137.27 110.26 7.71 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.891 0.377 . . . . 0.0 110.328 -175.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -113.23 6.53 17.47 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.063 0.545 . . . . 0.0 111.53 -178.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 60.6 m -106.73 142.5 36.27 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 120.988 0.423 . . . . 0.0 110.797 -176.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 38.9 pt -116.85 147.38 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 173.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 288' ' ' PHE . . . . . 0.474 ' CE1' ' C6 ' ' A' ' 14' ' ' ' U' . 53.3 t80 -100.78 144.36 29.83 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 174.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 18.4 t -129.72 143.13 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.004 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -131.44 151.61 51.4 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 175.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 88.84 11.77 65.02 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 119.782 -0.455 . . . . 0.0 112.272 169.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 76.4 mt -56.47 -51.37 68.71 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.705 0.752 . . . . 0.0 110.46 -176.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 147.61 174.41 19.51 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 -179.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -99.07 -0.32 42.1 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.879 0.34 . . . . 0.0 111.644 -178.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -128.83 13.0 6.32 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.4 m -73.58 162.8 4.27 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -172.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 47.4 p -130.04 158.18 40.33 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 123.532 0.733 . . . . 0.0 111.129 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 298' ' ' ILE . . . . . . . . . . . . . 30.7 mt -62.41 -44.87 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.506 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -63.13 -34.7 78.17 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.448 0.299 . . . . 0.0 111.609 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 47.0 t -73.64 -44.29 57.3 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 79.2 t -62.45 -40.82 89.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 177.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.77 -36.2 83.55 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 303' ' ' ASP . . . . . 0.418 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 44.9 t0 -70.52 -27.95 64.57 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 304' ' ' TYR . . . . . 0.407 ' CE2' ' CD1' ' B' ' 354' ' ' PHE . 60.8 t80 -82.9 -26.42 31.53 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -179.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -96.63 -24.65 15.9 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 179.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 306' ' ' LYS . . . . . 0.418 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.6 ptpt -66.61 -19.25 65.73 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 111.526 0.195 . . . . 0.0 111.526 -177.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -71.01 -19.77 62.48 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -178.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 5.0 mm -88.79 -46.43 15.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 N-CA-C 110.554 -0.165 . . . . 0.0 110.554 175.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.19 167.43 37.49 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 179.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 84.2 mt -68.03 120.44 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-O 120.989 0.423 . . . . 0.0 110.353 -176.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 80.5 mt -74.29 137.37 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 172.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -69.61 125.48 26.85 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -177.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 2.0 m -94.08 142.95 26.81 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 178.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.96 133.34 38.04 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.77 -9.8 59.56 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.45 0.3 . . . . 0.0 110.334 177.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -108.88 -19.97 13.22 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.948 0.499 . . . . 0.0 111.599 -170.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 13.6 p -124.91 -22.45 4.49 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 81.13 -10.21 49.69 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.911 -0.475 . . . . 0.0 111.911 174.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -88.71 156.29 50.15 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 117.879 0.839 . . . . 0.0 109.568 176.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -70.57 156.28 61.55 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.358 2.038 . . . . 0.0 110.358 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 321' ' ' MET . . . . . . . . . . . . . 37.0 mtt -73.08 91.49 1.61 Allowed 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 122.523 0.329 . . . . 0.0 111.685 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 322' ' ' ILE . . . . . . . . . . . . . 4.1 mp -136.6 139.89 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 170.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -135.21 111.05 9.36 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 25.0 mt -81.44 151.96 27.62 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 176.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -115.99 152.34 33.7 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 177.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.9 146.14 51.54 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -174.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -78.59 133.77 37.27 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 21.6 mtp180 -88.66 -8.27 54.91 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.217 0.207 . . . . 0.0 110.905 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -97.8 -14.59 20.7 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.621 0.368 . . . . 0.0 111.925 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 2.9 p -136.56 -22.62 1.27 Allowed 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 83.01 0.48 90.34 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 176.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -84.02 158.85 21.34 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 117.703 0.752 . . . . 0.0 109.4 176.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 39.5 mt -72.02 142.54 49.31 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -71.82 -15.1 62.14 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 123.6 0.76 . . . . 0.0 110.442 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.13 3.59 76.06 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -172.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -103.56 150.05 24.31 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.163 0.585 . . . . 0.0 110.104 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -162.81 157.55 21.58 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.705 177.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 7.6 p -105.31 152.67 22.62 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 170.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 38.2 t -135.78 126.17 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 123.597 0.759 . . . . 0.0 109.056 170.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 48.3 t -105.39 139.2 40.38 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.701 0.286 . . . . 0.0 110.983 -178.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -104.57 159.76 15.49 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -178.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -72.08 -31.61 66.25 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -130.98 149.85 74.92 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 344' ' ' PRO . . . . . 0.441 ' HG2' ' HD3' ' B' ' 345' ' ' PRO . 40.7 Cg_endo -70.27 -32.12 17.02 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 123.256 2.637 . . . . 0.0 114.396 -177.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 345' ' ' PRO . . . . . 0.441 ' HD3' ' HG2' ' B' ' 344' ' ' PRO . 74.0 Cg_endo -73.68 -21.34 19.19 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 CA-C-N 121.255 1.484 . . . . 0.0 110.199 -177.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 57.6 m -72.09 -36.3 69.46 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 175.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -67.28 -38.64 85.4 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 174.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -63.63 -43.96 95.27 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.23 -34.67 76.67 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 122.227 -0.296 . . . . 0.0 110.542 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.64 -37.18 86.71 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 61.5 mt -69.58 -51.85 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.86 175.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -53.19 -30.63 38.55 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 53.8 t-105 -97.09 -55.39 2.87 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -176.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 354' ' ' PHE . . . . . 0.407 ' CD1' ' CE2' ' B' ' 304' ' ' TYR . 51.9 m-85 -76.35 -26.94 56.22 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -173.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -49.22 109.16 0.24 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 177.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 97.3 -0.32 60.01 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 119.508 -0.606 . . . . 0.0 112.499 174.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -83.25 -165.74 1.17 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 118.203 1.001 . . . . 0.0 110.374 176.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -127.99 154.96 45.01 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.387 0.613 . . . . 0.0 111.233 177.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -145.71 136.44 24.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.531 1.133 . . . . 0.0 112.247 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 13.3 t 54.89 18.11 2.07 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.711 0.291 . . . . 0.0 111.346 -175.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.4 22.92 38.75 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.963 -0.455 . . . . 0.0 111.963 178.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 51.6 m-20 -132.64 142.16 43.8 Favored Pre-proline 0 N--CA 1.457 -0.112 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -177.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.27 135.97 33.05 Favored 'Trans proline' 0 N--CA 1.446 -1.305 0 C-N-CA 122.895 2.397 . . . . 0.0 109.532 178.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 29.8 pt -122.56 171.4 11.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 121.176 0.513 . . . . 0.0 111.009 -177.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -144.45 115.38 7.83 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.781 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 11.7 t -105.9 147.63 11.27 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 C-N-CA 123.174 0.59 . . . . 0.0 112.165 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 22.6 t -162.71 173.04 14.37 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 176.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -70.1 130.17 41.4 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 176.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -89.13 -179.91 6.0 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.053 -178.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 10.5 t -148.13 -156.01 0.68 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.796 1.238 . . . . 0.0 107.918 173.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 31.8 mtp-105 -121.88 90.61 3.34 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 118.715 0.689 . . . . 0.0 111.31 173.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -69.03 -13.31 62.38 Favored 'General case' 0 C--N 1.334 -0.073 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 169.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -63.55 -22.2 66.76 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 122.807 0.443 . . . . 0.0 110.338 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -63.34 -18.33 63.52 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.477 0.311 . . . . 0.0 110.894 -176.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -71.83 -12.75 61.43 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 177.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -138.01 -14.86 1.35 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.967 0 CA-C-O 116.467 -1.73 . . . . 0.0 110.68 177.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.457 0 N19-C1'-C2' 108.981 -2.762 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.427 0 C5'-C4'-C3' 111.622 -2.585 . 0.714 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ' C' . . . . . 0.523 HO2' " H5'" ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.516 0 O4'-C1'-N19 110.862 2.662 . 0.803 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . 0.523 " H5'" HO2' ' A' ' 3' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.422 -2.595 0 N19-C1'-C2' 108.868 -2.833 . 0.687 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.513 0 N19-C1'-C2' 108.912 -2.805 . 0.699 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ' A' . . . . . 0.521 HO2' " H5'" ' A' ' 7' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.423 -2.485 0 N19-C1'-C2' 108.956 -2.778 . 0.729 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ' U' . . . . . 0.529 HO2' " H5'" ' A' ' 8' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.42 -2.757 0 O4'-C1'-N19 111.34 3.14 . 0.817 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ' U' . . . . . 0.529 " H5'" HO2' ' A' ' 7' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.423 -2.514 0 C4'-C3'-C2' 99.956 -2.744 . 0.737 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ' A' . . . . . 0.583 HO2' " H5'" ' A' ' 10' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.419 -2.803 0 C4'-C3'-C2' 99.956 -2.744 . 0.668 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ' C' . . . . . 0.583 " H5'" HO2' ' A' ' 9' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.585 0 C4'-C3'-C2' 99.877 -2.823 . 0.618 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ' A' . . . . . 0.682 HO2' " C5'" ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.624 0 C4'-C3'-C2' 99.931 -2.769 . 0.379 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ' A' . . . . . 0.682 " C5'" HO2' ' A' ' 11' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.424 -2.377 1 O4'-C1'-N19 112.242 4.042 . 0.105 1b . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.847 1 C5'-C4'-C3' 109.414 -4.058 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ' U' . . . . . 0.474 ' C6 ' ' CE1' ' B' ' 288' ' ' PHE . . . . . . . . 0 O4'--C4' 1.425 -2.305 0 O4'-C1'-N19 112.08 3.88 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.623 2.991 0 C5'-C4'-C3' 112.205 -2.197 . 0.46 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ' U' . . . . . 0.626 HO2' " H5'" ' A' ' 17' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.426 -2.225 0 O4'-C1'-N19 111.242 3.042 . 0.272 2h . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ' A' . . . . . 0.626 " H5'" HO2' ' A' ' 16' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.423 -2.541 0 N19-C1'-C2' 109.689 -2.32 . 0.627 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.367 0 O4'-C1'-N19 111.106 2.906 . 0.7 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.509 0 O4'-C1'-N19 111.011 2.811 . 0.75 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ' U' . . . . . 0.606 HO2' " H5'" ' A' ' 21' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.425 -2.369 0 O4'-C1'-N19 110.821 2.621 . 0.71 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ' G' . . . . . 0.606 " H5'" HO2' ' A' ' 20' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.424 -2.437 0 C5'-C4'-C3' 111.905 -2.397 . 0.707 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.732 0 C5'-C4'-C3' 111.601 -2.599 . 0.789 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.7 0 C5'-C4'-C3' 112.15 -2.233 . 0.811 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.131 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 88.7 p -70.16 162.55 28.12 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.806 0.303 . . . . 0.0 110.707 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -70.35 161.89 29.59 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 178.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 279' ' ' MET . . . . . 0.548 ' HG2' ' H ' ' B' ' 281' ' ' ASN . 51.1 ttp -67.57 142.55 56.46 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.458 0.303 . . . . 0.0 110.827 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -72.16 -23.41 61.28 Favored 'General case' 0 CA--C 1.527 0.088 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -177.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 281' ' ' ASN . . . . . 0.548 ' H ' ' HG2' ' B' ' 279' ' ' MET . 35.6 m-20 -83.15 26.86 0.6 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.994 0.518 . . . . 0.0 111.507 -178.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 35.5 t -64.53 -15.53 61.07 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 122.011 -0.431 . . . . 0.0 110.686 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 26.2 p30 -98.89 4.7 47.5 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.366 0.667 . . . . 0.0 112.173 177.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -131.02 110.17 11.03 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.078 0.465 . . . . 0.0 110.133 -177.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.5 11.9 18.5 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.431 0.692 . . . . 0.0 111.443 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 28.2 m -113.49 143.96 43.64 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.866 0.365 . . . . 0.0 111.603 -174.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 32.1 pt -122.02 146.82 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 175.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -100.33 144.24 29.57 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 174.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 20.4 t -129.83 142.24 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 122.808 0.443 . . . . 0.0 111.008 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -129.82 151.98 49.81 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.128 -0.694 . . . . 0.0 109.128 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.61 11.89 67.78 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-O 119.911 -0.383 . . . . 0.0 112.448 169.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 75.4 mt -55.42 -50.27 70.24 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 117.625 0.713 . . . . 0.0 110.679 -175.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 145.71 174.07 17.56 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -100.98 2.16 40.38 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -178.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -128.64 13.94 6.46 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.792 0.437 . . . . 0.0 111.795 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.6 m -75.56 165.32 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -172.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 26.7 p -131.81 160.53 35.35 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.587 0.755 . . . . 0.0 111.969 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 298' ' ' ILE . . . . . . . . . . . . . 48.3 mt -63.82 -43.71 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.099 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.6 -36.6 84.76 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 122.428 0.291 . . . . 0.0 111.499 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 45.4 t -71.82 -46.26 58.72 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.792 0.269 . . . . 0.0 110.795 -177.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 8.2 p -68.33 -32.55 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.271 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -66.76 -32.66 74.09 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 303' ' ' ASP . . . . . 0.428 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.0 t0 -74.15 -27.58 60.91 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 304' ' ' TYR . . . . . 0.417 ' CE1' ' CD2' ' B' ' 354' ' ' PHE . 67.7 t80 -84.19 -24.36 30.16 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -97.01 -24.41 15.81 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 178.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 306' ' ' LYS . . . . . 0.428 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.8 ptpt -66.13 -17.86 64.98 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -177.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -71.78 -20.67 61.83 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 5.1 mm -86.81 -46.09 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 N-CA-C 110.525 -0.176 . . . . 0.0 110.525 175.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.58 165.86 37.01 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.346 -0.701 . . . . 0.0 111.346 178.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 79.5 mt -66.81 119.46 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 122.586 0.354 . . . . 0.0 110.642 -176.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 94.5 mt -72.06 135.55 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 172.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -70.87 130.69 42.32 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -178.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 3.2 m -91.67 142.35 27.7 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 178.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -70.11 128.16 35.33 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 315' ' ' LYS . . . . . 0.559 ' HE3' ' HA ' ' B' ' 315' ' ' LYS . 0.2 OUTLIER -78.91 -8.79 59.17 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 122.537 0.335 . . . . 0.0 111.011 176.072 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 18.7 mmmt -107.0 -19.61 13.57 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.421 0.288 . . . . 0.0 110.592 -172.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 19.0 p -133.28 -21.08 2.08 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -175.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 82.28 -9.71 56.9 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-O 119.74 -0.478 . . . . 0.0 112.449 175.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -84.1 158.27 61.62 Favored Pre-proline 0 CA--C 1.53 0.207 0 CA-C-N 118.01 0.905 . . . . 0.0 108.944 174.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.54 154.95 70.59 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.105 1.87 . . . . 0.0 110.032 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 321' ' ' MET . . . . . . . . . . . . . 37.1 mtt -72.64 95.0 1.79 Allowed 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 120.906 0.384 . . . . 0.0 111.757 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 322' ' ' ILE . . . . . . . . . . . . . 3.5 mp -141.31 141.05 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 173.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -132.75 107.31 8.28 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 174.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 36.6 mt -80.04 154.78 27.93 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -122.7 149.2 44.38 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 176.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 8.7 m -135.49 149.03 49.41 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -174.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -74.39 127.52 33.24 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' B' ' 328' ' ' ARG . 25.9 mtp180 -80.32 -6.39 57.88 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 122.483 -0.135 . . . . 0.0 110.817 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -99.54 -13.84 19.28 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.72 0.408 . . . . 0.0 111.893 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 2.9 p -135.71 -25.53 1.27 Allowed 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 75.28 12.37 83.58 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 119.751 -0.471 . . . . 0.0 112.092 172.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -73.75 -108.42 0.01 OUTLIER 'General case' 0 C--N 1.343 0.315 0 C-N-CA 123.316 0.646 . . . . 0.0 110.536 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 5.9 mt -158.67 144.65 16.82 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.357 1.063 . . . . 0.0 108.424 172.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? -80.11 -19.64 46.9 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 122.287 0.235 . . . . 0.0 110.579 178.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.01 5.44 80.29 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -172.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -102.74 147.38 26.92 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.591 0.756 . . . . 0.0 110.313 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -164.17 158.23 18.89 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.639 0.257 . . . . 0.0 111.423 177.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 32.2 p -104.12 153.3 21.09 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 169.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 40.6 t -136.81 130.94 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 171.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 41.9 t -108.66 149.54 28.8 Favored 'General case' 0 N--CA 1.46 0.072 0 CA-C-O 120.672 0.272 . . . . 0.0 111.425 -178.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -115.27 157.82 23.22 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -70.46 -32.53 70.13 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -129.86 149.05 71.97 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -178.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 344' ' ' PRO . . . . . 0.456 ' HG2' ' HD3' ' B' ' 345' ' ' PRO . 41.0 Cg_endo -69.95 -32.42 17.81 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.198 2.599 . . . . 0.0 114.537 -176.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 345' ' ' PRO . . . . . 0.456 ' HD3' ' HG2' ' B' ' 344' ' ' PRO . 92.7 Cg_endo -74.16 -20.95 18.45 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 CA-C-N 120.874 1.348 . . . . 0.0 110.315 -177.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 68.3 m -71.05 -37.84 72.54 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 175.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.62 -38.18 86.41 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 174.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -64.69 -42.38 95.36 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -69.33 -34.1 74.11 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 110.48 -0.192 . . . . 0.0 110.48 178.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -63.87 -38.02 89.56 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 67.8 mt -68.08 -53.43 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 120.369 -0.532 . . . . 0.0 109.658 175.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -55.54 -27.72 50.55 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -178.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -96.6 -55.22 2.98 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 354' ' ' PHE . . . . . 0.417 ' CD2' ' CE1' ' B' ' 304' ' ' TYR . 48.9 m-85 -76.2 -27.0 56.7 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -173.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -49.18 108.43 0.19 Allowed 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 176.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 96.57 1.03 60.58 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-N 116.154 -0.475 . . . . 0.0 113.068 174.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -82.97 -164.47 0.88 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 117.89 0.845 . . . . 0.0 110.17 176.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -129.46 152.21 49.25 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-O 121.006 0.432 . . . . 0.0 110.982 178.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -145.08 137.27 25.86 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.891 0.877 . . . . 0.0 112.334 178.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 22.0 t 54.73 18.31 2.06 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.69 0.281 . . . . 0.0 111.196 -175.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.65 23.39 39.53 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -132.9 142.94 46.55 Favored Pre-proline 0 N--CA 1.457 -0.09 0 CA-C-N 117.537 0.668 . . . . 0.0 109.312 -177.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.24 135.51 31.89 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 123.148 2.565 . . . . 0.0 109.738 177.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 30.8 pt -123.03 170.43 13.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.122 0.487 . . . . 0.0 111.176 -177.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -144.31 116.91 8.64 Favored 'General case' 0 C--O 1.228 -0.071 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.898 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 12.6 t -106.13 149.0 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 C-N-CA 123.088 0.555 . . . . 0.0 112.124 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 22.6 t -163.27 172.92 14.01 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 177.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -69.94 129.68 40.14 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 176.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -87.51 175.92 7.71 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.096 0.474 . . . . 0.0 111.608 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 10.2 t -143.19 -146.52 0.19 Allowed 'General case' 0 C--O 1.234 0.241 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 172.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 26.7 mtp180 -131.9 86.93 2.39 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 119.015 0.825 . . . . 0.0 111.105 172.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -63.34 -16.14 59.52 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 169.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -63.98 -29.53 70.68 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.449 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -65.04 -10.72 32.16 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -176.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -78.99 -11.76 60.02 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 175.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -137.47 -3.2 1.92 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -174.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 . . . . . 0 C--O 1.252 1.201 0 CA-C-O 116.973 -1.489 . . . . 0.0 110.493 174.948 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ' G' . . . . . 0.666 HO2' " H5'" ' A' ' 2' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.422 -2.558 0 N19-C1'-C2' 108.962 -2.774 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ' G' . . . . . 0.666 " H5'" HO2' ' A' ' 1' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.421 -2.659 0 C5'-C4'-C3' 111.732 -2.512 . 0.665 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ' C' . . . . . 0.489 HO2' " H5'" ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.424 -2.397 0 N19-C1'-C2' 108.771 -2.893 . 0.805 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . 0.489 " H5'" HO2' ' A' ' 3' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.421 -2.627 0 N19-C1'-C2' 108.69 -2.944 . 0.748 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ' G' . . . . . 0.541 HO2' " H5'" ' A' ' 6' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.424 -2.43 0 N19-C1'-C2' 108.671 -2.956 . 0.682 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ' A' . . . . . 0.541 " H5'" HO2' ' A' ' 5' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.424 -2.444 0 N19-C1'-C2' 108.723 -2.923 . 0.733 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ' U' . . . . . 0.53 " H5'" HO2' ' A' ' 6' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.533 0 O4'-C1'-N19 111.058 2.858 . 0.797 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ' U' . . . . . 0.49 " H5'" HO2' ' A' ' 7' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.545 0 C4'-C3'-C2' 99.663 -3.037 . 0.69 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ' A' . . . . . 0.589 HO2' " H5'" ' A' ' 10' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.423 -2.477 0 C4'-C3'-C2' 99.771 -2.929 . 0.634 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ' C' . . . . . 0.589 " H5'" HO2' ' A' ' 9' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.641 0 O4'-C1'-N19 110.976 2.776 . 0.607 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ' A' . . . . . 0.667 HO2' " H5'" ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.587 0 O4'-C1'-N19 110.794 2.594 . 0.593 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ' A' . . . . . 0.667 " H5'" HO2' ' A' ' 11' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.425 -2.349 0 O4'-C1'-N19 112.194 3.994 . 0.209 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.533 0 C5'-C4'-C3' 109.72 -3.854 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.504 1 C5'-C4'-C3' 108.328 -4.781 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.81 0 C5'-C4'-C3' 111.433 -2.711 . 0.182 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.616 2.337 0 N19-C1'-C2' 108.574 -3.016 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ' A' . . . . . 0.458 HO2' " H5'" ' A' ' 18' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.423 -2.52 0 N19-C1'-C2' 108.28 -3.2 . 0.755 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ' U' . . . . . 0.458 " H5'" HO2' ' A' ' 17' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.424 -2.425 0 C5'-C4'-C3' 111.464 -2.691 . 0.767 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ' U' . . . . . 0.494 HO2' " H5'" ' A' ' 20' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.424 -2.436 0 O4'-C1'-N19 111.014 2.814 . 0.745 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ' U' . . . . . 0.623 HO2' " H5'" ' A' ' 21' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.423 -2.516 0 O4'-C1'-N19 111.154 2.954 . 0.644 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ' G' . . . . . 0.623 " H5'" HO2' ' A' ' 20' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.42 -2.72 0 C4'-C3'-C2' 100.378 -2.322 . 0.715 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.577 0 C5'-C4'-C3' 111.452 -2.699 . 0.816 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.805 0 N19-C1'-C2' 109.706 -2.309 . 0.812 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.121 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 66.3 m 55.69 29.23 13.36 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.33 0.652 . . . . 0.0 112.287 178.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -63.31 157.16 23.59 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.737 0.303 . . . . 0.0 110.52 178.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 46.7 ttm -153.24 147.7 26.0 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.57 0.348 . . . . 0.0 110.245 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -72.58 121.48 19.78 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 122.688 0.395 . . . . 0.0 110.631 178.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -139.11 25.35 2.49 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.478 0.711 . . . . 0.0 110.748 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 69.3 m -69.39 0.63 4.82 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 122.582 0.353 . . . . 0.0 111.252 177.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 38.1 p30 -139.4 19.84 2.56 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.804 0.842 . . . . 0.0 111.118 179.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -134.38 122.6 22.81 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.961 0.41 . . . . 0.0 111.072 -177.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.65 9.51 17.84 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.374 0.67 . . . . 0.0 111.691 178.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 72.1 m -109.07 145.39 35.71 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.024 0.44 . . . . 0.0 111.152 -173.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 46.1 pt -121.9 149.6 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -102.67 145.53 29.54 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 175.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 57.5 t -128.26 136.61 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.412 -178.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -127.23 153.95 45.46 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 176.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 84.31 12.22 76.47 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 173.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 292' ' ' LEU . . . . . 0.403 HD13 ' CD1' ' B' ' 359' ' ' PHE . 4.6 tp -59.1 -49.36 78.18 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.984 0.914 . . . . 0.0 111.219 -170.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 146.59 167.11 12.64 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 176.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -95.38 -1.19 51.62 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.341 0.257 . . . . 0.0 111.312 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -130.67 14.69 5.4 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.5 m -68.58 164.85 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -173.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 77.5 p -135.17 156.76 48.44 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 123.838 0.855 . . . . 0.0 109.782 177.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 298' ' ' ILE . . . . . 0.404 HG21 ' HB ' ' B' ' 322' ' ' ILE . 29.6 mt -61.94 -43.74 97.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.626 -178.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -64.25 -34.24 77.67 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 47.7 t -72.58 -45.36 59.54 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 117.864 0.302 . . . . 0.0 110.482 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 72.5 t -62.16 -41.63 92.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.93 -36.02 83.04 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 303' ' ' ASP . . . . . 0.42 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.2 t0 -69.74 -29.66 67.08 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 304' ' ' TYR . . . . . 0.401 ' CE1' ' CD2' ' B' ' 354' ' ' PHE . 56.3 t80 -82.52 -25.89 33.01 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -96.46 -24.47 16.09 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 306' ' ' LYS . . . . . 0.42 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.6 ptpt -67.15 -18.56 65.34 Favored 'General case' 0 N--CA 1.461 0.077 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -176.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -71.69 -19.73 62.03 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 5.2 mm -88.43 -46.28 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.092 0 CA-C-N 117.729 0.241 . . . . 0.0 110.471 175.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.83 170.53 39.17 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 83.5 mt -70.06 120.18 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 122.675 0.39 . . . . 0.0 110.352 -175.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 87.7 mt -73.83 138.9 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 172.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -71.03 130.3 41.19 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -178.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 4.0 m -92.6 138.23 31.68 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -70.09 128.93 38.01 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 174.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -82.92 -14.24 54.54 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -93.73 -20.72 19.86 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 122.652 0.381 . . . . 0.0 110.447 -176.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 7.2 p -129.22 -24.89 2.79 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -174.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 83.77 -9.18 63.29 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-O 119.874 -0.403 . . . . 0.0 112.3 174.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -84.1 156.47 63.55 Favored Pre-proline 0 C--O 1.234 0.254 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 174.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.92 157.09 61.23 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.147 1.898 . . . . 0.0 110.262 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 321' ' ' MET . . . . . 0.419 ' C ' HD12 ' B' ' 322' ' ' ILE . 34.2 mtt -74.94 86.02 2.27 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 120.913 0.387 . . . . 0.0 111.895 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 322' ' ' ILE . . . . . 0.419 HD12 ' C ' ' B' ' 321' ' ' MET . 3.4 mp -130.65 137.64 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 169.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -133.64 110.72 10.07 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.508 176.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 20.3 mt -78.75 151.77 31.88 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.334 0.654 . . . . 0.0 109.362 177.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -117.58 147.29 42.97 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 177.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 4.7 m -130.2 148.4 52.03 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -176.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -77.91 128.01 33.27 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 60.4 mtm180 -80.8 -8.06 59.59 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 121.245 -0.182 . . . . 0.0 110.6 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -93.87 -14.31 26.23 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 2.7 p -136.29 -26.26 1.14 Allowed 'General case' 0 C--N 1.341 0.233 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 76.17 11.99 84.47 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 119.936 -0.369 . . . . 0.0 112.185 174.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -76.76 -107.16 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 117.434 0.617 . . . . 0.0 110.136 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 6.3 mt -157.48 146.11 19.48 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.521 1.128 . . . . 0.0 108.076 171.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 10.5 mmmm -75.97 -20.8 57.61 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 122.639 0.376 . . . . 0.0 110.914 -179.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.77 21.87 73.47 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -172.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -127.61 144.87 51.03 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.013 0.525 . . . . 0.0 110.242 -177.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -155.21 155.37 33.75 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.584 0.231 . . . . 0.0 111.229 172.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 1.9 p -96.12 152.28 18.69 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 170.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 23.2 t -134.29 125.65 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 169.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 22.8 t -106.03 141.86 36.7 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.618 -177.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -107.79 158.54 17.22 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -73.06 -31.72 64.59 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -130.07 147.99 67.85 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -178.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 344' ' ' PRO . . . . . 0.442 ' N ' ' CD ' ' B' ' 345' ' ' PRO . 47.7 Cg_endo -71.64 -30.9 14.11 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 123.389 2.726 . . . . 0.0 114.672 -176.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 345' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' B' ' 344' ' ' PRO . 78.3 Cg_endo -73.83 -22.52 17.5 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 CA-C-N 121.326 1.509 . . . . 0.0 109.946 -177.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 71.1 m -71.68 -35.71 70.39 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 175.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -68.72 -38.03 79.9 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 175.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -63.87 -44.56 92.72 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.04 -33.6 74.89 Favored 'General case' 0 N--CA 1.455 -0.175 0 O-C-N 122.474 -0.141 . . . . 0.0 110.63 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.14 -37.69 88.24 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 67.6 mt -68.78 -53.68 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.929 174.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -54.21 -28.67 42.45 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -178.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 56.8 t-105 -95.89 -56.27 2.72 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 354' ' ' PHE . . . . . 0.401 ' CD2' ' CE1' ' B' ' 304' ' ' TYR . 47.3 m-85 -75.99 -25.59 55.94 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -173.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -45.86 107.51 0.1 Allowed 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 175.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 92.64 3.36 66.56 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 119.515 -0.603 . . . . 0.0 113.058 174.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -82.37 -170.84 3.13 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.178 0.989 . . . . 0.0 111.201 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -112.21 150.15 31.28 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.684 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 359' ' ' PHE . . . . . 0.403 ' CD1' HD13 ' B' ' 292' ' ' LEU . 14.2 t80 -146.12 130.8 17.93 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.654 0.782 . . . . 0.0 112.52 173.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 17.5 t 54.71 19.65 2.6 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.807 0.443 . . . . 0.0 111.089 -176.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.16 28.3 25.8 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 111.921 -0.472 . . . . 0.0 111.921 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -140.01 142.69 31.4 Favored Pre-proline 0 N--CA 1.456 -0.157 0 CA-C-N 117.385 0.592 . . . . 0.0 109.62 -177.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.97 136.27 32.01 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.814 2.343 . . . . 0.0 110.019 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 31.8 pt -124.79 170.27 15.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 121.103 0.478 . . . . 0.0 110.979 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -142.73 116.54 9.28 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.229 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 11.6 t -104.58 147.89 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 123.115 0.566 . . . . 0.0 111.78 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 24.4 t -162.41 172.23 15.9 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 177.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -70.06 128.65 37.05 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 177.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -91.18 -179.5 5.44 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.345 0.593 . . . . 0.0 111.996 -178.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 13.8 t -150.44 -164.35 2.0 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.69 1.196 . . . . 0.0 109.025 174.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 68.1 mtt180 -117.9 91.24 3.51 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 118.378 0.535 . . . . 0.0 110.263 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -60.53 -18.22 50.75 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 172.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -64.32 -8.96 14.79 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.35 0.66 . . . . 0.0 111.493 176.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -113.91 -10.88 12.89 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -175.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -135.83 -23.03 1.39 Allowed 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -85.07 -1.76 57.21 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 . . . . . 0 C--O 1.25 1.124 0 CA-C-O 117.495 -1.241 . . . . 0.0 110.241 179.835 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ' G' . . . . . 0.648 HO2' " H5'" ' A' ' 2' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.421 -2.675 0 N19-C1'-C2' 108.938 -2.789 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ' G' . . . . . 0.648 " H5'" HO2' ' A' ' 1' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.421 -2.692 0 O4'-C1'-N19 110.645 2.445 . 0.656 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.329 0 N19-C1'-C2' 109.062 -2.711 . 0.708 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . 0.634 HO2' " H5'" ' A' ' 5' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.425 -2.368 0 N19-C1'-C2' 109.167 -2.645 . 0.801 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ' G' . . . . . 0.634 " H5'" HO2' ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.53 0 N19-C1'-C2' 108.764 -2.898 . 0.677 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.569 0 N19-C1'-C2' 108.972 -2.768 . 0.816 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ' U' . . . . . 0.559 HO2' " H5'" ' A' ' 8' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.609 0 O4'-C1'-N19 110.98 2.78 . 0.816 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ' U' . . . . . 0.561 HO2' " H5'" ' A' ' 9' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.424 -2.432 0 O4'-C1'-N19 111.186 2.986 . 0.725 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ' A' . . . . . 0.561 " H5'" HO2' ' A' ' 8' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.423 -2.541 0 C4'-C3'-C2' 99.749 -2.951 . 0.648 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ' C' . . . . . 0.544 " H5'" HO2' ' A' ' 9' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.424 -2.438 0 O4'-C1'-N19 111.468 3.268 . 0.533 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.552 0 C4'-C3'-C2' 100.203 -2.497 . 0.553 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.452 0 O4'-C1'-N19 111.917 3.717 . 0.229 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.877 1 C5'-C4'-C3' 108.612 -4.592 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.517 0 O4'-C1'-N19 111.816 3.616 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.621 2.762 0 O4'-C1'-N19 111.546 3.346 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ' U' . . . . . 0.685 HO2' " H5'" ' A' ' 17' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.425 -2.298 0 O4'-C1'-N19 111.311 3.111 . 0.309 2h . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ' A' . . . . . 0.685 " H5'" HO2' ' A' ' 16' ' ' ' U' . . . . . . . . 0 P--O5' 1.616 2.348 0 N19-C1'-C2' 108.463 -3.085 . 0.552 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.38 0 O4'-C1'-N19 110.918 2.718 . 0.792 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ' U' . . . . . 0.502 HO2' " C5'" ' A' ' 20' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.624 0 O4'-C1'-N19 110.98 2.78 . 0.769 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ' U' . . . . . 0.502 " C5'" HO2' ' A' ' 19' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.425 -2.373 0 O4'-C1'-N19 111.191 2.991 . 0.664 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ' G' . . . . . 0.557 HO2' " H5'" ' A' ' 22' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.423 -2.524 0 C5'-C4'-C3' 112.015 -2.323 . 0.74 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ' C' . . . . . 0.557 " H5'" HO2' ' A' ' 21' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.42 -2.752 0 C5'-C4'-C3' 111.353 -2.765 . 0.768 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ' C' . . . . . 0.538 " H5'" HO2' ' A' ' 22' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.42 -2.752 0 N19-C1'-C2' 109.694 -2.317 . 0.765 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.192 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 46.4 t -68.12 155.51 39.44 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.536 0.334 . . . . 0.0 110.77 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 -154.95 147.83 24.55 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 122.854 0.462 . . . . 0.0 109.969 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 96.9 mmm -140.18 156.77 46.38 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 123.162 0.585 . . . . 0.0 110.44 -178.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -66.61 -12.72 59.31 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -78.46 8.62 4.89 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 45.9 t -64.38 -25.26 67.95 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 174.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -100.62 14.54 31.11 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.598 0.759 . . . . 0.0 111.515 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -125.02 110.42 14.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -175.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -113.49 5.87 16.86 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.931 -178.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 99.4 m -111.24 146.63 36.62 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.211 0.529 . . . . 0.0 110.369 -176.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 39.8 pt -119.04 146.89 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.227 175.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 288' ' ' PHE . . . . . 0.425 ' CE2' ' C6 ' ' A' ' 14' ' ' ' U' . 52.0 t80 -96.97 145.5 25.86 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 173.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 18.0 t -131.3 142.23 43.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 O-C-N 123.211 0.319 . . . . 0.0 111.148 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -131.17 150.37 52.18 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 177.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.81 12.99 65.48 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 119.776 -0.458 . . . . 0.0 112.402 169.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 65.5 mt -57.29 -49.95 74.47 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 117.653 0.726 . . . . 0.0 110.645 -175.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 146.47 175.41 19.44 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -101.3 0.23 36.87 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.898 0.349 . . . . 0.0 111.861 -177.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -128.66 13.91 6.45 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.57 0.348 . . . . 0.0 111.666 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.5 m -75.33 166.7 2.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -172.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 14.1 p -131.36 162.15 30.77 Favored 'General case' 0 CA--C 1.522 -0.11 0 C-N-CA 123.744 0.818 . . . . 0.0 112.596 -177.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 298' ' ' ILE . . . . . . . . . . . . . 44.1 mt -62.88 -45.45 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.347 178.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -69.79 -33.51 72.48 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -178.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 80.9 p -72.41 -44.66 62.14 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 118.398 0.544 . . . . 0.0 110.37 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 9.5 p -68.35 -33.76 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 O-C-N 121.917 -0.489 . . . . 0.0 110.668 176.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.58 -33.48 76.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 175.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 303' ' ' ASP . . . . . 0.452 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.3 t0 -73.7 -27.32 61.15 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 304' ' ' TYR . . . . . 0.408 ' CE1' ' CD1' ' B' ' 354' ' ' PHE . 59.5 t80 -83.23 -25.85 31.31 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -96.67 -25.48 15.54 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 178.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 306' ' ' LYS . . . . . 0.452 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.9 ptpt -65.86 -18.09 65.1 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -177.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -72.67 -20.06 61.31 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 122.169 -0.332 . . . . 0.0 111.82 -178.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.1 mm -86.29 -46.87 16.62 Favored 'Isoleucine or valine' 0 C--N 1.338 0.071 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 174.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -162.51 166.06 36.44 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 85.6 mt -68.22 121.31 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 C-N-CA 122.604 0.362 . . . . 0.0 110.595 -175.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 94.9 mt -73.94 136.06 26.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 172.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -70.43 133.0 46.45 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -178.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 4.5 m -93.23 136.97 33.0 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 178.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -66.4 126.21 28.08 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 174.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? -82.07 -13.02 57.92 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.392 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -95.31 -23.94 16.98 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 122.381 0.272 . . . . 0.0 110.703 -175.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 14.6 p -125.39 -24.41 3.94 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -175.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 84.92 -9.49 65.77 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 119.719 -0.489 . . . . 0.0 112.245 174.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -82.85 156.91 67.32 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 118.073 0.937 . . . . 0.0 108.626 174.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.24 154.61 65.67 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 121.907 1.738 . . . . 0.0 109.993 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 321' ' ' MET . . . . . . . . . . . . . 35.3 mtt -71.86 95.48 1.54 Allowed 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 120.814 0.34 . . . . 0.0 111.482 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 322' ' ' ILE . . . . . . . . . . . . . 3.3 mp -144.51 145.68 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 323' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' B' ' 337' ' ' ALA . 18.1 m-80 -134.04 129.16 35.68 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 171.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -97.95 139.59 33.56 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -105.81 149.43 26.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 179.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -133.93 146.3 50.37 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -75.62 134.53 40.62 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 -87.7 -10.7 50.43 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.281 0.232 . . . . 0.0 111.09 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -97.29 -13.94 21.64 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.936 0.495 . . . . 0.0 111.695 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 3.7 p -136.78 -21.06 1.28 Allowed 'General case' 0 C--O 1.232 0.174 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -178.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 79.18 2.13 86.76 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 176.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -88.8 157.34 18.51 Favored 'General case' 0 C--O 1.228 -0.041 0 CA-C-N 117.794 0.797 . . . . 0.0 109.502 178.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 41.0 mt -69.88 141.9 53.11 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.86 0.362 . . . . 0.0 110.557 -176.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -73.92 -16.16 61.11 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.178 0.591 . . . . 0.0 110.302 178.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 75.95 5.51 80.17 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -171.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -100.05 149.22 23.71 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.491 0.716 . . . . 0.0 110.164 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 337' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' B' ' 323' ' ' ASN . . . -161.14 166.26 28.22 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 120.871 0.367 . . . . 0.0 111.398 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 2.7 p -118.71 149.84 40.76 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 169.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 42.8 t -135.58 123.21 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 171.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 16.0 t -102.04 137.99 39.58 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.001 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -101.75 161.67 13.48 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -74.42 -26.06 59.83 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -137.24 149.48 65.99 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -176.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 344' ' ' PRO . . . . . 0.445 ' HG2' ' HD3' ' B' ' 345' ' ' PRO . 41.6 Cg_endo -70.79 -32.25 14.59 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.391 2.727 . . . . 0.0 114.39 -177.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 345' ' ' PRO . . . . . 0.445 ' HD3' ' HG2' ' B' ' 344' ' ' PRO . 79.2 Cg_endo -73.89 -22.11 17.82 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 CA-C-N 121.324 1.509 . . . . 0.0 110.075 -177.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 61.2 m -71.81 -37.64 70.35 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 175.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -67.05 -37.66 84.46 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 174.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -64.82 -43.52 92.83 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.94 -34.22 75.0 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 110.675 -0.12 . . . . 0.0 110.675 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.41 -36.41 84.07 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 64.4 mt -69.73 -52.62 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 120.357 -0.537 . . . . 0.0 109.758 175.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -55.82 -28.14 54.84 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 59.8 t-105 -96.79 -54.88 3.07 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -177.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 354' ' ' PHE . . . . . 0.408 ' CD1' ' CE1' ' B' ' 304' ' ' TYR . 50.7 m-85 -78.36 -29.86 47.72 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -174.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -51.17 110.77 0.47 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.222 0.465 . . . . 0.0 111.839 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 99.7 -2.18 57.09 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 119.541 -0.588 . . . . 0.0 112.715 175.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -83.54 -163.71 0.8 Allowed 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.065 0.932 . . . . 0.0 110.641 177.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -128.53 155.6 44.61 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 121.315 0.579 . . . . 0.0 111.356 178.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -146.78 136.73 23.33 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 124.637 1.175 . . . . 0.0 112.007 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 64.2 m 52.73 19.53 1.29 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -173.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.51 23.4 39.91 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -133.0 141.48 41.13 Favored Pre-proline 0 N--CA 1.453 -0.29 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -178.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.6 135.37 30.66 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 122.862 2.375 . . . . 0.0 109.611 178.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 27.0 pt -122.48 170.82 12.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 121.187 0.518 . . . . 0.0 110.807 -177.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 9.7 tmtm? -145.66 117.93 8.42 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.537 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 10.9 t -105.48 150.13 8.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 C-N-CA 123.324 0.65 . . . . 0.0 112.01 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 30.0 t -162.27 173.88 13.61 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 176.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -71.16 130.24 40.97 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 176.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -87.18 -174.51 4.91 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.696 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 15.3 t -157.47 -172.77 4.11 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.326 1.05 . . . . 0.0 109.27 176.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 20.3 mmt85 -98.81 67.01 1.66 Allowed 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 -60.52 -16.84 41.23 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 173.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.71 -31.25 69.43 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.818 0.847 . . . . 0.0 110.989 173.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -67.1 -9.32 38.34 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -173.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -92.37 -19.73 21.78 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 175.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -93.53 -40.78 10.12 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 122.5 0.32 . . . . 0.0 111.524 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 . . . . . 0 C--O 1.25 1.111 0 CA-C-O 117.573 -1.203 . . . . 0.0 110.192 -176.791 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.581 0 N19-C1'-C2' 109.003 -2.748 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.699 0 C5'-C4'-C3' 112.213 -2.191 . 0.707 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.299 0 N19-C1'-C2' 108.68 -2.95 . 0.696 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . 0.603 HO2' " H5'" ' A' ' 5' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.422 -2.6 0 N19-C1'-C2' 108.909 -2.807 . 0.829 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ' G' . . . . . 0.603 " H5'" HO2' ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.424 -2.392 0 N19-C1'-C2' 108.62 -2.987 . 0.68 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ' A' . . . . . 0.572 HO2' " H5'" ' A' ' 7' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.425 -2.352 0 N19-C1'-C2' 108.736 -2.915 . 0.769 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ' U' . . . . . 0.572 " H5'" HO2' ' A' ' 6' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.666 0 O4'-C1'-N19 111.016 2.816 . 0.796 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ' U' . . . . . 0.525 HO2' " H5'" ' A' ' 9' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.425 -2.308 0 C4'-C3'-C2' 99.956 -2.744 . 0.745 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ' A' . . . . . 0.582 HO2' " H5'" ' A' ' 10' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.421 -2.666 0 C4'-C3'-C2' 99.899 -2.801 . 0.639 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ' C' . . . . . 0.582 " H5'" HO2' ' A' ' 9' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.641 0 C4'-C3'-C2' 99.835 -2.865 . 0.591 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.396 0 C4'-C3'-C2' 99.823 -2.877 . 0.507 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.574 0 O4'-C1'-N19 112.063 3.863 . 0.148 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.51 1 C5'-C4'-C3' 108.698 -4.534 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ' U' . . . . . 0.425 ' C6 ' ' CE2' ' B' ' 288' ' ' PHE . . . . . . . . 0 O4'--C4' 1.422 -2.589 0 O4'-C1'-N19 112.135 3.935 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.626 3.255 0 O4'-C1'-N19 110.654 2.454 . 0.67 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.338 0 N19-C1'-C2' 108.814 -2.866 . 0.328 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ' A' . . . . . 0.615 HO2' " H5'" ' A' ' 18' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.424 -2.418 0 N19-C1'-C2' 108.79 -2.881 . 0.653 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ' U' . . . . . 0.615 " H5'" HO2' ' A' ' 17' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.621 0 O4'-C1'-N19 110.818 2.618 . 0.743 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ' U' . . . . . 0.473 HO2' " H5'" ' A' ' 20' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.59 0 C5'-C4'-C3' 111.59 -2.607 . 0.778 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ' U' . . . . . 0.567 HO2' " H5'" ' A' ' 21' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.423 -2.48 0 O4'-C1'-N19 110.897 2.697 . 0.673 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ' G' . . . . . 0.567 " H5'" HO2' ' A' ' 20' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.423 -2.54 0 C4'-C3'-C2' 100.397 -2.303 . 0.75 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ' C' . . . . . 0.584 HO2' " H5'" ' A' ' 23' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.422 -2.571 0 C5'-C4'-C3' 111.373 -2.751 . 0.786 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ' C' . . . . . 0.584 " H5'" HO2' ' A' ' 22' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.42 -2.777 0 C5'-C4'-C3' 112.056 -2.296 . 0.789 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 59.2 m -109.01 143.12 38.72 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 120.956 0.408 . . . . 0.0 110.961 -176.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 24.7 pt -117.8 147.84 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 174.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -99.71 143.54 29.82 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 173.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 19.5 t -127.72 141.36 46.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.813 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -129.06 149.62 50.8 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 88.54 12.67 64.39 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-O 119.818 -0.434 . . . . 0.0 112.633 169.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 65.6 mt -56.93 -51.62 68.44 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 117.532 0.666 . . . . 0.0 110.599 -175.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 147.44 173.41 18.52 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -98.58 -0.85 42.34 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 122.368 -0.489 . . . . 0.0 111.984 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -128.66 13.63 6.44 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.804 0.441 . . . . 0.0 112.168 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.1 m -75.81 165.69 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -173.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 20.7 p -131.17 158.39 40.62 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 123.335 0.654 . . . . 0.0 112.168 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 298' ' ' ILE . . . . . 0.596 HG23 ' HB ' ' B' ' 322' ' ' ILE . 37.5 mt -60.11 -44.27 94.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.267 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -62.93 -36.0 81.95 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.689 0.395 . . . . 0.0 111.505 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 75.3 m -72.22 -43.43 64.44 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 117.893 0.315 . . . . 0.0 110.258 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 71.4 t -62.62 -41.87 93.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.54 -36.86 85.57 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 303' ' ' ASP . . . . . 0.409 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 44.1 t0 -70.21 -27.19 64.29 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 304' ' ' TYR . . . . . 0.418 ' CE2' ' CD1' ' B' ' 354' ' ' PHE . 59.6 t80 -85.21 -25.97 27.03 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -96.54 -23.92 16.3 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 306' ' ' LYS . . . . . 0.409 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.6 ptpt -66.95 -18.19 65.27 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -177.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -72.69 -20.28 61.26 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.8 mm -87.01 -46.46 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.06 0 N-CA-C 110.51 -0.181 . . . . 0.0 110.51 175.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -162.22 167.63 36.91 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 80.0 mt -68.76 119.7 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 120.853 0.358 . . . . 0.0 110.499 -176.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 93.9 mt -73.84 136.39 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 172.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -178.474 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo . . . . . 0 N--CA 1.453 -0.907 0 N-CA-C 109.855 -0.864 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 321' ' ' MET . . . . . 0.415 ' CB ' ' HB3' ' B' ' 340' ' ' SER . 36.0 mtt -72.62 88.34 1.26 Allowed 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 322' ' ' ILE . . . . . 0.596 ' HB ' HG23 ' B' ' 298' ' ' ILE . 4.0 mp -136.07 140.26 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 171.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -133.41 108.09 8.47 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.28 151.04 35.24 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.796 0.839 . . . . 0.0 109.273 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -117.22 150.56 38.55 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 176.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.141 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -175.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 9.2 mmmm . . . . . 0 C--O 1.231 0.097 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.19 6.94 84.2 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -171.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -104.9 148.27 26.86 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.666 0.786 . . . . 0.0 110.379 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -161.96 156.67 22.65 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.845 175.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 21.3 p -103.95 153.15 21.15 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 169.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 23.3 t -135.67 128.37 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 123.582 0.753 . . . . 0.0 109.312 170.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 340' ' ' SER . . . . . 0.415 ' HB3' ' CB ' ' B' ' 321' ' ' MET . 38.7 t -106.73 144.15 33.8 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.883 0.373 . . . . 0.0 111.132 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -109.71 158.77 17.76 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -73.93 -17.61 61.0 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -145.41 149.98 42.75 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 344' ' ' PRO . . . . . 0.467 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 49.2 Cg_endo -70.51 -31.78 16.63 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.272 2.648 . . . . 0.0 114.408 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 345' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 81.0 Cg_endo -73.43 -21.65 19.45 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 CA-C-N 121.515 1.577 . . . . 0.0 110.261 -177.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 60.1 m -73.05 -37.51 66.82 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 175.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.0 -38.35 88.26 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 174.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 9.5 tmtm? -65.13 -43.42 91.99 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -66.83 -34.15 77.18 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.92 -36.74 85.35 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 67.2 mt -69.73 -51.62 39.32 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.094 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.733 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -54.74 -29.49 53.77 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 57.5 t-105 -97.79 -56.4 2.52 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -177.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 354' ' ' PHE . . . . . 0.418 ' CD1' ' CE2' ' B' ' 304' ' ' TYR . 50.7 m-85 -75.8 -28.42 58.33 Favored 'General case' 0 CA--C 1.523 -0.08 0 N-CA-C 114.571 1.322 . . . . 0.0 114.571 -173.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -52.27 108.23 0.27 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 117.844 0.293 . . . . 0.0 111.506 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 100.41 -0.89 55.78 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-O 119.662 -0.521 . . . . 0.0 112.729 175.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -83.72 -165.01 1.0 Allowed 'General case' 0 N--CA 1.461 0.096 0 CA-C-N 118.296 1.048 . . . . 0.0 110.371 176.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -127.41 153.37 46.34 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-O 121.02 0.438 . . . . 0.0 110.83 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -145.57 136.64 24.73 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.307 1.043 . . . . 0.0 112.212 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 21.5 t 53.99 19.28 1.96 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.57 0.348 . . . . 0.0 111.302 -175.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.14 23.18 41.88 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.871 -0.492 . . . . 0.0 111.871 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -132.37 142.42 44.9 Favored Pre-proline 0 N--CA 1.455 -0.22 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.52 136.15 32.87 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 122.873 2.382 . . . . 0.0 109.67 178.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 25.5 pt -124.05 171.07 13.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-O 121.173 0.511 . . . . 0.0 111.025 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -146.02 119.4 9.0 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.434 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 13.3 t -108.04 150.03 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 123.14 0.576 . . . . 0.0 112.133 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 29.1 t -163.85 173.12 13.11 Favored 'General case' 0 C--N 1.339 0.15 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -69.93 130.13 41.37 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 176.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 121.144 0.497 . . . . 0.0 111.922 -179.094 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 10.4 p30 . . . . . 0 N--CA 1.456 -0.174 0 N-CA-C 110.584 -0.154 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 29.3 m -101.5 141.77 33.87 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.011 0.434 . . . . 0.0 111.521 -173.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 38.2 pt -116.6 146.63 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.958 172.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -97.94 144.56 27.36 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 173.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 19.4 t -132.34 141.5 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 122.783 0.433 . . . . 0.0 110.969 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -130.92 154.4 48.15 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 122.858 0.463 . . . . 0.0 109.797 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 86.46 12.92 68.89 Favored Glycine 0 CA--C 1.521 0.469 0 CA-C-O 119.831 -0.427 . . . . 0.0 112.355 169.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 74.7 mt -57.49 -50.1 74.16 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 117.54 0.67 . . . . 0.0 110.336 -176.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 144.16 171.03 13.93 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -98.0 3.21 49.49 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 122.544 -0.386 . . . . 0.0 111.855 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -128.29 11.9 6.46 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.638 0.375 . . . . 0.0 111.769 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.6 m -74.8 163.75 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -173.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 20.3 p -128.87 158.93 37.37 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 123.589 0.755 . . . . 0.0 111.85 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 298' ' ' ILE . . . . . 0.548 HG23 ' HB ' ' B' ' 322' ' ' ILE . 40.4 mt -60.29 -44.38 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.547 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -68.72 -30.48 69.13 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 74.8 m -72.16 -43.96 63.81 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 118.17 0.441 . . . . 0.0 109.837 177.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 71.8 t -62.78 -41.05 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.21 -37.38 87.27 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 303' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -70.16 -26.87 64.12 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -85.71 -25.46 26.48 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -96.71 -24.18 16.09 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 306' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -67.11 -18.12 65.17 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 111.576 0.213 . . . . 0.0 111.576 -177.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -72.79 -20.01 61.24 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.2 mm -87.18 -45.69 16.26 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 CA-C-N 117.732 0.242 . . . . 0.0 110.48 175.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.4 167.68 37.74 Favored Glycine 0 C--N 1.335 0.502 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 78.3 mt -69.35 120.4 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-O 120.935 0.397 . . . . 0.0 110.717 -175.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 86.8 mt -75.19 134.47 29.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 171.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt . . . . . 0 N--CA 1.453 -0.314 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.903 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo . . . . . 0 N--CA 1.447 -1.215 0 N-CA-C 109.288 -1.082 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 321' ' ' MET . . . . . 0.461 ' CB ' ' HB2' ' B' ' 340' ' ' SER . 30.1 mtt -71.38 93.62 1.16 Allowed 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.152 0.501 . . . . 0.0 111.636 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 322' ' ' ILE . . . . . 0.548 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.4 mp -140.89 139.52 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 173.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -132.01 106.32 7.96 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 35.0 mt -78.32 153.41 31.74 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 123.891 0.744 . . . . 0.0 109.361 176.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -119.87 149.49 41.99 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 176.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.454 -0.229 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -174.924 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt . . . . . 0 CA--C 1.519 -0.215 0 CA-C-O 120.445 0.164 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 74.44 5.34 72.41 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -173.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -106.02 149.77 26.37 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.017 0.527 . . . . 0.0 110.167 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -163.52 160.1 22.77 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.727 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 27.4 p -106.88 153.82 21.96 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 169.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 22.1 t -134.26 129.36 53.32 Favored 'Isoleucine or valine' 0 C--O 1.23 0.038 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 170.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 340' ' ' SER . . . . . 0.461 ' HB2' ' CB ' ' B' ' 321' ' ' MET . 20.4 m -108.54 134.62 51.05 Favored 'General case' 0 C--O 1.23 0.068 0 CA-C-O 120.677 0.275 . . . . 0.0 110.3 -176.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -101.14 159.98 14.78 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -70.67 -36.04 73.15 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -127.52 149.06 69.08 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 344' ' ' PRO . . . . . 0.468 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 45.4 Cg_endo -70.83 -31.31 15.98 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.006 2.47 . . . . 0.0 114.647 -177.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 345' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 89.6 Cg_endo -73.61 -21.05 19.7 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 CA-C-N 121.222 1.472 . . . . 0.0 110.087 -177.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 49.0 m -71.25 -37.64 71.95 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 175.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.14 -39.44 89.84 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 174.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -63.36 -44.22 95.43 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.9 -33.92 75.64 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.117 0.167 . . . . 0.0 110.616 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.71 -37.86 89.04 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 67.3 mt -68.59 -53.05 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 120.35 -0.54 . . . . 0.0 109.973 175.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -54.93 -28.08 48.29 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -97.51 -55.47 2.81 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -76.92 -28.29 55.21 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -173.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -52.29 108.5 0.3 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 117.953 0.342 . . . . 0.0 111.366 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 101.61 -0.8 52.82 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.547 -0.585 . . . . 0.0 112.647 175.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -83.88 -163.11 0.72 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 118.09 0.945 . . . . 0.0 110.57 177.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -130.71 153.27 49.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.046 0.451 . . . . 0.0 110.464 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -145.81 138.0 25.43 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.224 1.01 . . . . 0.0 112.408 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 19.2 t 55.49 17.13 2.09 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.858 0.361 . . . . 0.0 111.026 -175.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.01 22.57 41.44 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.858 -0.497 . . . . 0.0 111.858 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 42.6 m-20 -132.26 142.41 44.89 Favored Pre-proline 0 N--CA 1.455 -0.181 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.84 135.5 32.87 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 122.709 2.272 . . . . 0.0 109.872 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 31.3 pt -121.63 170.69 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-O 120.948 0.404 . . . . 0.0 111.16 -177.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -143.21 112.84 6.93 Favored 'General case' 0 C--O 1.227 -0.083 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.793 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 6.3 t -103.85 149.73 7.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 C-N-CA 122.878 0.471 . . . . 0.0 112.258 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 29.4 t -164.13 175.02 10.59 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -71.73 129.77 39.47 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 175.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 121.329 0.585 . . . . 0.0 112.325 -179.089 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 17.4 p30 . . . . . 0 CA--C 1.53 0.173 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 87.7 m -107.97 143.76 36.19 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.148 0.499 . . . . 0.0 110.887 -174.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 41.5 pt -117.34 147.13 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.528 -0.76 . . . . 0.0 108.971 174.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -99.45 145.67 27.18 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 173.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 13.5 t -129.69 143.25 41.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 122.651 0.38 . . . . 0.0 111.403 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -131.65 149.57 52.45 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 122.952 0.501 . . . . 0.0 109.829 175.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 88.57 12.06 65.25 Favored Glycine 0 CA--C 1.522 0.494 0 CA-C-O 119.69 -0.506 . . . . 0.0 112.511 169.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 47.0 mt -57.45 -51.53 69.06 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 117.659 0.729 . . . . 0.0 110.836 -174.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 152.55 176.97 25.71 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -95.72 -14.85 23.05 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 122.311 -0.523 . . . . 0.0 112.118 -175.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -128.62 18.72 6.26 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.278 0.49 . . . . 0.0 112.093 -178.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.3 m -65.96 164.4 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -175.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 18.1 p -126.26 160.89 29.07 Favored 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 123.267 0.627 . . . . 0.0 112.265 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 298' ' ' ILE . . . . . 0.565 HG23 ' HB ' ' B' ' 322' ' ' ILE . 28.6 mt -64.54 -43.5 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.966 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -65.26 -37.29 86.76 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 79.5 p -73.29 -42.63 62.2 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 118.137 0.426 . . . . 0.0 110.494 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.5 -41.57 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.79 -36.0 82.92 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 303' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -70.43 -26.62 63.75 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -84.17 -26.68 28.63 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -96.43 -24.9 15.9 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 306' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -66.5 -18.89 65.62 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -177.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -71.8 -20.04 61.91 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -178.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 5.4 mm -87.21 -46.17 16.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 175.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -164.03 168.19 38.39 Favored Glycine 0 C--N 1.335 0.49 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 82.4 mt -69.16 122.03 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 122.603 0.361 . . . . 0.0 110.433 -175.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 95.9 mt -75.69 137.58 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 173.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt . . . . . 0 N--CA 1.45 -0.458 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -178.953 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo . . . . . 0 N--CA 1.451 -1.018 0 N-CA-C 109.453 -1.018 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 321' ' ' MET . . . . . 0.455 ' C ' HD12 ' B' ' 322' ' ' ILE . 35.9 mtt -71.54 86.14 0.87 Allowed 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.907 0.384 . . . . 0.0 111.617 -178.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 322' ' ' ILE . . . . . 0.565 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.7 mp -134.07 143.48 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 171.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -130.76 138.38 49.92 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 171.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 86.4 mt -110.48 129.36 55.8 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 176.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -94.55 154.23 17.49 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -177.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.141 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -173.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? . . . . . 0 CA--C 1.528 0.098 0 N-CA-C 110.483 -0.191 . . . . 0.0 110.483 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.8 6.07 84.78 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -171.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -104.11 152.16 22.44 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.629 0.771 . . . . 0.0 109.91 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -160.25 169.66 22.74 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.898 0.38 . . . . 0.0 111.171 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 1.7 p -126.48 150.47 48.7 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 170.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 21.3 t -135.35 125.06 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 C-N-CA 123.577 0.751 . . . . 0.0 109.252 172.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 23.5 t -104.26 136.17 44.36 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.552 0.215 . . . . 0.0 110.605 -178.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -101.66 158.63 15.96 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -177.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -72.87 -31.08 64.47 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -129.54 146.68 62.11 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 344' ' ' PRO . . . . . 0.463 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 46.8 Cg_endo -70.99 -32.21 13.82 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.219 2.613 . . . . 0.0 114.38 -177.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 345' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 77.9 Cg_endo -73.49 -21.93 18.99 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 CA-C-N 121.256 1.484 . . . . 0.0 110.101 -176.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 67.3 m -70.73 -35.14 72.55 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 175.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -68.73 -39.28 80.46 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.62 -43.73 98.31 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 177.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.94 -35.09 76.38 Favored 'General case' 0 C--O 1.225 -0.201 0 O-C-N 122.371 -0.206 . . . . 0.0 110.462 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.31 -36.52 84.33 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 60.0 mt -71.21 -49.18 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.165 175.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -59.98 -27.58 66.95 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -175.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -96.55 -57.33 2.34 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -75.09 -30.93 61.06 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -173.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -54.19 111.17 0.72 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 118.128 0.422 . . . . 0.0 110.947 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 102.03 -3.0 51.65 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 119.556 -0.58 . . . . 0.0 112.559 176.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -84.42 -164.15 0.91 Allowed 'General case' 0 C--O 1.232 0.137 0 CA-C-N 118.093 0.947 . . . . 0.0 109.787 177.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -128.53 153.34 47.28 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.06 0.457 . . . . 0.0 110.971 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -145.01 135.96 24.73 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.041 0.936 . . . . 0.0 112.101 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 62.7 m 53.31 19.5 1.59 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.516 0.327 . . . . 0.0 111.802 -174.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.74 23.23 39.79 Favored Glycine 0 C--N 1.339 0.733 0 N-CA-C 111.784 -0.526 . . . . 0.0 111.784 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 56.9 m-20 -132.55 142.25 44.17 Favored Pre-proline 0 N--CA 1.452 -0.333 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -177.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.83 135.37 30.11 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.804 2.336 . . . . 0.0 109.72 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 30.6 pt -122.9 169.91 13.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.22 0.533 . . . . 0.0 111.166 -177.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 5.3 tmtm? -145.72 114.05 6.66 Favored 'General case' 0 C--N 1.338 0.069 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 11.2 t -103.89 149.73 7.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.077 0.551 . . . . 0.0 112.24 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 28.1 t -162.71 172.42 15.31 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 176.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -70.48 130.17 41.17 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.388 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.277 -177.841 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 285' ' ' ASN . . . . . 0.408 HD22 ' C ' ' B' ' 285' ' ' ASN . 0.4 OUTLIER . . . . . 0 N--CA 1.456 -0.136 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 35.0 m -104.88 140.79 37.61 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -173.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 41.1 pt -110.29 142.82 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -93.79 141.91 27.97 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 172.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 15.9 t -130.38 141.18 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 O-C-N 123.156 0.285 . . . . 0.0 111.173 177.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -126.98 154.12 45.01 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 174.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 85.47 12.18 73.31 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-O 119.772 -0.46 . . . . 0.0 112.425 169.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 60.0 mt -56.69 -50.59 71.7 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 117.536 0.668 . . . . 0.0 110.752 -175.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 156.79 179.69 31.95 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -97.79 -8.43 28.49 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -177.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -141.22 24.4 2.13 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.5 m -67.95 162.81 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -174.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 20.8 p -122.84 156.51 34.43 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 298' ' ' ILE . . . . . 0.438 HG23 ' HB ' ' B' ' 322' ' ' ILE . 35.4 mt -61.56 -43.23 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.038 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -65.15 -35.73 82.02 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.61 0.364 . . . . 0.0 111.54 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 38.6 t -73.23 -44.1 60.11 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 122.25 -0.281 . . . . 0.0 110.389 -178.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 93.9 t -62.08 -41.51 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.95 -35.23 80.51 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 303' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -70.97 -29.28 65.22 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 304' ' ' TYR . . . . . 0.413 ' CE1' ' CD1' ' B' ' 354' ' ' PHE . 59.9 t80 -83.77 -24.96 30.88 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -96.62 -23.35 16.53 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 306' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -67.81 -16.76 64.26 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -177.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -73.02 -19.86 61.11 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 111.561 0.208 . . . . 0.0 111.561 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 3.9 mm -87.07 -47.76 15.8 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.109 0 CA-C-O 120.525 0.202 . . . . 0.0 110.781 175.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -161.4 175.38 38.0 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 74.4 mt -73.86 111.89 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-O 120.808 0.337 . . . . 0.0 110.133 -176.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 73.6 mt -68.16 135.53 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 172.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 312' ' ' LYS . . . . . 0.433 ' HG2' ' SD ' ' B' ' 321' ' ' MET . 40.7 ttmt . . . . . 0 N--CA 1.451 -0.379 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo . . . . . 0 N--CA 1.445 -1.331 0 N-CA-C 108.88 -1.239 . . . . 0.0 108.88 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 321' ' ' MET . . . . . 0.433 ' SD ' ' HG2' ' B' ' 312' ' ' LYS . 81.2 mtp -85.65 85.27 7.42 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.573 0.702 . . . . 0.0 111.09 -172.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 322' ' ' ILE . . . . . 0.438 ' HB ' HG23 ' B' ' 298' ' ' ILE . 2.3 mp -118.12 149.78 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 125.257 1.423 . . . . 0.0 108.328 174.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -134.94 116.16 14.4 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 170.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 55.5 mt -90.44 150.06 21.98 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 177.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -115.12 150.89 35.29 Favored 'General case' 0 C--O 1.226 -0.183 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 3.1 m . . . . . 0 CA--C 1.52 -0.175 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -176.912 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? . . . . . 0 N--CA 1.461 0.092 0 N-CA-C 110.533 -0.173 . . . . 0.0 110.533 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 72.59 5.12 62.99 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -172.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -103.48 150.63 23.7 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.275 0.63 . . . . 0.0 110.354 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.16 169.4 24.25 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.008 0.433 . . . . 0.0 110.328 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 2.5 p -132.3 147.44 52.4 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 171.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 339' ' ' VAL . . . . . 0.402 ' CG1' HG13 ' B' ' 322' ' ' ILE . 1.0 OUTLIER -137.27 141.46 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 169.818 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 44.6 t -92.36 145.46 24.46 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.585 -177.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -112.46 151.92 29.34 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 175.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -70.61 -22.77 62.5 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 343' ' ' ASP . . . . . 0.435 ' HB3' ' HD2' ' B' ' 345' ' ' PRO . 48.3 m-20 -144.49 148.31 39.82 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 124.025 0.93 . . . . 0.0 111.769 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 344' ' ' PRO . . . . . 0.466 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 53.6 Cg_endo -71.62 -31.81 12.87 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.507 2.804 . . . . 0.0 115.063 -172.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 345' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 98.7 Cg_endo -73.51 -22.44 18.35 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 CA-C-N 121.286 1.495 . . . . 0.0 109.841 -178.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 48.7 m -73.21 -34.14 65.76 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 175.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -67.31 -41.21 85.73 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 175.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -70.85 -32.91 70.07 Favored 'General case' 0 C--O 1.227 -0.108 0 C-N-CA 121.16 -0.216 . . . . 0.0 110.841 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.07 -36.88 80.56 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 175.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.43 -36.99 85.58 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 71.5 mt -68.16 -52.67 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 175.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -55.12 -29.75 58.33 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 54.1 t-105 -96.64 -55.14 3.0 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 354' ' ' PHE . . . . . 0.413 ' CD1' ' CE1' ' B' ' 304' ' ' TYR . 51.0 m-85 -76.16 -27.21 56.89 Favored 'General case' 0 CA--C 1.522 -0.119 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 -173.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -49.19 109.68 0.29 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 117.98 0.355 . . . . 0.0 111.932 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 96.79 0.45 60.47 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 119.477 -0.624 . . . . 0.0 112.736 174.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -83.62 -164.6 0.94 Allowed 'General case' 0 C--N 1.339 0.111 0 CA-C-N 118.209 1.004 . . . . 0.0 110.186 176.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -128.97 152.12 48.93 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 120.981 0.42 . . . . 0.0 110.83 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -144.25 136.45 26.45 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.186 0.994 . . . . 0.0 112.451 177.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 20.7 t 54.36 19.0 2.08 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.517 0.327 . . . . 0.0 111.125 -175.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.48 23.78 38.67 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 112.004 -0.438 . . . . 0.0 112.004 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -132.8 142.62 45.4 Favored Pre-proline 0 N--CA 1.455 -0.213 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -177.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.8 136.61 33.32 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 122.751 2.3 . . . . 0.0 109.441 178.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 33.6 pt -123.69 169.95 14.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 CA-C-O 121.203 0.525 . . . . 0.0 111.259 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -143.33 113.79 7.43 Favored 'General case' 0 C--O 1.23 0.043 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.765 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 12.2 t -105.39 147.55 10.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.002 0.521 . . . . 0.0 112.2 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 23.0 t -163.68 172.94 13.53 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -71.76 129.58 39.01 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 175.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.464 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.878 -178.498 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 12.2 p30 . . . . . 0 CA--C 1.531 0.226 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 26.4 m -107.39 145.11 33.34 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.044 0.45 . . . . 0.0 111.84 -173.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 30.4 pt -122.06 146.69 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.028 175.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -98.63 143.18 29.3 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 173.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 18.4 t -128.41 142.93 42.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 O-C-N 123.312 0.382 . . . . 0.0 111.177 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -131.69 150.33 52.19 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 176.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.86 12.72 65.84 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-O 119.669 -0.517 . . . . 0.0 112.397 169.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 65.7 mt -55.24 -51.46 66.52 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 117.598 0.699 . . . . 0.0 110.571 -175.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 146.74 176.25 20.37 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -101.54 1.26 37.79 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.607 0.363 . . . . 0.0 111.81 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -128.7 12.12 6.28 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.6 m -74.41 162.93 4.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -172.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 30.5 p -132.12 159.72 38.1 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 123.724 0.81 . . . . 0.0 111.268 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 298' ' ' ILE . . . . . 0.577 HG23 ' HB ' ' B' ' 322' ' ' ILE . 37.7 mt -61.85 -43.6 97.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.169 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -63.53 -35.63 81.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 122.527 0.331 . . . . 0.0 111.472 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 75.0 m -71.73 -44.56 63.91 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-N 118.06 0.391 . . . . 0.0 110.349 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 74.9 t -63.03 -40.68 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -65.18 -36.26 83.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 303' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -70.61 -26.65 63.59 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -85.05 -25.52 27.58 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -96.44 -24.8 15.94 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 306' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -66.43 -18.9 65.62 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 122.396 -0.19 . . . . 0.0 111.467 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -71.84 -19.78 61.92 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 111.682 0.252 . . . . 0.0 111.682 -178.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.8 mm -88.15 -45.48 15.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.086 0 CA-C-N 117.632 0.196 . . . . 0.0 110.561 175.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -164.4 168.66 38.86 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 87.8 mt -69.02 122.14 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 121.021 0.439 . . . . 0.0 110.305 -175.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 92.0 mt -75.66 138.46 20.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 172.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 312' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' B' ' 312' ' ' LYS . 36.2 ttmt . . . . . 0 N--CA 1.454 -0.242 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 N--CA 1.449 -1.121 0 N-CA-C 110.074 -0.779 . . . . 0.0 110.074 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 321' ' ' MET . . . . . . . . . . . . . 39.0 mtt -70.97 92.86 0.95 Allowed 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.023 0.439 . . . . 0.0 111.53 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 322' ' ' ILE . . . . . 0.577 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.9 mp -140.4 141.56 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 172.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -127.06 132.55 50.66 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 170.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 73.4 mt -107.64 135.12 49.61 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 177.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -102.7 146.25 28.49 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.455 -0.198 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -174.692 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt . . . . . 0 N--CA 1.464 0.227 0 CA-C-O 120.311 0.101 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.41 3.04 76.41 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -174.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -102.84 149.32 24.62 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 117.288 0.544 . . . . 0.0 109.682 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -160.16 167.45 27.66 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.793 0.33 . . . . 0.0 111.473 -176.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 2.7 p -120.25 151.6 38.93 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 169.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 32.4 t -136.73 129.5 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 123.668 0.787 . . . . 0.0 108.927 171.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 47.3 t -109.19 140.45 42.78 Favored 'General case' 0 CA--C 1.523 -0.091 0 CA-C-N 117.795 0.27 . . . . 0.0 111.311 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -105.91 158.88 16.45 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -70.93 -33.78 70.85 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -128.4 147.45 63.88 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 344' ' ' PRO . . . . . 0.475 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 42.6 Cg_endo -70.69 -31.85 15.68 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 123.223 2.616 . . . . 0.0 114.549 -176.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 345' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 89.7 Cg_endo -73.62 -21.17 19.52 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 CA-C-N 121.059 1.414 . . . . 0.0 110.431 -177.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 69.8 m -70.98 -36.85 72.68 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 175.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -69.27 -36.78 77.44 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 175.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -64.62 -43.37 93.95 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -69.22 -33.43 73.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 110.624 -0.139 . . . . 0.0 110.624 177.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.38 -37.13 86.44 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 63.3 mt -69.69 -52.84 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -55.57 -27.32 48.5 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -97.56 -56.62 2.46 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -75.58 -29.5 59.34 Favored 'General case' 0 C--N 1.337 0.052 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -173.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -53.08 107.71 0.26 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.944 0.338 . . . . 0.0 111.412 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 101.58 -0.98 52.93 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 119.533 -0.593 . . . . 0.0 112.737 176.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -84.75 -164.39 0.97 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-N 117.989 0.895 . . . . 0.0 110.154 176.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -128.91 152.38 48.62 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.825 0.345 . . . . 0.0 111.004 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -143.77 137.07 27.8 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.12 0.968 . . . . 0.0 112.398 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 59.7 m 53.14 18.87 1.28 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -174.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 89.21 21.47 41.52 Favored Glycine 0 C--N 1.338 0.676 0 CA-C-O 119.821 -0.433 . . . . 0.0 112.158 179.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -132.19 143.06 47.35 Favored Pre-proline 0 N--CA 1.457 -0.118 0 CA-C-N 117.501 0.65 . . . . 0.0 109.295 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.57 135.85 31.97 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.987 2.458 . . . . 0.0 109.651 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 25.8 pt -124.11 170.77 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-O 121.112 0.482 . . . . 0.0 110.946 -178.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -145.18 118.13 8.79 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.118 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 12.7 t -106.78 150.32 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 123.165 0.586 . . . . 0.0 111.729 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 27.0 t -163.79 172.5 14.03 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 175.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -70.04 130.64 42.69 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 176.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.484 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.359 177.918 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 8.9 p30 . . . . . 0 CA--C 1.53 0.198 0 CA-C-O 119.933 -0.08 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 84.8 m -103.87 142.4 34.46 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.105 0.479 . . . . 0.0 110.558 -174.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 44.5 pt -114.93 146.75 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -98.85 144.44 28.05 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 173.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 289' ' ' VAL . . . . . 0.552 ' CG1' HD13 ' B' ' 292' ' ' LEU . 60.7 t -129.28 136.16 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 O-C-N 123.411 0.445 . . . . 0.0 110.57 -178.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -126.64 155.16 43.01 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 176.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 83.32 12.71 78.2 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 172.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 292' ' ' LEU . . . . . 0.552 HD13 ' CG1' ' B' ' 289' ' ' VAL . 4.2 tp -59.27 -50.82 72.54 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.98 0.912 . . . . 0.0 110.996 -170.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 143.64 165.04 10.63 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.311 -0.715 . . . . 0.0 111.311 176.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -95.81 3.93 53.31 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.532 0.333 . . . . 0.0 111.34 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -128.71 12.73 6.35 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.764 0.426 . . . . 0.0 111.84 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 4.2 m -72.63 166.75 2.45 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -173.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 32.5 p -137.82 160.76 38.39 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 124.072 0.949 . . . . 0.0 110.835 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 298' ' ' ILE . . . . . 0.502 HG23 ' HB ' ' B' ' 322' ' ' ILE . 41.7 mt -63.08 -40.74 90.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -66.36 -38.07 86.75 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 80.6 p -73.25 -44.17 59.89 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 117.945 0.339 . . . . 0.0 110.237 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 71.0 t -60.76 -42.87 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -65.24 -34.82 79.27 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 122.224 -0.297 . . . . 0.0 110.293 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 303' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -69.83 -28.09 65.41 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -84.17 -25.83 29.27 Favored 'General case' 0 C--O 1.226 -0.157 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -96.16 -23.71 16.61 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 306' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -68.19 -18.06 64.49 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -177.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -72.45 -19.17 61.61 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -178.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 3.6 mm -87.89 -47.81 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 CA-C-N 117.564 0.165 . . . . 0.0 110.746 175.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -161.61 173.82 38.04 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 76.1 mt -71.89 116.35 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 120.861 0.363 . . . . 0.0 110.099 -175.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 76.1 mt -71.59 137.93 22.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 172.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 312' ' ' LYS . . . . . 0.448 ' HG2' ' SD ' ' B' ' 321' ' ' MET . 40.9 ttmt . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo . . . . . 0 N--CA 1.447 -1.256 0 N-CA-C 109.178 -1.124 . . . . 0.0 109.178 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 321' ' ' MET . . . . . 0.488 ' C ' HD12 ' B' ' 322' ' ' ILE . 62.3 mtp -82.43 85.88 6.84 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.37 0.605 . . . . 0.0 111.558 -172.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 322' ' ' ILE . . . . . 0.502 ' HB ' HG23 ' B' ' 298' ' ' ILE . 2.7 mp -126.46 147.83 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 174.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -134.25 111.88 10.61 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 173.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 30.6 mt -80.76 149.76 29.52 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 123.93 0.769 . . . . 0.0 108.936 176.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -115.48 145.79 42.27 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 6.8 m . . . . . 0 N--CA 1.453 -0.277 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -175.378 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? . . . . . 0 N--CA 1.465 0.298 0 N-CA-C 111.329 0.122 . . . . 0.0 111.329 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.62 22.16 73.16 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -173.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -128.36 146.62 50.72 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.073 0.549 . . . . 0.0 110.18 -178.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -156.04 159.44 39.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.727 0.298 . . . . 0.0 111.587 174.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 3.4 p -104.1 155.81 18.39 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 170.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 16.7 t -138.12 122.48 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.042 0 C-N-CA 123.432 0.693 . . . . 0.0 110.312 172.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 69.2 m -90.78 144.21 25.95 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 117.961 0.346 . . . . 0.0 110.967 177.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 341' ' ' PHE . . . . . 0.403 ' O ' ' HE3' ' B' ' 312' ' ' LYS . 26.3 m-85 -112.89 151.2 30.75 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 177.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -69.92 -28.91 65.99 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -177.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -132.71 148.51 69.8 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -178.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 344' ' ' PRO . . . . . 0.474 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 37.9 Cg_endo -70.42 -33.14 14.59 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.357 2.705 . . . . 0.0 114.205 -177.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 345' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 85.8 Cg_endo -73.54 -20.96 19.98 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 CA-C-N 121.225 1.473 . . . . 0.0 110.252 -177.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 70.3 m -72.05 -37.14 69.75 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -68.26 -38.37 81.71 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 175.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -65.06 -42.43 94.19 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -69.16 -34.71 75.39 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.399 -0.188 . . . . 0.0 110.956 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.17 -37.67 88.28 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 66.0 mt -68.56 -53.62 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.775 175.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -55.01 -27.73 46.53 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 54.8 t-105 -97.52 -55.35 2.85 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -76.26 -28.21 57.01 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -173.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -51.92 109.52 0.38 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 120.959 0.409 . . . . 0.0 111.555 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 101.29 -1.18 54.01 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 119.515 -0.603 . . . . 0.0 112.278 175.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -86.43 -165.64 1.32 Allowed 'General case' 0 C--O 1.231 0.084 0 CA-C-N 118.277 1.039 . . . . 0.0 110.698 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -127.28 155.59 43.26 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 121.061 0.458 . . . . 0.0 111.089 178.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -145.88 135.82 23.55 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.515 1.126 . . . . 0.0 112.196 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 20.8 t 54.11 18.77 1.85 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 120.873 0.368 . . . . 0.0 111.647 -176.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.67 24.17 33.9 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 112.031 -0.427 . . . . 0.0 112.031 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 53.1 m-20 -133.91 142.61 44.13 Favored Pre-proline 0 N--CA 1.454 -0.265 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -69.6 136.53 33.67 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 122.808 2.338 . . . . 0.0 109.308 176.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 31.2 pt -124.25 169.2 15.89 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 121.001 0.429 . . . . 0.0 110.96 -177.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -142.92 113.69 7.54 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.52 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 12.0 t -103.06 148.03 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 C-N-CA 123.144 0.577 . . . . 0.0 111.727 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 22.7 t -162.6 173.54 13.81 Favored 'General case' 0 C--N 1.338 0.099 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 177.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -70.64 128.31 35.65 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 176.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.367 0 CA-C-O 121.125 0.488 . . . . 0.0 112.008 -178.771 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 14.0 p30 . . . . . 0 CA--C 1.53 0.201 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 87.6 m -109.76 141.67 42.07 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.265 0.555 . . . . 0.0 110.831 -175.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 41.1 pt -118.6 148.92 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-N 115.492 -0.776 . . . . 0.0 108.954 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -98.58 146.95 25.29 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 173.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 15.0 t -131.98 141.37 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-O 120.839 0.352 . . . . 0.0 111.259 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -129.47 150.73 50.69 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 176.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.86 12.5 66.19 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 119.793 -0.448 . . . . 0.0 112.76 169.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 73.3 mt -56.06 -51.61 67.23 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 117.62 0.71 . . . . 0.0 110.748 -175.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 148.51 175.89 21.46 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -101.43 -0.93 34.42 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 122.555 -0.379 . . . . 0.0 111.69 -176.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -128.71 11.29 6.16 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.075 0.55 . . . . 0.0 112.402 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.0 m -73.06 163.94 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -172.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 26.7 p -130.24 158.76 38.87 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 123.661 0.784 . . . . 0.0 111.773 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 298' ' ' ILE . . . . . 0.564 HG23 ' HB ' ' B' ' 322' ' ' ILE . 36.9 mt -60.2 -44.65 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.242 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -62.53 -36.2 81.83 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.711 0.404 . . . . 0.0 111.416 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 72.6 m -71.8 -43.79 65.07 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.991 0.359 . . . . 0.0 110.183 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 71.4 t -62.47 -41.41 91.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.95 -36.32 84.0 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 303' ' ' ASP . . . . . 0.4 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 44.9 t0 -69.91 -27.97 65.23 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -85.33 -25.38 27.18 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -96.28 -23.86 16.48 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 178.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 306' ' ' LYS . . . . . 0.4 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.6 ptpt -66.93 -18.69 65.5 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 -177.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -72.3 -20.41 61.51 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 117.731 0.241 . . . . 0.0 111.612 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.8 mm -87.27 -45.73 16.22 Favored 'Isoleucine or valine' 0 C--N 1.338 0.089 0 CA-C-N 117.677 0.217 . . . . 0.0 110.535 175.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.23 167.38 37.5 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 83.9 mt -68.5 121.79 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 120.834 0.349 . . . . 0.0 110.539 -175.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 89.1 mt -74.37 138.11 21.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 173.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 312' ' ' LYS . . . . . 0.656 ' HE3' ' SD ' ' B' ' 321' ' ' MET . 25.4 ttpt . . . . . 0 N--CA 1.45 -0.43 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -178.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo . . . . . 0 N--CA 1.45 -1.081 0 N-CA-C 109.921 -0.838 . . . . 0.0 109.921 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 321' ' ' MET . . . . . 0.656 ' SD ' ' HE3' ' B' ' 312' ' ' LYS . 33.9 mtt -72.61 92.51 1.52 Allowed 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 120.952 0.406 . . . . 0.0 111.656 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 322' ' ' ILE . . . . . 0.564 ' HB ' HG23 ' B' ' 298' ' ' ILE . 4.2 mp -139.73 138.51 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 171.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -131.36 105.93 7.94 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 176.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -75.39 153.58 37.64 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.812 0.845 . . . . 0.0 109.102 177.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -115.67 148.0 40.2 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.455 -0.199 0 C-N-CA 123.666 0.787 . . . . 0.0 112.82 -175.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt . . . . . 0 CA--C 1.527 0.085 0 N-CA-C 110.76 -0.089 . . . . 0.0 110.76 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 77.81 6.37 87.06 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -174.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -102.76 152.5 21.17 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.034 0.534 . . . . 0.0 110.162 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -164.66 161.38 20.79 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 116.698 -0.228 . . . . 0.0 110.966 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 5.3 p -109.04 155.06 21.37 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 169.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 33.7 t -137.64 128.39 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.043 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 171.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 340' ' ' SER . . . . . 0.411 ' HB3' ' SD ' ' B' ' 321' ' ' MET . 8.2 t -104.0 146.92 28.0 Favored 'General case' 0 C--O 1.228 -0.064 0 CA-C-N 117.975 0.352 . . . . 0.0 110.689 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -112.71 158.46 20.03 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -77.17 -17.3 58.66 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -143.66 146.83 36.72 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 344' ' ' PRO . . . . . 0.479 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 41.0 Cg_endo -70.61 -31.87 16.03 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.329 2.686 . . . . 0.0 114.587 -177.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 345' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 80.8 Cg_endo -73.9 -22.5 17.35 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 CA-C-N 121.117 1.435 . . . . 0.0 110.123 -177.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 66.1 m -72.25 -35.1 68.71 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 175.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -68.76 -39.95 80.01 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 175.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -64.81 -42.09 95.27 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.11 -34.89 77.22 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 122.237 -0.289 . . . . 0.0 110.687 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.05 -36.13 83.37 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 67.3 mt -70.92 -50.78 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 C-N-CA 120.626 -0.43 . . . . 0.0 109.873 175.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -54.49 -30.14 52.41 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 55.8 t-105 -97.8 -56.74 2.41 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -177.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -75.83 -29.84 58.77 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -172.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -56.29 110.09 0.71 Allowed 'General case' 0 C--O 1.234 0.247 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.793 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 103.01 -2.83 47.92 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-O 119.647 -0.529 . . . . 0.0 112.234 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -84.44 -163.17 0.76 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 118.092 0.946 . . . . 0.0 110.364 176.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -129.75 152.91 48.73 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.056 0.455 . . . . 0.0 111.239 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -145.49 136.54 24.73 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.135 0.974 . . . . 0.0 112.352 178.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 12.5 t 55.19 17.69 2.11 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.888 0.375 . . . . 0.0 111.077 -174.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.23 22.56 40.77 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.995 -0.442 . . . . 0.0 111.995 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -132.15 142.73 46.1 Favored Pre-proline 0 N--CA 1.454 -0.257 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.48 135.73 31.87 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 123.059 2.506 . . . . 0.0 109.707 178.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 30.1 pt -122.93 170.4 13.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-O 121.025 0.441 . . . . 0.0 111.101 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 5.7 tmtm? -145.66 113.6 6.48 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 9.7 t -103.25 150.27 6.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.21 0.604 . . . . 0.0 112.444 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 28.5 t -162.94 176.11 10.5 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 177.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -74.66 133.52 42.11 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 175.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.353 0 C-N-CA 123.027 0.531 . . . . 0.0 111.94 179.887 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 11.5 p30 . . . . . 0 N--CA 1.454 -0.251 0 N-CA-C 111.466 0.172 . . . . 0.0 111.466 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 31.3 m -109.62 145.37 36.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.074 0.464 . . . . 0.0 111.854 -176.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 34.2 pt -122.09 147.51 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.433 176.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -98.7 143.88 28.58 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 173.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 289' ' ' VAL . . . . . 0.581 HG11 HD13 ' B' ' 292' ' ' LEU . 59.7 t -129.17 132.33 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 122.646 0.379 . . . . 0.0 110.57 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -120.78 155.45 33.98 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 175.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 83.82 12.01 78.19 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 171.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 292' ' ' LEU . . . . . 0.581 HD13 HG11 ' B' ' 289' ' ' VAL . 4.4 tp -59.09 -51.39 70.25 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.581 0.752 . . . . 0.0 110.946 -171.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 144.8 164.45 10.6 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.449 -0.661 . . . . 0.0 111.449 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -93.45 -1.11 56.1 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.578 0.351 . . . . 0.0 111.36 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -128.86 13.12 6.31 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 5.1 m -68.77 162.67 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -174.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 20.2 p -130.53 158.42 40.0 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.429 175.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 298' ' ' ILE . . . . . 0.552 HG23 ' HB ' ' B' ' 322' ' ' ILE . 25.0 mt -60.26 -43.21 92.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.31 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -70.68 -30.2 66.73 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -177.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 72.0 m -72.98 -45.36 58.4 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 118.298 0.499 . . . . 0.0 109.943 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 74.3 t -62.03 -41.31 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 176.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.3 -36.78 85.23 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 303' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -70.58 -27.63 64.26 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -83.86 -26.52 29.39 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -178.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -96.55 -24.95 15.81 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 115.073 1.509 . . . . 0.0 115.073 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 306' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -66.75 -18.38 65.35 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -176.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -71.85 -19.97 61.88 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 111.486 0.18 . . . . 0.0 111.486 -178.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 5.3 mm -87.49 -45.9 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 175.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.9 167.88 38.17 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 178.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 87.9 mt -67.72 123.66 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 122.674 0.389 . . . . 0.0 110.581 -176.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 86.7 mt -77.36 137.29 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 173.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt . . . . . 0 N--CA 1.45 -0.454 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -178.671 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo . . . . . 0 N--CA 1.448 -1.176 0 N-CA-C 109.353 -1.057 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 321' ' ' MET . . . . . 0.465 ' C ' HD12 ' B' ' 322' ' ' ILE . 34.9 mtt -70.97 85.74 0.7 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.84 0.353 . . . . 0.0 111.39 -177.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 322' ' ' ILE . . . . . 0.552 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.1 mp -129.84 137.04 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 170.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -130.45 107.23 9.08 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.839 176.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 23.7 mt -78.13 151.52 33.27 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 123.947 0.78 . . . . 0.0 109.249 176.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -115.9 151.02 36.15 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.52 -0.211 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -174.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.313 0.102 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.95 20.64 75.7 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.154 -1.179 . . . . 0.0 110.154 -174.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -129.94 144.48 51.34 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.177 0.591 . . . . 0.0 110.181 -176.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -156.39 160.26 39.49 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.858 174.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 1.2 p -102.0 155.95 17.84 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 170.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 19.0 t -134.75 129.5 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 123.85 0.86 . . . . 0.0 108.989 169.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 340' ' ' SER . . . . . 0.424 ' HB3' ' CB ' ' B' ' 321' ' ' MET . 45.5 t -109.47 140.75 42.84 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.942 0.401 . . . . 0.0 110.957 -178.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -106.08 158.02 17.11 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -73.62 -20.43 60.59 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -140.81 148.03 50.92 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 123.514 0.726 . . . . 0.0 109.12 -178.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 344' ' ' PRO . . . . . 0.463 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 40.4 Cg_endo -70.46 -33.32 14.14 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.43 2.753 . . . . 0.0 114.245 -176.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 345' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 83.6 Cg_endo -73.82 -22.47 17.58 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 CA-C-N 121.074 1.419 . . . . 0.0 110.057 -176.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 67.1 m -71.66 -36.47 70.67 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 176.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -69.08 -38.21 78.87 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -65.8 -41.75 91.53 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -69.47 -33.61 73.15 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 110.629 -0.138 . . . . 0.0 110.629 177.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.83 -37.19 86.79 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 68.5 mt -68.1 -53.62 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.673 174.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -54.87 -28.48 50.47 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -178.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 53.6 t-105 -96.67 -54.66 3.15 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -77.73 -27.89 50.66 Favored 'General case' 0 CA--C 1.522 -0.119 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -174.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -52.28 109.3 0.37 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.889 0.313 . . . . 0.0 111.194 178.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 100.29 -1.25 56.02 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-O 119.695 -0.503 . . . . 0.0 112.548 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -84.85 -164.42 0.98 Allowed 'General case' 0 C--O 1.228 -0.065 0 CA-C-N 117.939 0.869 . . . . 0.0 110.434 176.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -128.46 152.69 47.94 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.919 0.39 . . . . 0.0 110.739 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -142.2 134.71 28.06 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.271 1.028 . . . . 0.0 112.252 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 64.5 m 52.77 20.84 1.71 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.79 0.436 . . . . 0.0 111.975 -175.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.93 21.73 41.49 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 112.036 -0.426 . . . . 0.0 112.036 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -131.67 141.45 41.68 Favored Pre-proline 0 N--CA 1.456 -0.126 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.12 136.43 34.68 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.84 2.36 . . . . 0.0 109.464 177.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 32.4 pt -124.34 168.91 16.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-O 121.222 0.534 . . . . 0.0 110.789 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 22.9 tptp -142.89 112.3 6.74 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.035 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 8.6 t -101.96 148.55 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 29.3 t -162.38 175.27 11.72 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 177.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -72.19 130.97 42.1 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 176.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.318 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.082 -178.555 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 12.9 p30 . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 111.222 0.082 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 89.5 m -101.06 137.99 38.7 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.978 0.418 . . . . 0.0 109.909 -174.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 45.9 pt -105.91 148.28 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 172.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -99.94 142.98 30.7 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 171.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 14.6 t -133.77 141.51 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -128.92 154.6 46.39 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 122.873 0.469 . . . . 0.0 109.738 173.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.7 12.35 66.8 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-O 119.932 -0.371 . . . . 0.0 112.497 169.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 85.0 mt -57.14 -51.05 70.87 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 117.677 0.739 . . . . 0.0 110.202 -176.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 143.38 169.6 12.67 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -95.94 3.93 53.14 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 122.621 -0.341 . . . . 0.0 111.585 -178.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -128.86 11.55 6.12 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.8 m -76.03 165.48 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -173.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 29.9 p -130.99 157.74 42.16 Favored 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 123.615 0.766 . . . . 0.0 111.623 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 298' ' ' ILE . . . . . 0.484 HG23 ' HB ' ' B' ' 322' ' ' ILE . 34.4 mt -62.06 -42.34 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.154 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.45 -36.41 84.09 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.401 0.28 . . . . 0.0 111.737 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 43.6 t -72.44 -44.04 62.93 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 117.668 0.213 . . . . 0.0 110.48 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 76.9 t -61.61 -41.95 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.67 -35.25 80.44 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 303' ' ' ASP . . . . . 0.415 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.4 t0 -70.68 -29.07 65.29 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 304' ' ' TYR . . . . . 0.4 ' CE2' ' CD1' ' B' ' 354' ' ' PHE . 63.2 t80 -82.61 -25.77 32.88 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -96.88 -24.23 15.97 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 306' ' ' LYS . . . . . 0.415 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.6 ptpt -66.86 -18.77 65.54 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -177.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -71.9 -19.46 61.92 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.5 mm -88.05 -46.73 15.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 120.419 0.152 . . . . 0.0 110.651 175.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -161.73 169.17 37.11 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 90.2 mt -69.18 122.36 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 120.767 0.318 . . . . 0.0 110.261 -175.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 67.7 mt -77.63 137.26 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 175.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm . . . . . 0 N--CA 1.455 -0.209 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -179.339 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo . . . . . 0 N--CA 1.445 -1.355 0 N-CA-C 108.639 -1.331 . . . . 0.0 108.639 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 321' ' ' MET . . . . . 0.42 ' C ' HD12 ' B' ' 322' ' ' ILE . 88.0 mtp -78.02 85.91 4.22 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.452 0.644 . . . . 0.0 111.796 -170.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 322' ' ' ILE . . . . . 0.484 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.1 mp -124.71 143.28 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 174.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -129.66 99.03 5.0 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 48.8 mt -75.56 154.24 36.91 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 176.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -117.54 148.41 41.9 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 175.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 7.6 m . . . . . 0 N--CA 1.454 -0.244 0 C-N-CA 123.113 0.565 . . . . 0.0 111.986 -179.262 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt . . . . . 0 N--CA 1.461 0.115 0 CA-C-O 120.249 0.071 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.17 5.78 81.75 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -175.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -105.76 150.32 25.64 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 117.27 0.535 . . . . 0.0 109.884 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -163.98 163.21 23.53 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.112 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 60.5 p -111.76 155.67 23.15 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 169.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 16.4 t -135.8 120.53 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 O-C-N 123.415 0.447 . . . . 0.0 110.542 173.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 14.8 t -88.42 134.81 33.74 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -103.04 152.54 21.24 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 176.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -65.8 -33.66 76.37 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -178.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -130.36 150.86 77.4 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 344' ' ' PRO . . . . . 0.468 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 40.5 Cg_endo -70.42 -31.99 16.62 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.604 2.869 . . . . 0.0 114.425 -177.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 345' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 76.9 Cg_endo -73.75 -21.08 19.32 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 CA-C-N 121.078 1.421 . . . . 0.0 110.028 -176.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 66.9 m -72.6 -36.09 68.04 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 175.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -67.64 -38.57 84.03 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 174.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -65.19 -42.18 93.86 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.58 -35.55 77.51 Favored 'General case' 0 N--CA 1.458 -0.035 0 O-C-N 122.446 -0.159 . . . . 0.0 110.574 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -63.75 -37.68 88.26 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 63.1 mt -68.74 -51.62 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 120.379 -0.529 . . . . 0.0 109.634 175.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -55.92 -28.32 56.27 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 53.3 t-105 -97.16 -54.77 3.06 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 354' ' ' PHE . . . . . 0.4 ' CD1' ' CE2' ' B' ' 304' ' ' TYR . 51.7 m-85 -76.95 -27.77 54.95 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -173.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -50.38 109.23 0.28 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 117.993 0.361 . . . . 0.0 111.858 178.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 98.8 -0.43 57.81 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 119.537 -0.591 . . . . 0.0 112.654 175.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -83.55 -164.87 0.97 Allowed 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.136 0.968 . . . . 0.0 110.073 176.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -128.19 152.91 47.49 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 121.084 0.469 . . . . 0.0 110.727 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -144.9 136.27 25.22 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.331 1.053 . . . . 0.0 112.585 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 17.4 t 55.24 17.94 2.26 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 120.794 0.331 . . . . 0.0 110.951 -175.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.89 22.85 40.72 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 112.013 -0.435 . . . . 0.0 112.013 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 41.9 m-20 -132.31 142.6 45.58 Favored Pre-proline 0 C--O 1.226 -0.165 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 -177.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.48 135.73 31.88 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.855 2.37 . . . . 0.0 109.54 178.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 31.9 pt -121.34 170.79 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.101 0 CA-C-O 121.265 0.555 . . . . 0.0 111.207 -177.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -143.18 109.42 5.32 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.747 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 11.3 t -99.45 148.89 5.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 C-N-CA 123.164 0.586 . . . . 0.0 111.952 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 84.7 p -163.47 177.14 9.1 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -76.83 129.4 36.19 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 174.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.413 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.403 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 . . . . . 0 CA--C 1.53 0.201 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 95.4 m -113.22 145.52 40.87 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.318 0.58 . . . . 0.0 110.708 -175.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 33.7 pt -119.85 148.77 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.436 -0.802 . . . . 0.0 108.846 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -101.65 143.87 31.07 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 173.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 12.1 t -127.25 139.87 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 CA-C-O 120.963 0.411 . . . . 0.0 111.302 177.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -125.58 154.1 42.73 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.601 0.76 . . . . 0.0 108.968 177.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 83.3 12.96 77.79 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 173.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 1.5 tp -52.69 -55.08 25.17 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.583 0.753 . . . . 0.0 110.707 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 142.11 172.24 13.48 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -101.45 2.6 39.48 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -128.7 16.77 6.38 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.814 0.446 . . . . 0.0 111.285 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 10.3 m -74.47 166.85 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -173.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 43.1 p -138.23 159.52 41.84 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.729 0.811 . . . . 0.0 110.762 177.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 298' ' ' ILE . . . . . 0.549 HG23 ' HB ' ' B' ' 322' ' ' ILE . 45.3 mt -62.65 -44.13 99.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.16 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -64.39 -35.52 81.18 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.443 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 44.8 t -71.56 -49.97 35.51 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 118.036 0.38 . . . . 0.0 110.741 -177.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 7.5 p -65.44 -33.44 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.681 177.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -65.97 -32.62 74.22 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.579 176.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 303' ' ' ASP . . . . . 0.41 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 44.9 t0 -75.39 -27.25 59.01 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -178.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -85.26 -23.88 28.01 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -96.93 -24.18 15.96 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 178.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 306' ' ' LYS . . . . . 0.41 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.7 ptpt -66.4 -17.7 64.93 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -177.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -72.45 -20.73 61.35 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.6 mm -86.37 -45.94 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 CA-C-N 117.873 0.306 . . . . 0.0 110.226 175.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -162.4 167.0 36.78 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 79.2 mt -69.19 120.42 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 120.725 0.298 . . . . 0.0 110.683 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 88.6 mt -73.97 134.85 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 172.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm . . . . . 0 N--CA 1.451 -0.421 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.028 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo . . . . . 0 N--CA 1.45 -1.047 0 N-CA-C 110.054 -0.787 . . . . 0.0 110.054 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 321' ' ' MET . . . . . . . . . . . . . 37.4 mtt -72.04 94.15 1.47 Allowed 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 120.951 0.405 . . . . 0.0 111.793 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 322' ' ' ILE . . . . . 0.549 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.5 mp -141.61 142.27 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 173.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -132.3 108.83 9.47 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 173.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 38.0 mt -77.64 153.2 33.38 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 175.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -120.86 143.3 48.98 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 175.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.52 -0.179 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -174.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt . . . . . 0 N--CA 1.461 0.11 0 N-CA-C 110.568 -0.16 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 74.82 22.23 77.29 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 -174.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -133.06 146.55 51.79 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 117.236 0.518 . . . . 0.0 110.511 -178.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -157.76 155.71 30.33 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.133 174.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 10.9 p -95.7 152.6 18.32 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 170.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 40.9 t -135.63 129.96 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 170.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 9.0 t -110.47 143.38 40.88 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-N 117.888 0.313 . . . . 0.0 111.029 -177.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -108.4 160.23 16.04 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -176.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -72.42 -28.57 63.05 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -135.54 150.11 71.25 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -177.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 344' ' ' PRO . . . . . 0.47 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 39.5 Cg_endo -69.69 -32.71 18.34 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.457 2.772 . . . . 0.0 114.487 -177.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 345' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 96.1 Cg_endo -73.74 -20.88 19.55 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 CA-C-N 121.381 1.529 . . . . 0.0 110.324 -177.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 66.3 m -73.11 -37.48 66.67 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 175.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.13 -38.47 88.25 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 173.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -63.19 -46.09 88.69 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -66.74 -34.09 77.08 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 110.584 -0.154 . . . . 0.0 110.584 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.44 -35.96 82.49 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 64.8 mt -70.71 -51.71 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 175.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -55.17 -28.76 55.19 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 57.5 t-105 -98.04 -55.9 2.65 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -76.16 -30.66 58.2 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -173.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -55.21 110.73 0.72 Allowed 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 118.289 0.495 . . . . 0.0 110.777 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 103.56 -4.42 47.07 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.516 -0.602 . . . . 0.0 112.308 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -84.22 -163.76 0.84 Allowed 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 118.077 0.938 . . . . 0.0 110.165 176.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -127.82 150.67 49.73 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-O 120.95 0.405 . . . . 0.0 110.853 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -141.67 137.35 31.71 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.345 1.058 . . . . 0.0 112.487 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 20.5 t 53.91 18.96 1.78 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.563 0.345 . . . . 0.0 111.183 -175.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.4 21.96 42.56 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 112.056 -0.418 . . . . 0.0 112.056 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 41.0 m-20 -131.91 141.7 42.49 Favored Pre-proline 0 N--CA 1.453 -0.285 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -177.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -68.95 133.5 27.24 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 122.611 2.208 . . . . 0.0 109.403 177.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 29.8 pt -120.47 170.24 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.146 0 CA-C-O 121.336 0.588 . . . . 0.0 111.107 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -144.51 111.24 5.72 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 10.7 t -99.98 149.25 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.305 0.642 . . . . 0.0 111.966 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 23.2 t -162.46 172.72 15.08 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -69.57 128.72 37.46 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 176.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.499 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.905 -179.629 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.454 -0.26 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 91.7 m -105.11 142.24 35.24 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.054 0.454 . . . . 0.0 111.046 -174.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 30.5 pt -115.31 149.46 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -99.87 146.2 26.91 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 173.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 289' ' ' VAL . . . . . 0.562 ' CG1' HD13 ' B' ' 292' ' ' LEU . 60.3 t -131.26 133.75 61.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.532 -178.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -123.65 153.55 40.61 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 83.31 13.11 77.42 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 172.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 292' ' ' LEU . . . . . 0.562 HD13 ' CG1' ' B' ' 289' ' ' VAL . 4.4 tp -59.07 -50.7 73.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 123.763 0.825 . . . . 0.0 111.027 -169.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 143.89 165.65 10.97 Favored Glycine 0 C--N 1.337 0.637 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 177.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -96.82 2.13 51.47 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.347 0.259 . . . . 0.0 111.282 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -128.47 11.86 6.37 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.868 0.467 . . . . 0.0 111.699 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 4.7 m -68.19 162.63 3.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -174.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 29.8 p -134.33 159.72 40.13 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 123.596 0.758 . . . . 0.0 110.697 176.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 298' ' ' ILE . . . . . 0.512 HG23 ' HB ' ' B' ' 322' ' ' ILE . 33.9 mt -61.33 -41.82 91.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.133 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -66.52 -36.05 81.75 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 122.554 0.342 . . . . 0.0 111.709 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 75.5 m -72.24 -46.08 57.51 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 118.175 0.443 . . . . 0.0 110.319 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 69.9 t -60.56 -42.65 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.32 -36.31 83.7 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 122.201 -0.312 . . . . 0.0 110.203 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 303' ' ' ASP . . . . . 0.423 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.1 t0 -69.88 -28.18 65.43 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -84.35 -25.84 28.88 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -96.1 -24.04 16.49 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 306' ' ' LYS . . . . . 0.423 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.6 ptpt -67.42 -18.68 65.2 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -176.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -72.57 -21.14 61.19 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -177.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.2 mm -85.94 -44.96 17.0 Favored 'Isoleucine or valine' 0 C--O 1.23 0.072 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 175.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.87 165.5 37.01 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 85.2 mt -66.04 123.49 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 120.854 0.359 . . . . 0.0 110.26 -177.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 85.8 mt -77.08 135.79 25.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 173.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm . . . . . 0 N--CA 1.451 -0.401 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -178.265 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 N--CA 1.448 -1.151 0 N-CA-C 109.874 -0.856 . . . . 0.0 109.874 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 321' ' ' MET . . . . . 0.47 ' C ' HD12 ' B' ' 322' ' ' ILE . 33.6 mtt -72.51 86.23 1.16 Allowed 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -177.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 322' ' ' ILE . . . . . 0.512 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.2 mp -130.29 138.73 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 170.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -129.8 105.15 7.82 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 174.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 31.2 mt -77.82 153.38 32.83 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 123.952 0.783 . . . . 0.0 109.085 177.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -116.39 147.95 41.14 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.455 -0.207 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -177.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt . . . . . 0 N--CA 1.462 0.141 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 78.02 20.81 72.33 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -175.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -129.94 147.67 51.72 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 122.948 0.499 . . . . 0.0 110.252 -178.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -156.38 162.04 40.08 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 120.759 0.314 . . . . 0.0 110.799 174.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 19.1 p -104.79 154.4 20.07 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 169.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 17.3 t -135.47 132.11 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 123.454 0.702 . . . . 0.0 109.345 171.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 340' ' ' SER . . . . . 0.431 ' HB3' ' CB ' ' B' ' 321' ' ' MET . 46.2 t -110.82 136.46 49.84 Favored 'General case' 0 C--O 1.227 -0.109 0 CA-C-N 118.002 0.365 . . . . 0.0 111.101 -178.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -100.5 159.55 15.06 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -178.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -71.91 -30.95 65.9 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -130.04 148.99 71.9 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 344' ' ' PRO . . . . . 0.462 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 38.0 Cg_endo -69.96 -33.56 15.61 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.361 2.708 . . . . 0.0 114.636 -177.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 345' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 87.5 Cg_endo -73.5 -23.04 17.69 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 CA-C-N 121.083 1.423 . . . . 0.0 110.016 -177.268 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 58.8 m -71.95 -34.83 69.31 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 175.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.85 -41.07 87.96 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 175.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 40.2 tptt -69.53 -36.14 76.11 Favored 'General case' 0 C--N 1.339 0.121 0 O-C-N 122.176 -0.328 . . . . 0.0 110.706 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -65.75 -35.49 80.87 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 175.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -66.26 -37.49 85.59 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 72.2 mt -67.6 -53.62 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.772 175.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -56.85 -27.47 60.32 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -177.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -96.7 -55.15 2.99 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -76.5 -30.93 57.41 Favored 'General case' 0 CA--C 1.522 -0.117 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -173.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -54.53 110.26 0.61 Allowed 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.126 0.421 . . . . 0.0 110.876 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 104.31 -3.96 43.98 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 119.609 -0.551 . . . . 0.0 112.423 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -84.9 -164.32 0.96 Allowed 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 117.814 0.807 . . . . 0.0 110.373 176.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 42.0 mp0 -128.68 152.6 48.2 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.927 0.394 . . . . 0.0 110.858 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -143.91 134.83 25.32 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.195 0.998 . . . . 0.0 112.329 178.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 58.8 m 52.59 20.73 1.59 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -174.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.63 22.2 40.81 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 112.099 -0.4 . . . . 0.0 112.099 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 50.9 m-20 -132.21 141.83 42.82 Favored Pre-proline 0 N--CA 1.456 -0.174 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.62 137.91 36.99 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 122.713 2.275 . . . . 0.0 109.472 177.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 35.3 pt -125.87 168.98 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 CA-C-O 121.035 0.445 . . . . 0.0 110.667 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -144.68 113.35 6.7 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 10.7 t -103.16 150.06 6.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 123.165 0.586 . . . . 0.0 112.097 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 31.8 t -161.4 173.16 15.32 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -74.04 130.81 40.56 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 176.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.467 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.062 -179.712 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 285' ' ' ASN . . . . . 0.467 HD22 ' C ' ' B' ' 285' ' ' ASN . 0.3 OUTLIER . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 85.4 m -106.21 143.58 34.14 Favored 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 122.09 -0.381 . . . . 0.0 110.675 -174.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 40.6 pt -120.16 144.53 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 176.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -96.18 145.36 25.59 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 174.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 19.0 t -130.85 144.79 36.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.156 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -133.47 152.97 51.98 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 175.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.55 11.27 68.98 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-O 119.78 -0.456 . . . . 0.0 112.361 169.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 63.8 mt -57.32 -49.95 74.49 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 117.645 0.723 . . . . 0.0 110.78 -175.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 148.54 172.93 18.91 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 -178.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -97.17 -6.25 35.24 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -175.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -128.64 15.77 6.47 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 4.3 m -67.59 161.38 3.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -174.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 19.4 p -123.88 159.95 28.52 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.441 0.696 . . . . 0.0 112.254 -178.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 298' ' ' ILE . . . . . 0.573 HG23 ' HB ' ' B' ' 322' ' ' ILE . 54.7 mt -63.68 -44.51 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.938 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -64.2 -36.3 83.6 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 122.565 0.346 . . . . 0.0 111.38 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 46.8 t -72.3 -47.04 53.01 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 122.247 -0.283 . . . . 0.0 110.812 -177.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 8.1 p -68.31 -33.98 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.005 178.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -65.22 -32.84 74.72 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 176.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 303' ' ' ASP . . . . . 0.402 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.6 t0 -74.02 -27.4 60.93 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -84.06 -24.69 30.31 Favored 'General case' 0 C--O 1.227 -0.13 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -96.8 -24.59 15.84 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 306' ' ' LYS . . . . . 0.402 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.7 ptpt -66.81 -18.04 65.18 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -177.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -70.9 -20.44 62.5 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 122.276 -0.265 . . . . 0.0 111.649 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.9 mm -87.61 -46.3 16.02 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-N 117.584 0.175 . . . . 0.0 110.644 175.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.71 168.78 38.44 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 85.7 mt -69.57 120.5 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-O 121.014 0.435 . . . . 0.0 110.695 -175.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 88.0 mt -73.01 138.77 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 172.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 312' ' ' LYS . . . . . 0.661 ' HE3' ' SD ' ' B' ' 321' ' ' MET . 28.8 ttpt . . . . . 0 N--CA 1.448 -0.548 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -176.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo . . . . . 0 N--CA 1.451 -1.006 0 N-CA-C 110.145 -0.752 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 321' ' ' MET . . . . . 0.661 ' SD ' ' HE3' ' B' ' 312' ' ' LYS . 36.1 mtt -73.87 98.28 2.96 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 322' ' ' ILE . . . . . 0.573 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.3 mp -144.51 144.8 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 175.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -130.13 133.84 46.92 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 170.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 86.6 mt -106.54 133.8 50.65 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -96.54 151.19 19.83 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -177.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.452 -0.337 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -174.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt . . . . . 0 CA--C 1.527 0.083 0 N-CA-C 110.673 -0.121 . . . . 0.0 110.673 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 79.04 3.4 88.2 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -173.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -99.03 151.39 20.98 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.008 0.523 . . . . 0.0 110.142 178.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -161.65 167.0 25.95 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 120.836 0.351 . . . . 0.0 111.331 -177.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 1.2 p -120.69 149.94 41.72 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 169.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 44.3 t -137.39 124.6 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 173.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 8.5 t -100.87 144.41 29.85 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 118.074 0.397 . . . . 0.0 110.815 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -109.8 158.65 17.93 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -79.09 -14.69 58.99 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -146.63 146.33 26.44 Favored Pre-proline 0 CA--C 1.53 0.204 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 344' ' ' PRO . . . . . 0.464 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 48.2 Cg_endo -70.84 -31.03 16.39 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.051 2.501 . . . . 0.0 114.469 -177.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 345' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 77.1 Cg_endo -74.14 -22.84 16.42 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 CA-C-N 121.29 1.496 . . . . 0.0 110.01 -177.225 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 70.1 m -72.62 -34.3 67.26 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 176.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -69.9 -38.46 76.31 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 175.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -63.96 -42.55 97.25 Favored 'General case' 0 CA--C 1.527 0.094 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.26 -34.76 76.78 Favored 'General case' 0 C--N 1.34 0.17 0 O-C-N 122.287 -0.258 . . . . 0.0 110.506 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.59 -36.46 83.8 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 67.6 mt -69.79 -51.99 35.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.811 174.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -53.94 -29.64 43.25 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 56.2 t-105 -97.69 -56.04 2.63 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -75.64 -27.39 58.37 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 -173.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -50.13 110.68 0.42 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.015 0.371 . . . . 0.0 111.814 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 94.66 1.36 63.86 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.55 -0.583 . . . . 0.0 112.606 174.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -83.98 -164.71 0.97 Allowed 'General case' 0 C--N 1.339 0.152 0 CA-C-N 118.32 1.06 . . . . 0.0 110.146 176.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -129.41 152.96 48.39 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.209 0.528 . . . . 0.0 111.246 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -145.51 137.45 25.45 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.188 0.995 . . . . 0.0 112.061 177.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 21.1 t 54.19 18.51 1.82 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.87 0.468 . . . . 0.0 111.211 -175.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 89.29 22.58 37.23 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 111.939 -0.464 . . . . 0.0 111.939 178.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -133.67 141.81 41.45 Favored Pre-proline 0 N--CA 1.455 -0.205 0 CA-C-N 117.442 0.621 . . . . 0.0 109.428 -177.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.32 136.18 33.48 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 122.68 2.253 . . . . 0.0 109.567 177.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 30.4 pt -121.47 170.63 11.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-O 120.957 0.408 . . . . 0.0 111.383 -177.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -144.78 115.68 7.82 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.719 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 12.4 t -107.0 147.86 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 C-N-CA 123.429 0.692 . . . . 0.0 112.416 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 28.5 t -162.73 173.22 14.12 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 176.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -71.11 133.28 46.12 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.308 0 CA-C-O 121.216 0.531 . . . . 0.0 111.647 178.078 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 14.7 p30 . . . . . 0 N--CA 1.454 -0.244 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 33.7 m -106.1 143.07 34.76 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 120.764 0.316 . . . . 0.0 111.477 -175.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 45.3 pt -120.72 146.73 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -99.41 146.77 25.95 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 174.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 21.0 t -131.97 144.7 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.972 177.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -131.15 152.41 50.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 176.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.0 11.94 69.15 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 112.324 -0.311 . . . . 0.0 112.324 169.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 77.5 mt -55.6 -49.59 72.39 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 117.605 0.702 . . . . 0.0 110.492 -176.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 145.59 172.51 16.04 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -99.78 1.59 43.29 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.875 0.338 . . . . 0.0 111.787 -177.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -128.87 14.09 6.35 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.7 m -75.41 166.17 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -172.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 25.8 p -130.69 159.73 36.37 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.598 0.759 . . . . 0.0 112.168 -179.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 298' ' ' ILE . . . . . 0.562 HG23 ' HB ' ' B' ' 322' ' ' ILE . 44.4 mt -63.04 -46.38 96.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.337 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -62.37 -36.37 82.07 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.386 0.274 . . . . 0.0 111.437 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 47.0 t -72.44 -46.7 53.82 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 117.71 0.232 . . . . 0.0 110.836 -177.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.94 -33.28 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.341 178.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -65.3 -32.84 74.7 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 303' ' ' ASP . . . . . 0.41 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.4 t0 -74.64 -27.57 60.5 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 304' ' ' TYR . . . . . 0.404 ' CE2' ' CD2' ' B' ' 354' ' ' PHE . 52.3 t80 -83.48 -24.98 31.53 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -96.48 -25.09 15.79 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 178.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 306' ' ' LYS . . . . . 0.41 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.7 ptpt -66.35 -18.24 65.24 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -177.428 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -71.67 -20.19 61.98 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -178.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 3.9 mm -87.11 -46.33 16.23 Favored 'Isoleucine or valine' 0 C--N 1.337 0.059 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 175.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.98 167.95 38.25 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 85.8 mt -68.41 120.03 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 122.505 0.322 . . . . 0.0 110.634 -175.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 94.0 mt -71.72 138.06 22.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 172.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 312' ' ' LYS . . . . . 0.401 ' HE3' ' HB2' ' B' ' 312' ' ' LYS . 35.8 ttmt . . . . . 0 N--CA 1.45 -0.439 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -177.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo . . . . . 0 N--CA 1.45 -1.053 0 N-CA-C 110.096 -0.771 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 321' ' ' MET . . . . . 0.429 ' CB ' ' HB3' ' B' ' 340' ' ' SER . 33.9 mtt -73.45 95.8 2.28 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 120.68 0.276 . . . . 0.0 111.712 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 322' ' ' ILE . . . . . 0.562 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.7 mp -141.29 141.05 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 172.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -134.37 110.9 9.75 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 175.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.68 152.69 33.63 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.673 0.789 . . . . 0.0 108.895 175.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -121.12 149.1 43.27 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 175.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.454 -0.273 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -175.607 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 8.5 mmmm . . . . . 0 N--CA 1.461 0.11 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 77.26 5.64 85.58 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 -171.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -103.36 147.61 26.89 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.389 0.675 . . . . 0.0 109.992 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -161.95 153.83 19.02 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.006 176.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 12.8 p -98.72 151.77 20.38 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 169.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 42.5 t -136.13 125.99 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 170.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 340' ' ' SER . . . . . 0.429 ' HB3' ' CB ' ' B' ' 321' ' ' MET . 46.5 t -103.18 149.12 24.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 117.862 0.301 . . . . 0.0 111.316 -178.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -114.49 156.81 23.88 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -72.21 -29.11 63.65 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -132.46 147.83 67.2 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -178.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 344' ' ' PRO . . . . . 0.467 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 45.3 Cg_endo -71.39 -31.71 13.59 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.446 2.764 . . . . 0.0 114.649 -178.083 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 345' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 78.5 Cg_endo -73.68 -21.86 18.6 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 CA-C-N 121.255 1.484 . . . . 0.0 110.04 -177.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 70.7 m -71.23 -35.92 71.63 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 175.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -68.03 -38.74 82.88 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 174.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -64.06 -42.07 97.14 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.43 -34.6 76.29 Favored 'General case' 0 C--O 1.226 -0.148 0 O-C-N 122.255 -0.278 . . . . 0.0 110.737 178.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.36 -36.71 84.83 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 66.4 mt -70.25 -52.05 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.691 175.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -53.77 -29.86 41.96 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 58.9 t-105 -97.58 -53.95 3.28 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -176.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 354' ' ' PHE . . . . . 0.43 ' HB2' HG21 ' B' ' 366' ' ' VAL . 47.7 m-85 -78.09 -27.08 48.43 Favored 'General case' 0 C--O 1.226 -0.134 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -174.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -48.09 110.4 0.32 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 178.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 95.18 1.74 62.61 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 119.612 -0.549 . . . . 0.0 112.764 174.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -84.5 -164.87 1.03 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.261 1.03 . . . . 0.0 110.524 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 41.8 mp0 -127.75 152.85 47.24 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.107 0.479 . . . . 0.0 110.84 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -145.31 136.76 25.15 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.181 0.992 . . . . 0.0 112.349 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 14.8 t 55.32 17.29 2.04 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.075 0.464 . . . . 0.0 111.175 -175.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.72 22.63 38.84 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.955 -0.458 . . . . 0.0 111.955 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 44.9 m-20 -132.07 143.02 47.23 Favored Pre-proline 0 N--CA 1.455 -0.218 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -177.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -68.9 136.69 36.01 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.849 2.366 . . . . 0.0 109.415 177.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 33.5 pt -124.04 171.05 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 CA-C-O 121.178 0.513 . . . . 0.0 111.125 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -143.81 114.89 7.87 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.759 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 366' ' ' VAL . . . . . 0.43 HG21 ' HB2' ' B' ' 354' ' ' PHE . 11.9 t -102.33 148.65 7.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 123.256 0.623 . . . . 0.0 111.99 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 80.3 p -162.53 168.6 21.63 Favored 'General case' 0 CA--C 1.528 0.1 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -70.28 130.97 43.42 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 174.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.401 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.882 -179.795 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 285' ' ' ASN . . . . . 0.426 HD22 ' C ' ' B' ' 285' ' ' ASN . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.275 0 N-CA-C 111.375 0.139 . . . . 0.0 111.375 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 63.7 m -108.98 146.22 34.22 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.877 0.37 . . . . 0.0 111.206 -172.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 44.9 pt -120.24 148.09 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 174.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -101.4 145.77 28.49 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 174.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 17.2 t -129.75 144.46 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.236 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -133.16 152.45 51.94 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 175.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.21 12.38 67.87 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 119.814 -0.436 . . . . 0.0 112.663 169.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 59.3 mt -57.14 -50.1 73.85 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 117.414 0.607 . . . . 0.0 110.912 -174.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 157.0 -177.94 33.64 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -99.63 -9.32 23.32 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -176.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -139.95 22.0 2.45 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.2 m -68.11 165.15 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -173.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 16.0 p -123.11 159.56 28.27 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -177.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 298' ' ' ILE . . . . . 0.607 HG23 ' HB ' ' B' ' 322' ' ' ILE . 41.1 mt -62.32 -45.8 97.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.128 177.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -63.43 -37.56 87.77 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -177.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 81.1 p -73.35 -42.39 62.31 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 118.043 0.383 . . . . 0.0 110.376 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 54.4 t -61.69 -42.06 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -65.56 -34.36 78.06 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 303' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -70.55 -26.96 63.79 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -84.41 -25.68 28.86 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -96.3 -25.0 15.93 Favored 'General case' 0 C--O 1.231 0.091 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 306' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -66.55 -19.08 65.69 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.241 0.216 . . . . 0.0 111.458 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -71.28 -20.01 62.27 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 111.644 0.238 . . . . 0.0 111.644 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 5.1 mm -88.9 -46.25 15.46 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-N 117.602 0.183 . . . . 0.0 110.945 176.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -162.18 170.37 37.79 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 85.4 mt -72.12 118.58 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 122.61 0.364 . . . . 0.0 110.39 -175.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 93.6 mt -72.56 135.02 28.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 173.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt . . . . . 0 N--CA 1.45 -0.472 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.317 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo . . . . . 0 N--CA 1.449 -1.108 0 N-CA-C 110.144 -0.752 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 321' ' ' MET . . . . . 0.419 ' CB ' ' HB3' ' B' ' 340' ' ' SER . 38.6 mtt -72.53 93.05 1.53 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.863 0.363 . . . . 0.0 111.72 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 322' ' ' ILE . . . . . 0.607 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.9 mp -140.5 144.21 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 173.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -131.62 132.78 44.31 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 171.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -103.15 137.8 40.82 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 174.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -104.11 155.24 18.86 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 2.9 m . . . . . 0 CA--C 1.523 -0.093 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -176.19 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt . . . . . 0 N--CA 1.465 0.291 0 CA-C-O 120.491 0.186 . . . . 0.0 110.632 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 73.52 5.49 68.11 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -172.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -100.06 151.11 21.75 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.336 0.654 . . . . 0.0 110.024 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.42 167.25 29.21 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.052 0.453 . . . . 0.0 111.592 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 1.4 p -120.66 151.15 39.86 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 169.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 31.3 t -137.66 124.99 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 172.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 340' ' ' SER . . . . . 0.419 ' HB3' ' CB ' ' B' ' 321' ' ' MET . 46.9 t -101.41 148.93 24.59 Favored 'General case' 0 C--O 1.231 0.113 0 O-C-N 122.202 -0.311 . . . . 0.0 111.135 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -116.92 154.12 31.38 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 -178.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -71.74 -13.11 61.62 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 176.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -149.26 146.77 21.78 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 344' ' ' PRO . . . . . 0.478 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 53.4 Cg_endo -71.32 -30.18 15.97 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 123.239 2.626 . . . . 0.0 114.363 -177.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 345' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 71.5 Cg_endo -73.99 -22.45 17.21 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 CA-C-N 121.403 1.537 . . . . 0.0 109.964 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 66.3 m -71.7 -36.97 70.74 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 175.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.98 -37.83 84.94 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -63.72 -45.02 91.84 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.77 -34.44 76.81 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 110.538 -0.171 . . . . 0.0 110.538 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.33 -38.66 91.81 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 68.8 mt -68.57 -54.0 24.02 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.56 175.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -54.41 -27.9 40.12 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 54.9 t-105 -96.76 -55.07 3.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -76.29 -26.79 56.24 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -174.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -48.35 109.43 0.24 Allowed 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 176.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 94.94 0.76 63.63 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.394 -0.67 . . . . 0.0 112.814 174.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -83.38 -164.94 0.97 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 118.177 0.988 . . . . 0.0 110.374 176.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -128.48 155.11 45.33 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.191 0.519 . . . . 0.0 111.454 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -146.89 136.44 22.92 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.478 1.111 . . . . 0.0 112.158 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 22.7 t 54.45 18.77 2.06 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.455 0.302 . . . . 0.0 111.335 -175.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 86.95 24.31 38.35 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 112.154 -0.378 . . . . 0.0 112.154 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -132.87 142.48 44.88 Favored Pre-proline 0 N--CA 1.454 -0.23 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 -178.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.41 136.16 33.18 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.681 2.254 . . . . 0.0 109.602 177.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 27.9 pt -122.97 171.9 11.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-O 121.25 0.548 . . . . 0.0 110.831 -177.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -144.0 118.13 9.5 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.947 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 11.9 t -107.64 148.52 11.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 C-N-CA 123.22 0.608 . . . . 0.0 112.242 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 27.4 t -163.75 172.57 13.98 Favored 'General case' 0 C--N 1.341 0.204 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 176.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -70.51 130.25 41.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 176.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.314 0 CA-C-N 115.965 -0.562 . . . . 0.0 112.31 -179.027 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 285' ' ' ASN . . . . . 0.449 HD22 ' C ' ' B' ' 285' ' ' ASN . 0.4 OUTLIER . . . . . 0 N--CA 1.452 -0.349 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 60.5 m -107.5 142.16 37.81 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.092 0.473 . . . . 0.0 109.987 -175.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 44.4 pt -113.72 146.69 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 174.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -97.97 141.06 31.4 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 172.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 17.4 t -130.26 142.34 44.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 O-C-N 123.331 0.394 . . . . 0.0 111.252 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -132.3 153.13 51.0 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.46 11.47 68.86 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 119.863 -0.409 . . . . 0.0 112.423 169.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 77.4 mt -56.29 -51.95 66.31 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 117.348 0.574 . . . . 0.0 110.548 -175.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 151.15 171.56 19.31 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -91.47 -9.13 45.62 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 122.484 -0.421 . . . . 0.0 111.772 -174.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -134.34 15.91 3.75 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -177.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.2 m -66.6 160.76 3.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -175.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 25.7 p -117.87 156.66 28.03 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 122.957 0.503 . . . . 0.0 112.053 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 298' ' ' ILE . . . . . 0.49 HG23 ' HB ' ' B' ' 322' ' ' ILE . 40.6 mt -60.67 -44.03 96.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.44 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -68.89 -30.54 69.05 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -177.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 46.6 t -73.79 -43.6 58.44 Favored 'General case' 0 N--CA 1.458 -0.07 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 78.8 t -61.97 -41.25 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.61 -34.84 79.21 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 303' ' ' ASP . . . . . 0.408 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.9 t0 -71.02 -29.01 64.83 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 304' ' ' TYR . . . . . 0.402 ' CE2' ' CD2' ' B' ' 354' ' ' PHE . 59.0 t80 -82.47 -25.31 33.66 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -96.63 -24.88 15.8 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 306' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.9 ptpt -67.76 -17.59 64.6 Favored 'General case' 0 C--N 1.338 0.107 0 N-CA-C 111.446 0.165 . . . . 0.0 111.446 -176.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -72.2 -20.07 61.63 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 3.8 mm -87.84 -46.35 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.122 0 CA-C-N 117.61 0.186 . . . . 0.0 110.632 175.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -162.24 172.16 38.29 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 72.5 mt -71.11 118.29 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 122.68 0.392 . . . . 0.0 110.11 -175.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 77.4 mt -74.91 136.93 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 173.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 312' ' ' LYS . . . . . 0.442 ' HG2' ' SD ' ' B' ' 321' ' ' MET . 39.8 ttmt . . . . . 0 N--CA 1.453 -0.275 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo . . . . . 0 N--CA 1.448 -1.195 0 N-CA-C 108.746 -1.29 . . . . 0.0 108.746 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 321' ' ' MET . . . . . 0.442 ' SD ' ' HG2' ' B' ' 312' ' ' LYS . 72.4 mtp -79.77 85.7 5.42 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.307 0.575 . . . . 0.0 111.665 -170.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 322' ' ' ILE . . . . . 0.49 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.3 mp -129.7 147.08 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.575 1.15 . . . . 0.0 108.25 176.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -132.93 111.08 10.74 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -80.98 148.79 29.6 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.267 1.027 . . . . 0.0 108.833 176.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -113.29 151.66 30.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.522 -0.13 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -173.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt . . . . . 0 CA--C 1.527 0.096 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 78.56 10.29 86.33 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 110.709 -0.957 . . . . 0.0 110.709 -174.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -116.97 150.33 38.74 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.881 0.472 . . . . 0.0 110.408 -177.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -160.06 162.91 34.26 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.881 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 29.6 p -112.4 153.86 26.67 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 169.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 21.8 t -136.6 124.19 33.15 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.11 0 C-N-CA 123.249 0.62 . . . . 0.0 110.218 175.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 45.0 t -90.98 140.85 29.45 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 117.906 0.321 . . . . 0.0 110.404 177.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -108.85 152.84 24.36 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 176.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -70.08 -28.82 65.73 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -177.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -133.05 149.0 71.6 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 344' ' ' PRO . . . . . 0.467 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 36.9 Cg_endo -69.44 -33.33 18.04 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 123.274 2.649 . . . . 0.0 114.2 -177.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 345' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 93.8 Cg_endo -74.97 -20.2 17.15 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 CA-C-N 121.136 1.441 . . . . 0.0 110.384 -176.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 66.3 m -71.88 -35.72 69.84 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 175.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -70.4 -38.36 74.64 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 174.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -63.6 -43.14 97.78 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.62 -35.33 77.17 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 110.561 -0.162 . . . . 0.0 110.561 178.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -63.88 -37.62 88.06 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 59.2 mt -70.66 -49.16 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.094 175.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -58.95 -27.9 65.76 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -176.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -97.26 -56.47 2.53 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -177.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 354' ' ' PHE . . . . . 0.402 ' CD2' ' CE2' ' B' ' 304' ' ' TYR . 52.2 m-85 -75.7 -25.74 56.95 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -173.133 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -48.49 108.4 0.17 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 176.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 96.34 2.2 60.52 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 119.435 -0.647 . . . . 0.0 113.227 174.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -84.91 -164.02 0.92 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.3 1.05 . . . . 0.0 110.386 177.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -129.9 153.23 48.53 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-O 121.058 0.456 . . . . 0.0 110.776 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -145.17 136.69 25.26 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.395 1.078 . . . . 0.0 112.296 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 63.4 m 53.35 19.48 1.61 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -173.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 86.38 22.81 46.25 Favored Glycine 0 C--N 1.342 0.868 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 52.6 m-20 -130.71 141.96 43.81 Favored Pre-proline 0 N--CA 1.454 -0.239 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -177.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.18 135.31 31.48 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.998 2.465 . . . . 0.0 109.267 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 29.6 pt -122.4 171.48 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 CA-C-O 121.285 0.564 . . . . 0.0 111.061 -177.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -144.25 116.59 8.51 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.688 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 10.8 t -107.28 147.27 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 123.026 0.53 . . . . 0.0 111.801 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 28.0 t -162.63 174.87 12.01 Favored 'General case' 0 C--N 1.339 0.147 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 177.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -71.97 130.07 40.09 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 176.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.358 177.946 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 285' ' ' ASN . . . . . 0.44 HD22 ' C ' ' B' ' 285' ' ' ASN . 0.3 OUTLIER . . . . . 0 N--CA 1.455 -0.223 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 80.4 m -108.13 144.36 35.63 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.024 0.44 . . . . 0.0 110.912 -174.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 44.5 pt -120.41 147.35 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -99.83 145.93 27.18 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 174.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 16.8 t -129.46 142.14 44.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 122.636 0.374 . . . . 0.0 111.22 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -129.54 149.9 51.11 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.05 14.24 64.88 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-O 119.894 -0.392 . . . . 0.0 112.361 169.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 61.4 mt -57.1 -51.1 70.65 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 117.545 0.673 . . . . 0.0 110.615 -175.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 148.84 177.16 22.8 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -101.54 -2.25 31.04 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -178.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -129.14 14.67 6.23 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.778 0.431 . . . . 0.0 112.145 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.2 m -73.65 163.16 4.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -172.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 27.3 p -129.23 160.71 32.08 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 123.501 0.72 . . . . 0.0 111.604 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 298' ' ' ILE . . . . . 0.533 HG23 ' HB ' ' B' ' 322' ' ' ILE . 44.8 mt -64.51 -45.51 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.274 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -63.6 -35.65 81.22 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 122.497 0.319 . . . . 0.0 111.601 179.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 47.1 t -72.28 -47.01 53.37 Favored 'General case' 0 C--O 1.228 -0.057 0 CA-C-N 117.919 0.327 . . . . 0.0 110.772 -177.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 7.8 p -68.16 -33.41 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.2 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -65.78 -32.56 74.16 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 176.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 303' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -74.23 -28.21 61.14 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 304' ' ' TYR . . . . . 0.409 ' CE1' ' CD1' ' B' ' 354' ' ' PHE . 54.6 t80 -82.2 -25.47 34.21 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -96.51 -25.93 15.47 Favored 'General case' 0 CA--C 1.527 0.086 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 306' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -65.73 -17.69 64.8 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 111.631 0.234 . . . . 0.0 111.631 -177.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -71.72 -20.52 61.89 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 5.0 mm -86.72 -45.8 16.49 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 175.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -165.22 167.92 39.05 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 178.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 82.4 mt -68.13 122.59 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-O 120.854 0.359 . . . . 0.0 110.752 -174.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 92.1 mt -74.56 136.53 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt . . . . . 0 N--CA 1.448 -0.568 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -178.131 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo . . . . . 0 N--CA 1.452 -0.959 0 N-CA-C 109.861 -0.861 . . . . 0.0 109.861 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 321' ' ' MET . . . . . . . . . . . . . 36.4 mtt -71.31 95.71 1.34 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 120.571 0.224 . . . . 0.0 111.576 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 322' ' ' ILE . . . . . 0.533 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.6 mp -142.44 141.67 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 173.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 323' ' ' ASN . . . . . 0.403 ' O ' ' HA ' ' B' ' 337' ' ' ALA . 17.3 m-80 -132.75 111.16 10.91 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 171.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 43.2 mt -81.55 148.15 29.29 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 174.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -115.28 151.62 34.21 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 178.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.333 -0.141 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -176.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 9.3 mmmm . . . . . 0 N--CA 1.458 -0.048 0 N-CA-C 110.566 -0.161 . . . . 0.0 110.566 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.33 5.24 81.38 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -170.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -103.73 149.68 24.77 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.324 0.65 . . . . 0.0 110.121 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 337' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' B' ' 323' ' ' ASN . . . -164.25 159.69 20.3 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.027 176.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 6.1 p -106.26 151.65 24.53 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 169.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 42.9 t -135.89 126.22 42.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 170.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 23.0 t -105.96 141.88 36.61 Favored 'General case' 0 CA--C 1.527 0.086 0 O-C-N 122.129 -0.357 . . . . 0.0 110.948 -177.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -106.6 158.53 16.87 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -177.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -73.41 -29.97 62.94 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -131.26 146.9 64.04 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -177.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 344' ' ' PRO . . . . . 0.463 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 40.6 Cg_endo -70.83 -33.23 12.86 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.414 2.743 . . . . 0.0 114.484 -177.083 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 345' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 87.4 Cg_endo -73.82 -22.65 17.38 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 CA-C-N 121.185 1.459 . . . . 0.0 109.926 -176.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 71.2 m -71.48 -35.74 70.91 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 175.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -68.7 -37.91 79.9 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 175.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -64.77 -43.12 94.3 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -69.45 -33.26 72.67 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 110.474 -0.195 . . . . 0.0 110.474 178.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.89 -36.8 85.52 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 67.9 mt -69.67 -52.36 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 120.378 -0.529 . . . . 0.0 109.612 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -55.74 -29.37 59.42 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 55.5 t-105 -95.55 -55.87 2.88 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 354' ' ' PHE . . . . . 0.409 ' CD1' ' CE1' ' B' ' 304' ' ' TYR . 46.7 m-85 -75.8 -31.54 59.48 Favored 'General case' 0 C--N 1.337 0.06 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -173.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -55.46 108.04 0.39 Allowed 'General case' 0 C--O 1.232 0.16 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.753 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 106.98 -3.17 35.57 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.272 176.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -86.47 -164.78 1.11 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 117.843 0.821 . . . . 0.0 110.428 176.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -128.91 154.69 46.28 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.958 0.409 . . . . 0.0 111.306 177.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -145.19 137.2 25.67 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.573 1.149 . . . . 0.0 112.348 177.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 15.5 t 54.9 16.15 1.37 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 122.773 0.429 . . . . 0.0 111.189 -175.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 90.71 23.45 30.71 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 111.886 -0.485 . . . . 0.0 111.886 178.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -133.9 142.07 42.15 Favored Pre-proline 0 N--CA 1.453 -0.321 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -177.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -68.94 136.33 34.9 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 122.702 2.268 . . . . 0.0 109.518 177.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 29.1 pt -122.12 170.68 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-O 120.978 0.418 . . . . 0.0 111.01 -178.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -144.84 114.1 7.03 Favored 'General case' 0 N--CA 1.457 -0.086 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 11.2 t -102.67 150.47 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 122.907 0.483 . . . . 0.0 112.131 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 23.8 t -163.54 173.43 13.07 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 176.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -70.55 131.09 43.46 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 176.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.47 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.683 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.455 -0.213 0 N-CA-C 111.53 0.196 . . . . 0.0 111.53 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 60.6 m -106.73 142.5 36.27 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 120.988 0.423 . . . . 0.0 110.797 -176.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 38.9 pt -116.85 147.38 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 173.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -100.78 144.36 29.83 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 174.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 18.4 t -129.72 143.13 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.004 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -131.44 151.61 51.4 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 175.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 88.84 11.77 65.02 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 119.782 -0.455 . . . . 0.0 112.272 169.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 76.4 mt -56.47 -51.37 68.71 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.705 0.752 . . . . 0.0 110.46 -176.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 147.61 174.41 19.51 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 -179.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -99.07 -0.32 42.1 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.879 0.34 . . . . 0.0 111.644 -178.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -128.83 13.0 6.32 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.4 m -73.58 162.8 4.27 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -172.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 47.4 p -130.04 158.18 40.33 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 123.532 0.733 . . . . 0.0 111.129 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 298' ' ' ILE . . . . . 0.566 HG23 ' HB ' ' B' ' 322' ' ' ILE . 30.7 mt -62.41 -44.87 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.506 -179.127 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -63.13 -34.7 78.17 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.448 0.299 . . . . 0.0 111.609 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 47.0 t -73.64 -44.29 57.3 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 79.2 t -62.45 -40.82 89.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 177.175 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.77 -36.2 83.55 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 303' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -70.52 -27.95 64.57 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 304' ' ' TYR . . . . . 0.407 ' CE2' ' CD1' ' B' ' 354' ' ' PHE . 60.8 t80 -82.9 -26.42 31.53 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -179.139 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -96.63 -24.65 15.9 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 179.111 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 306' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -66.61 -19.25 65.73 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 111.526 0.195 . . . . 0.0 111.526 -177.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -71.01 -19.77 62.48 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -178.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 5.0 mm -88.79 -46.43 15.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 N-CA-C 110.554 -0.165 . . . . 0.0 110.554 175.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.19 167.43 37.49 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 179.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 84.2 mt -68.03 120.44 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-O 120.989 0.423 . . . . 0.0 110.353 -176.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 80.5 mt -74.29 137.37 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 172.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 312' ' ' LYS . . . . . 0.429 ' HE2' ' HB2' ' B' ' 312' ' ' LYS . 22.3 ttmm . . . . . 0 N--CA 1.45 -0.466 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -177.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo . . . . . 0 N--CA 1.449 -1.103 0 N-CA-C 110.358 -0.67 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 321' ' ' MET . . . . . 0.404 ' C ' HD12 ' B' ' 322' ' ' ILE . 37.0 mtt -73.08 91.49 1.61 Allowed 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 122.523 0.329 . . . . 0.0 111.685 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 322' ' ' ILE . . . . . 0.566 ' HB ' HG23 ' B' ' 298' ' ' ILE . 4.1 mp -136.6 139.89 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 170.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -135.21 111.05 9.36 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 25.0 mt -81.44 151.96 27.62 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 176.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -115.99 152.34 33.7 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 177.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.092 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -174.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt . . . . . 0 N--CA 1.461 0.089 0 N-CA-C 110.442 -0.207 . . . . 0.0 110.442 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.13 3.59 76.06 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -172.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -103.56 150.05 24.31 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.163 0.585 . . . . 0.0 110.104 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -162.81 157.55 21.58 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.705 177.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 7.6 p -105.31 152.67 22.62 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 170.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 38.2 t -135.78 126.17 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 123.597 0.759 . . . . 0.0 109.056 170.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 340' ' ' SER . . . . . 0.401 ' HB3' ' CB ' ' B' ' 321' ' ' MET . 48.3 t -105.39 139.2 40.38 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.701 0.286 . . . . 0.0 110.983 -178.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -104.57 159.76 15.49 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -178.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -72.08 -31.61 66.25 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -130.98 149.85 74.92 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 344' ' ' PRO . . . . . 0.474 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 40.7 Cg_endo -70.27 -32.12 17.02 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 123.256 2.637 . . . . 0.0 114.396 -177.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 345' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 74.0 Cg_endo -73.68 -21.34 19.19 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 CA-C-N 121.255 1.484 . . . . 0.0 110.199 -177.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 57.6 m -72.09 -36.3 69.46 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 175.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -67.28 -38.64 85.4 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 174.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -63.63 -43.96 95.27 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.23 -34.67 76.67 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 122.227 -0.296 . . . . 0.0 110.542 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.64 -37.18 86.71 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 61.5 mt -69.58 -51.85 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.86 175.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -53.19 -30.63 38.55 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 53.8 t-105 -97.09 -55.39 2.87 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -176.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 354' ' ' PHE . . . . . 0.407 ' CD1' ' CE2' ' B' ' 304' ' ' TYR . 51.9 m-85 -76.35 -26.94 56.22 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -173.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -49.22 109.16 0.24 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 177.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 97.3 -0.32 60.01 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 119.508 -0.606 . . . . 0.0 112.499 174.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -83.25 -165.74 1.17 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 118.203 1.001 . . . . 0.0 110.374 176.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -127.99 154.96 45.01 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.387 0.613 . . . . 0.0 111.233 177.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -145.71 136.44 24.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.531 1.133 . . . . 0.0 112.247 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 13.3 t 54.89 18.11 2.07 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.711 0.291 . . . . 0.0 111.346 -175.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.4 22.92 38.75 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.963 -0.455 . . . . 0.0 111.963 178.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 51.6 m-20 -132.64 142.16 43.8 Favored Pre-proline 0 N--CA 1.457 -0.112 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -177.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.27 135.97 33.05 Favored 'Trans proline' 0 N--CA 1.446 -1.305 0 C-N-CA 122.895 2.397 . . . . 0.0 109.532 178.048 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 29.8 pt -122.56 171.4 11.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 121.176 0.513 . . . . 0.0 111.009 -177.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -144.45 115.38 7.83 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.781 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 11.7 t -105.9 147.63 11.27 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 C-N-CA 123.174 0.59 . . . . 0.0 112.165 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 22.6 t -162.71 173.04 14.37 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 176.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -70.1 130.17 41.4 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 176.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.439 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.053 -178.954 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.455 -0.205 0 N-CA-C 111.443 0.164 . . . . 0.0 111.443 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 28.2 m -113.49 143.96 43.64 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.866 0.365 . . . . 0.0 111.603 -174.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 32.1 pt -122.02 146.82 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 175.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -100.33 144.24 29.57 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 174.002 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 20.4 t -129.83 142.24 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 122.808 0.443 . . . . 0.0 111.008 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -129.82 151.98 49.81 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.128 -0.694 . . . . 0.0 109.128 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.61 11.89 67.78 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-O 119.911 -0.383 . . . . 0.0 112.448 169.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 75.4 mt -55.42 -50.27 70.24 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 117.625 0.713 . . . . 0.0 110.679 -175.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 145.71 174.07 17.56 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -100.98 2.16 40.38 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -178.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -128.64 13.94 6.46 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.792 0.437 . . . . 0.0 111.795 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.6 m -75.56 165.32 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -172.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 26.7 p -131.81 160.53 35.35 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.587 0.755 . . . . 0.0 111.969 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 298' ' ' ILE . . . . . 0.522 HG23 ' HB ' ' B' ' 322' ' ' ILE . 48.3 mt -63.82 -43.71 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.099 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.6 -36.6 84.76 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 122.428 0.291 . . . . 0.0 111.499 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 45.4 t -71.82 -46.26 58.72 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.792 0.269 . . . . 0.0 110.795 -177.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 8.2 p -68.33 -32.55 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.271 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -66.76 -32.66 74.09 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 303' ' ' ASP . . . . . 0.409 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.0 t0 -74.15 -27.58 60.91 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 304' ' ' TYR . . . . . 0.417 ' CE1' ' CD2' ' B' ' 354' ' ' PHE . 67.7 t80 -84.19 -24.36 30.16 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -97.01 -24.41 15.81 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 178.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 306' ' ' LYS . . . . . 0.409 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.8 ptpt -66.13 -17.86 64.98 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -177.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -71.78 -20.67 61.83 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 5.1 mm -86.81 -46.09 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 N-CA-C 110.525 -0.176 . . . . 0.0 110.525 175.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.58 165.86 37.01 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.346 -0.701 . . . . 0.0 111.346 178.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 79.5 mt -66.81 119.46 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 122.586 0.354 . . . . 0.0 110.642 -176.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 94.5 mt -72.06 135.55 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 172.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt . . . . . 0 N--CA 1.453 -0.314 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -178.338 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo . . . . . 0 N--CA 1.448 -1.156 0 N-CA-C 110.032 -0.795 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 321' ' ' MET . . . . . 0.406 ' CB ' ' HB3' ' B' ' 340' ' ' SER . 37.1 mtt -72.64 95.0 1.79 Allowed 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 120.906 0.384 . . . . 0.0 111.757 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 322' ' ' ILE . . . . . 0.522 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.5 mp -141.31 141.05 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 173.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -132.75 107.31 8.28 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 174.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 36.6 mt -80.04 154.78 27.93 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -122.7 149.2 44.38 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 176.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 8.7 m . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -174.097 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? . . . . . 0 N--CA 1.463 0.198 0 N-CA-C 110.579 -0.156 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.01 5.44 80.29 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -172.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -102.74 147.38 26.92 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.591 0.756 . . . . 0.0 110.313 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -164.17 158.23 18.89 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.639 0.257 . . . . 0.0 111.423 177.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 32.2 p -104.12 153.3 21.09 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 169.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 40.6 t -136.81 130.94 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 171.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 340' ' ' SER . . . . . 0.406 ' HB3' ' CB ' ' B' ' 321' ' ' MET . 41.9 t -108.66 149.54 28.8 Favored 'General case' 0 N--CA 1.46 0.072 0 CA-C-O 120.672 0.272 . . . . 0.0 111.425 -178.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -115.27 157.82 23.22 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -70.46 -32.53 70.13 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -129.86 149.05 71.97 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -178.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 344' ' ' PRO . . . . . 0.469 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 41.0 Cg_endo -69.95 -32.42 17.81 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.198 2.599 . . . . 0.0 114.537 -176.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 345' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 92.7 Cg_endo -74.16 -20.95 18.45 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 CA-C-N 120.874 1.348 . . . . 0.0 110.315 -177.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 68.3 m -71.05 -37.84 72.54 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 175.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.62 -38.18 86.41 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 174.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -64.69 -42.38 95.36 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -69.33 -34.1 74.11 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 110.48 -0.192 . . . . 0.0 110.48 178.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -63.87 -38.02 89.56 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 67.8 mt -68.08 -53.43 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 120.369 -0.532 . . . . 0.0 109.658 175.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -55.54 -27.72 50.55 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -178.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -96.6 -55.22 2.98 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 354' ' ' PHE . . . . . 0.417 ' CD2' ' CE1' ' B' ' 304' ' ' TYR . 48.9 m-85 -76.2 -27.0 56.7 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -173.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -49.18 108.43 0.19 Allowed 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 176.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 96.57 1.03 60.58 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-N 116.154 -0.475 . . . . 0.0 113.068 174.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -82.97 -164.47 0.88 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 117.89 0.845 . . . . 0.0 110.17 176.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -129.46 152.21 49.25 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-O 121.006 0.432 . . . . 0.0 110.982 178.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -145.08 137.27 25.86 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.891 0.877 . . . . 0.0 112.334 178.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 22.0 t 54.73 18.31 2.06 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.69 0.281 . . . . 0.0 111.196 -175.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.65 23.39 39.53 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -132.9 142.94 46.55 Favored Pre-proline 0 N--CA 1.457 -0.09 0 CA-C-N 117.537 0.668 . . . . 0.0 109.312 -177.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.24 135.51 31.89 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 123.148 2.565 . . . . 0.0 109.738 177.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 30.8 pt -123.03 170.43 13.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.122 0.487 . . . . 0.0 111.176 -177.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -144.31 116.91 8.64 Favored 'General case' 0 C--O 1.228 -0.071 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.898 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 366' ' ' VAL . . . . . 0.402 HG21 ' HB2' ' B' ' 354' ' ' PHE . 12.6 t -106.13 149.0 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 C-N-CA 123.088 0.555 . . . . 0.0 112.124 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 22.6 t -163.27 172.92 14.01 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 177.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -69.94 129.68 40.14 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 176.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.342 0 CA-C-O 121.096 0.474 . . . . 0.0 111.608 179.757 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 285' ' ' ASN . . . . . 0.403 HD22 ' C ' ' B' ' 285' ' ' ASN . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.287 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 72.1 m -109.07 145.39 35.71 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.024 0.44 . . . . 0.0 111.152 -173.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 46.1 pt -121.9 149.6 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -102.67 145.53 29.54 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 175.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 289' ' ' VAL . . . . . 0.553 HG11 HD13 ' B' ' 292' ' ' LEU . 57.5 t -128.26 136.61 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.412 -178.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -127.23 153.95 45.46 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 176.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 84.31 12.22 76.47 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 173.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 292' ' ' LEU . . . . . 0.553 HD13 HG11 ' B' ' 289' ' ' VAL . 4.6 tp -59.1 -49.36 78.18 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.984 0.914 . . . . 0.0 111.219 -170.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 146.59 167.11 12.64 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 176.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -95.38 -1.19 51.62 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.341 0.257 . . . . 0.0 111.312 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -130.67 14.69 5.4 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.5 m -68.58 164.85 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -173.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 77.5 p -135.17 156.76 48.44 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 123.838 0.855 . . . . 0.0 109.782 177.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 298' ' ' ILE . . . . . 0.582 HG23 ' HB ' ' B' ' 322' ' ' ILE . 29.6 mt -61.94 -43.74 97.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.626 -178.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -64.25 -34.24 77.67 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 47.7 t -72.58 -45.36 59.54 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 117.864 0.302 . . . . 0.0 110.482 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 72.5 t -62.16 -41.63 92.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.93 -36.02 83.04 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 303' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -69.74 -29.66 67.08 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 304' ' ' TYR . . . . . 0.401 ' CE1' ' CD2' ' B' ' 354' ' ' PHE . 56.3 t80 -82.52 -25.89 33.01 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -96.46 -24.47 16.09 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 306' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -67.15 -18.56 65.34 Favored 'General case' 0 N--CA 1.461 0.077 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -176.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -71.69 -19.73 62.03 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 5.2 mm -88.43 -46.28 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.092 0 CA-C-N 117.729 0.241 . . . . 0.0 110.471 175.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.83 170.53 39.17 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 83.5 mt -70.06 120.18 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 122.675 0.39 . . . . 0.0 110.352 -175.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 87.7 mt -73.83 138.9 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 172.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -178.009 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo . . . . . 0 N--CA 1.45 -1.056 0 N-CA-C 110.262 -0.707 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 321' ' ' MET . . . . . 0.482 ' C ' HD12 ' B' ' 322' ' ' ILE . 34.2 mtt -74.94 86.02 2.27 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 120.913 0.387 . . . . 0.0 111.895 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 322' ' ' ILE . . . . . 0.582 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.4 mp -130.65 137.64 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 169.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -133.64 110.72 10.07 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.508 176.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 20.3 mt -78.75 151.77 31.88 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.334 0.654 . . . . 0.0 109.362 177.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -117.58 147.29 42.97 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 177.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.454 -0.225 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -176.806 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 10.5 mmmm . . . . . 0 CA--C 1.521 -0.138 0 CA-C-O 120.244 0.068 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.77 21.87 73.47 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -172.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -127.61 144.87 51.03 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.013 0.525 . . . . 0.0 110.242 -177.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -155.21 155.37 33.75 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.584 0.231 . . . . 0.0 111.229 172.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 1.9 p -96.12 152.28 18.69 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 170.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 23.2 t -134.29 125.65 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 169.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 22.8 t -106.03 141.86 36.7 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.618 -177.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -107.79 158.54 17.22 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -73.06 -31.72 64.59 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -130.07 147.99 67.85 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -178.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 344' ' ' PRO . . . . . 0.469 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 47.7 Cg_endo -71.64 -30.9 14.11 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 123.389 2.726 . . . . 0.0 114.672 -176.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 345' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 78.3 Cg_endo -73.83 -22.52 17.5 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 CA-C-N 121.326 1.509 . . . . 0.0 109.946 -177.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 71.1 m -71.68 -35.71 70.39 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 175.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -68.72 -38.03 79.9 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 175.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -63.87 -44.56 92.72 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.04 -33.6 74.89 Favored 'General case' 0 N--CA 1.455 -0.175 0 O-C-N 122.474 -0.141 . . . . 0.0 110.63 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.14 -37.69 88.24 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 67.6 mt -68.78 -53.68 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.929 174.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -54.21 -28.67 42.45 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -178.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 56.8 t-105 -95.89 -56.27 2.72 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 354' ' ' PHE . . . . . 0.401 ' CD2' ' CE1' ' B' ' 304' ' ' TYR . 47.3 m-85 -75.99 -25.59 55.94 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -173.201 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -45.86 107.51 0.1 Allowed 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 175.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 92.64 3.36 66.56 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 119.515 -0.603 . . . . 0.0 113.058 174.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -82.37 -170.84 3.13 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.178 0.989 . . . . 0.0 111.201 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -112.21 150.15 31.28 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.684 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -146.12 130.8 17.93 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.654 0.782 . . . . 0.0 112.52 173.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 17.5 t 54.71 19.65 2.6 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.807 0.443 . . . . 0.0 111.089 -176.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.16 28.3 25.8 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 111.921 -0.472 . . . . 0.0 111.921 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -140.01 142.69 31.4 Favored Pre-proline 0 N--CA 1.456 -0.157 0 CA-C-N 117.385 0.592 . . . . 0.0 109.62 -177.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.97 136.27 32.01 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.814 2.343 . . . . 0.0 110.019 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 31.8 pt -124.79 170.27 15.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 121.103 0.478 . . . . 0.0 110.979 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -142.73 116.54 9.28 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.229 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 11.6 t -104.58 147.89 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 123.115 0.566 . . . . 0.0 111.78 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 24.4 t -162.41 172.23 15.9 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 177.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -70.06 128.65 37.05 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 177.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.245 0 CA-C-O 121.345 0.593 . . . . 0.0 111.996 -178.575 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 99.4 m -111.24 146.63 36.62 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.211 0.529 . . . . 0.0 110.369 -176.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 39.8 pt -119.04 146.89 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.227 175.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -96.97 145.5 25.86 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 173.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 18.0 t -131.3 142.23 43.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 O-C-N 123.211 0.319 . . . . 0.0 111.148 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -131.17 150.37 52.18 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 177.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.81 12.99 65.48 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 119.776 -0.458 . . . . 0.0 112.402 169.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 65.5 mt -57.29 -49.95 74.47 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 117.653 0.726 . . . . 0.0 110.645 -175.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 146.47 175.41 19.44 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -101.3 0.23 36.87 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.898 0.349 . . . . 0.0 111.861 -177.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -128.66 13.91 6.45 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.57 0.348 . . . . 0.0 111.666 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.5 m -75.33 166.7 2.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -172.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 14.1 p -131.36 162.15 30.77 Favored 'General case' 0 CA--C 1.522 -0.11 0 C-N-CA 123.744 0.818 . . . . 0.0 112.596 -177.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 298' ' ' ILE . . . . . 0.576 HG23 ' HB ' ' B' ' 322' ' ' ILE . 44.1 mt -62.88 -45.45 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.347 178.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -69.79 -33.51 72.48 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -178.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 80.9 p -72.41 -44.66 62.14 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 118.398 0.544 . . . . 0.0 110.37 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 9.5 p -68.35 -33.76 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 O-C-N 121.917 -0.489 . . . . 0.0 110.668 176.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.58 -33.48 76.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 175.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 303' ' ' ASP . . . . . 0.425 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.3 t0 -73.7 -27.32 61.15 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 304' ' ' TYR . . . . . 0.408 ' CE1' ' CD1' ' B' ' 354' ' ' PHE . 59.5 t80 -83.23 -25.85 31.31 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -96.67 -25.48 15.54 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 178.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 306' ' ' LYS . . . . . 0.425 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.9 ptpt -65.86 -18.09 65.1 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -177.221 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -72.67 -20.06 61.31 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 122.169 -0.332 . . . . 0.0 111.82 -178.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.1 mm -86.29 -46.87 16.62 Favored 'Isoleucine or valine' 0 C--N 1.338 0.071 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 174.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -162.51 166.06 36.44 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 85.6 mt -68.22 121.31 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 C-N-CA 122.604 0.362 . . . . 0.0 110.595 -175.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 94.9 mt -73.94 136.06 26.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 172.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -178.255 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo . . . . . 0 N--CA 1.45 -1.079 0 N-CA-C 109.993 -0.81 . . . . 0.0 109.993 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 321' ' ' MET . . . . . . . . . . . . . 35.3 mtt -71.86 95.48 1.54 Allowed 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 120.814 0.34 . . . . 0.0 111.482 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 322' ' ' ILE . . . . . 0.576 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.3 mp -144.51 145.68 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 175.191 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 323' ' ' ASN . . . . . 0.409 ' O ' ' HA ' ' B' ' 337' ' ' ALA . 18.1 m-80 -134.04 129.16 35.68 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 171.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -97.95 139.59 33.56 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -105.81 149.43 26.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 179.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.455 -0.223 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? . . . . . 0 C--O 1.23 0.058 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 75.95 5.51 80.17 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -171.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -100.05 149.22 23.71 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.491 0.716 . . . . 0.0 110.164 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 337' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' B' ' 323' ' ' ASN . . . -161.14 166.26 28.22 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 120.871 0.367 . . . . 0.0 111.398 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 2.7 p -118.71 149.84 40.76 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 169.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 42.8 t -135.58 123.21 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 171.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 16.0 t -102.04 137.99 39.58 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.001 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -101.75 161.67 13.48 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -74.42 -26.06 59.83 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -137.24 149.48 65.99 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -176.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 344' ' ' PRO . . . . . 0.469 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 41.6 Cg_endo -70.79 -32.25 14.59 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.391 2.727 . . . . 0.0 114.39 -177.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 345' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 79.2 Cg_endo -73.89 -22.11 17.82 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 CA-C-N 121.324 1.509 . . . . 0.0 110.075 -177.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 61.2 m -71.81 -37.64 70.35 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 175.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -67.05 -37.66 84.46 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 174.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -64.82 -43.52 92.83 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.94 -34.22 75.0 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 110.675 -0.12 . . . . 0.0 110.675 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.41 -36.41 84.07 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 64.4 mt -69.73 -52.62 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 120.357 -0.537 . . . . 0.0 109.758 175.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -55.82 -28.14 54.84 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 59.8 t-105 -96.79 -54.88 3.07 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -177.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 354' ' ' PHE . . . . . 0.408 ' CD1' ' CE1' ' B' ' 304' ' ' TYR . 50.7 m-85 -78.36 -29.86 47.72 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -174.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -51.17 110.77 0.47 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.222 0.465 . . . . 0.0 111.839 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 99.7 -2.18 57.09 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 119.541 -0.588 . . . . 0.0 112.715 175.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -83.54 -163.71 0.8 Allowed 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.065 0.932 . . . . 0.0 110.641 177.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -128.53 155.6 44.61 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 121.315 0.579 . . . . 0.0 111.356 178.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -146.78 136.73 23.33 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 124.637 1.175 . . . . 0.0 112.007 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 64.2 m 52.73 19.53 1.29 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -173.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.51 23.4 39.91 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -133.0 141.48 41.13 Favored Pre-proline 0 N--CA 1.453 -0.29 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -178.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.6 135.37 30.66 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 122.862 2.375 . . . . 0.0 109.611 178.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 27.0 pt -122.48 170.82 12.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 121.187 0.518 . . . . 0.0 110.807 -177.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 9.7 tmtm? -145.66 117.93 8.42 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.537 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 10.9 t -105.48 150.13 8.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 C-N-CA 123.324 0.65 . . . . 0.0 112.01 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 30.0 t -162.27 173.88 13.61 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 176.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -71.16 130.24 40.97 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 176.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.281 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.696 179.551 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.279 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 91.9 p -78.59 7.55 6.62 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.994 0.518 . . . . 0.0 111.589 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -68.03 -6.0 20.29 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.175 0.59 . . . . 0.0 111.559 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 90.8 mtp -140.09 161.49 37.5 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.967 0.507 . . . . 0.0 110.109 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -72.77 -16.88 61.63 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 54.63 21.92 3.72 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.821 0.848 . . . . 0.0 112.578 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 44.5 t -69.97 -14.09 62.54 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.769 0.319 . . . . 0.0 110.622 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 33.7 p30 -128.05 17.62 6.67 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.041 0.937 . . . . 0.0 111.176 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -116.4 110.4 18.6 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -177.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -113.32 6.53 17.35 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.161 0.585 . . . . 0.0 111.7 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 59.2 m -109.01 143.12 38.72 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 120.956 0.408 . . . . 0.0 110.961 -176.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 24.7 pt -117.8 147.84 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 174.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 288' ' ' PHE . . . . . 0.448 ' CE2' ' C6 ' ' A' ' 14' ' ' ' U' . 48.9 t80 -99.71 143.54 29.82 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 173.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 19.5 t -127.72 141.36 46.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.813 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -129.06 149.62 50.8 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 88.54 12.67 64.39 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-O 119.818 -0.434 . . . . 0.0 112.633 169.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 65.6 mt -56.93 -51.62 68.44 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 117.532 0.666 . . . . 0.0 110.599 -175.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 147.44 173.41 18.52 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -98.58 -0.85 42.34 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 122.368 -0.489 . . . . 0.0 111.984 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -128.66 13.63 6.44 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.804 0.441 . . . . 0.0 112.168 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.1 m -75.81 165.69 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -173.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 20.7 p -131.17 158.39 40.62 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 123.335 0.654 . . . . 0.0 112.168 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 298' ' ' ILE . . . . . 0.596 HG23 ' HB ' ' B' ' 322' ' ' ILE . 37.5 mt -60.11 -44.27 94.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.267 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -62.93 -36.0 81.95 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.689 0.395 . . . . 0.0 111.505 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 75.3 m -72.22 -43.43 64.44 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 117.893 0.315 . . . . 0.0 110.258 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 71.4 t -62.62 -41.87 93.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.54 -36.86 85.57 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 303' ' ' ASP . . . . . 0.409 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 44.1 t0 -70.21 -27.19 64.29 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 304' ' ' TYR . . . . . 0.418 ' CE2' ' CD1' ' B' ' 354' ' ' PHE . 59.6 t80 -85.21 -25.97 27.03 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -96.54 -23.92 16.3 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 306' ' ' LYS . . . . . 0.409 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.6 ptpt -66.95 -18.19 65.27 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -177.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -72.69 -20.28 61.26 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.8 mm -87.01 -46.46 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.06 0 N-CA-C 110.51 -0.181 . . . . 0.0 110.51 175.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -162.22 167.63 36.91 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 80.0 mt -68.76 119.7 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 120.853 0.358 . . . . 0.0 110.499 -176.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 93.9 mt -73.84 136.39 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 172.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -71.87 133.44 45.45 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -178.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 2.1 m -95.41 139.29 31.9 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 113.18 0.808 . . . . 0.0 113.18 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -70.93 131.85 44.34 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 175.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -91.56 -4.63 55.17 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -96.8 -23.43 16.39 Favored 'General case' 0 C--N 1.338 0.095 0 C-N-CA 122.995 0.518 . . . . 0.0 110.249 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 7.1 p -128.86 -25.78 2.76 Favored 'General case' 0 C--O 1.231 0.085 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -172.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 85.27 -9.48 66.88 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 119.711 -0.494 . . . . 0.0 111.923 173.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -85.16 156.32 60.2 Favored Pre-proline 0 CA--C 1.53 0.202 0 CA-C-N 118.033 0.917 . . . . 0.0 108.91 175.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.09 156.36 66.09 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.052 1.834 . . . . 0.0 109.855 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 321' ' ' MET . . . . . 0.415 ' CB ' ' HB3' ' B' ' 340' ' ' SER . 36.0 mtt -72.62 88.34 1.26 Allowed 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 322' ' ' ILE . . . . . 0.596 ' HB ' HG23 ' B' ' 298' ' ' ILE . 4.0 mp -136.07 140.26 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 171.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -133.41 108.09 8.47 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.28 151.04 35.24 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.796 0.839 . . . . 0.0 109.273 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -117.22 150.56 38.55 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 176.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -131.52 146.98 52.49 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -175.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -78.55 129.86 35.3 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 48.4 mtp85 -85.65 -8.8 58.01 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 122.455 -0.153 . . . . 0.0 110.699 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -96.92 -14.59 21.66 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.521 0.328 . . . . 0.0 111.733 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 2.9 p -136.41 -22.79 1.29 Allowed 'General case' 0 N--CA 1.462 0.125 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 84.12 -0.03 89.49 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 176.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -82.99 157.42 22.96 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 117.579 0.69 . . . . 0.0 109.487 177.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 32.1 mt -71.68 142.08 49.87 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 9.2 mmmm -70.3 -16.99 63.08 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 123.167 0.587 . . . . 0.0 110.479 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.19 6.94 84.2 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -171.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -104.9 148.27 26.86 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.666 0.786 . . . . 0.0 110.379 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -161.96 156.67 22.65 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.845 175.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 21.3 p -103.95 153.15 21.15 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 169.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 23.3 t -135.67 128.37 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 123.582 0.753 . . . . 0.0 109.312 170.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 340' ' ' SER . . . . . 0.415 ' HB3' ' CB ' ' B' ' 321' ' ' MET . 38.7 t -106.73 144.15 33.8 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.883 0.373 . . . . 0.0 111.132 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -109.71 158.77 17.76 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -73.93 -17.61 61.0 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -145.41 149.98 42.75 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 344' ' ' PRO . . . . . 0.467 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 49.2 Cg_endo -70.51 -31.78 16.63 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.272 2.648 . . . . 0.0 114.408 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 345' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 81.0 Cg_endo -73.43 -21.65 19.45 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 CA-C-N 121.515 1.577 . . . . 0.0 110.261 -177.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 60.1 m -73.05 -37.51 66.82 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 175.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.0 -38.35 88.26 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 174.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 9.5 tmtm? -65.13 -43.42 91.99 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -66.83 -34.15 77.18 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.92 -36.74 85.35 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 67.2 mt -69.73 -51.62 39.32 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.094 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.733 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -54.74 -29.49 53.77 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 57.5 t-105 -97.79 -56.4 2.52 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -177.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 354' ' ' PHE . . . . . 0.418 ' CD1' ' CE2' ' B' ' 304' ' ' TYR . 50.7 m-85 -75.8 -28.42 58.33 Favored 'General case' 0 CA--C 1.523 -0.08 0 N-CA-C 114.571 1.322 . . . . 0.0 114.571 -173.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -52.27 108.23 0.27 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 117.844 0.293 . . . . 0.0 111.506 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 100.41 -0.89 55.78 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-O 119.662 -0.521 . . . . 0.0 112.729 175.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -83.72 -165.01 1.0 Allowed 'General case' 0 N--CA 1.461 0.096 0 CA-C-N 118.296 1.048 . . . . 0.0 110.371 176.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -127.41 153.37 46.34 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-O 121.02 0.438 . . . . 0.0 110.83 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -145.57 136.64 24.73 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.307 1.043 . . . . 0.0 112.212 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 21.5 t 53.99 19.28 1.96 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.57 0.348 . . . . 0.0 111.302 -175.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.14 23.18 41.88 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.871 -0.492 . . . . 0.0 111.871 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -132.37 142.42 44.9 Favored Pre-proline 0 N--CA 1.455 -0.22 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.52 136.15 32.87 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 122.873 2.382 . . . . 0.0 109.67 178.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 25.5 pt -124.05 171.07 13.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-O 121.173 0.511 . . . . 0.0 111.025 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -146.02 119.4 9.0 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.434 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 13.3 t -108.04 150.03 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 123.14 0.576 . . . . 0.0 112.133 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 29.1 t -163.85 173.12 13.11 Favored 'General case' 0 C--N 1.339 0.15 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -69.93 130.13 41.37 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 176.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -90.15 178.67 6.11 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.144 0.497 . . . . 0.0 111.922 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 10.2 t -144.56 -154.81 0.56 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.827 1.251 . . . . 0.0 107.783 172.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -124.87 82.08 2.02 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 118.966 0.803 . . . . 0.0 110.832 174.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -62.92 -17.25 61.54 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 172.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.89 -31.65 69.99 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 122.499 0.319 . . . . 0.0 110.278 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -63.01 -11.61 20.2 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -174.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -76.41 -15.21 59.99 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -136.83 -12.23 1.73 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -177.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 52.8 mmm-85 . . . . . 0 C--O 1.252 1.184 0 CA-C-O 117.11 -1.424 . . . . 0.0 110.718 175.63 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.537 0 N19-C1'-C2' 109.232 -2.605 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.518 0 C5'-C4'-C3' 111.969 -2.354 . 0.732 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.518 0 N19-C1'-C2' 109.089 -2.694 . 0.717 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.478 0 N19-C1'-C2' 108.695 -2.941 . 0.804 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.557 0 N19-C1'-C2' 108.271 -3.206 . 0.784 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.423 0 N19-C1'-C2' 108.829 -2.857 . 0.785 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.753 0 O4'-C1'-N19 111.169 2.969 . 0.785 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.501 0 O4'-C1'-N19 111.35 3.15 . 0.745 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.484 0 C4'-C3'-C2' 99.647 -3.053 . 0.667 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.619 0 C4'-C3'-C2' 99.908 -2.792 . 0.585 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.417 0 O4'-C1'-N19 110.842 2.642 . 0.268 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.364 0 O4'-C1'-N19 112.15 3.95 . 0.141 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.707 1 C5'-C4'-C3' 109.399 -4.067 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ' U' . . . . . 0.448 ' C6 ' ' CE2' ' B' ' 288' ' ' PHE . . . . . . . . 0 O4'--C4' 1.425 -2.293 0 O4'-C1'-N19 112.054 3.854 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.623 3.042 0 C5'-C4'-C3' 112.162 -2.225 . 0.257 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.162 0 O4'-C1'-N19 111.739 3.539 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.328 0 N19-C1'-C2' 109.061 -2.712 . 0.581 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.523 0 O4'-C1'-N19 110.884 2.684 . 0.823 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.597 0 O4'-C1'-N19 110.897 2.697 . 0.841 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.483 0 C4'-C3'-C2' 100.252 -2.448 . 0.637 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.577 0 C5'-C4'-C3' 112.076 -2.283 . 0.748 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.654 0 O4'-C1'-N19 110.882 2.682 . 0.813 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.797 0 C5'-C4'-C3' 111.911 -2.393 . 0.749 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.265 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 91.2 p -77.69 3.25 14.44 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.932 0.493 . . . . 0.0 111.407 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 16.8 m80 -63.34 158.57 20.1 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.191 0.597 . . . . 0.0 110.847 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.7 159.37 27.93 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 122.585 0.354 . . . . 0.0 110.619 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -155.67 155.97 34.14 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 53.83 21.72 2.89 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.573 0.749 . . . . 0.0 112.204 -177.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 88.1 p -69.18 -12.99 62.16 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.646 0.378 . . . . 0.0 110.484 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 32.7 p30 -124.27 20.63 8.88 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.063 0.945 . . . . 0.0 111.139 177.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -128.02 113.78 16.25 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -177.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -113.26 2.34 15.52 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.833 0.453 . . . . 0.0 110.584 -178.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 29.3 m -101.5 141.77 33.87 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.011 0.434 . . . . 0.0 111.521 -173.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 38.2 pt -116.6 146.63 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.958 172.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 288' ' ' PHE . . . . . 0.486 ' CE1' ' C6 ' ' A' ' 14' ' ' ' U' . 54.2 t80 -97.94 144.56 27.36 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 173.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 19.4 t -132.34 141.5 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 122.783 0.433 . . . . 0.0 110.969 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -130.92 154.4 48.15 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 122.858 0.463 . . . . 0.0 109.797 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 86.46 12.92 68.89 Favored Glycine 0 CA--C 1.521 0.469 0 CA-C-O 119.831 -0.427 . . . . 0.0 112.355 169.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 74.7 mt -57.49 -50.1 74.16 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 117.54 0.67 . . . . 0.0 110.336 -176.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 144.16 171.03 13.93 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -98.0 3.21 49.49 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 122.544 -0.386 . . . . 0.0 111.855 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -128.29 11.9 6.46 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.638 0.375 . . . . 0.0 111.769 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.6 m -74.8 163.75 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -173.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 20.3 p -128.87 158.93 37.37 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 123.589 0.755 . . . . 0.0 111.85 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 298' ' ' ILE . . . . . 0.548 HG23 ' HB ' ' B' ' 322' ' ' ILE . 40.4 mt -60.29 -44.38 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.547 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -68.72 -30.48 69.13 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 74.8 m -72.16 -43.96 63.81 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 118.17 0.441 . . . . 0.0 109.837 177.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 71.8 t -62.78 -41.05 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.21 -37.38 87.27 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 303' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -70.16 -26.87 64.12 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -85.71 -25.46 26.48 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -96.71 -24.18 16.09 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 306' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -67.11 -18.12 65.17 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 111.576 0.213 . . . . 0.0 111.576 -177.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -72.79 -20.01 61.24 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.2 mm -87.18 -45.69 16.26 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 CA-C-N 117.732 0.242 . . . . 0.0 110.48 175.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.4 167.68 37.74 Favored Glycine 0 C--N 1.335 0.502 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 78.3 mt -69.35 120.4 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-O 120.935 0.397 . . . . 0.0 110.717 -175.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 86.8 mt -75.19 134.47 29.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 171.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -71.11 136.21 48.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 4.8 m -96.86 139.86 32.28 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 176.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.74 135.6 40.32 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -90.33 -9.45 47.75 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 174.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 316' ' ' LYS . . . . . 0.536 ' HB3' ' H62' ' A' ' 17' ' ' ' A' . 71.4 mmtt -91.39 -20.39 21.87 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.603 0.761 . . . . 0.0 110.106 -177.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 11.2 p -135.73 -23.42 1.39 Allowed 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -174.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 83.64 -11.36 56.59 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 119.879 -0.401 . . . . 0.0 112.448 175.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -86.83 159.17 52.49 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 117.876 0.838 . . . . 0.0 109.277 175.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -67.21 155.09 72.13 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 121.724 1.616 . . . . 0.0 109.288 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 321' ' ' MET . . . . . 0.461 ' CB ' ' HB2' ' B' ' 340' ' ' SER . 30.1 mtt -71.38 93.62 1.16 Allowed 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.152 0.501 . . . . 0.0 111.636 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 322' ' ' ILE . . . . . 0.548 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.4 mp -140.89 139.52 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 173.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -132.01 106.32 7.96 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 35.0 mt -78.32 153.41 31.74 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 123.891 0.744 . . . . 0.0 109.361 176.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -119.87 149.49 41.99 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 176.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 3.0 m -131.1 148.16 52.7 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -174.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -76.43 131.24 38.97 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 54.0 mtp85 -84.37 -4.39 58.86 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -99.63 -12.48 20.02 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.936 0.494 . . . . 0.0 111.883 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 29.8 p -136.77 -28.2 0.98 Allowed 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 75.29 12.47 83.53 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -70.28 -108.79 0.0 OUTLIER 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.113 0.965 . . . . 0.0 110.395 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 5.8 mt -160.83 143.63 12.89 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 171.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -77.02 -18.14 58.35 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 122.656 0.382 . . . . 0.0 110.622 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 74.44 5.34 72.41 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -173.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -106.02 149.77 26.37 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.017 0.527 . . . . 0.0 110.167 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -163.52 160.1 22.77 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.727 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 27.4 p -106.88 153.82 21.96 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 169.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 22.1 t -134.26 129.36 53.32 Favored 'Isoleucine or valine' 0 C--O 1.23 0.038 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 170.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 340' ' ' SER . . . . . 0.461 ' HB2' ' CB ' ' B' ' 321' ' ' MET . 20.4 m -108.54 134.62 51.05 Favored 'General case' 0 C--O 1.23 0.068 0 CA-C-O 120.677 0.275 . . . . 0.0 110.3 -176.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -101.14 159.98 14.78 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -70.67 -36.04 73.15 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -127.52 149.06 69.08 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 344' ' ' PRO . . . . . 0.468 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 45.4 Cg_endo -70.83 -31.31 15.98 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.006 2.47 . . . . 0.0 114.647 -177.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 345' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 89.6 Cg_endo -73.61 -21.05 19.7 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 CA-C-N 121.222 1.472 . . . . 0.0 110.087 -177.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 49.0 m -71.25 -37.64 71.95 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 175.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.14 -39.44 89.84 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 174.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -63.36 -44.22 95.43 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.9 -33.92 75.64 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.117 0.167 . . . . 0.0 110.616 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.71 -37.86 89.04 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 67.3 mt -68.59 -53.05 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 120.35 -0.54 . . . . 0.0 109.973 175.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -54.93 -28.08 48.29 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -97.51 -55.47 2.81 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -76.92 -28.29 55.21 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -173.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -52.29 108.5 0.3 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 117.953 0.342 . . . . 0.0 111.366 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 101.61 -0.8 52.82 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.547 -0.585 . . . . 0.0 112.647 175.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -83.88 -163.11 0.72 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 118.09 0.945 . . . . 0.0 110.57 177.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -130.71 153.27 49.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.046 0.451 . . . . 0.0 110.464 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -145.81 138.0 25.43 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.224 1.01 . . . . 0.0 112.408 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 19.2 t 55.49 17.13 2.09 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.858 0.361 . . . . 0.0 111.026 -175.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.01 22.57 41.44 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.858 -0.497 . . . . 0.0 111.858 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 42.6 m-20 -132.26 142.41 44.89 Favored Pre-proline 0 N--CA 1.455 -0.181 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.84 135.5 32.87 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 122.709 2.272 . . . . 0.0 109.872 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 31.3 pt -121.63 170.69 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-O 120.948 0.404 . . . . 0.0 111.16 -177.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -143.21 112.84 6.93 Favored 'General case' 0 C--O 1.227 -0.083 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.793 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 6.3 t -103.85 149.73 7.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 C-N-CA 122.878 0.471 . . . . 0.0 112.258 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 29.4 t -164.13 175.02 10.59 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -71.73 129.77 39.47 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 175.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 369' ' ' ALA . . . . . 0.406 ' HA ' ' O2 ' ' A' ' 14' ' ' ' U' . . . -85.44 177.23 7.85 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.329 0.585 . . . . 0.0 112.325 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 14.9 t -147.65 -155.01 0.59 Allowed 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.278 1.031 . . . . 0.0 109.208 174.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -121.56 76.27 1.25 Allowed 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 118.357 0.526 . . . . 0.0 110.356 176.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -61.86 -17.36 56.18 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 171.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.47 -35.17 71.76 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 123.108 0.563 . . . . 0.0 110.316 175.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -64.07 -10.38 21.84 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -173.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -79.96 -16.78 54.52 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 177.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -134.07 -16.12 2.22 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -176.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 7.2 mmp_? . . . . . 0 C--O 1.251 1.157 0 CA-C-O 117.18 -1.391 . . . . 0.0 110.57 177.171 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.667 0 N19-C1'-C2' 108.966 -2.772 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.427 0 O4'-C1'-N19 110.58 2.38 . 0.642 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.538 0 O4'-C1'-N19 111.187 2.987 . 0.8 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.407 0 N19-C1'-C2' 109.231 -2.606 . 0.738 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.371 0 N19-C1'-C2' 108.79 -2.881 . 0.739 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.29 0 N19-C1'-C2' 109.217 -2.615 . 0.774 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.392 0 O4'-C1'-N19 110.913 2.713 . 0.786 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.627 0 C4'-C3'-C2' 99.917 -2.783 . 0.738 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.479 0 C4'-C3'-C2' 99.639 -3.061 . 0.671 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.43 0 C4'-C3'-C2' 100.027 -2.673 . 0.638 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.514 0 O4'-C1'-N19 110.798 2.598 . 0.345 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.352 0 O4'-C1'-N19 111.993 3.793 . 0.103 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.876 1 C5'-C4'-C3' 109.406 -4.063 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ' U' . . . . . 0.486 ' C6 ' ' CE1' ' B' ' 288' ' ' PHE . . . . . . . . 0 O4'--C4' 1.424 -2.427 0 O4'-C1'-N19 112.184 3.984 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.622 2.872 0 C5'-C4'-C3' 111.592 -2.605 . 0.232 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.219 0 O4'-C1'-N19 111.419 3.219 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ' A' . . . . . 0.536 ' H62' ' HB3' ' B' ' 316' ' ' LYS . . . . . . . . 0 O4'--C4' 1.421 -2.649 0 N19-C1'-C2' 108.991 -2.756 . 0.702 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.398 0 O4'-C1'-N19 110.891 2.691 . 0.847 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.59 0 O4'-C1'-N19 110.966 2.766 . 0.807 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.632 0 O4'-C1'-N19 111.016 2.816 . 0.723 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.569 0 C4'-C3'-C2' 100.288 -2.412 . 0.711 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.704 0 C5'-C4'-C3' 111.353 -2.765 . 0.809 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.475 0 N19-C1'-C2' 109.705 -2.31 . 0.822 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 276' ' ' GLY . . . . . 0.511 ' N ' ' HG ' ' B' ' 282' ' ' SER . . . . . . . . 0 N--CA 1.472 1.076 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 96.2 p -75.16 167.55 21.7 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.72 0.408 . . . . 0.0 110.831 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 55.32 23.34 5.55 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.717 0.807 . . . . 0.0 112.336 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.22 124.04 7.33 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 14.5 p30 -88.01 -24.0 23.64 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 177.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -91.34 31.79 1.11 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.158 0.583 . . . . 0.0 110.608 176.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 282' ' ' SER . . . . . 0.511 ' HG ' ' N ' ' B' ' 276' ' ' GLY . 46.9 t -64.16 -16.38 61.77 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 122.379 -0.201 . . . . 0.0 111.412 -178.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 26.1 p30 -95.07 7.51 45.88 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.238 0.615 . . . . 0.0 112.554 177.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -144.12 110.82 5.63 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.889 0.376 . . . . 0.0 110.674 -176.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -113.11 8.87 18.45 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.696 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 87.7 m -107.97 143.76 36.19 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.148 0.499 . . . . 0.0 110.887 -174.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 41.5 pt -117.34 147.13 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.528 -0.76 . . . . 0.0 108.971 174.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 288' ' ' PHE . . . . . 0.477 ' CE1' ' C6 ' ' A' ' 14' ' ' ' U' . 54.0 t80 -99.45 145.67 27.18 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 173.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 13.5 t -129.69 143.25 41.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 122.651 0.38 . . . . 0.0 111.403 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -131.65 149.57 52.45 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 122.952 0.501 . . . . 0.0 109.829 175.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 88.57 12.06 65.25 Favored Glycine 0 CA--C 1.522 0.494 0 CA-C-O 119.69 -0.506 . . . . 0.0 112.511 169.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 47.0 mt -57.45 -51.53 69.06 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 117.659 0.729 . . . . 0.0 110.836 -174.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 152.55 176.97 25.71 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -95.72 -14.85 23.05 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 122.311 -0.523 . . . . 0.0 112.118 -175.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -128.62 18.72 6.26 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.278 0.49 . . . . 0.0 112.093 -178.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.3 m -65.96 164.4 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -175.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 18.1 p -126.26 160.89 29.07 Favored 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 123.267 0.627 . . . . 0.0 112.265 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 298' ' ' ILE . . . . . 0.565 HG23 ' HB ' ' B' ' 322' ' ' ILE . 28.6 mt -64.54 -43.5 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.966 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -65.26 -37.29 86.76 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 79.5 p -73.29 -42.63 62.2 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 118.137 0.426 . . . . 0.0 110.494 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.5 -41.57 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.79 -36.0 82.92 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 303' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -70.43 -26.62 63.75 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -84.17 -26.68 28.63 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -96.43 -24.9 15.9 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 306' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -66.5 -18.89 65.62 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -177.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -71.8 -20.04 61.91 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -178.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 5.4 mm -87.21 -46.17 16.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 175.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -164.03 168.19 38.39 Favored Glycine 0 C--N 1.335 0.49 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 82.4 mt -69.16 122.03 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 122.603 0.361 . . . . 0.0 110.433 -175.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 95.9 mt -75.69 137.58 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 173.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -72.19 134.08 45.48 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 1.5 m -94.39 139.82 30.61 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -68.75 126.04 28.46 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 175.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -82.37 -8.01 59.63 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 122.433 -0.167 . . . . 0.0 110.594 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.57 -46.05 4.27 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.05 0.54 . . . . 0.0 110.767 -176.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 15.6 p -91.24 -25.47 19.48 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 84.67 -11.54 58.99 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 119.733 -0.482 . . . . 0.0 112.219 174.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -83.9 158.34 62.12 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 117.966 0.883 . . . . 0.0 109.205 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -67.22 154.29 74.68 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 121.812 1.674 . . . . 0.0 109.453 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 321' ' ' MET . . . . . 0.455 ' C ' HD12 ' B' ' 322' ' ' ILE . 35.9 mtt -71.54 86.14 0.87 Allowed 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.907 0.384 . . . . 0.0 111.617 -178.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 322' ' ' ILE . . . . . 0.565 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.7 mp -134.07 143.48 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 171.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -130.76 138.38 49.92 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 171.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 86.4 mt -110.48 129.36 55.8 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 176.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -94.55 154.23 17.49 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -177.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.74 143.06 38.87 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -173.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -76.01 134.62 40.08 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -82.24 -15.15 54.1 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 122.588 -0.07 . . . . 0.0 110.875 176.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -92.3 -15.01 27.95 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -176.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 19.3 p -137.68 -22.37 1.1 Allowed 'General case' 0 C--N 1.339 0.145 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 80.04 2.4 88.73 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -85.33 158.64 20.22 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 117.849 0.824 . . . . 0.0 108.987 177.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 10.2 mp -68.23 143.23 55.37 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -178.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -73.15 -16.28 61.44 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 123.062 0.545 . . . . 0.0 110.483 176.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.8 6.07 84.78 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -171.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -104.11 152.16 22.44 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.629 0.771 . . . . 0.0 109.91 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -160.25 169.66 22.74 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.898 0.38 . . . . 0.0 111.171 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 1.7 p -126.48 150.47 48.7 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 170.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 21.3 t -135.35 125.06 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 C-N-CA 123.577 0.751 . . . . 0.0 109.252 172.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 23.5 t -104.26 136.17 44.36 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.552 0.215 . . . . 0.0 110.605 -178.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -101.66 158.63 15.96 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -177.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -72.87 -31.08 64.47 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -129.54 146.68 62.11 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 344' ' ' PRO . . . . . 0.463 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 46.8 Cg_endo -70.99 -32.21 13.82 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.219 2.613 . . . . 0.0 114.38 -177.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 345' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 77.9 Cg_endo -73.49 -21.93 18.99 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 CA-C-N 121.256 1.484 . . . . 0.0 110.101 -176.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 67.3 m -70.73 -35.14 72.55 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 175.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -68.73 -39.28 80.46 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.62 -43.73 98.31 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 177.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.94 -35.09 76.38 Favored 'General case' 0 C--O 1.225 -0.201 0 O-C-N 122.371 -0.206 . . . . 0.0 110.462 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.31 -36.52 84.33 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 60.0 mt -71.21 -49.18 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.165 175.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -59.98 -27.58 66.95 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -175.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -96.55 -57.33 2.34 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -75.09 -30.93 61.06 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -173.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -54.19 111.17 0.72 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 118.128 0.422 . . . . 0.0 110.947 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 102.03 -3.0 51.65 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 119.556 -0.58 . . . . 0.0 112.559 176.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -84.42 -164.15 0.91 Allowed 'General case' 0 C--O 1.232 0.137 0 CA-C-N 118.093 0.947 . . . . 0.0 109.787 177.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -128.53 153.34 47.28 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.06 0.457 . . . . 0.0 110.971 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -145.01 135.96 24.73 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.041 0.936 . . . . 0.0 112.101 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 62.7 m 53.31 19.5 1.59 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.516 0.327 . . . . 0.0 111.802 -174.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.74 23.23 39.79 Favored Glycine 0 C--N 1.339 0.733 0 N-CA-C 111.784 -0.526 . . . . 0.0 111.784 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 56.9 m-20 -132.55 142.25 44.17 Favored Pre-proline 0 N--CA 1.452 -0.333 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -177.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.83 135.37 30.11 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.804 2.336 . . . . 0.0 109.72 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 30.6 pt -122.9 169.91 13.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.22 0.533 . . . . 0.0 111.166 -177.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 5.3 tmtm? -145.72 114.05 6.66 Favored 'General case' 0 C--N 1.338 0.069 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 11.2 t -103.89 149.73 7.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.077 0.551 . . . . 0.0 112.24 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 28.1 t -162.71 172.42 15.31 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 176.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -70.48 130.17 41.17 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -91.66 -179.88 5.46 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.277 -177.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 9.3 t -148.3 -155.93 0.67 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.893 1.277 . . . . 0.0 107.782 173.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -122.56 92.83 3.8 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 119.033 0.833 . . . . 0.0 111.047 173.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -69.26 -9.05 51.33 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 116.763 -0.199 . . . . 0.0 110.754 173.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -61.21 -24.68 66.52 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 122.492 0.317 . . . . 0.0 110.622 175.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -65.56 -15.44 62.71 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.856 0.462 . . . . 0.0 112.098 -176.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -76.33 -17.77 59.25 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -132.64 -14.01 2.88 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 377' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' B' ' 377' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.312 0 CA-C-O 117.788 -1.101 . . . . 0.0 110.326 177.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.493 0 N19-C1'-C2' 108.918 -2.801 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.637 0 O4'-C1'-N19 110.336 2.136 . 0.68 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.624 0 C5'-C4'-C3' 111.386 -2.743 . 0.699 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.544 0 N19-C1'-C2' 109.04 -2.725 . 0.839 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.576 0 N19-C1'-C2' 108.444 -3.097 . 0.741 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.36 0 N19-C1'-C2' 108.965 -2.772 . 0.786 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.771 0 O4'-C1'-N19 111.07 2.87 . 0.74 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.441 0 C4'-C3'-C2' 99.938 -2.762 . 0.731 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.36 0 C4'-C3'-C2' 99.712 -2.988 . 0.662 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.644 0 C4'-C3'-C2' 99.516 -3.184 . 0.486 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.246 0 O4'-C1'-N19 110.973 2.773 . 0.232 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.419 1 O4'-C1'-N19 112.505 4.305 . 0.097 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.685 0 C5'-C4'-C3' 109.672 -3.885 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ' U' . . . . . 0.477 ' C6 ' ' CE1' ' B' ' 288' ' ' PHE . . . . . . . . 0 O4'--C4' 1.422 -2.572 0 O4'-C1'-N19 111.76 3.56 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.623 3.007 0 O4'-C1'-N19 110.31 2.11 . 0.51 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.5 0 O4'-C1'-N19 111.437 3.237 . 0.43 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.272 0 N19-C1'-C2' 109.298 -2.564 . 0.544 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.571 0 O4'-C1'-N19 110.808 2.608 . 0.803 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ' U' . . . . . 0.411 " H2'" ' C6 ' ' A' ' 20' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.423 -2.503 0 O4'-C1'-N19 111.03 2.83 . 0.849 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ' U' . . . . . 0.411 ' C6 ' " H2'" ' A' ' 19' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.574 0 O4'-C1'-N19 110.681 2.481 . 0.674 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.446 0 C4'-C3'-C2' 100.408 -2.292 . 0.738 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.649 0 C5'-C4'-C3' 111.643 -2.572 . 0.779 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.623 0 N19-C1'-C2' 109.492 -2.442 . 0.796 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.167 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 93.2 p -77.13 16.35 0.58 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.401 0.68 . . . . 0.0 111.753 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -66.12 -9.29 29.92 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.176 0.59 . . . . 0.0 111.704 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 279' ' ' MET . . . . . 0.557 ' HG3' ' H ' ' B' ' 281' ' ' ASN . 56.1 tpp -155.44 152.8 29.42 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -65.49 -20.2 66.25 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 281' ' ' ASN . . . . . 0.557 ' H ' ' HG3' ' B' ' 279' ' ' MET . 37.4 m-20 -84.61 39.7 0.75 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.3 0.64 . . . . 0.0 110.135 175.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 92.3 p -61.95 -19.3 62.6 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.545 0.338 . . . . 0.0 111.285 -177.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -93.22 3.72 55.2 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 176.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -144.41 109.96 5.24 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.957 0.408 . . . . 0.0 110.416 -176.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 285' ' ' ASN . . . . . 0.408 HD22 ' C ' ' B' ' 285' ' ' ASN . 0.4 OUTLIER -117.42 8.12 12.95 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 122.987 0.515 . . . . 0.0 112.354 -178.897 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 35.0 m -104.88 140.79 37.61 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -173.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 41.1 pt -110.29 142.82 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 288' ' ' PHE . . . . . 0.465 ' CE2' ' C6 ' ' A' ' 14' ' ' ' U' . 56.7 t80 -93.79 141.91 27.97 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 172.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 15.9 t -130.38 141.18 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 O-C-N 123.156 0.285 . . . . 0.0 111.173 177.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -126.98 154.12 45.01 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 174.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 85.47 12.18 73.31 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-O 119.772 -0.46 . . . . 0.0 112.425 169.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 60.0 mt -56.69 -50.59 71.7 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 117.536 0.668 . . . . 0.0 110.752 -175.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 156.79 179.69 31.95 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -97.79 -8.43 28.49 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -177.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -141.22 24.4 2.13 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.5 m -67.95 162.81 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -174.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 20.8 p -122.84 156.51 34.43 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 298' ' ' ILE . . . . . 0.438 HG23 ' HB ' ' B' ' 322' ' ' ILE . 35.4 mt -61.56 -43.23 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.038 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -65.15 -35.73 82.02 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.61 0.364 . . . . 0.0 111.54 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 38.6 t -73.23 -44.1 60.11 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 122.25 -0.281 . . . . 0.0 110.389 -178.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 93.9 t -62.08 -41.51 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.95 -35.23 80.51 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 303' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -70.97 -29.28 65.22 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 304' ' ' TYR . . . . . 0.413 ' CE1' ' CD1' ' B' ' 354' ' ' PHE . 59.9 t80 -83.77 -24.96 30.88 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -96.62 -23.35 16.53 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 306' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -67.81 -16.76 64.26 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -177.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -73.02 -19.86 61.11 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 111.561 0.208 . . . . 0.0 111.561 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 3.9 mm -87.07 -47.76 15.8 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.109 0 CA-C-O 120.525 0.202 . . . . 0.0 110.781 175.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -161.4 175.38 38.0 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 74.4 mt -73.86 111.89 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-O 120.808 0.337 . . . . 0.0 110.133 -176.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 73.6 mt -68.16 135.53 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 172.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 312' ' ' LYS . . . . . 0.433 ' HG2' ' SD ' ' B' ' 321' ' ' MET . 40.7 ttmt -66.39 136.17 55.36 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -178.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 4.9 m -110.96 135.69 51.09 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.444 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -67.39 132.8 48.37 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -176.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -80.96 -5.41 57.48 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -108.44 -14.55 14.64 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 123.281 0.632 . . . . 0.0 111.68 -175.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 7.5 p -133.42 -25.04 1.76 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -176.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 80.58 -5.99 62.78 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 119.822 -0.432 . . . . 0.0 112.6 174.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -90.24 157.3 45.35 Favored Pre-proline 0 CA--C 1.531 0.223 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 175.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -66.05 150.19 85.47 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 121.288 1.325 . . . . 0.0 108.88 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 321' ' ' MET . . . . . 0.433 ' SD ' ' HG2' ' B' ' 312' ' ' LYS . 81.2 mtp -85.65 85.27 7.42 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.573 0.702 . . . . 0.0 111.09 -172.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 322' ' ' ILE . . . . . 0.438 ' HB ' HG23 ' B' ' 298' ' ' ILE . 2.3 mp -118.12 149.78 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 125.257 1.423 . . . . 0.0 108.328 174.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -134.94 116.16 14.4 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 170.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 55.5 mt -90.44 150.06 21.98 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 177.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -115.12 150.89 35.29 Favored 'General case' 0 C--O 1.226 -0.183 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 3.1 m -137.7 148.09 45.37 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -176.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -81.47 135.13 35.61 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 38.4 mtt-85 -84.7 -9.82 57.87 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.387 -0.196 . . . . 0.0 110.98 175.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -91.15 -15.02 30.04 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.554 0.342 . . . . 0.0 111.794 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 6.1 p -137.58 -25.83 1.0 Allowed 'General case' 0 C--O 1.232 0.175 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 73.32 10.47 78.81 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 119.659 -0.523 . . . . 0.0 111.913 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -74.6 -101.62 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.173 0.589 . . . . 0.0 110.288 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 2.2 tp -164.84 146.18 7.85 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.072 0.949 . . . . 0.0 108.645 172.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -78.58 -18.93 53.86 Favored 'General case' 0 N--CA 1.461 0.092 0 CA-C-N 117.836 0.289 . . . . 0.0 110.533 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 72.59 5.12 62.99 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -172.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -103.48 150.63 23.7 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.275 0.63 . . . . 0.0 110.354 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.16 169.4 24.25 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.008 0.433 . . . . 0.0 110.328 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 2.5 p -132.3 147.44 52.4 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 171.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 339' ' ' VAL . . . . . 0.402 ' CG1' HG13 ' B' ' 322' ' ' ILE . 1.0 OUTLIER -137.27 141.46 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 169.818 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 44.6 t -92.36 145.46 24.46 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.585 -177.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -112.46 151.92 29.34 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 175.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -70.61 -22.77 62.5 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 343' ' ' ASP . . . . . 0.435 ' HB3' ' HD2' ' B' ' 345' ' ' PRO . 48.3 m-20 -144.49 148.31 39.82 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 124.025 0.93 . . . . 0.0 111.769 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 344' ' ' PRO . . . . . 0.466 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 53.6 Cg_endo -71.62 -31.81 12.87 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.507 2.804 . . . . 0.0 115.063 -172.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 345' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 98.7 Cg_endo -73.51 -22.44 18.35 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 CA-C-N 121.286 1.495 . . . . 0.0 109.841 -178.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 48.7 m -73.21 -34.14 65.76 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 175.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -67.31 -41.21 85.73 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 175.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -70.85 -32.91 70.07 Favored 'General case' 0 C--O 1.227 -0.108 0 C-N-CA 121.16 -0.216 . . . . 0.0 110.841 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.07 -36.88 80.56 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 175.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.43 -36.99 85.58 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 71.5 mt -68.16 -52.67 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 175.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -55.12 -29.75 58.33 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 54.1 t-105 -96.64 -55.14 3.0 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 354' ' ' PHE . . . . . 0.413 ' CD1' ' CE1' ' B' ' 304' ' ' TYR . 51.0 m-85 -76.16 -27.21 56.89 Favored 'General case' 0 CA--C 1.522 -0.119 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 -173.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -49.19 109.68 0.29 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 117.98 0.355 . . . . 0.0 111.932 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 96.79 0.45 60.47 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 119.477 -0.624 . . . . 0.0 112.736 174.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -83.62 -164.6 0.94 Allowed 'General case' 0 C--N 1.339 0.111 0 CA-C-N 118.209 1.004 . . . . 0.0 110.186 176.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -128.97 152.12 48.93 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 120.981 0.42 . . . . 0.0 110.83 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -144.25 136.45 26.45 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.186 0.994 . . . . 0.0 112.451 177.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 20.7 t 54.36 19.0 2.08 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.517 0.327 . . . . 0.0 111.125 -175.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.48 23.78 38.67 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 112.004 -0.438 . . . . 0.0 112.004 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -132.8 142.62 45.4 Favored Pre-proline 0 N--CA 1.455 -0.213 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -177.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.8 136.61 33.32 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 122.751 2.3 . . . . 0.0 109.441 178.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 33.6 pt -123.69 169.95 14.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 CA-C-O 121.203 0.525 . . . . 0.0 111.259 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -143.33 113.79 7.43 Favored 'General case' 0 C--O 1.23 0.043 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.765 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 12.2 t -105.39 147.55 10.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.002 0.521 . . . . 0.0 112.2 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 23.0 t -163.68 172.94 13.53 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -71.76 129.58 39.01 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 175.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -80.58 174.43 11.62 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.878 -178.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 3.6 p -134.45 -155.77 0.68 Allowed 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.647 1.179 . . . . 0.0 110.644 174.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -120.43 71.19 0.91 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 118.185 0.448 . . . . 0.0 110.981 176.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -65.24 -10.71 34.13 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 170.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -64.17 -35.53 81.09 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.55 0.74 . . . . 0.0 110.473 171.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -70.24 -6.61 35.93 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -171.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -74.79 -16.28 60.72 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 176.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -136.59 -14.48 1.67 Allowed 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 8.7 ptp85 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 117.787 -1.102 . . . . 0.0 110.477 178.815 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.725 0 N19-C1'-C2' 108.965 -2.772 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.396 0 O4'-C1'-N19 110.667 2.467 . 0.712 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.487 0 C5'-C4'-C3' 111.523 -2.651 . 0.738 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.661 0 N19-C1'-C2' 108.788 -2.882 . 0.778 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.793 0 C4'-C3'-C2' 99.578 -3.122 . 0.638 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.603 0 N19-C1'-C2' 109.017 -2.739 . 0.734 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.551 0 O4'-C1'-N19 111.1 2.9 . 0.732 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.504 0 O4'-C1'-N19 111.343 3.143 . 0.702 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.345 0 C4'-C3'-C2' 99.792 -2.908 . 0.62 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.58 0 O4'-C1'-N19 111.195 2.995 . 0.599 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ' A' . . . . . 0.402 " H2'" ' C8 ' ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.624 0 O4'-C1'-N19 110.838 2.638 . 0.579 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ' A' . . . . . 0.402 ' C8 ' " H2'" ' A' ' 11' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.428 -2.044 1 O4'-C1'-N19 112.584 4.384 . 0.23 1b . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.64 0 C5'-C4'-C3' 110.129 -3.581 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ' U' . . . . . 0.465 ' C6 ' ' CE2' ' B' ' 288' ' ' PHE . . . . . . . . 0 O4'--C4' 1.422 -2.606 0 O4'-C1'-N19 111.812 3.612 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.624 3.087 0 C5'-C4'-C3' 111.71 -2.527 . 0.627 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.644 0 O4'-C1'-N19 111.634 3.434 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.515 0 N19-C1'-C2' 108.473 -3.079 . 0.712 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.333 0 O4'-C1'-N19 110.97 2.77 . 0.828 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.738 0 O4'-C1'-N19 111.091 2.891 . 0.8 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.264 0 O4'-C1'-N19 111.003 2.803 . 0.648 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.515 0 C5'-C4'-C3' 111.821 -2.452 . 0.716 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.893 0 C5'-C4'-C3' 111.447 -2.702 . 0.803 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.662 0 N19-C1'-C2' 109.667 -2.333 . 0.77 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.333 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 42.1 t -155.42 162.16 40.83 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.788 0.435 . . . . 0.0 110.071 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 33.4 m170 59.58 12.5 2.86 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.017 0.927 . . . . 0.0 112.04 -178.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 50.9 tpp -75.83 131.94 40.06 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 51.74 17.68 0.64 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 53.3 25.76 4.71 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.672 0.789 . . . . 0.0 112.303 -176.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 74.3 m -71.7 -4.25 26.42 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.59 0.356 . . . . 0.0 111.155 178.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 52.3 p30 -143.22 26.9 1.62 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.105 0.962 . . . . 0.0 109.774 178.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -130.61 111.04 11.86 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.092 -176.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -113.47 11.23 18.37 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.296 0.639 . . . . 0.0 111.584 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 26.4 m -107.39 145.11 33.34 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.044 0.45 . . . . 0.0 111.84 -173.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 30.4 pt -122.06 146.69 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.028 175.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -98.63 143.18 29.3 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 173.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 18.4 t -128.41 142.93 42.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 O-C-N 123.312 0.382 . . . . 0.0 111.177 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -131.69 150.33 52.19 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 176.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.86 12.72 65.84 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-O 119.669 -0.517 . . . . 0.0 112.397 169.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 65.7 mt -55.24 -51.46 66.52 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 117.598 0.699 . . . . 0.0 110.571 -175.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 146.74 176.25 20.37 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -101.54 1.26 37.79 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.607 0.363 . . . . 0.0 111.81 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -128.7 12.12 6.28 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.6 m -74.41 162.93 4.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -172.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 30.5 p -132.12 159.72 38.1 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 123.724 0.81 . . . . 0.0 111.268 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 298' ' ' ILE . . . . . 0.577 HG23 ' HB ' ' B' ' 322' ' ' ILE . 37.7 mt -61.85 -43.6 97.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.169 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -63.53 -35.63 81.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 122.527 0.331 . . . . 0.0 111.472 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 75.0 m -71.73 -44.56 63.91 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-N 118.06 0.391 . . . . 0.0 110.349 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 74.9 t -63.03 -40.68 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -65.18 -36.26 83.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 303' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -70.61 -26.65 63.59 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -85.05 -25.52 27.58 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -96.44 -24.8 15.94 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 306' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -66.43 -18.9 65.62 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 122.396 -0.19 . . . . 0.0 111.467 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -71.84 -19.78 61.92 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 111.682 0.252 . . . . 0.0 111.682 -178.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.8 mm -88.15 -45.48 15.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.086 0 CA-C-N 117.632 0.196 . . . . 0.0 110.561 175.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -164.4 168.66 38.86 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 87.8 mt -69.02 122.14 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 121.021 0.439 . . . . 0.0 110.305 -175.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 92.0 mt -75.66 138.46 20.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 172.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 312' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' B' ' 312' ' ' LYS . 36.2 ttmt -72.35 130.09 39.91 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -178.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 3.4 m -92.04 143.17 26.74 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 177.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -76.75 134.57 39.12 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 315' ' ' LYS . . . . . 0.539 ' HE3' ' HA ' ' B' ' 315' ' ' LYS . 0.5 OUTLIER -80.49 -13.48 59.07 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 122.789 0.436 . . . . 0.0 110.458 172.944 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 316' ' ' LYS . . . . . 0.45 ' HB3' ' H62' ' A' ' 17' ' ' ' A' . 42.4 mmtm -94.27 -23.58 17.8 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.054 0.541 . . . . 0.0 111.439 -173.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 17.1 p -135.44 -20.61 1.6 Allowed 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -172.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 81.89 -11.34 48.2 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 119.837 -0.424 . . . . 0.0 112.411 175.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -84.89 158.83 58.57 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 117.813 0.806 . . . . 0.0 109.16 174.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.75 154.08 74.11 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 121.966 1.777 . . . . 0.0 110.074 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 321' ' ' MET . . . . . . . . . . . . . 39.0 mtt -70.97 92.86 0.95 Allowed 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.023 0.439 . . . . 0.0 111.53 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 322' ' ' ILE . . . . . 0.577 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.9 mp -140.4 141.56 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 172.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -127.06 132.55 50.66 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 170.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 73.4 mt -107.64 135.12 49.61 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 177.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -102.7 146.25 28.49 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 4.0 m -132.46 146.07 51.66 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -174.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -72.82 129.79 38.97 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 44.4 mtp85 -82.83 -6.78 59.59 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 122.451 -0.155 . . . . 0.0 110.946 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -98.55 -13.51 20.41 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 122.856 0.462 . . . . 0.0 112.113 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 6.3 p -136.21 -26.0 1.17 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 74.54 12.82 82.28 Favored Glycine 0 CA--C 1.533 1.205 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 175.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -72.94 -107.03 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.856 0.862 . . . . 0.0 110.463 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 4.7 mt -161.29 144.84 12.89 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.465 1.106 . . . . 0.0 108.11 171.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -81.59 -20.79 39.11 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 122.622 0.369 . . . . 0.0 110.733 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.41 3.04 76.41 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -174.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -102.84 149.32 24.62 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 117.288 0.544 . . . . 0.0 109.682 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -160.16 167.45 27.66 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.793 0.33 . . . . 0.0 111.473 -176.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 2.7 p -120.25 151.6 38.93 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 169.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 32.4 t -136.73 129.5 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 123.668 0.787 . . . . 0.0 108.927 171.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 47.3 t -109.19 140.45 42.78 Favored 'General case' 0 CA--C 1.523 -0.091 0 CA-C-N 117.795 0.27 . . . . 0.0 111.311 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -105.91 158.88 16.45 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -70.93 -33.78 70.85 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -128.4 147.45 63.88 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 344' ' ' PRO . . . . . 0.475 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 42.6 Cg_endo -70.69 -31.85 15.68 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 123.223 2.616 . . . . 0.0 114.549 -176.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 345' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 89.7 Cg_endo -73.62 -21.17 19.52 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 CA-C-N 121.059 1.414 . . . . 0.0 110.431 -177.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 69.8 m -70.98 -36.85 72.68 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 175.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -69.27 -36.78 77.44 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 175.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -64.62 -43.37 93.95 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -69.22 -33.43 73.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 110.624 -0.139 . . . . 0.0 110.624 177.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.38 -37.13 86.44 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 63.3 mt -69.69 -52.84 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -55.57 -27.32 48.5 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -97.56 -56.62 2.46 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -75.58 -29.5 59.34 Favored 'General case' 0 C--N 1.337 0.052 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -173.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -53.08 107.71 0.26 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.944 0.338 . . . . 0.0 111.412 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 101.58 -0.98 52.93 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 119.533 -0.593 . . . . 0.0 112.737 176.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -84.75 -164.39 0.97 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-N 117.989 0.895 . . . . 0.0 110.154 176.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -128.91 152.38 48.62 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.825 0.345 . . . . 0.0 111.004 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -143.77 137.07 27.8 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.12 0.968 . . . . 0.0 112.398 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 59.7 m 53.14 18.87 1.28 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -174.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 89.21 21.47 41.52 Favored Glycine 0 C--N 1.338 0.676 0 CA-C-O 119.821 -0.433 . . . . 0.0 112.158 179.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -132.19 143.06 47.35 Favored Pre-proline 0 N--CA 1.457 -0.118 0 CA-C-N 117.501 0.65 . . . . 0.0 109.295 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.57 135.85 31.97 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.987 2.458 . . . . 0.0 109.651 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 25.8 pt -124.11 170.77 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-O 121.112 0.482 . . . . 0.0 110.946 -178.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -145.18 118.13 8.79 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.118 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 12.7 t -106.78 150.32 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 123.165 0.586 . . . . 0.0 111.729 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 27.0 t -163.79 172.5 14.03 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 175.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -70.04 130.64 42.69 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 176.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -88.24 163.4 16.13 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.359 177.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -153.45 132.72 12.73 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 172.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 73.1 mtm-85 -51.27 102.28 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -168.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 372' ' ' ARG . . . . . 0.459 ' HA ' ' CZ ' ' B' ' 375' ' ' PHE . 54.9 ttt180 -69.31 -20.04 63.89 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 171.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -66.35 -7.3 18.13 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.414 0.686 . . . . 0.0 111.254 176.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -99.02 -10.2 22.94 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 114.317 1.228 . . . . 0.0 114.317 -176.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 375' ' ' PHE . . . . . 0.459 ' CZ ' ' HA ' ' B' ' 372' ' ' ARG . 15.0 p90 -138.83 -19.42 1.02 Allowed 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 -178.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -78.61 -12.26 60.01 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 122.386 -0.196 . . . . 0.0 110.723 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 . . . . . 0 C--O 1.252 1.185 0 CA-C-O 117.363 -1.303 . . . . 0.0 110.587 -177.543 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.632 0 N19-C1'-C2' 109.097 -2.689 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.442 0 O4'-C1'-N19 110.565 2.365 . 0.7 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.501 0 O4'-C1'-N19 110.928 2.728 . 0.773 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.531 0 N19-C1'-C2' 108.732 -2.917 . 0.749 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.489 0 N19-C1'-C2' 108.764 -2.897 . 0.663 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.233 0 N19-C1'-C2' 109.175 -2.64 . 0.808 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.781 0 O4'-C1'-N19 110.667 2.467 . 0.787 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.469 0 C4'-C3'-C2' 99.526 -3.174 . 0.775 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.439 0 C4'-C3'-C2' 99.519 -3.181 . 0.672 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.728 0 C4'-C3'-C2' 99.932 -2.768 . 0.606 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.258 0 C4'-C3'-C2' 100.027 -2.673 . 0.447 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.273 1 O4'-C1'-N19 112.224 4.024 . 0.183 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.496 0 C5'-C4'-C3' 109.639 -3.907 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.619 1 C3'-C2'-C1' 105.102 4.002 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.651 0 O4'-C1'-N19 110.896 2.696 . 0.282 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.237 0 O4'-C1'-N19 111.391 3.191 . 0.407 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ' A' . . . . . 0.45 ' H62' ' HB3' ' B' ' 316' ' ' LYS . . . . . . . . 0 O4'--C4' 1.424 -2.377 0 N19-C1'-C2' 109.209 -2.62 . 0.689 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.479 0 C5'-C4'-C3' 111.752 -2.499 . 0.821 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.708 0 O4'-C1'-N19 111.004 2.804 . 0.754 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.269 0 O4'-C1'-N19 110.78 2.58 . 0.649 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.384 0 C5'-C4'-C3' 112.138 -2.241 . 0.734 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.686 0 C5'-C4'-C3' 111.649 -2.567 . 0.789 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.433 0 O4'-C1'-N19 110.788 2.588 . 0.791 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.02 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 90.3 p -78.13 4.25 12.96 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.852 0.461 . . . . 0.0 111.436 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -63.05 157.62 21.62 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.039 0.535 . . . . 0.0 110.948 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 5.7 tpt -154.08 152.7 30.76 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 31.2 p30 -147.27 174.62 11.46 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.041 0.536 . . . . 0.0 110.967 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 45.2 m-20 52.2 30.99 8.46 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.347 0.659 . . . . 0.0 111.933 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 47.7 t -63.51 -18.97 64.37 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 122.155 -0.341 . . . . 0.0 110.652 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 22.0 p30 -93.7 8.74 39.79 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.398 0.679 . . . . 0.0 112.798 177.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -143.32 110.37 5.66 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.767 0.317 . . . . 0.0 110.2 -177.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -113.79 2.17 15.06 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.859 0.464 . . . . 0.0 111.193 -177.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 84.8 m -103.87 142.4 34.46 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.105 0.479 . . . . 0.0 110.558 -174.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 44.5 pt -114.93 146.75 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -98.85 144.44 28.05 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 173.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 289' ' ' VAL . . . . . 0.552 ' CG1' HD13 ' B' ' 292' ' ' LEU . 60.7 t -129.28 136.16 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 O-C-N 123.411 0.445 . . . . 0.0 110.57 -178.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -126.64 155.16 43.01 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 176.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 83.32 12.71 78.2 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 172.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 292' ' ' LEU . . . . . 0.552 HD13 ' CG1' ' B' ' 289' ' ' VAL . 4.2 tp -59.27 -50.82 72.54 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.98 0.912 . . . . 0.0 110.996 -170.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 143.64 165.04 10.63 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.311 -0.715 . . . . 0.0 111.311 176.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -95.81 3.93 53.31 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.532 0.333 . . . . 0.0 111.34 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -128.71 12.73 6.35 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.764 0.426 . . . . 0.0 111.84 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 4.2 m -72.63 166.75 2.45 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -173.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 32.5 p -137.82 160.76 38.39 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 124.072 0.949 . . . . 0.0 110.835 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 298' ' ' ILE . . . . . 0.502 HG23 ' HB ' ' B' ' 322' ' ' ILE . 41.7 mt -63.08 -40.74 90.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -66.36 -38.07 86.75 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 80.6 p -73.25 -44.17 59.89 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 117.945 0.339 . . . . 0.0 110.237 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 71.0 t -60.76 -42.87 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -65.24 -34.82 79.27 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 122.224 -0.297 . . . . 0.0 110.293 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 303' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -69.83 -28.09 65.41 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -84.17 -25.83 29.27 Favored 'General case' 0 C--O 1.226 -0.157 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -96.16 -23.71 16.61 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 306' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -68.19 -18.06 64.49 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -177.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -72.45 -19.17 61.61 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -178.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 3.6 mm -87.89 -47.81 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 CA-C-N 117.564 0.165 . . . . 0.0 110.746 175.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -161.61 173.82 38.04 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 76.1 mt -71.89 116.35 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 120.861 0.363 . . . . 0.0 110.099 -175.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 76.1 mt -71.59 137.93 22.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 172.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 312' ' ' LYS . . . . . 0.448 ' HG2' ' SD ' ' B' ' 321' ' ' MET . 40.9 ttmt -68.88 142.42 54.8 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 4.9 m -113.63 136.9 52.32 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -66.12 131.82 47.06 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -79.67 -11.05 59.87 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 32.7 mmtm -99.47 -25.43 14.45 Favored 'General case' 0 CA--C 1.527 0.061 0 C-N-CA 122.684 0.394 . . . . 0.0 111.019 -175.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 6.9 p -126.25 -25.16 3.56 Favored 'General case' 0 C--O 1.23 0.074 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -171.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 81.3 -6.4 64.09 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 119.773 -0.459 . . . . 0.0 112.423 174.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -85.25 156.75 59.79 Favored Pre-proline 0 C--O 1.234 0.249 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 174.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.67 150.67 74.72 Favored 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 121.485 1.456 . . . . 0.0 109.178 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 321' ' ' MET . . . . . 0.488 ' C ' HD12 ' B' ' 322' ' ' ILE . 62.3 mtp -82.43 85.88 6.84 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.37 0.605 . . . . 0.0 111.558 -172.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 322' ' ' ILE . . . . . 0.502 ' HB ' HG23 ' B' ' 298' ' ' ILE . 2.7 mp -126.46 147.83 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 174.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -134.25 111.88 10.61 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 173.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 30.6 mt -80.76 149.76 29.52 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 123.93 0.769 . . . . 0.0 108.936 176.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -115.48 145.79 42.27 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 326' ' ' THR . . . . . 0.413 HG23 ' O ' ' B' ' 332' ' ' LYS . 6.8 m -135.86 146.04 47.02 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -175.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -68.82 125.09 25.49 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 177.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -76.82 -12.63 60.0 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -177.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -94.79 -14.91 24.23 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.897 0.479 . . . . 0.0 111.91 -176.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 4.4 p -135.42 -24.62 1.37 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -177.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 75.54 13.91 82.51 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-O 119.71 -0.494 . . . . 0.0 112.221 172.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 332' ' ' LYS . . . . . 0.413 ' O ' HG23 ' B' ' 326' ' ' THR . 60.3 mtpt -72.75 -111.05 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.55 0.74 . . . . 0.0 110.841 178.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 6.2 mt -158.55 143.14 15.97 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.189 0.996 . . . . 0.0 108.532 170.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -79.15 -19.96 49.7 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.041 0.536 . . . . 0.0 111.329 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.62 22.16 73.16 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -173.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -128.36 146.62 50.72 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.073 0.549 . . . . 0.0 110.18 -178.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -156.04 159.44 39.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.727 0.298 . . . . 0.0 111.587 174.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 3.4 p -104.1 155.81 18.39 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 170.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 16.7 t -138.12 122.48 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.042 0 C-N-CA 123.432 0.693 . . . . 0.0 110.312 172.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 69.2 m -90.78 144.21 25.95 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 117.961 0.346 . . . . 0.0 110.967 177.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 341' ' ' PHE . . . . . 0.403 ' O ' ' HE3' ' B' ' 312' ' ' LYS . 26.3 m-85 -112.89 151.2 30.75 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 177.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -69.92 -28.91 65.99 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -177.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -132.71 148.51 69.8 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -178.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 344' ' ' PRO . . . . . 0.474 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 37.9 Cg_endo -70.42 -33.14 14.59 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.357 2.705 . . . . 0.0 114.205 -177.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 345' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 85.8 Cg_endo -73.54 -20.96 19.98 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 CA-C-N 121.225 1.473 . . . . 0.0 110.252 -177.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 70.3 m -72.05 -37.14 69.75 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -68.26 -38.37 81.71 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 175.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -65.06 -42.43 94.19 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -69.16 -34.71 75.39 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.399 -0.188 . . . . 0.0 110.956 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.17 -37.67 88.28 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 66.0 mt -68.56 -53.62 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.775 175.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -55.01 -27.73 46.53 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 54.8 t-105 -97.52 -55.35 2.85 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -76.26 -28.21 57.01 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -173.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -51.92 109.52 0.38 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 120.959 0.409 . . . . 0.0 111.555 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 101.29 -1.18 54.01 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 119.515 -0.603 . . . . 0.0 112.278 175.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -86.43 -165.64 1.32 Allowed 'General case' 0 C--O 1.231 0.084 0 CA-C-N 118.277 1.039 . . . . 0.0 110.698 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -127.28 155.59 43.26 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 121.061 0.458 . . . . 0.0 111.089 178.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -145.88 135.82 23.55 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.515 1.126 . . . . 0.0 112.196 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 20.8 t 54.11 18.77 1.85 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 120.873 0.368 . . . . 0.0 111.647 -176.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.67 24.17 33.9 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 112.031 -0.427 . . . . 0.0 112.031 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 53.1 m-20 -133.91 142.61 44.13 Favored Pre-proline 0 N--CA 1.454 -0.265 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -69.6 136.53 33.67 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 122.808 2.338 . . . . 0.0 109.308 176.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 31.2 pt -124.25 169.2 15.89 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 121.001 0.429 . . . . 0.0 110.96 -177.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -142.92 113.69 7.54 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.52 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 12.0 t -103.06 148.03 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 C-N-CA 123.144 0.577 . . . . 0.0 111.727 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 22.7 t -162.6 173.54 13.81 Favored 'General case' 0 C--N 1.338 0.099 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 177.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -70.64 128.31 35.65 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 176.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -88.24 179.71 6.31 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.125 0.488 . . . . 0.0 112.008 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 9.7 t -147.68 -154.04 0.53 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 173.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 72.9 mtt85 -124.48 92.19 3.61 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.037 0.835 . . . . 0.0 110.961 173.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 82.6 mtt-85 -62.95 -14.34 45.97 Favored 'General case' 0 C--N 1.339 0.124 0 N-CA-C 110.614 -0.143 . . . . 0.0 110.614 173.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.29 -8.94 6.62 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.033 0.533 . . . . 0.0 111.162 176.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -100.83 -12.95 18.62 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 114.152 1.168 . . . . 0.0 114.152 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -140.95 -26.41 0.73 Allowed 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 117.218 2.303 . . . . 0.0 117.218 -177.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -78.52 -7.03 57.06 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 . . . . . 0 C--O 1.253 1.28 0 CA-C-O 117.393 -1.289 . . . . 0.0 110.457 -178.296 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.449 0 N19-C1'-C2' 109.215 -2.616 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.631 0 C5'-C4'-C3' 111.765 -2.49 . 0.696 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.342 0 O4'-C1'-N19 111.07 2.87 . 0.706 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.477 0 N19-C1'-C2' 108.479 -3.075 . 0.744 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.459 0 C4'-C3'-C2' 99.56 -3.14 . 0.72 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.422 0 N19-C1'-C2' 108.765 -2.897 . 0.743 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.7 0 O4'-C1'-N19 111.146 2.946 . 0.808 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.755 0 O4'-C1'-N19 110.961 2.761 . 0.776 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.387 0 C4'-C3'-C2' 99.9 -2.8 . 0.679 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.593 0 C4'-C3'-C2' 99.961 -2.739 . 0.574 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.392 0 O4'-C1'-N19 110.564 2.364 . 0.586 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.458 1 O4'-C1'-N19 112.656 4.456 . 0.161 1t . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.412 -3.406 0 C3'-C2'-C1' 99.167 -2.592 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.592 1 C5'-C4'-C3' 108.687 -4.542 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.624 3.063 0 O4'-C1'-N19 110.376 2.176 . 0.314 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.437 0 O4'-C1'-N19 110.772 2.572 . 0.167 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.442 0 N19-C1'-C2' 108.986 -2.759 . 0.5 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.555 0 O4'-C1'-N19 110.926 2.726 . 0.797 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.743 0 O4'-C1'-N19 110.972 2.772 . 0.81 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.421 0 O4'-C1'-N19 111.05 2.85 . 0.646 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.603 0 C5'-C4'-C3' 112.227 -2.182 . 0.712 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.683 0 C5'-C4'-C3' 111.505 -2.664 . 0.802 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.59 0 N19-C1'-C2' 110.047 -2.095 . 0.829 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.16 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 65.6 m -146.62 161.06 41.32 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 123.031 0.532 . . . . 0.0 110.257 -178.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 55.6 23.35 6.0 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.403 0.681 . . . . 0.0 111.673 -178.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 90.8 mtp -71.9 170.82 12.91 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.791 0.329 . . . . 0.0 110.883 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 18.1 p30 -66.89 -12.58 59.81 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -83.26 19.54 1.47 Allowed 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.753 0.421 . . . . 0.0 111.276 175.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 43.7 t -62.01 -23.13 66.24 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 122.128 -0.357 . . . . 0.0 110.98 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -87.46 4.88 41.58 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 177.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -132.74 110.33 10.3 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.826 0.346 . . . . 0.0 110.146 -175.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -113.44 6.59 17.24 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.123 0.569 . . . . 0.0 112.094 -178.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 87.6 m -109.76 141.67 42.07 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.265 0.555 . . . . 0.0 110.831 -175.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 41.1 pt -118.6 148.92 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-N 115.492 -0.776 . . . . 0.0 108.954 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -98.58 146.95 25.29 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 173.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 15.0 t -131.98 141.37 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-O 120.839 0.352 . . . . 0.0 111.259 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -129.47 150.73 50.69 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 176.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.86 12.5 66.19 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 119.793 -0.448 . . . . 0.0 112.76 169.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 73.3 mt -56.06 -51.61 67.23 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 117.62 0.71 . . . . 0.0 110.748 -175.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 148.51 175.89 21.46 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -101.43 -0.93 34.42 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 122.555 -0.379 . . . . 0.0 111.69 -176.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -128.71 11.29 6.16 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.075 0.55 . . . . 0.0 112.402 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.0 m -73.06 163.94 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -172.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 26.7 p -130.24 158.76 38.87 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 123.661 0.784 . . . . 0.0 111.773 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 298' ' ' ILE . . . . . 0.564 HG23 ' HB ' ' B' ' 322' ' ' ILE . 36.9 mt -60.2 -44.65 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.242 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -62.53 -36.2 81.83 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.711 0.404 . . . . 0.0 111.416 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 72.6 m -71.8 -43.79 65.07 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.991 0.359 . . . . 0.0 110.183 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 71.4 t -62.47 -41.41 91.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.95 -36.32 84.0 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 303' ' ' ASP . . . . . 0.4 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 44.9 t0 -69.91 -27.97 65.23 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -85.33 -25.38 27.18 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -96.28 -23.86 16.48 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 178.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 306' ' ' LYS . . . . . 0.4 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.6 ptpt -66.93 -18.69 65.5 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 -177.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -72.3 -20.41 61.51 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 117.731 0.241 . . . . 0.0 111.612 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.8 mm -87.27 -45.73 16.22 Favored 'Isoleucine or valine' 0 C--N 1.338 0.089 0 CA-C-N 117.677 0.217 . . . . 0.0 110.535 175.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.23 167.38 37.5 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 83.9 mt -68.5 121.79 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 120.834 0.349 . . . . 0.0 110.539 -175.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 89.1 mt -74.37 138.11 21.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 173.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 312' ' ' LYS . . . . . 0.656 ' HE3' ' SD ' ' B' ' 321' ' ' MET . 25.4 ttpt -74.02 132.26 42.19 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -178.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 1.8 m -94.95 140.51 29.85 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -70.48 133.5 46.87 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -89.55 -5.39 57.28 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 178.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -105.8 -18.63 14.0 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 122.833 0.453 . . . . 0.0 110.542 -176.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 6.5 p -129.53 -25.59 2.62 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -174.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 84.23 -11.79 56.8 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 119.743 -0.476 . . . . 0.0 112.422 174.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -83.08 157.3 66.2 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 117.912 0.856 . . . . 0.0 109.243 175.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.28 156.16 66.73 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 121.949 1.766 . . . . 0.0 109.921 178.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 321' ' ' MET . . . . . 0.656 ' SD ' ' HE3' ' B' ' 312' ' ' LYS . 33.9 mtt -72.61 92.51 1.52 Allowed 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 120.952 0.406 . . . . 0.0 111.656 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 322' ' ' ILE . . . . . 0.564 ' HB ' HG23 ' B' ' 298' ' ' ILE . 4.2 mp -139.73 138.51 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 171.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -131.36 105.93 7.94 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 176.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -75.39 153.58 37.64 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.812 0.845 . . . . 0.0 109.102 177.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -115.67 148.0 40.2 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -136.66 146.34 45.85 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.666 0.787 . . . . 0.0 112.82 -175.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -73.35 130.82 40.99 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 23.0 mtp-105 -84.64 -7.7 59.14 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 119.674 -0.203 . . . . 0.0 111.098 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -103.57 -13.75 16.44 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.534 0.334 . . . . 0.0 111.567 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 6.6 p -136.34 -19.23 1.46 Allowed 'General case' 0 C--O 1.233 0.23 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 77.98 4.27 85.67 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 119.699 -0.501 . . . . 0.0 112.082 174.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 332' ' ' LYS . . . . . 0.618 ' HE2' ' HA ' ' B' ' 332' ' ' LYS . 7.9 mmpt? -86.32 154.22 21.39 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 117.821 0.811 . . . . 0.0 109.045 177.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 41.5 mt -70.54 139.43 51.54 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.838 0.351 . . . . 0.0 110.342 -177.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -77.59 -16.65 58.48 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 123.249 0.62 . . . . 0.0 110.76 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 77.81 6.37 87.06 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -174.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -102.76 152.5 21.17 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.034 0.534 . . . . 0.0 110.162 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -164.66 161.38 20.79 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 116.698 -0.228 . . . . 0.0 110.966 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 5.3 p -109.04 155.06 21.37 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 169.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 33.7 t -137.64 128.39 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.043 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 171.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 340' ' ' SER . . . . . 0.411 ' HB3' ' SD ' ' B' ' 321' ' ' MET . 8.2 t -104.0 146.92 28.0 Favored 'General case' 0 C--O 1.228 -0.064 0 CA-C-N 117.975 0.352 . . . . 0.0 110.689 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -112.71 158.46 20.03 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -77.17 -17.3 58.66 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -143.66 146.83 36.72 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 344' ' ' PRO . . . . . 0.479 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 41.0 Cg_endo -70.61 -31.87 16.03 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.329 2.686 . . . . 0.0 114.587 -177.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 345' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 80.8 Cg_endo -73.9 -22.5 17.35 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 CA-C-N 121.117 1.435 . . . . 0.0 110.123 -177.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 66.1 m -72.25 -35.1 68.71 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 175.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -68.76 -39.95 80.01 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 175.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -64.81 -42.09 95.27 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.11 -34.89 77.22 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 122.237 -0.289 . . . . 0.0 110.687 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.05 -36.13 83.37 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 67.3 mt -70.92 -50.78 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 C-N-CA 120.626 -0.43 . . . . 0.0 109.873 175.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -54.49 -30.14 52.41 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 55.8 t-105 -97.8 -56.74 2.41 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -177.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -75.83 -29.84 58.77 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -172.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -56.29 110.09 0.71 Allowed 'General case' 0 C--O 1.234 0.247 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.793 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 103.01 -2.83 47.92 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-O 119.647 -0.529 . . . . 0.0 112.234 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -84.44 -163.17 0.76 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 118.092 0.946 . . . . 0.0 110.364 176.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -129.75 152.91 48.73 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.056 0.455 . . . . 0.0 111.239 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -145.49 136.54 24.73 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.135 0.974 . . . . 0.0 112.352 178.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 12.5 t 55.19 17.69 2.11 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.888 0.375 . . . . 0.0 111.077 -174.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.23 22.56 40.77 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.995 -0.442 . . . . 0.0 111.995 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -132.15 142.73 46.1 Favored Pre-proline 0 N--CA 1.454 -0.257 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.48 135.73 31.87 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 123.059 2.506 . . . . 0.0 109.707 178.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 30.1 pt -122.93 170.4 13.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-O 121.025 0.441 . . . . 0.0 111.101 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 5.7 tmtm? -145.66 113.6 6.48 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 9.7 t -103.25 150.27 6.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.21 0.604 . . . . 0.0 112.444 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 28.5 t -162.94 176.11 10.5 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 177.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -74.66 133.52 42.11 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 175.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -98.95 177.88 5.12 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.027 0.531 . . . . 0.0 111.94 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 7.2 p -138.41 -158.91 0.9 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 126.028 1.731 . . . . 0.0 109.871 177.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 371' ' ' ARG . . . . . 0.439 ' HG2' ' C6 ' ' A' ' 15' ' ' ' C' . 64.1 mtt180 -120.78 76.89 1.24 Allowed 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.487 0.585 . . . . 0.0 111.829 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 64.2 mtt-85 -60.28 -19.66 55.8 Favored 'General case' 0 N--CA 1.458 -0.063 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 169.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.3 -12.13 5.18 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.471 0.708 . . . . 0.0 111.313 176.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -99.51 -12.09 20.47 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -177.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -139.72 -19.96 0.92 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 116.667 2.099 . . . . 0.0 116.667 -178.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -80.69 -5.19 56.67 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 177.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 33.8 mmm-85 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 117.441 -1.266 . . . . 0.0 110.387 179.672 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.589 0 N19-C1'-C2' 108.986 -2.759 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.451 0 O4'-C1'-N19 111.017 2.817 . 0.706 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.481 0 C5'-C4'-C3' 111.25 -2.834 . 0.72 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.755 0 N19-C1'-C2' 109.122 -2.674 . 0.781 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.695 0 N19-C1'-C2' 108.541 -3.037 . 0.712 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.531 0 N19-C1'-C2' 109.061 -2.712 . 0.774 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.717 0 O4'-C1'-N19 110.92 2.72 . 0.78 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.395 0 O4'-C1'-N19 110.896 2.696 . 0.747 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.762 0 C4'-C3'-C2' 99.871 -2.829 . 0.647 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.616 0 O4'-C1'-N19 110.947 2.747 . 0.624 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.559 0 O4'-C1'-N19 111.09 2.89 . 0.588 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.309 0 C5'-C4'-C3' 110.009 -3.661 . 0.214 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -1.987 1 O4'-C1'-N19 112.52 4.32 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.012 0 O4'-C1'-N19 110.595 2.395 . 0.629 6p . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ' C' . . . . . 0.439 ' C6 ' ' HG2' ' B' ' 371' ' ' ARG . . . . . . . . 0 P--O5' 1.621 2.806 0 C5'-C4'-C3' 110.77 -3.153 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.439 0 C5'-C4'-C3' 110.99 -3.007 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.19 0 N19-C1'-C2' 109.219 -2.613 . 0.621 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.395 0 O4'-C1'-N19 111.081 2.881 . 0.835 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.724 0 O4'-C1'-N19 111.102 2.902 . 0.819 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.374 0 O4'-C1'-N19 110.938 2.738 . 0.649 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.489 0 O4'-C1'-N19 110.461 2.261 . 0.748 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.673 0 C5'-C4'-C3' 111.341 -2.773 . 0.796 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.637 0 N19-C1'-C2' 109.789 -2.257 . 0.776 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.184 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 38.1 t -155.97 159.53 39.29 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.021 0.529 . . . . 0.0 109.993 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -67.16 157.9 32.57 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.819 0.448 . . . . 0.0 111.008 -179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 91.0 mtp -72.89 172.94 9.95 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.613 0.365 . . . . 0.0 110.578 178.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -65.22 -11.68 43.44 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -81.89 14.84 2.51 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.77 0.428 . . . . 0.0 111.307 175.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 46.1 t -62.14 -17.5 58.07 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.962 -0.461 . . . . 0.0 110.503 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -89.57 6.14 42.44 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 123.117 0.567 . . . . 0.0 112.422 177.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 -142.47 113.77 7.75 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.999 0.428 . . . . 0.0 110.072 -176.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -113.36 12.62 18.85 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.874 0.47 . . . . 0.0 111.466 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 31.3 m -109.62 145.37 36.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.074 0.464 . . . . 0.0 111.854 -176.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 34.2 pt -122.09 147.51 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.433 176.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -98.7 143.88 28.58 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 173.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 289' ' ' VAL . . . . . 0.581 HG11 HD13 ' B' ' 292' ' ' LEU . 59.7 t -129.17 132.33 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 122.646 0.379 . . . . 0.0 110.57 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -120.78 155.45 33.98 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 175.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 83.82 12.01 78.19 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 171.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 292' ' ' LEU . . . . . 0.581 HD13 HG11 ' B' ' 289' ' ' VAL . 4.4 tp -59.09 -51.39 70.25 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.581 0.752 . . . . 0.0 110.946 -171.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 144.8 164.45 10.6 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.449 -0.661 . . . . 0.0 111.449 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -93.45 -1.11 56.1 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.578 0.351 . . . . 0.0 111.36 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -128.86 13.12 6.31 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 5.1 m -68.77 162.67 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -174.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 20.2 p -130.53 158.42 40.0 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.429 175.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 298' ' ' ILE . . . . . 0.552 HG23 ' HB ' ' B' ' 322' ' ' ILE . 25.0 mt -60.26 -43.21 92.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.31 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -70.68 -30.2 66.73 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -177.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 72.0 m -72.98 -45.36 58.4 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 118.298 0.499 . . . . 0.0 109.943 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 74.3 t -62.03 -41.31 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 176.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.3 -36.78 85.23 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 303' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -70.58 -27.63 64.26 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -83.86 -26.52 29.39 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -178.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -96.55 -24.95 15.81 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 115.073 1.509 . . . . 0.0 115.073 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 306' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -66.75 -18.38 65.35 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -176.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -71.85 -19.97 61.88 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 111.486 0.18 . . . . 0.0 111.486 -178.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 5.3 mm -87.49 -45.9 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 175.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.9 167.88 38.17 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 178.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 87.9 mt -67.72 123.66 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 122.674 0.389 . . . . 0.0 110.581 -176.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 86.7 mt -77.36 137.29 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 173.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -72.91 142.29 47.87 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -178.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 1.8 m -98.44 142.09 30.5 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -67.09 144.14 56.28 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 174.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -84.74 -19.93 31.89 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.796 -0.184 . . . . 0.0 111.059 -177.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -109.13 -43.88 4.07 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -174.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 23.7 p -86.98 -22.3 25.64 Favored 'General case' 0 N--CA 1.46 0.043 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -177.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 75.96 -10.28 14.96 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 123.294 0.473 . . . . 0.0 112.08 174.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -79.7 160.14 70.09 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 117.769 0.784 . . . . 0.0 109.268 174.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -67.06 154.24 75.15 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 121.593 1.529 . . . . 0.0 109.353 176.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 321' ' ' MET . . . . . 0.465 ' C ' HD12 ' B' ' 322' ' ' ILE . 34.9 mtt -70.97 85.74 0.7 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.84 0.353 . . . . 0.0 111.39 -177.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 322' ' ' ILE . . . . . 0.552 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.1 mp -129.84 137.04 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 170.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -130.45 107.23 9.08 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.839 176.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 23.7 mt -78.13 151.52 33.27 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 123.947 0.78 . . . . 0.0 109.249 176.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -115.9 151.02 36.15 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.52 142.48 43.48 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -174.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -70.93 131.9 44.42 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 328' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' B' ' 328' ' ' ARG . 30.2 mtp180 -87.42 -6.26 58.5 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.12 0.168 . . . . 0.0 110.776 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -104.55 -13.84 15.87 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.844 0.458 . . . . 0.0 111.563 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 3.3 p -134.54 -20.19 1.83 Allowed 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 79.18 2.17 86.83 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 112.251 -0.34 . . . . 0.0 112.251 175.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt -88.42 156.76 18.95 Favored 'General case' 0 C--N 1.337 0.034 0 CA-C-N 117.482 0.641 . . . . 0.0 109.397 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 46.8 mt -70.0 143.47 52.58 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.855 0.36 . . . . 0.0 110.696 -176.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -73.7 -15.65 61.22 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 123.562 0.745 . . . . 0.0 111.145 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.95 20.64 75.7 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.154 -1.179 . . . . 0.0 110.154 -174.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -129.94 144.48 51.34 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.177 0.591 . . . . 0.0 110.181 -176.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -156.39 160.26 39.49 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.858 174.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 1.2 p -102.0 155.95 17.84 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 170.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 19.0 t -134.75 129.5 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 123.85 0.86 . . . . 0.0 108.989 169.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 340' ' ' SER . . . . . 0.424 ' HB3' ' CB ' ' B' ' 321' ' ' MET . 45.5 t -109.47 140.75 42.84 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.942 0.401 . . . . 0.0 110.957 -178.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -106.08 158.02 17.11 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -73.62 -20.43 60.59 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -140.81 148.03 50.92 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 123.514 0.726 . . . . 0.0 109.12 -178.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 344' ' ' PRO . . . . . 0.463 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 40.4 Cg_endo -70.46 -33.32 14.14 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.43 2.753 . . . . 0.0 114.245 -176.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 345' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 83.6 Cg_endo -73.82 -22.47 17.58 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 CA-C-N 121.074 1.419 . . . . 0.0 110.057 -176.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 67.1 m -71.66 -36.47 70.67 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 176.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -69.08 -38.21 78.87 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -65.8 -41.75 91.53 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -69.47 -33.61 73.15 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 110.629 -0.138 . . . . 0.0 110.629 177.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.83 -37.19 86.79 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 68.5 mt -68.1 -53.62 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.673 174.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -54.87 -28.48 50.47 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -178.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 53.6 t-105 -96.67 -54.66 3.15 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -77.73 -27.89 50.66 Favored 'General case' 0 CA--C 1.522 -0.119 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -174.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -52.28 109.3 0.37 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.889 0.313 . . . . 0.0 111.194 178.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 100.29 -1.25 56.02 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-O 119.695 -0.503 . . . . 0.0 112.548 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -84.85 -164.42 0.98 Allowed 'General case' 0 C--O 1.228 -0.065 0 CA-C-N 117.939 0.869 . . . . 0.0 110.434 176.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -128.46 152.69 47.94 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.919 0.39 . . . . 0.0 110.739 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -142.2 134.71 28.06 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.271 1.028 . . . . 0.0 112.252 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 64.5 m 52.77 20.84 1.71 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.79 0.436 . . . . 0.0 111.975 -175.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.93 21.73 41.49 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 112.036 -0.426 . . . . 0.0 112.036 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -131.67 141.45 41.68 Favored Pre-proline 0 N--CA 1.456 -0.126 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.12 136.43 34.68 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.84 2.36 . . . . 0.0 109.464 177.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 32.4 pt -124.34 168.91 16.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-O 121.222 0.534 . . . . 0.0 110.789 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 22.9 tptp -142.89 112.3 6.74 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.035 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 8.6 t -101.96 148.55 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 29.3 t -162.38 175.27 11.72 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 177.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -72.19 130.97 42.1 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 176.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -80.83 175.45 10.67 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.082 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 61.1 p -142.16 -130.95 0.1 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 125.543 1.537 . . . . 0.0 107.913 -178.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -122.28 -33.5 3.47 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.039 0.381 . . . . 0.0 111.492 170.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 60.76 -39.17 0.1 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.506 1.522 . . . . 0.0 113.462 -174.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -63.78 -24.47 67.77 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 123.201 0.6 . . . . 0.0 109.626 176.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 19.6 p30 -62.04 -18.8 61.76 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 112.359 0.504 . . . . 0.0 112.359 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -78.73 -12.7 60.03 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 174.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -129.06 -16.67 4.02 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -173.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 . . . . . 0 C--O 1.252 1.201 0 CA-C-O 117.28 -1.343 . . . . 0.0 110.689 179.259 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.456 0 N19-C1'-C2' 109.724 -2.298 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.412 0 C5'-C4'-C3' 111.904 -2.398 . 0.624 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ' C' . . . . . 0.418 " H2'" ' C8 ' ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.628 0 O4'-C1'-N19 110.84 2.64 . 0.673 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . 0.418 ' C8 ' " H2'" ' A' ' 3' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.423 -2.516 0 N19-C1'-C2' 108.755 -2.903 . 0.72 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.425 0 N19-C1'-C2' 108.489 -3.069 . 0.785 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.311 0 N19-C1'-C2' 109.287 -2.571 . 0.752 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.72 0 O4'-C1'-N19 111.192 2.992 . 0.784 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.567 0 O4'-C1'-N19 110.808 2.608 . 0.736 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.701 0 C4'-C3'-C2' 100.06 -2.64 . 0.655 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.896 0 C4'-C3'-C2' 100.444 -2.256 . 0.546 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.506 0 C4'-C3'-C2' 100.07 -2.63 . 0.378 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.231 0 O4'-C1'-N19 112.164 3.964 . 0.078 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.693 0 C5'-C4'-C3' 110.083 -3.611 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.988 1 C5'-C4'-C3' 108.764 -4.491 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.488 0 O4'-C1'-N19 111.861 3.661 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.661 0 O4'-C1'-N19 110.957 2.757 . 0.442 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.438 0 N19-C1'-C2' 109.289 -2.569 . 0.591 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.333 0 O4'-C1'-N19 111.541 3.341 . 0.756 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ' U' . . . . . 0.443 " H2'" ' C6 ' ' A' ' 20' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.811 0 C5'-C4'-C3' 111.495 -2.67 . 0.8 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ' U' . . . . . 0.443 ' C6 ' " H2'" ' A' ' 19' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.424 -2.425 0 O4'-C1'-N19 110.842 2.642 . 0.654 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.748 0 C5'-C4'-C3' 112.196 -2.203 . 0.741 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.594 0 C5'-C4'-C3' 111.509 -2.661 . 0.795 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.63 0 N19-C1'-C2' 109.677 -2.327 . 0.767 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.253 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 69.3 m -67.54 158.59 31.63 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.641 0.376 . . . . 0.0 110.85 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 22.2 t-80 -68.43 143.36 55.08 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 122.699 0.4 . . . . 0.0 110.546 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 91.4 mtp -147.65 156.63 42.98 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.205 0.602 . . . . 0.0 110.111 178.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 60.95 150.46 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -86.7 25.79 1.21 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.465 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 44.0 t -64.38 -12.36 41.86 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.824 0.449 . . . . 0.0 111.278 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 34.1 p30 -134.25 18.83 3.7 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.28 0.632 . . . . 0.0 111.198 178.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -114.25 113.42 24.59 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -113.25 -2.41 14.07 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.222 -177.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 89.5 m -101.06 137.99 38.7 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.978 0.418 . . . . 0.0 109.909 -174.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 45.9 pt -105.91 148.28 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 172.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -99.94 142.98 30.7 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 171.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 14.6 t -133.77 141.51 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -128.92 154.6 46.39 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 122.873 0.469 . . . . 0.0 109.738 173.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.7 12.35 66.8 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-O 119.932 -0.371 . . . . 0.0 112.497 169.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 85.0 mt -57.14 -51.05 70.87 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 117.677 0.739 . . . . 0.0 110.202 -176.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 143.38 169.6 12.67 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -95.94 3.93 53.14 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 122.621 -0.341 . . . . 0.0 111.585 -178.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -128.86 11.55 6.12 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.8 m -76.03 165.48 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -173.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 29.9 p -130.99 157.74 42.16 Favored 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 123.615 0.766 . . . . 0.0 111.623 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 298' ' ' ILE . . . . . 0.484 HG23 ' HB ' ' B' ' 322' ' ' ILE . 34.4 mt -62.06 -42.34 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.154 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.45 -36.41 84.09 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.401 0.28 . . . . 0.0 111.737 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 43.6 t -72.44 -44.04 62.93 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 117.668 0.213 . . . . 0.0 110.48 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 76.9 t -61.61 -41.95 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.67 -35.25 80.44 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 303' ' ' ASP . . . . . 0.415 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.4 t0 -70.68 -29.07 65.29 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 304' ' ' TYR . . . . . 0.4 ' CE2' ' CD1' ' B' ' 354' ' ' PHE . 63.2 t80 -82.61 -25.77 32.88 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -96.88 -24.23 15.97 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 306' ' ' LYS . . . . . 0.415 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.6 ptpt -66.86 -18.77 65.54 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -177.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -71.9 -19.46 61.92 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.5 mm -88.05 -46.73 15.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 120.419 0.152 . . . . 0.0 110.651 175.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -161.73 169.17 37.11 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 90.2 mt -69.18 122.36 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 120.767 0.318 . . . . 0.0 110.261 -175.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 67.7 mt -77.63 137.26 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 175.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -69.98 151.0 46.09 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 2.6 m -118.97 139.86 50.97 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -71.79 146.61 47.94 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -90.84 -9.01 47.96 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 122.491 0.316 . . . . 0.0 111.532 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 316' ' ' LYS . . . . . 0.453 ' HA ' ' HE2' ' B' ' 316' ' ' LYS . 7.0 mmpt? -108.87 -46.11 3.68 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 122.325 0.25 . . . . 0.0 110.888 -176.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 18.0 p -89.63 -25.76 21.11 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -177.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 77.14 -6.47 42.69 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 123.273 0.464 . . . . 0.0 112.38 175.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -87.01 160.89 48.43 Favored Pre-proline 0 C--O 1.233 0.196 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 176.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.35 150.28 87.33 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 N-CA-C 108.639 -1.331 . . . . 0.0 108.639 176.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 321' ' ' MET . . . . . 0.42 ' C ' HD12 ' B' ' 322' ' ' ILE . 88.0 mtp -78.02 85.91 4.22 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.452 0.644 . . . . 0.0 111.796 -170.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 322' ' ' ILE . . . . . 0.484 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.1 mp -124.71 143.28 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 174.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -129.66 99.03 5.0 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 48.8 mt -75.56 154.24 36.91 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 176.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 325' ' ' TYR . . . . . 0.403 ' CZ ' H5'' ' A' ' 14' ' ' ' U' . 83.5 m-85 -117.54 148.41 41.9 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 175.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 326' ' ' THR . . . . . 0.406 HG23 ' O ' ' B' ' 332' ' ' LYS . 7.6 m -134.99 148.84 50.08 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.113 0.565 . . . . 0.0 111.986 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -75.73 121.29 22.32 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 177.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -76.95 2.86 13.56 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 122.389 -0.194 . . . . 0.0 111.399 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -107.02 -13.13 15.27 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 122.733 0.413 . . . . 0.0 111.623 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 2.8 p -135.01 -27.68 1.23 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 78.2 13.82 82.9 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-O 119.834 -0.426 . . . . 0.0 112.167 172.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 332' ' ' LYS . . . . . 0.406 ' O ' HG23 ' B' ' 326' ' ' THR . 25.9 mtpp -73.56 -114.33 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.295 0.638 . . . . 0.0 110.849 178.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 6.1 mt -158.89 138.79 11.98 Favored 'General case' 0 C--N 1.334 -0.077 0 C-N-CA 124.766 1.226 . . . . 0.0 107.748 171.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -77.68 -19.22 55.7 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 122.115 0.166 . . . . 0.0 111.134 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.17 5.78 81.75 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -175.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -105.76 150.32 25.64 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 117.27 0.535 . . . . 0.0 109.884 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -163.98 163.21 23.53 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.112 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 60.5 p -111.76 155.67 23.15 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 169.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 16.4 t -135.8 120.53 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 O-C-N 123.415 0.447 . . . . 0.0 110.542 173.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 14.8 t -88.42 134.81 33.74 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -103.04 152.54 21.24 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 176.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -65.8 -33.66 76.37 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -178.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -130.36 150.86 77.4 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 344' ' ' PRO . . . . . 0.468 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 40.5 Cg_endo -70.42 -31.99 16.62 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.604 2.869 . . . . 0.0 114.425 -177.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 345' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 76.9 Cg_endo -73.75 -21.08 19.32 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 CA-C-N 121.078 1.421 . . . . 0.0 110.028 -176.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 66.9 m -72.6 -36.09 68.04 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 175.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -67.64 -38.57 84.03 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 174.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -65.19 -42.18 93.86 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.58 -35.55 77.51 Favored 'General case' 0 N--CA 1.458 -0.035 0 O-C-N 122.446 -0.159 . . . . 0.0 110.574 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -63.75 -37.68 88.26 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 63.1 mt -68.74 -51.62 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 120.379 -0.529 . . . . 0.0 109.634 175.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -55.92 -28.32 56.27 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 53.3 t-105 -97.16 -54.77 3.06 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 354' ' ' PHE . . . . . 0.4 ' CD1' ' CE2' ' B' ' 304' ' ' TYR . 51.7 m-85 -76.95 -27.77 54.95 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -173.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -50.38 109.23 0.28 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 117.993 0.361 . . . . 0.0 111.858 178.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 98.8 -0.43 57.81 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 119.537 -0.591 . . . . 0.0 112.654 175.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -83.55 -164.87 0.97 Allowed 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.136 0.968 . . . . 0.0 110.073 176.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -128.19 152.91 47.49 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 121.084 0.469 . . . . 0.0 110.727 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -144.9 136.27 25.22 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.331 1.053 . . . . 0.0 112.585 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 17.4 t 55.24 17.94 2.26 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 120.794 0.331 . . . . 0.0 110.951 -175.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.89 22.85 40.72 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 112.013 -0.435 . . . . 0.0 112.013 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 41.9 m-20 -132.31 142.6 45.58 Favored Pre-proline 0 C--O 1.226 -0.165 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 -177.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.48 135.73 31.88 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.855 2.37 . . . . 0.0 109.54 178.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 31.9 pt -121.34 170.79 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.101 0 CA-C-O 121.265 0.555 . . . . 0.0 111.207 -177.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -143.18 109.42 5.32 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.747 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 11.3 t -99.45 148.89 5.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 C-N-CA 123.164 0.586 . . . . 0.0 111.952 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 84.7 p -163.47 177.14 9.1 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -76.83 129.4 36.19 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 174.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 369' ' ' ALA . . . . . 0.411 ' HA ' ' O2 ' ' A' ' 14' ' ' ' U' . . . -86.29 -178.72 6.54 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 11.2 t -149.73 -162.98 1.67 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.014 1.325 . . . . 0.0 109.645 175.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -108.7 70.23 0.74 Allowed 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.118 0.417 . . . . 0.0 111.54 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 55.7 mtt180 -68.71 -6.68 27.72 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 169.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.59 -31.01 71.76 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 123.494 0.718 . . . . 0.0 110.081 169.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -71.05 -1.03 10.81 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -174.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -78.65 -11.56 59.98 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -141.58 -9.25 0.95 Allowed 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 12.6 ptm85 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 117.638 -1.172 . . . . 0.0 110.583 -177.511 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.632 0 N19-C1'-C2' 109.402 -2.499 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.532 0 C5'-C4'-C3' 111.644 -2.57 . 0.668 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ' C' . . . . . 0.42 " H2'" ' C8 ' ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.606 0 N19-C1'-C2' 109.503 -2.436 . 0.77 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . 0.42 ' C8 ' " H2'" ' A' ' 3' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.423 -2.503 0 N19-C1'-C2' 109.061 -2.712 . 0.759 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.824 0 N19-C1'-C2' 108.509 -3.057 . 0.766 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.798 0 C4'-C3'-C2' 100.093 -2.607 . 0.802 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.718 0 C5'-C4'-C3' 111.416 -2.723 . 0.807 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ' U' . . . . . 0.432 " H2'" ' C8 ' ' A' ' 9' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.825 0 C4'-C3'-C2' 100.106 -2.594 . 0.749 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ' A' . . . . . 0.432 ' C8 ' " H2'" ' A' ' 8' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.424 -2.437 0 C4'-C3'-C2' 99.856 -2.844 . 0.634 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.621 0 O4'-C1'-N19 110.533 2.333 . 0.475 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.493 0 O4'-C1'-N19 111.023 2.823 . 0.217 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -1.981 0 C5'-C4'-C3' 109.576 -3.95 . 0.219 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.627 1 O4'-C1'-N19 112.641 4.441 . 0.01 2[ . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ' U' . . . . . 0.411 ' O2 ' ' HA ' ' B' ' 369' ' ' ALA . . . . . . . . 0 O4'--C4' 1.42 -2.762 0 O4'-C1'-N19 111.079 2.879 . 0.594 6p . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.618 2.522 0 O4'-C1'-N19 111.687 3.487 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.439 0 O4'-C1'-N19 111.226 3.026 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.314 0 N19-C1'-C2' 109.46 -2.462 . 0.72 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.648 0 O4'-C1'-N19 111.249 3.049 . 0.776 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ' U' . . . . . 0.407 " H2'" ' C6 ' ' A' ' 20' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.61 0 O4'-C1'-N19 111.253 3.053 . 0.823 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ' U' . . . . . 0.407 ' C6 ' " H2'" ' A' ' 19' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.598 0 O4'-C1'-N19 111.036 2.836 . 0.652 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.682 0 C5'-C4'-C3' 112.101 -2.266 . 0.735 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.638 0 C5'-C4'-C3' 111.785 -2.477 . 0.782 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.571 0 N19-C1'-C2' 109.573 -2.392 . 0.771 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.275 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 99.8 p -155.97 166.14 34.37 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.857 0.463 . . . . 0.0 110.231 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -153.91 150.97 28.91 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 97.6 mmm -139.39 159.02 43.13 Favored 'General case' 0 C--O 1.23 0.068 0 C-N-CA 123.255 0.622 . . . . 0.0 110.632 -178.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -66.1 -13.04 59.4 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -87.78 15.03 7.51 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.597 0.359 . . . . 0.0 111.702 178.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 42.9 t -63.09 -14.77 52.37 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.807 0.443 . . . . 0.0 111.025 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 26.7 p30 -134.07 15.28 3.87 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.291 0.636 . . . . 0.0 111.531 177.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -103.35 110.14 22.03 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -113.69 9.19 17.74 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.806 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 95.4 m -113.22 145.52 40.87 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.318 0.58 . . . . 0.0 110.708 -175.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 33.7 pt -119.85 148.77 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.436 -0.802 . . . . 0.0 108.846 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -101.65 143.87 31.07 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 173.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 12.1 t -127.25 139.87 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 CA-C-O 120.963 0.411 . . . . 0.0 111.302 177.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -125.58 154.1 42.73 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.601 0.76 . . . . 0.0 108.968 177.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 83.3 12.96 77.79 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 173.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 1.5 tp -52.69 -55.08 25.17 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.583 0.753 . . . . 0.0 110.707 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 142.11 172.24 13.48 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -101.45 2.6 39.48 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -128.7 16.77 6.38 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.814 0.446 . . . . 0.0 111.285 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 10.3 m -74.47 166.85 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -173.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 43.1 p -138.23 159.52 41.84 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.729 0.811 . . . . 0.0 110.762 177.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 298' ' ' ILE . . . . . 0.549 HG23 ' HB ' ' B' ' 322' ' ' ILE . 45.3 mt -62.65 -44.13 99.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.16 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -64.39 -35.52 81.18 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.443 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 44.8 t -71.56 -49.97 35.51 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 118.036 0.38 . . . . 0.0 110.741 -177.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 7.5 p -65.44 -33.44 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.681 177.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -65.97 -32.62 74.22 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.579 176.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 303' ' ' ASP . . . . . 0.41 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 44.9 t0 -75.39 -27.25 59.01 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -178.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -85.26 -23.88 28.01 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -96.93 -24.18 15.96 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 178.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 306' ' ' LYS . . . . . 0.41 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.7 ptpt -66.4 -17.7 64.93 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -177.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -72.45 -20.73 61.35 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.6 mm -86.37 -45.94 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 CA-C-N 117.873 0.306 . . . . 0.0 110.226 175.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -162.4 167.0 36.78 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 79.2 mt -69.19 120.42 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 120.725 0.298 . . . . 0.0 110.683 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 88.6 mt -73.97 134.85 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 172.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -70.9 133.3 46.33 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 1.4 m -88.79 139.53 30.36 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 177.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -66.64 128.63 36.97 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 175.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -85.66 -5.03 59.32 Favored 'General case' 0 C--N 1.334 -0.104 0 O-C-N 122.28 -0.263 . . . . 0.0 110.391 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -107.14 -20.98 13.13 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 122.878 0.471 . . . . 0.0 110.769 -176.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 12.2 p -128.09 -23.44 3.31 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -174.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 84.65 -10.37 62.33 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 112.053 -0.419 . . . . 0.0 112.053 173.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -83.01 157.41 66.24 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 117.956 0.878 . . . . 0.0 109.097 174.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.9 155.67 68.88 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.023 1.815 . . . . 0.0 110.054 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 321' ' ' MET . . . . . . . . . . . . . 37.4 mtt -72.04 94.15 1.47 Allowed 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 120.951 0.405 . . . . 0.0 111.793 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 322' ' ' ILE . . . . . 0.549 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.5 mp -141.61 142.27 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 173.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -132.3 108.83 9.47 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 173.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 38.0 mt -77.64 153.2 33.38 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 175.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -120.86 143.3 48.98 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 175.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.7 142.59 51.43 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -174.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -70.38 126.84 30.78 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -85.92 -5.9 59.16 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 117.018 -0.083 . . . . 0.0 111.137 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -99.66 -13.88 19.17 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.521 0.328 . . . . 0.0 111.655 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 4.0 p -138.31 -23.89 0.99 Allowed 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -178.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 78.6 11.56 85.14 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.649 -0.581 . . . . 0.0 111.649 174.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -73.44 -100.62 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 117.538 0.669 . . . . 0.0 110.724 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 5.7 mt -165.2 146.89 7.66 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.574 1.55 . . . . 0.0 107.697 173.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -77.15 -18.23 58.01 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 122.274 0.229 . . . . 0.0 110.568 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 74.82 22.23 77.29 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 -174.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -133.06 146.55 51.79 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 117.236 0.518 . . . . 0.0 110.511 -178.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -157.76 155.71 30.33 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.133 174.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 10.9 p -95.7 152.6 18.32 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 170.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 40.9 t -135.63 129.96 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 170.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 9.0 t -110.47 143.38 40.88 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-N 117.888 0.313 . . . . 0.0 111.029 -177.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -108.4 160.23 16.04 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -176.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -72.42 -28.57 63.05 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -135.54 150.11 71.25 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -177.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 344' ' ' PRO . . . . . 0.47 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 39.5 Cg_endo -69.69 -32.71 18.34 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.457 2.772 . . . . 0.0 114.487 -177.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 345' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 96.1 Cg_endo -73.74 -20.88 19.55 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 CA-C-N 121.381 1.529 . . . . 0.0 110.324 -177.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 66.3 m -73.11 -37.48 66.67 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 175.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.13 -38.47 88.25 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 173.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -63.19 -46.09 88.69 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -66.74 -34.09 77.08 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 110.584 -0.154 . . . . 0.0 110.584 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.44 -35.96 82.49 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 64.8 mt -70.71 -51.71 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 175.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -55.17 -28.76 55.19 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 57.5 t-105 -98.04 -55.9 2.65 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -76.16 -30.66 58.2 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -173.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -55.21 110.73 0.72 Allowed 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 118.289 0.495 . . . . 0.0 110.777 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 103.56 -4.42 47.07 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.516 -0.602 . . . . 0.0 112.308 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -84.22 -163.76 0.84 Allowed 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 118.077 0.938 . . . . 0.0 110.165 176.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -127.82 150.67 49.73 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-O 120.95 0.405 . . . . 0.0 110.853 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -141.67 137.35 31.71 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.345 1.058 . . . . 0.0 112.487 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 20.5 t 53.91 18.96 1.78 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.563 0.345 . . . . 0.0 111.183 -175.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.4 21.96 42.56 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 112.056 -0.418 . . . . 0.0 112.056 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 41.0 m-20 -131.91 141.7 42.49 Favored Pre-proline 0 N--CA 1.453 -0.285 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -177.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -68.95 133.5 27.24 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 122.611 2.208 . . . . 0.0 109.403 177.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 29.8 pt -120.47 170.24 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.146 0 CA-C-O 121.336 0.588 . . . . 0.0 111.107 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -144.51 111.24 5.72 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 10.7 t -99.98 149.25 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.305 0.642 . . . . 0.0 111.966 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 23.2 t -162.46 172.72 15.08 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -69.57 128.72 37.46 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 176.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -85.11 179.33 7.28 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.905 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 10.9 t -146.53 -152.57 0.44 Allowed 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.654 1.181 . . . . 0.0 108.054 174.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 371' ' ' ARG . . . . . 0.442 ' HD3' ' C6 ' ' A' ' 15' ' ' ' C' . 54.5 mmm-85 -123.69 95.33 4.54 Favored 'General case' 0 C--N 1.337 0.062 0 CA-C-N 118.691 0.678 . . . . 0.0 110.728 174.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 27.3 mtp85 -68.98 -12.78 61.99 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 120.615 0.245 . . . . 0.0 110.401 170.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.14 -25.05 60.96 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 122.881 0.472 . . . . 0.0 110.621 176.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -63.27 -18.56 63.71 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 122.838 0.455 . . . . 0.0 112.177 -178.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -76.84 -11.79 59.88 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -131.16 -17.76 3.01 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -175.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.235 0 CA-C-O 116.781 -1.58 . . . . 0.0 111.224 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.494 0 N19-C1'-C2' 108.686 -2.946 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.509 0 C5'-C4'-C3' 111.498 -2.668 . 0.704 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.537 0 N19-C1'-C2' 108.822 -2.861 . 0.659 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.414 0 N19-C1'-C2' 108.926 -2.796 . 0.823 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.627 0 N19-C1'-C2' 108.793 -2.879 . 0.653 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.409 0 N19-C1'-C2' 108.765 -2.897 . 0.751 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.517 0 O4'-C1'-N19 111.016 2.816 . 0.805 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.423 0 O4'-C1'-N19 111.141 2.941 . 0.754 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.658 0 C4'-C3'-C2' 99.917 -2.783 . 0.657 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.571 0 O4'-C1'-N19 111.005 2.805 . 0.631 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.435 0 O4'-C1'-N19 110.983 2.783 . 0.633 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.219 1 O4'-C1'-N19 112.344 4.144 . 0.038 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.489 0 C5'-C4'-C3' 110.233 -3.512 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.631 1 C5'-C4'-C3' 109.491 -4.006 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ' C' . . . . . 0.442 ' C6 ' ' HD3' ' B' ' 371' ' ' ARG . . . . . . . . 0 O4'--C4' 1.415 -3.132 0 C5'-C4'-C3' 111.525 -2.65 . 0.128 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.454 0 O4'-C1'-N19 111.076 2.876 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.616 2.348 0 N19-C1'-C2' 108.936 -2.79 . 0.756 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.723 0 O4'-C1'-N19 111.015 2.815 . 0.839 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.724 0 O4'-C1'-N19 110.937 2.737 . 0.781 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.621 0 O4'-C1'-N19 110.791 2.591 . 0.65 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.761 0 C4'-C3'-C2' 100.142 -2.558 . 0.734 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.638 0 O4'-C1'-N19 110.72 2.52 . 0.791 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.71 0 N19-C1'-C2' 109.702 -2.311 . 0.809 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.344 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 67.9 m -72.08 -9.39 58.33 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 122.244 0.218 . . . . 0.0 111.422 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 54.1 m80 -142.03 167.55 21.85 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.192 0.597 . . . . 0.0 109.536 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 91.2 mtp -67.3 159.69 28.71 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.607 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -69.55 -7.02 34.73 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 21.5 m-20 -78.63 23.59 0.31 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.103 0.561 . . . . 0.0 111.21 178.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 90.1 p -63.38 -17.77 62.98 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.708 0.403 . . . . 0.0 111.171 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 29.3 p30 -98.86 7.53 45.94 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.372 0.669 . . . . 0.0 112.326 177.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -130.45 110.19 11.28 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 120.844 0.354 . . . . 0.0 110.067 -177.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.79 2.84 14.5 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.213 0.605 . . . . 0.0 112.392 -178.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 91.7 m -105.11 142.24 35.24 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.054 0.454 . . . . 0.0 111.046 -174.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 30.5 pt -115.31 149.46 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -99.87 146.2 26.91 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 173.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 289' ' ' VAL . . . . . 0.562 ' CG1' HD13 ' B' ' 292' ' ' LEU . 60.3 t -131.26 133.75 61.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.532 -178.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -123.65 153.55 40.61 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 83.31 13.11 77.42 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 172.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 292' ' ' LEU . . . . . 0.562 HD13 ' CG1' ' B' ' 289' ' ' VAL . 4.4 tp -59.07 -50.7 73.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 123.763 0.825 . . . . 0.0 111.027 -169.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 143.89 165.65 10.97 Favored Glycine 0 C--N 1.337 0.637 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 177.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -96.82 2.13 51.47 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.347 0.259 . . . . 0.0 111.282 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -128.47 11.86 6.37 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.868 0.467 . . . . 0.0 111.699 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 4.7 m -68.19 162.63 3.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -174.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 29.8 p -134.33 159.72 40.13 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 123.596 0.758 . . . . 0.0 110.697 176.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 298' ' ' ILE . . . . . 0.512 HG23 ' HB ' ' B' ' 322' ' ' ILE . 33.9 mt -61.33 -41.82 91.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.133 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -66.52 -36.05 81.75 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 122.554 0.342 . . . . 0.0 111.709 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 75.5 m -72.24 -46.08 57.51 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 118.175 0.443 . . . . 0.0 110.319 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 69.9 t -60.56 -42.65 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.32 -36.31 83.7 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 122.201 -0.312 . . . . 0.0 110.203 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 303' ' ' ASP . . . . . 0.423 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.1 t0 -69.88 -28.18 65.43 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -84.35 -25.84 28.88 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -96.1 -24.04 16.49 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 306' ' ' LYS . . . . . 0.423 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.6 ptpt -67.42 -18.68 65.2 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -176.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -72.57 -21.14 61.19 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -177.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.2 mm -85.94 -44.96 17.0 Favored 'Isoleucine or valine' 0 C--O 1.23 0.072 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 175.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.87 165.5 37.01 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 85.2 mt -66.04 123.49 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 120.854 0.359 . . . . 0.0 110.26 -177.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 85.8 mt -77.08 135.79 25.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 173.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -70.16 135.35 49.03 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 1.8 m -97.3 144.41 27.11 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -77.4 131.15 37.89 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 174.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -84.56 -10.09 57.72 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 117.326 0.057 . . . . 0.0 111.017 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -102.81 -19.08 14.84 Favored 'General case' 0 C--O 1.227 -0.079 0 C-N-CA 122.516 0.326 . . . . 0.0 110.714 -174.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 10.4 p -127.23 -22.81 3.66 Favored 'General case' 0 N--CA 1.462 0.13 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 -177.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 81.67 -9.61 54.99 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-O 119.899 -0.39 . . . . 0.0 112.361 173.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -85.78 156.87 58.26 Favored Pre-proline 0 N--CA 1.453 -0.323 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.66 156.48 65.37 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.047 1.831 . . . . 0.0 109.874 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 321' ' ' MET . . . . . 0.47 ' C ' HD12 ' B' ' 322' ' ' ILE . 33.6 mtt -72.51 86.23 1.16 Allowed 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -177.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 322' ' ' ILE . . . . . 0.512 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.2 mp -130.29 138.73 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 170.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -129.8 105.15 7.82 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 174.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 31.2 mt -77.82 153.38 32.83 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 123.952 0.783 . . . . 0.0 109.085 177.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -116.39 147.95 41.14 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -135.1 145.01 47.48 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -177.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -74.16 133.17 42.75 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 46.1 mtp85 -86.42 -6.41 58.93 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 122.22 0.208 . . . . 0.0 111.183 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -101.81 -13.19 17.8 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.722 0.409 . . . . 0.0 111.887 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 26.4 p -138.44 -22.04 1.02 Allowed 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 80.25 3.48 89.75 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 111.549 -0.621 . . . . 0.0 111.549 177.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -84.1 154.72 23.01 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 117.797 0.798 . . . . 0.0 109.189 176.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 48.3 mt -71.3 141.66 50.49 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -177.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -74.81 -15.53 60.74 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 123.343 0.657 . . . . 0.0 111.639 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 78.02 20.81 72.33 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -175.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -129.94 147.67 51.72 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 122.948 0.499 . . . . 0.0 110.252 -178.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -156.38 162.04 40.08 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 120.759 0.314 . . . . 0.0 110.799 174.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 19.1 p -104.79 154.4 20.07 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 169.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 17.3 t -135.47 132.11 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 123.454 0.702 . . . . 0.0 109.345 171.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 340' ' ' SER . . . . . 0.431 ' HB3' ' CB ' ' B' ' 321' ' ' MET . 46.2 t -110.82 136.46 49.84 Favored 'General case' 0 C--O 1.227 -0.109 0 CA-C-N 118.002 0.365 . . . . 0.0 111.101 -178.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -100.5 159.55 15.06 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -178.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -71.91 -30.95 65.9 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -130.04 148.99 71.9 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 344' ' ' PRO . . . . . 0.462 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 38.0 Cg_endo -69.96 -33.56 15.61 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.361 2.708 . . . . 0.0 114.636 -177.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 345' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 87.5 Cg_endo -73.5 -23.04 17.69 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 CA-C-N 121.083 1.423 . . . . 0.0 110.016 -177.268 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 58.8 m -71.95 -34.83 69.31 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 175.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.85 -41.07 87.96 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 175.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 40.2 tptt -69.53 -36.14 76.11 Favored 'General case' 0 C--N 1.339 0.121 0 O-C-N 122.176 -0.328 . . . . 0.0 110.706 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -65.75 -35.49 80.87 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 175.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -66.26 -37.49 85.59 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 72.2 mt -67.6 -53.62 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.772 175.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -56.85 -27.47 60.32 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -177.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -96.7 -55.15 2.99 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -76.5 -30.93 57.41 Favored 'General case' 0 CA--C 1.522 -0.117 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -173.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -54.53 110.26 0.61 Allowed 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.126 0.421 . . . . 0.0 110.876 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 104.31 -3.96 43.98 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 119.609 -0.551 . . . . 0.0 112.423 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -84.9 -164.32 0.96 Allowed 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 117.814 0.807 . . . . 0.0 110.373 176.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 42.0 mp0 -128.68 152.6 48.2 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.927 0.394 . . . . 0.0 110.858 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -143.91 134.83 25.32 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.195 0.998 . . . . 0.0 112.329 178.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 58.8 m 52.59 20.73 1.59 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -174.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.63 22.2 40.81 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 112.099 -0.4 . . . . 0.0 112.099 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 50.9 m-20 -132.21 141.83 42.82 Favored Pre-proline 0 N--CA 1.456 -0.174 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.62 137.91 36.99 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 122.713 2.275 . . . . 0.0 109.472 177.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 35.3 pt -125.87 168.98 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 CA-C-O 121.035 0.445 . . . . 0.0 110.667 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -144.68 113.35 6.7 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 10.7 t -103.16 150.06 6.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 123.165 0.586 . . . . 0.0 112.097 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 31.8 t -161.4 173.16 15.32 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -74.04 130.81 40.56 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 176.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -95.66 -177.17 3.97 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.062 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 12.5 t -153.23 -174.34 4.91 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.825 1.25 . . . . 0.0 108.308 174.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 69.4 mtp85 -97.11 86.59 3.99 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 118.755 0.707 . . . . 0.0 111.435 175.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 372' ' ' ARG . . . . . 0.457 ' HA ' ' CZ ' ' B' ' 375' ' ' PHE . 19.9 ttt180 -67.9 -14.42 62.95 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 169.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -66.74 -4.62 9.45 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.496 1.118 . . . . 0.0 111.931 174.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -104.4 -5.74 21.4 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 114.903 1.445 . . . . 0.0 114.903 -175.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 375' ' ' PHE . . . . . 0.457 ' CZ ' ' HA ' ' B' ' 372' ' ' ARG . 10.9 p90 -131.72 -18.71 2.72 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 176.011 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -77.27 -8.72 58.07 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.089 0.156 . . . . 0.0 111.336 173.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 . . . . . 0 C--O 1.251 1.183 0 CA-C-O 117.252 -1.356 . . . . 0.0 110.38 -176.092 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.583 0 N19-C1'-C2' 109.573 -2.392 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.501 0 C5'-C4'-C3' 111.461 -2.692 . 0.715 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.43 0 O4'-C1'-N19 111.21 3.01 . 0.842 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.164 0 C4'-C3'-C2' 100.04 -2.66 . 0.736 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.642 0 C4'-C3'-C2' 99.867 -2.833 . 0.696 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.519 0 N19-C1'-C2' 109.109 -2.682 . 0.792 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.621 0 C5'-C4'-C3' 111.819 -2.454 . 0.799 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.751 0 O4'-C1'-N19 110.987 2.787 . 0.736 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.714 0 C4'-C3'-C2' 99.853 -2.847 . 0.644 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.591 0 O4'-C1'-N19 110.577 2.377 . 0.63 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.599 0 O4'-C1'-N19 111.133 2.933 . 0.539 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.255 0 C5'-C4'-C3' 109.595 -3.937 . 0.442 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.299 1 O4'-C1'-N19 113.178 4.978 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.62 2.678 0 O4'-C1'-N19 111.801 3.601 . 0.443 6p . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.628 3.466 0 N19-C1'-C2' 109.795 -2.253 . 0.158 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.301 0 O4'-C1'-N19 111.116 2.916 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.453 0 O4'-C1'-N19 110.578 2.378 . 0.666 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.418 0 O4'-C1'-N19 110.873 2.673 . 0.767 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ' U' . . . . . 0.438 " H2'" ' C6 ' ' A' ' 20' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.425 -2.348 0 O4'-C1'-N19 111.27 3.07 . 0.771 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ' U' . . . . . 0.438 ' C6 ' " H2'" ' A' ' 19' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.545 0 O4'-C1'-N19 111.146 2.946 . 0.636 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.629 0 C5'-C4'-C3' 111.606 -2.596 . 0.728 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.582 0 C5'-C4'-C3' 111.056 -2.963 . 0.765 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.53 0 O4'-C1'-N19 110.593 2.393 . 0.767 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.079 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 25.8 t -150.26 10.52 0.68 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.478 0.311 . . . . 0.0 110.888 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 41.4 m80 57.2 -178.86 0.05 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.817 0.847 . . . . 0.0 111.911 -177.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 14.2 tmm? -66.93 137.52 56.6 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -155.08 136.35 14.01 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.716 0.406 . . . . 0.0 109.995 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -139.36 20.58 2.57 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.686 0.795 . . . . 0.0 111.018 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 45.2 t -64.55 -16.93 63.41 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.523 0.201 . . . . 0.0 110.956 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 31.5 p30 -114.92 16.62 17.19 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.025 0.93 . . . . 0.0 111.588 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -128.69 110.54 12.3 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 122.6 0.36 . . . . 0.0 110.383 -175.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 285' ' ' ASN . . . . . 0.467 HD22 ' C ' ' B' ' 285' ' ' ASN . 0.3 OUTLIER -113.7 5.36 16.41 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.148 -178.75 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 85.4 m -106.21 143.58 34.14 Favored 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 122.09 -0.381 . . . . 0.0 110.675 -174.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 40.6 pt -120.16 144.53 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 176.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -96.18 145.36 25.59 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 174.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 19.0 t -130.85 144.79 36.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.156 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -133.47 152.97 51.98 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 175.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.55 11.27 68.98 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-O 119.78 -0.456 . . . . 0.0 112.361 169.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 63.8 mt -57.32 -49.95 74.49 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 117.645 0.723 . . . . 0.0 110.78 -175.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 148.54 172.93 18.91 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 -178.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -97.17 -6.25 35.24 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -175.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -128.64 15.77 6.47 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 4.3 m -67.59 161.38 3.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -174.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 19.4 p -123.88 159.95 28.52 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.441 0.696 . . . . 0.0 112.254 -178.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 298' ' ' ILE . . . . . 0.573 HG23 ' HB ' ' B' ' 322' ' ' ILE . 54.7 mt -63.68 -44.51 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.938 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -64.2 -36.3 83.6 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 122.565 0.346 . . . . 0.0 111.38 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 46.8 t -72.3 -47.04 53.01 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 122.247 -0.283 . . . . 0.0 110.812 -177.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 8.1 p -68.31 -33.98 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.005 178.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -65.22 -32.84 74.72 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 176.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 303' ' ' ASP . . . . . 0.402 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.6 t0 -74.02 -27.4 60.93 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -84.06 -24.69 30.31 Favored 'General case' 0 C--O 1.227 -0.13 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -96.8 -24.59 15.84 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 306' ' ' LYS . . . . . 0.402 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.7 ptpt -66.81 -18.04 65.18 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -177.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -70.9 -20.44 62.5 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 122.276 -0.265 . . . . 0.0 111.649 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.9 mm -87.61 -46.3 16.02 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-N 117.584 0.175 . . . . 0.0 110.644 175.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.71 168.78 38.44 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 85.7 mt -69.57 120.5 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-O 121.014 0.435 . . . . 0.0 110.695 -175.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 88.0 mt -73.01 138.77 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 172.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 312' ' ' LYS . . . . . 0.661 ' HE3' ' SD ' ' B' ' 321' ' ' MET . 28.8 ttpt -72.59 119.88 17.43 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -176.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 1.2 m -87.12 139.9 30.09 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 178.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -69.39 127.86 34.52 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 177.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -82.17 -5.53 58.54 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -108.92 -14.65 14.53 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.141 0.577 . . . . 0.0 111.568 -174.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 16.7 p -133.64 -23.48 1.83 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -178.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 83.56 -8.72 64.15 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 119.715 -0.492 . . . . 0.0 112.316 174.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -84.4 155.72 62.83 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 117.887 0.844 . . . . 0.0 109.248 174.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.61 155.27 59.32 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.227 1.952 . . . . 0.0 110.145 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 321' ' ' MET . . . . . 0.661 ' SD ' ' HE3' ' B' ' 312' ' ' LYS . 36.1 mtt -73.87 98.28 2.96 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 322' ' ' ILE . . . . . 0.573 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.3 mp -144.51 144.8 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 175.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -130.13 133.84 46.92 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 170.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 86.6 mt -106.54 133.8 50.65 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 325' ' ' TYR . . . . . 0.436 ' CE1' ' C2 ' ' A' ' 12' ' ' ' A' . 67.7 m-85 -96.54 151.19 19.83 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -177.11 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -139.91 140.56 36.45 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -174.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -76.78 137.56 39.36 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -177.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -83.51 -15.92 47.57 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.407 0.283 . . . . 0.0 110.688 175.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -90.27 -16.02 30.14 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -177.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 2.5 p -137.75 -21.82 1.11 Allowed 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -178.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 80.68 1.88 89.49 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 177.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -90.07 161.19 15.93 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 117.481 0.64 . . . . 0.0 109.801 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 10.4 mp -68.19 141.92 55.85 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -76.45 -16.96 59.55 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.673 176.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 79.04 3.4 88.2 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -173.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -99.03 151.39 20.98 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.008 0.523 . . . . 0.0 110.142 178.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -161.65 167.0 25.95 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 120.836 0.351 . . . . 0.0 111.331 -177.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 1.2 p -120.69 149.94 41.72 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 169.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 44.3 t -137.39 124.6 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 173.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 8.5 t -100.87 144.41 29.85 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 118.074 0.397 . . . . 0.0 110.815 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -109.8 158.65 17.93 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -79.09 -14.69 58.99 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -146.63 146.33 26.44 Favored Pre-proline 0 CA--C 1.53 0.204 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 344' ' ' PRO . . . . . 0.464 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 48.2 Cg_endo -70.84 -31.03 16.39 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.051 2.501 . . . . 0.0 114.469 -177.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 345' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 77.1 Cg_endo -74.14 -22.84 16.42 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 CA-C-N 121.29 1.496 . . . . 0.0 110.01 -177.225 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 70.1 m -72.62 -34.3 67.26 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 176.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -69.9 -38.46 76.31 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 175.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -63.96 -42.55 97.25 Favored 'General case' 0 CA--C 1.527 0.094 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.26 -34.76 76.78 Favored 'General case' 0 C--N 1.34 0.17 0 O-C-N 122.287 -0.258 . . . . 0.0 110.506 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.59 -36.46 83.8 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 67.6 mt -69.79 -51.99 35.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.811 174.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -53.94 -29.64 43.25 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 56.2 t-105 -97.69 -56.04 2.63 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -75.64 -27.39 58.37 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 -173.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -50.13 110.68 0.42 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.015 0.371 . . . . 0.0 111.814 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 94.66 1.36 63.86 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.55 -0.583 . . . . 0.0 112.606 174.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -83.98 -164.71 0.97 Allowed 'General case' 0 C--N 1.339 0.152 0 CA-C-N 118.32 1.06 . . . . 0.0 110.146 176.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -129.41 152.96 48.39 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.209 0.528 . . . . 0.0 111.246 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -145.51 137.45 25.45 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.188 0.995 . . . . 0.0 112.061 177.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 21.1 t 54.19 18.51 1.82 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.87 0.468 . . . . 0.0 111.211 -175.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 89.29 22.58 37.23 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 111.939 -0.464 . . . . 0.0 111.939 178.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -133.67 141.81 41.45 Favored Pre-proline 0 N--CA 1.455 -0.205 0 CA-C-N 117.442 0.621 . . . . 0.0 109.428 -177.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.32 136.18 33.48 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 122.68 2.253 . . . . 0.0 109.567 177.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 30.4 pt -121.47 170.63 11.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-O 120.957 0.408 . . . . 0.0 111.383 -177.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -144.78 115.68 7.82 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.719 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 12.4 t -107.0 147.86 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 C-N-CA 123.429 0.692 . . . . 0.0 112.416 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 28.5 t -162.73 173.22 14.12 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 176.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -71.11 133.28 46.12 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -101.28 177.29 4.97 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.216 0.531 . . . . 0.0 111.647 178.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 9.0 p -139.63 -157.1 0.74 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.4 1.48 . . . . 0.0 110.055 174.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 -115.5 81.95 1.67 Allowed 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 118.379 0.536 . . . . 0.0 110.614 170.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 372' ' ' ARG . . . . . 0.523 ' HA ' ' CZ ' ' B' ' 375' ' ' PHE . 26.4 ttt180 -59.34 -22.34 61.16 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 169.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -61.81 -10.35 8.85 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.9 0.88 . . . . 0.0 112.005 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -95.68 -10.28 29.73 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -177.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 375' ' ' PHE . . . . . 0.523 ' CZ ' ' HA ' ' B' ' 372' ' ' ARG . 15.8 p90 -135.11 -15.39 1.97 Allowed 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 35.4 p-10 -76.56 -8.8 57.93 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.585 0.231 . . . . 0.0 110.545 175.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 117.027 -1.463 . . . . 0.0 110.298 -179.346 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.63 0 N19-C1'-C2' 109.25 -2.594 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.724 0 C5'-C4'-C3' 111.379 -2.747 . 0.668 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.613 0 O4'-C1'-N19 110.905 2.705 . 0.793 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.604 0 N19-C1'-C2' 108.62 -2.987 . 0.78 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.644 0 C4'-C3'-C2' 99.42 -3.28 . 0.681 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.382 0 N19-C1'-C2' 108.718 -2.926 . 0.744 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.552 0 O4'-C1'-N19 110.981 2.781 . 0.785 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.618 0 O4'-C1'-N19 111.156 2.956 . 0.754 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.723 0 C4'-C3'-C2' 99.86 -2.84 . 0.666 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.667 0 C4'-C3'-C2' 99.908 -2.792 . 0.606 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ' A' . . . . . 0.404 " H2'" ' C8 ' ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.633 0 O4'-C1'-N19 111.016 2.816 . 0.421 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ' A' . . . . . 0.436 ' C2 ' ' CE1' ' B' ' 325' ' ' TYR . . . . . . . . 0 O4'--C4' 1.43 -1.957 0 O4'-C1'-N19 112.159 3.959 . 0.247 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.615 1 O4'-C1'-N19 112.362 4.162 . 0.0 OUTLIER '7D dist 2[' 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.622 2.854 1 C5'-C4'-C3' 107.785 -5.143 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.626 3.305 0 O4'-C1'-N19 110.22 2.02 . 0.144 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.549 0 O4'-C1'-N19 111.405 3.205 . 0.177 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.342 0 N19-C1'-C2' 108.409 -3.119 . 0.507 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.607 0 O4'-C1'-N19 111.0 2.8 . 0.721 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.664 0 O4'-C1'-N19 110.955 2.755 . 0.809 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.474 0 O4'-C1'-N19 110.9 2.7 . 0.69 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.68 0 C5'-C4'-C3' 111.879 -2.414 . 0.753 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.748 0 O4'-C1'-N19 110.785 2.585 . 0.797 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.653 0 N19-C1'-C2' 109.763 -2.273 . 0.804 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.114 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 96.1 p -151.92 171.78 17.25 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.134 0.574 . . . . 0.0 110.345 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 43.5 m80 -73.9 -11.66 60.43 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.24 0.216 . . . . 0.0 111.231 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 90.2 mtp -79.23 159.77 27.17 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 120.75 0.309 . . . . 0.0 110.576 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -70.01 -14.32 62.64 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 176.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 -83.37 12.37 5.55 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 122.897 0.479 . . . . 0.0 111.345 179.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 44.5 t -62.92 -20.99 65.72 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 122.092 -0.38 . . . . 0.0 110.864 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -89.78 8.31 32.48 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -138.15 110.49 7.43 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 122.2 -0.312 . . . . 0.0 110.47 -175.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -113.23 7.7 17.91 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.991 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 33.7 m -106.1 143.07 34.76 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 120.764 0.316 . . . . 0.0 111.477 -175.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 45.3 pt -120.72 146.73 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 288' ' ' PHE . . . . . 0.438 ' CE1' ' C6 ' ' A' ' 14' ' ' ' U' . 44.8 t80 -99.41 146.77 25.95 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 174.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 21.0 t -131.97 144.7 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.972 177.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -131.15 152.41 50.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 176.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.0 11.94 69.15 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 112.324 -0.311 . . . . 0.0 112.324 169.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 77.5 mt -55.6 -49.59 72.39 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 117.605 0.702 . . . . 0.0 110.492 -176.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 145.59 172.51 16.04 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -99.78 1.59 43.29 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.875 0.338 . . . . 0.0 111.787 -177.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -128.87 14.09 6.35 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.7 m -75.41 166.17 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -172.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 25.8 p -130.69 159.73 36.37 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.598 0.759 . . . . 0.0 112.168 -179.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 298' ' ' ILE . . . . . 0.562 HG23 ' HB ' ' B' ' 322' ' ' ILE . 44.4 mt -63.04 -46.38 96.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.337 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -62.37 -36.37 82.07 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.386 0.274 . . . . 0.0 111.437 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 47.0 t -72.44 -46.7 53.82 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 117.71 0.232 . . . . 0.0 110.836 -177.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.94 -33.28 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.341 178.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -65.3 -32.84 74.7 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 303' ' ' ASP . . . . . 0.41 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.4 t0 -74.64 -27.57 60.5 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 304' ' ' TYR . . . . . 0.404 ' CE2' ' CD2' ' B' ' 354' ' ' PHE . 52.3 t80 -83.48 -24.98 31.53 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -96.48 -25.09 15.79 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 178.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 306' ' ' LYS . . . . . 0.41 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.7 ptpt -66.35 -18.24 65.24 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -177.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -71.67 -20.19 61.98 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -178.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 3.9 mm -87.11 -46.33 16.23 Favored 'Isoleucine or valine' 0 C--N 1.337 0.059 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 175.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.98 167.95 38.25 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 85.8 mt -68.41 120.03 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 122.505 0.322 . . . . 0.0 110.634 -175.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 94.0 mt -71.72 138.06 22.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 172.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 312' ' ' LYS . . . . . 0.401 ' HE3' ' HB2' ' B' ' 312' ' ' LYS . 35.8 ttmt -68.86 125.2 25.88 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -177.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 2.5 m -95.98 137.48 34.99 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -71.05 130.31 41.21 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -82.03 -6.28 59.02 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -108.76 -14.79 14.53 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.043 0.537 . . . . 0.0 111.392 -174.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 10.1 p -131.27 -25.01 2.25 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 82.62 -9.14 59.93 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 119.516 -0.602 . . . . 0.0 112.197 175.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -86.59 155.91 56.3 Favored Pre-proline 0 CA--C 1.53 0.174 0 CA-C-N 117.913 0.857 . . . . 0.0 109.039 175.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -70.78 155.58 62.31 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 122.279 1.986 . . . . 0.0 110.096 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 321' ' ' MET . . . . . 0.429 ' CB ' ' HB3' ' B' ' 340' ' ' SER . 33.9 mtt -73.45 95.8 2.28 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 120.68 0.276 . . . . 0.0 111.712 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 322' ' ' ILE . . . . . 0.562 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.7 mp -141.29 141.05 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 172.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -134.37 110.9 9.75 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 175.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.68 152.69 33.63 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.673 0.789 . . . . 0.0 108.895 175.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -121.12 149.1 43.27 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 175.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 3.0 m -130.05 148.89 51.95 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -175.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -75.61 129.33 37.0 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 -84.11 -5.16 59.2 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 122.46 -0.15 . . . . 0.0 110.95 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -101.19 -14.33 17.76 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.693 0.397 . . . . 0.0 111.882 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 11.7 p -137.14 -22.94 1.15 Allowed 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 73.32 12.27 79.83 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-O 119.519 -0.6 . . . . 0.0 112.765 171.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -75.12 -103.45 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.929 0.864 . . . . 0.0 110.139 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 5.4 mt -159.45 144.7 15.7 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.688 1.195 . . . . 0.0 108.183 171.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 8.5 mmmm -76.02 -23.18 55.17 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 122.725 0.41 . . . . 0.0 110.32 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 77.26 5.64 85.58 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 -171.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -103.36 147.61 26.89 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.389 0.675 . . . . 0.0 109.992 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -161.95 153.83 19.02 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.006 176.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 12.8 p -98.72 151.77 20.38 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 169.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 42.5 t -136.13 125.99 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 170.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 340' ' ' SER . . . . . 0.429 ' HB3' ' CB ' ' B' ' 321' ' ' MET . 46.5 t -103.18 149.12 24.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 117.862 0.301 . . . . 0.0 111.316 -178.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -114.49 156.81 23.88 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -72.21 -29.11 63.65 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -132.46 147.83 67.2 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -178.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 344' ' ' PRO . . . . . 0.467 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 45.3 Cg_endo -71.39 -31.71 13.59 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.446 2.764 . . . . 0.0 114.649 -178.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 345' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 78.5 Cg_endo -73.68 -21.86 18.6 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 CA-C-N 121.255 1.484 . . . . 0.0 110.04 -177.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 70.7 m -71.23 -35.92 71.63 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 175.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -68.03 -38.74 82.88 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 174.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -64.06 -42.07 97.14 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.43 -34.6 76.29 Favored 'General case' 0 C--O 1.226 -0.148 0 O-C-N 122.255 -0.278 . . . . 0.0 110.737 178.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.36 -36.71 84.83 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 66.4 mt -70.25 -52.05 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.691 175.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -53.77 -29.86 41.96 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 58.9 t-105 -97.58 -53.95 3.28 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -176.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 354' ' ' PHE . . . . . 0.43 ' HB2' HG21 ' B' ' 366' ' ' VAL . 47.7 m-85 -78.09 -27.08 48.43 Favored 'General case' 0 C--O 1.226 -0.134 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -174.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -48.09 110.4 0.32 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 178.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 95.18 1.74 62.61 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 119.612 -0.549 . . . . 0.0 112.764 174.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -84.5 -164.87 1.03 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.261 1.03 . . . . 0.0 110.524 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 41.8 mp0 -127.75 152.85 47.24 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.107 0.479 . . . . 0.0 110.84 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -145.31 136.76 25.15 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.181 0.992 . . . . 0.0 112.349 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 14.8 t 55.32 17.29 2.04 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.075 0.464 . . . . 0.0 111.175 -175.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.72 22.63 38.84 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.955 -0.458 . . . . 0.0 111.955 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 44.9 m-20 -132.07 143.02 47.23 Favored Pre-proline 0 N--CA 1.455 -0.218 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -177.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -68.9 136.69 36.01 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.849 2.366 . . . . 0.0 109.415 177.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 33.5 pt -124.04 171.05 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 CA-C-O 121.178 0.513 . . . . 0.0 111.125 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -143.81 114.89 7.87 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.759 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 366' ' ' VAL . . . . . 0.43 HG21 ' HB2' ' B' ' 354' ' ' PHE . 11.9 t -102.33 148.65 7.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 123.256 0.623 . . . . 0.0 111.99 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 80.3 p -162.53 168.6 21.63 Favored 'General case' 0 CA--C 1.528 0.1 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -70.28 130.97 43.42 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 174.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -93.82 -179.1 4.88 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.882 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 9.6 t -150.48 -165.83 2.38 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.68 1.192 . . . . 0.0 107.877 172.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 75.5 mtt85 -108.11 75.66 1.0 Allowed 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.804 0.729 . . . . 0.0 110.161 173.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 25.2 ttt180 -60.62 -17.8 49.29 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 175.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.52 -38.55 77.94 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 122.47 0.308 . . . . 0.0 110.576 175.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -61.52 -10.41 7.83 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -171.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -82.29 -16.75 48.29 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 176.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -126.96 -20.27 4.24 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -173.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 75.1 mmt-85 . . . . . 0 C--O 1.253 1.253 0 CA-C-O 117.55 -1.214 . . . . 0.0 110.093 178.394 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.53 0 N19-C1'-C2' 109.273 -2.58 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.688 0 C5'-C4'-C3' 111.309 -2.794 . 0.709 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.384 0 O4'-C1'-N19 111.142 2.942 . 0.767 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.43 0 N19-C1'-C2' 108.295 -3.191 . 0.746 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.513 0 N19-C1'-C2' 108.401 -3.124 . 0.689 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.322 0 N19-C1'-C2' 108.717 -2.927 . 0.736 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.531 0 O4'-C1'-N19 110.899 2.699 . 0.757 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.357 0 C4'-C3'-C2' 99.696 -3.004 . 0.73 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.511 0 C4'-C3'-C2' 99.477 -3.223 . 0.628 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.679 0 C4'-C3'-C2' 100.025 -2.675 . 0.569 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.412 0 C5'-C4'-C3' 112.312 -2.126 . 0.624 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.419 1 C5'-C4'-C3' 109.08 -4.28 . 0.208 1t . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.69 1 C5'-C4'-C3' 108.885 -4.41 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ' U' . . . . . 0.438 ' C6 ' ' CE1' ' B' ' 288' ' ' PHE . . . . . . . . 0 O4'--C4' 1.427 -2.205 1 O4'-C1'-N19 112.54 4.34 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.626 3.281 0 C5'-C4'-C3' 112.75 -1.833 . 0.414 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.39 0 O4'-C1'-N19 111.312 3.112 . 0.089 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.238 0 N19-C1'-C2' 108.612 -2.992 . 0.4 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.302 0 O4'-C1'-N19 111.301 3.101 . 0.697 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.707 0 O4'-C1'-N19 111.151 2.951 . 0.796 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.501 0 O4'-C1'-N19 110.792 2.592 . 0.655 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.644 0 C5'-C4'-C3' 111.892 -2.405 . 0.747 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.549 0 O4'-C1'-N19 110.715 2.515 . 0.818 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.509 0 O4'-C1'-N19 110.509 2.309 . 0.818 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.169 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 35.4 t 61.11 162.96 0.07 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.259 1.023 . . . . 0.0 112.152 -177.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -76.43 -13.37 60.12 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.858 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 93.8 mmm 58.55 179.88 0.07 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.979 0.912 . . . . 0.0 111.378 -175.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -72.9 139.22 46.7 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 122.597 0.359 . . . . 0.0 111.923 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -146.39 25.69 1.21 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.673 0.789 . . . . 0.0 110.967 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 88.4 p -66.97 -7.51 22.85 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.59 0.356 . . . . 0.0 110.84 178.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 28.1 p30 -131.63 22.0 4.67 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.908 0.883 . . . . 0.0 111.855 178.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -141.53 122.58 14.62 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.744 0.307 . . . . 0.0 111.034 -178.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 285' ' ' ASN . . . . . 0.426 HD22 ' C ' ' B' ' 285' ' ' ASN . 0.3 OUTLIER -113.6 12.28 18.47 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.409 0.684 . . . . 0.0 111.375 177.18 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 63.7 m -108.98 146.22 34.22 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.877 0.37 . . . . 0.0 111.206 -172.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 44.9 pt -120.24 148.09 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 174.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 288' ' ' PHE . . . . . 0.448 ' CE2' ' C6 ' ' A' ' 14' ' ' ' U' . 54.1 t80 -101.4 145.77 28.49 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 174.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 17.2 t -129.75 144.46 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.236 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -133.16 152.45 51.94 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 175.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.21 12.38 67.87 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 119.814 -0.436 . . . . 0.0 112.663 169.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 59.3 mt -57.14 -50.1 73.85 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 117.414 0.607 . . . . 0.0 110.912 -174.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 157.0 -177.94 33.64 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -99.63 -9.32 23.32 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -176.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -139.95 22.0 2.45 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.2 m -68.11 165.15 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -173.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 16.0 p -123.11 159.56 28.27 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -177.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 298' ' ' ILE . . . . . 0.607 HG23 ' HB ' ' B' ' 322' ' ' ILE . 41.1 mt -62.32 -45.8 97.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.128 177.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -63.43 -37.56 87.77 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -177.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 81.1 p -73.35 -42.39 62.31 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 118.043 0.383 . . . . 0.0 110.376 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 54.4 t -61.69 -42.06 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -65.56 -34.36 78.06 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 303' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -70.55 -26.96 63.79 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -84.41 -25.68 28.86 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -96.3 -25.0 15.93 Favored 'General case' 0 C--O 1.231 0.091 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 306' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -66.55 -19.08 65.69 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.241 0.216 . . . . 0.0 111.458 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -71.28 -20.01 62.27 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 111.644 0.238 . . . . 0.0 111.644 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 5.1 mm -88.9 -46.25 15.46 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-N 117.602 0.183 . . . . 0.0 110.945 176.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -162.18 170.37 37.79 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 85.4 mt -72.12 118.58 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 122.61 0.364 . . . . 0.0 110.39 -175.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 93.6 mt -72.56 135.02 28.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 173.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -68.56 130.52 43.09 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 1.5 m -89.7 139.22 30.78 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -65.38 129.35 39.43 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 175.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -79.47 -10.43 59.8 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.789 -0.187 . . . . 0.0 110.962 -177.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -106.18 -48.02 3.69 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 -176.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 17.6 p -92.6 -23.76 18.92 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -174.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 82.29 -9.7 56.96 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 119.737 -0.479 . . . . 0.0 112.289 175.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -83.12 158.64 64.01 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 117.97 0.885 . . . . 0.0 108.887 174.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.37 154.39 69.36 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 121.685 1.59 . . . . 0.0 110.144 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 321' ' ' MET . . . . . 0.419 ' CB ' ' HB3' ' B' ' 340' ' ' SER . 38.6 mtt -72.53 93.05 1.53 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.863 0.363 . . . . 0.0 111.72 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 322' ' ' ILE . . . . . 0.607 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.9 mp -140.5 144.21 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 173.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -131.62 132.78 44.31 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 171.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -103.15 137.8 40.82 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 174.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -104.11 155.24 18.86 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 2.9 m -135.41 148.15 49.23 Favored 'General case' 0 CA--C 1.523 -0.093 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -176.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -78.67 130.75 36.21 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -79.85 -12.95 59.72 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 122.368 -0.207 . . . . 0.0 111.003 177.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -91.98 -14.83 28.85 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.494 0.317 . . . . 0.0 111.816 -178.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 2.8 p -137.35 -26.18 1.01 Allowed 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 75.31 10.48 84.41 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.849 -0.5 . . . . 0.0 111.849 175.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -75.36 -96.37 0.02 OUTLIER 'General case' 0 C--N 1.341 0.207 0 CA-C-N 117.68 0.74 . . . . 0.0 110.53 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 1.8 tp -164.81 149.49 9.37 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.532 0.733 . . . . 0.0 109.089 172.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -83.09 -22.69 33.37 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.491 0.186 . . . . 0.0 110.632 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 73.52 5.49 68.11 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -172.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -100.06 151.11 21.75 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.336 0.654 . . . . 0.0 110.024 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.42 167.25 29.21 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.052 0.453 . . . . 0.0 111.592 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 1.4 p -120.66 151.15 39.86 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 169.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 31.3 t -137.66 124.99 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 172.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 340' ' ' SER . . . . . 0.419 ' HB3' ' CB ' ' B' ' 321' ' ' MET . 46.9 t -101.41 148.93 24.59 Favored 'General case' 0 C--O 1.231 0.113 0 O-C-N 122.202 -0.311 . . . . 0.0 111.135 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -116.92 154.12 31.38 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 -178.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -71.74 -13.11 61.62 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 176.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -149.26 146.77 21.78 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 344' ' ' PRO . . . . . 0.478 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 53.4 Cg_endo -71.32 -30.18 15.97 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 123.239 2.626 . . . . 0.0 114.363 -177.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 345' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 71.5 Cg_endo -73.99 -22.45 17.21 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 CA-C-N 121.403 1.537 . . . . 0.0 109.964 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 66.3 m -71.7 -36.97 70.74 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 175.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.98 -37.83 84.94 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -63.72 -45.02 91.84 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.77 -34.44 76.81 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 110.538 -0.171 . . . . 0.0 110.538 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.33 -38.66 91.81 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 68.8 mt -68.57 -54.0 24.02 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.56 175.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -54.41 -27.9 40.12 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 54.9 t-105 -96.76 -55.07 3.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -76.29 -26.79 56.24 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -174.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -48.35 109.43 0.24 Allowed 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 176.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 94.94 0.76 63.63 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.394 -0.67 . . . . 0.0 112.814 174.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -83.38 -164.94 0.97 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 118.177 0.988 . . . . 0.0 110.374 176.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -128.48 155.11 45.33 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.191 0.519 . . . . 0.0 111.454 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -146.89 136.44 22.92 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.478 1.111 . . . . 0.0 112.158 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 22.7 t 54.45 18.77 2.06 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.455 0.302 . . . . 0.0 111.335 -175.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 86.95 24.31 38.35 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 112.154 -0.378 . . . . 0.0 112.154 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -132.87 142.48 44.88 Favored Pre-proline 0 N--CA 1.454 -0.23 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 -178.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.41 136.16 33.18 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.681 2.254 . . . . 0.0 109.602 177.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 27.9 pt -122.97 171.9 11.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-O 121.25 0.548 . . . . 0.0 110.831 -177.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -144.0 118.13 9.5 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.947 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 11.9 t -107.64 148.52 11.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 C-N-CA 123.22 0.608 . . . . 0.0 112.242 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 27.4 t -163.75 172.57 13.98 Favored 'General case' 0 C--N 1.341 0.204 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 176.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -70.51 130.25 41.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 176.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -84.86 -178.2 6.78 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.965 -0.562 . . . . 0.0 112.31 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 10.0 t -148.32 -158.68 0.94 Allowed 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 174.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 371' ' ' ARG . . . . . 0.535 ' C ' ' H ' ' B' ' 373' ' ' ALA . 23.4 mmm180 -92.97 -41.78 9.82 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 118.845 0.748 . . . . 0.0 111.752 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? 60.71 -28.39 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.581 1.153 . . . . 0.0 112.83 -175.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 373' ' ' ALA . . . . . 0.535 ' H ' ' C ' ' B' ' 371' ' ' ARG . . . -83.47 -36.54 24.07 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 124.449 1.1 . . . . 0.0 111.126 -178.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -67.79 -4.47 12.61 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -170.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -85.69 -7.59 58.71 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.41 0.284 . . . . 0.0 111.57 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -139.93 -22.4 0.86 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -174.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 12.1 ptp85 . . . . . 0 C--O 1.251 1.137 0 CA-C-O 117.284 -1.341 . . . . 0.0 110.952 -179.822 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.587 0 N19-C1'-C2' 109.019 -2.738 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.743 0 C5'-C4'-C3' 112.224 -2.184 . 0.657 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.558 0 O4'-C1'-N19 111.003 2.803 . 0.652 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.571 0 N19-C1'-C2' 109.099 -2.688 . 0.76 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.657 0 C4'-C3'-C2' 99.979 -2.721 . 0.632 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.407 0 N19-C1'-C2' 108.875 -2.828 . 0.772 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.571 0 O4'-C1'-N19 110.922 2.722 . 0.793 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.578 0 C4'-C3'-C2' 100.048 -2.652 . 0.727 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.511 0 C4'-C3'-C2' 99.634 -3.066 . 0.637 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.318 0 C4'-C3'-C2' 99.821 -2.879 . 0.565 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.39 0 O4'-C1'-N19 111.024 2.824 . 0.54 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.47 1 O4'-C1'-N19 112.56 4.36 . 0.129 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.071 0 C5'-C4'-C3' 111.424 -2.718 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ' U' . . . . . 0.448 ' C6 ' ' CE2' ' B' ' 288' ' ' PHE . . . . . . . . 0 O4'--C4' 1.422 -2.589 0 O4'-C1'-N19 111.463 3.263 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.734 0 C5'-C4'-C3' 111.666 -2.556 . 0.287 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.413 0 O4'-C1'-N19 111.251 3.051 . 0.34 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.551 0 N19-C1'-C2' 109.13 -2.669 . 0.638 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.382 0 O4'-C1'-N19 110.939 2.739 . 0.733 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.548 0 O4'-C1'-N19 110.899 2.699 . 0.744 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.515 0 O4'-C1'-N19 110.878 2.678 . 0.723 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.623 0 C4'-C3'-C2' 100.399 -2.301 . 0.741 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.867 0 C5'-C4'-C3' 111.381 -2.746 . 0.78 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.737 0 N19-C1'-C2' 109.562 -2.399 . 0.756 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.014 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 90.5 p -151.27 15.51 0.71 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.633 0.373 . . . . 0.0 110.916 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -148.33 152.71 37.54 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 122.931 0.492 . . . . 0.0 109.894 -178.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 55.3 ttm 62.45 152.58 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.624 1.169 . . . . 0.0 112.1 -175.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 22.0 t0 53.16 88.55 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.371 1.069 . . . . 0.0 113.428 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 53.46 36.4 23.08 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.265 0.626 . . . . 0.0 112.374 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 88.6 p -65.21 -17.98 64.94 Favored 'General case' 0 N--CA 1.456 -0.141 0 O-C-N 122.342 -0.224 . . . . 0.0 110.921 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 18.5 p30 -95.71 6.32 49.22 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.706 0.802 . . . . 0.0 112.742 178.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -140.14 110.2 6.51 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.954 0.407 . . . . 0.0 110.05 -176.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 285' ' ' ASN . . . . . 0.449 HD22 ' C ' ' B' ' 285' ' ' ASN . 0.4 OUTLIER -113.43 8.28 17.83 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.859 -177.972 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 60.5 m -107.5 142.16 37.81 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.092 0.473 . . . . 0.0 109.987 -175.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 44.4 pt -113.72 146.69 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 174.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -97.97 141.06 31.4 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 172.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 17.4 t -130.26 142.34 44.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 O-C-N 123.331 0.394 . . . . 0.0 111.252 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -132.3 153.13 51.0 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.46 11.47 68.86 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 119.863 -0.409 . . . . 0.0 112.423 169.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 77.4 mt -56.29 -51.95 66.31 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 117.348 0.574 . . . . 0.0 110.548 -175.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 151.15 171.56 19.31 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -91.47 -9.13 45.62 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 122.484 -0.421 . . . . 0.0 111.772 -174.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -134.34 15.91 3.75 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -177.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.2 m -66.6 160.76 3.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -175.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 25.7 p -117.87 156.66 28.03 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 122.957 0.503 . . . . 0.0 112.053 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 298' ' ' ILE . . . . . 0.49 HG23 ' HB ' ' B' ' 322' ' ' ILE . 40.6 mt -60.67 -44.03 96.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.44 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -68.89 -30.54 69.05 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -177.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 46.6 t -73.79 -43.6 58.44 Favored 'General case' 0 N--CA 1.458 -0.07 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 78.8 t -61.97 -41.25 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.61 -34.84 79.21 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 303' ' ' ASP . . . . . 0.408 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.9 t0 -71.02 -29.01 64.83 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 304' ' ' TYR . . . . . 0.402 ' CE2' ' CD2' ' B' ' 354' ' ' PHE . 59.0 t80 -82.47 -25.31 33.66 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -96.63 -24.88 15.8 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 306' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.9 ptpt -67.76 -17.59 64.6 Favored 'General case' 0 C--N 1.338 0.107 0 N-CA-C 111.446 0.165 . . . . 0.0 111.446 -176.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -72.2 -20.07 61.63 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 3.8 mm -87.84 -46.35 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.122 0 CA-C-N 117.61 0.186 . . . . 0.0 110.632 175.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -162.24 172.16 38.29 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 72.5 mt -71.11 118.29 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 122.68 0.392 . . . . 0.0 110.11 -175.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 77.4 mt -74.91 136.93 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 173.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 312' ' ' LYS . . . . . 0.442 ' HG2' ' SD ' ' B' ' 321' ' ' MET . 39.8 ttmt -69.55 142.65 53.58 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 11.0 m -117.59 136.55 53.21 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.618 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -68.49 131.98 46.21 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -178.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.99 -10.67 59.17 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 121.321 -0.152 . . . . 0.0 111.313 178.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 316' ' ' LYS . . . . . 0.442 ' HG2' ' H62' ' A' ' 17' ' ' ' A' . 7.6 mptt -99.05 -49.08 4.63 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.247 0.219 . . . . 0.0 111.354 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 5.9 p -87.04 -25.81 24.03 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -177.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 79.37 -8.73 45.33 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 123.377 0.513 . . . . 0.0 112.407 174.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -88.46 159.39 47.18 Favored Pre-proline 0 CA--C 1.53 0.201 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.84 148.64 82.74 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 121.314 1.343 . . . . 0.0 108.746 177.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 321' ' ' MET . . . . . 0.442 ' SD ' ' HG2' ' B' ' 312' ' ' LYS . 72.4 mtp -79.77 85.7 5.42 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.307 0.575 . . . . 0.0 111.665 -170.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 322' ' ' ILE . . . . . 0.49 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.3 mp -129.7 147.08 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.575 1.15 . . . . 0.0 108.25 176.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -132.93 111.08 10.74 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -80.98 148.79 29.6 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.267 1.027 . . . . 0.0 108.833 176.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -113.29 151.66 30.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.84 143.41 40.96 Favored 'General case' 0 CA--C 1.522 -0.13 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -173.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -73.7 133.72 43.42 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -87.3 -9.48 54.84 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.179 0.192 . . . . 0.0 110.856 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -98.97 -14.19 19.6 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.808 0.443 . . . . 0.0 111.745 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 4.0 p -136.61 -20.92 1.32 Allowed 'General case' 0 C--N 1.34 0.16 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -178.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 80.0 1.28 87.39 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 175.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -87.87 159.04 18.55 Favored 'General case' 0 C--N 1.338 0.096 0 CA-C-N 117.66 0.73 . . . . 0.0 109.447 177.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 10.5 mp -67.65 144.73 55.38 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.837 0.351 . . . . 0.0 110.112 -175.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -75.26 -15.83 60.49 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 122.873 0.469 . . . . 0.0 110.338 176.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 78.56 10.29 86.33 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 110.709 -0.957 . . . . 0.0 110.709 -174.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -116.97 150.33 38.74 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.881 0.472 . . . . 0.0 110.408 -177.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -160.06 162.91 34.26 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.881 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 29.6 p -112.4 153.86 26.67 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 169.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 21.8 t -136.6 124.19 33.15 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.11 0 C-N-CA 123.249 0.62 . . . . 0.0 110.218 175.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 45.0 t -90.98 140.85 29.45 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 117.906 0.321 . . . . 0.0 110.404 177.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -108.85 152.84 24.36 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 176.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -70.08 -28.82 65.73 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -177.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -133.05 149.0 71.6 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 344' ' ' PRO . . . . . 0.467 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 36.9 Cg_endo -69.44 -33.33 18.04 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 123.274 2.649 . . . . 0.0 114.2 -177.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 345' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 93.8 Cg_endo -74.97 -20.2 17.15 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 CA-C-N 121.136 1.441 . . . . 0.0 110.384 -176.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 66.3 m -71.88 -35.72 69.84 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 175.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -70.4 -38.36 74.64 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 174.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -63.6 -43.14 97.78 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.62 -35.33 77.17 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 110.561 -0.162 . . . . 0.0 110.561 178.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -63.88 -37.62 88.06 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 59.2 mt -70.66 -49.16 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.094 175.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -58.95 -27.9 65.76 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -176.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -97.26 -56.47 2.53 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -177.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 354' ' ' PHE . . . . . 0.402 ' CD2' ' CE2' ' B' ' 304' ' ' TYR . 52.2 m-85 -75.7 -25.74 56.95 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -173.133 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -48.49 108.4 0.17 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 176.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 96.34 2.2 60.52 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 119.435 -0.647 . . . . 0.0 113.227 174.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -84.91 -164.02 0.92 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.3 1.05 . . . . 0.0 110.386 177.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -129.9 153.23 48.53 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-O 121.058 0.456 . . . . 0.0 110.776 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -145.17 136.69 25.26 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.395 1.078 . . . . 0.0 112.296 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 63.4 m 53.35 19.48 1.61 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -173.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 86.38 22.81 46.25 Favored Glycine 0 C--N 1.342 0.868 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 52.6 m-20 -130.71 141.96 43.81 Favored Pre-proline 0 N--CA 1.454 -0.239 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -177.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.18 135.31 31.48 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.998 2.465 . . . . 0.0 109.267 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 29.6 pt -122.4 171.48 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 CA-C-O 121.285 0.564 . . . . 0.0 111.061 -177.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -144.25 116.59 8.51 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.688 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 10.8 t -107.28 147.27 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 123.026 0.53 . . . . 0.0 111.801 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 28.0 t -162.63 174.87 12.01 Favored 'General case' 0 C--N 1.339 0.147 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 177.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -71.97 130.07 40.09 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 176.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -82.74 177.95 8.42 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.358 177.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 15.7 p -144.02 -155.37 0.6 Allowed 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.454 1.101 . . . . 0.0 110.212 178.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -118.63 66.56 0.77 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 171.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 372' ' ' ARG . . . . . 0.462 ' HA ' ' CZ ' ' B' ' 375' ' ' PHE . 61.4 ttt180 -57.37 -18.0 15.32 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 173.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.6 -12.93 25.96 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.403 1.081 . . . . 0.0 111.965 176.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -98.74 -32.3 11.45 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -174.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 375' ' ' PHE . . . . . 0.462 ' CZ ' ' HA ' ' B' ' 372' ' ' ARG . 14.2 p90 -113.35 -18.58 12.0 Favored 'General case' 0 N--CA 1.457 -0.083 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 -173.15 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -81.55 -8.21 59.69 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 . . . . . 0 C--O 1.252 1.187 0 CA-C-O 117.069 -1.443 . . . . 0.0 110.381 -179.002 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.579 0 N19-C1'-C2' 108.955 -2.778 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.512 0 O4'-C1'-N19 110.547 2.347 . 0.684 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ' C' . . . . . 0.43 " H2'" ' C8 ' ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.539 0 C5'-C4'-C3' 111.486 -2.676 . 0.667 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . 0.43 ' C8 ' " H2'" ' A' ' 3' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.42 -2.71 0 N19-C1'-C2' 108.76 -2.9 . 0.779 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.542 0 N19-C1'-C2' 108.721 -2.924 . 0.707 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.547 0 N19-C1'-C2' 109.194 -2.629 . 0.739 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.754 0 O4'-C1'-N19 110.922 2.722 . 0.785 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.383 0 O4'-C1'-N19 110.989 2.789 . 0.744 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.276 0 C4'-C3'-C2' 100.031 -2.669 . 0.643 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.532 0 C4'-C3'-C2' 100.111 -2.589 . 0.62 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.696 0 O4'-C1'-N19 110.633 2.433 . 0.537 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.308 1 O4'-C1'-N19 112.606 4.406 . 0.101 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.702 0 C5'-C4'-C3' 109.871 -3.753 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.363 1 C5'-C4'-C3' 109.398 -4.068 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.156 0 C5'-C4'-C3' 111.875 -2.417 . 0.263 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.617 2.426 0 O4'-C1'-N19 111.646 3.446 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ' A' . . . . . 0.442 ' H62' ' HG2' ' B' ' 316' ' ' LYS . . . . . . . . 0 O4'--C4' 1.425 -2.347 0 N19-C1'-C2' 109.512 -2.43 . 0.61 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.683 0 O4'-C1'-N19 111.158 2.958 . 0.765 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ' U' . . . . . 0.417 " H2'" ' C6 ' ' A' ' 20' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.423 -2.515 0 O4'-C1'-N19 111.169 2.969 . 0.817 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ' U' . . . . . 0.417 ' C6 ' " H2'" ' A' ' 19' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.423 -2.489 0 O4'-C1'-N19 110.981 2.781 . 0.645 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.475 0 C5'-C4'-C3' 111.952 -2.365 . 0.761 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.561 0 C5'-C4'-C3' 111.541 -2.639 . 0.778 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.799 0 N19-C1'-C2' 109.778 -2.264 . 0.798 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.053 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 40.4 t -68.8 153.61 43.48 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 122.851 0.46 . . . . 0.0 110.759 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -76.49 -8.35 57.01 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 122.856 0.462 . . . . 0.0 111.038 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 97.9 mmm -69.33 156.92 38.0 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.819 0.342 . . . . 0.0 110.924 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -157.37 164.35 37.64 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 51.55 32.93 9.64 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.191 0.596 . . . . 0.0 111.811 -178.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 47.5 t -64.01 -22.06 66.77 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 122.37 -0.206 . . . . 0.0 110.739 -178.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -89.35 6.51 40.24 Favored 'General case' 0 C--N 1.34 0.18 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -141.8 110.11 5.96 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 120.813 0.34 . . . . 0.0 110.757 -175.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 285' ' ' ASN . . . . . 0.44 HD22 ' C ' ' B' ' 285' ' ' ASN . 0.3 OUTLIER -113.33 8.41 18.0 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.995 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 80.4 m -108.13 144.36 35.63 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.024 0.44 . . . . 0.0 110.912 -174.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 44.5 pt -120.41 147.35 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 288' ' ' PHE . . . . . 0.455 ' CE2' ' C6 ' ' A' ' 14' ' ' ' U' . 50.9 t80 -99.83 145.93 27.18 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 174.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 16.8 t -129.46 142.14 44.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 122.636 0.374 . . . . 0.0 111.22 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -129.54 149.9 51.11 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.05 14.24 64.88 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-O 119.894 -0.392 . . . . 0.0 112.361 169.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 61.4 mt -57.1 -51.1 70.65 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 117.545 0.673 . . . . 0.0 110.615 -175.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 148.84 177.16 22.8 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -101.54 -2.25 31.04 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -178.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -129.14 14.67 6.23 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.778 0.431 . . . . 0.0 112.145 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.2 m -73.65 163.16 4.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -172.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 27.3 p -129.23 160.71 32.08 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 123.501 0.72 . . . . 0.0 111.604 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 298' ' ' ILE . . . . . 0.533 HG23 ' HB ' ' B' ' 322' ' ' ILE . 44.8 mt -64.51 -45.51 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.274 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -63.6 -35.65 81.22 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 122.497 0.319 . . . . 0.0 111.601 179.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 47.1 t -72.28 -47.01 53.37 Favored 'General case' 0 C--O 1.228 -0.057 0 CA-C-N 117.919 0.327 . . . . 0.0 110.772 -177.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 7.8 p -68.16 -33.41 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.2 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -65.78 -32.56 74.16 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 176.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 303' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -74.23 -28.21 61.14 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 304' ' ' TYR . . . . . 0.409 ' CE1' ' CD1' ' B' ' 354' ' ' PHE . 54.6 t80 -82.2 -25.47 34.21 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -96.51 -25.93 15.47 Favored 'General case' 0 CA--C 1.527 0.086 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 306' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -65.73 -17.69 64.8 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 111.631 0.234 . . . . 0.0 111.631 -177.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -71.72 -20.52 61.89 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 5.0 mm -86.72 -45.8 16.49 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 175.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -165.22 167.92 39.05 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 178.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 82.4 mt -68.13 122.59 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-O 120.854 0.359 . . . . 0.0 110.752 -174.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 92.1 mt -74.56 136.53 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -70.98 130.34 41.32 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -178.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 1.8 m -88.9 138.75 31.12 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 178.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -63.71 131.88 49.29 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -80.62 -10.52 59.73 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.691 -0.231 . . . . 0.0 110.663 -176.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 58.4 mmtt -108.65 -50.0 3.08 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 122.656 0.382 . . . . 0.0 109.985 -175.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 18.1 p -89.56 -24.68 21.67 Favored 'General case' 0 C--N 1.338 0.081 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -175.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 81.92 -9.29 57.22 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-O 119.565 -0.575 . . . . 0.0 112.234 175.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -82.48 159.43 64.27 Favored Pre-proline 0 C--O 1.235 0.313 0 CA-C-N 118.308 1.054 . . . . 0.0 108.896 174.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.62 153.97 74.72 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.741 1.627 . . . . 0.0 109.861 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 321' ' ' MET . . . . . . . . . . . . . 36.4 mtt -71.31 95.71 1.34 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 120.571 0.224 . . . . 0.0 111.576 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 322' ' ' ILE . . . . . 0.533 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.6 mp -142.44 141.67 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 173.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 323' ' ' ASN . . . . . 0.403 ' O ' ' HA ' ' B' ' 337' ' ' ALA . 17.3 m-80 -132.75 111.16 10.91 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 171.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 43.2 mt -81.55 148.15 29.29 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 174.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -115.28 151.62 34.21 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 178.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -131.41 145.29 51.74 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -176.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -77.51 133.6 38.52 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -87.21 -8.42 56.87 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 122.445 -0.159 . . . . 0.0 111.146 177.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -96.81 -14.57 21.82 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 122.643 0.377 . . . . 0.0 111.567 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 3.2 p -136.17 -22.34 1.36 Allowed 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 80.77 0.46 88.07 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.591 -0.603 . . . . 0.0 111.591 176.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -89.35 158.13 17.91 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 117.647 0.723 . . . . 0.0 109.136 177.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 38.8 mt -69.21 143.1 54.07 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.982 0.42 . . . . 0.0 109.882 -177.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 9.3 mmmm -71.71 -18.74 62.14 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 123.338 0.655 . . . . 0.0 110.566 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.33 5.24 81.38 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -170.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -103.73 149.68 24.77 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.324 0.65 . . . . 0.0 110.121 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 337' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' B' ' 323' ' ' ASN . . . -164.25 159.69 20.3 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.027 176.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 6.1 p -106.26 151.65 24.53 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 169.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 42.9 t -135.89 126.22 42.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 170.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 23.0 t -105.96 141.88 36.61 Favored 'General case' 0 CA--C 1.527 0.086 0 O-C-N 122.129 -0.357 . . . . 0.0 110.948 -177.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -106.6 158.53 16.87 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -177.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -73.41 -29.97 62.94 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -131.26 146.9 64.04 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -177.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 344' ' ' PRO . . . . . 0.463 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 40.6 Cg_endo -70.83 -33.23 12.86 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.414 2.743 . . . . 0.0 114.484 -177.083 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 345' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 87.4 Cg_endo -73.82 -22.65 17.38 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 CA-C-N 121.185 1.459 . . . . 0.0 109.926 -176.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 71.2 m -71.48 -35.74 70.91 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 175.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -68.7 -37.91 79.9 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 175.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -64.77 -43.12 94.3 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -69.45 -33.26 72.67 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 110.474 -0.195 . . . . 0.0 110.474 178.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.89 -36.8 85.52 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 67.9 mt -69.67 -52.36 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 120.378 -0.529 . . . . 0.0 109.612 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -55.74 -29.37 59.42 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 55.5 t-105 -95.55 -55.87 2.88 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 354' ' ' PHE . . . . . 0.409 ' CD1' ' CE1' ' B' ' 304' ' ' TYR . 46.7 m-85 -75.8 -31.54 59.48 Favored 'General case' 0 C--N 1.337 0.06 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -173.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -55.46 108.04 0.39 Allowed 'General case' 0 C--O 1.232 0.16 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.753 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 106.98 -3.17 35.57 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.272 176.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -86.47 -164.78 1.11 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 117.843 0.821 . . . . 0.0 110.428 176.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -128.91 154.69 46.28 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.958 0.409 . . . . 0.0 111.306 177.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -145.19 137.2 25.67 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.573 1.149 . . . . 0.0 112.348 177.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 15.5 t 54.9 16.15 1.37 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 122.773 0.429 . . . . 0.0 111.189 -175.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 90.71 23.45 30.71 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 111.886 -0.485 . . . . 0.0 111.886 178.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -133.9 142.07 42.15 Favored Pre-proline 0 N--CA 1.453 -0.321 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -177.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -68.94 136.33 34.9 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 122.702 2.268 . . . . 0.0 109.518 177.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 29.1 pt -122.12 170.68 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-O 120.978 0.418 . . . . 0.0 111.01 -178.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -144.84 114.1 7.03 Favored 'General case' 0 N--CA 1.457 -0.086 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 11.2 t -102.67 150.47 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 122.907 0.483 . . . . 0.0 112.131 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 23.8 t -163.54 173.43 13.07 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 176.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -70.55 131.09 43.46 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 176.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -93.61 178.16 5.78 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 12.2 t -147.69 -159.18 0.99 Allowed 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 125.002 1.321 . . . . 0.0 108.277 173.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 77.0 mtt85 -119.41 88.15 2.88 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 119.033 0.833 . . . . 0.0 110.909 174.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -65.44 -16.37 63.56 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 171.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.02 -27.58 65.59 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 122.969 0.508 . . . . 0.0 110.763 178.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -63.13 -17.31 62.2 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.733 0.413 . . . . 0.0 110.851 -175.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -81.6 -13.31 58.15 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -136.7 -6.18 1.94 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -173.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 117.616 -1.183 . . . . 0.0 110.629 175.935 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.721 0 N19-C1'-C2' 109.248 -2.595 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.545 0 C5'-C4'-C3' 111.948 -2.368 . 0.691 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ' C' . . . . . 0.423 " H2'" ' C8 ' ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.424 -2.427 0 O4'-C1'-N19 111.083 2.883 . 0.704 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . 0.423 ' C8 ' " H2'" ' A' ' 3' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.422 -2.585 0 N19-C1'-C2' 108.759 -2.901 . 0.716 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.638 0 N19-C1'-C2' 108.678 -2.951 . 0.725 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.409 0 N19-C1'-C2' 108.983 -2.761 . 0.781 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.469 0 O4'-C1'-N19 111.326 3.126 . 0.805 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.521 0 O4'-C1'-N19 111.175 2.975 . 0.697 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.689 0 C4'-C3'-C2' 99.748 -2.952 . 0.665 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.509 0 O4'-C1'-N19 110.91 2.71 . 0.624 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.34 0 O4'-C1'-N19 111.273 3.073 . 0.631 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ' A' . . . . . 0.42 " O3'" " H4'" ' A' ' 13' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.426 -2.276 1 O4'-C1'-N19 112.71 4.51 . 0.107 1b . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ' U' . . . . . 0.42 " H4'" " O3'" ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.941 0 C5'-C4'-C3' 111.309 -2.794 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ' U' . . . . . 0.455 ' C6 ' ' CE2' ' B' ' 288' ' ' PHE . . . . . . . . 0 O4'--C4' 1.427 -2.167 1 O4'-C1'-N19 112.283 4.083 . 0.0 OUTLIER '7D dist 6p' 0.0 . . . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.624 3.132 0 C5'-C4'-C3' 112.765 -1.823 . 0.487 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.615 2.172 0 O4'-C1'-N19 111.214 3.014 . 0.23 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.261 0 N19-C1'-C2' 108.806 -2.871 . 0.642 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.479 0 O4'-C1'-N19 110.765 2.565 . 0.74 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.524 0 O4'-C1'-N19 110.879 2.679 . 0.762 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.352 0 O4'-C1'-N19 110.809 2.609 . 0.688 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.586 0 C5'-C4'-C3' 111.973 -2.352 . 0.74 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.47 0 C5'-C4'-C3' 111.422 -2.719 . 0.824 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.918 0 O4'-C1'-N19 110.716 2.516 . 0.768 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.278 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 39.1 t -154.95 158.62 39.52 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 122.879 0.472 . . . . 0.0 110.356 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -72.81 -16.54 61.61 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.192 0.197 . . . . 0.0 110.534 176.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 279' ' ' MET . . . . . 0.609 ' HG3' ' H ' ' B' ' 281' ' ' ASN . 17.5 tpt -77.75 151.61 34.01 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 122.826 0.45 . . . . 0.0 109.999 177.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -65.39 -12.86 56.28 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 281' ' ' ASN . . . . . 0.609 ' H ' ' HG3' ' B' ' 279' ' ' MET . 9.2 m-20 -81.44 10.67 5.39 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.874 0.47 . . . . 0.0 111.198 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 37.7 t -63.75 -20.39 65.71 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 122.3 -0.25 . . . . 0.0 110.574 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -89.45 7.21 37.18 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.963 0.505 . . . . 0.0 112.175 177.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -137.27 110.26 7.71 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.891 0.377 . . . . 0.0 110.328 -175.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -113.23 6.53 17.47 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.063 0.545 . . . . 0.0 111.53 -178.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 60.6 m -106.73 142.5 36.27 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 120.988 0.423 . . . . 0.0 110.797 -176.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 38.9 pt -116.85 147.38 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 173.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 288' ' ' PHE . . . . . 0.474 ' CE1' ' C6 ' ' A' ' 14' ' ' ' U' . 53.3 t80 -100.78 144.36 29.83 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 174.104 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 18.4 t -129.72 143.13 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.004 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -131.44 151.61 51.4 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 175.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 88.84 11.77 65.02 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 119.782 -0.455 . . . . 0.0 112.272 169.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 76.4 mt -56.47 -51.37 68.71 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.705 0.752 . . . . 0.0 110.46 -176.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 147.61 174.41 19.51 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 -179.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -99.07 -0.32 42.1 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.879 0.34 . . . . 0.0 111.644 -178.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -128.83 13.0 6.32 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.4 m -73.58 162.8 4.27 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -172.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 47.4 p -130.04 158.18 40.33 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 123.532 0.733 . . . . 0.0 111.129 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 298' ' ' ILE . . . . . 0.566 HG23 ' HB ' ' B' ' 322' ' ' ILE . 30.7 mt -62.41 -44.87 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.506 -179.127 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -63.13 -34.7 78.17 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.448 0.299 . . . . 0.0 111.609 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 47.0 t -73.64 -44.29 57.3 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 79.2 t -62.45 -40.82 89.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 177.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.77 -36.2 83.55 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 303' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -70.52 -27.95 64.57 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 304' ' ' TYR . . . . . 0.407 ' CE2' ' CD1' ' B' ' 354' ' ' PHE . 60.8 t80 -82.9 -26.42 31.53 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -179.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -96.63 -24.65 15.9 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 179.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 306' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -66.61 -19.25 65.73 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 111.526 0.195 . . . . 0.0 111.526 -177.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -71.01 -19.77 62.48 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -178.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 5.0 mm -88.79 -46.43 15.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 N-CA-C 110.554 -0.165 . . . . 0.0 110.554 175.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.19 167.43 37.49 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 179.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 84.2 mt -68.03 120.44 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-O 120.989 0.423 . . . . 0.0 110.353 -176.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 80.5 mt -74.29 137.37 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 172.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 312' ' ' LYS . . . . . 0.429 ' HE2' ' HB2' ' B' ' 312' ' ' LYS . 22.3 ttmm -69.61 125.48 26.85 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -177.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 2.0 m -94.08 142.95 26.81 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 178.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.96 133.34 38.04 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.188 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.77 -9.8 59.56 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.45 0.3 . . . . 0.0 110.334 177.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -108.88 -19.97 13.22 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.948 0.499 . . . . 0.0 111.599 -170.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 13.6 p -124.91 -22.45 4.49 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 81.13 -10.21 49.69 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.911 -0.475 . . . . 0.0 111.911 174.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -88.71 156.29 50.15 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 117.879 0.839 . . . . 0.0 109.568 176.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -70.57 156.28 61.55 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.358 2.038 . . . . 0.0 110.358 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 321' ' ' MET . . . . . 0.404 ' C ' HD12 ' B' ' 322' ' ' ILE . 37.0 mtt -73.08 91.49 1.61 Allowed 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 122.523 0.329 . . . . 0.0 111.685 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 322' ' ' ILE . . . . . 0.566 ' HB ' HG23 ' B' ' 298' ' ' ILE . 4.1 mp -136.6 139.89 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 170.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -135.21 111.05 9.36 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 25.0 mt -81.44 151.96 27.62 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 176.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -115.99 152.34 33.7 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 177.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.9 146.14 51.54 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -174.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -78.59 133.77 37.27 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 21.6 mtp180 -88.66 -8.27 54.91 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.217 0.207 . . . . 0.0 110.905 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -97.8 -14.59 20.7 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.621 0.368 . . . . 0.0 111.925 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 2.9 p -136.56 -22.62 1.27 Allowed 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 83.01 0.48 90.34 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 176.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -84.02 158.85 21.34 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 117.703 0.752 . . . . 0.0 109.4 176.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 39.5 mt -72.02 142.54 49.31 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -71.82 -15.1 62.14 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 123.6 0.76 . . . . 0.0 110.442 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.13 3.59 76.06 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -172.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -103.56 150.05 24.31 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.163 0.585 . . . . 0.0 110.104 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -162.81 157.55 21.58 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.705 177.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 7.6 p -105.31 152.67 22.62 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 170.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 38.2 t -135.78 126.17 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 123.597 0.759 . . . . 0.0 109.056 170.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 340' ' ' SER . . . . . 0.401 ' HB3' ' CB ' ' B' ' 321' ' ' MET . 48.3 t -105.39 139.2 40.38 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.701 0.286 . . . . 0.0 110.983 -178.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -104.57 159.76 15.49 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -178.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -72.08 -31.61 66.25 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -130.98 149.85 74.92 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 344' ' ' PRO . . . . . 0.474 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 40.7 Cg_endo -70.27 -32.12 17.02 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 123.256 2.637 . . . . 0.0 114.396 -177.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 345' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 74.0 Cg_endo -73.68 -21.34 19.19 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 CA-C-N 121.255 1.484 . . . . 0.0 110.199 -177.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 57.6 m -72.09 -36.3 69.46 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 175.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -67.28 -38.64 85.4 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 174.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -63.63 -43.96 95.27 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.23 -34.67 76.67 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 122.227 -0.296 . . . . 0.0 110.542 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.64 -37.18 86.71 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 61.5 mt -69.58 -51.85 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.86 175.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -53.19 -30.63 38.55 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 53.8 t-105 -97.09 -55.39 2.87 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -176.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 354' ' ' PHE . . . . . 0.407 ' CD1' ' CE2' ' B' ' 304' ' ' TYR . 51.9 m-85 -76.35 -26.94 56.22 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -173.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -49.22 109.16 0.24 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 177.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 97.3 -0.32 60.01 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 119.508 -0.606 . . . . 0.0 112.499 174.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -83.25 -165.74 1.17 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 118.203 1.001 . . . . 0.0 110.374 176.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -127.99 154.96 45.01 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.387 0.613 . . . . 0.0 111.233 177.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -145.71 136.44 24.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.531 1.133 . . . . 0.0 112.247 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 13.3 t 54.89 18.11 2.07 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.711 0.291 . . . . 0.0 111.346 -175.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.4 22.92 38.75 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.963 -0.455 . . . . 0.0 111.963 178.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 51.6 m-20 -132.64 142.16 43.8 Favored Pre-proline 0 N--CA 1.457 -0.112 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -177.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.27 135.97 33.05 Favored 'Trans proline' 0 N--CA 1.446 -1.305 0 C-N-CA 122.895 2.397 . . . . 0.0 109.532 178.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 29.8 pt -122.56 171.4 11.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 121.176 0.513 . . . . 0.0 111.009 -177.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -144.45 115.38 7.83 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.781 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 11.7 t -105.9 147.63 11.27 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 C-N-CA 123.174 0.59 . . . . 0.0 112.165 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 22.6 t -162.71 173.04 14.37 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 176.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -70.1 130.17 41.4 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 176.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -89.13 -179.91 6.0 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.053 -178.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 10.5 t -148.13 -156.01 0.68 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.796 1.238 . . . . 0.0 107.918 173.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 31.8 mtp-105 -121.88 90.61 3.34 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 118.715 0.689 . . . . 0.0 111.31 173.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -69.03 -13.31 62.38 Favored 'General case' 0 C--N 1.334 -0.073 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 169.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -63.55 -22.2 66.76 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 122.807 0.443 . . . . 0.0 110.338 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -63.34 -18.33 63.52 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.477 0.311 . . . . 0.0 110.894 -176.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -71.83 -12.75 61.43 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 177.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -138.01 -14.86 1.35 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.967 0 CA-C-O 116.467 -1.73 . . . . 0.0 110.68 177.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.457 0 N19-C1'-C2' 108.981 -2.762 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.427 0 C5'-C4'-C3' 111.622 -2.585 . 0.714 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.516 0 O4'-C1'-N19 110.862 2.662 . 0.803 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.595 0 N19-C1'-C2' 108.868 -2.833 . 0.687 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.513 0 N19-C1'-C2' 108.912 -2.805 . 0.699 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.485 0 N19-C1'-C2' 108.956 -2.778 . 0.729 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.757 0 O4'-C1'-N19 111.34 3.14 . 0.817 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.514 0 C4'-C3'-C2' 99.956 -2.744 . 0.737 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.803 0 C4'-C3'-C2' 99.956 -2.744 . 0.668 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.585 0 C4'-C3'-C2' 99.877 -2.823 . 0.618 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.624 0 C4'-C3'-C2' 99.931 -2.769 . 0.379 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.377 1 O4'-C1'-N19 112.242 4.042 . 0.105 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.847 1 C5'-C4'-C3' 109.414 -4.058 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ' U' . . . . . 0.474 ' C6 ' ' CE1' ' B' ' 288' ' ' PHE . . . . . . . . 0 O4'--C4' 1.425 -2.305 0 O4'-C1'-N19 112.08 3.88 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.623 2.991 0 C5'-C4'-C3' 112.205 -2.197 . 0.46 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.225 0 O4'-C1'-N19 111.242 3.042 . 0.272 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.541 0 N19-C1'-C2' 109.689 -2.32 . 0.627 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.367 0 O4'-C1'-N19 111.106 2.906 . 0.7 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.509 0 O4'-C1'-N19 111.011 2.811 . 0.75 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.369 0 O4'-C1'-N19 110.821 2.621 . 0.71 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.437 0 C5'-C4'-C3' 111.905 -2.397 . 0.707 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.732 0 C5'-C4'-C3' 111.601 -2.599 . 0.789 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.7 0 C5'-C4'-C3' 112.15 -2.233 . 0.811 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.131 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 88.7 p -70.16 162.55 28.12 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.806 0.303 . . . . 0.0 110.707 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -70.35 161.89 29.59 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 178.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 279' ' ' MET . . . . . 0.557 ' HG2' ' H ' ' B' ' 281' ' ' ASN . 51.1 ttp -67.57 142.55 56.46 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.458 0.303 . . . . 0.0 110.827 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -72.16 -23.41 61.28 Favored 'General case' 0 CA--C 1.527 0.088 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -177.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 281' ' ' ASN . . . . . 0.557 ' H ' ' HG2' ' B' ' 279' ' ' MET . 35.6 m-20 -83.15 26.86 0.6 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.994 0.518 . . . . 0.0 111.507 -178.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 35.5 t -64.53 -15.53 61.07 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 122.011 -0.431 . . . . 0.0 110.686 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 26.2 p30 -98.89 4.7 47.5 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.366 0.667 . . . . 0.0 112.173 177.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -131.02 110.17 11.03 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.078 0.465 . . . . 0.0 110.133 -177.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.5 11.9 18.5 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.431 0.692 . . . . 0.0 111.443 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 28.2 m -113.49 143.96 43.64 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.866 0.365 . . . . 0.0 111.603 -174.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 32.1 pt -122.02 146.82 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 175.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -100.33 144.24 29.57 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 174.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 20.4 t -129.83 142.24 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 122.808 0.443 . . . . 0.0 111.008 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -129.82 151.98 49.81 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.128 -0.694 . . . . 0.0 109.128 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.61 11.89 67.78 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-O 119.911 -0.383 . . . . 0.0 112.448 169.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 75.4 mt -55.42 -50.27 70.24 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 117.625 0.713 . . . . 0.0 110.679 -175.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 145.71 174.07 17.56 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -100.98 2.16 40.38 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -178.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -128.64 13.94 6.46 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.792 0.437 . . . . 0.0 111.795 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.6 m -75.56 165.32 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -172.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 26.7 p -131.81 160.53 35.35 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.587 0.755 . . . . 0.0 111.969 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 298' ' ' ILE . . . . . 0.522 HG23 ' HB ' ' B' ' 322' ' ' ILE . 48.3 mt -63.82 -43.71 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.099 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.6 -36.6 84.76 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 122.428 0.291 . . . . 0.0 111.499 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 45.4 t -71.82 -46.26 58.72 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.792 0.269 . . . . 0.0 110.795 -177.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 8.2 p -68.33 -32.55 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.271 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -66.76 -32.66 74.09 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 303' ' ' ASP . . . . . 0.409 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.0 t0 -74.15 -27.58 60.91 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 304' ' ' TYR . . . . . 0.417 ' CE1' ' CD2' ' B' ' 354' ' ' PHE . 67.7 t80 -84.19 -24.36 30.16 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -97.01 -24.41 15.81 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 178.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 306' ' ' LYS . . . . . 0.409 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.8 ptpt -66.13 -17.86 64.98 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -177.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -71.78 -20.67 61.83 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 5.1 mm -86.81 -46.09 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 N-CA-C 110.525 -0.176 . . . . 0.0 110.525 175.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.58 165.86 37.01 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.346 -0.701 . . . . 0.0 111.346 178.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 79.5 mt -66.81 119.46 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 122.586 0.354 . . . . 0.0 110.642 -176.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 94.5 mt -72.06 135.55 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 172.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -70.87 130.69 42.32 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -178.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 3.2 m -91.67 142.35 27.7 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 178.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -70.11 128.16 35.33 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 315' ' ' LYS . . . . . 0.587 ' HE3' ' HA ' ' B' ' 315' ' ' LYS . 0.2 OUTLIER -78.91 -8.79 59.17 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 122.537 0.335 . . . . 0.0 111.011 176.072 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 18.7 mmmt -107.0 -19.61 13.57 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.421 0.288 . . . . 0.0 110.592 -172.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 19.0 p -133.28 -21.08 2.08 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -175.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 82.28 -9.71 56.9 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-O 119.74 -0.478 . . . . 0.0 112.449 175.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -84.1 158.27 61.62 Favored Pre-proline 0 CA--C 1.53 0.207 0 CA-C-N 118.01 0.905 . . . . 0.0 108.944 174.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.54 154.95 70.59 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.105 1.87 . . . . 0.0 110.032 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 321' ' ' MET . . . . . 0.406 ' CB ' ' HB3' ' B' ' 340' ' ' SER . 37.1 mtt -72.64 95.0 1.79 Allowed 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 120.906 0.384 . . . . 0.0 111.757 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 322' ' ' ILE . . . . . 0.522 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.5 mp -141.31 141.05 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 173.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -132.75 107.31 8.28 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 174.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 36.6 mt -80.04 154.78 27.93 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -122.7 149.2 44.38 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 176.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 8.7 m -135.49 149.03 49.41 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -174.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -74.39 127.52 33.24 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 328' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' B' ' 328' ' ' ARG . 25.9 mtp180 -80.32 -6.39 57.88 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 122.483 -0.135 . . . . 0.0 110.817 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -99.54 -13.84 19.28 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.72 0.408 . . . . 0.0 111.893 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 2.9 p -135.71 -25.53 1.27 Allowed 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 75.28 12.37 83.58 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 119.751 -0.471 . . . . 0.0 112.092 172.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -73.75 -108.42 0.01 OUTLIER 'General case' 0 C--N 1.343 0.315 0 C-N-CA 123.316 0.646 . . . . 0.0 110.536 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 5.9 mt -158.67 144.65 16.82 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.357 1.063 . . . . 0.0 108.424 172.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? -80.11 -19.64 46.9 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 122.287 0.235 . . . . 0.0 110.579 178.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.01 5.44 80.29 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -172.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -102.74 147.38 26.92 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.591 0.756 . . . . 0.0 110.313 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -164.17 158.23 18.89 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.639 0.257 . . . . 0.0 111.423 177.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 32.2 p -104.12 153.3 21.09 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 169.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 40.6 t -136.81 130.94 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 171.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 340' ' ' SER . . . . . 0.406 ' HB3' ' CB ' ' B' ' 321' ' ' MET . 41.9 t -108.66 149.54 28.8 Favored 'General case' 0 N--CA 1.46 0.072 0 CA-C-O 120.672 0.272 . . . . 0.0 111.425 -178.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -115.27 157.82 23.22 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -70.46 -32.53 70.13 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -129.86 149.05 71.97 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -178.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 344' ' ' PRO . . . . . 0.469 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 41.0 Cg_endo -69.95 -32.42 17.81 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.198 2.599 . . . . 0.0 114.537 -176.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 345' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 92.7 Cg_endo -74.16 -20.95 18.45 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 CA-C-N 120.874 1.348 . . . . 0.0 110.315 -177.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 68.3 m -71.05 -37.84 72.54 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 175.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.62 -38.18 86.41 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 174.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -64.69 -42.38 95.36 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -69.33 -34.1 74.11 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 110.48 -0.192 . . . . 0.0 110.48 178.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -63.87 -38.02 89.56 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 67.8 mt -68.08 -53.43 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 120.369 -0.532 . . . . 0.0 109.658 175.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -55.54 -27.72 50.55 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -178.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -96.6 -55.22 2.98 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 354' ' ' PHE . . . . . 0.417 ' CD2' ' CE1' ' B' ' 304' ' ' TYR . 48.9 m-85 -76.2 -27.0 56.7 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -173.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -49.18 108.43 0.19 Allowed 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 176.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 96.57 1.03 60.58 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-N 116.154 -0.475 . . . . 0.0 113.068 174.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -82.97 -164.47 0.88 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 117.89 0.845 . . . . 0.0 110.17 176.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -129.46 152.21 49.25 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-O 121.006 0.432 . . . . 0.0 110.982 178.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -145.08 137.27 25.86 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.891 0.877 . . . . 0.0 112.334 178.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 22.0 t 54.73 18.31 2.06 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.69 0.281 . . . . 0.0 111.196 -175.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.65 23.39 39.53 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -132.9 142.94 46.55 Favored Pre-proline 0 N--CA 1.457 -0.09 0 CA-C-N 117.537 0.668 . . . . 0.0 109.312 -177.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.24 135.51 31.89 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 123.148 2.565 . . . . 0.0 109.738 177.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 30.8 pt -123.03 170.43 13.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.122 0.487 . . . . 0.0 111.176 -177.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -144.31 116.91 8.64 Favored 'General case' 0 C--O 1.228 -0.071 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.898 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 366' ' ' VAL . . . . . 0.402 HG21 ' HB2' ' B' ' 354' ' ' PHE . 12.6 t -106.13 149.0 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 C-N-CA 123.088 0.555 . . . . 0.0 112.124 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 22.6 t -163.27 172.92 14.01 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 177.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -69.94 129.68 40.14 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 176.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -87.51 175.92 7.71 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.096 0.474 . . . . 0.0 111.608 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 10.2 t -143.19 -146.52 0.19 Allowed 'General case' 0 C--O 1.234 0.241 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 172.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 26.7 mtp180 -131.9 86.93 2.39 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 119.015 0.825 . . . . 0.0 111.105 172.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -63.34 -16.14 59.52 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 169.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -63.98 -29.53 70.68 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.449 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -65.04 -10.72 32.16 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -176.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -78.99 -11.76 60.02 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 175.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -137.47 -3.2 1.92 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -174.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 . . . . . 0 C--O 1.252 1.201 0 CA-C-O 116.973 -1.489 . . . . 0.0 110.493 174.948 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.558 0 N19-C1'-C2' 108.962 -2.774 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.659 0 C5'-C4'-C3' 111.732 -2.512 . 0.665 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.397 0 N19-C1'-C2' 108.771 -2.893 . 0.805 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.627 0 N19-C1'-C2' 108.69 -2.944 . 0.748 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.43 0 N19-C1'-C2' 108.671 -2.956 . 0.682 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.444 0 N19-C1'-C2' 108.723 -2.923 . 0.733 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.533 0 O4'-C1'-N19 111.058 2.858 . 0.797 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.545 0 C4'-C3'-C2' 99.663 -3.037 . 0.69 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.477 0 C4'-C3'-C2' 99.771 -2.929 . 0.634 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.641 0 O4'-C1'-N19 110.976 2.776 . 0.607 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.587 0 O4'-C1'-N19 110.794 2.594 . 0.593 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.349 0 O4'-C1'-N19 112.194 3.994 . 0.209 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.533 0 C5'-C4'-C3' 109.72 -3.854 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.504 1 C5'-C4'-C3' 108.328 -4.781 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.81 0 C5'-C4'-C3' 111.433 -2.711 . 0.182 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.616 2.337 0 N19-C1'-C2' 108.574 -3.016 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.52 0 N19-C1'-C2' 108.28 -3.2 . 0.755 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.425 0 C5'-C4'-C3' 111.464 -2.691 . 0.767 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.436 0 O4'-C1'-N19 111.014 2.814 . 0.745 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.516 0 O4'-C1'-N19 111.154 2.954 . 0.644 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.72 0 C4'-C3'-C2' 100.378 -2.322 . 0.715 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.577 0 C5'-C4'-C3' 111.452 -2.699 . 0.816 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.805 0 N19-C1'-C2' 109.706 -2.309 . 0.812 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.121 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 66.3 m 55.69 29.23 13.36 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.33 0.652 . . . . 0.0 112.287 178.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -63.31 157.16 23.59 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.737 0.303 . . . . 0.0 110.52 178.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 46.7 ttm -153.24 147.7 26.0 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.57 0.348 . . . . 0.0 110.245 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -72.58 121.48 19.78 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 122.688 0.395 . . . . 0.0 110.631 178.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -139.11 25.35 2.49 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.478 0.711 . . . . 0.0 110.748 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 69.3 m -69.39 0.63 4.82 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 122.582 0.353 . . . . 0.0 111.252 177.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 38.1 p30 -139.4 19.84 2.56 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.804 0.842 . . . . 0.0 111.118 179.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -134.38 122.6 22.81 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.961 0.41 . . . . 0.0 111.072 -177.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 285' ' ' ASN . . . . . 0.403 HD22 ' C ' ' B' ' 285' ' ' ASN . 0.3 OUTLIER -113.65 9.51 17.84 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.374 0.67 . . . . 0.0 111.691 178.01 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 72.1 m -109.07 145.39 35.71 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.024 0.44 . . . . 0.0 111.152 -173.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 46.1 pt -121.9 149.6 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -102.67 145.53 29.54 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 175.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 289' ' ' VAL . . . . . 0.553 HG11 HD13 ' B' ' 292' ' ' LEU . 57.5 t -128.26 136.61 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.412 -178.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -127.23 153.95 45.46 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 176.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 84.31 12.22 76.47 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 173.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 292' ' ' LEU . . . . . 0.553 HD13 HG11 ' B' ' 289' ' ' VAL . 4.6 tp -59.1 -49.36 78.18 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.984 0.914 . . . . 0.0 111.219 -170.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 146.59 167.11 12.64 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 176.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -95.38 -1.19 51.62 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.341 0.257 . . . . 0.0 111.312 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -130.67 14.69 5.4 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.5 m -68.58 164.85 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -173.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 77.5 p -135.17 156.76 48.44 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 123.838 0.855 . . . . 0.0 109.782 177.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 298' ' ' ILE . . . . . 0.582 HG23 ' HB ' ' B' ' 322' ' ' ILE . 29.6 mt -61.94 -43.74 97.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.626 -178.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -64.25 -34.24 77.67 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 47.7 t -72.58 -45.36 59.54 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 117.864 0.302 . . . . 0.0 110.482 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 72.5 t -62.16 -41.63 92.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.93 -36.02 83.04 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 303' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -69.74 -29.66 67.08 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 304' ' ' TYR . . . . . 0.401 ' CE1' ' CD2' ' B' ' 354' ' ' PHE . 56.3 t80 -82.52 -25.89 33.01 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -96.46 -24.47 16.09 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 306' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -67.15 -18.56 65.34 Favored 'General case' 0 N--CA 1.461 0.077 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -176.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -71.69 -19.73 62.03 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 5.2 mm -88.43 -46.28 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.092 0 CA-C-N 117.729 0.241 . . . . 0.0 110.471 175.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.83 170.53 39.17 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 83.5 mt -70.06 120.18 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 122.675 0.39 . . . . 0.0 110.352 -175.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 87.7 mt -73.83 138.9 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 172.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -71.03 130.3 41.19 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -178.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 4.0 m -92.6 138.23 31.68 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -70.09 128.93 38.01 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 174.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -82.92 -14.24 54.54 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -93.73 -20.72 19.86 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 122.652 0.381 . . . . 0.0 110.447 -176.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 7.2 p -129.22 -24.89 2.79 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -174.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 83.77 -9.18 63.29 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-O 119.874 -0.403 . . . . 0.0 112.3 174.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -84.1 156.47 63.55 Favored Pre-proline 0 C--O 1.234 0.254 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 174.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.92 157.09 61.23 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.147 1.898 . . . . 0.0 110.262 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 321' ' ' MET . . . . . 0.482 ' C ' HD12 ' B' ' 322' ' ' ILE . 34.2 mtt -74.94 86.02 2.27 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 120.913 0.387 . . . . 0.0 111.895 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 322' ' ' ILE . . . . . 0.582 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.4 mp -130.65 137.64 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 169.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -133.64 110.72 10.07 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.508 176.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 20.3 mt -78.75 151.77 31.88 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.334 0.654 . . . . 0.0 109.362 177.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -117.58 147.29 42.97 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 177.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 4.7 m -130.2 148.4 52.03 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -176.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -77.91 128.01 33.27 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 60.4 mtm180 -80.8 -8.06 59.59 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 121.245 -0.182 . . . . 0.0 110.6 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -93.87 -14.31 26.23 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 2.7 p -136.29 -26.26 1.14 Allowed 'General case' 0 C--N 1.341 0.233 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 76.17 11.99 84.47 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 119.936 -0.369 . . . . 0.0 112.185 174.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -76.76 -107.16 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 117.434 0.617 . . . . 0.0 110.136 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 6.3 mt -157.48 146.11 19.48 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.521 1.128 . . . . 0.0 108.076 171.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 10.5 mmmm -75.97 -20.8 57.61 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 122.639 0.376 . . . . 0.0 110.914 -179.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.77 21.87 73.47 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -172.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -127.61 144.87 51.03 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.013 0.525 . . . . 0.0 110.242 -177.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -155.21 155.37 33.75 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.584 0.231 . . . . 0.0 111.229 172.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 1.9 p -96.12 152.28 18.69 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 170.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 23.2 t -134.29 125.65 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 169.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 22.8 t -106.03 141.86 36.7 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.618 -177.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -107.79 158.54 17.22 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -73.06 -31.72 64.59 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -130.07 147.99 67.85 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -178.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 344' ' ' PRO . . . . . 0.469 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 47.7 Cg_endo -71.64 -30.9 14.11 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 123.389 2.726 . . . . 0.0 114.672 -176.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 345' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 78.3 Cg_endo -73.83 -22.52 17.5 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 CA-C-N 121.326 1.509 . . . . 0.0 109.946 -177.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 71.1 m -71.68 -35.71 70.39 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 175.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -68.72 -38.03 79.9 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 175.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -63.87 -44.56 92.72 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.04 -33.6 74.89 Favored 'General case' 0 N--CA 1.455 -0.175 0 O-C-N 122.474 -0.141 . . . . 0.0 110.63 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.14 -37.69 88.24 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 67.6 mt -68.78 -53.68 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.929 174.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -54.21 -28.67 42.45 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -178.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 56.8 t-105 -95.89 -56.27 2.72 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 354' ' ' PHE . . . . . 0.401 ' CD2' ' CE1' ' B' ' 304' ' ' TYR . 47.3 m-85 -75.99 -25.59 55.94 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -173.201 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -45.86 107.51 0.1 Allowed 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 175.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 92.64 3.36 66.56 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 119.515 -0.603 . . . . 0.0 113.058 174.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -82.37 -170.84 3.13 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.178 0.989 . . . . 0.0 111.201 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -112.21 150.15 31.28 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.684 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -146.12 130.8 17.93 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.654 0.782 . . . . 0.0 112.52 173.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 17.5 t 54.71 19.65 2.6 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.807 0.443 . . . . 0.0 111.089 -176.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.16 28.3 25.8 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 111.921 -0.472 . . . . 0.0 111.921 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -140.01 142.69 31.4 Favored Pre-proline 0 N--CA 1.456 -0.157 0 CA-C-N 117.385 0.592 . . . . 0.0 109.62 -177.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.97 136.27 32.01 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.814 2.343 . . . . 0.0 110.019 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 31.8 pt -124.79 170.27 15.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 121.103 0.478 . . . . 0.0 110.979 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -142.73 116.54 9.28 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.229 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 11.6 t -104.58 147.89 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 123.115 0.566 . . . . 0.0 111.78 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 24.4 t -162.41 172.23 15.9 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 177.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -70.06 128.65 37.05 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 177.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -91.18 -179.5 5.44 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.345 0.593 . . . . 0.0 111.996 -178.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 13.8 t -150.44 -164.35 2.0 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.69 1.196 . . . . 0.0 109.025 174.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 68.1 mtt180 -117.9 91.24 3.51 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 118.378 0.535 . . . . 0.0 110.263 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -60.53 -18.22 50.75 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 172.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -64.32 -8.96 14.79 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.35 0.66 . . . . 0.0 111.493 176.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -113.91 -10.88 12.89 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -175.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -135.83 -23.03 1.39 Allowed 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -85.07 -1.76 57.21 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 . . . . . 0 C--O 1.25 1.124 0 CA-C-O 117.495 -1.241 . . . . 0.0 110.241 179.835 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.675 0 N19-C1'-C2' 108.938 -2.789 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.692 0 O4'-C1'-N19 110.645 2.445 . 0.656 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.329 0 N19-C1'-C2' 109.062 -2.711 . 0.708 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.368 0 N19-C1'-C2' 109.167 -2.645 . 0.801 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.53 0 N19-C1'-C2' 108.764 -2.898 . 0.677 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.569 0 N19-C1'-C2' 108.972 -2.768 . 0.816 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.609 0 O4'-C1'-N19 110.98 2.78 . 0.816 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.432 0 O4'-C1'-N19 111.186 2.986 . 0.725 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.541 0 C4'-C3'-C2' 99.749 -2.951 . 0.648 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.438 0 O4'-C1'-N19 111.468 3.268 . 0.533 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.552 0 C4'-C3'-C2' 100.203 -2.497 . 0.553 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.452 0 O4'-C1'-N19 111.917 3.717 . 0.229 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.877 1 C5'-C4'-C3' 108.612 -4.592 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.517 0 O4'-C1'-N19 111.816 3.616 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.621 2.762 0 O4'-C1'-N19 111.546 3.346 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.298 0 O4'-C1'-N19 111.311 3.111 . 0.309 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.616 2.348 0 N19-C1'-C2' 108.463 -3.085 . 0.552 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.38 0 O4'-C1'-N19 110.918 2.718 . 0.792 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.624 0 O4'-C1'-N19 110.98 2.78 . 0.769 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.373 0 O4'-C1'-N19 111.191 2.991 . 0.664 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.524 0 C5'-C4'-C3' 112.015 -2.323 . 0.74 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.752 0 C5'-C4'-C3' 111.353 -2.765 . 0.768 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.752 0 N19-C1'-C2' 109.694 -2.317 . 0.765 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.192 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 46.4 t -68.12 155.51 39.44 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.536 0.334 . . . . 0.0 110.77 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 -154.95 147.83 24.55 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 122.854 0.462 . . . . 0.0 109.969 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 96.9 mmm -140.18 156.77 46.38 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 123.162 0.585 . . . . 0.0 110.44 -178.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -66.61 -12.72 59.31 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -78.46 8.62 4.89 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 45.9 t -64.38 -25.26 67.95 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 174.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -100.62 14.54 31.11 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.598 0.759 . . . . 0.0 111.515 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -125.02 110.42 14.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -175.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -113.49 5.87 16.86 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.931 -178.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 99.4 m -111.24 146.63 36.62 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.211 0.529 . . . . 0.0 110.369 -176.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 39.8 pt -119.04 146.89 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.227 175.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 288' ' ' PHE . . . . . 0.425 ' CE2' ' C6 ' ' A' ' 14' ' ' ' U' . 52.0 t80 -96.97 145.5 25.86 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 173.173 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 18.0 t -131.3 142.23 43.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 O-C-N 123.211 0.319 . . . . 0.0 111.148 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -131.17 150.37 52.18 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 177.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.81 12.99 65.48 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 119.776 -0.458 . . . . 0.0 112.402 169.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 65.5 mt -57.29 -49.95 74.47 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 117.653 0.726 . . . . 0.0 110.645 -175.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 146.47 175.41 19.44 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -101.3 0.23 36.87 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.898 0.349 . . . . 0.0 111.861 -177.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -128.66 13.91 6.45 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.57 0.348 . . . . 0.0 111.666 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.5 m -75.33 166.7 2.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -172.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 14.1 p -131.36 162.15 30.77 Favored 'General case' 0 CA--C 1.522 -0.11 0 C-N-CA 123.744 0.818 . . . . 0.0 112.596 -177.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 298' ' ' ILE . . . . . 0.576 HG23 ' HB ' ' B' ' 322' ' ' ILE . 44.1 mt -62.88 -45.45 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.347 178.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -69.79 -33.51 72.48 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -178.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 80.9 p -72.41 -44.66 62.14 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 118.398 0.544 . . . . 0.0 110.37 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 9.5 p -68.35 -33.76 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 O-C-N 121.917 -0.489 . . . . 0.0 110.668 176.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.58 -33.48 76.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 175.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 303' ' ' ASP . . . . . 0.425 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.3 t0 -73.7 -27.32 61.15 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 304' ' ' TYR . . . . . 0.408 ' CE1' ' CD1' ' B' ' 354' ' ' PHE . 59.5 t80 -83.23 -25.85 31.31 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -96.67 -25.48 15.54 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 178.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 306' ' ' LYS . . . . . 0.425 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.9 ptpt -65.86 -18.09 65.1 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -177.221 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -72.67 -20.06 61.31 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 122.169 -0.332 . . . . 0.0 111.82 -178.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.1 mm -86.29 -46.87 16.62 Favored 'Isoleucine or valine' 0 C--N 1.338 0.071 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 174.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -162.51 166.06 36.44 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 85.6 mt -68.22 121.31 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 C-N-CA 122.604 0.362 . . . . 0.0 110.595 -175.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 94.9 mt -73.94 136.06 26.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 172.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -70.43 133.0 46.45 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -178.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 4.5 m -93.23 136.97 33.0 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 178.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -66.4 126.21 28.08 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 174.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? -82.07 -13.02 57.92 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.392 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -95.31 -23.94 16.98 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 122.381 0.272 . . . . 0.0 110.703 -175.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 14.6 p -125.39 -24.41 3.94 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -175.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 84.92 -9.49 65.77 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 119.719 -0.489 . . . . 0.0 112.245 174.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -82.85 156.91 67.32 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 118.073 0.937 . . . . 0.0 108.626 174.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.24 154.61 65.67 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 121.907 1.738 . . . . 0.0 109.993 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 321' ' ' MET . . . . . . . . . . . . . 35.3 mtt -71.86 95.48 1.54 Allowed 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 120.814 0.34 . . . . 0.0 111.482 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 322' ' ' ILE . . . . . 0.576 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.3 mp -144.51 145.68 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 175.191 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 323' ' ' ASN . . . . . 0.409 ' O ' ' HA ' ' B' ' 337' ' ' ALA . 18.1 m-80 -134.04 129.16 35.68 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 171.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -97.95 139.59 33.56 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -105.81 149.43 26.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 179.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -133.93 146.3 50.37 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -75.62 134.53 40.62 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 -87.7 -10.7 50.43 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.281 0.232 . . . . 0.0 111.09 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -97.29 -13.94 21.64 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.936 0.495 . . . . 0.0 111.695 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 3.7 p -136.78 -21.06 1.28 Allowed 'General case' 0 C--O 1.232 0.174 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -178.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 79.18 2.13 86.76 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 176.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -88.8 157.34 18.51 Favored 'General case' 0 C--O 1.228 -0.041 0 CA-C-N 117.794 0.797 . . . . 0.0 109.502 178.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 41.0 mt -69.88 141.9 53.11 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.86 0.362 . . . . 0.0 110.557 -176.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -73.92 -16.16 61.11 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.178 0.591 . . . . 0.0 110.302 178.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 75.95 5.51 80.17 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -171.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -100.05 149.22 23.71 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.491 0.716 . . . . 0.0 110.164 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 337' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' B' ' 323' ' ' ASN . . . -161.14 166.26 28.22 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 120.871 0.367 . . . . 0.0 111.398 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 2.7 p -118.71 149.84 40.76 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 169.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 42.8 t -135.58 123.21 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 171.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 16.0 t -102.04 137.99 39.58 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.001 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -101.75 161.67 13.48 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -74.42 -26.06 59.83 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -137.24 149.48 65.99 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -176.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 344' ' ' PRO . . . . . 0.469 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 41.6 Cg_endo -70.79 -32.25 14.59 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.391 2.727 . . . . 0.0 114.39 -177.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 345' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 79.2 Cg_endo -73.89 -22.11 17.82 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 CA-C-N 121.324 1.509 . . . . 0.0 110.075 -177.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 61.2 m -71.81 -37.64 70.35 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 175.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -67.05 -37.66 84.46 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 174.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -64.82 -43.52 92.83 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.94 -34.22 75.0 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 110.675 -0.12 . . . . 0.0 110.675 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.41 -36.41 84.07 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 64.4 mt -69.73 -52.62 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 120.357 -0.537 . . . . 0.0 109.758 175.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -55.82 -28.14 54.84 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 59.8 t-105 -96.79 -54.88 3.07 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -177.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 354' ' ' PHE . . . . . 0.408 ' CD1' ' CE1' ' B' ' 304' ' ' TYR . 50.7 m-85 -78.36 -29.86 47.72 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -174.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -51.17 110.77 0.47 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.222 0.465 . . . . 0.0 111.839 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 99.7 -2.18 57.09 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 119.541 -0.588 . . . . 0.0 112.715 175.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -83.54 -163.71 0.8 Allowed 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.065 0.932 . . . . 0.0 110.641 177.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -128.53 155.6 44.61 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 121.315 0.579 . . . . 0.0 111.356 178.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -146.78 136.73 23.33 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 124.637 1.175 . . . . 0.0 112.007 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 64.2 m 52.73 19.53 1.29 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -173.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.51 23.4 39.91 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -133.0 141.48 41.13 Favored Pre-proline 0 N--CA 1.453 -0.29 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -178.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.6 135.37 30.66 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 122.862 2.375 . . . . 0.0 109.611 178.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 27.0 pt -122.48 170.82 12.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 121.187 0.518 . . . . 0.0 110.807 -177.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 9.7 tmtm? -145.66 117.93 8.42 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.537 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 10.9 t -105.48 150.13 8.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 C-N-CA 123.324 0.65 . . . . 0.0 112.01 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 30.0 t -162.27 173.88 13.61 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 176.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -71.16 130.24 40.97 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 176.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -87.18 -174.51 4.91 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.696 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 15.3 t -157.47 -172.77 4.11 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.326 1.05 . . . . 0.0 109.27 176.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 20.3 mmt85 -98.81 67.01 1.66 Allowed 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 -60.52 -16.84 41.23 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 173.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.71 -31.25 69.43 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.818 0.847 . . . . 0.0 110.989 173.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -67.1 -9.32 38.34 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -173.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -92.37 -19.73 21.78 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 175.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -93.53 -40.78 10.12 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 122.5 0.32 . . . . 0.0 111.524 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 . . . . . 0 C--O 1.25 1.111 0 CA-C-O 117.573 -1.203 . . . . 0.0 110.192 -176.791 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.581 0 N19-C1'-C2' 109.003 -2.748 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.699 0 C5'-C4'-C3' 112.213 -2.191 . 0.707 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.299 0 N19-C1'-C2' 108.68 -2.95 . 0.696 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.6 0 N19-C1'-C2' 108.909 -2.807 . 0.829 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.392 0 N19-C1'-C2' 108.62 -2.987 . 0.68 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.352 0 N19-C1'-C2' 108.736 -2.915 . 0.769 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.666 0 O4'-C1'-N19 111.016 2.816 . 0.796 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.308 0 C4'-C3'-C2' 99.956 -2.744 . 0.745 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.666 0 C4'-C3'-C2' 99.899 -2.801 . 0.639 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.641 0 C4'-C3'-C2' 99.835 -2.865 . 0.591 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.396 0 C4'-C3'-C2' 99.823 -2.877 . 0.507 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.574 0 O4'-C1'-N19 112.063 3.863 . 0.148 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.51 1 C5'-C4'-C3' 108.698 -4.534 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ' U' . . . . . 0.425 ' C6 ' ' CE2' ' B' ' 288' ' ' PHE . . . . . . . . 0 O4'--C4' 1.422 -2.589 0 O4'-C1'-N19 112.135 3.935 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.626 3.255 0 O4'-C1'-N19 110.654 2.454 . 0.67 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.338 0 N19-C1'-C2' 108.814 -2.866 . 0.328 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.418 0 N19-C1'-C2' 108.79 -2.881 . 0.653 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.621 0 O4'-C1'-N19 110.818 2.618 . 0.743 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.59 0 C5'-C4'-C3' 111.59 -2.607 . 0.778 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.48 0 O4'-C1'-N19 110.897 2.697 . 0.673 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.54 0 C4'-C3'-C2' 100.397 -2.303 . 0.75 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.571 0 C5'-C4'-C3' 111.373 -2.751 . 0.786 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.777 0 C5'-C4'-C3' 112.056 -2.296 . 0.789 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 59.2 m -109.01 143.12 38.72 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 120.956 0.408 . . . . 0.0 110.961 -176.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 24.7 pt -117.8 147.84 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 174.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -99.71 143.54 29.82 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 173.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 19.5 t -127.72 141.36 46.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.813 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -129.06 149.62 50.8 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 88.54 12.67 64.39 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-O 119.818 -0.434 . . . . 0.0 112.633 169.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 65.6 mt -56.93 -51.62 68.44 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 117.532 0.666 . . . . 0.0 110.599 -175.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 147.44 173.41 18.52 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -98.58 -0.85 42.34 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 122.368 -0.489 . . . . 0.0 111.984 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -128.66 13.63 6.44 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.804 0.441 . . . . 0.0 112.168 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.1 m -75.81 165.69 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -173.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 20.7 p -131.17 158.39 40.62 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 123.335 0.654 . . . . 0.0 112.168 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 298' ' ' ILE . . . . . 0.596 HG23 ' HB ' ' B' ' 322' ' ' ILE . 37.5 mt -60.11 -44.27 94.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.267 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -62.93 -36.0 81.95 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.689 0.395 . . . . 0.0 111.505 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 75.3 m -72.22 -43.43 64.44 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 117.893 0.315 . . . . 0.0 110.258 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 71.4 t -62.62 -41.87 93.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.54 -36.86 85.57 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 303' ' ' ASP . . . . . 0.409 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 44.1 t0 -70.21 -27.19 64.29 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 304' ' ' TYR . . . . . 0.418 ' CE2' ' CD1' ' B' ' 354' ' ' PHE . 59.6 t80 -85.21 -25.97 27.03 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -96.54 -23.92 16.3 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 306' ' ' LYS . . . . . 0.409 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.6 ptpt -66.95 -18.19 65.27 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -177.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -72.69 -20.28 61.26 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.8 mm -87.01 -46.46 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.06 0 N-CA-C 110.51 -0.181 . . . . 0.0 110.51 175.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -162.22 167.63 36.91 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 80.0 mt -68.76 119.7 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 120.853 0.358 . . . . 0.0 110.499 -176.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 93.9 mt -73.84 136.39 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 172.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -178.474 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo . . . . . 0 N--CA 1.453 -0.907 0 N-CA-C 109.855 -0.864 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 321' ' ' MET . . . . . 0.415 ' CB ' ' HB3' ' B' ' 340' ' ' SER . 36.0 mtt -72.62 88.34 1.26 Allowed 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 322' ' ' ILE . . . . . 0.596 ' HB ' HG23 ' B' ' 298' ' ' ILE . 4.0 mp -136.07 140.26 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 171.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -133.41 108.09 8.47 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.28 151.04 35.24 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.796 0.839 . . . . 0.0 109.273 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -117.22 150.56 38.55 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 176.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.141 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -175.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 9.2 mmmm . . . . . 0 C--O 1.231 0.097 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.19 6.94 84.2 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -171.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -104.9 148.27 26.86 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.666 0.786 . . . . 0.0 110.379 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -161.96 156.67 22.65 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.845 175.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 21.3 p -103.95 153.15 21.15 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 169.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 23.3 t -135.67 128.37 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 123.582 0.753 . . . . 0.0 109.312 170.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 340' ' ' SER . . . . . 0.415 ' HB3' ' CB ' ' B' ' 321' ' ' MET . 38.7 t -106.73 144.15 33.8 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.883 0.373 . . . . 0.0 111.132 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -109.71 158.77 17.76 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -73.93 -17.61 61.0 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -145.41 149.98 42.75 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 344' ' ' PRO . . . . . 0.467 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 49.2 Cg_endo -70.51 -31.78 16.63 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.272 2.648 . . . . 0.0 114.408 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 345' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 81.0 Cg_endo -73.43 -21.65 19.45 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 CA-C-N 121.515 1.577 . . . . 0.0 110.261 -177.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 60.1 m -73.05 -37.51 66.82 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 175.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.0 -38.35 88.26 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 174.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 9.5 tmtm? -65.13 -43.42 91.99 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -66.83 -34.15 77.18 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.92 -36.74 85.35 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 67.2 mt -69.73 -51.62 39.32 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.094 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.733 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -54.74 -29.49 53.77 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 57.5 t-105 -97.79 -56.4 2.52 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -177.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 354' ' ' PHE . . . . . 0.418 ' CD1' ' CE2' ' B' ' 304' ' ' TYR . 50.7 m-85 -75.8 -28.42 58.33 Favored 'General case' 0 CA--C 1.523 -0.08 0 N-CA-C 114.571 1.322 . . . . 0.0 114.571 -173.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -52.27 108.23 0.27 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 117.844 0.293 . . . . 0.0 111.506 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 100.41 -0.89 55.78 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-O 119.662 -0.521 . . . . 0.0 112.729 175.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -83.72 -165.01 1.0 Allowed 'General case' 0 N--CA 1.461 0.096 0 CA-C-N 118.296 1.048 . . . . 0.0 110.371 176.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -127.41 153.37 46.34 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-O 121.02 0.438 . . . . 0.0 110.83 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -145.57 136.64 24.73 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.307 1.043 . . . . 0.0 112.212 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 21.5 t 53.99 19.28 1.96 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.57 0.348 . . . . 0.0 111.302 -175.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.14 23.18 41.88 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.871 -0.492 . . . . 0.0 111.871 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -132.37 142.42 44.9 Favored Pre-proline 0 N--CA 1.455 -0.22 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.52 136.15 32.87 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 122.873 2.382 . . . . 0.0 109.67 178.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 25.5 pt -124.05 171.07 13.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-O 121.173 0.511 . . . . 0.0 111.025 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -146.02 119.4 9.0 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.434 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 13.3 t -108.04 150.03 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 123.14 0.576 . . . . 0.0 112.133 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 29.1 t -163.85 173.12 13.11 Favored 'General case' 0 C--N 1.339 0.15 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -69.93 130.13 41.37 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 176.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 121.144 0.497 . . . . 0.0 111.922 -179.094 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 10.4 p30 . . . . . 0 N--CA 1.456 -0.174 0 N-CA-C 110.584 -0.154 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 29.3 m -101.5 141.77 33.87 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.011 0.434 . . . . 0.0 111.521 -173.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 38.2 pt -116.6 146.63 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.958 172.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -97.94 144.56 27.36 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 173.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 19.4 t -132.34 141.5 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 122.783 0.433 . . . . 0.0 110.969 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -130.92 154.4 48.15 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 122.858 0.463 . . . . 0.0 109.797 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 86.46 12.92 68.89 Favored Glycine 0 CA--C 1.521 0.469 0 CA-C-O 119.831 -0.427 . . . . 0.0 112.355 169.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 74.7 mt -57.49 -50.1 74.16 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 117.54 0.67 . . . . 0.0 110.336 -176.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 144.16 171.03 13.93 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -98.0 3.21 49.49 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 122.544 -0.386 . . . . 0.0 111.855 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -128.29 11.9 6.46 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.638 0.375 . . . . 0.0 111.769 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.6 m -74.8 163.75 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -173.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 20.3 p -128.87 158.93 37.37 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 123.589 0.755 . . . . 0.0 111.85 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 298' ' ' ILE . . . . . 0.548 HG23 ' HB ' ' B' ' 322' ' ' ILE . 40.4 mt -60.29 -44.38 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.547 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -68.72 -30.48 69.13 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 74.8 m -72.16 -43.96 63.81 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 118.17 0.441 . . . . 0.0 109.837 177.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 71.8 t -62.78 -41.05 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.21 -37.38 87.27 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 303' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -70.16 -26.87 64.12 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -85.71 -25.46 26.48 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -96.71 -24.18 16.09 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 306' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -67.11 -18.12 65.17 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 111.576 0.213 . . . . 0.0 111.576 -177.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -72.79 -20.01 61.24 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.2 mm -87.18 -45.69 16.26 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 CA-C-N 117.732 0.242 . . . . 0.0 110.48 175.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.4 167.68 37.74 Favored Glycine 0 C--N 1.335 0.502 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 78.3 mt -69.35 120.4 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-O 120.935 0.397 . . . . 0.0 110.717 -175.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 86.8 mt -75.19 134.47 29.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 171.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt . . . . . 0 N--CA 1.453 -0.314 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.903 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo . . . . . 0 N--CA 1.447 -1.215 0 N-CA-C 109.288 -1.082 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 321' ' ' MET . . . . . 0.461 ' CB ' ' HB2' ' B' ' 340' ' ' SER . 30.1 mtt -71.38 93.62 1.16 Allowed 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.152 0.501 . . . . 0.0 111.636 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 322' ' ' ILE . . . . . 0.548 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.4 mp -140.89 139.52 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 173.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -132.01 106.32 7.96 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 35.0 mt -78.32 153.41 31.74 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 123.891 0.744 . . . . 0.0 109.361 176.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -119.87 149.49 41.99 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 176.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.454 -0.229 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -174.924 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt . . . . . 0 CA--C 1.519 -0.215 0 CA-C-O 120.445 0.164 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 74.44 5.34 72.41 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -173.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -106.02 149.77 26.37 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.017 0.527 . . . . 0.0 110.167 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -163.52 160.1 22.77 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.727 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 27.4 p -106.88 153.82 21.96 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 169.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 22.1 t -134.26 129.36 53.32 Favored 'Isoleucine or valine' 0 C--O 1.23 0.038 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 170.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 340' ' ' SER . . . . . 0.461 ' HB2' ' CB ' ' B' ' 321' ' ' MET . 20.4 m -108.54 134.62 51.05 Favored 'General case' 0 C--O 1.23 0.068 0 CA-C-O 120.677 0.275 . . . . 0.0 110.3 -176.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -101.14 159.98 14.78 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -70.67 -36.04 73.15 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -127.52 149.06 69.08 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 344' ' ' PRO . . . . . 0.468 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 45.4 Cg_endo -70.83 -31.31 15.98 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.006 2.47 . . . . 0.0 114.647 -177.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 345' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 89.6 Cg_endo -73.61 -21.05 19.7 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 CA-C-N 121.222 1.472 . . . . 0.0 110.087 -177.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 49.0 m -71.25 -37.64 71.95 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 175.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.14 -39.44 89.84 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 174.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -63.36 -44.22 95.43 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.9 -33.92 75.64 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.117 0.167 . . . . 0.0 110.616 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.71 -37.86 89.04 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 67.3 mt -68.59 -53.05 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 120.35 -0.54 . . . . 0.0 109.973 175.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -54.93 -28.08 48.29 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -97.51 -55.47 2.81 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -76.92 -28.29 55.21 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -173.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -52.29 108.5 0.3 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 117.953 0.342 . . . . 0.0 111.366 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 101.61 -0.8 52.82 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.547 -0.585 . . . . 0.0 112.647 175.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -83.88 -163.11 0.72 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 118.09 0.945 . . . . 0.0 110.57 177.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -130.71 153.27 49.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.046 0.451 . . . . 0.0 110.464 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -145.81 138.0 25.43 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.224 1.01 . . . . 0.0 112.408 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 19.2 t 55.49 17.13 2.09 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.858 0.361 . . . . 0.0 111.026 -175.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.01 22.57 41.44 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.858 -0.497 . . . . 0.0 111.858 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 42.6 m-20 -132.26 142.41 44.89 Favored Pre-proline 0 N--CA 1.455 -0.181 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.84 135.5 32.87 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 122.709 2.272 . . . . 0.0 109.872 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 31.3 pt -121.63 170.69 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-O 120.948 0.404 . . . . 0.0 111.16 -177.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -143.21 112.84 6.93 Favored 'General case' 0 C--O 1.227 -0.083 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.793 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 6.3 t -103.85 149.73 7.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 C-N-CA 122.878 0.471 . . . . 0.0 112.258 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 29.4 t -164.13 175.02 10.59 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -71.73 129.77 39.47 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 175.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 121.329 0.585 . . . . 0.0 112.325 -179.089 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 285' ' ' ASN . . . . . 0.438 HD22 ' C ' ' B' ' 285' ' ' ASN . 0.2 OUTLIER . . . . . 0 CA--C 1.53 0.173 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 87.7 m -107.97 143.76 36.19 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.148 0.499 . . . . 0.0 110.887 -174.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 41.5 pt -117.34 147.13 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.528 -0.76 . . . . 0.0 108.971 174.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -99.45 145.67 27.18 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 173.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 13.5 t -129.69 143.25 41.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 122.651 0.38 . . . . 0.0 111.403 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -131.65 149.57 52.45 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 122.952 0.501 . . . . 0.0 109.829 175.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 88.57 12.06 65.25 Favored Glycine 0 CA--C 1.522 0.494 0 CA-C-O 119.69 -0.506 . . . . 0.0 112.511 169.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 47.0 mt -57.45 -51.53 69.06 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 117.659 0.729 . . . . 0.0 110.836 -174.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 152.55 176.97 25.71 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -95.72 -14.85 23.05 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 122.311 -0.523 . . . . 0.0 112.118 -175.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -128.62 18.72 6.26 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.278 0.49 . . . . 0.0 112.093 -178.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.3 m -65.96 164.4 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -175.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 18.1 p -126.26 160.89 29.07 Favored 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 123.267 0.627 . . . . 0.0 112.265 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 298' ' ' ILE . . . . . 0.565 HG23 ' HB ' ' B' ' 322' ' ' ILE . 28.6 mt -64.54 -43.5 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.966 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -65.26 -37.29 86.76 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 79.5 p -73.29 -42.63 62.2 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 118.137 0.426 . . . . 0.0 110.494 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.5 -41.57 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.79 -36.0 82.92 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 303' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -70.43 -26.62 63.75 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -84.17 -26.68 28.63 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -96.43 -24.9 15.9 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 306' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -66.5 -18.89 65.62 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -177.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -71.8 -20.04 61.91 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -178.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 5.4 mm -87.21 -46.17 16.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 175.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -164.03 168.19 38.39 Favored Glycine 0 C--N 1.335 0.49 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 82.4 mt -69.16 122.03 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 122.603 0.361 . . . . 0.0 110.433 -175.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 95.9 mt -75.69 137.58 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 173.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt . . . . . 0 N--CA 1.45 -0.458 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -178.953 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo . . . . . 0 N--CA 1.451 -1.018 0 N-CA-C 109.453 -1.018 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 321' ' ' MET . . . . . 0.455 ' C ' HD12 ' B' ' 322' ' ' ILE . 35.9 mtt -71.54 86.14 0.87 Allowed 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.907 0.384 . . . . 0.0 111.617 -178.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 322' ' ' ILE . . . . . 0.565 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.7 mp -134.07 143.48 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 171.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -130.76 138.38 49.92 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 171.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 86.4 mt -110.48 129.36 55.8 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 176.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -94.55 154.23 17.49 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -177.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.141 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -173.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? . . . . . 0 CA--C 1.528 0.098 0 N-CA-C 110.483 -0.191 . . . . 0.0 110.483 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.8 6.07 84.78 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -171.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -104.11 152.16 22.44 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.629 0.771 . . . . 0.0 109.91 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -160.25 169.66 22.74 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.898 0.38 . . . . 0.0 111.171 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 1.7 p -126.48 150.47 48.7 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 170.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 21.3 t -135.35 125.06 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 C-N-CA 123.577 0.751 . . . . 0.0 109.252 172.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 23.5 t -104.26 136.17 44.36 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.552 0.215 . . . . 0.0 110.605 -178.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -101.66 158.63 15.96 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -177.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -72.87 -31.08 64.47 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -129.54 146.68 62.11 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 344' ' ' PRO . . . . . 0.463 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 46.8 Cg_endo -70.99 -32.21 13.82 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.219 2.613 . . . . 0.0 114.38 -177.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 345' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 77.9 Cg_endo -73.49 -21.93 18.99 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 CA-C-N 121.256 1.484 . . . . 0.0 110.101 -176.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 67.3 m -70.73 -35.14 72.55 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 175.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -68.73 -39.28 80.46 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.62 -43.73 98.31 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 177.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.94 -35.09 76.38 Favored 'General case' 0 C--O 1.225 -0.201 0 O-C-N 122.371 -0.206 . . . . 0.0 110.462 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.31 -36.52 84.33 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 60.0 mt -71.21 -49.18 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.165 175.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -59.98 -27.58 66.95 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -175.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -96.55 -57.33 2.34 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -75.09 -30.93 61.06 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -173.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -54.19 111.17 0.72 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 118.128 0.422 . . . . 0.0 110.947 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 102.03 -3.0 51.65 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 119.556 -0.58 . . . . 0.0 112.559 176.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -84.42 -164.15 0.91 Allowed 'General case' 0 C--O 1.232 0.137 0 CA-C-N 118.093 0.947 . . . . 0.0 109.787 177.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -128.53 153.34 47.28 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.06 0.457 . . . . 0.0 110.971 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -145.01 135.96 24.73 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.041 0.936 . . . . 0.0 112.101 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 62.7 m 53.31 19.5 1.59 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.516 0.327 . . . . 0.0 111.802 -174.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.74 23.23 39.79 Favored Glycine 0 C--N 1.339 0.733 0 N-CA-C 111.784 -0.526 . . . . 0.0 111.784 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 56.9 m-20 -132.55 142.25 44.17 Favored Pre-proline 0 N--CA 1.452 -0.333 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -177.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.83 135.37 30.11 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.804 2.336 . . . . 0.0 109.72 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 30.6 pt -122.9 169.91 13.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.22 0.533 . . . . 0.0 111.166 -177.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 5.3 tmtm? -145.72 114.05 6.66 Favored 'General case' 0 C--N 1.338 0.069 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 11.2 t -103.89 149.73 7.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.077 0.551 . . . . 0.0 112.24 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 28.1 t -162.71 172.42 15.31 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 176.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -70.48 130.17 41.17 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.388 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.277 -177.841 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 285' ' ' ASN . . . . . 0.408 HD22 ' C ' ' B' ' 285' ' ' ASN . 0.4 OUTLIER . . . . . 0 N--CA 1.456 -0.136 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 35.0 m -104.88 140.79 37.61 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -173.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 41.1 pt -110.29 142.82 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -93.79 141.91 27.97 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 172.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 15.9 t -130.38 141.18 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 O-C-N 123.156 0.285 . . . . 0.0 111.173 177.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -126.98 154.12 45.01 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 174.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 85.47 12.18 73.31 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-O 119.772 -0.46 . . . . 0.0 112.425 169.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 60.0 mt -56.69 -50.59 71.7 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 117.536 0.668 . . . . 0.0 110.752 -175.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 156.79 179.69 31.95 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -97.79 -8.43 28.49 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -177.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -141.22 24.4 2.13 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.5 m -67.95 162.81 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -174.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 20.8 p -122.84 156.51 34.43 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 298' ' ' ILE . . . . . 0.438 HG23 ' HB ' ' B' ' 322' ' ' ILE . 35.4 mt -61.56 -43.23 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.038 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -65.15 -35.73 82.02 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.61 0.364 . . . . 0.0 111.54 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 38.6 t -73.23 -44.1 60.11 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 122.25 -0.281 . . . . 0.0 110.389 -178.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 93.9 t -62.08 -41.51 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.95 -35.23 80.51 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 303' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -70.97 -29.28 65.22 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 304' ' ' TYR . . . . . 0.413 ' CE1' ' CD1' ' B' ' 354' ' ' PHE . 59.9 t80 -83.77 -24.96 30.88 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -96.62 -23.35 16.53 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 306' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -67.81 -16.76 64.26 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -177.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -73.02 -19.86 61.11 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 111.561 0.208 . . . . 0.0 111.561 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 3.9 mm -87.07 -47.76 15.8 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.109 0 CA-C-O 120.525 0.202 . . . . 0.0 110.781 175.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -161.4 175.38 38.0 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 74.4 mt -73.86 111.89 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-O 120.808 0.337 . . . . 0.0 110.133 -176.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 73.6 mt -68.16 135.53 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 172.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 312' ' ' LYS . . . . . 0.433 ' HG2' ' SD ' ' B' ' 321' ' ' MET . 40.7 ttmt . . . . . 0 N--CA 1.451 -0.379 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo . . . . . 0 N--CA 1.445 -1.331 0 N-CA-C 108.88 -1.239 . . . . 0.0 108.88 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 321' ' ' MET . . . . . 0.433 ' SD ' ' HG2' ' B' ' 312' ' ' LYS . 81.2 mtp -85.65 85.27 7.42 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.573 0.702 . . . . 0.0 111.09 -172.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 322' ' ' ILE . . . . . 0.438 ' HB ' HG23 ' B' ' 298' ' ' ILE . 2.3 mp -118.12 149.78 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 125.257 1.423 . . . . 0.0 108.328 174.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -134.94 116.16 14.4 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 170.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 55.5 mt -90.44 150.06 21.98 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 177.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -115.12 150.89 35.29 Favored 'General case' 0 C--O 1.226 -0.183 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 3.1 m . . . . . 0 CA--C 1.52 -0.175 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -176.912 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? . . . . . 0 N--CA 1.461 0.092 0 N-CA-C 110.533 -0.173 . . . . 0.0 110.533 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 72.59 5.12 62.99 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -172.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -103.48 150.63 23.7 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.275 0.63 . . . . 0.0 110.354 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.16 169.4 24.25 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.008 0.433 . . . . 0.0 110.328 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 2.5 p -132.3 147.44 52.4 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 171.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 339' ' ' VAL . . . . . 0.402 ' CG1' HG13 ' B' ' 322' ' ' ILE . 1.0 OUTLIER -137.27 141.46 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 169.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 44.6 t -92.36 145.46 24.46 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.585 -177.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -112.46 151.92 29.34 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 175.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -70.61 -22.77 62.5 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 343' ' ' ASP . . . . . 0.435 ' HB3' ' HD2' ' B' ' 345' ' ' PRO . 48.3 m-20 -144.49 148.31 39.82 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 124.025 0.93 . . . . 0.0 111.769 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 344' ' ' PRO . . . . . 0.466 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 53.6 Cg_endo -71.62 -31.81 12.87 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.507 2.804 . . . . 0.0 115.063 -172.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 345' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 98.7 Cg_endo -73.51 -22.44 18.35 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 CA-C-N 121.286 1.495 . . . . 0.0 109.841 -178.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 48.7 m -73.21 -34.14 65.76 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 175.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -67.31 -41.21 85.73 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 175.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -70.85 -32.91 70.07 Favored 'General case' 0 C--O 1.227 -0.108 0 C-N-CA 121.16 -0.216 . . . . 0.0 110.841 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.07 -36.88 80.56 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 175.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.43 -36.99 85.58 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 71.5 mt -68.16 -52.67 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 175.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -55.12 -29.75 58.33 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 54.1 t-105 -96.64 -55.14 3.0 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 354' ' ' PHE . . . . . 0.413 ' CD1' ' CE1' ' B' ' 304' ' ' TYR . 51.0 m-85 -76.16 -27.21 56.89 Favored 'General case' 0 CA--C 1.522 -0.119 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 -173.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -49.19 109.68 0.29 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 117.98 0.355 . . . . 0.0 111.932 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 96.79 0.45 60.47 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 119.477 -0.624 . . . . 0.0 112.736 174.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -83.62 -164.6 0.94 Allowed 'General case' 0 C--N 1.339 0.111 0 CA-C-N 118.209 1.004 . . . . 0.0 110.186 176.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -128.97 152.12 48.93 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 120.981 0.42 . . . . 0.0 110.83 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -144.25 136.45 26.45 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.186 0.994 . . . . 0.0 112.451 177.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 20.7 t 54.36 19.0 2.08 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.517 0.327 . . . . 0.0 111.125 -175.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.48 23.78 38.67 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 112.004 -0.438 . . . . 0.0 112.004 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -132.8 142.62 45.4 Favored Pre-proline 0 N--CA 1.455 -0.213 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -177.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.8 136.61 33.32 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 122.751 2.3 . . . . 0.0 109.441 178.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 33.6 pt -123.69 169.95 14.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 CA-C-O 121.203 0.525 . . . . 0.0 111.259 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -143.33 113.79 7.43 Favored 'General case' 0 C--O 1.23 0.043 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.765 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 12.2 t -105.39 147.55 10.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.002 0.521 . . . . 0.0 112.2 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 23.0 t -163.68 172.94 13.53 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -71.76 129.58 39.01 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 175.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.464 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.878 -178.498 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.531 0.226 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 26.4 m -107.39 145.11 33.34 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.044 0.45 . . . . 0.0 111.84 -173.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 30.4 pt -122.06 146.69 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.028 175.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -98.63 143.18 29.3 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 173.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 18.4 t -128.41 142.93 42.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 O-C-N 123.312 0.382 . . . . 0.0 111.177 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -131.69 150.33 52.19 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 176.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.86 12.72 65.84 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-O 119.669 -0.517 . . . . 0.0 112.397 169.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 65.7 mt -55.24 -51.46 66.52 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 117.598 0.699 . . . . 0.0 110.571 -175.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 146.74 176.25 20.37 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -101.54 1.26 37.79 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.607 0.363 . . . . 0.0 111.81 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -128.7 12.12 6.28 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.6 m -74.41 162.93 4.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -172.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 30.5 p -132.12 159.72 38.1 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 123.724 0.81 . . . . 0.0 111.268 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 298' ' ' ILE . . . . . 0.577 HG23 ' HB ' ' B' ' 322' ' ' ILE . 37.7 mt -61.85 -43.6 97.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.169 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -63.53 -35.63 81.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 122.527 0.331 . . . . 0.0 111.472 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 75.0 m -71.73 -44.56 63.91 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-N 118.06 0.391 . . . . 0.0 110.349 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 74.9 t -63.03 -40.68 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -65.18 -36.26 83.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 303' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -70.61 -26.65 63.59 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -85.05 -25.52 27.58 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -96.44 -24.8 15.94 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 306' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -66.43 -18.9 65.62 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 122.396 -0.19 . . . . 0.0 111.467 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -71.84 -19.78 61.92 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 111.682 0.252 . . . . 0.0 111.682 -178.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.8 mm -88.15 -45.48 15.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.086 0 CA-C-N 117.632 0.196 . . . . 0.0 110.561 175.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -164.4 168.66 38.86 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 87.8 mt -69.02 122.14 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 121.021 0.439 . . . . 0.0 110.305 -175.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 92.0 mt -75.66 138.46 20.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 172.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 312' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' B' ' 312' ' ' LYS . 36.2 ttmt . . . . . 0 N--CA 1.454 -0.242 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 N--CA 1.449 -1.121 0 N-CA-C 110.074 -0.779 . . . . 0.0 110.074 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 321' ' ' MET . . . . . . . . . . . . . 39.0 mtt -70.97 92.86 0.95 Allowed 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.023 0.439 . . . . 0.0 111.53 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 322' ' ' ILE . . . . . 0.577 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.9 mp -140.4 141.56 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 172.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -127.06 132.55 50.66 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 170.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 73.4 mt -107.64 135.12 49.61 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 177.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -102.7 146.25 28.49 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.455 -0.198 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -174.692 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt . . . . . 0 N--CA 1.464 0.227 0 CA-C-O 120.311 0.101 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.41 3.04 76.41 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -174.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -102.84 149.32 24.62 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 117.288 0.544 . . . . 0.0 109.682 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -160.16 167.45 27.66 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.793 0.33 . . . . 0.0 111.473 -176.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 2.7 p -120.25 151.6 38.93 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 169.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 32.4 t -136.73 129.5 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 123.668 0.787 . . . . 0.0 108.927 171.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 47.3 t -109.19 140.45 42.78 Favored 'General case' 0 CA--C 1.523 -0.091 0 CA-C-N 117.795 0.27 . . . . 0.0 111.311 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -105.91 158.88 16.45 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -70.93 -33.78 70.85 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -128.4 147.45 63.88 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 344' ' ' PRO . . . . . 0.475 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 42.6 Cg_endo -70.69 -31.85 15.68 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 123.223 2.616 . . . . 0.0 114.549 -176.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 345' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 89.7 Cg_endo -73.62 -21.17 19.52 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 CA-C-N 121.059 1.414 . . . . 0.0 110.431 -177.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 69.8 m -70.98 -36.85 72.68 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 175.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -69.27 -36.78 77.44 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 175.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -64.62 -43.37 93.95 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -69.22 -33.43 73.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 110.624 -0.139 . . . . 0.0 110.624 177.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.38 -37.13 86.44 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 63.3 mt -69.69 -52.84 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -55.57 -27.32 48.5 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -97.56 -56.62 2.46 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -75.58 -29.5 59.34 Favored 'General case' 0 C--N 1.337 0.052 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -173.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -53.08 107.71 0.26 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.944 0.338 . . . . 0.0 111.412 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 101.58 -0.98 52.93 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 119.533 -0.593 . . . . 0.0 112.737 176.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -84.75 -164.39 0.97 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-N 117.989 0.895 . . . . 0.0 110.154 176.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -128.91 152.38 48.62 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.825 0.345 . . . . 0.0 111.004 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -143.77 137.07 27.8 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.12 0.968 . . . . 0.0 112.398 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 59.7 m 53.14 18.87 1.28 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -174.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 89.21 21.47 41.52 Favored Glycine 0 C--N 1.338 0.676 0 CA-C-O 119.821 -0.433 . . . . 0.0 112.158 179.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -132.19 143.06 47.35 Favored Pre-proline 0 N--CA 1.457 -0.118 0 CA-C-N 117.501 0.65 . . . . 0.0 109.295 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.57 135.85 31.97 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.987 2.458 . . . . 0.0 109.651 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 25.8 pt -124.11 170.77 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-O 121.112 0.482 . . . . 0.0 110.946 -178.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -145.18 118.13 8.79 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.118 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 12.7 t -106.78 150.32 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 123.165 0.586 . . . . 0.0 111.729 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 27.0 t -163.79 172.5 14.03 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 175.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -70.04 130.64 42.69 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 176.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.484 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.359 177.918 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 8.9 p30 . . . . . 0 CA--C 1.53 0.198 0 CA-C-O 119.933 -0.08 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 84.8 m -103.87 142.4 34.46 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.105 0.479 . . . . 0.0 110.558 -174.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 44.5 pt -114.93 146.75 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -98.85 144.44 28.05 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 173.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 289' ' ' VAL . . . . . 0.552 ' CG1' HD13 ' B' ' 292' ' ' LEU . 60.7 t -129.28 136.16 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 O-C-N 123.411 0.445 . . . . 0.0 110.57 -178.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -126.64 155.16 43.01 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 176.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 83.32 12.71 78.2 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 172.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 292' ' ' LEU . . . . . 0.552 HD13 ' CG1' ' B' ' 289' ' ' VAL . 4.2 tp -59.27 -50.82 72.54 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.98 0.912 . . . . 0.0 110.996 -170.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 143.64 165.04 10.63 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.311 -0.715 . . . . 0.0 111.311 176.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -95.81 3.93 53.31 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.532 0.333 . . . . 0.0 111.34 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -128.71 12.73 6.35 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.764 0.426 . . . . 0.0 111.84 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 4.2 m -72.63 166.75 2.45 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -173.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 32.5 p -137.82 160.76 38.39 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 124.072 0.949 . . . . 0.0 110.835 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 298' ' ' ILE . . . . . 0.502 HG23 ' HB ' ' B' ' 322' ' ' ILE . 41.7 mt -63.08 -40.74 90.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -66.36 -38.07 86.75 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 80.6 p -73.25 -44.17 59.89 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 117.945 0.339 . . . . 0.0 110.237 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 71.0 t -60.76 -42.87 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -65.24 -34.82 79.27 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 122.224 -0.297 . . . . 0.0 110.293 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 303' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -69.83 -28.09 65.41 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -84.17 -25.83 29.27 Favored 'General case' 0 C--O 1.226 -0.157 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -96.16 -23.71 16.61 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 306' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -68.19 -18.06 64.49 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -177.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -72.45 -19.17 61.61 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -178.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 3.6 mm -87.89 -47.81 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 CA-C-N 117.564 0.165 . . . . 0.0 110.746 175.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -161.61 173.82 38.04 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 76.1 mt -71.89 116.35 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 120.861 0.363 . . . . 0.0 110.099 -175.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 76.1 mt -71.59 137.93 22.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 172.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 312' ' ' LYS . . . . . 0.448 ' HG2' ' SD ' ' B' ' 321' ' ' MET . 40.9 ttmt . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo . . . . . 0 N--CA 1.447 -1.256 0 N-CA-C 109.178 -1.124 . . . . 0.0 109.178 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 321' ' ' MET . . . . . 0.488 ' C ' HD12 ' B' ' 322' ' ' ILE . 62.3 mtp -82.43 85.88 6.84 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.37 0.605 . . . . 0.0 111.558 -172.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 322' ' ' ILE . . . . . 0.502 ' HB ' HG23 ' B' ' 298' ' ' ILE . 2.7 mp -126.46 147.83 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 174.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -134.25 111.88 10.61 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 173.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 30.6 mt -80.76 149.76 29.52 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 123.93 0.769 . . . . 0.0 108.936 176.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -115.48 145.79 42.27 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 6.8 m . . . . . 0 N--CA 1.453 -0.277 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -175.378 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? . . . . . 0 N--CA 1.465 0.298 0 N-CA-C 111.329 0.122 . . . . 0.0 111.329 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.62 22.16 73.16 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -173.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -128.36 146.62 50.72 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.073 0.549 . . . . 0.0 110.18 -178.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -156.04 159.44 39.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.727 0.298 . . . . 0.0 111.587 174.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 3.4 p -104.1 155.81 18.39 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 170.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 16.7 t -138.12 122.48 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.042 0 C-N-CA 123.432 0.693 . . . . 0.0 110.312 172.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 69.2 m -90.78 144.21 25.95 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 117.961 0.346 . . . . 0.0 110.967 177.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 341' ' ' PHE . . . . . 0.403 ' O ' ' HE3' ' B' ' 312' ' ' LYS . 26.3 m-85 -112.89 151.2 30.75 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 177.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -69.92 -28.91 65.99 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -177.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -132.71 148.51 69.8 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -178.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 344' ' ' PRO . . . . . 0.474 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 37.9 Cg_endo -70.42 -33.14 14.59 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.357 2.705 . . . . 0.0 114.205 -177.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 345' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 85.8 Cg_endo -73.54 -20.96 19.98 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 CA-C-N 121.225 1.473 . . . . 0.0 110.252 -177.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 70.3 m -72.05 -37.14 69.75 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -68.26 -38.37 81.71 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 175.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -65.06 -42.43 94.19 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -69.16 -34.71 75.39 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.399 -0.188 . . . . 0.0 110.956 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.17 -37.67 88.28 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 66.0 mt -68.56 -53.62 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.775 175.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -55.01 -27.73 46.53 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 54.8 t-105 -97.52 -55.35 2.85 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -76.26 -28.21 57.01 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -173.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -51.92 109.52 0.38 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 120.959 0.409 . . . . 0.0 111.555 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 101.29 -1.18 54.01 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 119.515 -0.603 . . . . 0.0 112.278 175.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -86.43 -165.64 1.32 Allowed 'General case' 0 C--O 1.231 0.084 0 CA-C-N 118.277 1.039 . . . . 0.0 110.698 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -127.28 155.59 43.26 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 121.061 0.458 . . . . 0.0 111.089 178.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -145.88 135.82 23.55 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.515 1.126 . . . . 0.0 112.196 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 20.8 t 54.11 18.77 1.85 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 120.873 0.368 . . . . 0.0 111.647 -176.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.67 24.17 33.9 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 112.031 -0.427 . . . . 0.0 112.031 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 53.1 m-20 -133.91 142.61 44.13 Favored Pre-proline 0 N--CA 1.454 -0.265 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -69.6 136.53 33.67 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 122.808 2.338 . . . . 0.0 109.308 176.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 31.2 pt -124.25 169.2 15.89 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 121.001 0.429 . . . . 0.0 110.96 -177.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -142.92 113.69 7.54 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.52 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 12.0 t -103.06 148.03 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 C-N-CA 123.144 0.577 . . . . 0.0 111.727 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 22.7 t -162.6 173.54 13.81 Favored 'General case' 0 C--N 1.338 0.099 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 177.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -70.64 128.31 35.65 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 176.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.367 0 CA-C-O 121.125 0.488 . . . . 0.0 112.008 -178.771 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 285' ' ' ASN . . . . . 0.43 HD22 ' C ' ' B' ' 285' ' ' ASN . 0.4 OUTLIER . . . . . 0 CA--C 1.53 0.201 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 87.6 m -109.76 141.67 42.07 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.265 0.555 . . . . 0.0 110.831 -175.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 41.1 pt -118.6 148.92 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-N 115.492 -0.776 . . . . 0.0 108.954 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -98.58 146.95 25.29 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 173.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 15.0 t -131.98 141.37 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-O 120.839 0.352 . . . . 0.0 111.259 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -129.47 150.73 50.69 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 176.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.86 12.5 66.19 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 119.793 -0.448 . . . . 0.0 112.76 169.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 73.3 mt -56.06 -51.61 67.23 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 117.62 0.71 . . . . 0.0 110.748 -175.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 148.51 175.89 21.46 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -101.43 -0.93 34.42 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 122.555 -0.379 . . . . 0.0 111.69 -176.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -128.71 11.29 6.16 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.075 0.55 . . . . 0.0 112.402 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.0 m -73.06 163.94 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -172.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 26.7 p -130.24 158.76 38.87 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 123.661 0.784 . . . . 0.0 111.773 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 298' ' ' ILE . . . . . 0.564 HG23 ' HB ' ' B' ' 322' ' ' ILE . 36.9 mt -60.2 -44.65 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.242 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -62.53 -36.2 81.83 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.711 0.404 . . . . 0.0 111.416 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 72.6 m -71.8 -43.79 65.07 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.991 0.359 . . . . 0.0 110.183 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 71.4 t -62.47 -41.41 91.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.95 -36.32 84.0 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 303' ' ' ASP . . . . . 0.4 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 44.9 t0 -69.91 -27.97 65.23 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -85.33 -25.38 27.18 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -96.28 -23.86 16.48 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 178.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 306' ' ' LYS . . . . . 0.4 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.6 ptpt -66.93 -18.69 65.5 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 -177.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -72.3 -20.41 61.51 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 117.731 0.241 . . . . 0.0 111.612 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.8 mm -87.27 -45.73 16.22 Favored 'Isoleucine or valine' 0 C--N 1.338 0.089 0 CA-C-N 117.677 0.217 . . . . 0.0 110.535 175.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.23 167.38 37.5 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 83.9 mt -68.5 121.79 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 120.834 0.349 . . . . 0.0 110.539 -175.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 89.1 mt -74.37 138.11 21.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 173.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 312' ' ' LYS . . . . . 0.656 ' HE3' ' SD ' ' B' ' 321' ' ' MET . 25.4 ttpt . . . . . 0 N--CA 1.45 -0.43 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -178.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo . . . . . 0 N--CA 1.45 -1.081 0 N-CA-C 109.921 -0.838 . . . . 0.0 109.921 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 321' ' ' MET . . . . . 0.656 ' SD ' ' HE3' ' B' ' 312' ' ' LYS . 33.9 mtt -72.61 92.51 1.52 Allowed 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 120.952 0.406 . . . . 0.0 111.656 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 322' ' ' ILE . . . . . 0.564 ' HB ' HG23 ' B' ' 298' ' ' ILE . 4.2 mp -139.73 138.51 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 171.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -131.36 105.93 7.94 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 176.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -75.39 153.58 37.64 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.812 0.845 . . . . 0.0 109.102 177.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -115.67 148.0 40.2 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.455 -0.199 0 C-N-CA 123.666 0.787 . . . . 0.0 112.82 -175.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt . . . . . 0 CA--C 1.527 0.085 0 N-CA-C 110.76 -0.089 . . . . 0.0 110.76 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 77.81 6.37 87.06 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -174.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -102.76 152.5 21.17 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.034 0.534 . . . . 0.0 110.162 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -164.66 161.38 20.79 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 116.698 -0.228 . . . . 0.0 110.966 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 5.3 p -109.04 155.06 21.37 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 169.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 33.7 t -137.64 128.39 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.043 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 171.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 340' ' ' SER . . . . . 0.411 ' HB3' ' SD ' ' B' ' 321' ' ' MET . 8.2 t -104.0 146.92 28.0 Favored 'General case' 0 C--O 1.228 -0.064 0 CA-C-N 117.975 0.352 . . . . 0.0 110.689 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -112.71 158.46 20.03 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -77.17 -17.3 58.66 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -143.66 146.83 36.72 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 344' ' ' PRO . . . . . 0.479 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 41.0 Cg_endo -70.61 -31.87 16.03 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.329 2.686 . . . . 0.0 114.587 -177.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 345' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 80.8 Cg_endo -73.9 -22.5 17.35 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 CA-C-N 121.117 1.435 . . . . 0.0 110.123 -177.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 66.1 m -72.25 -35.1 68.71 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 175.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -68.76 -39.95 80.01 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 175.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -64.81 -42.09 95.27 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.11 -34.89 77.22 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 122.237 -0.289 . . . . 0.0 110.687 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.05 -36.13 83.37 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 67.3 mt -70.92 -50.78 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 C-N-CA 120.626 -0.43 . . . . 0.0 109.873 175.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -54.49 -30.14 52.41 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 55.8 t-105 -97.8 -56.74 2.41 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -177.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -75.83 -29.84 58.77 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -172.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -56.29 110.09 0.71 Allowed 'General case' 0 C--O 1.234 0.247 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.793 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 103.01 -2.83 47.92 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-O 119.647 -0.529 . . . . 0.0 112.234 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -84.44 -163.17 0.76 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 118.092 0.946 . . . . 0.0 110.364 176.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -129.75 152.91 48.73 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.056 0.455 . . . . 0.0 111.239 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -145.49 136.54 24.73 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.135 0.974 . . . . 0.0 112.352 178.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 12.5 t 55.19 17.69 2.11 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.888 0.375 . . . . 0.0 111.077 -174.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.23 22.56 40.77 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.995 -0.442 . . . . 0.0 111.995 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -132.15 142.73 46.1 Favored Pre-proline 0 N--CA 1.454 -0.257 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.48 135.73 31.87 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 123.059 2.506 . . . . 0.0 109.707 178.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 30.1 pt -122.93 170.4 13.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-O 121.025 0.441 . . . . 0.0 111.101 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 5.7 tmtm? -145.66 113.6 6.48 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 9.7 t -103.25 150.27 6.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.21 0.604 . . . . 0.0 112.444 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 28.5 t -162.94 176.11 10.5 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 177.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -74.66 133.52 42.11 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 175.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.353 0 C-N-CA 123.027 0.531 . . . . 0.0 111.94 179.887 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.454 -0.251 0 N-CA-C 111.466 0.172 . . . . 0.0 111.466 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 31.3 m -109.62 145.37 36.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.074 0.464 . . . . 0.0 111.854 -176.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 34.2 pt -122.09 147.51 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.433 176.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -98.7 143.88 28.58 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 173.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 289' ' ' VAL . . . . . 0.581 HG11 HD13 ' B' ' 292' ' ' LEU . 59.7 t -129.17 132.33 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 122.646 0.379 . . . . 0.0 110.57 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -120.78 155.45 33.98 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 175.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 83.82 12.01 78.19 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 171.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 292' ' ' LEU . . . . . 0.581 HD13 HG11 ' B' ' 289' ' ' VAL . 4.4 tp -59.09 -51.39 70.25 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.581 0.752 . . . . 0.0 110.946 -171.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 144.8 164.45 10.6 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.449 -0.661 . . . . 0.0 111.449 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -93.45 -1.11 56.1 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.578 0.351 . . . . 0.0 111.36 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -128.86 13.12 6.31 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 5.1 m -68.77 162.67 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -174.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 20.2 p -130.53 158.42 40.0 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.429 175.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 298' ' ' ILE . . . . . 0.552 HG23 ' HB ' ' B' ' 322' ' ' ILE . 25.0 mt -60.26 -43.21 92.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.31 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -70.68 -30.2 66.73 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -177.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 72.0 m -72.98 -45.36 58.4 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 118.298 0.499 . . . . 0.0 109.943 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 74.3 t -62.03 -41.31 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 176.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.3 -36.78 85.23 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 303' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -70.58 -27.63 64.26 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -83.86 -26.52 29.39 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -178.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -96.55 -24.95 15.81 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 115.073 1.509 . . . . 0.0 115.073 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 306' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -66.75 -18.38 65.35 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -176.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -71.85 -19.97 61.88 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 111.486 0.18 . . . . 0.0 111.486 -178.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 5.3 mm -87.49 -45.9 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 175.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.9 167.88 38.17 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 178.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 87.9 mt -67.72 123.66 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 122.674 0.389 . . . . 0.0 110.581 -176.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 86.7 mt -77.36 137.29 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 173.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt . . . . . 0 N--CA 1.45 -0.454 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -178.671 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo . . . . . 0 N--CA 1.448 -1.176 0 N-CA-C 109.353 -1.057 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 321' ' ' MET . . . . . 0.465 ' C ' HD12 ' B' ' 322' ' ' ILE . 34.9 mtt -70.97 85.74 0.7 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.84 0.353 . . . . 0.0 111.39 -177.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 322' ' ' ILE . . . . . 0.552 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.1 mp -129.84 137.04 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 170.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -130.45 107.23 9.08 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.839 176.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 23.7 mt -78.13 151.52 33.27 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 123.947 0.78 . . . . 0.0 109.249 176.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -115.9 151.02 36.15 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.52 -0.211 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -174.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.313 0.102 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.95 20.64 75.7 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.154 -1.179 . . . . 0.0 110.154 -174.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -129.94 144.48 51.34 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.177 0.591 . . . . 0.0 110.181 -176.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -156.39 160.26 39.49 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.858 174.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 1.2 p -102.0 155.95 17.84 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 170.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 19.0 t -134.75 129.5 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 123.85 0.86 . . . . 0.0 108.989 169.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 340' ' ' SER . . . . . 0.424 ' HB3' ' CB ' ' B' ' 321' ' ' MET . 45.5 t -109.47 140.75 42.84 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.942 0.401 . . . . 0.0 110.957 -178.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -106.08 158.02 17.11 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -73.62 -20.43 60.59 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -140.81 148.03 50.92 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 123.514 0.726 . . . . 0.0 109.12 -178.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 344' ' ' PRO . . . . . 0.463 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 40.4 Cg_endo -70.46 -33.32 14.14 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.43 2.753 . . . . 0.0 114.245 -176.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 345' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 83.6 Cg_endo -73.82 -22.47 17.58 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 CA-C-N 121.074 1.419 . . . . 0.0 110.057 -176.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 67.1 m -71.66 -36.47 70.67 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 176.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -69.08 -38.21 78.87 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -65.8 -41.75 91.53 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -69.47 -33.61 73.15 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 110.629 -0.138 . . . . 0.0 110.629 177.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.83 -37.19 86.79 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 68.5 mt -68.1 -53.62 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.673 174.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -54.87 -28.48 50.47 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -178.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 53.6 t-105 -96.67 -54.66 3.15 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -77.73 -27.89 50.66 Favored 'General case' 0 CA--C 1.522 -0.119 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -174.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -52.28 109.3 0.37 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.889 0.313 . . . . 0.0 111.194 178.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 100.29 -1.25 56.02 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-O 119.695 -0.503 . . . . 0.0 112.548 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -84.85 -164.42 0.98 Allowed 'General case' 0 C--O 1.228 -0.065 0 CA-C-N 117.939 0.869 . . . . 0.0 110.434 176.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -128.46 152.69 47.94 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.919 0.39 . . . . 0.0 110.739 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -142.2 134.71 28.06 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.271 1.028 . . . . 0.0 112.252 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 64.5 m 52.77 20.84 1.71 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.79 0.436 . . . . 0.0 111.975 -175.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.93 21.73 41.49 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 112.036 -0.426 . . . . 0.0 112.036 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -131.67 141.45 41.68 Favored Pre-proline 0 N--CA 1.456 -0.126 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.12 136.43 34.68 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.84 2.36 . . . . 0.0 109.464 177.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 32.4 pt -124.34 168.91 16.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-O 121.222 0.534 . . . . 0.0 110.789 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 22.9 tptp -142.89 112.3 6.74 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.035 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 8.6 t -101.96 148.55 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 29.3 t -162.38 175.27 11.72 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 177.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -72.19 130.97 42.1 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 176.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.318 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.082 -178.555 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 12.9 p30 . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 111.222 0.082 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 89.5 m -101.06 137.99 38.7 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.978 0.418 . . . . 0.0 109.909 -174.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 45.9 pt -105.91 148.28 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 172.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -99.94 142.98 30.7 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 171.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 14.6 t -133.77 141.51 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -128.92 154.6 46.39 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 122.873 0.469 . . . . 0.0 109.738 173.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.7 12.35 66.8 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-O 119.932 -0.371 . . . . 0.0 112.497 169.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 85.0 mt -57.14 -51.05 70.87 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 117.677 0.739 . . . . 0.0 110.202 -176.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 143.38 169.6 12.67 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -95.94 3.93 53.14 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 122.621 -0.341 . . . . 0.0 111.585 -178.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -128.86 11.55 6.12 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.8 m -76.03 165.48 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -173.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 29.9 p -130.99 157.74 42.16 Favored 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 123.615 0.766 . . . . 0.0 111.623 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 298' ' ' ILE . . . . . 0.484 HG23 ' HB ' ' B' ' 322' ' ' ILE . 34.4 mt -62.06 -42.34 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.154 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.45 -36.41 84.09 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.401 0.28 . . . . 0.0 111.737 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 43.6 t -72.44 -44.04 62.93 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 117.668 0.213 . . . . 0.0 110.48 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 76.9 t -61.61 -41.95 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.67 -35.25 80.44 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 303' ' ' ASP . . . . . 0.415 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.4 t0 -70.68 -29.07 65.29 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 304' ' ' TYR . . . . . 0.4 ' CE2' ' CD1' ' B' ' 354' ' ' PHE . 63.2 t80 -82.61 -25.77 32.88 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -96.88 -24.23 15.97 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 306' ' ' LYS . . . . . 0.415 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.6 ptpt -66.86 -18.77 65.54 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -177.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -71.9 -19.46 61.92 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.5 mm -88.05 -46.73 15.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 120.419 0.152 . . . . 0.0 110.651 175.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -161.73 169.17 37.11 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 90.2 mt -69.18 122.36 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 120.767 0.318 . . . . 0.0 110.261 -175.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 67.7 mt -77.63 137.26 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 175.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm . . . . . 0 N--CA 1.455 -0.209 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -179.339 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo . . . . . 0 N--CA 1.445 -1.355 0 N-CA-C 108.639 -1.331 . . . . 0.0 108.639 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 321' ' ' MET . . . . . 0.42 ' C ' HD12 ' B' ' 322' ' ' ILE . 88.0 mtp -78.02 85.91 4.22 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.452 0.644 . . . . 0.0 111.796 -170.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 322' ' ' ILE . . . . . 0.484 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.1 mp -124.71 143.28 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 174.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -129.66 99.03 5.0 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 48.8 mt -75.56 154.24 36.91 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 176.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -117.54 148.41 41.9 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 175.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 7.6 m . . . . . 0 N--CA 1.454 -0.244 0 C-N-CA 123.113 0.565 . . . . 0.0 111.986 -179.262 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt . . . . . 0 N--CA 1.461 0.115 0 CA-C-O 120.249 0.071 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.17 5.78 81.75 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -175.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -105.76 150.32 25.64 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 117.27 0.535 . . . . 0.0 109.884 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -163.98 163.21 23.53 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.112 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 60.5 p -111.76 155.67 23.15 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 169.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 16.4 t -135.8 120.53 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 O-C-N 123.415 0.447 . . . . 0.0 110.542 173.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 14.8 t -88.42 134.81 33.74 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -103.04 152.54 21.24 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 176.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -65.8 -33.66 76.37 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -178.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -130.36 150.86 77.4 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 344' ' ' PRO . . . . . 0.468 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 40.5 Cg_endo -70.42 -31.99 16.62 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.604 2.869 . . . . 0.0 114.425 -177.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 345' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 76.9 Cg_endo -73.75 -21.08 19.32 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 CA-C-N 121.078 1.421 . . . . 0.0 110.028 -176.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 66.9 m -72.6 -36.09 68.04 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 175.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -67.64 -38.57 84.03 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 174.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -65.19 -42.18 93.86 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.58 -35.55 77.51 Favored 'General case' 0 N--CA 1.458 -0.035 0 O-C-N 122.446 -0.159 . . . . 0.0 110.574 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -63.75 -37.68 88.26 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 63.1 mt -68.74 -51.62 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 120.379 -0.529 . . . . 0.0 109.634 175.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -55.92 -28.32 56.27 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 53.3 t-105 -97.16 -54.77 3.06 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 354' ' ' PHE . . . . . 0.4 ' CD1' ' CE2' ' B' ' 304' ' ' TYR . 51.7 m-85 -76.95 -27.77 54.95 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -173.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -50.38 109.23 0.28 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 117.993 0.361 . . . . 0.0 111.858 178.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 98.8 -0.43 57.81 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 119.537 -0.591 . . . . 0.0 112.654 175.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -83.55 -164.87 0.97 Allowed 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.136 0.968 . . . . 0.0 110.073 176.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -128.19 152.91 47.49 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 121.084 0.469 . . . . 0.0 110.727 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -144.9 136.27 25.22 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.331 1.053 . . . . 0.0 112.585 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 17.4 t 55.24 17.94 2.26 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 120.794 0.331 . . . . 0.0 110.951 -175.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.89 22.85 40.72 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 112.013 -0.435 . . . . 0.0 112.013 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 41.9 m-20 -132.31 142.6 45.58 Favored Pre-proline 0 C--O 1.226 -0.165 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 -177.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.48 135.73 31.88 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.855 2.37 . . . . 0.0 109.54 178.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 31.9 pt -121.34 170.79 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.101 0 CA-C-O 121.265 0.555 . . . . 0.0 111.207 -177.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -143.18 109.42 5.32 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.747 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 11.3 t -99.45 148.89 5.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 C-N-CA 123.164 0.586 . . . . 0.0 111.952 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 84.7 p -163.47 177.14 9.1 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -76.83 129.4 36.19 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 174.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.413 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.403 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 . . . . . 0 CA--C 1.53 0.201 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 95.4 m -113.22 145.52 40.87 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.318 0.58 . . . . 0.0 110.708 -175.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 33.7 pt -119.85 148.77 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.436 -0.802 . . . . 0.0 108.846 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -101.65 143.87 31.07 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 173.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 12.1 t -127.25 139.87 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 CA-C-O 120.963 0.411 . . . . 0.0 111.302 177.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -125.58 154.1 42.73 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.601 0.76 . . . . 0.0 108.968 177.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 83.3 12.96 77.79 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 173.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 1.5 tp -52.69 -55.08 25.17 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.583 0.753 . . . . 0.0 110.707 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 142.11 172.24 13.48 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -101.45 2.6 39.48 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -128.7 16.77 6.38 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.814 0.446 . . . . 0.0 111.285 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 10.3 m -74.47 166.85 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -173.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 43.1 p -138.23 159.52 41.84 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.729 0.811 . . . . 0.0 110.762 177.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 298' ' ' ILE . . . . . 0.549 HG23 ' HB ' ' B' ' 322' ' ' ILE . 45.3 mt -62.65 -44.13 99.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.16 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -64.39 -35.52 81.18 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.443 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 44.8 t -71.56 -49.97 35.51 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 118.036 0.38 . . . . 0.0 110.741 -177.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 7.5 p -65.44 -33.44 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.681 177.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -65.97 -32.62 74.22 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.579 176.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 303' ' ' ASP . . . . . 0.41 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 44.9 t0 -75.39 -27.25 59.01 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -178.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -85.26 -23.88 28.01 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -96.93 -24.18 15.96 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 178.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 306' ' ' LYS . . . . . 0.41 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.7 ptpt -66.4 -17.7 64.93 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -177.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -72.45 -20.73 61.35 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.6 mm -86.37 -45.94 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 CA-C-N 117.873 0.306 . . . . 0.0 110.226 175.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -162.4 167.0 36.78 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 79.2 mt -69.19 120.42 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 120.725 0.298 . . . . 0.0 110.683 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 88.6 mt -73.97 134.85 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 172.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm . . . . . 0 N--CA 1.451 -0.421 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.028 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo . . . . . 0 N--CA 1.45 -1.047 0 N-CA-C 110.054 -0.787 . . . . 0.0 110.054 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 321' ' ' MET . . . . . . . . . . . . . 37.4 mtt -72.04 94.15 1.47 Allowed 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 120.951 0.405 . . . . 0.0 111.793 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 322' ' ' ILE . . . . . 0.549 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.5 mp -141.61 142.27 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 173.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -132.3 108.83 9.47 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 173.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 38.0 mt -77.64 153.2 33.38 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 175.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -120.86 143.3 48.98 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 175.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.52 -0.179 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -174.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt . . . . . 0 N--CA 1.461 0.11 0 N-CA-C 110.568 -0.16 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 74.82 22.23 77.29 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 -174.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -133.06 146.55 51.79 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 117.236 0.518 . . . . 0.0 110.511 -178.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -157.76 155.71 30.33 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.133 174.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 10.9 p -95.7 152.6 18.32 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 170.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 40.9 t -135.63 129.96 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 170.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 9.0 t -110.47 143.38 40.88 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-N 117.888 0.313 . . . . 0.0 111.029 -177.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -108.4 160.23 16.04 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -176.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -72.42 -28.57 63.05 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -135.54 150.11 71.25 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -177.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 344' ' ' PRO . . . . . 0.47 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 39.5 Cg_endo -69.69 -32.71 18.34 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.457 2.772 . . . . 0.0 114.487 -177.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 345' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 96.1 Cg_endo -73.74 -20.88 19.55 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 CA-C-N 121.381 1.529 . . . . 0.0 110.324 -177.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 66.3 m -73.11 -37.48 66.67 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 175.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.13 -38.47 88.25 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 173.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -63.19 -46.09 88.69 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -66.74 -34.09 77.08 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 110.584 -0.154 . . . . 0.0 110.584 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.44 -35.96 82.49 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 64.8 mt -70.71 -51.71 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 175.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -55.17 -28.76 55.19 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 57.5 t-105 -98.04 -55.9 2.65 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -76.16 -30.66 58.2 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -173.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -55.21 110.73 0.72 Allowed 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 118.289 0.495 . . . . 0.0 110.777 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 103.56 -4.42 47.07 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.516 -0.602 . . . . 0.0 112.308 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -84.22 -163.76 0.84 Allowed 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 118.077 0.938 . . . . 0.0 110.165 176.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -127.82 150.67 49.73 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-O 120.95 0.405 . . . . 0.0 110.853 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -141.67 137.35 31.71 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.345 1.058 . . . . 0.0 112.487 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 20.5 t 53.91 18.96 1.78 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.563 0.345 . . . . 0.0 111.183 -175.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.4 21.96 42.56 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 112.056 -0.418 . . . . 0.0 112.056 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 41.0 m-20 -131.91 141.7 42.49 Favored Pre-proline 0 N--CA 1.453 -0.285 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -177.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -68.95 133.5 27.24 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 122.611 2.208 . . . . 0.0 109.403 177.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 29.8 pt -120.47 170.24 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.146 0 CA-C-O 121.336 0.588 . . . . 0.0 111.107 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -144.51 111.24 5.72 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 10.7 t -99.98 149.25 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.305 0.642 . . . . 0.0 111.966 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 23.2 t -162.46 172.72 15.08 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -69.57 128.72 37.46 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 176.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.499 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.905 -179.629 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.454 -0.26 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 91.7 m -105.11 142.24 35.24 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.054 0.454 . . . . 0.0 111.046 -174.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 30.5 pt -115.31 149.46 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -99.87 146.2 26.91 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 173.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 289' ' ' VAL . . . . . 0.562 ' CG1' HD13 ' B' ' 292' ' ' LEU . 60.3 t -131.26 133.75 61.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.532 -178.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -123.65 153.55 40.61 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 83.31 13.11 77.42 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 172.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 292' ' ' LEU . . . . . 0.562 HD13 ' CG1' ' B' ' 289' ' ' VAL . 4.4 tp -59.07 -50.7 73.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 123.763 0.825 . . . . 0.0 111.027 -169.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 143.89 165.65 10.97 Favored Glycine 0 C--N 1.337 0.637 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 177.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -96.82 2.13 51.47 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.347 0.259 . . . . 0.0 111.282 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -128.47 11.86 6.37 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.868 0.467 . . . . 0.0 111.699 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 4.7 m -68.19 162.63 3.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -174.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 29.8 p -134.33 159.72 40.13 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 123.596 0.758 . . . . 0.0 110.697 176.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 298' ' ' ILE . . . . . 0.512 HG23 ' HB ' ' B' ' 322' ' ' ILE . 33.9 mt -61.33 -41.82 91.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.133 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -66.52 -36.05 81.75 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 122.554 0.342 . . . . 0.0 111.709 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 75.5 m -72.24 -46.08 57.51 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 118.175 0.443 . . . . 0.0 110.319 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 69.9 t -60.56 -42.65 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.32 -36.31 83.7 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 122.201 -0.312 . . . . 0.0 110.203 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 303' ' ' ASP . . . . . 0.423 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.1 t0 -69.88 -28.18 65.43 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -84.35 -25.84 28.88 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -96.1 -24.04 16.49 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 306' ' ' LYS . . . . . 0.423 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.6 ptpt -67.42 -18.68 65.2 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -176.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -72.57 -21.14 61.19 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -177.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.2 mm -85.94 -44.96 17.0 Favored 'Isoleucine or valine' 0 C--O 1.23 0.072 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 175.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.87 165.5 37.01 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 85.2 mt -66.04 123.49 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 120.854 0.359 . . . . 0.0 110.26 -177.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 85.8 mt -77.08 135.79 25.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 173.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm . . . . . 0 N--CA 1.451 -0.401 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -178.265 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 N--CA 1.448 -1.151 0 N-CA-C 109.874 -0.856 . . . . 0.0 109.874 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 321' ' ' MET . . . . . 0.47 ' C ' HD12 ' B' ' 322' ' ' ILE . 33.6 mtt -72.51 86.23 1.16 Allowed 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -177.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 322' ' ' ILE . . . . . 0.512 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.2 mp -130.29 138.73 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 170.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -129.8 105.15 7.82 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 174.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 31.2 mt -77.82 153.38 32.83 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 123.952 0.783 . . . . 0.0 109.085 177.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -116.39 147.95 41.14 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.455 -0.207 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -177.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt . . . . . 0 N--CA 1.462 0.141 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 78.02 20.81 72.33 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -175.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -129.94 147.67 51.72 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 122.948 0.499 . . . . 0.0 110.252 -178.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -156.38 162.04 40.08 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 120.759 0.314 . . . . 0.0 110.799 174.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 19.1 p -104.79 154.4 20.07 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 169.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 17.3 t -135.47 132.11 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 123.454 0.702 . . . . 0.0 109.345 171.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 340' ' ' SER . . . . . 0.431 ' HB3' ' CB ' ' B' ' 321' ' ' MET . 46.2 t -110.82 136.46 49.84 Favored 'General case' 0 C--O 1.227 -0.109 0 CA-C-N 118.002 0.365 . . . . 0.0 111.101 -178.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -100.5 159.55 15.06 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -178.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -71.91 -30.95 65.9 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -130.04 148.99 71.9 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 344' ' ' PRO . . . . . 0.462 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 38.0 Cg_endo -69.96 -33.56 15.61 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.361 2.708 . . . . 0.0 114.636 -177.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 345' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 87.5 Cg_endo -73.5 -23.04 17.69 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 CA-C-N 121.083 1.423 . . . . 0.0 110.016 -177.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 58.8 m -71.95 -34.83 69.31 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 175.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.85 -41.07 87.96 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 175.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 40.2 tptt -69.53 -36.14 76.11 Favored 'General case' 0 C--N 1.339 0.121 0 O-C-N 122.176 -0.328 . . . . 0.0 110.706 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -65.75 -35.49 80.87 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 175.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -66.26 -37.49 85.59 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 72.2 mt -67.6 -53.62 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.772 175.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -56.85 -27.47 60.32 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -177.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -96.7 -55.15 2.99 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -76.5 -30.93 57.41 Favored 'General case' 0 CA--C 1.522 -0.117 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -173.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -54.53 110.26 0.61 Allowed 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.126 0.421 . . . . 0.0 110.876 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 104.31 -3.96 43.98 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 119.609 -0.551 . . . . 0.0 112.423 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -84.9 -164.32 0.96 Allowed 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 117.814 0.807 . . . . 0.0 110.373 176.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 42.0 mp0 -128.68 152.6 48.2 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.927 0.394 . . . . 0.0 110.858 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -143.91 134.83 25.32 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.195 0.998 . . . . 0.0 112.329 178.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 58.8 m 52.59 20.73 1.59 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -174.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.63 22.2 40.81 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 112.099 -0.4 . . . . 0.0 112.099 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 50.9 m-20 -132.21 141.83 42.82 Favored Pre-proline 0 N--CA 1.456 -0.174 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.62 137.91 36.99 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 122.713 2.275 . . . . 0.0 109.472 177.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 35.3 pt -125.87 168.98 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 CA-C-O 121.035 0.445 . . . . 0.0 110.667 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -144.68 113.35 6.7 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 10.7 t -103.16 150.06 6.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 123.165 0.586 . . . . 0.0 112.097 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 31.8 t -161.4 173.16 15.32 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -74.04 130.81 40.56 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 176.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.467 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.062 -179.712 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 285' ' ' ASN . . . . . 0.467 HD22 ' C ' ' B' ' 285' ' ' ASN . 0.3 OUTLIER . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 85.4 m -106.21 143.58 34.14 Favored 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 122.09 -0.381 . . . . 0.0 110.675 -174.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 40.6 pt -120.16 144.53 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 176.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -96.18 145.36 25.59 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 174.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 19.0 t -130.85 144.79 36.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.156 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -133.47 152.97 51.98 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 175.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.55 11.27 68.98 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-O 119.78 -0.456 . . . . 0.0 112.361 169.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 63.8 mt -57.32 -49.95 74.49 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 117.645 0.723 . . . . 0.0 110.78 -175.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 148.54 172.93 18.91 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 -178.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -97.17 -6.25 35.24 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -175.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -128.64 15.77 6.47 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 4.3 m -67.59 161.38 3.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -174.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 19.4 p -123.88 159.95 28.52 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.441 0.696 . . . . 0.0 112.254 -178.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 298' ' ' ILE . . . . . 0.573 HG23 ' HB ' ' B' ' 322' ' ' ILE . 54.7 mt -63.68 -44.51 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.938 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -64.2 -36.3 83.6 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 122.565 0.346 . . . . 0.0 111.38 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 46.8 t -72.3 -47.04 53.01 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 122.247 -0.283 . . . . 0.0 110.812 -177.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 8.1 p -68.31 -33.98 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.005 178.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -65.22 -32.84 74.72 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 176.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 303' ' ' ASP . . . . . 0.402 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.6 t0 -74.02 -27.4 60.93 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -84.06 -24.69 30.31 Favored 'General case' 0 C--O 1.227 -0.13 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -96.8 -24.59 15.84 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 306' ' ' LYS . . . . . 0.402 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.7 ptpt -66.81 -18.04 65.18 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -177.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -70.9 -20.44 62.5 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 122.276 -0.265 . . . . 0.0 111.649 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.9 mm -87.61 -46.3 16.02 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-N 117.584 0.175 . . . . 0.0 110.644 175.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.71 168.78 38.44 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 85.7 mt -69.57 120.5 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-O 121.014 0.435 . . . . 0.0 110.695 -175.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 88.0 mt -73.01 138.77 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 172.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 312' ' ' LYS . . . . . 0.661 ' HE3' ' SD ' ' B' ' 321' ' ' MET . 28.8 ttpt . . . . . 0 N--CA 1.448 -0.548 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -176.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo . . . . . 0 N--CA 1.451 -1.006 0 N-CA-C 110.145 -0.752 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 321' ' ' MET . . . . . 0.661 ' SD ' ' HE3' ' B' ' 312' ' ' LYS . 36.1 mtt -73.87 98.28 2.96 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 322' ' ' ILE . . . . . 0.573 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.3 mp -144.51 144.8 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 175.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -130.13 133.84 46.92 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 170.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 86.6 mt -106.54 133.8 50.65 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -96.54 151.19 19.83 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -177.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.452 -0.337 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -174.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt . . . . . 0 CA--C 1.527 0.083 0 N-CA-C 110.673 -0.121 . . . . 0.0 110.673 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 79.04 3.4 88.2 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -173.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -99.03 151.39 20.98 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.008 0.523 . . . . 0.0 110.142 178.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -161.65 167.0 25.95 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 120.836 0.351 . . . . 0.0 111.331 -177.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 1.2 p -120.69 149.94 41.72 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 169.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 44.3 t -137.39 124.6 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 173.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 8.5 t -100.87 144.41 29.85 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 118.074 0.397 . . . . 0.0 110.815 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -109.8 158.65 17.93 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -79.09 -14.69 58.99 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -146.63 146.33 26.44 Favored Pre-proline 0 CA--C 1.53 0.204 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 344' ' ' PRO . . . . . 0.464 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 48.2 Cg_endo -70.84 -31.03 16.39 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.051 2.501 . . . . 0.0 114.469 -177.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 345' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 77.1 Cg_endo -74.14 -22.84 16.42 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 CA-C-N 121.29 1.496 . . . . 0.0 110.01 -177.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 70.1 m -72.62 -34.3 67.26 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 176.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -69.9 -38.46 76.31 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 175.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -63.96 -42.55 97.25 Favored 'General case' 0 CA--C 1.527 0.094 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.26 -34.76 76.78 Favored 'General case' 0 C--N 1.34 0.17 0 O-C-N 122.287 -0.258 . . . . 0.0 110.506 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.59 -36.46 83.8 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 67.6 mt -69.79 -51.99 35.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.811 174.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -53.94 -29.64 43.25 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 56.2 t-105 -97.69 -56.04 2.63 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -75.64 -27.39 58.37 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 -173.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -50.13 110.68 0.42 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.015 0.371 . . . . 0.0 111.814 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 94.66 1.36 63.86 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.55 -0.583 . . . . 0.0 112.606 174.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -83.98 -164.71 0.97 Allowed 'General case' 0 C--N 1.339 0.152 0 CA-C-N 118.32 1.06 . . . . 0.0 110.146 176.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -129.41 152.96 48.39 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.209 0.528 . . . . 0.0 111.246 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -145.51 137.45 25.45 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.188 0.995 . . . . 0.0 112.061 177.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 21.1 t 54.19 18.51 1.82 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.87 0.468 . . . . 0.0 111.211 -175.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 89.29 22.58 37.23 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 111.939 -0.464 . . . . 0.0 111.939 178.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -133.67 141.81 41.45 Favored Pre-proline 0 N--CA 1.455 -0.205 0 CA-C-N 117.442 0.621 . . . . 0.0 109.428 -177.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.32 136.18 33.48 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 122.68 2.253 . . . . 0.0 109.567 177.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 30.4 pt -121.47 170.63 11.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-O 120.957 0.408 . . . . 0.0 111.383 -177.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -144.78 115.68 7.82 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.719 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 12.4 t -107.0 147.86 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 C-N-CA 123.429 0.692 . . . . 0.0 112.416 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 28.5 t -162.73 173.22 14.12 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 176.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -71.11 133.28 46.12 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.308 0 CA-C-O 121.216 0.531 . . . . 0.0 111.647 178.078 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.454 -0.244 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 33.7 m -106.1 143.07 34.76 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 120.764 0.316 . . . . 0.0 111.477 -175.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 45.3 pt -120.72 146.73 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -99.41 146.77 25.95 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 174.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 21.0 t -131.97 144.7 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.972 177.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -131.15 152.41 50.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 176.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.0 11.94 69.15 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 112.324 -0.311 . . . . 0.0 112.324 169.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 77.5 mt -55.6 -49.59 72.39 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 117.605 0.702 . . . . 0.0 110.492 -176.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 145.59 172.51 16.04 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -99.78 1.59 43.29 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.875 0.338 . . . . 0.0 111.787 -177.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -128.87 14.09 6.35 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.7 m -75.41 166.17 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -172.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 25.8 p -130.69 159.73 36.37 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.598 0.759 . . . . 0.0 112.168 -179.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 298' ' ' ILE . . . . . 0.562 HG23 ' HB ' ' B' ' 322' ' ' ILE . 44.4 mt -63.04 -46.38 96.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.337 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -62.37 -36.37 82.07 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.386 0.274 . . . . 0.0 111.437 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 47.0 t -72.44 -46.7 53.82 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 117.71 0.232 . . . . 0.0 110.836 -177.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.94 -33.28 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.341 178.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -65.3 -32.84 74.7 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 303' ' ' ASP . . . . . 0.41 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.4 t0 -74.64 -27.57 60.5 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 304' ' ' TYR . . . . . 0.404 ' CE2' ' CD2' ' B' ' 354' ' ' PHE . 52.3 t80 -83.48 -24.98 31.53 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -96.48 -25.09 15.79 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 178.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 306' ' ' LYS . . . . . 0.41 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.7 ptpt -66.35 -18.24 65.24 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -177.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -71.67 -20.19 61.98 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -178.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 3.9 mm -87.11 -46.33 16.23 Favored 'Isoleucine or valine' 0 C--N 1.337 0.059 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 175.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.98 167.95 38.25 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 85.8 mt -68.41 120.03 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 122.505 0.322 . . . . 0.0 110.634 -175.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 94.0 mt -71.72 138.06 22.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 172.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 312' ' ' LYS . . . . . 0.401 ' HE3' ' HB2' ' B' ' 312' ' ' LYS . 35.8 ttmt . . . . . 0 N--CA 1.45 -0.439 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -177.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo . . . . . 0 N--CA 1.45 -1.053 0 N-CA-C 110.096 -0.771 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 321' ' ' MET . . . . . 0.429 ' CB ' ' HB3' ' B' ' 340' ' ' SER . 33.9 mtt -73.45 95.8 2.28 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 120.68 0.276 . . . . 0.0 111.712 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 322' ' ' ILE . . . . . 0.562 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.7 mp -141.29 141.05 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 172.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -134.37 110.9 9.75 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 175.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.68 152.69 33.63 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.673 0.789 . . . . 0.0 108.895 175.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -121.12 149.1 43.27 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 175.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.454 -0.273 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -175.607 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 8.5 mmmm . . . . . 0 N--CA 1.461 0.11 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 77.26 5.64 85.58 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 -171.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -103.36 147.61 26.89 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.389 0.675 . . . . 0.0 109.992 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -161.95 153.83 19.02 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.006 176.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 12.8 p -98.72 151.77 20.38 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 169.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 42.5 t -136.13 125.99 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 170.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 340' ' ' SER . . . . . 0.429 ' HB3' ' CB ' ' B' ' 321' ' ' MET . 46.5 t -103.18 149.12 24.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 117.862 0.301 . . . . 0.0 111.316 -178.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -114.49 156.81 23.88 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -72.21 -29.11 63.65 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -132.46 147.83 67.2 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -178.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 344' ' ' PRO . . . . . 0.467 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 45.3 Cg_endo -71.39 -31.71 13.59 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.446 2.764 . . . . 0.0 114.649 -178.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 345' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 78.5 Cg_endo -73.68 -21.86 18.6 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 CA-C-N 121.255 1.484 . . . . 0.0 110.04 -177.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 70.7 m -71.23 -35.92 71.63 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 175.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -68.03 -38.74 82.88 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 174.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -64.06 -42.07 97.14 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.43 -34.6 76.29 Favored 'General case' 0 C--O 1.226 -0.148 0 O-C-N 122.255 -0.278 . . . . 0.0 110.737 178.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.36 -36.71 84.83 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 66.4 mt -70.25 -52.05 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.691 175.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -53.77 -29.86 41.96 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 58.9 t-105 -97.58 -53.95 3.28 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -176.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 354' ' ' PHE . . . . . 0.43 ' HB2' HG21 ' B' ' 366' ' ' VAL . 47.7 m-85 -78.09 -27.08 48.43 Favored 'General case' 0 C--O 1.226 -0.134 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -174.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -48.09 110.4 0.32 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 178.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 95.18 1.74 62.61 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 119.612 -0.549 . . . . 0.0 112.764 174.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -84.5 -164.87 1.03 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.261 1.03 . . . . 0.0 110.524 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 41.8 mp0 -127.75 152.85 47.24 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.107 0.479 . . . . 0.0 110.84 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -145.31 136.76 25.15 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.181 0.992 . . . . 0.0 112.349 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 14.8 t 55.32 17.29 2.04 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.075 0.464 . . . . 0.0 111.175 -175.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.72 22.63 38.84 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.955 -0.458 . . . . 0.0 111.955 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 44.9 m-20 -132.07 143.02 47.23 Favored Pre-proline 0 N--CA 1.455 -0.218 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -177.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -68.9 136.69 36.01 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.849 2.366 . . . . 0.0 109.415 177.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 33.5 pt -124.04 171.05 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 CA-C-O 121.178 0.513 . . . . 0.0 111.125 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -143.81 114.89 7.87 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.759 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 366' ' ' VAL . . . . . 0.43 HG21 ' HB2' ' B' ' 354' ' ' PHE . 11.9 t -102.33 148.65 7.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 123.256 0.623 . . . . 0.0 111.99 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 80.3 p -162.53 168.6 21.63 Favored 'General case' 0 CA--C 1.528 0.1 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -70.28 130.97 43.42 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 174.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.401 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.882 -179.795 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 285' ' ' ASN . . . . . 0.426 HD22 ' C ' ' B' ' 285' ' ' ASN . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.275 0 N-CA-C 111.375 0.139 . . . . 0.0 111.375 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 63.7 m -108.98 146.22 34.22 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.877 0.37 . . . . 0.0 111.206 -172.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 44.9 pt -120.24 148.09 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 174.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -101.4 145.77 28.49 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 174.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 17.2 t -129.75 144.46 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.236 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -133.16 152.45 51.94 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 175.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.21 12.38 67.87 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 119.814 -0.436 . . . . 0.0 112.663 169.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 59.3 mt -57.14 -50.1 73.85 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 117.414 0.607 . . . . 0.0 110.912 -174.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 157.0 -177.94 33.64 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -99.63 -9.32 23.32 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -176.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -139.95 22.0 2.45 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.2 m -68.11 165.15 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -173.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 16.0 p -123.11 159.56 28.27 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -177.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 298' ' ' ILE . . . . . 0.607 HG23 ' HB ' ' B' ' 322' ' ' ILE . 41.1 mt -62.32 -45.8 97.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.128 177.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -63.43 -37.56 87.77 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -177.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 81.1 p -73.35 -42.39 62.31 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 118.043 0.383 . . . . 0.0 110.376 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 54.4 t -61.69 -42.06 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -65.56 -34.36 78.06 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 303' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -70.55 -26.96 63.79 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -84.41 -25.68 28.86 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -96.3 -25.0 15.93 Favored 'General case' 0 C--O 1.231 0.091 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 306' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -66.55 -19.08 65.69 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.241 0.216 . . . . 0.0 111.458 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -71.28 -20.01 62.27 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 111.644 0.238 . . . . 0.0 111.644 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 5.1 mm -88.9 -46.25 15.46 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-N 117.602 0.183 . . . . 0.0 110.945 176.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -162.18 170.37 37.79 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 85.4 mt -72.12 118.58 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 122.61 0.364 . . . . 0.0 110.39 -175.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 93.6 mt -72.56 135.02 28.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 173.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt . . . . . 0 N--CA 1.45 -0.472 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.317 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo . . . . . 0 N--CA 1.449 -1.108 0 N-CA-C 110.144 -0.752 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 321' ' ' MET . . . . . 0.419 ' CB ' ' HB3' ' B' ' 340' ' ' SER . 38.6 mtt -72.53 93.05 1.53 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.863 0.363 . . . . 0.0 111.72 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 322' ' ' ILE . . . . . 0.607 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.9 mp -140.5 144.21 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 173.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -131.62 132.78 44.31 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 171.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -103.15 137.8 40.82 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 174.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -104.11 155.24 18.86 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 2.9 m . . . . . 0 CA--C 1.523 -0.093 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -176.19 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt . . . . . 0 N--CA 1.465 0.291 0 CA-C-O 120.491 0.186 . . . . 0.0 110.632 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 73.52 5.49 68.11 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -172.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -100.06 151.11 21.75 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.336 0.654 . . . . 0.0 110.024 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.42 167.25 29.21 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.052 0.453 . . . . 0.0 111.592 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 1.4 p -120.66 151.15 39.86 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 169.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 31.3 t -137.66 124.99 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 172.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 340' ' ' SER . . . . . 0.419 ' HB3' ' CB ' ' B' ' 321' ' ' MET . 46.9 t -101.41 148.93 24.59 Favored 'General case' 0 C--O 1.231 0.113 0 O-C-N 122.202 -0.311 . . . . 0.0 111.135 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -116.92 154.12 31.38 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 -178.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -71.74 -13.11 61.62 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 176.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -149.26 146.77 21.78 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 344' ' ' PRO . . . . . 0.478 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 53.4 Cg_endo -71.32 -30.18 15.97 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 123.239 2.626 . . . . 0.0 114.363 -177.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 345' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 71.5 Cg_endo -73.99 -22.45 17.21 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 CA-C-N 121.403 1.537 . . . . 0.0 109.964 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 66.3 m -71.7 -36.97 70.74 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 175.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.98 -37.83 84.94 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -63.72 -45.02 91.84 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.77 -34.44 76.81 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 110.538 -0.171 . . . . 0.0 110.538 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.33 -38.66 91.81 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 68.8 mt -68.57 -54.0 24.02 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.56 175.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -54.41 -27.9 40.12 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 54.9 t-105 -96.76 -55.07 3.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -76.29 -26.79 56.24 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -174.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -48.35 109.43 0.24 Allowed 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 176.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 94.94 0.76 63.63 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.394 -0.67 . . . . 0.0 112.814 174.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -83.38 -164.94 0.97 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 118.177 0.988 . . . . 0.0 110.374 176.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -128.48 155.11 45.33 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.191 0.519 . . . . 0.0 111.454 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -146.89 136.44 22.92 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.478 1.111 . . . . 0.0 112.158 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 22.7 t 54.45 18.77 2.06 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.455 0.302 . . . . 0.0 111.335 -175.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 86.95 24.31 38.35 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 112.154 -0.378 . . . . 0.0 112.154 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -132.87 142.48 44.88 Favored Pre-proline 0 N--CA 1.454 -0.23 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 -178.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.41 136.16 33.18 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.681 2.254 . . . . 0.0 109.602 177.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 27.9 pt -122.97 171.9 11.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-O 121.25 0.548 . . . . 0.0 110.831 -177.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -144.0 118.13 9.5 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.947 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 11.9 t -107.64 148.52 11.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 C-N-CA 123.22 0.608 . . . . 0.0 112.242 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 27.4 t -163.75 172.57 13.98 Favored 'General case' 0 C--N 1.341 0.204 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 176.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -70.51 130.25 41.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 176.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.314 0 CA-C-N 115.965 -0.562 . . . . 0.0 112.31 -179.027 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 285' ' ' ASN . . . . . 0.449 HD22 ' C ' ' B' ' 285' ' ' ASN . 0.4 OUTLIER . . . . . 0 N--CA 1.452 -0.349 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 60.5 m -107.5 142.16 37.81 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.092 0.473 . . . . 0.0 109.987 -175.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 44.4 pt -113.72 146.69 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 174.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -97.97 141.06 31.4 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 172.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 17.4 t -130.26 142.34 44.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 O-C-N 123.331 0.394 . . . . 0.0 111.252 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -132.3 153.13 51.0 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.46 11.47 68.86 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 119.863 -0.409 . . . . 0.0 112.423 169.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 77.4 mt -56.29 -51.95 66.31 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 117.348 0.574 . . . . 0.0 110.548 -175.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 151.15 171.56 19.31 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -91.47 -9.13 45.62 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 122.484 -0.421 . . . . 0.0 111.772 -174.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -134.34 15.91 3.75 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -177.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.2 m -66.6 160.76 3.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -175.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 25.7 p -117.87 156.66 28.03 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 122.957 0.503 . . . . 0.0 112.053 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 298' ' ' ILE . . . . . 0.49 HG23 ' HB ' ' B' ' 322' ' ' ILE . 40.6 mt -60.67 -44.03 96.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.44 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -68.89 -30.54 69.05 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -177.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 46.6 t -73.79 -43.6 58.44 Favored 'General case' 0 N--CA 1.458 -0.07 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 78.8 t -61.97 -41.25 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.61 -34.84 79.21 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 303' ' ' ASP . . . . . 0.408 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.9 t0 -71.02 -29.01 64.83 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 304' ' ' TYR . . . . . 0.402 ' CE2' ' CD2' ' B' ' 354' ' ' PHE . 59.0 t80 -82.47 -25.31 33.66 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -96.63 -24.88 15.8 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 306' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.9 ptpt -67.76 -17.59 64.6 Favored 'General case' 0 C--N 1.338 0.107 0 N-CA-C 111.446 0.165 . . . . 0.0 111.446 -176.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -72.2 -20.07 61.63 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 3.8 mm -87.84 -46.35 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.122 0 CA-C-N 117.61 0.186 . . . . 0.0 110.632 175.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -162.24 172.16 38.29 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 72.5 mt -71.11 118.29 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 122.68 0.392 . . . . 0.0 110.11 -175.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 77.4 mt -74.91 136.93 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 173.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 312' ' ' LYS . . . . . 0.442 ' HG2' ' SD ' ' B' ' 321' ' ' MET . 39.8 ttmt . . . . . 0 N--CA 1.453 -0.275 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo . . . . . 0 N--CA 1.448 -1.195 0 N-CA-C 108.746 -1.29 . . . . 0.0 108.746 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 321' ' ' MET . . . . . 0.442 ' SD ' ' HG2' ' B' ' 312' ' ' LYS . 72.4 mtp -79.77 85.7 5.42 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.307 0.575 . . . . 0.0 111.665 -170.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 322' ' ' ILE . . . . . 0.49 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.3 mp -129.7 147.08 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.575 1.15 . . . . 0.0 108.25 176.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -132.93 111.08 10.74 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -80.98 148.79 29.6 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.267 1.027 . . . . 0.0 108.833 176.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -113.29 151.66 30.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.522 -0.13 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -173.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt . . . . . 0 CA--C 1.527 0.096 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 78.56 10.29 86.33 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 110.709 -0.957 . . . . 0.0 110.709 -174.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -116.97 150.33 38.74 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.881 0.472 . . . . 0.0 110.408 -177.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -160.06 162.91 34.26 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.881 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 29.6 p -112.4 153.86 26.67 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 169.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 21.8 t -136.6 124.19 33.15 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.11 0 C-N-CA 123.249 0.62 . . . . 0.0 110.218 175.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 45.0 t -90.98 140.85 29.45 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 117.906 0.321 . . . . 0.0 110.404 177.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -108.85 152.84 24.36 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 176.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -70.08 -28.82 65.73 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -177.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -133.05 149.0 71.6 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 344' ' ' PRO . . . . . 0.467 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 36.9 Cg_endo -69.44 -33.33 18.04 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 123.274 2.649 . . . . 0.0 114.2 -177.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 345' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 93.8 Cg_endo -74.97 -20.2 17.15 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 CA-C-N 121.136 1.441 . . . . 0.0 110.384 -176.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 66.3 m -71.88 -35.72 69.84 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 175.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -70.4 -38.36 74.64 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 174.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -63.6 -43.14 97.78 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.62 -35.33 77.17 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 110.561 -0.162 . . . . 0.0 110.561 178.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -63.88 -37.62 88.06 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 59.2 mt -70.66 -49.16 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.094 175.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -58.95 -27.9 65.76 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -176.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -97.26 -56.47 2.53 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -177.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 354' ' ' PHE . . . . . 0.402 ' CD2' ' CE2' ' B' ' 304' ' ' TYR . 52.2 m-85 -75.7 -25.74 56.95 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -173.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -48.49 108.4 0.17 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 176.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 96.34 2.2 60.52 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 119.435 -0.647 . . . . 0.0 113.227 174.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -84.91 -164.02 0.92 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.3 1.05 . . . . 0.0 110.386 177.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -129.9 153.23 48.53 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-O 121.058 0.456 . . . . 0.0 110.776 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -145.17 136.69 25.26 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.395 1.078 . . . . 0.0 112.296 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 63.4 m 53.35 19.48 1.61 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -173.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 86.38 22.81 46.25 Favored Glycine 0 C--N 1.342 0.868 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 52.6 m-20 -130.71 141.96 43.81 Favored Pre-proline 0 N--CA 1.454 -0.239 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -177.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.18 135.31 31.48 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.998 2.465 . . . . 0.0 109.267 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 29.6 pt -122.4 171.48 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 CA-C-O 121.285 0.564 . . . . 0.0 111.061 -177.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -144.25 116.59 8.51 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.688 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 10.8 t -107.28 147.27 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 123.026 0.53 . . . . 0.0 111.801 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 28.0 t -162.63 174.87 12.01 Favored 'General case' 0 C--N 1.339 0.147 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 177.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -71.97 130.07 40.09 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 176.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.358 177.946 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 285' ' ' ASN . . . . . 0.44 HD22 ' C ' ' B' ' 285' ' ' ASN . 0.3 OUTLIER . . . . . 0 N--CA 1.455 -0.223 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 80.4 m -108.13 144.36 35.63 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.024 0.44 . . . . 0.0 110.912 -174.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 44.5 pt -120.41 147.35 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -99.83 145.93 27.18 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 174.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 16.8 t -129.46 142.14 44.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 122.636 0.374 . . . . 0.0 111.22 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -129.54 149.9 51.11 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.05 14.24 64.88 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-O 119.894 -0.392 . . . . 0.0 112.361 169.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 61.4 mt -57.1 -51.1 70.65 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 117.545 0.673 . . . . 0.0 110.615 -175.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 148.84 177.16 22.8 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -101.54 -2.25 31.04 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -178.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -129.14 14.67 6.23 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.778 0.431 . . . . 0.0 112.145 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.2 m -73.65 163.16 4.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -172.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 27.3 p -129.23 160.71 32.08 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 123.501 0.72 . . . . 0.0 111.604 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 298' ' ' ILE . . . . . 0.533 HG23 ' HB ' ' B' ' 322' ' ' ILE . 44.8 mt -64.51 -45.51 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.274 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -63.6 -35.65 81.22 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 122.497 0.319 . . . . 0.0 111.601 179.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 47.1 t -72.28 -47.01 53.37 Favored 'General case' 0 C--O 1.228 -0.057 0 CA-C-N 117.919 0.327 . . . . 0.0 110.772 -177.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 7.8 p -68.16 -33.41 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.2 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -65.78 -32.56 74.16 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 176.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 303' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -74.23 -28.21 61.14 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 304' ' ' TYR . . . . . 0.409 ' CE1' ' CD1' ' B' ' 354' ' ' PHE . 54.6 t80 -82.2 -25.47 34.21 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -96.51 -25.93 15.47 Favored 'General case' 0 CA--C 1.527 0.086 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 306' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -65.73 -17.69 64.8 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 111.631 0.234 . . . . 0.0 111.631 -177.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -71.72 -20.52 61.89 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 5.0 mm -86.72 -45.8 16.49 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 175.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -165.22 167.92 39.05 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 178.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 82.4 mt -68.13 122.59 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-O 120.854 0.359 . . . . 0.0 110.752 -174.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 92.1 mt -74.56 136.53 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt . . . . . 0 N--CA 1.448 -0.568 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -178.131 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo . . . . . 0 N--CA 1.452 -0.959 0 N-CA-C 109.861 -0.861 . . . . 0.0 109.861 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 321' ' ' MET . . . . . . . . . . . . . 36.4 mtt -71.31 95.71 1.34 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 120.571 0.224 . . . . 0.0 111.576 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 322' ' ' ILE . . . . . 0.533 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.6 mp -142.44 141.67 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 173.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 323' ' ' ASN . . . . . 0.403 ' O ' ' HA ' ' B' ' 337' ' ' ALA . 17.3 m-80 -132.75 111.16 10.91 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 171.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 43.2 mt -81.55 148.15 29.29 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 174.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -115.28 151.62 34.21 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 178.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.333 -0.141 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -176.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 9.3 mmmm . . . . . 0 N--CA 1.458 -0.048 0 N-CA-C 110.566 -0.161 . . . . 0.0 110.566 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.33 5.24 81.38 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -170.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -103.73 149.68 24.77 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.324 0.65 . . . . 0.0 110.121 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 337' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' B' ' 323' ' ' ASN . . . -164.25 159.69 20.3 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.027 176.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 6.1 p -106.26 151.65 24.53 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 169.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 42.9 t -135.89 126.22 42.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 170.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 23.0 t -105.96 141.88 36.61 Favored 'General case' 0 CA--C 1.527 0.086 0 O-C-N 122.129 -0.357 . . . . 0.0 110.948 -177.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -106.6 158.53 16.87 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -177.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -73.41 -29.97 62.94 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -131.26 146.9 64.04 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -177.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 344' ' ' PRO . . . . . 0.463 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 40.6 Cg_endo -70.83 -33.23 12.86 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.414 2.743 . . . . 0.0 114.484 -177.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 345' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 87.4 Cg_endo -73.82 -22.65 17.38 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 CA-C-N 121.185 1.459 . . . . 0.0 109.926 -176.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 71.2 m -71.48 -35.74 70.91 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 175.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -68.7 -37.91 79.9 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 175.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -64.77 -43.12 94.3 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -69.45 -33.26 72.67 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 110.474 -0.195 . . . . 0.0 110.474 178.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.89 -36.8 85.52 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 67.9 mt -69.67 -52.36 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 120.378 -0.529 . . . . 0.0 109.612 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -55.74 -29.37 59.42 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 55.5 t-105 -95.55 -55.87 2.88 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 354' ' ' PHE . . . . . 0.409 ' CD1' ' CE1' ' B' ' 304' ' ' TYR . 46.7 m-85 -75.8 -31.54 59.48 Favored 'General case' 0 C--N 1.337 0.06 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -173.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -55.46 108.04 0.39 Allowed 'General case' 0 C--O 1.232 0.16 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.753 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 106.98 -3.17 35.57 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.272 176.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -86.47 -164.78 1.11 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 117.843 0.821 . . . . 0.0 110.428 176.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -128.91 154.69 46.28 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.958 0.409 . . . . 0.0 111.306 177.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -145.19 137.2 25.67 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.573 1.149 . . . . 0.0 112.348 177.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 15.5 t 54.9 16.15 1.37 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 122.773 0.429 . . . . 0.0 111.189 -175.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 90.71 23.45 30.71 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 111.886 -0.485 . . . . 0.0 111.886 178.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -133.9 142.07 42.15 Favored Pre-proline 0 N--CA 1.453 -0.321 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -177.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -68.94 136.33 34.9 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 122.702 2.268 . . . . 0.0 109.518 177.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 29.1 pt -122.12 170.68 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-O 120.978 0.418 . . . . 0.0 111.01 -178.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -144.84 114.1 7.03 Favored 'General case' 0 N--CA 1.457 -0.086 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 11.2 t -102.67 150.47 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 122.907 0.483 . . . . 0.0 112.131 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 23.8 t -163.54 173.43 13.07 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 176.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -70.55 131.09 43.46 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 176.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.47 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.683 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.455 -0.213 0 N-CA-C 111.53 0.196 . . . . 0.0 111.53 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 60.6 m -106.73 142.5 36.27 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 120.988 0.423 . . . . 0.0 110.797 -176.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 38.9 pt -116.85 147.38 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 173.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -100.78 144.36 29.83 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 174.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 18.4 t -129.72 143.13 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.004 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -131.44 151.61 51.4 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 175.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 88.84 11.77 65.02 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 119.782 -0.455 . . . . 0.0 112.272 169.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 76.4 mt -56.47 -51.37 68.71 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.705 0.752 . . . . 0.0 110.46 -176.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 147.61 174.41 19.51 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 -179.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -99.07 -0.32 42.1 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.879 0.34 . . . . 0.0 111.644 -178.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -128.83 13.0 6.32 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.4 m -73.58 162.8 4.27 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -172.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 47.4 p -130.04 158.18 40.33 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 123.532 0.733 . . . . 0.0 111.129 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 298' ' ' ILE . . . . . 0.566 HG23 ' HB ' ' B' ' 322' ' ' ILE . 30.7 mt -62.41 -44.87 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.506 -179.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -63.13 -34.7 78.17 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.448 0.299 . . . . 0.0 111.609 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 47.0 t -73.64 -44.29 57.3 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 79.2 t -62.45 -40.82 89.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 177.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.77 -36.2 83.55 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 303' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -70.52 -27.95 64.57 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 304' ' ' TYR . . . . . 0.407 ' CE2' ' CD1' ' B' ' 354' ' ' PHE . 60.8 t80 -82.9 -26.42 31.53 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -179.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -96.63 -24.65 15.9 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 179.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 306' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -66.61 -19.25 65.73 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 111.526 0.195 . . . . 0.0 111.526 -177.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -71.01 -19.77 62.48 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -178.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 5.0 mm -88.79 -46.43 15.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 N-CA-C 110.554 -0.165 . . . . 0.0 110.554 175.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.19 167.43 37.49 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 179.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 84.2 mt -68.03 120.44 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-O 120.989 0.423 . . . . 0.0 110.353 -176.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 80.5 mt -74.29 137.37 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 172.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 312' ' ' LYS . . . . . 0.429 ' HE2' ' HB2' ' B' ' 312' ' ' LYS . 22.3 ttmm . . . . . 0 N--CA 1.45 -0.466 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -177.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo . . . . . 0 N--CA 1.449 -1.103 0 N-CA-C 110.358 -0.67 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 321' ' ' MET . . . . . 0.404 ' C ' HD12 ' B' ' 322' ' ' ILE . 37.0 mtt -73.08 91.49 1.61 Allowed 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 122.523 0.329 . . . . 0.0 111.685 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 322' ' ' ILE . . . . . 0.566 ' HB ' HG23 ' B' ' 298' ' ' ILE . 4.1 mp -136.6 139.89 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 170.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -135.21 111.05 9.36 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 25.0 mt -81.44 151.96 27.62 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 176.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -115.99 152.34 33.7 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 177.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.092 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -174.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt . . . . . 0 N--CA 1.461 0.089 0 N-CA-C 110.442 -0.207 . . . . 0.0 110.442 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.13 3.59 76.06 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -172.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -103.56 150.05 24.31 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.163 0.585 . . . . 0.0 110.104 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -162.81 157.55 21.58 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.705 177.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 7.6 p -105.31 152.67 22.62 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 170.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 38.2 t -135.78 126.17 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 123.597 0.759 . . . . 0.0 109.056 170.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 340' ' ' SER . . . . . 0.401 ' HB3' ' CB ' ' B' ' 321' ' ' MET . 48.3 t -105.39 139.2 40.38 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.701 0.286 . . . . 0.0 110.983 -178.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -104.57 159.76 15.49 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -178.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -72.08 -31.61 66.25 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -130.98 149.85 74.92 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 344' ' ' PRO . . . . . 0.474 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 40.7 Cg_endo -70.27 -32.12 17.02 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 123.256 2.637 . . . . 0.0 114.396 -177.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 345' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 74.0 Cg_endo -73.68 -21.34 19.19 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 CA-C-N 121.255 1.484 . . . . 0.0 110.199 -177.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 57.6 m -72.09 -36.3 69.46 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 175.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -67.28 -38.64 85.4 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 174.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -63.63 -43.96 95.27 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.23 -34.67 76.67 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 122.227 -0.296 . . . . 0.0 110.542 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.64 -37.18 86.71 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 61.5 mt -69.58 -51.85 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.86 175.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -53.19 -30.63 38.55 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 53.8 t-105 -97.09 -55.39 2.87 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -176.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 354' ' ' PHE . . . . . 0.407 ' CD1' ' CE2' ' B' ' 304' ' ' TYR . 51.9 m-85 -76.35 -26.94 56.22 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -173.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -49.22 109.16 0.24 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 177.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 97.3 -0.32 60.01 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 119.508 -0.606 . . . . 0.0 112.499 174.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -83.25 -165.74 1.17 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 118.203 1.001 . . . . 0.0 110.374 176.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -127.99 154.96 45.01 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.387 0.613 . . . . 0.0 111.233 177.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -145.71 136.44 24.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.531 1.133 . . . . 0.0 112.247 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 13.3 t 54.89 18.11 2.07 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.711 0.291 . . . . 0.0 111.346 -175.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.4 22.92 38.75 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.963 -0.455 . . . . 0.0 111.963 178.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 51.6 m-20 -132.64 142.16 43.8 Favored Pre-proline 0 N--CA 1.457 -0.112 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -177.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.27 135.97 33.05 Favored 'Trans proline' 0 N--CA 1.446 -1.305 0 C-N-CA 122.895 2.397 . . . . 0.0 109.532 178.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 29.8 pt -122.56 171.4 11.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 121.176 0.513 . . . . 0.0 111.009 -177.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -144.45 115.38 7.83 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.781 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 11.7 t -105.9 147.63 11.27 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 C-N-CA 123.174 0.59 . . . . 0.0 112.165 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 22.6 t -162.71 173.04 14.37 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 176.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -70.1 130.17 41.4 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 176.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.439 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.053 -178.954 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.455 -0.205 0 N-CA-C 111.443 0.164 . . . . 0.0 111.443 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 28.2 m -113.49 143.96 43.64 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.866 0.365 . . . . 0.0 111.603 -174.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 32.1 pt -122.02 146.82 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 175.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -100.33 144.24 29.57 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 174.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 20.4 t -129.83 142.24 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 122.808 0.443 . . . . 0.0 111.008 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -129.82 151.98 49.81 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.128 -0.694 . . . . 0.0 109.128 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.61 11.89 67.78 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-O 119.911 -0.383 . . . . 0.0 112.448 169.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 75.4 mt -55.42 -50.27 70.24 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 117.625 0.713 . . . . 0.0 110.679 -175.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 145.71 174.07 17.56 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -100.98 2.16 40.38 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -178.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -128.64 13.94 6.46 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.792 0.437 . . . . 0.0 111.795 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.6 m -75.56 165.32 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -172.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 26.7 p -131.81 160.53 35.35 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.587 0.755 . . . . 0.0 111.969 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 298' ' ' ILE . . . . . 0.522 HG23 ' HB ' ' B' ' 322' ' ' ILE . 48.3 mt -63.82 -43.71 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.099 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.6 -36.6 84.76 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 122.428 0.291 . . . . 0.0 111.499 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 45.4 t -71.82 -46.26 58.72 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.792 0.269 . . . . 0.0 110.795 -177.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 8.2 p -68.33 -32.55 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.271 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -66.76 -32.66 74.09 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 303' ' ' ASP . . . . . 0.409 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.0 t0 -74.15 -27.58 60.91 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 304' ' ' TYR . . . . . 0.417 ' CE1' ' CD2' ' B' ' 354' ' ' PHE . 67.7 t80 -84.19 -24.36 30.16 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -97.01 -24.41 15.81 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 178.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 306' ' ' LYS . . . . . 0.409 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.8 ptpt -66.13 -17.86 64.98 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -177.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -71.78 -20.67 61.83 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 5.1 mm -86.81 -46.09 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 N-CA-C 110.525 -0.176 . . . . 0.0 110.525 175.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.58 165.86 37.01 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.346 -0.701 . . . . 0.0 111.346 178.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 79.5 mt -66.81 119.46 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 122.586 0.354 . . . . 0.0 110.642 -176.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 94.5 mt -72.06 135.55 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 172.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt . . . . . 0 N--CA 1.453 -0.314 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -178.338 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo . . . . . 0 N--CA 1.448 -1.156 0 N-CA-C 110.032 -0.795 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 321' ' ' MET . . . . . 0.406 ' CB ' ' HB3' ' B' ' 340' ' ' SER . 37.1 mtt -72.64 95.0 1.79 Allowed 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 120.906 0.384 . . . . 0.0 111.757 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 322' ' ' ILE . . . . . 0.522 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.5 mp -141.31 141.05 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 173.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -132.75 107.31 8.28 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 174.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 36.6 mt -80.04 154.78 27.93 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -122.7 149.2 44.38 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 176.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 8.7 m . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -174.097 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? . . . . . 0 N--CA 1.463 0.198 0 N-CA-C 110.579 -0.156 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.01 5.44 80.29 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -172.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -102.74 147.38 26.92 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.591 0.756 . . . . 0.0 110.313 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -164.17 158.23 18.89 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.639 0.257 . . . . 0.0 111.423 177.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 32.2 p -104.12 153.3 21.09 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 169.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 40.6 t -136.81 130.94 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 171.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 340' ' ' SER . . . . . 0.406 ' HB3' ' CB ' ' B' ' 321' ' ' MET . 41.9 t -108.66 149.54 28.8 Favored 'General case' 0 N--CA 1.46 0.072 0 CA-C-O 120.672 0.272 . . . . 0.0 111.425 -178.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -115.27 157.82 23.22 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -70.46 -32.53 70.13 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -129.86 149.05 71.97 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -178.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 344' ' ' PRO . . . . . 0.469 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 41.0 Cg_endo -69.95 -32.42 17.81 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.198 2.599 . . . . 0.0 114.537 -176.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 345' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 92.7 Cg_endo -74.16 -20.95 18.45 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 CA-C-N 120.874 1.348 . . . . 0.0 110.315 -177.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 68.3 m -71.05 -37.84 72.54 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 175.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.62 -38.18 86.41 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 174.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -64.69 -42.38 95.36 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -69.33 -34.1 74.11 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 110.48 -0.192 . . . . 0.0 110.48 178.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -63.87 -38.02 89.56 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 67.8 mt -68.08 -53.43 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 120.369 -0.532 . . . . 0.0 109.658 175.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -55.54 -27.72 50.55 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -178.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -96.6 -55.22 2.98 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 354' ' ' PHE . . . . . 0.417 ' CD2' ' CE1' ' B' ' 304' ' ' TYR . 48.9 m-85 -76.2 -27.0 56.7 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -173.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -49.18 108.43 0.19 Allowed 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 176.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 96.57 1.03 60.58 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-N 116.154 -0.475 . . . . 0.0 113.068 174.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -82.97 -164.47 0.88 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 117.89 0.845 . . . . 0.0 110.17 176.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -129.46 152.21 49.25 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-O 121.006 0.432 . . . . 0.0 110.982 178.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -145.08 137.27 25.86 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.891 0.877 . . . . 0.0 112.334 178.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 22.0 t 54.73 18.31 2.06 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.69 0.281 . . . . 0.0 111.196 -175.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.65 23.39 39.53 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -132.9 142.94 46.55 Favored Pre-proline 0 N--CA 1.457 -0.09 0 CA-C-N 117.537 0.668 . . . . 0.0 109.312 -177.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.24 135.51 31.89 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 123.148 2.565 . . . . 0.0 109.738 177.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 30.8 pt -123.03 170.43 13.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.122 0.487 . . . . 0.0 111.176 -177.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -144.31 116.91 8.64 Favored 'General case' 0 C--O 1.228 -0.071 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.898 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 366' ' ' VAL . . . . . 0.402 HG21 ' HB2' ' B' ' 354' ' ' PHE . 12.6 t -106.13 149.0 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 C-N-CA 123.088 0.555 . . . . 0.0 112.124 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 22.6 t -163.27 172.92 14.01 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 177.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -69.94 129.68 40.14 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 176.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.342 0 CA-C-O 121.096 0.474 . . . . 0.0 111.608 179.757 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 285' ' ' ASN . . . . . 0.403 HD22 ' C ' ' B' ' 285' ' ' ASN . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.287 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 72.1 m -109.07 145.39 35.71 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.024 0.44 . . . . 0.0 111.152 -173.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 46.1 pt -121.9 149.6 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -102.67 145.53 29.54 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 175.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 289' ' ' VAL . . . . . 0.553 HG11 HD13 ' B' ' 292' ' ' LEU . 57.5 t -128.26 136.61 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.412 -178.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -127.23 153.95 45.46 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 176.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 84.31 12.22 76.47 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 173.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 292' ' ' LEU . . . . . 0.553 HD13 HG11 ' B' ' 289' ' ' VAL . 4.6 tp -59.1 -49.36 78.18 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.984 0.914 . . . . 0.0 111.219 -170.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 146.59 167.11 12.64 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 176.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -95.38 -1.19 51.62 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.341 0.257 . . . . 0.0 111.312 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -130.67 14.69 5.4 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.5 m -68.58 164.85 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -173.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 77.5 p -135.17 156.76 48.44 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 123.838 0.855 . . . . 0.0 109.782 177.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 298' ' ' ILE . . . . . 0.582 HG23 ' HB ' ' B' ' 322' ' ' ILE . 29.6 mt -61.94 -43.74 97.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.626 -178.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -64.25 -34.24 77.67 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 47.7 t -72.58 -45.36 59.54 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 117.864 0.302 . . . . 0.0 110.482 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 72.5 t -62.16 -41.63 92.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.93 -36.02 83.04 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 303' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -69.74 -29.66 67.08 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 304' ' ' TYR . . . . . 0.401 ' CE1' ' CD2' ' B' ' 354' ' ' PHE . 56.3 t80 -82.52 -25.89 33.01 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -96.46 -24.47 16.09 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 306' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -67.15 -18.56 65.34 Favored 'General case' 0 N--CA 1.461 0.077 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -176.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -71.69 -19.73 62.03 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 5.2 mm -88.43 -46.28 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.092 0 CA-C-N 117.729 0.241 . . . . 0.0 110.471 175.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.83 170.53 39.17 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 83.5 mt -70.06 120.18 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 122.675 0.39 . . . . 0.0 110.352 -175.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 87.7 mt -73.83 138.9 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 172.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -178.009 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo . . . . . 0 N--CA 1.45 -1.056 0 N-CA-C 110.262 -0.707 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 321' ' ' MET . . . . . 0.482 ' C ' HD12 ' B' ' 322' ' ' ILE . 34.2 mtt -74.94 86.02 2.27 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 120.913 0.387 . . . . 0.0 111.895 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 322' ' ' ILE . . . . . 0.582 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.4 mp -130.65 137.64 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 169.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -133.64 110.72 10.07 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.508 176.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 20.3 mt -78.75 151.77 31.88 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.334 0.654 . . . . 0.0 109.362 177.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -117.58 147.29 42.97 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 177.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.454 -0.225 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -176.806 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 10.5 mmmm . . . . . 0 CA--C 1.521 -0.138 0 CA-C-O 120.244 0.068 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.77 21.87 73.47 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -172.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -127.61 144.87 51.03 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.013 0.525 . . . . 0.0 110.242 -177.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -155.21 155.37 33.75 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.584 0.231 . . . . 0.0 111.229 172.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 1.9 p -96.12 152.28 18.69 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 170.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 23.2 t -134.29 125.65 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 169.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 22.8 t -106.03 141.86 36.7 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.618 -177.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -107.79 158.54 17.22 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -73.06 -31.72 64.59 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -130.07 147.99 67.85 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -178.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 344' ' ' PRO . . . . . 0.469 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 47.7 Cg_endo -71.64 -30.9 14.11 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 123.389 2.726 . . . . 0.0 114.672 -176.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 345' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 78.3 Cg_endo -73.83 -22.52 17.5 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 CA-C-N 121.326 1.509 . . . . 0.0 109.946 -177.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 71.1 m -71.68 -35.71 70.39 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 175.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -68.72 -38.03 79.9 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 175.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -63.87 -44.56 92.72 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.04 -33.6 74.89 Favored 'General case' 0 N--CA 1.455 -0.175 0 O-C-N 122.474 -0.141 . . . . 0.0 110.63 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.14 -37.69 88.24 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 67.6 mt -68.78 -53.68 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.929 174.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -54.21 -28.67 42.45 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -178.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 56.8 t-105 -95.89 -56.27 2.72 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 354' ' ' PHE . . . . . 0.401 ' CD2' ' CE1' ' B' ' 304' ' ' TYR . 47.3 m-85 -75.99 -25.59 55.94 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -173.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -45.86 107.51 0.1 Allowed 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 175.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 92.64 3.36 66.56 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 119.515 -0.603 . . . . 0.0 113.058 174.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -82.37 -170.84 3.13 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.178 0.989 . . . . 0.0 111.201 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -112.21 150.15 31.28 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.684 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -146.12 130.8 17.93 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.654 0.782 . . . . 0.0 112.52 173.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 17.5 t 54.71 19.65 2.6 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.807 0.443 . . . . 0.0 111.089 -176.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.16 28.3 25.8 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 111.921 -0.472 . . . . 0.0 111.921 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -140.01 142.69 31.4 Favored Pre-proline 0 N--CA 1.456 -0.157 0 CA-C-N 117.385 0.592 . . . . 0.0 109.62 -177.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.97 136.27 32.01 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.814 2.343 . . . . 0.0 110.019 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 31.8 pt -124.79 170.27 15.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 121.103 0.478 . . . . 0.0 110.979 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -142.73 116.54 9.28 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.229 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 11.6 t -104.58 147.89 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 123.115 0.566 . . . . 0.0 111.78 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 24.4 t -162.41 172.23 15.9 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 177.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -70.06 128.65 37.05 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 177.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.245 0 CA-C-O 121.345 0.593 . . . . 0.0 111.996 -178.575 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 99.4 m -111.24 146.63 36.62 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.211 0.529 . . . . 0.0 110.369 -176.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 39.8 pt -119.04 146.89 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.227 175.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -96.97 145.5 25.86 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 173.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 18.0 t -131.3 142.23 43.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 O-C-N 123.211 0.319 . . . . 0.0 111.148 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -131.17 150.37 52.18 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 177.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.81 12.99 65.48 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 119.776 -0.458 . . . . 0.0 112.402 169.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 65.5 mt -57.29 -49.95 74.47 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 117.653 0.726 . . . . 0.0 110.645 -175.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 146.47 175.41 19.44 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -101.3 0.23 36.87 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.898 0.349 . . . . 0.0 111.861 -177.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -128.66 13.91 6.45 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.57 0.348 . . . . 0.0 111.666 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.5 m -75.33 166.7 2.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -172.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 14.1 p -131.36 162.15 30.77 Favored 'General case' 0 CA--C 1.522 -0.11 0 C-N-CA 123.744 0.818 . . . . 0.0 112.596 -177.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 298' ' ' ILE . . . . . 0.576 HG23 ' HB ' ' B' ' 322' ' ' ILE . 44.1 mt -62.88 -45.45 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.347 178.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -69.79 -33.51 72.48 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -178.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 80.9 p -72.41 -44.66 62.14 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 118.398 0.544 . . . . 0.0 110.37 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 9.5 p -68.35 -33.76 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 O-C-N 121.917 -0.489 . . . . 0.0 110.668 176.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.58 -33.48 76.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 175.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 303' ' ' ASP . . . . . 0.425 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.3 t0 -73.7 -27.32 61.15 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 304' ' ' TYR . . . . . 0.408 ' CE1' ' CD1' ' B' ' 354' ' ' PHE . 59.5 t80 -83.23 -25.85 31.31 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -96.67 -25.48 15.54 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 178.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 306' ' ' LYS . . . . . 0.425 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.9 ptpt -65.86 -18.09 65.1 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -177.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -72.67 -20.06 61.31 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 122.169 -0.332 . . . . 0.0 111.82 -178.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.1 mm -86.29 -46.87 16.62 Favored 'Isoleucine or valine' 0 C--N 1.338 0.071 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 174.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -162.51 166.06 36.44 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 85.6 mt -68.22 121.31 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 C-N-CA 122.604 0.362 . . . . 0.0 110.595 -175.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 94.9 mt -73.94 136.06 26.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 172.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -178.255 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo . . . . . 0 N--CA 1.45 -1.079 0 N-CA-C 109.993 -0.81 . . . . 0.0 109.993 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 321' ' ' MET . . . . . . . . . . . . . 35.3 mtt -71.86 95.48 1.54 Allowed 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 120.814 0.34 . . . . 0.0 111.482 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 322' ' ' ILE . . . . . 0.576 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.3 mp -144.51 145.68 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 175.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 323' ' ' ASN . . . . . 0.409 ' O ' ' HA ' ' B' ' 337' ' ' ALA . 18.1 m-80 -134.04 129.16 35.68 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 171.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -97.95 139.59 33.56 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -105.81 149.43 26.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 179.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.455 -0.223 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? . . . . . 0 C--O 1.23 0.058 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 75.95 5.51 80.17 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -171.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -100.05 149.22 23.71 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.491 0.716 . . . . 0.0 110.164 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 337' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' B' ' 323' ' ' ASN . . . -161.14 166.26 28.22 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 120.871 0.367 . . . . 0.0 111.398 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 2.7 p -118.71 149.84 40.76 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 169.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 42.8 t -135.58 123.21 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 171.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 16.0 t -102.04 137.99 39.58 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.001 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -101.75 161.67 13.48 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -74.42 -26.06 59.83 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -137.24 149.48 65.99 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -176.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 344' ' ' PRO . . . . . 0.469 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 41.6 Cg_endo -70.79 -32.25 14.59 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.391 2.727 . . . . 0.0 114.39 -177.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 345' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 79.2 Cg_endo -73.89 -22.11 17.82 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 CA-C-N 121.324 1.509 . . . . 0.0 110.075 -177.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 61.2 m -71.81 -37.64 70.35 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 175.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -67.05 -37.66 84.46 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 174.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -64.82 -43.52 92.83 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.94 -34.22 75.0 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 110.675 -0.12 . . . . 0.0 110.675 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.41 -36.41 84.07 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 64.4 mt -69.73 -52.62 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 120.357 -0.537 . . . . 0.0 109.758 175.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -55.82 -28.14 54.84 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 59.8 t-105 -96.79 -54.88 3.07 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -177.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 354' ' ' PHE . . . . . 0.408 ' CD1' ' CE1' ' B' ' 304' ' ' TYR . 50.7 m-85 -78.36 -29.86 47.72 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -174.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -51.17 110.77 0.47 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.222 0.465 . . . . 0.0 111.839 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 99.7 -2.18 57.09 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 119.541 -0.588 . . . . 0.0 112.715 175.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -83.54 -163.71 0.8 Allowed 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.065 0.932 . . . . 0.0 110.641 177.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -128.53 155.6 44.61 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 121.315 0.579 . . . . 0.0 111.356 178.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -146.78 136.73 23.33 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 124.637 1.175 . . . . 0.0 112.007 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 64.2 m 52.73 19.53 1.29 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -173.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.51 23.4 39.91 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -133.0 141.48 41.13 Favored Pre-proline 0 N--CA 1.453 -0.29 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -178.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.6 135.37 30.66 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 122.862 2.375 . . . . 0.0 109.611 178.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 27.0 pt -122.48 170.82 12.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 121.187 0.518 . . . . 0.0 110.807 -177.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 9.7 tmtm? -145.66 117.93 8.42 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.537 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 10.9 t -105.48 150.13 8.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 C-N-CA 123.324 0.65 . . . . 0.0 112.01 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 30.0 t -162.27 173.88 13.61 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 176.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -71.16 130.24 40.97 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 176.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.281 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.696 179.551 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.279 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 91.9 p -78.59 7.55 6.62 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.994 0.518 . . . . 0.0 111.589 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -68.03 -6.0 20.29 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.175 0.59 . . . . 0.0 111.559 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 90.8 mtp -140.09 161.49 37.5 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.967 0.507 . . . . 0.0 110.109 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -72.77 -16.88 61.63 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 54.63 21.92 3.72 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.821 0.848 . . . . 0.0 112.578 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 44.5 t -69.97 -14.09 62.54 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.769 0.319 . . . . 0.0 110.622 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 33.7 p30 -128.05 17.62 6.67 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.041 0.937 . . . . 0.0 111.176 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -116.4 110.4 18.6 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -177.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -113.32 6.53 17.35 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.161 0.585 . . . . 0.0 111.7 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 59.2 m -109.01 143.12 38.72 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 120.956 0.408 . . . . 0.0 110.961 -176.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 24.7 pt -117.8 147.84 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 174.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 288' ' ' PHE . . . . . 0.448 ' CE2' ' C6 ' ' A' ' 14' ' ' ' U' . 48.9 t80 -99.71 143.54 29.82 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 173.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 19.5 t -127.72 141.36 46.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.813 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -129.06 149.62 50.8 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 88.54 12.67 64.39 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-O 119.818 -0.434 . . . . 0.0 112.633 169.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 65.6 mt -56.93 -51.62 68.44 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 117.532 0.666 . . . . 0.0 110.599 -175.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 147.44 173.41 18.52 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -98.58 -0.85 42.34 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 122.368 -0.489 . . . . 0.0 111.984 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -128.66 13.63 6.44 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.804 0.441 . . . . 0.0 112.168 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.1 m -75.81 165.69 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -173.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 20.7 p -131.17 158.39 40.62 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 123.335 0.654 . . . . 0.0 112.168 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 298' ' ' ILE . . . . . 0.596 HG23 ' HB ' ' B' ' 322' ' ' ILE . 37.5 mt -60.11 -44.27 94.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.267 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -62.93 -36.0 81.95 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.689 0.395 . . . . 0.0 111.505 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 75.3 m -72.22 -43.43 64.44 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 117.893 0.315 . . . . 0.0 110.258 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 71.4 t -62.62 -41.87 93.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.54 -36.86 85.57 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 303' ' ' ASP . . . . . 0.409 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 44.1 t0 -70.21 -27.19 64.29 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 304' ' ' TYR . . . . . 0.418 ' CE2' ' CD1' ' B' ' 354' ' ' PHE . 59.6 t80 -85.21 -25.97 27.03 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -96.54 -23.92 16.3 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 306' ' ' LYS . . . . . 0.409 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.6 ptpt -66.95 -18.19 65.27 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -177.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -72.69 -20.28 61.26 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.8 mm -87.01 -46.46 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.06 0 N-CA-C 110.51 -0.181 . . . . 0.0 110.51 175.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -162.22 167.63 36.91 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 80.0 mt -68.76 119.7 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 120.853 0.358 . . . . 0.0 110.499 -176.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 93.9 mt -73.84 136.39 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 172.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -71.87 133.44 45.45 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -178.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 2.1 m -95.41 139.29 31.9 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 113.18 0.808 . . . . 0.0 113.18 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -70.93 131.85 44.34 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 175.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -91.56 -4.63 55.17 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -96.8 -23.43 16.39 Favored 'General case' 0 C--N 1.338 0.095 0 C-N-CA 122.995 0.518 . . . . 0.0 110.249 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 7.1 p -128.86 -25.78 2.76 Favored 'General case' 0 C--O 1.231 0.085 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -172.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 85.27 -9.48 66.88 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 119.711 -0.494 . . . . 0.0 111.923 173.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -85.16 156.32 60.2 Favored Pre-proline 0 CA--C 1.53 0.202 0 CA-C-N 118.033 0.917 . . . . 0.0 108.91 175.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.09 156.36 66.09 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.052 1.834 . . . . 0.0 109.855 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 321' ' ' MET . . . . . 0.415 ' CB ' ' HB3' ' B' ' 340' ' ' SER . 36.0 mtt -72.62 88.34 1.26 Allowed 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 322' ' ' ILE . . . . . 0.596 ' HB ' HG23 ' B' ' 298' ' ' ILE . 4.0 mp -136.07 140.26 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 171.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -133.41 108.09 8.47 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.28 151.04 35.24 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.796 0.839 . . . . 0.0 109.273 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -117.22 150.56 38.55 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 176.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -131.52 146.98 52.49 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -175.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -78.55 129.86 35.3 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 48.4 mtp85 -85.65 -8.8 58.01 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 122.455 -0.153 . . . . 0.0 110.699 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -96.92 -14.59 21.66 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.521 0.328 . . . . 0.0 111.733 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 2.9 p -136.41 -22.79 1.29 Allowed 'General case' 0 N--CA 1.462 0.125 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 84.12 -0.03 89.49 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 176.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -82.99 157.42 22.96 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 117.579 0.69 . . . . 0.0 109.487 177.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 32.1 mt -71.68 142.08 49.87 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 9.2 mmmm -70.3 -16.99 63.08 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 123.167 0.587 . . . . 0.0 110.479 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.19 6.94 84.2 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -171.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -104.9 148.27 26.86 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.666 0.786 . . . . 0.0 110.379 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -161.96 156.67 22.65 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.845 175.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 21.3 p -103.95 153.15 21.15 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 169.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 23.3 t -135.67 128.37 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 123.582 0.753 . . . . 0.0 109.312 170.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 340' ' ' SER . . . . . 0.415 ' HB3' ' CB ' ' B' ' 321' ' ' MET . 38.7 t -106.73 144.15 33.8 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.883 0.373 . . . . 0.0 111.132 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -109.71 158.77 17.76 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -73.93 -17.61 61.0 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -145.41 149.98 42.75 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 344' ' ' PRO . . . . . 0.467 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 49.2 Cg_endo -70.51 -31.78 16.63 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.272 2.648 . . . . 0.0 114.408 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 345' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 81.0 Cg_endo -73.43 -21.65 19.45 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 CA-C-N 121.515 1.577 . . . . 0.0 110.261 -177.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 60.1 m -73.05 -37.51 66.82 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 175.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.0 -38.35 88.26 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 174.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 9.5 tmtm? -65.13 -43.42 91.99 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -66.83 -34.15 77.18 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.92 -36.74 85.35 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 67.2 mt -69.73 -51.62 39.32 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.094 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.733 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -54.74 -29.49 53.77 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 57.5 t-105 -97.79 -56.4 2.52 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -177.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 354' ' ' PHE . . . . . 0.418 ' CD1' ' CE2' ' B' ' 304' ' ' TYR . 50.7 m-85 -75.8 -28.42 58.33 Favored 'General case' 0 CA--C 1.523 -0.08 0 N-CA-C 114.571 1.322 . . . . 0.0 114.571 -173.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -52.27 108.23 0.27 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 117.844 0.293 . . . . 0.0 111.506 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 100.41 -0.89 55.78 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-O 119.662 -0.521 . . . . 0.0 112.729 175.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -83.72 -165.01 1.0 Allowed 'General case' 0 N--CA 1.461 0.096 0 CA-C-N 118.296 1.048 . . . . 0.0 110.371 176.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -127.41 153.37 46.34 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-O 121.02 0.438 . . . . 0.0 110.83 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -145.57 136.64 24.73 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.307 1.043 . . . . 0.0 112.212 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 21.5 t 53.99 19.28 1.96 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.57 0.348 . . . . 0.0 111.302 -175.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.14 23.18 41.88 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.871 -0.492 . . . . 0.0 111.871 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -132.37 142.42 44.9 Favored Pre-proline 0 N--CA 1.455 -0.22 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.52 136.15 32.87 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 122.873 2.382 . . . . 0.0 109.67 178.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 25.5 pt -124.05 171.07 13.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-O 121.173 0.511 . . . . 0.0 111.025 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -146.02 119.4 9.0 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.434 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 13.3 t -108.04 150.03 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 123.14 0.576 . . . . 0.0 112.133 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 29.1 t -163.85 173.12 13.11 Favored 'General case' 0 C--N 1.339 0.15 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -69.93 130.13 41.37 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 176.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -90.15 178.67 6.11 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.144 0.497 . . . . 0.0 111.922 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 10.2 t -144.56 -154.81 0.56 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.827 1.251 . . . . 0.0 107.783 172.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -124.87 82.08 2.02 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 118.966 0.803 . . . . 0.0 110.832 174.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -62.92 -17.25 61.54 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 172.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.89 -31.65 69.99 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 122.499 0.319 . . . . 0.0 110.278 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -63.01 -11.61 20.2 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -174.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -76.41 -15.21 59.99 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -136.83 -12.23 1.73 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -177.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 52.8 mmm-85 . . . . . 0 C--O 1.252 1.184 0 CA-C-O 117.11 -1.424 . . . . 0.0 110.718 175.63 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.537 0 N19-C1'-C2' 109.232 -2.605 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.518 0 C5'-C4'-C3' 111.969 -2.354 . 0.732 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.518 0 N19-C1'-C2' 109.089 -2.694 . 0.717 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.478 0 N19-C1'-C2' 108.695 -2.941 . 0.804 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.557 0 N19-C1'-C2' 108.271 -3.206 . 0.784 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.423 0 N19-C1'-C2' 108.829 -2.857 . 0.785 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.753 0 O4'-C1'-N19 111.169 2.969 . 0.785 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.501 0 O4'-C1'-N19 111.35 3.15 . 0.745 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.484 0 C4'-C3'-C2' 99.647 -3.053 . 0.667 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.619 0 C4'-C3'-C2' 99.908 -2.792 . 0.585 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.417 0 O4'-C1'-N19 110.842 2.642 . 0.268 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.364 0 O4'-C1'-N19 112.15 3.95 . 0.141 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.707 1 C5'-C4'-C3' 109.399 -4.067 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ' U' . . . . . 0.448 ' C6 ' ' CE2' ' B' ' 288' ' ' PHE . . . . . . . . 0 O4'--C4' 1.425 -2.293 0 O4'-C1'-N19 112.054 3.854 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.623 3.042 0 C5'-C4'-C3' 112.162 -2.225 . 0.257 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.162 0 O4'-C1'-N19 111.739 3.539 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.328 0 N19-C1'-C2' 109.061 -2.712 . 0.581 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.523 0 O4'-C1'-N19 110.884 2.684 . 0.823 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.597 0 O4'-C1'-N19 110.897 2.697 . 0.841 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.483 0 C4'-C3'-C2' 100.252 -2.448 . 0.637 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.577 0 C5'-C4'-C3' 112.076 -2.283 . 0.748 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.654 0 O4'-C1'-N19 110.882 2.682 . 0.813 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.797 0 C5'-C4'-C3' 111.911 -2.393 . 0.749 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.265 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 91.2 p -77.69 3.25 14.44 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.932 0.493 . . . . 0.0 111.407 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 16.8 m80 -63.34 158.57 20.1 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.191 0.597 . . . . 0.0 110.847 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.7 159.37 27.93 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 122.585 0.354 . . . . 0.0 110.619 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -155.67 155.97 34.14 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 53.83 21.72 2.89 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.573 0.749 . . . . 0.0 112.204 -177.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 88.1 p -69.18 -12.99 62.16 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.646 0.378 . . . . 0.0 110.484 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 32.7 p30 -124.27 20.63 8.88 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.063 0.945 . . . . 0.0 111.139 177.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -128.02 113.78 16.25 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -177.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -113.26 2.34 15.52 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.833 0.453 . . . . 0.0 110.584 -178.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 29.3 m -101.5 141.77 33.87 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.011 0.434 . . . . 0.0 111.521 -173.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 38.2 pt -116.6 146.63 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.958 172.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 288' ' ' PHE . . . . . 0.486 ' CE1' ' C6 ' ' A' ' 14' ' ' ' U' . 54.2 t80 -97.94 144.56 27.36 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 173.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 19.4 t -132.34 141.5 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 122.783 0.433 . . . . 0.0 110.969 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -130.92 154.4 48.15 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 122.858 0.463 . . . . 0.0 109.797 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 86.46 12.92 68.89 Favored Glycine 0 CA--C 1.521 0.469 0 CA-C-O 119.831 -0.427 . . . . 0.0 112.355 169.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 74.7 mt -57.49 -50.1 74.16 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 117.54 0.67 . . . . 0.0 110.336 -176.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 144.16 171.03 13.93 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -98.0 3.21 49.49 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 122.544 -0.386 . . . . 0.0 111.855 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -128.29 11.9 6.46 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.638 0.375 . . . . 0.0 111.769 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.6 m -74.8 163.75 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -173.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 20.3 p -128.87 158.93 37.37 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 123.589 0.755 . . . . 0.0 111.85 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 298' ' ' ILE . . . . . 0.548 HG23 ' HB ' ' B' ' 322' ' ' ILE . 40.4 mt -60.29 -44.38 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.547 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -68.72 -30.48 69.13 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 74.8 m -72.16 -43.96 63.81 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 118.17 0.441 . . . . 0.0 109.837 177.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 71.8 t -62.78 -41.05 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.21 -37.38 87.27 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 303' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -70.16 -26.87 64.12 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -85.71 -25.46 26.48 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -96.71 -24.18 16.09 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 306' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -67.11 -18.12 65.17 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 111.576 0.213 . . . . 0.0 111.576 -177.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -72.79 -20.01 61.24 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.2 mm -87.18 -45.69 16.26 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 CA-C-N 117.732 0.242 . . . . 0.0 110.48 175.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.4 167.68 37.74 Favored Glycine 0 C--N 1.335 0.502 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 78.3 mt -69.35 120.4 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-O 120.935 0.397 . . . . 0.0 110.717 -175.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 86.8 mt -75.19 134.47 29.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 171.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -71.11 136.21 48.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 4.8 m -96.86 139.86 32.28 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 176.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.74 135.6 40.32 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -90.33 -9.45 47.75 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 174.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 316' ' ' LYS . . . . . 0.536 ' HB3' ' H62' ' A' ' 17' ' ' ' A' . 71.4 mmtt -91.39 -20.39 21.87 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.603 0.761 . . . . 0.0 110.106 -177.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 11.2 p -135.73 -23.42 1.39 Allowed 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -174.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 83.64 -11.36 56.59 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 119.879 -0.401 . . . . 0.0 112.448 175.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -86.83 159.17 52.49 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 117.876 0.838 . . . . 0.0 109.277 175.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -67.21 155.09 72.13 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 121.724 1.616 . . . . 0.0 109.288 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 321' ' ' MET . . . . . 0.461 ' CB ' ' HB2' ' B' ' 340' ' ' SER . 30.1 mtt -71.38 93.62 1.16 Allowed 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.152 0.501 . . . . 0.0 111.636 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 322' ' ' ILE . . . . . 0.548 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.4 mp -140.89 139.52 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 173.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -132.01 106.32 7.96 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 35.0 mt -78.32 153.41 31.74 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 123.891 0.744 . . . . 0.0 109.361 176.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -119.87 149.49 41.99 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 176.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 3.0 m -131.1 148.16 52.7 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -174.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -76.43 131.24 38.97 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 54.0 mtp85 -84.37 -4.39 58.86 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -99.63 -12.48 20.02 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.936 0.494 . . . . 0.0 111.883 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 29.8 p -136.77 -28.2 0.98 Allowed 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 75.29 12.47 83.53 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -70.28 -108.79 0.0 OUTLIER 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.113 0.965 . . . . 0.0 110.395 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 5.8 mt -160.83 143.63 12.89 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 171.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -77.02 -18.14 58.35 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 122.656 0.382 . . . . 0.0 110.622 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 74.44 5.34 72.41 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -173.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -106.02 149.77 26.37 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.017 0.527 . . . . 0.0 110.167 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -163.52 160.1 22.77 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.727 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 27.4 p -106.88 153.82 21.96 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 169.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 22.1 t -134.26 129.36 53.32 Favored 'Isoleucine or valine' 0 C--O 1.23 0.038 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 170.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 340' ' ' SER . . . . . 0.461 ' HB2' ' CB ' ' B' ' 321' ' ' MET . 20.4 m -108.54 134.62 51.05 Favored 'General case' 0 C--O 1.23 0.068 0 CA-C-O 120.677 0.275 . . . . 0.0 110.3 -176.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -101.14 159.98 14.78 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -70.67 -36.04 73.15 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -127.52 149.06 69.08 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 344' ' ' PRO . . . . . 0.468 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 45.4 Cg_endo -70.83 -31.31 15.98 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.006 2.47 . . . . 0.0 114.647 -177.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 345' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 89.6 Cg_endo -73.61 -21.05 19.7 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 CA-C-N 121.222 1.472 . . . . 0.0 110.087 -177.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 49.0 m -71.25 -37.64 71.95 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 175.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.14 -39.44 89.84 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 174.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -63.36 -44.22 95.43 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.9 -33.92 75.64 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.117 0.167 . . . . 0.0 110.616 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.71 -37.86 89.04 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 67.3 mt -68.59 -53.05 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 120.35 -0.54 . . . . 0.0 109.973 175.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -54.93 -28.08 48.29 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -97.51 -55.47 2.81 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -76.92 -28.29 55.21 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -173.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -52.29 108.5 0.3 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 117.953 0.342 . . . . 0.0 111.366 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 101.61 -0.8 52.82 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.547 -0.585 . . . . 0.0 112.647 175.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -83.88 -163.11 0.72 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 118.09 0.945 . . . . 0.0 110.57 177.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -130.71 153.27 49.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.046 0.451 . . . . 0.0 110.464 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -145.81 138.0 25.43 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.224 1.01 . . . . 0.0 112.408 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 19.2 t 55.49 17.13 2.09 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.858 0.361 . . . . 0.0 111.026 -175.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.01 22.57 41.44 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.858 -0.497 . . . . 0.0 111.858 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 42.6 m-20 -132.26 142.41 44.89 Favored Pre-proline 0 N--CA 1.455 -0.181 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.84 135.5 32.87 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 122.709 2.272 . . . . 0.0 109.872 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 31.3 pt -121.63 170.69 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-O 120.948 0.404 . . . . 0.0 111.16 -177.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -143.21 112.84 6.93 Favored 'General case' 0 C--O 1.227 -0.083 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.793 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 6.3 t -103.85 149.73 7.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 C-N-CA 122.878 0.471 . . . . 0.0 112.258 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 29.4 t -164.13 175.02 10.59 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -71.73 129.77 39.47 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 175.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 369' ' ' ALA . . . . . 0.406 ' HA ' ' O2 ' ' A' ' 14' ' ' ' U' . . . -85.44 177.23 7.85 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.329 0.585 . . . . 0.0 112.325 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 14.9 t -147.65 -155.01 0.59 Allowed 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.278 1.031 . . . . 0.0 109.208 174.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -121.56 76.27 1.25 Allowed 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 118.357 0.526 . . . . 0.0 110.356 176.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -61.86 -17.36 56.18 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 171.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.47 -35.17 71.76 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 123.108 0.563 . . . . 0.0 110.316 175.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -64.07 -10.38 21.84 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -173.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -79.96 -16.78 54.52 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 177.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -134.07 -16.12 2.22 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -176.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 7.2 mmp_? . . . . . 0 C--O 1.251 1.157 0 CA-C-O 117.18 -1.391 . . . . 0.0 110.57 177.171 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.667 0 N19-C1'-C2' 108.966 -2.772 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.427 0 O4'-C1'-N19 110.58 2.38 . 0.642 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.538 0 O4'-C1'-N19 111.187 2.987 . 0.8 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.407 0 N19-C1'-C2' 109.231 -2.606 . 0.738 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.371 0 N19-C1'-C2' 108.79 -2.881 . 0.739 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.29 0 N19-C1'-C2' 109.217 -2.615 . 0.774 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.392 0 O4'-C1'-N19 110.913 2.713 . 0.786 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.627 0 C4'-C3'-C2' 99.917 -2.783 . 0.738 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.479 0 C4'-C3'-C2' 99.639 -3.061 . 0.671 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.43 0 C4'-C3'-C2' 100.027 -2.673 . 0.638 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.514 0 O4'-C1'-N19 110.798 2.598 . 0.345 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.352 0 O4'-C1'-N19 111.993 3.793 . 0.103 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.876 1 C5'-C4'-C3' 109.406 -4.063 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ' U' . . . . . 0.486 ' C6 ' ' CE1' ' B' ' 288' ' ' PHE . . . . . . . . 0 O4'--C4' 1.424 -2.427 0 O4'-C1'-N19 112.184 3.984 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.622 2.872 0 C5'-C4'-C3' 111.592 -2.605 . 0.232 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.219 0 O4'-C1'-N19 111.419 3.219 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ' A' . . . . . 0.536 ' H62' ' HB3' ' B' ' 316' ' ' LYS . . . . . . . . 0 O4'--C4' 1.421 -2.649 0 N19-C1'-C2' 108.991 -2.756 . 0.702 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.398 0 O4'-C1'-N19 110.891 2.691 . 0.847 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.59 0 O4'-C1'-N19 110.966 2.766 . 0.807 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.632 0 O4'-C1'-N19 111.016 2.816 . 0.723 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.569 0 C4'-C3'-C2' 100.288 -2.412 . 0.711 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.704 0 C5'-C4'-C3' 111.353 -2.765 . 0.809 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.475 0 N19-C1'-C2' 109.705 -2.31 . 0.822 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 276' ' ' GLY . . . . . 0.511 ' N ' ' HG ' ' B' ' 282' ' ' SER . . . . . . . . 0 N--CA 1.472 1.076 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 96.2 p -75.16 167.55 21.7 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.72 0.408 . . . . 0.0 110.831 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 55.32 23.34 5.55 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.717 0.807 . . . . 0.0 112.336 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.22 124.04 7.33 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 14.5 p30 -88.01 -24.0 23.64 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 177.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -91.34 31.79 1.11 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.158 0.583 . . . . 0.0 110.608 176.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 282' ' ' SER . . . . . 0.511 ' HG ' ' N ' ' B' ' 276' ' ' GLY . 46.9 t -64.16 -16.38 61.77 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 122.379 -0.201 . . . . 0.0 111.412 -178.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 26.1 p30 -95.07 7.51 45.88 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.238 0.615 . . . . 0.0 112.554 177.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -144.12 110.82 5.63 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.889 0.376 . . . . 0.0 110.674 -176.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . 0.438 HD22 ' C ' ' B' ' 285' ' ' ASN . 0.2 OUTLIER -113.11 8.87 18.45 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.696 -179.57 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 87.7 m -107.97 143.76 36.19 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.148 0.499 . . . . 0.0 110.887 -174.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 41.5 pt -117.34 147.13 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.528 -0.76 . . . . 0.0 108.971 174.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 288' ' ' PHE . . . . . 0.477 ' CE1' ' C6 ' ' A' ' 14' ' ' ' U' . 54.0 t80 -99.45 145.67 27.18 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 173.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 13.5 t -129.69 143.25 41.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 122.651 0.38 . . . . 0.0 111.403 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -131.65 149.57 52.45 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 122.952 0.501 . . . . 0.0 109.829 175.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 88.57 12.06 65.25 Favored Glycine 0 CA--C 1.522 0.494 0 CA-C-O 119.69 -0.506 . . . . 0.0 112.511 169.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 47.0 mt -57.45 -51.53 69.06 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 117.659 0.729 . . . . 0.0 110.836 -174.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 152.55 176.97 25.71 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -95.72 -14.85 23.05 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 122.311 -0.523 . . . . 0.0 112.118 -175.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -128.62 18.72 6.26 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.278 0.49 . . . . 0.0 112.093 -178.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.3 m -65.96 164.4 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -175.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 18.1 p -126.26 160.89 29.07 Favored 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 123.267 0.627 . . . . 0.0 112.265 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 298' ' ' ILE . . . . . 0.565 HG23 ' HB ' ' B' ' 322' ' ' ILE . 28.6 mt -64.54 -43.5 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.966 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -65.26 -37.29 86.76 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 79.5 p -73.29 -42.63 62.2 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 118.137 0.426 . . . . 0.0 110.494 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.5 -41.57 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.79 -36.0 82.92 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 303' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -70.43 -26.62 63.75 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -84.17 -26.68 28.63 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -96.43 -24.9 15.9 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 306' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -66.5 -18.89 65.62 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -177.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -71.8 -20.04 61.91 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -178.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 5.4 mm -87.21 -46.17 16.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 175.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -164.03 168.19 38.39 Favored Glycine 0 C--N 1.335 0.49 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 82.4 mt -69.16 122.03 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 122.603 0.361 . . . . 0.0 110.433 -175.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 95.9 mt -75.69 137.58 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 173.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -72.19 134.08 45.48 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 1.5 m -94.39 139.82 30.61 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -68.75 126.04 28.46 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 175.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -82.37 -8.01 59.63 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 122.433 -0.167 . . . . 0.0 110.594 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.57 -46.05 4.27 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.05 0.54 . . . . 0.0 110.767 -176.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 15.6 p -91.24 -25.47 19.48 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 84.67 -11.54 58.99 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 119.733 -0.482 . . . . 0.0 112.219 174.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -83.9 158.34 62.12 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 117.966 0.883 . . . . 0.0 109.205 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -67.22 154.29 74.68 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 121.812 1.674 . . . . 0.0 109.453 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 321' ' ' MET . . . . . 0.455 ' C ' HD12 ' B' ' 322' ' ' ILE . 35.9 mtt -71.54 86.14 0.87 Allowed 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.907 0.384 . . . . 0.0 111.617 -178.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 322' ' ' ILE . . . . . 0.565 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.7 mp -134.07 143.48 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 171.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -130.76 138.38 49.92 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 171.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 86.4 mt -110.48 129.36 55.8 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 176.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -94.55 154.23 17.49 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -177.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.74 143.06 38.87 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -173.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -76.01 134.62 40.08 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -82.24 -15.15 54.1 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 122.588 -0.07 . . . . 0.0 110.875 176.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -92.3 -15.01 27.95 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -176.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 19.3 p -137.68 -22.37 1.1 Allowed 'General case' 0 C--N 1.339 0.145 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 80.04 2.4 88.73 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -85.33 158.64 20.22 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 117.849 0.824 . . . . 0.0 108.987 177.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 10.2 mp -68.23 143.23 55.37 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -178.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -73.15 -16.28 61.44 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 123.062 0.545 . . . . 0.0 110.483 176.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.8 6.07 84.78 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -171.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -104.11 152.16 22.44 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.629 0.771 . . . . 0.0 109.91 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -160.25 169.66 22.74 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.898 0.38 . . . . 0.0 111.171 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 1.7 p -126.48 150.47 48.7 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 170.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 21.3 t -135.35 125.06 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 C-N-CA 123.577 0.751 . . . . 0.0 109.252 172.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 23.5 t -104.26 136.17 44.36 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.552 0.215 . . . . 0.0 110.605 -178.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -101.66 158.63 15.96 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -177.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -72.87 -31.08 64.47 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -129.54 146.68 62.11 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 344' ' ' PRO . . . . . 0.463 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 46.8 Cg_endo -70.99 -32.21 13.82 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.219 2.613 . . . . 0.0 114.38 -177.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 345' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 77.9 Cg_endo -73.49 -21.93 18.99 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 CA-C-N 121.256 1.484 . . . . 0.0 110.101 -176.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 67.3 m -70.73 -35.14 72.55 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 175.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -68.73 -39.28 80.46 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.62 -43.73 98.31 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 177.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.94 -35.09 76.38 Favored 'General case' 0 C--O 1.225 -0.201 0 O-C-N 122.371 -0.206 . . . . 0.0 110.462 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.31 -36.52 84.33 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 60.0 mt -71.21 -49.18 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.165 175.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -59.98 -27.58 66.95 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -175.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -96.55 -57.33 2.34 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -75.09 -30.93 61.06 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -173.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -54.19 111.17 0.72 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 118.128 0.422 . . . . 0.0 110.947 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 102.03 -3.0 51.65 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 119.556 -0.58 . . . . 0.0 112.559 176.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -84.42 -164.15 0.91 Allowed 'General case' 0 C--O 1.232 0.137 0 CA-C-N 118.093 0.947 . . . . 0.0 109.787 177.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -128.53 153.34 47.28 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.06 0.457 . . . . 0.0 110.971 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -145.01 135.96 24.73 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.041 0.936 . . . . 0.0 112.101 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 62.7 m 53.31 19.5 1.59 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.516 0.327 . . . . 0.0 111.802 -174.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.74 23.23 39.79 Favored Glycine 0 C--N 1.339 0.733 0 N-CA-C 111.784 -0.526 . . . . 0.0 111.784 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 56.9 m-20 -132.55 142.25 44.17 Favored Pre-proline 0 N--CA 1.452 -0.333 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -177.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.83 135.37 30.11 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.804 2.336 . . . . 0.0 109.72 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 30.6 pt -122.9 169.91 13.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.22 0.533 . . . . 0.0 111.166 -177.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 5.3 tmtm? -145.72 114.05 6.66 Favored 'General case' 0 C--N 1.338 0.069 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 11.2 t -103.89 149.73 7.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.077 0.551 . . . . 0.0 112.24 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 28.1 t -162.71 172.42 15.31 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 176.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -70.48 130.17 41.17 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -91.66 -179.88 5.46 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.277 -177.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 9.3 t -148.3 -155.93 0.67 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.893 1.277 . . . . 0.0 107.782 173.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -122.56 92.83 3.8 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 119.033 0.833 . . . . 0.0 111.047 173.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -69.26 -9.05 51.33 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 116.763 -0.199 . . . . 0.0 110.754 173.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -61.21 -24.68 66.52 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 122.492 0.317 . . . . 0.0 110.622 175.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -65.56 -15.44 62.71 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.856 0.462 . . . . 0.0 112.098 -176.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -76.33 -17.77 59.25 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -132.64 -14.01 2.88 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 377' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' B' ' 377' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.312 0 CA-C-O 117.788 -1.101 . . . . 0.0 110.326 177.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.493 0 N19-C1'-C2' 108.918 -2.801 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.637 0 O4'-C1'-N19 110.336 2.136 . 0.68 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.624 0 C5'-C4'-C3' 111.386 -2.743 . 0.699 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.544 0 N19-C1'-C2' 109.04 -2.725 . 0.839 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.576 0 N19-C1'-C2' 108.444 -3.097 . 0.741 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.36 0 N19-C1'-C2' 108.965 -2.772 . 0.786 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.771 0 O4'-C1'-N19 111.07 2.87 . 0.74 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.441 0 C4'-C3'-C2' 99.938 -2.762 . 0.731 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.36 0 C4'-C3'-C2' 99.712 -2.988 . 0.662 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.644 0 C4'-C3'-C2' 99.516 -3.184 . 0.486 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.246 0 O4'-C1'-N19 110.973 2.773 . 0.232 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.419 1 O4'-C1'-N19 112.505 4.305 . 0.097 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.685 0 C5'-C4'-C3' 109.672 -3.885 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ' U' . . . . . 0.477 ' C6 ' ' CE1' ' B' ' 288' ' ' PHE . . . . . . . . 0 O4'--C4' 1.422 -2.572 0 O4'-C1'-N19 111.76 3.56 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.623 3.007 0 O4'-C1'-N19 110.31 2.11 . 0.51 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.5 0 O4'-C1'-N19 111.437 3.237 . 0.43 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.272 0 N19-C1'-C2' 109.298 -2.564 . 0.544 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.571 0 O4'-C1'-N19 110.808 2.608 . 0.803 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ' U' . . . . . 0.411 " H2'" ' C6 ' ' A' ' 20' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.423 -2.503 0 O4'-C1'-N19 111.03 2.83 . 0.849 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ' U' . . . . . 0.411 ' C6 ' " H2'" ' A' ' 19' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.574 0 O4'-C1'-N19 110.681 2.481 . 0.674 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.446 0 C4'-C3'-C2' 100.408 -2.292 . 0.738 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.649 0 C5'-C4'-C3' 111.643 -2.572 . 0.779 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.623 0 N19-C1'-C2' 109.492 -2.442 . 0.796 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.167 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 93.2 p -77.13 16.35 0.58 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.401 0.68 . . . . 0.0 111.753 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -66.12 -9.29 29.92 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.176 0.59 . . . . 0.0 111.704 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 279' ' ' MET . . . . . 0.557 ' HG3' ' H ' ' B' ' 281' ' ' ASN . 56.1 tpp -155.44 152.8 29.42 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -65.49 -20.2 66.25 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 281' ' ' ASN . . . . . 0.557 ' H ' ' HG3' ' B' ' 279' ' ' MET . 37.4 m-20 -84.61 39.7 0.75 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.3 0.64 . . . . 0.0 110.135 175.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 92.3 p -61.95 -19.3 62.6 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.545 0.338 . . . . 0.0 111.285 -177.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -93.22 3.72 55.2 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 176.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -144.41 109.96 5.24 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.957 0.408 . . . . 0.0 110.416 -176.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . 0.408 HD22 ' C ' ' B' ' 285' ' ' ASN . 0.4 OUTLIER -117.42 8.12 12.95 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 122.987 0.515 . . . . 0.0 112.354 -178.897 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 35.0 m -104.88 140.79 37.61 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -173.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 41.1 pt -110.29 142.82 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 288' ' ' PHE . . . . . 0.465 ' CE2' ' C6 ' ' A' ' 14' ' ' ' U' . 56.7 t80 -93.79 141.91 27.97 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 172.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 15.9 t -130.38 141.18 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 O-C-N 123.156 0.285 . . . . 0.0 111.173 177.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -126.98 154.12 45.01 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 174.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 85.47 12.18 73.31 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-O 119.772 -0.46 . . . . 0.0 112.425 169.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 60.0 mt -56.69 -50.59 71.7 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 117.536 0.668 . . . . 0.0 110.752 -175.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 156.79 179.69 31.95 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -97.79 -8.43 28.49 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -177.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -141.22 24.4 2.13 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.5 m -67.95 162.81 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -174.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 20.8 p -122.84 156.51 34.43 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 298' ' ' ILE . . . . . 0.438 HG23 ' HB ' ' B' ' 322' ' ' ILE . 35.4 mt -61.56 -43.23 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.038 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -65.15 -35.73 82.02 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.61 0.364 . . . . 0.0 111.54 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 38.6 t -73.23 -44.1 60.11 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 122.25 -0.281 . . . . 0.0 110.389 -178.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 93.9 t -62.08 -41.51 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.95 -35.23 80.51 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 303' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -70.97 -29.28 65.22 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 304' ' ' TYR . . . . . 0.413 ' CE1' ' CD1' ' B' ' 354' ' ' PHE . 59.9 t80 -83.77 -24.96 30.88 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -96.62 -23.35 16.53 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 306' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -67.81 -16.76 64.26 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -177.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -73.02 -19.86 61.11 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 111.561 0.208 . . . . 0.0 111.561 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 3.9 mm -87.07 -47.76 15.8 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.109 0 CA-C-O 120.525 0.202 . . . . 0.0 110.781 175.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -161.4 175.38 38.0 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 74.4 mt -73.86 111.89 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-O 120.808 0.337 . . . . 0.0 110.133 -176.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 73.6 mt -68.16 135.53 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 172.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 312' ' ' LYS . . . . . 0.433 ' HG2' ' SD ' ' B' ' 321' ' ' MET . 40.7 ttmt -66.39 136.17 55.36 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -178.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 4.9 m -110.96 135.69 51.09 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.444 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -67.39 132.8 48.37 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -176.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -80.96 -5.41 57.48 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -108.44 -14.55 14.64 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 123.281 0.632 . . . . 0.0 111.68 -175.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 7.5 p -133.42 -25.04 1.76 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -176.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 80.58 -5.99 62.78 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 119.822 -0.432 . . . . 0.0 112.6 174.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -90.24 157.3 45.35 Favored Pre-proline 0 CA--C 1.531 0.223 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 175.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -66.05 150.19 85.47 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 121.288 1.325 . . . . 0.0 108.88 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 321' ' ' MET . . . . . 0.433 ' SD ' ' HG2' ' B' ' 312' ' ' LYS . 81.2 mtp -85.65 85.27 7.42 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.573 0.702 . . . . 0.0 111.09 -172.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 322' ' ' ILE . . . . . 0.438 ' HB ' HG23 ' B' ' 298' ' ' ILE . 2.3 mp -118.12 149.78 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 125.257 1.423 . . . . 0.0 108.328 174.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -134.94 116.16 14.4 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 170.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 55.5 mt -90.44 150.06 21.98 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 177.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -115.12 150.89 35.29 Favored 'General case' 0 C--O 1.226 -0.183 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 3.1 m -137.7 148.09 45.37 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -176.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -81.47 135.13 35.61 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 38.4 mtt-85 -84.7 -9.82 57.87 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.387 -0.196 . . . . 0.0 110.98 175.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -91.15 -15.02 30.04 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.554 0.342 . . . . 0.0 111.794 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 6.1 p -137.58 -25.83 1.0 Allowed 'General case' 0 C--O 1.232 0.175 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 73.32 10.47 78.81 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 119.659 -0.523 . . . . 0.0 111.913 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -74.6 -101.62 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.173 0.589 . . . . 0.0 110.288 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 2.2 tp -164.84 146.18 7.85 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.072 0.949 . . . . 0.0 108.645 172.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -78.58 -18.93 53.86 Favored 'General case' 0 N--CA 1.461 0.092 0 CA-C-N 117.836 0.289 . . . . 0.0 110.533 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 72.59 5.12 62.99 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -172.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -103.48 150.63 23.7 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.275 0.63 . . . . 0.0 110.354 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.16 169.4 24.25 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.008 0.433 . . . . 0.0 110.328 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 2.5 p -132.3 147.44 52.4 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 171.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 339' ' ' VAL . . . . . 0.402 ' CG1' HG13 ' B' ' 322' ' ' ILE . 1.0 OUTLIER -137.27 141.46 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 169.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 44.6 t -92.36 145.46 24.46 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.585 -177.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -112.46 151.92 29.34 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 175.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -70.61 -22.77 62.5 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 343' ' ' ASP . . . . . 0.435 ' HB3' ' HD2' ' B' ' 345' ' ' PRO . 48.3 m-20 -144.49 148.31 39.82 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 124.025 0.93 . . . . 0.0 111.769 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 344' ' ' PRO . . . . . 0.466 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 53.6 Cg_endo -71.62 -31.81 12.87 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.507 2.804 . . . . 0.0 115.063 -172.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 345' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 98.7 Cg_endo -73.51 -22.44 18.35 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 CA-C-N 121.286 1.495 . . . . 0.0 109.841 -178.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 48.7 m -73.21 -34.14 65.76 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 175.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -67.31 -41.21 85.73 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 175.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -70.85 -32.91 70.07 Favored 'General case' 0 C--O 1.227 -0.108 0 C-N-CA 121.16 -0.216 . . . . 0.0 110.841 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.07 -36.88 80.56 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 175.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.43 -36.99 85.58 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 71.5 mt -68.16 -52.67 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 175.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -55.12 -29.75 58.33 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 54.1 t-105 -96.64 -55.14 3.0 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 354' ' ' PHE . . . . . 0.413 ' CD1' ' CE1' ' B' ' 304' ' ' TYR . 51.0 m-85 -76.16 -27.21 56.89 Favored 'General case' 0 CA--C 1.522 -0.119 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 -173.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -49.19 109.68 0.29 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 117.98 0.355 . . . . 0.0 111.932 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 96.79 0.45 60.47 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 119.477 -0.624 . . . . 0.0 112.736 174.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -83.62 -164.6 0.94 Allowed 'General case' 0 C--N 1.339 0.111 0 CA-C-N 118.209 1.004 . . . . 0.0 110.186 176.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -128.97 152.12 48.93 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 120.981 0.42 . . . . 0.0 110.83 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -144.25 136.45 26.45 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.186 0.994 . . . . 0.0 112.451 177.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 20.7 t 54.36 19.0 2.08 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.517 0.327 . . . . 0.0 111.125 -175.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.48 23.78 38.67 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 112.004 -0.438 . . . . 0.0 112.004 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -132.8 142.62 45.4 Favored Pre-proline 0 N--CA 1.455 -0.213 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -177.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.8 136.61 33.32 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 122.751 2.3 . . . . 0.0 109.441 178.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 33.6 pt -123.69 169.95 14.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 CA-C-O 121.203 0.525 . . . . 0.0 111.259 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -143.33 113.79 7.43 Favored 'General case' 0 C--O 1.23 0.043 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.765 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 12.2 t -105.39 147.55 10.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.002 0.521 . . . . 0.0 112.2 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 23.0 t -163.68 172.94 13.53 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -71.76 129.58 39.01 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 175.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -80.58 174.43 11.62 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.878 -178.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 3.6 p -134.45 -155.77 0.68 Allowed 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.647 1.179 . . . . 0.0 110.644 174.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -120.43 71.19 0.91 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 118.185 0.448 . . . . 0.0 110.981 176.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -65.24 -10.71 34.13 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 170.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -64.17 -35.53 81.09 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.55 0.74 . . . . 0.0 110.473 171.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -70.24 -6.61 35.93 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -171.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -74.79 -16.28 60.72 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 176.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -136.59 -14.48 1.67 Allowed 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 8.7 ptp85 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 117.787 -1.102 . . . . 0.0 110.477 178.815 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.725 0 N19-C1'-C2' 108.965 -2.772 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.396 0 O4'-C1'-N19 110.667 2.467 . 0.712 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.487 0 C5'-C4'-C3' 111.523 -2.651 . 0.738 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.661 0 N19-C1'-C2' 108.788 -2.882 . 0.778 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.793 0 C4'-C3'-C2' 99.578 -3.122 . 0.638 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.603 0 N19-C1'-C2' 109.017 -2.739 . 0.734 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.551 0 O4'-C1'-N19 111.1 2.9 . 0.732 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.504 0 O4'-C1'-N19 111.343 3.143 . 0.702 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.345 0 C4'-C3'-C2' 99.792 -2.908 . 0.62 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.58 0 O4'-C1'-N19 111.195 2.995 . 0.599 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ' A' . . . . . 0.402 " H2'" ' C8 ' ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.624 0 O4'-C1'-N19 110.838 2.638 . 0.579 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ' A' . . . . . 0.402 ' C8 ' " H2'" ' A' ' 11' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.428 -2.044 1 O4'-C1'-N19 112.584 4.384 . 0.23 1b . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.64 0 C5'-C4'-C3' 110.129 -3.581 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ' U' . . . . . 0.465 ' C6 ' ' CE2' ' B' ' 288' ' ' PHE . . . . . . . . 0 O4'--C4' 1.422 -2.606 0 O4'-C1'-N19 111.812 3.612 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.624 3.087 0 C5'-C4'-C3' 111.71 -2.527 . 0.627 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.644 0 O4'-C1'-N19 111.634 3.434 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.515 0 N19-C1'-C2' 108.473 -3.079 . 0.712 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.333 0 O4'-C1'-N19 110.97 2.77 . 0.828 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.738 0 O4'-C1'-N19 111.091 2.891 . 0.8 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.264 0 O4'-C1'-N19 111.003 2.803 . 0.648 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.515 0 C5'-C4'-C3' 111.821 -2.452 . 0.716 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.893 0 C5'-C4'-C3' 111.447 -2.702 . 0.803 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.662 0 N19-C1'-C2' 109.667 -2.333 . 0.77 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.333 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 42.1 t -155.42 162.16 40.83 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.788 0.435 . . . . 0.0 110.071 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 33.4 m170 59.58 12.5 2.86 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.017 0.927 . . . . 0.0 112.04 -178.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 50.9 tpp -75.83 131.94 40.06 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 51.74 17.68 0.64 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 53.3 25.76 4.71 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.672 0.789 . . . . 0.0 112.303 -176.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 74.3 m -71.7 -4.25 26.42 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.59 0.356 . . . . 0.0 111.155 178.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 52.3 p30 -143.22 26.9 1.62 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.105 0.962 . . . . 0.0 109.774 178.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -130.61 111.04 11.86 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.092 -176.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.47 11.23 18.37 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.296 0.639 . . . . 0.0 111.584 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 26.4 m -107.39 145.11 33.34 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.044 0.45 . . . . 0.0 111.84 -173.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 30.4 pt -122.06 146.69 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.028 175.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -98.63 143.18 29.3 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 173.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 18.4 t -128.41 142.93 42.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 O-C-N 123.312 0.382 . . . . 0.0 111.177 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -131.69 150.33 52.19 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 176.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.86 12.72 65.84 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-O 119.669 -0.517 . . . . 0.0 112.397 169.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 65.7 mt -55.24 -51.46 66.52 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 117.598 0.699 . . . . 0.0 110.571 -175.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 146.74 176.25 20.37 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -101.54 1.26 37.79 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.607 0.363 . . . . 0.0 111.81 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -128.7 12.12 6.28 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.6 m -74.41 162.93 4.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -172.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 30.5 p -132.12 159.72 38.1 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 123.724 0.81 . . . . 0.0 111.268 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 298' ' ' ILE . . . . . 0.577 HG23 ' HB ' ' B' ' 322' ' ' ILE . 37.7 mt -61.85 -43.6 97.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.169 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -63.53 -35.63 81.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 122.527 0.331 . . . . 0.0 111.472 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 75.0 m -71.73 -44.56 63.91 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-N 118.06 0.391 . . . . 0.0 110.349 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 74.9 t -63.03 -40.68 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -65.18 -36.26 83.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 303' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -70.61 -26.65 63.59 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -85.05 -25.52 27.58 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -96.44 -24.8 15.94 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 306' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -66.43 -18.9 65.62 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 122.396 -0.19 . . . . 0.0 111.467 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -71.84 -19.78 61.92 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 111.682 0.252 . . . . 0.0 111.682 -178.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.8 mm -88.15 -45.48 15.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.086 0 CA-C-N 117.632 0.196 . . . . 0.0 110.561 175.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -164.4 168.66 38.86 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 87.8 mt -69.02 122.14 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 121.021 0.439 . . . . 0.0 110.305 -175.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 92.0 mt -75.66 138.46 20.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 172.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 312' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' B' ' 312' ' ' LYS . 36.2 ttmt -72.35 130.09 39.91 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -178.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 3.4 m -92.04 143.17 26.74 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 177.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -76.75 134.57 39.12 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 315' ' ' LYS . . . . . 0.539 ' HE3' ' HA ' ' B' ' 315' ' ' LYS . 0.5 OUTLIER -80.49 -13.48 59.07 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 122.789 0.436 . . . . 0.0 110.458 172.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 316' ' ' LYS . . . . . 0.45 ' HB3' ' H62' ' A' ' 17' ' ' ' A' . 42.4 mmtm -94.27 -23.58 17.8 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.054 0.541 . . . . 0.0 111.439 -173.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 17.1 p -135.44 -20.61 1.6 Allowed 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -172.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 81.89 -11.34 48.2 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 119.837 -0.424 . . . . 0.0 112.411 175.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -84.89 158.83 58.57 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 117.813 0.806 . . . . 0.0 109.16 174.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.75 154.08 74.11 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 121.966 1.777 . . . . 0.0 110.074 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 321' ' ' MET . . . . . . . . . . . . . 39.0 mtt -70.97 92.86 0.95 Allowed 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.023 0.439 . . . . 0.0 111.53 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 322' ' ' ILE . . . . . 0.577 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.9 mp -140.4 141.56 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 172.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -127.06 132.55 50.66 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 170.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 73.4 mt -107.64 135.12 49.61 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 177.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -102.7 146.25 28.49 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 4.0 m -132.46 146.07 51.66 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -174.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -72.82 129.79 38.97 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 44.4 mtp85 -82.83 -6.78 59.59 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 122.451 -0.155 . . . . 0.0 110.946 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -98.55 -13.51 20.41 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 122.856 0.462 . . . . 0.0 112.113 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 6.3 p -136.21 -26.0 1.17 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 74.54 12.82 82.28 Favored Glycine 0 CA--C 1.533 1.205 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 175.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -72.94 -107.03 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.856 0.862 . . . . 0.0 110.463 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 4.7 mt -161.29 144.84 12.89 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.465 1.106 . . . . 0.0 108.11 171.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -81.59 -20.79 39.11 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 122.622 0.369 . . . . 0.0 110.733 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.41 3.04 76.41 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -174.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -102.84 149.32 24.62 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 117.288 0.544 . . . . 0.0 109.682 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -160.16 167.45 27.66 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.793 0.33 . . . . 0.0 111.473 -176.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 2.7 p -120.25 151.6 38.93 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 169.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 32.4 t -136.73 129.5 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 123.668 0.787 . . . . 0.0 108.927 171.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 47.3 t -109.19 140.45 42.78 Favored 'General case' 0 CA--C 1.523 -0.091 0 CA-C-N 117.795 0.27 . . . . 0.0 111.311 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -105.91 158.88 16.45 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -70.93 -33.78 70.85 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -128.4 147.45 63.88 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 344' ' ' PRO . . . . . 0.475 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 42.6 Cg_endo -70.69 -31.85 15.68 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 123.223 2.616 . . . . 0.0 114.549 -176.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 345' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 89.7 Cg_endo -73.62 -21.17 19.52 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 CA-C-N 121.059 1.414 . . . . 0.0 110.431 -177.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 69.8 m -70.98 -36.85 72.68 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 175.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -69.27 -36.78 77.44 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 175.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -64.62 -43.37 93.95 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -69.22 -33.43 73.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 110.624 -0.139 . . . . 0.0 110.624 177.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.38 -37.13 86.44 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 63.3 mt -69.69 -52.84 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -55.57 -27.32 48.5 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -97.56 -56.62 2.46 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -75.58 -29.5 59.34 Favored 'General case' 0 C--N 1.337 0.052 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -173.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -53.08 107.71 0.26 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.944 0.338 . . . . 0.0 111.412 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 101.58 -0.98 52.93 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 119.533 -0.593 . . . . 0.0 112.737 176.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -84.75 -164.39 0.97 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-N 117.989 0.895 . . . . 0.0 110.154 176.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -128.91 152.38 48.62 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.825 0.345 . . . . 0.0 111.004 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -143.77 137.07 27.8 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.12 0.968 . . . . 0.0 112.398 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 59.7 m 53.14 18.87 1.28 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -174.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 89.21 21.47 41.52 Favored Glycine 0 C--N 1.338 0.676 0 CA-C-O 119.821 -0.433 . . . . 0.0 112.158 179.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -132.19 143.06 47.35 Favored Pre-proline 0 N--CA 1.457 -0.118 0 CA-C-N 117.501 0.65 . . . . 0.0 109.295 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.57 135.85 31.97 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.987 2.458 . . . . 0.0 109.651 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 25.8 pt -124.11 170.77 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-O 121.112 0.482 . . . . 0.0 110.946 -178.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -145.18 118.13 8.79 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.118 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 12.7 t -106.78 150.32 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 123.165 0.586 . . . . 0.0 111.729 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 27.0 t -163.79 172.5 14.03 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 175.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -70.04 130.64 42.69 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 176.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -88.24 163.4 16.13 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.359 177.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -153.45 132.72 12.73 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 172.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 73.1 mtm-85 -51.27 102.28 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -168.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 372' ' ' ARG . . . . . 0.459 ' HA ' ' CZ ' ' B' ' 375' ' ' PHE . 54.9 ttt180 -69.31 -20.04 63.89 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 171.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -66.35 -7.3 18.13 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.414 0.686 . . . . 0.0 111.254 176.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -99.02 -10.2 22.94 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 114.317 1.228 . . . . 0.0 114.317 -176.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 375' ' ' PHE . . . . . 0.459 ' CZ ' ' HA ' ' B' ' 372' ' ' ARG . 15.0 p90 -138.83 -19.42 1.02 Allowed 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 -178.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -78.61 -12.26 60.01 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 122.386 -0.196 . . . . 0.0 110.723 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 . . . . . 0 C--O 1.252 1.185 0 CA-C-O 117.363 -1.303 . . . . 0.0 110.587 -177.543 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.632 0 N19-C1'-C2' 109.097 -2.689 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.442 0 O4'-C1'-N19 110.565 2.365 . 0.7 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.501 0 O4'-C1'-N19 110.928 2.728 . 0.773 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.531 0 N19-C1'-C2' 108.732 -2.917 . 0.749 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.489 0 N19-C1'-C2' 108.764 -2.897 . 0.663 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.233 0 N19-C1'-C2' 109.175 -2.64 . 0.808 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.781 0 O4'-C1'-N19 110.667 2.467 . 0.787 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.469 0 C4'-C3'-C2' 99.526 -3.174 . 0.775 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.439 0 C4'-C3'-C2' 99.519 -3.181 . 0.672 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.728 0 C4'-C3'-C2' 99.932 -2.768 . 0.606 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.258 0 C4'-C3'-C2' 100.027 -2.673 . 0.447 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.273 1 O4'-C1'-N19 112.224 4.024 . 0.183 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.496 0 C5'-C4'-C3' 109.639 -3.907 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.619 1 C3'-C2'-C1' 105.102 4.002 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.651 0 O4'-C1'-N19 110.896 2.696 . 0.282 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.237 0 O4'-C1'-N19 111.391 3.191 . 0.407 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ' A' . . . . . 0.45 ' H62' ' HB3' ' B' ' 316' ' ' LYS . . . . . . . . 0 O4'--C4' 1.424 -2.377 0 N19-C1'-C2' 109.209 -2.62 . 0.689 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.479 0 C5'-C4'-C3' 111.752 -2.499 . 0.821 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.708 0 O4'-C1'-N19 111.004 2.804 . 0.754 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.269 0 O4'-C1'-N19 110.78 2.58 . 0.649 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.384 0 C5'-C4'-C3' 112.138 -2.241 . 0.734 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.686 0 C5'-C4'-C3' 111.649 -2.567 . 0.789 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.433 0 O4'-C1'-N19 110.788 2.588 . 0.791 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.02 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 90.3 p -78.13 4.25 12.96 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.852 0.461 . . . . 0.0 111.436 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -63.05 157.62 21.62 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.039 0.535 . . . . 0.0 110.948 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 5.7 tpt -154.08 152.7 30.76 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 31.2 p30 -147.27 174.62 11.46 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.041 0.536 . . . . 0.0 110.967 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 45.2 m-20 52.2 30.99 8.46 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.347 0.659 . . . . 0.0 111.933 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 47.7 t -63.51 -18.97 64.37 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 122.155 -0.341 . . . . 0.0 110.652 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 22.0 p30 -93.7 8.74 39.79 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.398 0.679 . . . . 0.0 112.798 177.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -143.32 110.37 5.66 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.767 0.317 . . . . 0.0 110.2 -177.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -113.79 2.17 15.06 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.859 0.464 . . . . 0.0 111.193 -177.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 84.8 m -103.87 142.4 34.46 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.105 0.479 . . . . 0.0 110.558 -174.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 44.5 pt -114.93 146.75 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -98.85 144.44 28.05 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 173.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 289' ' ' VAL . . . . . 0.552 ' CG1' HD13 ' B' ' 292' ' ' LEU . 60.7 t -129.28 136.16 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 O-C-N 123.411 0.445 . . . . 0.0 110.57 -178.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -126.64 155.16 43.01 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 176.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 83.32 12.71 78.2 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 172.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 292' ' ' LEU . . . . . 0.552 HD13 ' CG1' ' B' ' 289' ' ' VAL . 4.2 tp -59.27 -50.82 72.54 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.98 0.912 . . . . 0.0 110.996 -170.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 143.64 165.04 10.63 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.311 -0.715 . . . . 0.0 111.311 176.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -95.81 3.93 53.31 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.532 0.333 . . . . 0.0 111.34 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -128.71 12.73 6.35 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.764 0.426 . . . . 0.0 111.84 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 4.2 m -72.63 166.75 2.45 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -173.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 32.5 p -137.82 160.76 38.39 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 124.072 0.949 . . . . 0.0 110.835 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 298' ' ' ILE . . . . . 0.502 HG23 ' HB ' ' B' ' 322' ' ' ILE . 41.7 mt -63.08 -40.74 90.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -66.36 -38.07 86.75 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 80.6 p -73.25 -44.17 59.89 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 117.945 0.339 . . . . 0.0 110.237 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 71.0 t -60.76 -42.87 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -65.24 -34.82 79.27 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 122.224 -0.297 . . . . 0.0 110.293 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 303' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -69.83 -28.09 65.41 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -84.17 -25.83 29.27 Favored 'General case' 0 C--O 1.226 -0.157 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -96.16 -23.71 16.61 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 306' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -68.19 -18.06 64.49 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -177.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -72.45 -19.17 61.61 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -178.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 3.6 mm -87.89 -47.81 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 CA-C-N 117.564 0.165 . . . . 0.0 110.746 175.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -161.61 173.82 38.04 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 76.1 mt -71.89 116.35 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 120.861 0.363 . . . . 0.0 110.099 -175.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 76.1 mt -71.59 137.93 22.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 172.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 312' ' ' LYS . . . . . 0.448 ' HG2' ' SD ' ' B' ' 321' ' ' MET . 40.9 ttmt -68.88 142.42 54.8 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 4.9 m -113.63 136.9 52.32 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -66.12 131.82 47.06 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -79.67 -11.05 59.87 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 32.7 mmtm -99.47 -25.43 14.45 Favored 'General case' 0 CA--C 1.527 0.061 0 C-N-CA 122.684 0.394 . . . . 0.0 111.019 -175.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 6.9 p -126.25 -25.16 3.56 Favored 'General case' 0 C--O 1.23 0.074 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -171.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 81.3 -6.4 64.09 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 119.773 -0.459 . . . . 0.0 112.423 174.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -85.25 156.75 59.79 Favored Pre-proline 0 C--O 1.234 0.249 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 174.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.67 150.67 74.72 Favored 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 121.485 1.456 . . . . 0.0 109.178 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 321' ' ' MET . . . . . 0.488 ' C ' HD12 ' B' ' 322' ' ' ILE . 62.3 mtp -82.43 85.88 6.84 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.37 0.605 . . . . 0.0 111.558 -172.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 322' ' ' ILE . . . . . 0.502 ' HB ' HG23 ' B' ' 298' ' ' ILE . 2.7 mp -126.46 147.83 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 174.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -134.25 111.88 10.61 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 173.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 30.6 mt -80.76 149.76 29.52 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 123.93 0.769 . . . . 0.0 108.936 176.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -115.48 145.79 42.27 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 326' ' ' THR . . . . . 0.413 HG23 ' O ' ' B' ' 332' ' ' LYS . 6.8 m -135.86 146.04 47.02 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -175.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -68.82 125.09 25.49 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 177.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -76.82 -12.63 60.0 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -177.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -94.79 -14.91 24.23 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.897 0.479 . . . . 0.0 111.91 -176.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 4.4 p -135.42 -24.62 1.37 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -177.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 75.54 13.91 82.51 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-O 119.71 -0.494 . . . . 0.0 112.221 172.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 332' ' ' LYS . . . . . 0.413 ' O ' HG23 ' B' ' 326' ' ' THR . 60.3 mtpt -72.75 -111.05 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.55 0.74 . . . . 0.0 110.841 178.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 6.2 mt -158.55 143.14 15.97 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.189 0.996 . . . . 0.0 108.532 170.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -79.15 -19.96 49.7 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.041 0.536 . . . . 0.0 111.329 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.62 22.16 73.16 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -173.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -128.36 146.62 50.72 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.073 0.549 . . . . 0.0 110.18 -178.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -156.04 159.44 39.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.727 0.298 . . . . 0.0 111.587 174.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 3.4 p -104.1 155.81 18.39 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 170.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 16.7 t -138.12 122.48 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.042 0 C-N-CA 123.432 0.693 . . . . 0.0 110.312 172.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 69.2 m -90.78 144.21 25.95 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 117.961 0.346 . . . . 0.0 110.967 177.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 341' ' ' PHE . . . . . 0.403 ' O ' ' HE3' ' B' ' 312' ' ' LYS . 26.3 m-85 -112.89 151.2 30.75 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 177.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -69.92 -28.91 65.99 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -177.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -132.71 148.51 69.8 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -178.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 344' ' ' PRO . . . . . 0.474 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 37.9 Cg_endo -70.42 -33.14 14.59 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.357 2.705 . . . . 0.0 114.205 -177.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 345' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 85.8 Cg_endo -73.54 -20.96 19.98 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 CA-C-N 121.225 1.473 . . . . 0.0 110.252 -177.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 70.3 m -72.05 -37.14 69.75 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -68.26 -38.37 81.71 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 175.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -65.06 -42.43 94.19 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -69.16 -34.71 75.39 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.399 -0.188 . . . . 0.0 110.956 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.17 -37.67 88.28 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 66.0 mt -68.56 -53.62 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.775 175.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -55.01 -27.73 46.53 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 54.8 t-105 -97.52 -55.35 2.85 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -76.26 -28.21 57.01 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -173.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -51.92 109.52 0.38 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 120.959 0.409 . . . . 0.0 111.555 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 101.29 -1.18 54.01 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 119.515 -0.603 . . . . 0.0 112.278 175.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -86.43 -165.64 1.32 Allowed 'General case' 0 C--O 1.231 0.084 0 CA-C-N 118.277 1.039 . . . . 0.0 110.698 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -127.28 155.59 43.26 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 121.061 0.458 . . . . 0.0 111.089 178.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -145.88 135.82 23.55 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.515 1.126 . . . . 0.0 112.196 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 20.8 t 54.11 18.77 1.85 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 120.873 0.368 . . . . 0.0 111.647 -176.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.67 24.17 33.9 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 112.031 -0.427 . . . . 0.0 112.031 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 53.1 m-20 -133.91 142.61 44.13 Favored Pre-proline 0 N--CA 1.454 -0.265 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -69.6 136.53 33.67 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 122.808 2.338 . . . . 0.0 109.308 176.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 31.2 pt -124.25 169.2 15.89 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 121.001 0.429 . . . . 0.0 110.96 -177.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -142.92 113.69 7.54 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.52 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 12.0 t -103.06 148.03 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 C-N-CA 123.144 0.577 . . . . 0.0 111.727 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 22.7 t -162.6 173.54 13.81 Favored 'General case' 0 C--N 1.338 0.099 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 177.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -70.64 128.31 35.65 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 176.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -88.24 179.71 6.31 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.125 0.488 . . . . 0.0 112.008 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 9.7 t -147.68 -154.04 0.53 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 173.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 72.9 mtt85 -124.48 92.19 3.61 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.037 0.835 . . . . 0.0 110.961 173.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 82.6 mtt-85 -62.95 -14.34 45.97 Favored 'General case' 0 C--N 1.339 0.124 0 N-CA-C 110.614 -0.143 . . . . 0.0 110.614 173.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.29 -8.94 6.62 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.033 0.533 . . . . 0.0 111.162 176.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -100.83 -12.95 18.62 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 114.152 1.168 . . . . 0.0 114.152 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -140.95 -26.41 0.73 Allowed 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 117.218 2.303 . . . . 0.0 117.218 -177.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -78.52 -7.03 57.06 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 . . . . . 0 C--O 1.253 1.28 0 CA-C-O 117.393 -1.289 . . . . 0.0 110.457 -178.296 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.449 0 N19-C1'-C2' 109.215 -2.616 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.631 0 C5'-C4'-C3' 111.765 -2.49 . 0.696 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.342 0 O4'-C1'-N19 111.07 2.87 . 0.706 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.477 0 N19-C1'-C2' 108.479 -3.075 . 0.744 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.459 0 C4'-C3'-C2' 99.56 -3.14 . 0.72 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.422 0 N19-C1'-C2' 108.765 -2.897 . 0.743 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.7 0 O4'-C1'-N19 111.146 2.946 . 0.808 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.755 0 O4'-C1'-N19 110.961 2.761 . 0.776 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.387 0 C4'-C3'-C2' 99.9 -2.8 . 0.679 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.593 0 C4'-C3'-C2' 99.961 -2.739 . 0.574 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.392 0 O4'-C1'-N19 110.564 2.364 . 0.586 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.458 1 O4'-C1'-N19 112.656 4.456 . 0.161 1t . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.412 -3.406 0 C3'-C2'-C1' 99.167 -2.592 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.592 1 C5'-C4'-C3' 108.687 -4.542 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.624 3.063 0 O4'-C1'-N19 110.376 2.176 . 0.314 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.437 0 O4'-C1'-N19 110.772 2.572 . 0.167 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.442 0 N19-C1'-C2' 108.986 -2.759 . 0.5 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.555 0 O4'-C1'-N19 110.926 2.726 . 0.797 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.743 0 O4'-C1'-N19 110.972 2.772 . 0.81 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.421 0 O4'-C1'-N19 111.05 2.85 . 0.646 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.603 0 C5'-C4'-C3' 112.227 -2.182 . 0.712 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.683 0 C5'-C4'-C3' 111.505 -2.664 . 0.802 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.59 0 N19-C1'-C2' 110.047 -2.095 . 0.829 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.16 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 65.6 m -146.62 161.06 41.32 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 123.031 0.532 . . . . 0.0 110.257 -178.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 55.6 23.35 6.0 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.403 0.681 . . . . 0.0 111.673 -178.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 90.8 mtp -71.9 170.82 12.91 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.791 0.329 . . . . 0.0 110.883 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 18.1 p30 -66.89 -12.58 59.81 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -83.26 19.54 1.47 Allowed 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.753 0.421 . . . . 0.0 111.276 175.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 43.7 t -62.01 -23.13 66.24 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 122.128 -0.357 . . . . 0.0 110.98 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -87.46 4.88 41.58 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 177.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -132.74 110.33 10.3 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.826 0.346 . . . . 0.0 110.146 -175.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . 0.43 HD22 ' C ' ' B' ' 285' ' ' ASN . 0.4 OUTLIER -113.44 6.59 17.24 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.123 0.569 . . . . 0.0 112.094 -178.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 87.6 m -109.76 141.67 42.07 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.265 0.555 . . . . 0.0 110.831 -175.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 41.1 pt -118.6 148.92 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-N 115.492 -0.776 . . . . 0.0 108.954 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -98.58 146.95 25.29 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 173.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 15.0 t -131.98 141.37 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-O 120.839 0.352 . . . . 0.0 111.259 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -129.47 150.73 50.69 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 176.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.86 12.5 66.19 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 119.793 -0.448 . . . . 0.0 112.76 169.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 73.3 mt -56.06 -51.61 67.23 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 117.62 0.71 . . . . 0.0 110.748 -175.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 148.51 175.89 21.46 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -101.43 -0.93 34.42 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 122.555 -0.379 . . . . 0.0 111.69 -176.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -128.71 11.29 6.16 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.075 0.55 . . . . 0.0 112.402 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.0 m -73.06 163.94 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -172.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 26.7 p -130.24 158.76 38.87 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 123.661 0.784 . . . . 0.0 111.773 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 298' ' ' ILE . . . . . 0.564 HG23 ' HB ' ' B' ' 322' ' ' ILE . 36.9 mt -60.2 -44.65 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.242 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -62.53 -36.2 81.83 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.711 0.404 . . . . 0.0 111.416 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 72.6 m -71.8 -43.79 65.07 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.991 0.359 . . . . 0.0 110.183 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 71.4 t -62.47 -41.41 91.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.95 -36.32 84.0 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 303' ' ' ASP . . . . . 0.4 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 44.9 t0 -69.91 -27.97 65.23 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -85.33 -25.38 27.18 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -96.28 -23.86 16.48 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 178.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 306' ' ' LYS . . . . . 0.4 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.6 ptpt -66.93 -18.69 65.5 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 -177.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -72.3 -20.41 61.51 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 117.731 0.241 . . . . 0.0 111.612 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.8 mm -87.27 -45.73 16.22 Favored 'Isoleucine or valine' 0 C--N 1.338 0.089 0 CA-C-N 117.677 0.217 . . . . 0.0 110.535 175.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.23 167.38 37.5 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 83.9 mt -68.5 121.79 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 120.834 0.349 . . . . 0.0 110.539 -175.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 89.1 mt -74.37 138.11 21.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 173.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 312' ' ' LYS . . . . . 0.656 ' HE3' ' SD ' ' B' ' 321' ' ' MET . 25.4 ttpt -74.02 132.26 42.19 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -178.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 1.8 m -94.95 140.51 29.85 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -70.48 133.5 46.87 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -89.55 -5.39 57.28 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 178.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -105.8 -18.63 14.0 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 122.833 0.453 . . . . 0.0 110.542 -176.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 6.5 p -129.53 -25.59 2.62 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -174.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 84.23 -11.79 56.8 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 119.743 -0.476 . . . . 0.0 112.422 174.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -83.08 157.3 66.2 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 117.912 0.856 . . . . 0.0 109.243 175.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.28 156.16 66.73 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 121.949 1.766 . . . . 0.0 109.921 178.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 321' ' ' MET . . . . . 0.656 ' SD ' ' HE3' ' B' ' 312' ' ' LYS . 33.9 mtt -72.61 92.51 1.52 Allowed 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 120.952 0.406 . . . . 0.0 111.656 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 322' ' ' ILE . . . . . 0.564 ' HB ' HG23 ' B' ' 298' ' ' ILE . 4.2 mp -139.73 138.51 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 171.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -131.36 105.93 7.94 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 176.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -75.39 153.58 37.64 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.812 0.845 . . . . 0.0 109.102 177.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -115.67 148.0 40.2 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -136.66 146.34 45.85 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.666 0.787 . . . . 0.0 112.82 -175.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -73.35 130.82 40.99 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 23.0 mtp-105 -84.64 -7.7 59.14 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 119.674 -0.203 . . . . 0.0 111.098 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -103.57 -13.75 16.44 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.534 0.334 . . . . 0.0 111.567 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 6.6 p -136.34 -19.23 1.46 Allowed 'General case' 0 C--O 1.233 0.23 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 77.98 4.27 85.67 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 119.699 -0.501 . . . . 0.0 112.082 174.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 332' ' ' LYS . . . . . 0.618 ' HE2' ' HA ' ' B' ' 332' ' ' LYS . 7.9 mmpt? -86.32 154.22 21.39 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 117.821 0.811 . . . . 0.0 109.045 177.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 41.5 mt -70.54 139.43 51.54 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.838 0.351 . . . . 0.0 110.342 -177.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -77.59 -16.65 58.48 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 123.249 0.62 . . . . 0.0 110.76 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 77.81 6.37 87.06 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -174.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -102.76 152.5 21.17 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.034 0.534 . . . . 0.0 110.162 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -164.66 161.38 20.79 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 116.698 -0.228 . . . . 0.0 110.966 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 5.3 p -109.04 155.06 21.37 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 169.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 33.7 t -137.64 128.39 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.043 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 171.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 340' ' ' SER . . . . . 0.411 ' HB3' ' SD ' ' B' ' 321' ' ' MET . 8.2 t -104.0 146.92 28.0 Favored 'General case' 0 C--O 1.228 -0.064 0 CA-C-N 117.975 0.352 . . . . 0.0 110.689 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -112.71 158.46 20.03 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -77.17 -17.3 58.66 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -143.66 146.83 36.72 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 344' ' ' PRO . . . . . 0.479 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 41.0 Cg_endo -70.61 -31.87 16.03 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.329 2.686 . . . . 0.0 114.587 -177.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 345' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 80.8 Cg_endo -73.9 -22.5 17.35 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 CA-C-N 121.117 1.435 . . . . 0.0 110.123 -177.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 66.1 m -72.25 -35.1 68.71 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 175.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -68.76 -39.95 80.01 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 175.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -64.81 -42.09 95.27 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.11 -34.89 77.22 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 122.237 -0.289 . . . . 0.0 110.687 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.05 -36.13 83.37 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 67.3 mt -70.92 -50.78 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 C-N-CA 120.626 -0.43 . . . . 0.0 109.873 175.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -54.49 -30.14 52.41 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 55.8 t-105 -97.8 -56.74 2.41 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -177.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -75.83 -29.84 58.77 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -172.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -56.29 110.09 0.71 Allowed 'General case' 0 C--O 1.234 0.247 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.793 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 103.01 -2.83 47.92 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-O 119.647 -0.529 . . . . 0.0 112.234 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -84.44 -163.17 0.76 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 118.092 0.946 . . . . 0.0 110.364 176.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -129.75 152.91 48.73 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.056 0.455 . . . . 0.0 111.239 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -145.49 136.54 24.73 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.135 0.974 . . . . 0.0 112.352 178.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 12.5 t 55.19 17.69 2.11 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.888 0.375 . . . . 0.0 111.077 -174.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.23 22.56 40.77 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.995 -0.442 . . . . 0.0 111.995 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -132.15 142.73 46.1 Favored Pre-proline 0 N--CA 1.454 -0.257 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.48 135.73 31.87 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 123.059 2.506 . . . . 0.0 109.707 178.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 30.1 pt -122.93 170.4 13.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-O 121.025 0.441 . . . . 0.0 111.101 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 5.7 tmtm? -145.66 113.6 6.48 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 9.7 t -103.25 150.27 6.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.21 0.604 . . . . 0.0 112.444 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 28.5 t -162.94 176.11 10.5 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 177.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -74.66 133.52 42.11 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 175.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -98.95 177.88 5.12 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.027 0.531 . . . . 0.0 111.94 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 7.2 p -138.41 -158.91 0.9 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 126.028 1.731 . . . . 0.0 109.871 177.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 371' ' ' ARG . . . . . 0.439 ' HG2' ' C6 ' ' A' ' 15' ' ' ' C' . 64.1 mtt180 -120.78 76.89 1.24 Allowed 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.487 0.585 . . . . 0.0 111.829 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 64.2 mtt-85 -60.28 -19.66 55.8 Favored 'General case' 0 N--CA 1.458 -0.063 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 169.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.3 -12.13 5.18 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.471 0.708 . . . . 0.0 111.313 176.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -99.51 -12.09 20.47 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -177.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -139.72 -19.96 0.92 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 116.667 2.099 . . . . 0.0 116.667 -178.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -80.69 -5.19 56.67 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 177.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 33.8 mmm-85 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 117.441 -1.266 . . . . 0.0 110.387 179.672 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.589 0 N19-C1'-C2' 108.986 -2.759 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.451 0 O4'-C1'-N19 111.017 2.817 . 0.706 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.481 0 C5'-C4'-C3' 111.25 -2.834 . 0.72 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.755 0 N19-C1'-C2' 109.122 -2.674 . 0.781 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.695 0 N19-C1'-C2' 108.541 -3.037 . 0.712 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.531 0 N19-C1'-C2' 109.061 -2.712 . 0.774 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.717 0 O4'-C1'-N19 110.92 2.72 . 0.78 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.395 0 O4'-C1'-N19 110.896 2.696 . 0.747 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.762 0 C4'-C3'-C2' 99.871 -2.829 . 0.647 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.616 0 O4'-C1'-N19 110.947 2.747 . 0.624 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.559 0 O4'-C1'-N19 111.09 2.89 . 0.588 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.309 0 C5'-C4'-C3' 110.009 -3.661 . 0.214 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -1.987 1 O4'-C1'-N19 112.52 4.32 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.012 0 O4'-C1'-N19 110.595 2.395 . 0.629 6p . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ' C' . . . . . 0.439 ' C6 ' ' HG2' ' B' ' 371' ' ' ARG . . . . . . . . 0 P--O5' 1.621 2.806 0 C5'-C4'-C3' 110.77 -3.153 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.439 0 C5'-C4'-C3' 110.99 -3.007 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.19 0 N19-C1'-C2' 109.219 -2.613 . 0.621 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.395 0 O4'-C1'-N19 111.081 2.881 . 0.835 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.724 0 O4'-C1'-N19 111.102 2.902 . 0.819 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.374 0 O4'-C1'-N19 110.938 2.738 . 0.649 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.489 0 O4'-C1'-N19 110.461 2.261 . 0.748 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.673 0 C5'-C4'-C3' 111.341 -2.773 . 0.796 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.637 0 N19-C1'-C2' 109.789 -2.257 . 0.776 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.184 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 38.1 t -155.97 159.53 39.29 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.021 0.529 . . . . 0.0 109.993 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -67.16 157.9 32.57 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.819 0.448 . . . . 0.0 111.008 -179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 91.0 mtp -72.89 172.94 9.95 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.613 0.365 . . . . 0.0 110.578 178.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -65.22 -11.68 43.44 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -81.89 14.84 2.51 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.77 0.428 . . . . 0.0 111.307 175.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 46.1 t -62.14 -17.5 58.07 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.962 -0.461 . . . . 0.0 110.503 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -89.57 6.14 42.44 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 123.117 0.567 . . . . 0.0 112.422 177.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 -142.47 113.77 7.75 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.999 0.428 . . . . 0.0 110.072 -176.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.36 12.62 18.85 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.874 0.47 . . . . 0.0 111.466 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 31.3 m -109.62 145.37 36.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.074 0.464 . . . . 0.0 111.854 -176.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 34.2 pt -122.09 147.51 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.433 176.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -98.7 143.88 28.58 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 173.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 289' ' ' VAL . . . . . 0.581 HG11 HD13 ' B' ' 292' ' ' LEU . 59.7 t -129.17 132.33 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 122.646 0.379 . . . . 0.0 110.57 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -120.78 155.45 33.98 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 175.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 83.82 12.01 78.19 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 171.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 292' ' ' LEU . . . . . 0.581 HD13 HG11 ' B' ' 289' ' ' VAL . 4.4 tp -59.09 -51.39 70.25 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.581 0.752 . . . . 0.0 110.946 -171.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 144.8 164.45 10.6 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.449 -0.661 . . . . 0.0 111.449 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -93.45 -1.11 56.1 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.578 0.351 . . . . 0.0 111.36 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -128.86 13.12 6.31 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 5.1 m -68.77 162.67 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -174.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 20.2 p -130.53 158.42 40.0 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.429 175.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 298' ' ' ILE . . . . . 0.552 HG23 ' HB ' ' B' ' 322' ' ' ILE . 25.0 mt -60.26 -43.21 92.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.31 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -70.68 -30.2 66.73 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -177.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 72.0 m -72.98 -45.36 58.4 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 118.298 0.499 . . . . 0.0 109.943 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 74.3 t -62.03 -41.31 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 176.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.3 -36.78 85.23 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 303' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -70.58 -27.63 64.26 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -83.86 -26.52 29.39 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -178.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -96.55 -24.95 15.81 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 115.073 1.509 . . . . 0.0 115.073 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 306' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -66.75 -18.38 65.35 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -176.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -71.85 -19.97 61.88 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 111.486 0.18 . . . . 0.0 111.486 -178.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 5.3 mm -87.49 -45.9 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 175.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.9 167.88 38.17 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 178.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 87.9 mt -67.72 123.66 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 122.674 0.389 . . . . 0.0 110.581 -176.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 86.7 mt -77.36 137.29 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 173.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -72.91 142.29 47.87 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -178.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 1.8 m -98.44 142.09 30.5 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -67.09 144.14 56.28 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 174.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -84.74 -19.93 31.89 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.796 -0.184 . . . . 0.0 111.059 -177.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -109.13 -43.88 4.07 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -174.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 23.7 p -86.98 -22.3 25.64 Favored 'General case' 0 N--CA 1.46 0.043 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -177.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 75.96 -10.28 14.96 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 123.294 0.473 . . . . 0.0 112.08 174.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -79.7 160.14 70.09 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 117.769 0.784 . . . . 0.0 109.268 174.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -67.06 154.24 75.15 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 121.593 1.529 . . . . 0.0 109.353 176.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 321' ' ' MET . . . . . 0.465 ' C ' HD12 ' B' ' 322' ' ' ILE . 34.9 mtt -70.97 85.74 0.7 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.84 0.353 . . . . 0.0 111.39 -177.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 322' ' ' ILE . . . . . 0.552 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.1 mp -129.84 137.04 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 170.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -130.45 107.23 9.08 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.839 176.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 23.7 mt -78.13 151.52 33.27 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 123.947 0.78 . . . . 0.0 109.249 176.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -115.9 151.02 36.15 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.52 142.48 43.48 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -174.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -70.93 131.9 44.42 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' B' ' 328' ' ' ARG . 30.2 mtp180 -87.42 -6.26 58.5 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.12 0.168 . . . . 0.0 110.776 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -104.55 -13.84 15.87 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.844 0.458 . . . . 0.0 111.563 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 3.3 p -134.54 -20.19 1.83 Allowed 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 79.18 2.17 86.83 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 112.251 -0.34 . . . . 0.0 112.251 175.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt -88.42 156.76 18.95 Favored 'General case' 0 C--N 1.337 0.034 0 CA-C-N 117.482 0.641 . . . . 0.0 109.397 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 46.8 mt -70.0 143.47 52.58 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.855 0.36 . . . . 0.0 110.696 -176.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -73.7 -15.65 61.22 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 123.562 0.745 . . . . 0.0 111.145 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.95 20.64 75.7 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.154 -1.179 . . . . 0.0 110.154 -174.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -129.94 144.48 51.34 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.177 0.591 . . . . 0.0 110.181 -176.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -156.39 160.26 39.49 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.858 174.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 1.2 p -102.0 155.95 17.84 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 170.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 19.0 t -134.75 129.5 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 123.85 0.86 . . . . 0.0 108.989 169.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 340' ' ' SER . . . . . 0.424 ' HB3' ' CB ' ' B' ' 321' ' ' MET . 45.5 t -109.47 140.75 42.84 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.942 0.401 . . . . 0.0 110.957 -178.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -106.08 158.02 17.11 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -73.62 -20.43 60.59 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -140.81 148.03 50.92 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 123.514 0.726 . . . . 0.0 109.12 -178.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 344' ' ' PRO . . . . . 0.463 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 40.4 Cg_endo -70.46 -33.32 14.14 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.43 2.753 . . . . 0.0 114.245 -176.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 345' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 83.6 Cg_endo -73.82 -22.47 17.58 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 CA-C-N 121.074 1.419 . . . . 0.0 110.057 -176.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 67.1 m -71.66 -36.47 70.67 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 176.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -69.08 -38.21 78.87 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -65.8 -41.75 91.53 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -69.47 -33.61 73.15 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 110.629 -0.138 . . . . 0.0 110.629 177.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.83 -37.19 86.79 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 68.5 mt -68.1 -53.62 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.673 174.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -54.87 -28.48 50.47 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -178.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 53.6 t-105 -96.67 -54.66 3.15 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -77.73 -27.89 50.66 Favored 'General case' 0 CA--C 1.522 -0.119 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -174.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -52.28 109.3 0.37 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.889 0.313 . . . . 0.0 111.194 178.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 100.29 -1.25 56.02 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-O 119.695 -0.503 . . . . 0.0 112.548 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -84.85 -164.42 0.98 Allowed 'General case' 0 C--O 1.228 -0.065 0 CA-C-N 117.939 0.869 . . . . 0.0 110.434 176.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -128.46 152.69 47.94 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.919 0.39 . . . . 0.0 110.739 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -142.2 134.71 28.06 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.271 1.028 . . . . 0.0 112.252 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 64.5 m 52.77 20.84 1.71 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.79 0.436 . . . . 0.0 111.975 -175.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.93 21.73 41.49 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 112.036 -0.426 . . . . 0.0 112.036 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -131.67 141.45 41.68 Favored Pre-proline 0 N--CA 1.456 -0.126 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.12 136.43 34.68 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.84 2.36 . . . . 0.0 109.464 177.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 32.4 pt -124.34 168.91 16.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-O 121.222 0.534 . . . . 0.0 110.789 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 22.9 tptp -142.89 112.3 6.74 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.035 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 8.6 t -101.96 148.55 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 29.3 t -162.38 175.27 11.72 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 177.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -72.19 130.97 42.1 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 176.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -80.83 175.45 10.67 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.082 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 61.1 p -142.16 -130.95 0.1 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 125.543 1.537 . . . . 0.0 107.913 -178.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -122.28 -33.5 3.47 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.039 0.381 . . . . 0.0 111.492 170.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 60.76 -39.17 0.1 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.506 1.522 . . . . 0.0 113.462 -174.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -63.78 -24.47 67.77 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 123.201 0.6 . . . . 0.0 109.626 176.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 19.6 p30 -62.04 -18.8 61.76 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 112.359 0.504 . . . . 0.0 112.359 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -78.73 -12.7 60.03 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 174.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -129.06 -16.67 4.02 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -173.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 . . . . . 0 C--O 1.252 1.201 0 CA-C-O 117.28 -1.343 . . . . 0.0 110.689 179.259 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.456 0 N19-C1'-C2' 109.724 -2.298 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.412 0 C5'-C4'-C3' 111.904 -2.398 . 0.624 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ' C' . . . . . 0.418 " H2'" ' C8 ' ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.628 0 O4'-C1'-N19 110.84 2.64 . 0.673 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . 0.418 ' C8 ' " H2'" ' A' ' 3' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.423 -2.516 0 N19-C1'-C2' 108.755 -2.903 . 0.72 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.425 0 N19-C1'-C2' 108.489 -3.069 . 0.785 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.311 0 N19-C1'-C2' 109.287 -2.571 . 0.752 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.72 0 O4'-C1'-N19 111.192 2.992 . 0.784 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.567 0 O4'-C1'-N19 110.808 2.608 . 0.736 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.701 0 C4'-C3'-C2' 100.06 -2.64 . 0.655 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.896 0 C4'-C3'-C2' 100.444 -2.256 . 0.546 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.506 0 C4'-C3'-C2' 100.07 -2.63 . 0.378 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.231 0 O4'-C1'-N19 112.164 3.964 . 0.078 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.693 0 C5'-C4'-C3' 110.083 -3.611 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.988 1 C5'-C4'-C3' 108.764 -4.491 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.488 0 O4'-C1'-N19 111.861 3.661 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.661 0 O4'-C1'-N19 110.957 2.757 . 0.442 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.438 0 N19-C1'-C2' 109.289 -2.569 . 0.591 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.333 0 O4'-C1'-N19 111.541 3.341 . 0.756 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ' U' . . . . . 0.443 " H2'" ' C6 ' ' A' ' 20' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.811 0 C5'-C4'-C3' 111.495 -2.67 . 0.8 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ' U' . . . . . 0.443 ' C6 ' " H2'" ' A' ' 19' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.424 -2.425 0 O4'-C1'-N19 110.842 2.642 . 0.654 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.748 0 C5'-C4'-C3' 112.196 -2.203 . 0.741 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.594 0 C5'-C4'-C3' 111.509 -2.661 . 0.795 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.63 0 N19-C1'-C2' 109.677 -2.327 . 0.767 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.253 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 69.3 m -67.54 158.59 31.63 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.641 0.376 . . . . 0.0 110.85 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 22.2 t-80 -68.43 143.36 55.08 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 122.699 0.4 . . . . 0.0 110.546 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 91.4 mtp -147.65 156.63 42.98 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.205 0.602 . . . . 0.0 110.111 178.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 60.95 150.46 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -86.7 25.79 1.21 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.465 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 44.0 t -64.38 -12.36 41.86 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.824 0.449 . . . . 0.0 111.278 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 34.1 p30 -134.25 18.83 3.7 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.28 0.632 . . . . 0.0 111.198 178.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -114.25 113.42 24.59 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -113.25 -2.41 14.07 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.222 -177.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 89.5 m -101.06 137.99 38.7 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.978 0.418 . . . . 0.0 109.909 -174.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 45.9 pt -105.91 148.28 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 172.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -99.94 142.98 30.7 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 171.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 14.6 t -133.77 141.51 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -128.92 154.6 46.39 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 122.873 0.469 . . . . 0.0 109.738 173.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.7 12.35 66.8 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-O 119.932 -0.371 . . . . 0.0 112.497 169.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 85.0 mt -57.14 -51.05 70.87 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 117.677 0.739 . . . . 0.0 110.202 -176.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 143.38 169.6 12.67 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -95.94 3.93 53.14 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 122.621 -0.341 . . . . 0.0 111.585 -178.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -128.86 11.55 6.12 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.8 m -76.03 165.48 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -173.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 29.9 p -130.99 157.74 42.16 Favored 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 123.615 0.766 . . . . 0.0 111.623 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 298' ' ' ILE . . . . . 0.484 HG23 ' HB ' ' B' ' 322' ' ' ILE . 34.4 mt -62.06 -42.34 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.154 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.45 -36.41 84.09 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.401 0.28 . . . . 0.0 111.737 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 43.6 t -72.44 -44.04 62.93 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 117.668 0.213 . . . . 0.0 110.48 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 76.9 t -61.61 -41.95 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.67 -35.25 80.44 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 303' ' ' ASP . . . . . 0.415 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.4 t0 -70.68 -29.07 65.29 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 304' ' ' TYR . . . . . 0.4 ' CE2' ' CD1' ' B' ' 354' ' ' PHE . 63.2 t80 -82.61 -25.77 32.88 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -96.88 -24.23 15.97 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 306' ' ' LYS . . . . . 0.415 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.6 ptpt -66.86 -18.77 65.54 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -177.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -71.9 -19.46 61.92 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.5 mm -88.05 -46.73 15.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 120.419 0.152 . . . . 0.0 110.651 175.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -161.73 169.17 37.11 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 90.2 mt -69.18 122.36 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 120.767 0.318 . . . . 0.0 110.261 -175.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 67.7 mt -77.63 137.26 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 175.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -69.98 151.0 46.09 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 2.6 m -118.97 139.86 50.97 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -71.79 146.61 47.94 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -90.84 -9.01 47.96 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 122.491 0.316 . . . . 0.0 111.532 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 316' ' ' LYS . . . . . 0.453 ' HA ' ' HE2' ' B' ' 316' ' ' LYS . 7.0 mmpt? -108.87 -46.11 3.68 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 122.325 0.25 . . . . 0.0 110.888 -176.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 18.0 p -89.63 -25.76 21.11 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -177.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 77.14 -6.47 42.69 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 123.273 0.464 . . . . 0.0 112.38 175.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -87.01 160.89 48.43 Favored Pre-proline 0 C--O 1.233 0.196 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 176.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.35 150.28 87.33 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 N-CA-C 108.639 -1.331 . . . . 0.0 108.639 176.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 321' ' ' MET . . . . . 0.42 ' C ' HD12 ' B' ' 322' ' ' ILE . 88.0 mtp -78.02 85.91 4.22 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.452 0.644 . . . . 0.0 111.796 -170.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 322' ' ' ILE . . . . . 0.484 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.1 mp -124.71 143.28 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 174.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -129.66 99.03 5.0 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 48.8 mt -75.56 154.24 36.91 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 176.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 325' ' ' TYR . . . . . 0.403 ' CZ ' H5'' ' A' ' 14' ' ' ' U' . 83.5 m-85 -117.54 148.41 41.9 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 175.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 326' ' ' THR . . . . . 0.406 HG23 ' O ' ' B' ' 332' ' ' LYS . 7.6 m -134.99 148.84 50.08 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.113 0.565 . . . . 0.0 111.986 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -75.73 121.29 22.32 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 177.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -76.95 2.86 13.56 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 122.389 -0.194 . . . . 0.0 111.399 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -107.02 -13.13 15.27 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 122.733 0.413 . . . . 0.0 111.623 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 2.8 p -135.01 -27.68 1.23 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 78.2 13.82 82.9 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-O 119.834 -0.426 . . . . 0.0 112.167 172.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 332' ' ' LYS . . . . . 0.406 ' O ' HG23 ' B' ' 326' ' ' THR . 25.9 mtpp -73.56 -114.33 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.295 0.638 . . . . 0.0 110.849 178.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 6.1 mt -158.89 138.79 11.98 Favored 'General case' 0 C--N 1.334 -0.077 0 C-N-CA 124.766 1.226 . . . . 0.0 107.748 171.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -77.68 -19.22 55.7 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 122.115 0.166 . . . . 0.0 111.134 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.17 5.78 81.75 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -175.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -105.76 150.32 25.64 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 117.27 0.535 . . . . 0.0 109.884 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -163.98 163.21 23.53 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.112 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 60.5 p -111.76 155.67 23.15 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 169.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 16.4 t -135.8 120.53 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 O-C-N 123.415 0.447 . . . . 0.0 110.542 173.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 14.8 t -88.42 134.81 33.74 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -103.04 152.54 21.24 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 176.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -65.8 -33.66 76.37 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -178.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -130.36 150.86 77.4 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 344' ' ' PRO . . . . . 0.468 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 40.5 Cg_endo -70.42 -31.99 16.62 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.604 2.869 . . . . 0.0 114.425 -177.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 345' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 76.9 Cg_endo -73.75 -21.08 19.32 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 CA-C-N 121.078 1.421 . . . . 0.0 110.028 -176.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 66.9 m -72.6 -36.09 68.04 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 175.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -67.64 -38.57 84.03 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 174.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -65.19 -42.18 93.86 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.58 -35.55 77.51 Favored 'General case' 0 N--CA 1.458 -0.035 0 O-C-N 122.446 -0.159 . . . . 0.0 110.574 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -63.75 -37.68 88.26 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 63.1 mt -68.74 -51.62 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 120.379 -0.529 . . . . 0.0 109.634 175.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -55.92 -28.32 56.27 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 53.3 t-105 -97.16 -54.77 3.06 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 354' ' ' PHE . . . . . 0.4 ' CD1' ' CE2' ' B' ' 304' ' ' TYR . 51.7 m-85 -76.95 -27.77 54.95 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -173.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -50.38 109.23 0.28 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 117.993 0.361 . . . . 0.0 111.858 178.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 98.8 -0.43 57.81 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 119.537 -0.591 . . . . 0.0 112.654 175.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -83.55 -164.87 0.97 Allowed 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.136 0.968 . . . . 0.0 110.073 176.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -128.19 152.91 47.49 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 121.084 0.469 . . . . 0.0 110.727 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -144.9 136.27 25.22 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.331 1.053 . . . . 0.0 112.585 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 17.4 t 55.24 17.94 2.26 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 120.794 0.331 . . . . 0.0 110.951 -175.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.89 22.85 40.72 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 112.013 -0.435 . . . . 0.0 112.013 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 41.9 m-20 -132.31 142.6 45.58 Favored Pre-proline 0 C--O 1.226 -0.165 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 -177.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.48 135.73 31.88 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.855 2.37 . . . . 0.0 109.54 178.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 31.9 pt -121.34 170.79 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.101 0 CA-C-O 121.265 0.555 . . . . 0.0 111.207 -177.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -143.18 109.42 5.32 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.747 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 11.3 t -99.45 148.89 5.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 C-N-CA 123.164 0.586 . . . . 0.0 111.952 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 84.7 p -163.47 177.14 9.1 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -76.83 129.4 36.19 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 174.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 369' ' ' ALA . . . . . 0.411 ' HA ' ' O2 ' ' A' ' 14' ' ' ' U' . . . -86.29 -178.72 6.54 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 11.2 t -149.73 -162.98 1.67 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.014 1.325 . . . . 0.0 109.645 175.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -108.7 70.23 0.74 Allowed 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.118 0.417 . . . . 0.0 111.54 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 55.7 mtt180 -68.71 -6.68 27.72 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 169.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.59 -31.01 71.76 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 123.494 0.718 . . . . 0.0 110.081 169.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -71.05 -1.03 10.81 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -174.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -78.65 -11.56 59.98 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -141.58 -9.25 0.95 Allowed 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 12.6 ptm85 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 117.638 -1.172 . . . . 0.0 110.583 -177.511 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.632 0 N19-C1'-C2' 109.402 -2.499 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.532 0 C5'-C4'-C3' 111.644 -2.57 . 0.668 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ' C' . . . . . 0.42 " H2'" ' C8 ' ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.606 0 N19-C1'-C2' 109.503 -2.436 . 0.77 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . 0.42 ' C8 ' " H2'" ' A' ' 3' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.423 -2.503 0 N19-C1'-C2' 109.061 -2.712 . 0.759 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.824 0 N19-C1'-C2' 108.509 -3.057 . 0.766 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.798 0 C4'-C3'-C2' 100.093 -2.607 . 0.802 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.718 0 C5'-C4'-C3' 111.416 -2.723 . 0.807 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ' U' . . . . . 0.432 " H2'" ' C8 ' ' A' ' 9' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.825 0 C4'-C3'-C2' 100.106 -2.594 . 0.749 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ' A' . . . . . 0.432 ' C8 ' " H2'" ' A' ' 8' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.424 -2.437 0 C4'-C3'-C2' 99.856 -2.844 . 0.634 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.621 0 O4'-C1'-N19 110.533 2.333 . 0.475 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.493 0 O4'-C1'-N19 111.023 2.823 . 0.217 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -1.981 0 C5'-C4'-C3' 109.576 -3.95 . 0.219 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.627 1 O4'-C1'-N19 112.641 4.441 . 0.01 2[ . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ' U' . . . . . 0.411 ' O2 ' ' HA ' ' B' ' 369' ' ' ALA . . . . . . . . 0 O4'--C4' 1.42 -2.762 0 O4'-C1'-N19 111.079 2.879 . 0.594 6p . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.618 2.522 0 O4'-C1'-N19 111.687 3.487 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.439 0 O4'-C1'-N19 111.226 3.026 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.314 0 N19-C1'-C2' 109.46 -2.462 . 0.72 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.648 0 O4'-C1'-N19 111.249 3.049 . 0.776 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ' U' . . . . . 0.407 " H2'" ' C6 ' ' A' ' 20' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.61 0 O4'-C1'-N19 111.253 3.053 . 0.823 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ' U' . . . . . 0.407 ' C6 ' " H2'" ' A' ' 19' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.598 0 O4'-C1'-N19 111.036 2.836 . 0.652 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.682 0 C5'-C4'-C3' 112.101 -2.266 . 0.735 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.638 0 C5'-C4'-C3' 111.785 -2.477 . 0.782 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.571 0 N19-C1'-C2' 109.573 -2.392 . 0.771 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.275 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 99.8 p -155.97 166.14 34.37 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.857 0.463 . . . . 0.0 110.231 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -153.91 150.97 28.91 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 97.6 mmm -139.39 159.02 43.13 Favored 'General case' 0 C--O 1.23 0.068 0 C-N-CA 123.255 0.622 . . . . 0.0 110.632 -178.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -66.1 -13.04 59.4 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -87.78 15.03 7.51 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.597 0.359 . . . . 0.0 111.702 178.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 42.9 t -63.09 -14.77 52.37 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.807 0.443 . . . . 0.0 111.025 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 26.7 p30 -134.07 15.28 3.87 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.291 0.636 . . . . 0.0 111.531 177.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -103.35 110.14 22.03 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -113.69 9.19 17.74 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.806 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 95.4 m -113.22 145.52 40.87 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.318 0.58 . . . . 0.0 110.708 -175.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 33.7 pt -119.85 148.77 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.436 -0.802 . . . . 0.0 108.846 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -101.65 143.87 31.07 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 173.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 12.1 t -127.25 139.87 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 CA-C-O 120.963 0.411 . . . . 0.0 111.302 177.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -125.58 154.1 42.73 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.601 0.76 . . . . 0.0 108.968 177.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 83.3 12.96 77.79 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 173.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 1.5 tp -52.69 -55.08 25.17 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.583 0.753 . . . . 0.0 110.707 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 142.11 172.24 13.48 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -101.45 2.6 39.48 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -128.7 16.77 6.38 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.814 0.446 . . . . 0.0 111.285 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 10.3 m -74.47 166.85 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -173.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 43.1 p -138.23 159.52 41.84 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.729 0.811 . . . . 0.0 110.762 177.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 298' ' ' ILE . . . . . 0.549 HG23 ' HB ' ' B' ' 322' ' ' ILE . 45.3 mt -62.65 -44.13 99.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.16 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -64.39 -35.52 81.18 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.443 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 44.8 t -71.56 -49.97 35.51 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 118.036 0.38 . . . . 0.0 110.741 -177.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 7.5 p -65.44 -33.44 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.681 177.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -65.97 -32.62 74.22 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.579 176.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 303' ' ' ASP . . . . . 0.41 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 44.9 t0 -75.39 -27.25 59.01 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -178.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -85.26 -23.88 28.01 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -96.93 -24.18 15.96 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 178.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 306' ' ' LYS . . . . . 0.41 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.7 ptpt -66.4 -17.7 64.93 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -177.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -72.45 -20.73 61.35 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.6 mm -86.37 -45.94 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 CA-C-N 117.873 0.306 . . . . 0.0 110.226 175.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -162.4 167.0 36.78 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 79.2 mt -69.19 120.42 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 120.725 0.298 . . . . 0.0 110.683 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 88.6 mt -73.97 134.85 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 172.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -70.9 133.3 46.33 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 1.4 m -88.79 139.53 30.36 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 177.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -66.64 128.63 36.97 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 175.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -85.66 -5.03 59.32 Favored 'General case' 0 C--N 1.334 -0.104 0 O-C-N 122.28 -0.263 . . . . 0.0 110.391 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -107.14 -20.98 13.13 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 122.878 0.471 . . . . 0.0 110.769 -176.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 12.2 p -128.09 -23.44 3.31 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -174.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 84.65 -10.37 62.33 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 112.053 -0.419 . . . . 0.0 112.053 173.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -83.01 157.41 66.24 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 117.956 0.878 . . . . 0.0 109.097 174.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.9 155.67 68.88 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.023 1.815 . . . . 0.0 110.054 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 321' ' ' MET . . . . . . . . . . . . . 37.4 mtt -72.04 94.15 1.47 Allowed 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 120.951 0.405 . . . . 0.0 111.793 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 322' ' ' ILE . . . . . 0.549 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.5 mp -141.61 142.27 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 173.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -132.3 108.83 9.47 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 173.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 38.0 mt -77.64 153.2 33.38 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 175.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -120.86 143.3 48.98 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 175.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.7 142.59 51.43 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -174.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -70.38 126.84 30.78 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -85.92 -5.9 59.16 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 117.018 -0.083 . . . . 0.0 111.137 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -99.66 -13.88 19.17 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.521 0.328 . . . . 0.0 111.655 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 4.0 p -138.31 -23.89 0.99 Allowed 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -178.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 78.6 11.56 85.14 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.649 -0.581 . . . . 0.0 111.649 174.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -73.44 -100.62 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 117.538 0.669 . . . . 0.0 110.724 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 5.7 mt -165.2 146.89 7.66 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.574 1.55 . . . . 0.0 107.697 173.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -77.15 -18.23 58.01 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 122.274 0.229 . . . . 0.0 110.568 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 74.82 22.23 77.29 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 -174.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -133.06 146.55 51.79 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 117.236 0.518 . . . . 0.0 110.511 -178.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -157.76 155.71 30.33 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.133 174.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 10.9 p -95.7 152.6 18.32 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 170.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 40.9 t -135.63 129.96 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 170.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 9.0 t -110.47 143.38 40.88 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-N 117.888 0.313 . . . . 0.0 111.029 -177.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -108.4 160.23 16.04 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -176.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -72.42 -28.57 63.05 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -135.54 150.11 71.25 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -177.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 344' ' ' PRO . . . . . 0.47 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 39.5 Cg_endo -69.69 -32.71 18.34 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.457 2.772 . . . . 0.0 114.487 -177.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 345' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 96.1 Cg_endo -73.74 -20.88 19.55 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 CA-C-N 121.381 1.529 . . . . 0.0 110.324 -177.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 66.3 m -73.11 -37.48 66.67 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 175.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.13 -38.47 88.25 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 173.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -63.19 -46.09 88.69 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -66.74 -34.09 77.08 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 110.584 -0.154 . . . . 0.0 110.584 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.44 -35.96 82.49 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 64.8 mt -70.71 -51.71 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 175.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -55.17 -28.76 55.19 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 57.5 t-105 -98.04 -55.9 2.65 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -76.16 -30.66 58.2 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -173.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -55.21 110.73 0.72 Allowed 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 118.289 0.495 . . . . 0.0 110.777 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 103.56 -4.42 47.07 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.516 -0.602 . . . . 0.0 112.308 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -84.22 -163.76 0.84 Allowed 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 118.077 0.938 . . . . 0.0 110.165 176.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -127.82 150.67 49.73 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-O 120.95 0.405 . . . . 0.0 110.853 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -141.67 137.35 31.71 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.345 1.058 . . . . 0.0 112.487 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 20.5 t 53.91 18.96 1.78 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.563 0.345 . . . . 0.0 111.183 -175.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.4 21.96 42.56 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 112.056 -0.418 . . . . 0.0 112.056 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 41.0 m-20 -131.91 141.7 42.49 Favored Pre-proline 0 N--CA 1.453 -0.285 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -177.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -68.95 133.5 27.24 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 122.611 2.208 . . . . 0.0 109.403 177.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 29.8 pt -120.47 170.24 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.146 0 CA-C-O 121.336 0.588 . . . . 0.0 111.107 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -144.51 111.24 5.72 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 10.7 t -99.98 149.25 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.305 0.642 . . . . 0.0 111.966 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 23.2 t -162.46 172.72 15.08 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -69.57 128.72 37.46 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 176.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -85.11 179.33 7.28 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.905 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 10.9 t -146.53 -152.57 0.44 Allowed 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.654 1.181 . . . . 0.0 108.054 174.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 371' ' ' ARG . . . . . 0.442 ' HD3' ' C6 ' ' A' ' 15' ' ' ' C' . 54.5 mmm-85 -123.69 95.33 4.54 Favored 'General case' 0 C--N 1.337 0.062 0 CA-C-N 118.691 0.678 . . . . 0.0 110.728 174.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 27.3 mtp85 -68.98 -12.78 61.99 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 120.615 0.245 . . . . 0.0 110.401 170.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.14 -25.05 60.96 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 122.881 0.472 . . . . 0.0 110.621 176.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -63.27 -18.56 63.71 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 122.838 0.455 . . . . 0.0 112.177 -178.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -76.84 -11.79 59.88 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -131.16 -17.76 3.01 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -175.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.235 0 CA-C-O 116.781 -1.58 . . . . 0.0 111.224 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.494 0 N19-C1'-C2' 108.686 -2.946 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.509 0 C5'-C4'-C3' 111.498 -2.668 . 0.704 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.537 0 N19-C1'-C2' 108.822 -2.861 . 0.659 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.414 0 N19-C1'-C2' 108.926 -2.796 . 0.823 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.627 0 N19-C1'-C2' 108.793 -2.879 . 0.653 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.409 0 N19-C1'-C2' 108.765 -2.897 . 0.751 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.517 0 O4'-C1'-N19 111.016 2.816 . 0.805 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.423 0 O4'-C1'-N19 111.141 2.941 . 0.754 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.658 0 C4'-C3'-C2' 99.917 -2.783 . 0.657 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.571 0 O4'-C1'-N19 111.005 2.805 . 0.631 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.435 0 O4'-C1'-N19 110.983 2.783 . 0.633 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.219 1 O4'-C1'-N19 112.344 4.144 . 0.038 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.489 0 C5'-C4'-C3' 110.233 -3.512 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.631 1 C5'-C4'-C3' 109.491 -4.006 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ' C' . . . . . 0.442 ' C6 ' ' HD3' ' B' ' 371' ' ' ARG . . . . . . . . 0 O4'--C4' 1.415 -3.132 0 C5'-C4'-C3' 111.525 -2.65 . 0.128 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.454 0 O4'-C1'-N19 111.076 2.876 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.616 2.348 0 N19-C1'-C2' 108.936 -2.79 . 0.756 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.723 0 O4'-C1'-N19 111.015 2.815 . 0.839 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.724 0 O4'-C1'-N19 110.937 2.737 . 0.781 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.621 0 O4'-C1'-N19 110.791 2.591 . 0.65 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.761 0 C4'-C3'-C2' 100.142 -2.558 . 0.734 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.638 0 O4'-C1'-N19 110.72 2.52 . 0.791 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.71 0 N19-C1'-C2' 109.702 -2.311 . 0.809 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.344 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 67.9 m -72.08 -9.39 58.33 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 122.244 0.218 . . . . 0.0 111.422 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 54.1 m80 -142.03 167.55 21.85 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.192 0.597 . . . . 0.0 109.536 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 91.2 mtp -67.3 159.69 28.71 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.607 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -69.55 -7.02 34.73 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 21.5 m-20 -78.63 23.59 0.31 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.103 0.561 . . . . 0.0 111.21 178.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 90.1 p -63.38 -17.77 62.98 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.708 0.403 . . . . 0.0 111.171 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 29.3 p30 -98.86 7.53 45.94 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.372 0.669 . . . . 0.0 112.326 177.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -130.45 110.19 11.28 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 120.844 0.354 . . . . 0.0 110.067 -177.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.79 2.84 14.5 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.213 0.605 . . . . 0.0 112.392 -178.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 91.7 m -105.11 142.24 35.24 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.054 0.454 . . . . 0.0 111.046 -174.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 30.5 pt -115.31 149.46 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -99.87 146.2 26.91 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 173.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 289' ' ' VAL . . . . . 0.562 ' CG1' HD13 ' B' ' 292' ' ' LEU . 60.3 t -131.26 133.75 61.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.532 -178.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -123.65 153.55 40.61 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 83.31 13.11 77.42 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 172.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 292' ' ' LEU . . . . . 0.562 HD13 ' CG1' ' B' ' 289' ' ' VAL . 4.4 tp -59.07 -50.7 73.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 123.763 0.825 . . . . 0.0 111.027 -169.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 143.89 165.65 10.97 Favored Glycine 0 C--N 1.337 0.637 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 177.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -96.82 2.13 51.47 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.347 0.259 . . . . 0.0 111.282 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -128.47 11.86 6.37 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.868 0.467 . . . . 0.0 111.699 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 4.7 m -68.19 162.63 3.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -174.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 29.8 p -134.33 159.72 40.13 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 123.596 0.758 . . . . 0.0 110.697 176.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 298' ' ' ILE . . . . . 0.512 HG23 ' HB ' ' B' ' 322' ' ' ILE . 33.9 mt -61.33 -41.82 91.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.133 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -66.52 -36.05 81.75 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 122.554 0.342 . . . . 0.0 111.709 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 75.5 m -72.24 -46.08 57.51 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 118.175 0.443 . . . . 0.0 110.319 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 69.9 t -60.56 -42.65 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.32 -36.31 83.7 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 122.201 -0.312 . . . . 0.0 110.203 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 303' ' ' ASP . . . . . 0.423 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.1 t0 -69.88 -28.18 65.43 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -84.35 -25.84 28.88 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -96.1 -24.04 16.49 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 306' ' ' LYS . . . . . 0.423 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.6 ptpt -67.42 -18.68 65.2 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -176.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -72.57 -21.14 61.19 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -177.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.2 mm -85.94 -44.96 17.0 Favored 'Isoleucine or valine' 0 C--O 1.23 0.072 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 175.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.87 165.5 37.01 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 85.2 mt -66.04 123.49 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 120.854 0.359 . . . . 0.0 110.26 -177.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 85.8 mt -77.08 135.79 25.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 173.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -70.16 135.35 49.03 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 1.8 m -97.3 144.41 27.11 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -77.4 131.15 37.89 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 174.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -84.56 -10.09 57.72 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 117.326 0.057 . . . . 0.0 111.017 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -102.81 -19.08 14.84 Favored 'General case' 0 C--O 1.227 -0.079 0 C-N-CA 122.516 0.326 . . . . 0.0 110.714 -174.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 10.4 p -127.23 -22.81 3.66 Favored 'General case' 0 N--CA 1.462 0.13 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 -177.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 81.67 -9.61 54.99 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-O 119.899 -0.39 . . . . 0.0 112.361 173.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -85.78 156.87 58.26 Favored Pre-proline 0 N--CA 1.453 -0.323 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.66 156.48 65.37 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.047 1.831 . . . . 0.0 109.874 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 321' ' ' MET . . . . . 0.47 ' C ' HD12 ' B' ' 322' ' ' ILE . 33.6 mtt -72.51 86.23 1.16 Allowed 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -177.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 322' ' ' ILE . . . . . 0.512 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.2 mp -130.29 138.73 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 170.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -129.8 105.15 7.82 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 174.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 31.2 mt -77.82 153.38 32.83 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 123.952 0.783 . . . . 0.0 109.085 177.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -116.39 147.95 41.14 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -135.1 145.01 47.48 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -177.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -74.16 133.17 42.75 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 46.1 mtp85 -86.42 -6.41 58.93 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 122.22 0.208 . . . . 0.0 111.183 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -101.81 -13.19 17.8 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.722 0.409 . . . . 0.0 111.887 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 26.4 p -138.44 -22.04 1.02 Allowed 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 80.25 3.48 89.75 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 111.549 -0.621 . . . . 0.0 111.549 177.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -84.1 154.72 23.01 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 117.797 0.798 . . . . 0.0 109.189 176.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 48.3 mt -71.3 141.66 50.49 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -177.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -74.81 -15.53 60.74 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 123.343 0.657 . . . . 0.0 111.639 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 78.02 20.81 72.33 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -175.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -129.94 147.67 51.72 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 122.948 0.499 . . . . 0.0 110.252 -178.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -156.38 162.04 40.08 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 120.759 0.314 . . . . 0.0 110.799 174.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 19.1 p -104.79 154.4 20.07 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 169.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 17.3 t -135.47 132.11 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 123.454 0.702 . . . . 0.0 109.345 171.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 340' ' ' SER . . . . . 0.431 ' HB3' ' CB ' ' B' ' 321' ' ' MET . 46.2 t -110.82 136.46 49.84 Favored 'General case' 0 C--O 1.227 -0.109 0 CA-C-N 118.002 0.365 . . . . 0.0 111.101 -178.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -100.5 159.55 15.06 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -178.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -71.91 -30.95 65.9 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -130.04 148.99 71.9 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 344' ' ' PRO . . . . . 0.462 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 38.0 Cg_endo -69.96 -33.56 15.61 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.361 2.708 . . . . 0.0 114.636 -177.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 345' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 87.5 Cg_endo -73.5 -23.04 17.69 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 CA-C-N 121.083 1.423 . . . . 0.0 110.016 -177.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 58.8 m -71.95 -34.83 69.31 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 175.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.85 -41.07 87.96 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 175.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 40.2 tptt -69.53 -36.14 76.11 Favored 'General case' 0 C--N 1.339 0.121 0 O-C-N 122.176 -0.328 . . . . 0.0 110.706 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -65.75 -35.49 80.87 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 175.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -66.26 -37.49 85.59 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 72.2 mt -67.6 -53.62 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.772 175.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -56.85 -27.47 60.32 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -177.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -96.7 -55.15 2.99 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -76.5 -30.93 57.41 Favored 'General case' 0 CA--C 1.522 -0.117 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -173.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -54.53 110.26 0.61 Allowed 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.126 0.421 . . . . 0.0 110.876 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 104.31 -3.96 43.98 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 119.609 -0.551 . . . . 0.0 112.423 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -84.9 -164.32 0.96 Allowed 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 117.814 0.807 . . . . 0.0 110.373 176.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 42.0 mp0 -128.68 152.6 48.2 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.927 0.394 . . . . 0.0 110.858 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -143.91 134.83 25.32 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.195 0.998 . . . . 0.0 112.329 178.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 58.8 m 52.59 20.73 1.59 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -174.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.63 22.2 40.81 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 112.099 -0.4 . . . . 0.0 112.099 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 50.9 m-20 -132.21 141.83 42.82 Favored Pre-proline 0 N--CA 1.456 -0.174 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.62 137.91 36.99 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 122.713 2.275 . . . . 0.0 109.472 177.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 35.3 pt -125.87 168.98 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 CA-C-O 121.035 0.445 . . . . 0.0 110.667 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -144.68 113.35 6.7 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 10.7 t -103.16 150.06 6.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 123.165 0.586 . . . . 0.0 112.097 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 31.8 t -161.4 173.16 15.32 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -74.04 130.81 40.56 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 176.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -95.66 -177.17 3.97 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.062 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 12.5 t -153.23 -174.34 4.91 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.825 1.25 . . . . 0.0 108.308 174.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 69.4 mtp85 -97.11 86.59 3.99 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 118.755 0.707 . . . . 0.0 111.435 175.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 372' ' ' ARG . . . . . 0.457 ' HA ' ' CZ ' ' B' ' 375' ' ' PHE . 19.9 ttt180 -67.9 -14.42 62.95 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 169.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -66.74 -4.62 9.45 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.496 1.118 . . . . 0.0 111.931 174.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -104.4 -5.74 21.4 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 114.903 1.445 . . . . 0.0 114.903 -175.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 375' ' ' PHE . . . . . 0.457 ' CZ ' ' HA ' ' B' ' 372' ' ' ARG . 10.9 p90 -131.72 -18.71 2.72 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 176.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -77.27 -8.72 58.07 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.089 0.156 . . . . 0.0 111.336 173.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 . . . . . 0 C--O 1.251 1.183 0 CA-C-O 117.252 -1.356 . . . . 0.0 110.38 -176.092 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.583 0 N19-C1'-C2' 109.573 -2.392 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.501 0 C5'-C4'-C3' 111.461 -2.692 . 0.715 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.43 0 O4'-C1'-N19 111.21 3.01 . 0.842 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.164 0 C4'-C3'-C2' 100.04 -2.66 . 0.736 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.642 0 C4'-C3'-C2' 99.867 -2.833 . 0.696 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.519 0 N19-C1'-C2' 109.109 -2.682 . 0.792 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.621 0 C5'-C4'-C3' 111.819 -2.454 . 0.799 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.751 0 O4'-C1'-N19 110.987 2.787 . 0.736 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.714 0 C4'-C3'-C2' 99.853 -2.847 . 0.644 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.591 0 O4'-C1'-N19 110.577 2.377 . 0.63 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.599 0 O4'-C1'-N19 111.133 2.933 . 0.539 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.255 0 C5'-C4'-C3' 109.595 -3.937 . 0.442 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.299 1 O4'-C1'-N19 113.178 4.978 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.62 2.678 0 O4'-C1'-N19 111.801 3.601 . 0.443 6p . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.628 3.466 0 N19-C1'-C2' 109.795 -2.253 . 0.158 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.301 0 O4'-C1'-N19 111.116 2.916 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.453 0 O4'-C1'-N19 110.578 2.378 . 0.666 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.418 0 O4'-C1'-N19 110.873 2.673 . 0.767 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ' U' . . . . . 0.438 " H2'" ' C6 ' ' A' ' 20' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.425 -2.348 0 O4'-C1'-N19 111.27 3.07 . 0.771 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ' U' . . . . . 0.438 ' C6 ' " H2'" ' A' ' 19' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.545 0 O4'-C1'-N19 111.146 2.946 . 0.636 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.629 0 C5'-C4'-C3' 111.606 -2.596 . 0.728 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.582 0 C5'-C4'-C3' 111.056 -2.963 . 0.765 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.53 0 O4'-C1'-N19 110.593 2.393 . 0.767 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.079 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 25.8 t -150.26 10.52 0.68 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.478 0.311 . . . . 0.0 110.888 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 41.4 m80 57.2 -178.86 0.05 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.817 0.847 . . . . 0.0 111.911 -177.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 14.2 tmm? -66.93 137.52 56.6 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -155.08 136.35 14.01 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.716 0.406 . . . . 0.0 109.995 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -139.36 20.58 2.57 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.686 0.795 . . . . 0.0 111.018 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 45.2 t -64.55 -16.93 63.41 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.523 0.201 . . . . 0.0 110.956 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 31.5 p30 -114.92 16.62 17.19 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.025 0.93 . . . . 0.0 111.588 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -128.69 110.54 12.3 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 122.6 0.36 . . . . 0.0 110.383 -175.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . 0.467 HD22 ' C ' ' B' ' 285' ' ' ASN . 0.3 OUTLIER -113.7 5.36 16.41 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.148 -178.75 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 85.4 m -106.21 143.58 34.14 Favored 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 122.09 -0.381 . . . . 0.0 110.675 -174.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 40.6 pt -120.16 144.53 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 176.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -96.18 145.36 25.59 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 174.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 19.0 t -130.85 144.79 36.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.156 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -133.47 152.97 51.98 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 175.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.55 11.27 68.98 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-O 119.78 -0.456 . . . . 0.0 112.361 169.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 63.8 mt -57.32 -49.95 74.49 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 117.645 0.723 . . . . 0.0 110.78 -175.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 148.54 172.93 18.91 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 -178.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -97.17 -6.25 35.24 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -175.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -128.64 15.77 6.47 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 4.3 m -67.59 161.38 3.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -174.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 19.4 p -123.88 159.95 28.52 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.441 0.696 . . . . 0.0 112.254 -178.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 298' ' ' ILE . . . . . 0.573 HG23 ' HB ' ' B' ' 322' ' ' ILE . 54.7 mt -63.68 -44.51 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.938 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -64.2 -36.3 83.6 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 122.565 0.346 . . . . 0.0 111.38 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 46.8 t -72.3 -47.04 53.01 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 122.247 -0.283 . . . . 0.0 110.812 -177.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 8.1 p -68.31 -33.98 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.005 178.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -65.22 -32.84 74.72 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 176.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 303' ' ' ASP . . . . . 0.402 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.6 t0 -74.02 -27.4 60.93 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -84.06 -24.69 30.31 Favored 'General case' 0 C--O 1.227 -0.13 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -96.8 -24.59 15.84 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 306' ' ' LYS . . . . . 0.402 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.7 ptpt -66.81 -18.04 65.18 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -177.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -70.9 -20.44 62.5 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 122.276 -0.265 . . . . 0.0 111.649 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.9 mm -87.61 -46.3 16.02 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-N 117.584 0.175 . . . . 0.0 110.644 175.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.71 168.78 38.44 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 85.7 mt -69.57 120.5 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-O 121.014 0.435 . . . . 0.0 110.695 -175.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 88.0 mt -73.01 138.77 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 172.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 312' ' ' LYS . . . . . 0.661 ' HE3' ' SD ' ' B' ' 321' ' ' MET . 28.8 ttpt -72.59 119.88 17.43 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -176.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 1.2 m -87.12 139.9 30.09 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 178.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -69.39 127.86 34.52 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 177.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -82.17 -5.53 58.54 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -108.92 -14.65 14.53 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.141 0.577 . . . . 0.0 111.568 -174.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 16.7 p -133.64 -23.48 1.83 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -178.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 83.56 -8.72 64.15 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 119.715 -0.492 . . . . 0.0 112.316 174.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -84.4 155.72 62.83 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 117.887 0.844 . . . . 0.0 109.248 174.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.61 155.27 59.32 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.227 1.952 . . . . 0.0 110.145 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 321' ' ' MET . . . . . 0.661 ' SD ' ' HE3' ' B' ' 312' ' ' LYS . 36.1 mtt -73.87 98.28 2.96 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 322' ' ' ILE . . . . . 0.573 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.3 mp -144.51 144.8 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 175.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -130.13 133.84 46.92 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 170.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 86.6 mt -106.54 133.8 50.65 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 325' ' ' TYR . . . . . 0.436 ' CE1' ' C2 ' ' A' ' 12' ' ' ' A' . 67.7 m-85 -96.54 151.19 19.83 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -177.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -139.91 140.56 36.45 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -174.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -76.78 137.56 39.36 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -177.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -83.51 -15.92 47.57 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.407 0.283 . . . . 0.0 110.688 175.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -90.27 -16.02 30.14 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -177.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 2.5 p -137.75 -21.82 1.11 Allowed 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -178.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 80.68 1.88 89.49 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 177.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -90.07 161.19 15.93 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 117.481 0.64 . . . . 0.0 109.801 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 10.4 mp -68.19 141.92 55.85 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -76.45 -16.96 59.55 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.673 176.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 79.04 3.4 88.2 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -173.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -99.03 151.39 20.98 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.008 0.523 . . . . 0.0 110.142 178.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -161.65 167.0 25.95 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 120.836 0.351 . . . . 0.0 111.331 -177.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 1.2 p -120.69 149.94 41.72 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 169.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 44.3 t -137.39 124.6 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 173.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 8.5 t -100.87 144.41 29.85 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 118.074 0.397 . . . . 0.0 110.815 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -109.8 158.65 17.93 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -79.09 -14.69 58.99 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -146.63 146.33 26.44 Favored Pre-proline 0 CA--C 1.53 0.204 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 344' ' ' PRO . . . . . 0.464 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 48.2 Cg_endo -70.84 -31.03 16.39 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.051 2.501 . . . . 0.0 114.469 -177.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 345' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 77.1 Cg_endo -74.14 -22.84 16.42 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 CA-C-N 121.29 1.496 . . . . 0.0 110.01 -177.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 70.1 m -72.62 -34.3 67.26 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 176.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -69.9 -38.46 76.31 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 175.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -63.96 -42.55 97.25 Favored 'General case' 0 CA--C 1.527 0.094 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.26 -34.76 76.78 Favored 'General case' 0 C--N 1.34 0.17 0 O-C-N 122.287 -0.258 . . . . 0.0 110.506 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.59 -36.46 83.8 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 67.6 mt -69.79 -51.99 35.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.811 174.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -53.94 -29.64 43.25 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 56.2 t-105 -97.69 -56.04 2.63 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -75.64 -27.39 58.37 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 -173.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -50.13 110.68 0.42 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.015 0.371 . . . . 0.0 111.814 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 94.66 1.36 63.86 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.55 -0.583 . . . . 0.0 112.606 174.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -83.98 -164.71 0.97 Allowed 'General case' 0 C--N 1.339 0.152 0 CA-C-N 118.32 1.06 . . . . 0.0 110.146 176.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -129.41 152.96 48.39 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.209 0.528 . . . . 0.0 111.246 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -145.51 137.45 25.45 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.188 0.995 . . . . 0.0 112.061 177.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 21.1 t 54.19 18.51 1.82 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.87 0.468 . . . . 0.0 111.211 -175.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 89.29 22.58 37.23 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 111.939 -0.464 . . . . 0.0 111.939 178.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -133.67 141.81 41.45 Favored Pre-proline 0 N--CA 1.455 -0.205 0 CA-C-N 117.442 0.621 . . . . 0.0 109.428 -177.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.32 136.18 33.48 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 122.68 2.253 . . . . 0.0 109.567 177.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 30.4 pt -121.47 170.63 11.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-O 120.957 0.408 . . . . 0.0 111.383 -177.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -144.78 115.68 7.82 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.719 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 12.4 t -107.0 147.86 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 C-N-CA 123.429 0.692 . . . . 0.0 112.416 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 28.5 t -162.73 173.22 14.12 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 176.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -71.11 133.28 46.12 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -101.28 177.29 4.97 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.216 0.531 . . . . 0.0 111.647 178.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 9.0 p -139.63 -157.1 0.74 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.4 1.48 . . . . 0.0 110.055 174.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 -115.5 81.95 1.67 Allowed 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 118.379 0.536 . . . . 0.0 110.614 170.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 372' ' ' ARG . . . . . 0.523 ' HA ' ' CZ ' ' B' ' 375' ' ' PHE . 26.4 ttt180 -59.34 -22.34 61.16 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 169.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -61.81 -10.35 8.85 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.9 0.88 . . . . 0.0 112.005 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -95.68 -10.28 29.73 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -177.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 375' ' ' PHE . . . . . 0.523 ' CZ ' ' HA ' ' B' ' 372' ' ' ARG . 15.8 p90 -135.11 -15.39 1.97 Allowed 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 35.4 p-10 -76.56 -8.8 57.93 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.585 0.231 . . . . 0.0 110.545 175.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 117.027 -1.463 . . . . 0.0 110.298 -179.346 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.63 0 N19-C1'-C2' 109.25 -2.594 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.724 0 C5'-C4'-C3' 111.379 -2.747 . 0.668 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.613 0 O4'-C1'-N19 110.905 2.705 . 0.793 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.604 0 N19-C1'-C2' 108.62 -2.987 . 0.78 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.644 0 C4'-C3'-C2' 99.42 -3.28 . 0.681 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.382 0 N19-C1'-C2' 108.718 -2.926 . 0.744 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.552 0 O4'-C1'-N19 110.981 2.781 . 0.785 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.618 0 O4'-C1'-N19 111.156 2.956 . 0.754 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.723 0 C4'-C3'-C2' 99.86 -2.84 . 0.666 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.667 0 C4'-C3'-C2' 99.908 -2.792 . 0.606 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ' A' . . . . . 0.404 " H2'" ' C8 ' ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.633 0 O4'-C1'-N19 111.016 2.816 . 0.421 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ' A' . . . . . 0.436 ' C2 ' ' CE1' ' B' ' 325' ' ' TYR . . . . . . . . 0 O4'--C4' 1.43 -1.957 0 O4'-C1'-N19 112.159 3.959 . 0.247 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.615 1 O4'-C1'-N19 112.362 4.162 . 0.0 OUTLIER '7D dist 2[' 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.622 2.854 1 C5'-C4'-C3' 107.785 -5.143 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.626 3.305 0 O4'-C1'-N19 110.22 2.02 . 0.144 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.549 0 O4'-C1'-N19 111.405 3.205 . 0.177 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.342 0 N19-C1'-C2' 108.409 -3.119 . 0.507 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.607 0 O4'-C1'-N19 111.0 2.8 . 0.721 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.664 0 O4'-C1'-N19 110.955 2.755 . 0.809 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.474 0 O4'-C1'-N19 110.9 2.7 . 0.69 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.68 0 C5'-C4'-C3' 111.879 -2.414 . 0.753 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.748 0 O4'-C1'-N19 110.785 2.585 . 0.797 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.653 0 N19-C1'-C2' 109.763 -2.273 . 0.804 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.114 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 96.1 p -151.92 171.78 17.25 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.134 0.574 . . . . 0.0 110.345 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 43.5 m80 -73.9 -11.66 60.43 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.24 0.216 . . . . 0.0 111.231 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 90.2 mtp -79.23 159.77 27.17 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 120.75 0.309 . . . . 0.0 110.576 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -70.01 -14.32 62.64 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 176.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 -83.37 12.37 5.55 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 122.897 0.479 . . . . 0.0 111.345 179.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 44.5 t -62.92 -20.99 65.72 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 122.092 -0.38 . . . . 0.0 110.864 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -89.78 8.31 32.48 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -138.15 110.49 7.43 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 122.2 -0.312 . . . . 0.0 110.47 -175.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.23 7.7 17.91 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.991 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 33.7 m -106.1 143.07 34.76 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 120.764 0.316 . . . . 0.0 111.477 -175.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 45.3 pt -120.72 146.73 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 288' ' ' PHE . . . . . 0.438 ' CE1' ' C6 ' ' A' ' 14' ' ' ' U' . 44.8 t80 -99.41 146.77 25.95 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 174.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 21.0 t -131.97 144.7 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.972 177.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -131.15 152.41 50.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 176.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.0 11.94 69.15 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 112.324 -0.311 . . . . 0.0 112.324 169.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 77.5 mt -55.6 -49.59 72.39 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 117.605 0.702 . . . . 0.0 110.492 -176.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 145.59 172.51 16.04 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -99.78 1.59 43.29 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.875 0.338 . . . . 0.0 111.787 -177.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -128.87 14.09 6.35 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.7 m -75.41 166.17 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -172.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 25.8 p -130.69 159.73 36.37 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.598 0.759 . . . . 0.0 112.168 -179.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 298' ' ' ILE . . . . . 0.562 HG23 ' HB ' ' B' ' 322' ' ' ILE . 44.4 mt -63.04 -46.38 96.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.337 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -62.37 -36.37 82.07 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.386 0.274 . . . . 0.0 111.437 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 47.0 t -72.44 -46.7 53.82 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 117.71 0.232 . . . . 0.0 110.836 -177.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.94 -33.28 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.341 178.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -65.3 -32.84 74.7 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 303' ' ' ASP . . . . . 0.41 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.4 t0 -74.64 -27.57 60.5 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 304' ' ' TYR . . . . . 0.404 ' CE2' ' CD2' ' B' ' 354' ' ' PHE . 52.3 t80 -83.48 -24.98 31.53 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -96.48 -25.09 15.79 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 178.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 306' ' ' LYS . . . . . 0.41 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.7 ptpt -66.35 -18.24 65.24 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -177.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -71.67 -20.19 61.98 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -178.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 3.9 mm -87.11 -46.33 16.23 Favored 'Isoleucine or valine' 0 C--N 1.337 0.059 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 175.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.98 167.95 38.25 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 85.8 mt -68.41 120.03 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 122.505 0.322 . . . . 0.0 110.634 -175.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 94.0 mt -71.72 138.06 22.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 172.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 312' ' ' LYS . . . . . 0.401 ' HE3' ' HB2' ' B' ' 312' ' ' LYS . 35.8 ttmt -68.86 125.2 25.88 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -177.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 2.5 m -95.98 137.48 34.99 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -71.05 130.31 41.21 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -82.03 -6.28 59.02 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -108.76 -14.79 14.53 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.043 0.537 . . . . 0.0 111.392 -174.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 10.1 p -131.27 -25.01 2.25 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 82.62 -9.14 59.93 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 119.516 -0.602 . . . . 0.0 112.197 175.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -86.59 155.91 56.3 Favored Pre-proline 0 CA--C 1.53 0.174 0 CA-C-N 117.913 0.857 . . . . 0.0 109.039 175.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -70.78 155.58 62.31 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 122.279 1.986 . . . . 0.0 110.096 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 321' ' ' MET . . . . . 0.429 ' CB ' ' HB3' ' B' ' 340' ' ' SER . 33.9 mtt -73.45 95.8 2.28 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 120.68 0.276 . . . . 0.0 111.712 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 322' ' ' ILE . . . . . 0.562 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.7 mp -141.29 141.05 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 172.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -134.37 110.9 9.75 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 175.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.68 152.69 33.63 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.673 0.789 . . . . 0.0 108.895 175.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -121.12 149.1 43.27 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 175.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 3.0 m -130.05 148.89 51.95 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -175.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -75.61 129.33 37.0 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 -84.11 -5.16 59.2 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 122.46 -0.15 . . . . 0.0 110.95 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -101.19 -14.33 17.76 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.693 0.397 . . . . 0.0 111.882 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 11.7 p -137.14 -22.94 1.15 Allowed 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 73.32 12.27 79.83 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-O 119.519 -0.6 . . . . 0.0 112.765 171.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -75.12 -103.45 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.929 0.864 . . . . 0.0 110.139 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 5.4 mt -159.45 144.7 15.7 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.688 1.195 . . . . 0.0 108.183 171.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 8.5 mmmm -76.02 -23.18 55.17 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 122.725 0.41 . . . . 0.0 110.32 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 77.26 5.64 85.58 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 -171.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -103.36 147.61 26.89 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.389 0.675 . . . . 0.0 109.992 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -161.95 153.83 19.02 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.006 176.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 12.8 p -98.72 151.77 20.38 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 169.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 42.5 t -136.13 125.99 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 170.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 340' ' ' SER . . . . . 0.429 ' HB3' ' CB ' ' B' ' 321' ' ' MET . 46.5 t -103.18 149.12 24.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 117.862 0.301 . . . . 0.0 111.316 -178.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -114.49 156.81 23.88 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -72.21 -29.11 63.65 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -132.46 147.83 67.2 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -178.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 344' ' ' PRO . . . . . 0.467 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 45.3 Cg_endo -71.39 -31.71 13.59 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.446 2.764 . . . . 0.0 114.649 -178.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 345' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 78.5 Cg_endo -73.68 -21.86 18.6 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 CA-C-N 121.255 1.484 . . . . 0.0 110.04 -177.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 70.7 m -71.23 -35.92 71.63 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 175.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -68.03 -38.74 82.88 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 174.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -64.06 -42.07 97.14 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.43 -34.6 76.29 Favored 'General case' 0 C--O 1.226 -0.148 0 O-C-N 122.255 -0.278 . . . . 0.0 110.737 178.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.36 -36.71 84.83 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 66.4 mt -70.25 -52.05 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.691 175.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -53.77 -29.86 41.96 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 58.9 t-105 -97.58 -53.95 3.28 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -176.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 354' ' ' PHE . . . . . 0.43 ' HB2' HG21 ' B' ' 366' ' ' VAL . 47.7 m-85 -78.09 -27.08 48.43 Favored 'General case' 0 C--O 1.226 -0.134 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -174.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -48.09 110.4 0.32 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 178.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 95.18 1.74 62.61 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 119.612 -0.549 . . . . 0.0 112.764 174.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -84.5 -164.87 1.03 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.261 1.03 . . . . 0.0 110.524 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 41.8 mp0 -127.75 152.85 47.24 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.107 0.479 . . . . 0.0 110.84 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -145.31 136.76 25.15 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.181 0.992 . . . . 0.0 112.349 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 14.8 t 55.32 17.29 2.04 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.075 0.464 . . . . 0.0 111.175 -175.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.72 22.63 38.84 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.955 -0.458 . . . . 0.0 111.955 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 44.9 m-20 -132.07 143.02 47.23 Favored Pre-proline 0 N--CA 1.455 -0.218 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -177.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -68.9 136.69 36.01 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.849 2.366 . . . . 0.0 109.415 177.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 33.5 pt -124.04 171.05 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 CA-C-O 121.178 0.513 . . . . 0.0 111.125 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -143.81 114.89 7.87 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.759 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 366' ' ' VAL . . . . . 0.43 HG21 ' HB2' ' B' ' 354' ' ' PHE . 11.9 t -102.33 148.65 7.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 123.256 0.623 . . . . 0.0 111.99 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 80.3 p -162.53 168.6 21.63 Favored 'General case' 0 CA--C 1.528 0.1 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -70.28 130.97 43.42 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 174.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -93.82 -179.1 4.88 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.882 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 9.6 t -150.48 -165.83 2.38 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.68 1.192 . . . . 0.0 107.877 172.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 75.5 mtt85 -108.11 75.66 1.0 Allowed 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.804 0.729 . . . . 0.0 110.161 173.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 25.2 ttt180 -60.62 -17.8 49.29 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 175.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.52 -38.55 77.94 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 122.47 0.308 . . . . 0.0 110.576 175.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -61.52 -10.41 7.83 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -171.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -82.29 -16.75 48.29 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 176.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -126.96 -20.27 4.24 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -173.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 75.1 mmt-85 . . . . . 0 C--O 1.253 1.253 0 CA-C-O 117.55 -1.214 . . . . 0.0 110.093 178.394 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.53 0 N19-C1'-C2' 109.273 -2.58 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.688 0 C5'-C4'-C3' 111.309 -2.794 . 0.709 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.384 0 O4'-C1'-N19 111.142 2.942 . 0.767 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.43 0 N19-C1'-C2' 108.295 -3.191 . 0.746 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.513 0 N19-C1'-C2' 108.401 -3.124 . 0.689 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.322 0 N19-C1'-C2' 108.717 -2.927 . 0.736 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.531 0 O4'-C1'-N19 110.899 2.699 . 0.757 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.357 0 C4'-C3'-C2' 99.696 -3.004 . 0.73 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.511 0 C4'-C3'-C2' 99.477 -3.223 . 0.628 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.679 0 C4'-C3'-C2' 100.025 -2.675 . 0.569 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.412 0 C5'-C4'-C3' 112.312 -2.126 . 0.624 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.419 1 C5'-C4'-C3' 109.08 -4.28 . 0.208 1t . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.69 1 C5'-C4'-C3' 108.885 -4.41 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ' U' . . . . . 0.438 ' C6 ' ' CE1' ' B' ' 288' ' ' PHE . . . . . . . . 0 O4'--C4' 1.427 -2.205 1 O4'-C1'-N19 112.54 4.34 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.626 3.281 0 C5'-C4'-C3' 112.75 -1.833 . 0.414 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.39 0 O4'-C1'-N19 111.312 3.112 . 0.089 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.238 0 N19-C1'-C2' 108.612 -2.992 . 0.4 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.302 0 O4'-C1'-N19 111.301 3.101 . 0.697 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.707 0 O4'-C1'-N19 111.151 2.951 . 0.796 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.501 0 O4'-C1'-N19 110.792 2.592 . 0.655 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.644 0 C5'-C4'-C3' 111.892 -2.405 . 0.747 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.549 0 O4'-C1'-N19 110.715 2.515 . 0.818 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.509 0 O4'-C1'-N19 110.509 2.309 . 0.818 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.169 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 35.4 t 61.11 162.96 0.07 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.259 1.023 . . . . 0.0 112.152 -177.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -76.43 -13.37 60.12 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.858 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 93.8 mmm 58.55 179.88 0.07 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.979 0.912 . . . . 0.0 111.378 -175.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -72.9 139.22 46.7 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 122.597 0.359 . . . . 0.0 111.923 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -146.39 25.69 1.21 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.673 0.789 . . . . 0.0 110.967 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 88.4 p -66.97 -7.51 22.85 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.59 0.356 . . . . 0.0 110.84 178.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 28.1 p30 -131.63 22.0 4.67 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.908 0.883 . . . . 0.0 111.855 178.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -141.53 122.58 14.62 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.744 0.307 . . . . 0.0 111.034 -178.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . 0.426 HD22 ' C ' ' B' ' 285' ' ' ASN . 0.3 OUTLIER -113.6 12.28 18.47 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.409 0.684 . . . . 0.0 111.375 177.18 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 63.7 m -108.98 146.22 34.22 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.877 0.37 . . . . 0.0 111.206 -172.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 44.9 pt -120.24 148.09 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 174.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 288' ' ' PHE . . . . . 0.448 ' CE2' ' C6 ' ' A' ' 14' ' ' ' U' . 54.1 t80 -101.4 145.77 28.49 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 174.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 17.2 t -129.75 144.46 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.236 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -133.16 152.45 51.94 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 175.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.21 12.38 67.87 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 119.814 -0.436 . . . . 0.0 112.663 169.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 59.3 mt -57.14 -50.1 73.85 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 117.414 0.607 . . . . 0.0 110.912 -174.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 157.0 -177.94 33.64 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -99.63 -9.32 23.32 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -176.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -139.95 22.0 2.45 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.2 m -68.11 165.15 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -173.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 16.0 p -123.11 159.56 28.27 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -177.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 298' ' ' ILE . . . . . 0.607 HG23 ' HB ' ' B' ' 322' ' ' ILE . 41.1 mt -62.32 -45.8 97.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.128 177.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -63.43 -37.56 87.77 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -177.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 81.1 p -73.35 -42.39 62.31 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 118.043 0.383 . . . . 0.0 110.376 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 54.4 t -61.69 -42.06 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -65.56 -34.36 78.06 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 303' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -70.55 -26.96 63.79 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 304' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -84.41 -25.68 28.86 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -96.3 -25.0 15.93 Favored 'General case' 0 C--O 1.231 0.091 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 306' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -66.55 -19.08 65.69 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.241 0.216 . . . . 0.0 111.458 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -71.28 -20.01 62.27 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 111.644 0.238 . . . . 0.0 111.644 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 5.1 mm -88.9 -46.25 15.46 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-N 117.602 0.183 . . . . 0.0 110.945 176.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -162.18 170.37 37.79 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 85.4 mt -72.12 118.58 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 122.61 0.364 . . . . 0.0 110.39 -175.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 93.6 mt -72.56 135.02 28.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 173.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -68.56 130.52 43.09 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 1.5 m -89.7 139.22 30.78 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -65.38 129.35 39.43 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 175.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -79.47 -10.43 59.8 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.789 -0.187 . . . . 0.0 110.962 -177.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -106.18 -48.02 3.69 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 -176.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 17.6 p -92.6 -23.76 18.92 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -174.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 82.29 -9.7 56.96 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 119.737 -0.479 . . . . 0.0 112.289 175.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -83.12 158.64 64.01 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 117.97 0.885 . . . . 0.0 108.887 174.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.37 154.39 69.36 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 121.685 1.59 . . . . 0.0 110.144 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 321' ' ' MET . . . . . 0.419 ' CB ' ' HB3' ' B' ' 340' ' ' SER . 38.6 mtt -72.53 93.05 1.53 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.863 0.363 . . . . 0.0 111.72 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 322' ' ' ILE . . . . . 0.607 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.9 mp -140.5 144.21 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 173.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -131.62 132.78 44.31 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 171.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -103.15 137.8 40.82 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 174.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -104.11 155.24 18.86 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 2.9 m -135.41 148.15 49.23 Favored 'General case' 0 CA--C 1.523 -0.093 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -176.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -78.67 130.75 36.21 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -79.85 -12.95 59.72 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 122.368 -0.207 . . . . 0.0 111.003 177.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -91.98 -14.83 28.85 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.494 0.317 . . . . 0.0 111.816 -178.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 2.8 p -137.35 -26.18 1.01 Allowed 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 75.31 10.48 84.41 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.849 -0.5 . . . . 0.0 111.849 175.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -75.36 -96.37 0.02 OUTLIER 'General case' 0 C--N 1.341 0.207 0 CA-C-N 117.68 0.74 . . . . 0.0 110.53 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 1.8 tp -164.81 149.49 9.37 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.532 0.733 . . . . 0.0 109.089 172.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -83.09 -22.69 33.37 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.491 0.186 . . . . 0.0 110.632 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 73.52 5.49 68.11 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -172.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -100.06 151.11 21.75 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.336 0.654 . . . . 0.0 110.024 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.42 167.25 29.21 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.052 0.453 . . . . 0.0 111.592 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 1.4 p -120.66 151.15 39.86 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 169.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 31.3 t -137.66 124.99 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 172.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 340' ' ' SER . . . . . 0.419 ' HB3' ' CB ' ' B' ' 321' ' ' MET . 46.9 t -101.41 148.93 24.59 Favored 'General case' 0 C--O 1.231 0.113 0 O-C-N 122.202 -0.311 . . . . 0.0 111.135 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -116.92 154.12 31.38 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 -178.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -71.74 -13.11 61.62 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 176.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -149.26 146.77 21.78 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 344' ' ' PRO . . . . . 0.478 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 53.4 Cg_endo -71.32 -30.18 15.97 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 123.239 2.626 . . . . 0.0 114.363 -177.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 345' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 71.5 Cg_endo -73.99 -22.45 17.21 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 CA-C-N 121.403 1.537 . . . . 0.0 109.964 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 66.3 m -71.7 -36.97 70.74 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 175.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.98 -37.83 84.94 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -63.72 -45.02 91.84 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.77 -34.44 76.81 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 110.538 -0.171 . . . . 0.0 110.538 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.33 -38.66 91.81 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 68.8 mt -68.57 -54.0 24.02 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.56 175.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -54.41 -27.9 40.12 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 54.9 t-105 -96.76 -55.07 3.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 354' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -76.29 -26.79 56.24 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -174.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -48.35 109.43 0.24 Allowed 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 176.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 94.94 0.76 63.63 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.394 -0.67 . . . . 0.0 112.814 174.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -83.38 -164.94 0.97 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 118.177 0.988 . . . . 0.0 110.374 176.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -128.48 155.11 45.33 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.191 0.519 . . . . 0.0 111.454 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -146.89 136.44 22.92 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.478 1.111 . . . . 0.0 112.158 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 22.7 t 54.45 18.77 2.06 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.455 0.302 . . . . 0.0 111.335 -175.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 86.95 24.31 38.35 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 112.154 -0.378 . . . . 0.0 112.154 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -132.87 142.48 44.88 Favored Pre-proline 0 N--CA 1.454 -0.23 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 -178.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.41 136.16 33.18 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.681 2.254 . . . . 0.0 109.602 177.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 27.9 pt -122.97 171.9 11.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-O 121.25 0.548 . . . . 0.0 110.831 -177.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -144.0 118.13 9.5 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.947 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 11.9 t -107.64 148.52 11.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 C-N-CA 123.22 0.608 . . . . 0.0 112.242 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 27.4 t -163.75 172.57 13.98 Favored 'General case' 0 C--N 1.341 0.204 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 176.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -70.51 130.25 41.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 176.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -84.86 -178.2 6.78 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.965 -0.562 . . . . 0.0 112.31 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 10.0 t -148.32 -158.68 0.94 Allowed 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 174.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 371' ' ' ARG . . . . . 0.535 ' C ' ' H ' ' B' ' 373' ' ' ALA . 23.4 mmm180 -92.97 -41.78 9.82 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 118.845 0.748 . . . . 0.0 111.752 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? 60.71 -28.39 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.581 1.153 . . . . 0.0 112.83 -175.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . 0.535 ' H ' ' C ' ' B' ' 371' ' ' ARG . . . -83.47 -36.54 24.07 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 124.449 1.1 . . . . 0.0 111.126 -178.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -67.79 -4.47 12.61 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -170.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -85.69 -7.59 58.71 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.41 0.284 . . . . 0.0 111.57 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -139.93 -22.4 0.86 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -174.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 12.1 ptp85 . . . . . 0 C--O 1.251 1.137 0 CA-C-O 117.284 -1.341 . . . . 0.0 110.952 -179.822 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.587 0 N19-C1'-C2' 109.019 -2.738 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.743 0 C5'-C4'-C3' 112.224 -2.184 . 0.657 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.558 0 O4'-C1'-N19 111.003 2.803 . 0.652 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.571 0 N19-C1'-C2' 109.099 -2.688 . 0.76 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.657 0 C4'-C3'-C2' 99.979 -2.721 . 0.632 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.407 0 N19-C1'-C2' 108.875 -2.828 . 0.772 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.571 0 O4'-C1'-N19 110.922 2.722 . 0.793 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.578 0 C4'-C3'-C2' 100.048 -2.652 . 0.727 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.511 0 C4'-C3'-C2' 99.634 -3.066 . 0.637 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.318 0 C4'-C3'-C2' 99.821 -2.879 . 0.565 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.39 0 O4'-C1'-N19 111.024 2.824 . 0.54 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.47 1 O4'-C1'-N19 112.56 4.36 . 0.129 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.071 0 C5'-C4'-C3' 111.424 -2.718 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ' U' . . . . . 0.448 ' C6 ' ' CE2' ' B' ' 288' ' ' PHE . . . . . . . . 0 O4'--C4' 1.422 -2.589 0 O4'-C1'-N19 111.463 3.263 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.734 0 C5'-C4'-C3' 111.666 -2.556 . 0.287 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.413 0 O4'-C1'-N19 111.251 3.051 . 0.34 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.551 0 N19-C1'-C2' 109.13 -2.669 . 0.638 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.382 0 O4'-C1'-N19 110.939 2.739 . 0.733 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.548 0 O4'-C1'-N19 110.899 2.699 . 0.744 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.515 0 O4'-C1'-N19 110.878 2.678 . 0.723 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.623 0 C4'-C3'-C2' 100.399 -2.301 . 0.741 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.867 0 C5'-C4'-C3' 111.381 -2.746 . 0.78 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.737 0 N19-C1'-C2' 109.562 -2.399 . 0.756 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.014 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 90.5 p -151.27 15.51 0.71 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.633 0.373 . . . . 0.0 110.916 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -148.33 152.71 37.54 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 122.931 0.492 . . . . 0.0 109.894 -178.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 55.3 ttm 62.45 152.58 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.624 1.169 . . . . 0.0 112.1 -175.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 22.0 t0 53.16 88.55 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.371 1.069 . . . . 0.0 113.428 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 53.46 36.4 23.08 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.265 0.626 . . . . 0.0 112.374 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 88.6 p -65.21 -17.98 64.94 Favored 'General case' 0 N--CA 1.456 -0.141 0 O-C-N 122.342 -0.224 . . . . 0.0 110.921 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 18.5 p30 -95.71 6.32 49.22 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.706 0.802 . . . . 0.0 112.742 178.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -140.14 110.2 6.51 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.954 0.407 . . . . 0.0 110.05 -176.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . 0.449 HD22 ' C ' ' B' ' 285' ' ' ASN . 0.4 OUTLIER -113.43 8.28 17.83 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.859 -177.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 60.5 m -107.5 142.16 37.81 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.092 0.473 . . . . 0.0 109.987 -175.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 44.4 pt -113.72 146.69 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 174.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -97.97 141.06 31.4 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 172.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 17.4 t -130.26 142.34 44.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 O-C-N 123.331 0.394 . . . . 0.0 111.252 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -132.3 153.13 51.0 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.46 11.47 68.86 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 119.863 -0.409 . . . . 0.0 112.423 169.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 77.4 mt -56.29 -51.95 66.31 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 117.348 0.574 . . . . 0.0 110.548 -175.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 151.15 171.56 19.31 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -91.47 -9.13 45.62 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 122.484 -0.421 . . . . 0.0 111.772 -174.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -134.34 15.91 3.75 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -177.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.2 m -66.6 160.76 3.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -175.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 25.7 p -117.87 156.66 28.03 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 122.957 0.503 . . . . 0.0 112.053 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 298' ' ' ILE . . . . . 0.49 HG23 ' HB ' ' B' ' 322' ' ' ILE . 40.6 mt -60.67 -44.03 96.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.44 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -68.89 -30.54 69.05 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -177.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 46.6 t -73.79 -43.6 58.44 Favored 'General case' 0 N--CA 1.458 -0.07 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 78.8 t -61.97 -41.25 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.61 -34.84 79.21 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 303' ' ' ASP . . . . . 0.408 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.9 t0 -71.02 -29.01 64.83 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 304' ' ' TYR . . . . . 0.402 ' CE2' ' CD2' ' B' ' 354' ' ' PHE . 59.0 t80 -82.47 -25.31 33.66 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -96.63 -24.88 15.8 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 306' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.9 ptpt -67.76 -17.59 64.6 Favored 'General case' 0 C--N 1.338 0.107 0 N-CA-C 111.446 0.165 . . . . 0.0 111.446 -176.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -72.2 -20.07 61.63 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 3.8 mm -87.84 -46.35 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.122 0 CA-C-N 117.61 0.186 . . . . 0.0 110.632 175.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -162.24 172.16 38.29 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 72.5 mt -71.11 118.29 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 122.68 0.392 . . . . 0.0 110.11 -175.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 77.4 mt -74.91 136.93 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 173.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 312' ' ' LYS . . . . . 0.442 ' HG2' ' SD ' ' B' ' 321' ' ' MET . 39.8 ttmt -69.55 142.65 53.58 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 11.0 m -117.59 136.55 53.21 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.618 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -68.49 131.98 46.21 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -178.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.99 -10.67 59.17 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 121.321 -0.152 . . . . 0.0 111.313 178.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 316' ' ' LYS . . . . . 0.442 ' HG2' ' H62' ' A' ' 17' ' ' ' A' . 7.6 mptt -99.05 -49.08 4.63 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.247 0.219 . . . . 0.0 111.354 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 5.9 p -87.04 -25.81 24.03 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -177.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 79.37 -8.73 45.33 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 123.377 0.513 . . . . 0.0 112.407 174.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -88.46 159.39 47.18 Favored Pre-proline 0 CA--C 1.53 0.201 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.84 148.64 82.74 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 121.314 1.343 . . . . 0.0 108.746 177.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 321' ' ' MET . . . . . 0.442 ' SD ' ' HG2' ' B' ' 312' ' ' LYS . 72.4 mtp -79.77 85.7 5.42 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.307 0.575 . . . . 0.0 111.665 -170.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 322' ' ' ILE . . . . . 0.49 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.3 mp -129.7 147.08 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.575 1.15 . . . . 0.0 108.25 176.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -132.93 111.08 10.74 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -80.98 148.79 29.6 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.267 1.027 . . . . 0.0 108.833 176.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -113.29 151.66 30.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.84 143.41 40.96 Favored 'General case' 0 CA--C 1.522 -0.13 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -173.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -73.7 133.72 43.42 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -87.3 -9.48 54.84 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.179 0.192 . . . . 0.0 110.856 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -98.97 -14.19 19.6 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.808 0.443 . . . . 0.0 111.745 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 4.0 p -136.61 -20.92 1.32 Allowed 'General case' 0 C--N 1.34 0.16 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -178.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 80.0 1.28 87.39 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 175.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -87.87 159.04 18.55 Favored 'General case' 0 C--N 1.338 0.096 0 CA-C-N 117.66 0.73 . . . . 0.0 109.447 177.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 10.5 mp -67.65 144.73 55.38 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.837 0.351 . . . . 0.0 110.112 -175.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -75.26 -15.83 60.49 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 122.873 0.469 . . . . 0.0 110.338 176.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 78.56 10.29 86.33 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 110.709 -0.957 . . . . 0.0 110.709 -174.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -116.97 150.33 38.74 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.881 0.472 . . . . 0.0 110.408 -177.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -160.06 162.91 34.26 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.881 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 29.6 p -112.4 153.86 26.67 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 169.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 21.8 t -136.6 124.19 33.15 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.11 0 C-N-CA 123.249 0.62 . . . . 0.0 110.218 175.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 45.0 t -90.98 140.85 29.45 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 117.906 0.321 . . . . 0.0 110.404 177.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -108.85 152.84 24.36 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 176.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -70.08 -28.82 65.73 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -177.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -133.05 149.0 71.6 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 344' ' ' PRO . . . . . 0.467 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 36.9 Cg_endo -69.44 -33.33 18.04 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 123.274 2.649 . . . . 0.0 114.2 -177.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 345' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 93.8 Cg_endo -74.97 -20.2 17.15 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 CA-C-N 121.136 1.441 . . . . 0.0 110.384 -176.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 66.3 m -71.88 -35.72 69.84 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 175.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -70.4 -38.36 74.64 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 174.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -63.6 -43.14 97.78 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.62 -35.33 77.17 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 110.561 -0.162 . . . . 0.0 110.561 178.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -63.88 -37.62 88.06 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 59.2 mt -70.66 -49.16 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.094 175.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -58.95 -27.9 65.76 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -176.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -97.26 -56.47 2.53 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -177.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 354' ' ' PHE . . . . . 0.402 ' CD2' ' CE2' ' B' ' 304' ' ' TYR . 52.2 m-85 -75.7 -25.74 56.95 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -173.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -48.49 108.4 0.17 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 176.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 96.34 2.2 60.52 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 119.435 -0.647 . . . . 0.0 113.227 174.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -84.91 -164.02 0.92 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.3 1.05 . . . . 0.0 110.386 177.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -129.9 153.23 48.53 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-O 121.058 0.456 . . . . 0.0 110.776 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -145.17 136.69 25.26 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.395 1.078 . . . . 0.0 112.296 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 63.4 m 53.35 19.48 1.61 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -173.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 86.38 22.81 46.25 Favored Glycine 0 C--N 1.342 0.868 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 52.6 m-20 -130.71 141.96 43.81 Favored Pre-proline 0 N--CA 1.454 -0.239 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -177.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.18 135.31 31.48 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.998 2.465 . . . . 0.0 109.267 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 29.6 pt -122.4 171.48 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 CA-C-O 121.285 0.564 . . . . 0.0 111.061 -177.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -144.25 116.59 8.51 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.688 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 10.8 t -107.28 147.27 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 123.026 0.53 . . . . 0.0 111.801 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 28.0 t -162.63 174.87 12.01 Favored 'General case' 0 C--N 1.339 0.147 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 177.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -71.97 130.07 40.09 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 176.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -82.74 177.95 8.42 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.358 177.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 15.7 p -144.02 -155.37 0.6 Allowed 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.454 1.101 . . . . 0.0 110.212 178.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -118.63 66.56 0.77 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 171.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 372' ' ' ARG . . . . . 0.462 ' HA ' ' CZ ' ' B' ' 375' ' ' PHE . 61.4 ttt180 -57.37 -18.0 15.32 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 173.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.6 -12.93 25.96 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.403 1.081 . . . . 0.0 111.965 176.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -98.74 -32.3 11.45 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -174.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 375' ' ' PHE . . . . . 0.462 ' CZ ' ' HA ' ' B' ' 372' ' ' ARG . 14.2 p90 -113.35 -18.58 12.0 Favored 'General case' 0 N--CA 1.457 -0.083 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 -173.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -81.55 -8.21 59.69 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 . . . . . 0 C--O 1.252 1.187 0 CA-C-O 117.069 -1.443 . . . . 0.0 110.381 -179.002 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.579 0 N19-C1'-C2' 108.955 -2.778 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.512 0 O4'-C1'-N19 110.547 2.347 . 0.684 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ' C' . . . . . 0.43 " H2'" ' C8 ' ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.539 0 C5'-C4'-C3' 111.486 -2.676 . 0.667 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . 0.43 ' C8 ' " H2'" ' A' ' 3' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.42 -2.71 0 N19-C1'-C2' 108.76 -2.9 . 0.779 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.542 0 N19-C1'-C2' 108.721 -2.924 . 0.707 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.547 0 N19-C1'-C2' 109.194 -2.629 . 0.739 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.754 0 O4'-C1'-N19 110.922 2.722 . 0.785 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.383 0 O4'-C1'-N19 110.989 2.789 . 0.744 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.276 0 C4'-C3'-C2' 100.031 -2.669 . 0.643 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.532 0 C4'-C3'-C2' 100.111 -2.589 . 0.62 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.696 0 O4'-C1'-N19 110.633 2.433 . 0.537 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.308 1 O4'-C1'-N19 112.606 4.406 . 0.101 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.702 0 C5'-C4'-C3' 109.871 -3.753 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.363 1 C5'-C4'-C3' 109.398 -4.068 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.156 0 C5'-C4'-C3' 111.875 -2.417 . 0.263 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.617 2.426 0 O4'-C1'-N19 111.646 3.446 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ' A' . . . . . 0.442 ' H62' ' HG2' ' B' ' 316' ' ' LYS . . . . . . . . 0 O4'--C4' 1.425 -2.347 0 N19-C1'-C2' 109.512 -2.43 . 0.61 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.683 0 O4'-C1'-N19 111.158 2.958 . 0.765 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ' U' . . . . . 0.417 " H2'" ' C6 ' ' A' ' 20' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.423 -2.515 0 O4'-C1'-N19 111.169 2.969 . 0.817 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ' U' . . . . . 0.417 ' C6 ' " H2'" ' A' ' 19' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.423 -2.489 0 O4'-C1'-N19 110.981 2.781 . 0.645 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.475 0 C5'-C4'-C3' 111.952 -2.365 . 0.761 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.561 0 C5'-C4'-C3' 111.541 -2.639 . 0.778 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.799 0 N19-C1'-C2' 109.778 -2.264 . 0.798 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.053 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 40.4 t -68.8 153.61 43.48 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 122.851 0.46 . . . . 0.0 110.759 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -76.49 -8.35 57.01 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 122.856 0.462 . . . . 0.0 111.038 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 97.9 mmm -69.33 156.92 38.0 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.819 0.342 . . . . 0.0 110.924 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -157.37 164.35 37.64 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 51.55 32.93 9.64 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.191 0.596 . . . . 0.0 111.811 -178.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 47.5 t -64.01 -22.06 66.77 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 122.37 -0.206 . . . . 0.0 110.739 -178.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -89.35 6.51 40.24 Favored 'General case' 0 C--N 1.34 0.18 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -141.8 110.11 5.96 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 120.813 0.34 . . . . 0.0 110.757 -175.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . 0.44 HD22 ' C ' ' B' ' 285' ' ' ASN . 0.3 OUTLIER -113.33 8.41 18.0 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.995 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 80.4 m -108.13 144.36 35.63 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.024 0.44 . . . . 0.0 110.912 -174.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 44.5 pt -120.41 147.35 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 288' ' ' PHE . . . . . 0.455 ' CE2' ' C6 ' ' A' ' 14' ' ' ' U' . 50.9 t80 -99.83 145.93 27.18 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 174.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 16.8 t -129.46 142.14 44.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 122.636 0.374 . . . . 0.0 111.22 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -129.54 149.9 51.11 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.05 14.24 64.88 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-O 119.894 -0.392 . . . . 0.0 112.361 169.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 61.4 mt -57.1 -51.1 70.65 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 117.545 0.673 . . . . 0.0 110.615 -175.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 148.84 177.16 22.8 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -101.54 -2.25 31.04 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -178.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -129.14 14.67 6.23 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.778 0.431 . . . . 0.0 112.145 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.2 m -73.65 163.16 4.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -172.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 27.3 p -129.23 160.71 32.08 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 123.501 0.72 . . . . 0.0 111.604 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 298' ' ' ILE . . . . . 0.533 HG23 ' HB ' ' B' ' 322' ' ' ILE . 44.8 mt -64.51 -45.51 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.274 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -63.6 -35.65 81.22 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 122.497 0.319 . . . . 0.0 111.601 179.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 47.1 t -72.28 -47.01 53.37 Favored 'General case' 0 C--O 1.228 -0.057 0 CA-C-N 117.919 0.327 . . . . 0.0 110.772 -177.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 7.8 p -68.16 -33.41 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.2 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -65.78 -32.56 74.16 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 176.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 303' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -74.23 -28.21 61.14 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 304' ' ' TYR . . . . . 0.409 ' CE1' ' CD1' ' B' ' 354' ' ' PHE . 54.6 t80 -82.2 -25.47 34.21 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -96.51 -25.93 15.47 Favored 'General case' 0 CA--C 1.527 0.086 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 306' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -65.73 -17.69 64.8 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 111.631 0.234 . . . . 0.0 111.631 -177.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -71.72 -20.52 61.89 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 5.0 mm -86.72 -45.8 16.49 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 175.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -165.22 167.92 39.05 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 178.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 82.4 mt -68.13 122.59 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-O 120.854 0.359 . . . . 0.0 110.752 -174.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 92.1 mt -74.56 136.53 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -70.98 130.34 41.32 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -178.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 1.8 m -88.9 138.75 31.12 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 178.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -63.71 131.88 49.29 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -80.62 -10.52 59.73 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.691 -0.231 . . . . 0.0 110.663 -176.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 58.4 mmtt -108.65 -50.0 3.08 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 122.656 0.382 . . . . 0.0 109.985 -175.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 18.1 p -89.56 -24.68 21.67 Favored 'General case' 0 C--N 1.338 0.081 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -175.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 81.92 -9.29 57.22 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-O 119.565 -0.575 . . . . 0.0 112.234 175.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -82.48 159.43 64.27 Favored Pre-proline 0 C--O 1.235 0.313 0 CA-C-N 118.308 1.054 . . . . 0.0 108.896 174.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.62 153.97 74.72 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.741 1.627 . . . . 0.0 109.861 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 321' ' ' MET . . . . . . . . . . . . . 36.4 mtt -71.31 95.71 1.34 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 120.571 0.224 . . . . 0.0 111.576 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 322' ' ' ILE . . . . . 0.533 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.6 mp -142.44 141.67 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 173.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 323' ' ' ASN . . . . . 0.403 ' O ' ' HA ' ' B' ' 337' ' ' ALA . 17.3 m-80 -132.75 111.16 10.91 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 171.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 43.2 mt -81.55 148.15 29.29 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 174.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -115.28 151.62 34.21 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 178.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -131.41 145.29 51.74 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -176.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -77.51 133.6 38.52 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -87.21 -8.42 56.87 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 122.445 -0.159 . . . . 0.0 111.146 177.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -96.81 -14.57 21.82 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 122.643 0.377 . . . . 0.0 111.567 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 3.2 p -136.17 -22.34 1.36 Allowed 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 80.77 0.46 88.07 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.591 -0.603 . . . . 0.0 111.591 176.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -89.35 158.13 17.91 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 117.647 0.723 . . . . 0.0 109.136 177.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 38.8 mt -69.21 143.1 54.07 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.982 0.42 . . . . 0.0 109.882 -177.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 9.3 mmmm -71.71 -18.74 62.14 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 123.338 0.655 . . . . 0.0 110.566 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.33 5.24 81.38 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -170.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -103.73 149.68 24.77 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.324 0.65 . . . . 0.0 110.121 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 337' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' B' ' 323' ' ' ASN . . . -164.25 159.69 20.3 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.027 176.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 6.1 p -106.26 151.65 24.53 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 169.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 42.9 t -135.89 126.22 42.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 170.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 23.0 t -105.96 141.88 36.61 Favored 'General case' 0 CA--C 1.527 0.086 0 O-C-N 122.129 -0.357 . . . . 0.0 110.948 -177.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -106.6 158.53 16.87 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -177.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -73.41 -29.97 62.94 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -131.26 146.9 64.04 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -177.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 344' ' ' PRO . . . . . 0.463 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 40.6 Cg_endo -70.83 -33.23 12.86 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.414 2.743 . . . . 0.0 114.484 -177.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 345' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 87.4 Cg_endo -73.82 -22.65 17.38 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 CA-C-N 121.185 1.459 . . . . 0.0 109.926 -176.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 71.2 m -71.48 -35.74 70.91 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 175.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -68.7 -37.91 79.9 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 175.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -64.77 -43.12 94.3 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -69.45 -33.26 72.67 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 110.474 -0.195 . . . . 0.0 110.474 178.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.89 -36.8 85.52 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 67.9 mt -69.67 -52.36 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 120.378 -0.529 . . . . 0.0 109.612 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -55.74 -29.37 59.42 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 55.5 t-105 -95.55 -55.87 2.88 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 354' ' ' PHE . . . . . 0.409 ' CD1' ' CE1' ' B' ' 304' ' ' TYR . 46.7 m-85 -75.8 -31.54 59.48 Favored 'General case' 0 C--N 1.337 0.06 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -173.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -55.46 108.04 0.39 Allowed 'General case' 0 C--O 1.232 0.16 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.753 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 106.98 -3.17 35.57 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.272 176.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -86.47 -164.78 1.11 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 117.843 0.821 . . . . 0.0 110.428 176.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -128.91 154.69 46.28 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.958 0.409 . . . . 0.0 111.306 177.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -145.19 137.2 25.67 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.573 1.149 . . . . 0.0 112.348 177.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 15.5 t 54.9 16.15 1.37 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 122.773 0.429 . . . . 0.0 111.189 -175.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 90.71 23.45 30.71 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 111.886 -0.485 . . . . 0.0 111.886 178.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -133.9 142.07 42.15 Favored Pre-proline 0 N--CA 1.453 -0.321 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -177.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -68.94 136.33 34.9 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 122.702 2.268 . . . . 0.0 109.518 177.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 29.1 pt -122.12 170.68 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-O 120.978 0.418 . . . . 0.0 111.01 -178.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -144.84 114.1 7.03 Favored 'General case' 0 N--CA 1.457 -0.086 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 11.2 t -102.67 150.47 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 122.907 0.483 . . . . 0.0 112.131 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 23.8 t -163.54 173.43 13.07 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 176.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -70.55 131.09 43.46 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 176.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -93.61 178.16 5.78 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 12.2 t -147.69 -159.18 0.99 Allowed 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 125.002 1.321 . . . . 0.0 108.277 173.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 77.0 mtt85 -119.41 88.15 2.88 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 119.033 0.833 . . . . 0.0 110.909 174.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -65.44 -16.37 63.56 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 171.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.02 -27.58 65.59 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 122.969 0.508 . . . . 0.0 110.763 178.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -63.13 -17.31 62.2 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.733 0.413 . . . . 0.0 110.851 -175.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -81.6 -13.31 58.15 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -136.7 -6.18 1.94 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -173.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 117.616 -1.183 . . . . 0.0 110.629 175.935 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.721 0 N19-C1'-C2' 109.248 -2.595 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.545 0 C5'-C4'-C3' 111.948 -2.368 . 0.691 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ' C' . . . . . 0.423 " H2'" ' C8 ' ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.424 -2.427 0 O4'-C1'-N19 111.083 2.883 . 0.704 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . 0.423 ' C8 ' " H2'" ' A' ' 3' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.422 -2.585 0 N19-C1'-C2' 108.759 -2.901 . 0.716 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.638 0 N19-C1'-C2' 108.678 -2.951 . 0.725 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.409 0 N19-C1'-C2' 108.983 -2.761 . 0.781 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.469 0 O4'-C1'-N19 111.326 3.126 . 0.805 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.521 0 O4'-C1'-N19 111.175 2.975 . 0.697 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.689 0 C4'-C3'-C2' 99.748 -2.952 . 0.665 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.509 0 O4'-C1'-N19 110.91 2.71 . 0.624 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.34 0 O4'-C1'-N19 111.273 3.073 . 0.631 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ' A' . . . . . 0.42 " O3'" " H4'" ' A' ' 13' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.426 -2.276 1 O4'-C1'-N19 112.71 4.51 . 0.107 1b . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ' U' . . . . . 0.42 " H4'" " O3'" ' A' ' 12' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.941 0 C5'-C4'-C3' 111.309 -2.794 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ' U' . . . . . 0.455 ' C6 ' ' CE2' ' B' ' 288' ' ' PHE . . . . . . . . 0 O4'--C4' 1.427 -2.167 1 O4'-C1'-N19 112.283 4.083 . 0.0 OUTLIER '7D dist 6p' 0.0 . . . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.624 3.132 0 C5'-C4'-C3' 112.765 -1.823 . 0.487 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.615 2.172 0 O4'-C1'-N19 111.214 3.014 . 0.23 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.261 0 N19-C1'-C2' 108.806 -2.871 . 0.642 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.479 0 O4'-C1'-N19 110.765 2.565 . 0.74 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.524 0 O4'-C1'-N19 110.879 2.679 . 0.762 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.352 0 O4'-C1'-N19 110.809 2.609 . 0.688 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.586 0 C5'-C4'-C3' 111.973 -2.352 . 0.74 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.47 0 C5'-C4'-C3' 111.422 -2.719 . 0.824 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.918 0 O4'-C1'-N19 110.716 2.516 . 0.768 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.278 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 39.1 t -154.95 158.62 39.52 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 122.879 0.472 . . . . 0.0 110.356 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -72.81 -16.54 61.61 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.192 0.197 . . . . 0.0 110.534 176.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 279' ' ' MET . . . . . 0.609 ' HG3' ' H ' ' B' ' 281' ' ' ASN . 17.5 tpt -77.75 151.61 34.01 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 122.826 0.45 . . . . 0.0 109.999 177.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -65.39 -12.86 56.28 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 281' ' ' ASN . . . . . 0.609 ' H ' ' HG3' ' B' ' 279' ' ' MET . 9.2 m-20 -81.44 10.67 5.39 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.874 0.47 . . . . 0.0 111.198 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 37.7 t -63.75 -20.39 65.71 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 122.3 -0.25 . . . . 0.0 110.574 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -89.45 7.21 37.18 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.963 0.505 . . . . 0.0 112.175 177.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -137.27 110.26 7.71 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.891 0.377 . . . . 0.0 110.328 -175.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -113.23 6.53 17.47 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.063 0.545 . . . . 0.0 111.53 -178.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 60.6 m -106.73 142.5 36.27 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 120.988 0.423 . . . . 0.0 110.797 -176.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 38.9 pt -116.85 147.38 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 173.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 288' ' ' PHE . . . . . 0.474 ' CE1' ' C6 ' ' A' ' 14' ' ' ' U' . 53.3 t80 -100.78 144.36 29.83 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 174.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 18.4 t -129.72 143.13 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.004 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -131.44 151.61 51.4 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 175.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 88.84 11.77 65.02 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 119.782 -0.455 . . . . 0.0 112.272 169.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 76.4 mt -56.47 -51.37 68.71 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.705 0.752 . . . . 0.0 110.46 -176.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 147.61 174.41 19.51 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 -179.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -99.07 -0.32 42.1 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.879 0.34 . . . . 0.0 111.644 -178.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -128.83 13.0 6.32 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.4 m -73.58 162.8 4.27 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -172.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 47.4 p -130.04 158.18 40.33 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 123.532 0.733 . . . . 0.0 111.129 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 298' ' ' ILE . . . . . 0.566 HG23 ' HB ' ' B' ' 322' ' ' ILE . 30.7 mt -62.41 -44.87 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.506 -179.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -63.13 -34.7 78.17 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.448 0.299 . . . . 0.0 111.609 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 47.0 t -73.64 -44.29 57.3 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 79.2 t -62.45 -40.82 89.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 177.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.77 -36.2 83.55 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 303' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -70.52 -27.95 64.57 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 304' ' ' TYR . . . . . 0.407 ' CE2' ' CD1' ' B' ' 354' ' ' PHE . 60.8 t80 -82.9 -26.42 31.53 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -179.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -96.63 -24.65 15.9 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 179.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 306' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -66.61 -19.25 65.73 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 111.526 0.195 . . . . 0.0 111.526 -177.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -71.01 -19.77 62.48 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -178.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 5.0 mm -88.79 -46.43 15.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 N-CA-C 110.554 -0.165 . . . . 0.0 110.554 175.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.19 167.43 37.49 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 179.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 84.2 mt -68.03 120.44 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-O 120.989 0.423 . . . . 0.0 110.353 -176.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 80.5 mt -74.29 137.37 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 172.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 312' ' ' LYS . . . . . 0.429 ' HE2' ' HB2' ' B' ' 312' ' ' LYS . 22.3 ttmm -69.61 125.48 26.85 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -177.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 2.0 m -94.08 142.95 26.81 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 178.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.96 133.34 38.04 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.77 -9.8 59.56 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.45 0.3 . . . . 0.0 110.334 177.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -108.88 -19.97 13.22 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.948 0.499 . . . . 0.0 111.599 -170.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 13.6 p -124.91 -22.45 4.49 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 81.13 -10.21 49.69 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.911 -0.475 . . . . 0.0 111.911 174.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -88.71 156.29 50.15 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 117.879 0.839 . . . . 0.0 109.568 176.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -70.57 156.28 61.55 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.358 2.038 . . . . 0.0 110.358 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 321' ' ' MET . . . . . 0.404 ' C ' HD12 ' B' ' 322' ' ' ILE . 37.0 mtt -73.08 91.49 1.61 Allowed 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 122.523 0.329 . . . . 0.0 111.685 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 322' ' ' ILE . . . . . 0.566 ' HB ' HG23 ' B' ' 298' ' ' ILE . 4.1 mp -136.6 139.89 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 170.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -135.21 111.05 9.36 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 25.0 mt -81.44 151.96 27.62 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 176.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -115.99 152.34 33.7 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 177.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.9 146.14 51.54 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -174.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -78.59 133.77 37.27 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 21.6 mtp180 -88.66 -8.27 54.91 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.217 0.207 . . . . 0.0 110.905 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -97.8 -14.59 20.7 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.621 0.368 . . . . 0.0 111.925 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 2.9 p -136.56 -22.62 1.27 Allowed 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 83.01 0.48 90.34 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 176.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -84.02 158.85 21.34 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 117.703 0.752 . . . . 0.0 109.4 176.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 39.5 mt -72.02 142.54 49.31 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -71.82 -15.1 62.14 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 123.6 0.76 . . . . 0.0 110.442 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.13 3.59 76.06 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -172.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -103.56 150.05 24.31 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.163 0.585 . . . . 0.0 110.104 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -162.81 157.55 21.58 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.705 177.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 7.6 p -105.31 152.67 22.62 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 170.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 38.2 t -135.78 126.17 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 123.597 0.759 . . . . 0.0 109.056 170.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 340' ' ' SER . . . . . 0.401 ' HB3' ' CB ' ' B' ' 321' ' ' MET . 48.3 t -105.39 139.2 40.38 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.701 0.286 . . . . 0.0 110.983 -178.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -104.57 159.76 15.49 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -178.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -72.08 -31.61 66.25 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -130.98 149.85 74.92 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 344' ' ' PRO . . . . . 0.474 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 40.7 Cg_endo -70.27 -32.12 17.02 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 123.256 2.637 . . . . 0.0 114.396 -177.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 345' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 74.0 Cg_endo -73.68 -21.34 19.19 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 CA-C-N 121.255 1.484 . . . . 0.0 110.199 -177.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 57.6 m -72.09 -36.3 69.46 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 175.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -67.28 -38.64 85.4 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 174.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -63.63 -43.96 95.27 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.23 -34.67 76.67 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 122.227 -0.296 . . . . 0.0 110.542 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.64 -37.18 86.71 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 61.5 mt -69.58 -51.85 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.86 175.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -53.19 -30.63 38.55 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 53.8 t-105 -97.09 -55.39 2.87 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -176.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 354' ' ' PHE . . . . . 0.407 ' CD1' ' CE2' ' B' ' 304' ' ' TYR . 51.9 m-85 -76.35 -26.94 56.22 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -173.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -49.22 109.16 0.24 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 177.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 97.3 -0.32 60.01 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 119.508 -0.606 . . . . 0.0 112.499 174.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -83.25 -165.74 1.17 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 118.203 1.001 . . . . 0.0 110.374 176.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -127.99 154.96 45.01 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.387 0.613 . . . . 0.0 111.233 177.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -145.71 136.44 24.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.531 1.133 . . . . 0.0 112.247 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 13.3 t 54.89 18.11 2.07 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.711 0.291 . . . . 0.0 111.346 -175.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 88.4 22.92 38.75 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.963 -0.455 . . . . 0.0 111.963 178.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 51.6 m-20 -132.64 142.16 43.8 Favored Pre-proline 0 N--CA 1.457 -0.112 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -177.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.27 135.97 33.05 Favored 'Trans proline' 0 N--CA 1.446 -1.305 0 C-N-CA 122.895 2.397 . . . . 0.0 109.532 178.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 29.8 pt -122.56 171.4 11.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 121.176 0.513 . . . . 0.0 111.009 -177.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -144.45 115.38 7.83 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.781 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 11.7 t -105.9 147.63 11.27 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 C-N-CA 123.174 0.59 . . . . 0.0 112.165 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 22.6 t -162.71 173.04 14.37 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 176.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -70.1 130.17 41.4 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 176.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -89.13 -179.91 6.0 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.053 -178.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 10.5 t -148.13 -156.01 0.68 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.796 1.238 . . . . 0.0 107.918 173.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 31.8 mtp-105 -121.88 90.61 3.34 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 118.715 0.689 . . . . 0.0 111.31 173.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -69.03 -13.31 62.38 Favored 'General case' 0 C--N 1.334 -0.073 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 169.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -63.55 -22.2 66.76 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 122.807 0.443 . . . . 0.0 110.338 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -63.34 -18.33 63.52 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.477 0.311 . . . . 0.0 110.894 -176.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -71.83 -12.75 61.43 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 177.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -138.01 -14.86 1.35 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.967 0 CA-C-O 116.467 -1.73 . . . . 0.0 110.68 177.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.457 0 N19-C1'-C2' 108.981 -2.762 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.427 0 C5'-C4'-C3' 111.622 -2.585 . 0.714 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.516 0 O4'-C1'-N19 110.862 2.662 . 0.803 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.595 0 N19-C1'-C2' 108.868 -2.833 . 0.687 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.513 0 N19-C1'-C2' 108.912 -2.805 . 0.699 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.485 0 N19-C1'-C2' 108.956 -2.778 . 0.729 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.757 0 O4'-C1'-N19 111.34 3.14 . 0.817 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.514 0 C4'-C3'-C2' 99.956 -2.744 . 0.737 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.803 0 C4'-C3'-C2' 99.956 -2.744 . 0.668 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.585 0 C4'-C3'-C2' 99.877 -2.823 . 0.618 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.624 0 C4'-C3'-C2' 99.931 -2.769 . 0.379 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.377 1 O4'-C1'-N19 112.242 4.042 . 0.105 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.847 1 C5'-C4'-C3' 109.414 -4.058 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ' U' . . . . . 0.474 ' C6 ' ' CE1' ' B' ' 288' ' ' PHE . . . . . . . . 0 O4'--C4' 1.425 -2.305 0 O4'-C1'-N19 112.08 3.88 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.623 2.991 0 C5'-C4'-C3' 112.205 -2.197 . 0.46 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.225 0 O4'-C1'-N19 111.242 3.042 . 0.272 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.541 0 N19-C1'-C2' 109.689 -2.32 . 0.627 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.367 0 O4'-C1'-N19 111.106 2.906 . 0.7 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.509 0 O4'-C1'-N19 111.011 2.811 . 0.75 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.369 0 O4'-C1'-N19 110.821 2.621 . 0.71 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.437 0 C5'-C4'-C3' 111.905 -2.397 . 0.707 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.732 0 C5'-C4'-C3' 111.601 -2.599 . 0.789 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.7 0 C5'-C4'-C3' 112.15 -2.233 . 0.811 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.131 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 88.7 p -70.16 162.55 28.12 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.806 0.303 . . . . 0.0 110.707 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -70.35 161.89 29.59 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 178.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 279' ' ' MET . . . . . 0.557 ' HG2' ' H ' ' B' ' 281' ' ' ASN . 51.1 ttp -67.57 142.55 56.46 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.458 0.303 . . . . 0.0 110.827 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -72.16 -23.41 61.28 Favored 'General case' 0 CA--C 1.527 0.088 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -177.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 281' ' ' ASN . . . . . 0.557 ' H ' ' HG2' ' B' ' 279' ' ' MET . 35.6 m-20 -83.15 26.86 0.6 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.994 0.518 . . . . 0.0 111.507 -178.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 35.5 t -64.53 -15.53 61.07 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 122.011 -0.431 . . . . 0.0 110.686 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 26.2 p30 -98.89 4.7 47.5 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.366 0.667 . . . . 0.0 112.173 177.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -131.02 110.17 11.03 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.078 0.465 . . . . 0.0 110.133 -177.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.5 11.9 18.5 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.431 0.692 . . . . 0.0 111.443 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 28.2 m -113.49 143.96 43.64 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.866 0.365 . . . . 0.0 111.603 -174.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 32.1 pt -122.02 146.82 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 175.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -100.33 144.24 29.57 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 174.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 20.4 t -129.83 142.24 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 122.808 0.443 . . . . 0.0 111.008 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -129.82 151.98 49.81 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.128 -0.694 . . . . 0.0 109.128 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.61 11.89 67.78 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-O 119.911 -0.383 . . . . 0.0 112.448 169.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 75.4 mt -55.42 -50.27 70.24 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 117.625 0.713 . . . . 0.0 110.679 -175.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 145.71 174.07 17.56 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -100.98 2.16 40.38 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -178.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -128.64 13.94 6.46 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.792 0.437 . . . . 0.0 111.795 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.6 m -75.56 165.32 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -172.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 26.7 p -131.81 160.53 35.35 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.587 0.755 . . . . 0.0 111.969 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 298' ' ' ILE . . . . . 0.522 HG23 ' HB ' ' B' ' 322' ' ' ILE . 48.3 mt -63.82 -43.71 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.099 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.6 -36.6 84.76 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 122.428 0.291 . . . . 0.0 111.499 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 45.4 t -71.82 -46.26 58.72 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.792 0.269 . . . . 0.0 110.795 -177.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 8.2 p -68.33 -32.55 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.271 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -66.76 -32.66 74.09 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 303' ' ' ASP . . . . . 0.409 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.0 t0 -74.15 -27.58 60.91 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 304' ' ' TYR . . . . . 0.417 ' CE1' ' CD2' ' B' ' 354' ' ' PHE . 67.7 t80 -84.19 -24.36 30.16 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -97.01 -24.41 15.81 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 178.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 306' ' ' LYS . . . . . 0.409 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.8 ptpt -66.13 -17.86 64.98 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -177.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -71.78 -20.67 61.83 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 5.1 mm -86.81 -46.09 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 N-CA-C 110.525 -0.176 . . . . 0.0 110.525 175.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.58 165.86 37.01 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.346 -0.701 . . . . 0.0 111.346 178.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 79.5 mt -66.81 119.46 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 122.586 0.354 . . . . 0.0 110.642 -176.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 94.5 mt -72.06 135.55 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 172.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -70.87 130.69 42.32 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -178.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 3.2 m -91.67 142.35 27.7 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 178.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -70.11 128.16 35.33 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 315' ' ' LYS . . . . . 0.587 ' HE3' ' HA ' ' B' ' 315' ' ' LYS . 0.2 OUTLIER -78.91 -8.79 59.17 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 122.537 0.335 . . . . 0.0 111.011 176.072 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 18.7 mmmt -107.0 -19.61 13.57 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.421 0.288 . . . . 0.0 110.592 -172.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 19.0 p -133.28 -21.08 2.08 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -175.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 82.28 -9.71 56.9 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-O 119.74 -0.478 . . . . 0.0 112.449 175.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -84.1 158.27 61.62 Favored Pre-proline 0 CA--C 1.53 0.207 0 CA-C-N 118.01 0.905 . . . . 0.0 108.944 174.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.54 154.95 70.59 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.105 1.87 . . . . 0.0 110.032 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 321' ' ' MET . . . . . 0.406 ' CB ' ' HB3' ' B' ' 340' ' ' SER . 37.1 mtt -72.64 95.0 1.79 Allowed 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 120.906 0.384 . . . . 0.0 111.757 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 322' ' ' ILE . . . . . 0.522 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.5 mp -141.31 141.05 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 173.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -132.75 107.31 8.28 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 174.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 36.6 mt -80.04 154.78 27.93 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -122.7 149.2 44.38 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 176.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 8.7 m -135.49 149.03 49.41 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -174.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -74.39 127.52 33.24 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' B' ' 328' ' ' ARG . 25.9 mtp180 -80.32 -6.39 57.88 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 122.483 -0.135 . . . . 0.0 110.817 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -99.54 -13.84 19.28 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.72 0.408 . . . . 0.0 111.893 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 2.9 p -135.71 -25.53 1.27 Allowed 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 75.28 12.37 83.58 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 119.751 -0.471 . . . . 0.0 112.092 172.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -73.75 -108.42 0.01 OUTLIER 'General case' 0 C--N 1.343 0.315 0 C-N-CA 123.316 0.646 . . . . 0.0 110.536 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 5.9 mt -158.67 144.65 16.82 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.357 1.063 . . . . 0.0 108.424 172.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? -80.11 -19.64 46.9 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 122.287 0.235 . . . . 0.0 110.579 178.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.01 5.44 80.29 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -172.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -102.74 147.38 26.92 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.591 0.756 . . . . 0.0 110.313 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -164.17 158.23 18.89 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.639 0.257 . . . . 0.0 111.423 177.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 32.2 p -104.12 153.3 21.09 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 169.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 40.6 t -136.81 130.94 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 171.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 340' ' ' SER . . . . . 0.406 ' HB3' ' CB ' ' B' ' 321' ' ' MET . 41.9 t -108.66 149.54 28.8 Favored 'General case' 0 N--CA 1.46 0.072 0 CA-C-O 120.672 0.272 . . . . 0.0 111.425 -178.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -115.27 157.82 23.22 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -70.46 -32.53 70.13 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -129.86 149.05 71.97 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -178.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 344' ' ' PRO . . . . . 0.469 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 41.0 Cg_endo -69.95 -32.42 17.81 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.198 2.599 . . . . 0.0 114.537 -176.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 345' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 92.7 Cg_endo -74.16 -20.95 18.45 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 CA-C-N 120.874 1.348 . . . . 0.0 110.315 -177.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 68.3 m -71.05 -37.84 72.54 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 175.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.62 -38.18 86.41 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 174.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -64.69 -42.38 95.36 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -69.33 -34.1 74.11 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 110.48 -0.192 . . . . 0.0 110.48 178.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -63.87 -38.02 89.56 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 67.8 mt -68.08 -53.43 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 120.369 -0.532 . . . . 0.0 109.658 175.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -55.54 -27.72 50.55 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -178.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -96.6 -55.22 2.98 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 354' ' ' PHE . . . . . 0.417 ' CD2' ' CE1' ' B' ' 304' ' ' TYR . 48.9 m-85 -76.2 -27.0 56.7 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -173.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -49.18 108.43 0.19 Allowed 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 176.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 96.57 1.03 60.58 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-N 116.154 -0.475 . . . . 0.0 113.068 174.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -82.97 -164.47 0.88 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 117.89 0.845 . . . . 0.0 110.17 176.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -129.46 152.21 49.25 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-O 121.006 0.432 . . . . 0.0 110.982 178.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -145.08 137.27 25.86 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.891 0.877 . . . . 0.0 112.334 178.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 22.0 t 54.73 18.31 2.06 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.69 0.281 . . . . 0.0 111.196 -175.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.65 23.39 39.53 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -132.9 142.94 46.55 Favored Pre-proline 0 N--CA 1.457 -0.09 0 CA-C-N 117.537 0.668 . . . . 0.0 109.312 -177.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.24 135.51 31.89 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 123.148 2.565 . . . . 0.0 109.738 177.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 30.8 pt -123.03 170.43 13.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.122 0.487 . . . . 0.0 111.176 -177.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -144.31 116.91 8.64 Favored 'General case' 0 C--O 1.228 -0.071 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.898 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 366' ' ' VAL . . . . . 0.402 HG21 ' HB2' ' B' ' 354' ' ' PHE . 12.6 t -106.13 149.0 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 C-N-CA 123.088 0.555 . . . . 0.0 112.124 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 22.6 t -163.27 172.92 14.01 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 177.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -69.94 129.68 40.14 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 176.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -87.51 175.92 7.71 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.096 0.474 . . . . 0.0 111.608 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 10.2 t -143.19 -146.52 0.19 Allowed 'General case' 0 C--O 1.234 0.241 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 172.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 26.7 mtp180 -131.9 86.93 2.39 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 119.015 0.825 . . . . 0.0 111.105 172.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -63.34 -16.14 59.52 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 169.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -63.98 -29.53 70.68 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.449 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -65.04 -10.72 32.16 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -176.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -78.99 -11.76 60.02 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 175.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -137.47 -3.2 1.92 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -174.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 . . . . . 0 C--O 1.252 1.201 0 CA-C-O 116.973 -1.489 . . . . 0.0 110.493 174.948 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.558 0 N19-C1'-C2' 108.962 -2.774 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.659 0 C5'-C4'-C3' 111.732 -2.512 . 0.665 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.397 0 N19-C1'-C2' 108.771 -2.893 . 0.805 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.627 0 N19-C1'-C2' 108.69 -2.944 . 0.748 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.43 0 N19-C1'-C2' 108.671 -2.956 . 0.682 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.444 0 N19-C1'-C2' 108.723 -2.923 . 0.733 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.533 0 O4'-C1'-N19 111.058 2.858 . 0.797 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.545 0 C4'-C3'-C2' 99.663 -3.037 . 0.69 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.477 0 C4'-C3'-C2' 99.771 -2.929 . 0.634 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.641 0 O4'-C1'-N19 110.976 2.776 . 0.607 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.587 0 O4'-C1'-N19 110.794 2.594 . 0.593 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.349 0 O4'-C1'-N19 112.194 3.994 . 0.209 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.533 0 C5'-C4'-C3' 109.72 -3.854 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.504 1 C5'-C4'-C3' 108.328 -4.781 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.81 0 C5'-C4'-C3' 111.433 -2.711 . 0.182 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.616 2.337 0 N19-C1'-C2' 108.574 -3.016 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.52 0 N19-C1'-C2' 108.28 -3.2 . 0.755 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.425 0 C5'-C4'-C3' 111.464 -2.691 . 0.767 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.436 0 O4'-C1'-N19 111.014 2.814 . 0.745 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.516 0 O4'-C1'-N19 111.154 2.954 . 0.644 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.72 0 C4'-C3'-C2' 100.378 -2.322 . 0.715 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.577 0 C5'-C4'-C3' 111.452 -2.699 . 0.816 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.805 0 N19-C1'-C2' 109.706 -2.309 . 0.812 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.121 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 66.3 m 55.69 29.23 13.36 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.33 0.652 . . . . 0.0 112.287 178.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -63.31 157.16 23.59 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.737 0.303 . . . . 0.0 110.52 178.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 46.7 ttm -153.24 147.7 26.0 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.57 0.348 . . . . 0.0 110.245 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -72.58 121.48 19.78 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 122.688 0.395 . . . . 0.0 110.631 178.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -139.11 25.35 2.49 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.478 0.711 . . . . 0.0 110.748 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 69.3 m -69.39 0.63 4.82 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 122.582 0.353 . . . . 0.0 111.252 177.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 38.1 p30 -139.4 19.84 2.56 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.804 0.842 . . . . 0.0 111.118 179.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -134.38 122.6 22.81 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.961 0.41 . . . . 0.0 111.072 -177.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . 0.403 HD22 ' C ' ' B' ' 285' ' ' ASN . 0.3 OUTLIER -113.65 9.51 17.84 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.374 0.67 . . . . 0.0 111.691 178.01 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 72.1 m -109.07 145.39 35.71 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.024 0.44 . . . . 0.0 111.152 -173.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 46.1 pt -121.9 149.6 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 288' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -102.67 145.53 29.54 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 175.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 289' ' ' VAL . . . . . 0.553 HG11 HD13 ' B' ' 292' ' ' LEU . 57.5 t -128.26 136.61 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.412 -178.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -127.23 153.95 45.46 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 176.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 84.31 12.22 76.47 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 173.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 292' ' ' LEU . . . . . 0.553 HD13 HG11 ' B' ' 289' ' ' VAL . 4.6 tp -59.1 -49.36 78.18 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.984 0.914 . . . . 0.0 111.219 -170.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 146.59 167.11 12.64 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 176.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -95.38 -1.19 51.62 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.341 0.257 . . . . 0.0 111.312 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -130.67 14.69 5.4 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.5 m -68.58 164.85 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -173.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 77.5 p -135.17 156.76 48.44 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 123.838 0.855 . . . . 0.0 109.782 177.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 298' ' ' ILE . . . . . 0.582 HG23 ' HB ' ' B' ' 322' ' ' ILE . 29.6 mt -61.94 -43.74 97.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.626 -178.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -64.25 -34.24 77.67 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 47.7 t -72.58 -45.36 59.54 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 117.864 0.302 . . . . 0.0 110.482 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 72.5 t -62.16 -41.63 92.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.93 -36.02 83.04 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 303' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -69.74 -29.66 67.08 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 304' ' ' TYR . . . . . 0.401 ' CE1' ' CD2' ' B' ' 354' ' ' PHE . 56.3 t80 -82.52 -25.89 33.01 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -96.46 -24.47 16.09 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 306' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -67.15 -18.56 65.34 Favored 'General case' 0 N--CA 1.461 0.077 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -176.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -71.69 -19.73 62.03 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 5.2 mm -88.43 -46.28 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.092 0 CA-C-N 117.729 0.241 . . . . 0.0 110.471 175.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -163.83 170.53 39.17 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 83.5 mt -70.06 120.18 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 122.675 0.39 . . . . 0.0 110.352 -175.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 87.7 mt -73.83 138.9 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 172.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -71.03 130.3 41.19 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -178.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 4.0 m -92.6 138.23 31.68 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -70.09 128.93 38.01 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 174.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -82.92 -14.24 54.54 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -93.73 -20.72 19.86 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 122.652 0.381 . . . . 0.0 110.447 -176.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 7.2 p -129.22 -24.89 2.79 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -174.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 83.77 -9.18 63.29 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-O 119.874 -0.403 . . . . 0.0 112.3 174.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -84.1 156.47 63.55 Favored Pre-proline 0 C--O 1.234 0.254 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 174.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.92 157.09 61.23 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.147 1.898 . . . . 0.0 110.262 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 321' ' ' MET . . . . . 0.482 ' C ' HD12 ' B' ' 322' ' ' ILE . 34.2 mtt -74.94 86.02 2.27 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 120.913 0.387 . . . . 0.0 111.895 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 322' ' ' ILE . . . . . 0.582 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.4 mp -130.65 137.64 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 169.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -133.64 110.72 10.07 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.508 176.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 20.3 mt -78.75 151.77 31.88 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.334 0.654 . . . . 0.0 109.362 177.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -117.58 147.29 42.97 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 177.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 4.7 m -130.2 148.4 52.03 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -176.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -77.91 128.01 33.27 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 60.4 mtm180 -80.8 -8.06 59.59 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 121.245 -0.182 . . . . 0.0 110.6 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -93.87 -14.31 26.23 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 2.7 p -136.29 -26.26 1.14 Allowed 'General case' 0 C--N 1.341 0.233 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 76.17 11.99 84.47 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 119.936 -0.369 . . . . 0.0 112.185 174.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -76.76 -107.16 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 117.434 0.617 . . . . 0.0 110.136 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 6.3 mt -157.48 146.11 19.48 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.521 1.128 . . . . 0.0 108.076 171.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 10.5 mmmm -75.97 -20.8 57.61 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 122.639 0.376 . . . . 0.0 110.914 -179.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.77 21.87 73.47 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -172.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -127.61 144.87 51.03 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.013 0.525 . . . . 0.0 110.242 -177.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 337' ' ' ALA . . . . . . . . . . . . . . . -155.21 155.37 33.75 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.584 0.231 . . . . 0.0 111.229 172.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 1.9 p -96.12 152.28 18.69 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 170.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 23.2 t -134.29 125.65 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 169.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 22.8 t -106.03 141.86 36.7 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.618 -177.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -107.79 158.54 17.22 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -73.06 -31.72 64.59 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -130.07 147.99 67.85 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -178.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 344' ' ' PRO . . . . . 0.469 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 47.7 Cg_endo -71.64 -30.9 14.11 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 123.389 2.726 . . . . 0.0 114.672 -176.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 345' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 78.3 Cg_endo -73.83 -22.52 17.5 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 CA-C-N 121.326 1.509 . . . . 0.0 109.946 -177.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 71.1 m -71.68 -35.71 70.39 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 175.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -68.72 -38.03 79.9 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 175.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -63.87 -44.56 92.72 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.04 -33.6 74.89 Favored 'General case' 0 N--CA 1.455 -0.175 0 O-C-N 122.474 -0.141 . . . . 0.0 110.63 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.14 -37.69 88.24 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 67.6 mt -68.78 -53.68 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.929 174.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -54.21 -28.67 42.45 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -178.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 56.8 t-105 -95.89 -56.27 2.72 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 354' ' ' PHE . . . . . 0.401 ' CD2' ' CE1' ' B' ' 304' ' ' TYR . 47.3 m-85 -75.99 -25.59 55.94 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -173.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -45.86 107.51 0.1 Allowed 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 175.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 92.64 3.36 66.56 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 119.515 -0.603 . . . . 0.0 113.058 174.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -82.37 -170.84 3.13 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.178 0.989 . . . . 0.0 111.201 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -112.21 150.15 31.28 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.684 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -146.12 130.8 17.93 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.654 0.782 . . . . 0.0 112.52 173.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 17.5 t 54.71 19.65 2.6 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.807 0.443 . . . . 0.0 111.089 -176.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.16 28.3 25.8 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 111.921 -0.472 . . . . 0.0 111.921 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -140.01 142.69 31.4 Favored Pre-proline 0 N--CA 1.456 -0.157 0 CA-C-N 117.385 0.592 . . . . 0.0 109.62 -177.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.97 136.27 32.01 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.814 2.343 . . . . 0.0 110.019 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 31.8 pt -124.79 170.27 15.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 121.103 0.478 . . . . 0.0 110.979 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -142.73 116.54 9.28 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.229 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 11.6 t -104.58 147.89 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 123.115 0.566 . . . . 0.0 111.78 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 24.4 t -162.41 172.23 15.9 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 177.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -70.06 128.65 37.05 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 177.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -91.18 -179.5 5.44 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.345 0.593 . . . . 0.0 111.996 -178.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 13.8 t -150.44 -164.35 2.0 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.69 1.196 . . . . 0.0 109.025 174.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 68.1 mtt180 -117.9 91.24 3.51 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 118.378 0.535 . . . . 0.0 110.263 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -60.53 -18.22 50.75 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 172.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -64.32 -8.96 14.79 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.35 0.66 . . . . 0.0 111.493 176.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -113.91 -10.88 12.89 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -175.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -135.83 -23.03 1.39 Allowed 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -85.07 -1.76 57.21 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 . . . . . 0 C--O 1.25 1.124 0 CA-C-O 117.495 -1.241 . . . . 0.0 110.241 179.835 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.675 0 N19-C1'-C2' 108.938 -2.789 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.692 0 O4'-C1'-N19 110.645 2.445 . 0.656 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.329 0 N19-C1'-C2' 109.062 -2.711 . 0.708 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.368 0 N19-C1'-C2' 109.167 -2.645 . 0.801 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.53 0 N19-C1'-C2' 108.764 -2.898 . 0.677 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.569 0 N19-C1'-C2' 108.972 -2.768 . 0.816 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.609 0 O4'-C1'-N19 110.98 2.78 . 0.816 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.432 0 O4'-C1'-N19 111.186 2.986 . 0.725 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.541 0 C4'-C3'-C2' 99.749 -2.951 . 0.648 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.438 0 O4'-C1'-N19 111.468 3.268 . 0.533 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.552 0 C4'-C3'-C2' 100.203 -2.497 . 0.553 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.452 0 O4'-C1'-N19 111.917 3.717 . 0.229 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.877 1 C5'-C4'-C3' 108.612 -4.592 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.517 0 O4'-C1'-N19 111.816 3.616 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.621 2.762 0 O4'-C1'-N19 111.546 3.346 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.298 0 O4'-C1'-N19 111.311 3.111 . 0.309 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.616 2.348 0 N19-C1'-C2' 108.463 -3.085 . 0.552 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.38 0 O4'-C1'-N19 110.918 2.718 . 0.792 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.624 0 O4'-C1'-N19 110.98 2.78 . 0.769 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.373 0 O4'-C1'-N19 111.191 2.991 . 0.664 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.524 0 C5'-C4'-C3' 112.015 -2.323 . 0.74 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.752 0 C5'-C4'-C3' 111.353 -2.765 . 0.768 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.752 0 N19-C1'-C2' 109.694 -2.317 . 0.765 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.192 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 46.4 t -68.12 155.51 39.44 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.536 0.334 . . . . 0.0 110.77 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 278' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 -154.95 147.83 24.55 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 122.854 0.462 . . . . 0.0 109.969 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 279' ' ' MET . . . . . . . . . . . . . 96.9 mmm -140.18 156.77 46.38 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 123.162 0.585 . . . . 0.0 110.44 -178.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 280' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -66.61 -12.72 59.31 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 281' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -78.46 8.62 4.89 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 45.9 t -64.38 -25.26 67.95 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 174.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -100.62 14.54 31.11 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.598 0.759 . . . . 0.0 111.515 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -125.02 110.42 14.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -175.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -113.49 5.87 16.86 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.931 -178.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 286' ' ' THR . . . . . . . . . . . . . 99.4 m -111.24 146.63 36.62 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.211 0.529 . . . . 0.0 110.369 -176.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 287' ' ' ILE . . . . . . . . . . . . . 39.8 pt -119.04 146.89 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.227 175.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 288' ' ' PHE . . . . . 0.425 ' CE2' ' C6 ' ' A' ' 14' ' ' ' U' . 52.0 t80 -96.97 145.5 25.86 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 173.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 289' ' ' VAL . . . . . . . . . . . . . 18.0 t -131.3 142.23 43.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 O-C-N 123.211 0.319 . . . . 0.0 111.148 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 290' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -131.17 150.37 52.18 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 177.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . 87.81 12.99 65.48 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 119.776 -0.458 . . . . 0.0 112.402 169.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 292' ' ' LEU . . . . . . . . . . . . . 65.5 mt -57.29 -49.95 74.47 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 117.653 0.726 . . . . 0.0 110.645 -175.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . 146.47 175.41 19.44 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 294' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -101.3 0.23 36.87 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.898 0.349 . . . . 0.0 111.861 -177.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 295' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -128.66 13.91 6.45 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.57 0.348 . . . . 0.0 111.666 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 296' ' ' VAL . . . . . . . . . . . . . 3.5 m -75.33 166.7 2.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -172.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 14.1 p -131.36 162.15 30.77 Favored 'General case' 0 CA--C 1.522 -0.11 0 C-N-CA 123.744 0.818 . . . . 0.0 112.596 -177.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 298' ' ' ILE . . . . . 0.576 HG23 ' HB ' ' B' ' 322' ' ' ILE . 44.1 mt -62.88 -45.45 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.347 178.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 299' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -69.79 -33.51 72.48 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -178.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 300' ' ' SER . . . . . . . . . . . . . 80.9 p -72.41 -44.66 62.14 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 118.398 0.544 . . . . 0.0 110.37 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 301' ' ' VAL . . . . . . . . . . . . . 9.5 p -68.35 -33.76 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 O-C-N 121.917 -0.489 . . . . 0.0 110.668 176.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.58 -33.48 76.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 175.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 303' ' ' ASP . . . . . 0.425 ' HA ' ' HE3' ' B' ' 306' ' ' LYS . 45.3 t0 -73.7 -27.32 61.15 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 304' ' ' TYR . . . . . 0.408 ' CE1' ' CD1' ' B' ' 354' ' ' PHE . 59.5 t80 -83.23 -25.85 31.31 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 305' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -96.67 -25.48 15.54 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 178.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 306' ' ' LYS . . . . . 0.425 ' HE3' ' HA ' ' B' ' 303' ' ' ASP . 18.9 ptpt -65.86 -18.09 65.1 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -177.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 307' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -72.67 -20.06 61.31 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 122.169 -0.332 . . . . 0.0 111.82 -178.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 4.1 mm -86.29 -46.87 16.62 Favored 'Isoleucine or valine' 0 C--N 1.338 0.071 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 174.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -162.51 166.06 36.44 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 310' ' ' ILE . . . . . . . . . . . . . 85.6 mt -68.22 121.31 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 C-N-CA 122.604 0.362 . . . . 0.0 110.595 -175.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 94.9 mt -73.94 136.06 26.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 172.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 312' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -70.43 133.0 46.45 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -178.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 313' ' ' THR . . . . . . . . . . . . . 4.5 m -93.23 136.97 33.0 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 178.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -66.4 126.21 28.08 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 174.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 315' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? -82.07 -13.02 57.92 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.392 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -95.31 -23.94 16.98 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 122.381 0.272 . . . . 0.0 110.703 -175.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 317' ' ' THR . . . . . . . . . . . . . 14.6 p -125.39 -24.41 3.94 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -175.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 318' ' ' GLY . . . . . . . . . . . . . . . 84.92 -9.49 65.77 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 119.719 -0.489 . . . . 0.0 112.245 174.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 319' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -82.85 156.91 67.32 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 118.073 0.937 . . . . 0.0 108.626 174.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 320' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.24 154.61 65.67 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 121.907 1.738 . . . . 0.0 109.993 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 321' ' ' MET . . . . . . . . . . . . . 35.3 mtt -71.86 95.48 1.54 Allowed 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 120.814 0.34 . . . . 0.0 111.482 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 322' ' ' ILE . . . . . 0.576 ' HB ' HG23 ' B' ' 298' ' ' ILE . 3.3 mp -144.51 145.68 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 175.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 323' ' ' ASN . . . . . 0.409 ' O ' ' HA ' ' B' ' 337' ' ' ALA . 18.1 m-80 -134.04 129.16 35.68 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 171.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 324' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -97.95 139.59 33.56 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 325' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -105.81 149.43 26.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 179.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -133.93 146.3 50.37 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -173.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 327' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -75.62 134.53 40.62 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 -87.7 -10.7 50.43 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.281 0.232 . . . . 0.0 111.09 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -97.29 -13.94 21.64 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.936 0.495 . . . . 0.0 111.695 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 3.7 p -136.78 -21.06 1.28 Allowed 'General case' 0 C--O 1.232 0.174 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -178.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . 79.18 2.13 86.76 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 176.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 332' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -88.8 157.34 18.51 Favored 'General case' 0 C--O 1.228 -0.041 0 CA-C-N 117.794 0.797 . . . . 0.0 109.502 178.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 333' ' ' LEU . . . . . . . . . . . . . 41.0 mt -69.88 141.9 53.11 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.86 0.362 . . . . 0.0 110.557 -176.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -73.92 -16.16 61.11 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.178 0.591 . . . . 0.0 110.302 178.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 335' ' ' GLY . . . . . . . . . . . . . . . 75.95 5.51 80.17 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -171.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -100.05 149.22 23.71 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.491 0.716 . . . . 0.0 110.164 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 337' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' B' ' 323' ' ' ASN . . . -161.14 166.26 28.22 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 120.871 0.367 . . . . 0.0 111.398 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 338' ' ' THR . . . . . . . . . . . . . 2.7 p -118.71 149.84 40.76 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 169.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 42.8 t -135.58 123.21 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 171.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 340' ' ' SER . . . . . . . . . . . . . 16.0 t -102.04 137.99 39.58 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.001 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -101.75 161.67 13.48 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 342' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -74.42 -26.06 59.83 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 343' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -137.24 149.48 65.99 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -176.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 344' ' ' PRO . . . . . 0.469 ' N ' ' HD2' ' B' ' 345' ' ' PRO . 41.6 Cg_endo -70.79 -32.25 14.59 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.391 2.727 . . . . 0.0 114.39 -177.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 345' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' B' ' 344' ' ' PRO . 79.2 Cg_endo -73.89 -22.11 17.82 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 CA-C-N 121.324 1.509 . . . . 0.0 110.075 -177.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 61.2 m -71.81 -37.64 70.35 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 175.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 347' ' ' ALA . . . . . . . . . . . . . . . -67.05 -37.66 84.46 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 174.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 348' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -64.82 -43.52 92.83 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.94 -34.22 75.0 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 110.675 -0.12 . . . . 0.0 110.675 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.41 -36.41 84.07 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 351' ' ' ILE . . . . . . . . . . . . . 64.4 mt -69.73 -52.62 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 120.357 -0.537 . . . . 0.0 109.758 175.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -55.82 -28.14 54.84 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 353' ' ' TRP . . . . . . . . . . . . . 59.8 t-105 -96.79 -54.88 3.07 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -177.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 354' ' ' PHE . . . . . 0.408 ' CD1' ' CE1' ' B' ' 304' ' ' TYR . 50.7 m-85 -78.36 -29.86 47.72 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -174.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 355' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -51.17 110.77 0.47 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.222 0.465 . . . . 0.0 111.839 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . 99.7 -2.18 57.09 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 119.541 -0.588 . . . . 0.0 112.715 175.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -83.54 -163.71 0.8 Allowed 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.065 0.932 . . . . 0.0 110.641 177.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 358' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -128.53 155.6 44.61 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 121.315 0.579 . . . . 0.0 111.356 178.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 359' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -146.78 136.73 23.33 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 124.637 1.175 . . . . 0.0 112.007 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 360' ' ' SER . . . . . . . . . . . . . 64.2 m 52.73 19.53 1.29 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -173.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.51 23.4 39.91 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 362' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -133.0 141.48 41.13 Favored Pre-proline 0 N--CA 1.453 -0.29 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -178.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.6 135.37 30.66 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 122.862 2.375 . . . . 0.0 109.611 178.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 364' ' ' ILE . . . . . . . . . . . . . 27.0 pt -122.48 170.82 12.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 121.187 0.518 . . . . 0.0 110.807 -177.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 365' ' ' LYS . . . . . . . . . . . . . 9.7 tmtm? -145.66 117.93 8.42 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.537 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 366' ' ' VAL . . . . . . . . . . . . . 10.9 t -105.48 150.13 8.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 C-N-CA 123.324 0.65 . . . . 0.0 112.01 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 367' ' ' SER . . . . . . . . . . . . . 30.0 t -162.27 173.88 13.61 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 176.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 368' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -71.16 130.24 40.97 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 176.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -87.18 -174.51 4.91 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.696 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 370' ' ' THR . . . . . . . . . . . . . 15.3 t -157.47 -172.77 4.11 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.326 1.05 . . . . 0.0 109.27 176.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 371' ' ' ARG . . . . . . . . . . . . . 20.3 mmt85 -98.81 67.01 1.66 Allowed 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 372' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 -60.52 -16.84 41.23 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 173.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.71 -31.25 69.43 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.818 0.847 . . . . 0.0 110.989 173.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 374' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -67.1 -9.32 38.34 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -173.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 375' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -92.37 -19.73 21.78 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 175.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 376' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -93.53 -40.78 10.12 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 122.5 0.32 . . . . 0.0 111.524 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 377' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 . . . . . 0 C--O 1.25 1.111 0 CA-C-O 117.573 -1.203 . . . . 0.0 110.192 -176.791 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.581 0 N19-C1'-C2' 109.003 -2.748 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.699 0 C5'-C4'-C3' 112.213 -2.191 . 0.707 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.299 0 N19-C1'-C2' 108.68 -2.95 . 0.696 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.6 0 N19-C1'-C2' 108.909 -2.807 . 0.829 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.392 0 N19-C1'-C2' 108.62 -2.987 . 0.68 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.352 0 N19-C1'-C2' 108.736 -2.915 . 0.769 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.666 0 O4'-C1'-N19 111.016 2.816 . 0.796 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.308 0 C4'-C3'-C2' 99.956 -2.744 . 0.745 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.666 0 C4'-C3'-C2' 99.899 -2.801 . 0.639 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.641 0 C4'-C3'-C2' 99.835 -2.865 . 0.591 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.396 0 C4'-C3'-C2' 99.823 -2.877 . 0.507 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.574 0 O4'-C1'-N19 112.063 3.863 . 0.148 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.51 1 C5'-C4'-C3' 108.698 -4.534 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ' U' . . . . . 0.425 ' C6 ' ' CE2' ' B' ' 288' ' ' PHE . . . . . . . . 0 O4'--C4' 1.422 -2.589 0 O4'-C1'-N19 112.135 3.935 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.626 3.255 0 O4'-C1'-N19 110.654 2.454 . 0.67 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.338 0 N19-C1'-C2' 108.814 -2.866 . 0.328 2h . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.418 0 N19-C1'-C2' 108.79 -2.881 . 0.653 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.621 0 O4'-C1'-N19 110.818 2.618 . 0.743 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.59 0 C5'-C4'-C3' 111.59 -2.607 . 0.778 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.48 0 O4'-C1'-N19 110.897 2.697 . 0.673 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.54 0 C4'-C3'-C2' 100.397 -2.303 . 0.75 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.571 0 C5'-C4'-C3' 111.373 -2.751 . 0.786 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.777 0 C5'-C4'-C3' 112.056 -2.296 . 0.789 1a . 0.0 . . . . . . . . . . 0 0 . 1 stop_ save_